Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7187854821098385,-2.1512288791410166,0.0,0.004903319334001322,0.004,14/35,5.68%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;HOXB3;PCSK5;HOXA3;HOXB4;SULF2;RBP4;DYNC2I1;WNT9A;SIX1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.8850700394066952,-2.117553547753933,0.0,0.0044129874006011895,0.007,5/13,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,collagen fibril organization (GO:0030199),-0.5955703879795421,-2.1053046764232946,0.0,0.004249543422801145,0.011,41/88,8.48%,COL1A2;COL3A1;COL5A2;COL4A5;ADAMTS2;COL1A1;COL5A1;COL4A6;COL8A1;COL12A1;COL22A1;COL25A1;COL4A3;LOXL1;COL6A2;COL4A4;PLOD2;COL6A3;COL26A1;COL6A1;COL8A2;COL18A1;COL13A1;COL23A1;COL11A1;COL15A1;LOXL3;TGFBR1;P4HA1;SERPINH1;CYP1B1;COL20A1;COL27A1;TLL1;COL16A1;LOX;ATP7A;COL9A2;LUM;COL5A3;DPT
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.8916561900604107,-2.0617202338229386,0.0,0.008580808834502313,0.032,5/12,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.6312983428223118,-2.056650007006841,0.0,0.007845310934402116,0.036,20/50,10.29%,ZIC1;GLI3;FGFR2;GPC3;DCDC2;TULP3;GAS1;SMO;FBXL17;IFT81;SUFU;RORA;GLIS2;GLI1;MGRN1;IFT122;EVC;FUZ;ARMC9;BTRC
prerank,ureteric bud development (GO:0001657),-0.792581311561147,-2.0496262832654613,0.0,0.0073549790010019826,0.041,14/17,14.40%,BMP7;FGFR2;GPC3;BMP4;OSR1;SLIT2;SALL1;FOXC1;PKD2;SIX1;ROBO2;BMP2;NPNT;WNT11
prerank,mesonephric tubule development (GO:0072164),-0.8206728004844744,-2.0480653810614067,0.0,0.006304267715144557,0.041,13/15,14.40%,BMP7;FGFR2;BMP4;OSR1;SLIT2;PKD1;SALL1;FOXC1;PKD2;SIX1;ROBO2;NPNT;WNT11
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8001370584703631,-2.023923268781804,0.0,0.008335642867802247,0.063,10/17,12.08%,ATP1A2;CACNA1C;ANK2;CACNA2D1;KCNJ2;CACNA1G;SLC8A1;CACNA1D;TRPM4;CACNB2
prerank,skeletal system development (GO:0001501),-0.5204773780777031,-2.010973191548453,0.0,0.009697676016135947,0.081,51/148,14.60%,BMP6;COL1A2;SULF1;IGF1;SOX5;FBN1;COL1A1;GLI2;BMP5;BMP7;EXT1;CDH11;FGFR2;ITGB8;PCSK5;PKD1;MMP14;NPR3;COL13A1;MMP16;GJA1;SULF2;WWOX;CREB3L2;RBP4;SH3PXD2B;TGFBR1;SUFU;TNFRSF11B;PRELP;PAPSS2;AKAP13;IGF2;TLL1;GNAS;ATP7A;COL9A2;PTH1R;MYOC;SOX6;EVC;PAPSS1;CHRD;PTHLH;PKDCC;BMP2;CMKLR1;P3H1;COMP;WNT11;DDRGK1
prerank,establishment of endothelial barrier (GO:0061028),0.7994250839325114,1.9983027568867497,0.0,0.08502381785292103,0.064,15/29,8.79%,PECAM1;TJP1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;TJP2;F11R;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;SOX18;RAP1B;MSN
prerank,retinoid metabolic process (GO:0001523),-0.5773205202338022,-1.991999515821202,0.0,0.013140895815123543,0.119,17/71,8.01%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;CYP26B1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;CYP1B1;SCPEP1;SDC4;APOE
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.841028879679017,1.9358720008653088,0.0,0.15638309355090832,0.218,5/19,6.45%,SLCO1C1;PDGFB;APP;KLF2;KLF4
prerank,positive regulation of developmental growth (GO:0048639),0.6923777534034681,1.924052410980352,0.0,0.1309096878052911,0.263,15/49,12.62%,PLCB1;SEMA7A;INSR;MACF1;NTN1;NEDD4L;AGRN;ITSN2;DBNL;RASAL1;TWF2;SMURF1;CPNE5;SYT4;CPNE6
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.763241141801871,-1.9138495016096793,0.0,0.049568100903722455,0.384,9/16,12.61%,FOXD1;BMP4;FGF1;SALL1;PKD2;FGF2;SIX1;BMP2;NPNT
prerank,ceramide biosynthetic process (GO:0046513),0.7112763314816049,1.9098029442450015,0.0016025641025641025,0.13335580954907553,0.337,7/40,2.43%,SGMS1;ST8SIA4;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4
prerank,glycerolipid catabolic process (GO:0046503),0.820962394760646,1.9054335134595333,0.0,0.1176162813632074,0.368,5/19,5.89%,GPCPD1;ABHD2;PLA2G4B;PNPLA6;GDPD1
prerank,angiogenesis involved in wound healing (GO:0060055),0.8987479859147778,1.900541704401003,0.0,0.10796675282910605,0.398,6/11,4.52%,NDNF;KDR;ADIPOR2;CD34;PRCP;GATA2
prerank,hemopoiesis (GO:0030097),0.6311175193399118,1.8971030489812304,0.0,0.09904985583205934,0.418,18/87,5.83%,FLT1;MECOM;KITLG;TEK;PDGFB;KDR;CD34;TGFB2;NOTCH4;RASGRP4;TIRAP;FLT4;SNRK;ZFPM1;ZBTB16;TAL1;PLD4;ETV6
prerank,eye development (GO:0001654),-0.5848445267199969,-1.8964394249507832,0.0,0.061618379630616615,0.478,14/54,6.50%,CACNA1C;PBX1;FBN1;COL5A2;SMOC1;COL5A1;EFEMP1;LAMA1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,maintenance of blood-brain barrier (GO:0035633),0.7310317685145385,1.893467170957993,0.0,0.09286827723816075,0.436,12/30,3.99%,OCLN;SLC1A1;MFSD2A;PECAM1;ESAM;TJP1;CLDN5;JAM2;TJP2;F11R;ACTB;LSR
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7707908923439915,-1.8913871143533825,0.0,0.061480080880170415,0.504,7/16,8.16%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP6;IGFBP4;IGFBP3
prerank,membrane lipid biosynthetic process (GO:0046467),0.6641875338409526,1.8844746007330189,0.0,0.1022310190850598,0.498,15/58,5.12%,SGMS1;CERT1;SGPP2;ELOVL7;ST8SIA6;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.5672329083538514,-1.8769782674262505,0.0,0.07200874679076227,0.588,20/55,12.24%,GPC6;DCN;SDC2;OGN;CEMIP;FMOD;GPC3;BGN;CEMIP2;GPC4;FGF2;PRELP;CSPG4;SDC4;LUM;OMD;ARSB;SLC9A1;HEXA;GNS
prerank,extracellular matrix organization (GO:0030198),-0.44990840585027436,-1.8731053282902193,0.0,0.07171921745865933,0.605,99/276,9.26%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;GSN;COL8A1;COL12A1;TIMP2;ADAMTS10;COL22A1;NID1;VTN;COL25A1;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;PLOD2;COL6A3;COL26A1;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;SH3PXD2B;COL15A1;DDR1;CDH1;LOXL3;DAG1;TGFBR1;P4HA1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;SERPINH1;FGF2;ADAMTSL4;SCUBE1;CYP1B1;ST7;TNC;SPP1;COL20A1;CTSL;COL27A1;ADAMTS15;TLL1;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19;COL5A3;DPT;KLK2;LAMB1;CREB3L1;ITGB4
prerank,monocyte chemotaxis (GO:0002548),0.7280460290447545,1.8702983223012366,0.0,0.12065284628652602,0.603,4/32,2.32%,FLT1;PDGFB;IL6R;TNFRSF11A
prerank,sphingolipid metabolic process (GO:0006665),0.6023325609537544,1.8682736765142007,0.0,0.11382517606500356,0.614,34/108,13.93%,SGMS1;ST6GALNAC3;CERT1;SGPP2;ELOVL7;ESYT2;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1;NEU4;ESYT1;GAL3ST1;SPTLC2;CERKL;ELOVL5;ENPP2;GLB1;ORMDL1;GLTP;ORMDL3;ELOVL6;B4GALNT1;CERK;HACD2;DEGS1;SPTLC1;NEU2
prerank,regulation of interleukin-4 production (GO:0032673),0.7735737368807394,1.866767264108018,0.0,0.10737630964957189,0.631,5/21,8.41%,LEF1;SLC7A5;ZFPM1;LGALS9;FOXP3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7039859267494716,-1.8665520499310067,0.0,0.07471432835184515,0.645,12/22,20.69%,TIMP2;TIMP3;PTPN3;ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;TIMP4;ADAM8
prerank,regulation of cell junction assembly (GO:1901888),0.7565091595429518,1.8653222077768072,0.0,0.1023867403631787,0.642,11/27,7.23%,PRKCH;OCLN;TJP1;CLDN5;RAPGEF2;F11R;MEF2C;RAPGEF1;APLNR;SNAI2;RAP1B
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.7045005571514728,-1.86046668589741,0.0023923444976076554,0.0774147593674091,0.676,8/20,10.27%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA;SLC9A1
prerank,extracellular structure organization (GO:0043062),-0.4641497556304947,-1.858609163358076,0.0,0.07485734183242018,0.685,78/204,8.12%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;COL8A1;ADAMTS10;COL22A1;NID1;VTN;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;COL6A3;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;COL15A1;DDR1;CDH1;DAG1;TGFBR1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;FGF2;ADAMTSL4;ST7;TNC;SPP1;COL27A1;ADAMTS15;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19
prerank,organic anion transport (GO:0015711),0.625612328472505,1.856222664497045,0.0,0.11285899631667493,0.691,9/76,2.53%,SLCO1C1;ABCC4;ABCG2;CA4;ABCC6;SLCO2B1;SLC39A8;SLC16A2;LRRC8C
prerank,sulfur compound catabolic process (GO:0044273),-0.6016558363075287,-1.8517705187546782,0.0,0.0792273176599161,0.726,12/38,12.24%,DCN;OGN;FMOD;BGN;PRELP;CSPG4;GGT5;LUM;OMD;ARSB;HEXA;GNS
prerank,bile acid and bile salt transport (GO:0015721),0.781950587345913,1.8488450159366223,0.0033444816053511705,0.12260974368155357,0.738,6/24,7.18%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;ABCB11;NCOA2
prerank,external encapsulating structure organization (GO:0045229),-0.46096529118784213,-1.840306960992907,0.0,0.08845588078538386,0.78,77/205,8.12%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;COL8A1;ADAMTS10;COL22A1;NID1;VTN;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;COL6A3;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;COL15A1;DDR1;CDH1;DAG1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;FGF2;ADAMTSL4;ST7;TNC;SPP1;COL27A1;ADAMTS15;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7033316356211755,1.8399514221655775,0.0032679738562091504,0.13493735377997063,0.781,11/34,5.18%,FLT1;SEMA6A;KDR;DAB2IP;FLT4;PRKD1;NOTCH1;PRKD2;RAMP2;DLL4;GAB1
prerank,cellular response to interleukin-4 (GO:0071353),0.8810251958788415,1.8378653048481746,0.0,0.13140585854439543,0.798,3/10,5.83%,LEF1;JAK3;TCF7
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.8375389351674062,1.8365584363635394,0.003683241252302026,0.12018404328082068,0.803,2/14,1.07%,ABCG2;SLCO2B1
prerank,heme catabolic process (GO:0042167),0.8375389351674062,1.8365584363635394,0.003683241252302026,0.12018404328082068,0.803,2/14,1.07%,ABCG2;SLCO2B1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7607686796342814,-1.831987100139974,0.0,0.094844205403397,0.816,6/13,9.50%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2;TGFB3
prerank,endodermal cell differentiation (GO:0035987),-0.6160065240987718,-1.8277034779590737,0.0,0.09655081524951695,0.833,12/31,10.36%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;CTR9;MMP2;ITGA5;LAMB1;ITGAV
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7331252851798266,-1.819798947172469,0.0023094688221709007,0.10267124309804507,0.861,7/16,10.12%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.7555852858788588,-1.8180403862331909,0.002257336343115124,0.10092665629152721,0.868,5/13,11.96%,DCN;BGN;CSPG4;ARSB;HEXA
prerank,cardiac muscle cell action potential (GO:0086001),-0.6276428618348452,-1.8171729944220758,0.0,0.09798793357068242,0.869,9/30,7.86%,ATP1A2;CACNA1C;ANK2;DMD;CACNA2D1;KCNJ2;CACNA1G;SLC8A1;CACNA1D
prerank,cardiac muscle cell contraction (GO:0086003),-0.6841658311429192,-1.816301770952465,0.002232142857142857,0.0950489593975641,0.872,7/19,7.86%,CACNA1C;GSN;CAMK2D;CACNA2D1;KCNJ2;CACNA1G;CACNA1D
prerank,organic hydroxy compound transport (GO:0015850),0.7023313395310415,1.8145245332276048,0.0,0.16822569675185087,0.908,7/36,7.18%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;OSBP;ABCB11;NCOA2
prerank,neutral amino acid transport (GO:0015804),0.7273070082636724,1.8098549429001474,0.001658374792703151,0.1726504056401151,0.925,5/28,2.87%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,diterpenoid metabolic process (GO:0016101),-0.5487890091042733,-1.809522264097368,0.0032258064516129032,0.10035460236922705,0.898,13/55,8.01%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;SDC4;APOE
prerank,response to interleukin-4 (GO:0070670),0.8795105455384273,1.795296498329114,0.0019305019305019305,0.20943096259009553,0.96,3/10,5.83%,LEF1;JAK3;TCF7
prerank,regulation of JNK cascade (GO:0046328),0.5861880432374479,1.794644716213409,0.0,0.202261628805396,0.961,19/101,5.25%,IGF1R;MECOM;PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;TIRAP;SH3RF1;FLT4;PHLPP1;TPD52L1;NOD2;MEN1;DUSP3;WNT7A;CCR7
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.8665790463192453,1.7917908052779583,0.0037174721189591076,0.20285940668281255,0.965,3/10,3.20%,NAMPT;KDR;NOD2
prerank,glycerophospholipid catabolic process (GO:0046475),0.712649866680296,1.787554838843699,0.0,0.20697226517339634,0.971,9/27,14.91%,GPCPD1;PLA2G4B;PNPLA6;INPP5F;GDPD1;ENPP2;LIPC;PNPLA8;PRDX6
prerank,kidney development (GO:0001822),-0.5310764974568656,-1.782735121260176,0.0,0.13844872376648018,0.965,19/65,8.22%,SULF1;GLI2;WNT4;BMP7;BMP4;KANK2;OSR1;PCSK5;PKD1;GREB1L;SULF2;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;ACE;AGTR1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.5982270389263,-1.779290312274503,0.005235602094240838,0.14084362086976213,0.969,7/35,4.82%,LGR4;ADCY5;ADCY1;ADCY9;EDNRA;ADCY2;ADCY7
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.6457884139303119,-1.7786496950656214,0.0,0.13693336460087693,0.97,11/23,15.15%,GLI3;ENPP1;GPC3;TULP3;SUFU;GLIS2;MGRN1;IFT122;BTRC;KIF7;PTCH2
prerank,blood vessel morphogenesis (GO:0048514),0.6244971958684855,1.777229746809643,0.005891016200294551,0.23163540120186815,0.986,20/54,9.09%,FLT1;SLC1A1;EGFL7;KDR;ENG;RASIP1;CAV1;TBX1;SOX17;FLT4;ID1;APLNR;CDH2;RAMP2;SMAD7;COL4A1;SOX18;TGFB1;LRP5;CCM2
prerank,sphingolipid biosynthetic process (GO:0030148),0.6084878739294678,1.7735165924016987,0.0,0.23550247960848758,0.987,17/71,7.79%,SGMS1;CERT1;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1;TLCD3B;SPTLC2;ELOVL5
prerank,myeloid cell differentiation (GO:0030099),0.6408260125724791,1.7734543459595786,0.0,0.22730857425985007,0.987,13/47,7.67%,MFHAS1;RASGRP4;TIRAP;SNRK;JAK3;ZFPM1;LYN;ZBTB16;KLF1;SLC25A5;TAL1;CDKN2B;KAT6A
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.7170072781312029,1.7710166916453403,0.008319467554076539,0.22809139969985173,0.988,5/23,7.37%,PIK3R6;CADM1;LGALS9;PVR;CD160
prerank,amide transport (GO:0042886),0.7231270318698156,1.7701333456708346,0.0016313213703099511,0.22349117835624954,0.988,5/26,1.98%,CERT1;ABCG2;PLTP;AQP11;SLC38A5
prerank,dendritic spine organization (GO:0097061),0.7210534521562223,1.7681149052243703,0.00676818950930626,0.2223875665884198,0.99,6/26,6.12%,IGF1R;SHANK3;INSR;WNT7A;DIP2A;FYN
prerank,ganglioside biosynthetic process (GO:0001574),0.8049913716133448,1.7680406837459302,0.0035087719298245615,0.21565937132485696,0.99,5/15,2.10%,ST8SIA4;ST6GALNAC3;ST8SIA6;ST3GAL1;B4GALT5
prerank,positive regulation of neuron migration (GO:2001224),0.8527562265973071,1.7649314845267272,0.003629764065335753,0.21826460600338599,0.992,4/11,2.67%,SEMA6A;DAB2IP;RAPGEF2;ARHGEF2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.5465654660964694,-1.7648824707357265,0.0,0.15646333823206798,0.981,13/53,12.85%,EYA2;EYA1;EGFR;EYA4;DDX5;PLA2R1;PRKCD;FBH1;ATM;FXR2;SPRED1;TMEM161A;FMR1
prerank,protein targeting to ER (GO:0045047),0.5789845433876566,1.7626696324274578,0.0,0.2189899174110949,0.992,70/99,32.25%,SEC62;RPL38;RPL13;RPS29;RPL36A;ZFAND2A;RPL3;RPL27;RPSA;SRP14;SGTB;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;GET3;RPS9;SPCS2;RPL11;EDEM1;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;SPCS1;RPL18A;RPS21;RPL10A;RPL24;SRPRA;RPL7A;ZFAND2B;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7610185519020334,1.761964063407629,0.0016863406408094434,0.21498879657095743,0.992,7/19,5.99%,PRKCH;OCLN;TJP1;CLDN5;F11R;IKBKB;SNAI2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7365965674145366,-1.7605772909571749,0.01348314606741573,0.16082887415524336,0.985,6/14,10.18%,SULF1;SULF2;THBS1;FGF2;CREB3L1;FUZ
prerank,purine ribonucleotide transport (GO:0015868),0.7759246076805685,1.7599501728836138,0.007067137809187279,0.21534306247867793,0.993,3/16,2.53%,ABCC4;ABCC6;LRRC8C
prerank,adenine nucleotide transport (GO:0051503),0.7645293699225986,1.7599387185083475,0.0070052539404553416,0.20952297970898393,0.993,4/17,5.07%,ABCC4;ABCC6;LRRC8C;SLC25A5
prerank,relaxation of cardiac muscle (GO:0055119),-0.7687000157803412,-1.7592093463601688,0.0,0.15910528311662472,0.985,6/13,7.24%,ATP1A2;GSN;CAMK2D;KCNJ2;P2RX4;SLC8A1
prerank,ureteric bud morphogenesis (GO:0060675),-0.7021699291208638,-1.7580277811455076,0.002288329519450801,0.15656010202917162,0.985,9/16,17.88%,BMP4;SALL1;PKD2;FGF2;SIX1;BMP2;NPNT;WNT11;PAX2
prerank,phospholipid catabolic process (GO:0009395),0.714936550645524,1.756667539026371,0.005244755244755245,0.21439746550694275,0.995,5/24,8.63%,GPCPD1;PLA2G4B;PNPLA6;GDPD1;ENPP2
prerank,embryonic eye morphogenesis (GO:0048048),-0.7744021090954742,-1.756243420106385,0.006622516556291391,0.15592555482124204,0.989,10/11,22.61%,FBN1;EFEMP1;MFAP5;KDM2B;FBN2;LRP6;MFAP2;TBX2;RARG;ALDH1A3
prerank,vascular transport (GO:0010232),0.598621087836173,1.7548539787473985,0.0028530670470756064,0.21419461805255102,0.995,16/81,3.10%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,transport across blood-brain barrier (GO:0150104),0.5945058591009554,1.7544409295831018,0.002844950213371266,0.21000376915517605,0.995,16/83,3.10%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,regulation of epithelial cell migration (GO:0010632),0.6397260956157056,1.7541555143211676,0.0014749262536873156,0.20569641415520845,0.996,17/51,8.63%,PTPRG;DAB2IP;MACF1;BMPR2;TGFB2;DOCK1;MCC;PTK2;EVL;VIL1;PLCG1;RREB1;INSL3;RAB11A;PTPRR;PTN;ENPP2
prerank,positive regulation of axon extension (GO:0045773),0.7227128247223249,1.7529125242213879,0.005154639175257732,0.20460663649980143,0.996,5/22,8.14%,SEMA7A;MACF1;NTN1;DBNL;TWF2
prerank,regulation of protein import into nucleus (GO:0042306),-0.5859809145971477,-1.7494431923907536,0.002652519893899204,0.16428843835201096,0.992,13/36,14.13%,ZIC1;SMAD3;BMP4;MDFIC;APOD;CDH1;PRKCD;SUFU;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,relaxation of muscle (GO:0090075),-0.7575601258635768,-1.7446523024850407,0.0,0.16904524709329963,0.992,6/13,7.24%,ATP1A2;GSN;CAMK2D;KCNJ2;P2RX4;SLC8A1
prerank,ceramide transport (GO:0035627),0.8058060466901342,1.7422091670770345,0.0035026269702276708,0.23294454636558867,0.999,2/12,0.53%,CERT1;PLTP
prerank,membrane depolarization during action potential (GO:0086010),-0.6227959291688976,-1.7389487780250243,0.004830917874396135,0.1760807779783738,0.993,7/26,7.86%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1G;SLC8A1;CACNA1D
prerank,regulation of acrosome reaction (GO:0060046),0.8344359714339418,1.7374644961223524,0.0018214936247723133,0.24262613822910117,0.999,1/10,0.22%,PLCB1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5998340947093432,1.7364050896898544,0.0014534883720930232,0.24078835188241257,0.999,39/70,21.62%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.6406044722364567,-1.7361169264736027,0.002403846153846154,0.17719841716260162,0.995,7/23,13.30%,ATP1A2;ANK2;CAMK2D;CACNA2D1;DIAPH1;PTK2B;CACNB1
prerank,positive regulation of vasculature development (GO:1904018),0.5612672249118069,1.7357243743272086,0.0027662517289073307,0.23777623595203534,0.999,18/94,5.30%,FLT1;TEK;ETS1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD1;PRKD2;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB
prerank,cellular component maintenance (GO:0043954),0.8278224369229529,1.7316416468669984,0.00546448087431694,0.24460499573796274,0.999,3/12,6.12%,IGF1R;INSR;FYN
prerank,renal system development (GO:0072001),-0.5359954264647048,-1.7303399837351547,0.002840909090909091,0.1850757882618799,0.998,18/52,8.22%,SULF1;GLI2;WNT4;BMP4;PCSK5;PKD1;GREB1L;SULF2;RBP4;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;TBX18;ACE;AGTR1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7350228546364128,1.7296910435897803,0.008547008547008548,0.2451393557887418,0.999,3/21,3.43%,SLC39A10;PRKCH;PRKD2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5934771013424672,1.7262535584333436,0.0014347202295552368,0.2513945246039963,0.999,39/71,21.62%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,negative regulation of blood pressure (GO:0045776),0.8071917673491691,1.7235553667702583,0.009242144177449169,0.25523340368800673,0.999,5/13,4.86%,BMPR2;NOS3;PRCP;NOS2;NPPA
prerank,positive regulation of lymphocyte migration (GO:2000403),0.8112489644320868,1.7234714663810167,0.007462686567164179,0.25060591690682393,0.999,3/12,1.57%,CXCL12;JAM2;APP
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5857369242945938,1.7226259132992987,0.0014144271570014145,0.2484338340789448,0.999,39/73,21.62%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,positive regulation of JNK cascade (GO:0046330),0.5933383741489623,1.7212688190085936,0.0,0.2485781700749371,0.999,14/70,5.25%,PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;TIRAP;SH3RF1;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.5336685547621851,1.7202792403349054,0.0,0.24712390091995384,0.999,33/138,9.30%,PTPRG;FLT1;IGF1R;TEK;MPZL1;KDR;INSR;TIE1;BMPR2;RASGRP4;FES;FLT4;NEDD9;PTK2;MTSS1;JAK3;RAPGEF1;ZAP70;MERTK;LYN;NPPA;CD4;EPHA4;FYN;RET;YES1;EPHB4;HCK;PTN;SHC3;CD8B;NPR1;LIFR
prerank,cell junction assembly (GO:0034329),0.564853995199385,1.7200330029503028,0.0,0.24349570000259696,0.999,25/100,9.63%,SPOCK2;DNM3;ITGA6;SHANK3;TJP1;CLDN5;LIMS2;ADGRL3;GJC1;PLXND1;CDH2;ACTB;CDH20;CTNND1;CDH8;DBNL;DCHS1;CDH19;PKP4;SLITRK1;GPM6A;OPHN1;NRXN1;DNER;ACTG1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7262341284616369,1.7189266190277273,0.008333333333333333,0.24270829637096586,0.999,7/21,11.53%,SLC39A10;PRKCH;LYN;CD19;ELF2;CBFB;PRKCB
prerank,lipid transport (GO:0006869),0.5687940861373849,1.7180615955384553,0.002702702702702703,0.2412204556629238,0.999,20/97,7.36%,SLCO1C1;ABCC4;CERT1;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;PPARD;NCOA1;SCARB1;OSBP;ABCG1;PITPNC1;PRELID2;PITPNA;ABCA3;ABCB11;NCOA2;CHKA
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6694185846562436,1.7165322404413172,0.010033444816053512,0.24208752078319382,0.999,12/33,10.12%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;FBXW7;TGFA;SHKBP1;ADAM17;CNOT9;PTK6
prerank,cardiac conduction system development (GO:0003161),-0.6265942533684336,-1.7151744670168316,0.0024096385542168677,0.21275622183386222,0.999,7/24,5.68%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;CACNA1G;TBX18
prerank,regulation of angiogenesis (GO:0045765),0.5155776862533133,1.712707773476659,0.0,0.250113446424079,0.999,40/192,7.37%,FLT1;TEK;PTPRM;ETS1;SEMA6A;CLDN5;PIK3R6;KDR;PPP1R16B;TIE1;DAB2IP;CD34;TGFB2;NOS3;STAB1;RGCC;COL4A2;PLXND1;SP100;CD40;AMOT;APLNR;PRKD1;PRKD2;RAMP2;VASH1;RAPGEF3;PLCG1;HHEX;SARS1;CTNNB1;GATA2;TSPAN12;FGF16;GAB1;RHOB;KLF4;STAT1;GTF2I;CD160
prerank,negative regulation of reproductive process (GO:2000242),-0.6779928331130394,-1.7121007994442012,0.002188183807439825,0.21497552908642936,0.999,3/17,3.09%,SULF1;IGF1;GJA1
prerank,amino acid import (GO:0043090),0.7352819211991101,1.7096136808842555,0.0017482517482517483,0.2549364951177267,0.999,6/21,1.67%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SH3BP4;SLC16A2
prerank,digestive tract development (GO:0048565),-0.5760955357367838,-1.7085554982976714,0.007334963325183374,0.2177301845660959,0.999,13/32,7.73%,GLI3;CLMP;RARB;GLI2;FGFR2;PCSK5;COBL;PKD1;SMO;SALL1;KIT;GLI1;CHD8
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6474496721947972,1.7069475066195492,0.006309148264984227,0.259369105554061,0.999,6/36,4.52%,LEF1;PLCB1;FZD6;FZD4;CALM1;CTNNB1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.8240175832239491,1.706888012012536,0.003703703703703704,0.2552510353553034,0.999,3/11,5.83%,MECOM;CD34;ETV6
prerank,smooth muscle contraction (GO:0006939),-0.7045684164135919,-1.7049591803916184,0.004597701149425287,0.22111741414830507,0.999,7/14,9.85%,ROCK2;MYLK;EDNRA;SLC8A1;MYH11;BDKRB2;ACTA2
prerank,organic acid transport (GO:0015849),0.5584168247838444,1.7049243125564977,0.0,0.25711189665538453,0.999,11/94,2.87%,SLCO1C1;SLC6A6;ABCC4;SLC7A1;ABCG2;MFSD2A;SLCO2B1;PPARD;SLC38A5;NCOA1;SLC43A2
prerank,T-helper cell differentiation (GO:0042093),0.7818419894316668,1.7046410296822483,0.015957446808510637,0.25407508069329915,0.999,2/14,3.19%,LEF1;ZFPM1
prerank,tight junction assembly (GO:0120192),0.6156851898820302,1.7044423721375697,0.007763975155279503,0.250820262666117,0.999,10/49,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;LSR;MARVELD2;CLDN14
prerank,skeletal system morphogenesis (GO:0048705),-0.5506994651649298,-1.704210704931819,0.0029411764705882353,0.21790351120301873,0.999,18/42,16.74%,PDGFRA;HOXC4;FGFR2;HOXB3;CYP26B1;HOXA3;HOXB4;WWOX;DYNC2I1;TGFBR1;SIX1;SFRP4;FUZ;FBN2;SKI;HOXA9;LRP6;RFLNA
prerank,lung development (GO:0030324),-0.5642889442481227,-1.7012368625888654,0.01098901098901099,0.2201803568763724,1.0,11/33,6.13%,GLI2;ERRFI1;PDPN;FGFR2;BMP4;FGF1;PKD1;RBP4;LOXL3;FGF2;RCN3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6029368691245299,1.6986162939883147,0.007751937984496124,0.26447253587186564,1.0,25/54,14.67%,ETS1;PDGFB;KDR;NOS3;RGCC;MEF2C;CD40;ACVRL1;PRKD1;PRKD2;VASH1;TMSB4X;PLCG1;PRCP;GATA2;TGFB1;ADAM17;AGTR2;HSPB1;HIF1A;ATP5F1A;PPARG;CSNK2B;SP1;NUS1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5597101234767362,1.6975154979982459,0.0013850415512465374,0.2637128223952717,1.0,16/93,5.25%,PLCB1;MFHAS1;DAB2IP;TGFB2;MAP4K2;TNFRSF19;APP;XDH;ANKRD6;TIRAP;SH3RF1;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6172376306887172,-1.6958066337316573,0.011961722488038277,0.22851554615311692,1.0,7/21,9.50%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2;CCN3;TGFB3
prerank,bicellular tight junction assembly (GO:0070830),0.6178898706888769,1.6955678618247434,0.007739938080495356,0.26583339688993635,1.0,9/46,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;CLDN14
prerank,neurotransmitter uptake (GO:0001504),-0.729827284914145,-1.6941183340273647,0.008528784648187633,0.2277387525671364,1.0,2/12,0.90%,ATP1A2;SLC1A3
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7081524103426066,1.6922113023532663,0.012006861063464836,0.2727040672680818,1.0,6/20,12.39%,PLCB1;AGRN;GNAQ;LYPD1;CHRM3;GNB1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7044721627180655,-1.6918353003568407,0.01276595744680851,0.2281944777399309,1.0,4/14,7.08%,ANK2;ACTN2;ATP1B3;ATP1B2
prerank,chordate embryonic development (GO:0043009),-0.5146439697906007,-1.6909343308031668,0.002932551319648094,0.22570959558274883,1.0,16/55,6.93%,SULF1;ALDH1A2;COL1A1;BMP5;BMP7;FGFR2;ARNT2;PCSK5;PKD1;SULF2;RBP4;TGFBR1;PKD2;IGF2;DACT1;ZNF568
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5829546808052319,1.6907009931552042,0.007132667617689016,0.27316070460196107,1.0,17/67,6.86%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;FYN;MAPK3;AATK;HCK
prerank,alanine transport (GO:0032328),0.8115251427511543,1.690365792753837,0.022018348623853212,0.2702115096553094,1.0,1/10,0.07%,SLC6A6
prerank,carboxylic acid transport (GO:0046942),0.597277970585264,1.6887786263950229,0.004511278195488722,0.2716741534404264,1.0,7/55,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A4;SLC16A2;SLC38A5
prerank,ceramide metabolic process (GO:0006672),0.6089892159222331,1.6886293124002698,0.0030627871362940277,0.26827149833958186,1.0,16/49,15.00%,SGMS1;ST6GALNAC3;SGMS2;DEGS2;ACER2;CERS4;ACER1;TLCD3B;SPTLC2;ORMDL1;ORMDL3;CERK;DEGS1;SPTLC1;CLN8;FA2H
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6540548628903398,1.6860011275190294,0.0049504950495049506,0.27270267962253636,1.0,11/34,5.25%,FLT1;TEK;PDGFB;DAB2IP;PTK2;PIK3R3;NOD2;PIK3IP1;PRKD1;CD19;CCR7
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.4354024386272612,-1.6828789156034747,0.0,0.240820279760912,1.0,36/152,13.00%,RNF220;WLS;SULF1;ZEB2;EGFR;LGR4;COL1A1;PTK7;FGFR2;GPC3;WNT5B;RSPO3;LRRK1;KANK1;SULF2;SALL1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;RSPO2;SFRP4;DACT1;TNKS2;PSME4;UBR5;SMURF2;AXIN1;PPM1B;TRPM4;PSME3;LRRK2;CAPRIN2;BMP2;SCEL;SKI
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.7490117574575171,1.6823715253352085,0.01916376306620209,0.28028169034435935,1.0,2/16,0.95%,IGF1R;INSR
prerank,positive regulation of cell motility (GO:2000147),0.4969855901536688,1.6819100690468802,0.0,0.2780587827589732,1.0,33/205,6.46%,LEF1;SPOCK2;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;CXCL12;PDGFD;CAV1;NTN1;NEDD9;SEMA6B;PTK2;PIK3R3;TIAM1;NOTCH1;VIL1;RIPOR1;SEMA4F;CCR7;SNAI2;ACTN4;FAM107A;ADAM10;RET
prerank,nuclear migration (GO:0007097),-0.7161095989744454,-1.6814503142880302,0.013015184381778741,0.23977231543266467,1.0,7/13,17.33%,DOCK7;SYNE2;CLMN;SYNE3;PCM1;FBXW11;SUN2
prerank,phospholipid transport (GO:0015914),0.6049837075799145,1.6796796857314273,0.004545454545454545,0.2816512556148247,1.0,15/52,9.75%,ATP10A;MFSD2A;PLTP;ATP8A1;ATP11B;SCARB1;ABCG1;PITPNC1;ATP11A;PRELID2;PITPNA;ABCA3;ABCA7;ATP11C;ATP10B
prerank,positive regulation of angiogenesis (GO:0045766),0.5320043981467499,1.6782270648281872,0.0013513513513513514,0.2825822126931026,1.0,19/108,5.30%,FLT1;TEK;ETS1;TJP1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD1;PRKD2;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.516562420451854,1.677132291962124,0.0,0.28265678807313,1.0,36/151,13.84%,SGMS1;CERT1;MFSD2A;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;B4GALT5;GCH1;CERS4;ALAS1;PPM1L;PRKD1;PRKD2;PRKD3;SLC44A5;MGST2;ACER1;GSTA4;SPTLC2;GPHN;CHKA;ELOVL5;HPGDS;LPCAT3;GSTK1;SLC25A15;ELOVL6;CEPT1;CSNK2B;LPIN3;HACD2;DEGS1;SPTLC1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6946067217362553,-1.673990661420932,0.015283842794759825,0.25339984256282305,1.0,5/13,3.44%,FSTL1;FBN1;NBL1;LTBP1;GREM2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.7973085805434746,1.672745382220993,0.005504587155963303,0.2928387297925383,1.0,4/12,8.62%,IGF1R;INSR;IRGM;FYCO1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.8050747797382347,1.6717244699117895,0.015209125475285171,0.2922475056035073,1.0,4/11,2.47%,TJP1;RAPGEF2;TJP2;F11R
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6912319259796499,-1.6707869431054325,0.020689655172413793,0.25611671321266904,1.0,6/15,10.98%,IGF1;ROCK2;CAMK2D;PRKCA;SLC9A1;PARP1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6480074935838936,-1.669362424525722,0.011363636363636364,0.2553648709147888,1.0,10/20,9.01%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2;ACE;IGFBP3;CCN4
prerank,apical junction assembly (GO:0043297),0.5920020031403899,1.6690518019207545,0.00909090909090909,0.29737351856775845,1.0,10/53,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;PKN2;CLDN14
prerank,positive regulation of isotype switching (GO:0045830),0.7411084885458713,1.6669856590856509,0.02120141342756184,0.3003760266114885,1.0,4/15,8.09%,TFRC;CD40;SHLD1;TGFB1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.7029997923047517,-1.6660707047350716,0.013422818791946308,0.25940310462343424,1.0,2/12,3.28%,NUPR1;IL18
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7759226187736863,1.6655721192165667,0.013011152416356878,0.30155981655147407,1.0,6/13,7.04%,KDR;ENG;NOTCH4;CTNNB1;DLL4;COL4A1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.5574259185633149,1.6636173877749574,0.0103397341211226,0.3045138753690331,1.0,13/75,4.52%,TEK;EGFL7;JCAD;PDGFB;KDR;PPP1R16B;BMPR2;FLT4;APLNR;PRKD1;PRKD2;PLCG1;GATA2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6601450808954537,1.6635449202045172,0.009554140127388535,0.301196639351343,1.0,9/30,12.47%,DACH1;BMPR2;ACVRL1;MEN1;TERF2;HNRNPC;ACD;DCP2;TERF1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6699965551737419,1.6628186593032612,0.009966777408637873,0.30011965042883837,1.0,7/26,11.43%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1
prerank,cartilage development (GO:0051216),-0.508333090078938,-1.6626570357663866,0.011594202898550725,0.26371255702306057,1.0,15/49,9.47%,SULF1;SOX5;WNT5B;BMP4;OSR1;ITGB8;PKD1;SULF2;CREB3L2;SLC39A14;FGF2;RUNX2;ATP7A;CCN3;SOX6
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.534202754308008,-1.6592278083464191,0.0084985835694051,0.2679579476043205,1.0,17/40,12.43%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;CEBPB;FBN2;PKDCC;BMP2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.8055097001087612,1.6590631615576252,0.011152416356877323,0.30891297024836306,1.0,2/10,1.56%,PRKCH;TRIM16
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6458175378266697,-1.6588504473448882,0.01932367149758454,0.2642473585489933,1.0,10/19,9.61%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBP4;TGFBR1;RBPJ;FGF2;GLI1;VGLL4
prerank,positive regulation of cellular component movement (GO:0051272),0.6896540550339995,1.6570994092279934,0.010050251256281407,0.3122544064967629,1.0,6/24,6.03%,SPOCK2;ETS1;NTN1;LYN;CCR7;ACTN4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6654500495766839,-1.6549878582372897,0.024498886414253896,0.26964987457451267,1.0,8/16,6.56%,IGF1;TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,mesoderm development (GO:0007498),0.7068685901763199,1.653902213363778,0.011824324324324325,0.3193679041758464,1.0,5/18,6.86%,TIE1;TBX1;TBX3;MESD;HCK
prerank,regulation of neuron projection arborization (GO:0150011),0.73607691746429,1.6532135900517335,0.02512562814070352,0.3181052023516075,1.0,4/15,3.39%,MFSD2A;MACF1;FZD4;NTNG2
prerank,epithelial cell morphogenesis (GO:0003382),-0.6494686722275739,-1.65314913631752,0.011312217194570135,0.2700362454203941,1.0,6/17,13.60%,COL22A1;COL18A1;COL15A1;MET;DACT2;RILPL2
prerank,endothelial cell development (GO:0001885),0.6845208762036754,1.6509182117649752,0.023728813559322035,0.3224699924002478,1.0,12/25,8.79%,PECAM1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;SOX18;RAP1B;MSN
prerank,negative regulation of cell junction assembly (GO:1901889),-0.6029240505761487,-1.6488091880702895,0.007633587786259542,0.276167598618268,1.0,11/25,13.58%,PHLDB2;ARHGAP6;ROCK2;APOD;THBS1;ACE;ITGB1BP1;ROBO2;DMTN;BCAS3;PTEN
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5861195111740505,1.6484597703713955,0.009433962264150943,0.3273504057299418,1.0,11/48,12.52%,SLC7A5;IL1R1;ZFPM1;PDE4D;TLR3;LGALS9;TLR7;PDE4B;EBI3;TLR8;CYRIB
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.6769658349689822,-1.6473683099093006,0.015590200445434299,0.2755509804777505,1.0,4/14,13.99%,MOXD1;DAGLA;SLC5A7;SLC22A2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.7450356200376188,-1.6472839466001432,0.01939655172413793,0.27144469375572944,1.0,5/10,8.52%,PID1;APPL2;ENPP1;SELENOS;GRB10
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7296745809549521,1.6465553465525613,0.026223776223776224,0.3305979300557727,1.0,3/15,4.02%,PLTP;SCARB1;ABCG1
prerank,peptide catabolic process (GO:0043171),-0.6152884330192596,-1.6462550096712956,0.014778325123152709,0.2700597417803805,1.0,8/23,13.45%,CPQ;ANPEP;GGT5;ACE;ENPEP;NPEPPS;IDE;CTSH
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7669751927131746,1.6460742005680173,0.02462121212121212,0.32862025238566955,1.0,3/13,3.20%,NAMPT;KDR;NOD2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7587431256093619,1.6455364428550523,0.0273224043715847,0.3269368234106368,1.0,3/12,0.97%,PROM1;MYO1E;PODXL
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5530778129604539,1.644984722731411,0.005657708628005658,0.3253715837594416,1.0,62/87,32.25%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;SRP14;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;RPL7A;ZFAND2B;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7231322669903641,-1.644204635880667,0.020224719101123594,0.2715695983864914,1.0,3/11,2.31%,EGFR;BMP4;DDX5
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6714118752686671,-1.6437075356472906,0.016548463356973995,0.26873117305153515,1.0,7/16,10.98%,IGF1;ROCK2;CAMK2D;TRPC3;PRKCA;SLC9A1;PARP1
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5187874616689482,-1.642947751578654,0.0058823529411764705,0.2667982578794837,1.0,14/49,9.24%,GPC6;SDC2;B3GALT1;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;SDC4;HS6ST2;NDST2
prerank,insulin receptor signaling pathway (GO:0008286),0.5591650375100723,1.6407297742303097,0.0014245014245014246,0.33634604329207646,1.0,17/69,10.31%,IGF1R;GRB14;NAMPT;INSR;BCAR3;FOXO1;PIK3R3;ATP6V0A1;GRB2;GAB1;BAIAP2;SOS1;SORBS1;AP3S1;CAV2;PIK3C2A;GRB7
prerank,regulation of vasculogenesis (GO:2001212),0.7485540875600359,1.6401332577862582,0.01967799642218247,0.33507522637010345,1.0,4/14,1.74%,KDR;CD34;RAPGEF2;XDH
prerank,ameboidal-type cell migration (GO:0001667),0.5865772108187288,1.6397767614279324,0.0015174506828528073,0.33303019702342945,1.0,15/51,9.47%,SEMA3C;SEMA7A;SEMA6A;SRGAP2;TBX1;SEMA6B;PKN3;AMOT;SEMA4F;PKN1;NANOS1;PKN2;SEMA6D;SEMA4C;PHACTR4
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6808644973778675,-1.6388849292683245,0.01702127659574468,0.27330675592129106,1.0,9/13,21.31%,ADHFE1;IDH2;D2HGDH;GOT1;PHYH;GPT2;L2HGDH;IDH1;GOT2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6225612610407931,-1.6388654332170738,0.007317073170731708,0.2694163831776555,1.0,6/21,7.24%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1
prerank,embryonic organ morphogenesis (GO:0048562),-0.5273152427872839,-1.6379386296963347,0.005494505494505495,0.26796985464495676,1.0,13/42,5.68%,FBN1;PDGFRA;EFEMP1;HOXC4;FGFR2;HOXB3;HOXA3;MFAP5;HOXB4;RBP4;DYNC2I1;RBPMS2;SIX1
prerank,regulation of GTPase activity (GO:0043087),0.4945875035976883,1.6362411318130246,0.0012360939431396785,0.3419793446974395,1.0,45/177,11.60%,CHN2;ITGA6;DOCK9;FGD5;LRCH1;SRGAP2;DAB2IP;RASIP1;RAPGEF2;SH3BP4;ARHGAP27;NET1;BCAR3;F11R;AGRN;PTK2;PLXND1;RAPGEF1;CD40;SNX13;RAPGEF3;PRKG1;TGM2;TBC1D2;USP6NL;MAPRE2;EPHA4;OCRL;RSU1;RAP1GDS1;RASGRP2;STMN3;PKP4;FICD;ARHGEF5;PIN1;CAV2;ARHGEF7;FGD6;FERMT2;TBC1D10B;CCL1;PLXNB3;HRAS;TBC1D30
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5676726501893474,1.6331928148553854,0.004310344827586207,0.3491553491077295,1.0,9/63,6.19%,TFRC;SLC7A1;TIRAP;MEF2C;JAK3;CD40;CD6;CD38;CCDC88B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4330639437659357,-1.6322145539732094,0.0,0.27872646347500846,1.0,27/129,11.54%,RNF220;WLS;ZEB2;EGFR;LGR4;COL1A1;PTK7;FGFR2;GPC3;LRRK1;KANK1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;SFRP4;DACT1;TNKS2;PSME4;UBR5;SMURF2;AXIN1;PPM1B;TRPM4;PSME3;LRRK2;CAPRIN2
prerank,protein localization to cilium (GO:0061512),-0.5583975061641211,-1.6313517556647648,0.005128205128205128,0.2774069705400748,1.0,12/32,17.78%,TULP3;WDR35;INVS;ARL3;ZNF423;IFT122;EHD1;BBS9;RAB29;WDR19;SNX10;TULP1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7087686644638154,1.6312567068977908,0.019230769230769232,0.35255599737533455,1.0,9/17,16.13%,TGFB2;NOD2;LYN;SEMA4C;PDCD10;ARL6IP5;MID1;INAVA;KLHDC10
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5461064650529621,-1.6311298698028895,0.009569377990430622,0.2742943339869172,1.0,10/31,5.68%,PDGFRA;HOXC4;FGFR2;OSR1;HOXB3;HOXA3;HOXB4;DYNC2I1;TGFBR1;SIX1
prerank,sulfation (GO:0051923),-0.7117652015201525,-1.631075567155296,0.018518518518518517,0.270728604827993,1.0,1/11,0.06%,UST
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5440380635593453,1.630631442259182,0.011396011396011397,0.3514337269747167,1.0,11/72,5.18%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;TGFB2;PDGFD;PTK2;LYN;GAB1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.538007311765341,1.6289223389705536,0.005714285714285714,0.3542080683886315,1.0,16/88,3.62%,TEK;PTPRM;EGFL7;PDGFB;KDR;PPP1R16B;TIE1;BMPR2;XDH;CAV1;FLT4;RGCC;ACVRL1;PRKD1;PRKD2;VASH1
prerank,positive regulation of cell adhesion (GO:0045785),0.5541912037023417,1.6287752174794712,0.002976190476190476,0.35139167488428125,1.0,16/74,6.46%,NDNF;FRMD5;PDGFB;TGFB2;CXCL12;MAGI1;STX3;ADGRG1;PTPRJ;PRKD2;TGM2;SMAD7;CCR7;EPHA4;RSU1;RET
prerank,embryonic hemopoiesis (GO:0035162),0.7704614164914017,1.6281598061183817,0.023172905525846704,0.3504347276770649,1.0,4/12,5.20%,KITLG;KDR;ZFPM1;TAL1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6296223513927223,-1.6269764736577983,0.020361990950226245,0.27750206736061167,1.0,4/18,6.13%,IGF1;IGFBP2;IL18;IGF2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.746561496554341,-1.6268292666227502,0.011235955056179775,0.2742547494503493,1.0,7/10,18.63%,HOXB4;ACE;MLLT3;LMBR1L;SFRP1;BATF;SP7
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5968637869095473,1.6268136990817508,0.006230529595015576,0.35184790231860236,1.0,22/47,16.28%,IGF1R;DAB2IP;TGFB2;FAS;PHLPP1;FOXO1;NOD2;PPIA;MAPK3;LGALS9;GREM1;SEMA4C;AGER;PDCD10;ARL6IP5;MID1;MAP4K4;EPHB1;INAVA;MAPK1;KLHDC10;COPS5
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5863702877346766,1.6265655146171956,0.009375,0.3494185472007112,1.0,20/48,11.99%,ETS1;JCAD;PDGFB;KDR;NOS3;CD40;PRKD1;PRKD2;HDAC9;HDAC7;TMSB4X;PLCG1;GATA2;TGFB1;MAP3K3;ADAM17;PIK3C2A;HSPB1;HIF1A;ATP5F1A
prerank,metanephros development (GO:0001656),-0.5683019781351611,-1.6264356783766092,0.024509803921568627,0.2719079159908887,1.0,12/26,17.88%,FOXD1;BMP7;BMP4;OSR1;PKD1;PKD2;SIX1;ROBO2;NF1;CTSH;SIX4;PAX2
prerank,cardiac muscle contraction (GO:0060048),-0.5449438382938312,-1.6260869644190188,0.018518518518518517,0.26939705363670047,1.0,7/34,10.13%,ATP1A2;GSN;TPM1;DMD;CAMK2D;SLC8A1;GAA
prerank,cAMP biosynthetic process (GO:0006171),-0.7404596694692326,-1.6251476277962382,0.011235955056179775,0.26833415055322235,1.0,5/10,4.82%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7
prerank,retinoic acid metabolic process (GO:0042573),-0.6738256124093774,-1.6235553061534151,0.020316027088036117,0.26900457353623547,1.0,3/14,6.81%,ALDH1A2;CYP26B1;SCPEP1
prerank,oligosaccharide metabolic process (GO:0009311),0.5923844605783273,1.622940675163049,0.019548872180451128,0.35907840303836974,1.0,14/46,14.38%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;FUT8;NEU4;FUT9;B3GALT4;ST6GALNAC4;MAN1B1;B3GALT2;MANBA;NEU2;MAN2B1
prerank,regulation of cell projection organization (GO:0031344),0.7534321367006659,1.622646385608295,0.02142857142857143,0.35674622501522696,1.0,3/13,3.39%,MFSD2A;MACF1;NTNG2
prerank,regulation of protein neddylation (GO:2000434),0.7848664926937311,1.6207688751872187,0.022530329289428077,0.3602938505891159,1.0,6/10,13.34%,EPAS1;DCUN1D3;COPS9;HIF1A;DCUN1D1;RPL11
prerank,monocarboxylic acid transport (GO:0015718),0.5842321137606403,1.620332456529371,0.007587253414264037,0.3587983615588501,1.0,7/51,2.80%,SLCO1C1;ABCC4;ABCG2;SLCO2B1;SLC16A4;SLC16A2;NCOA1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6429217571896816,1.6200952389112497,0.01854974704890388,0.35641458816332033,1.0,12/28,21.14%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;GIT1;CKAP5;DCTN1;MECP2;CLASP1
prerank,positive regulation of cell migration (GO:0030335),0.46970399214430475,1.620008474921883,0.0,0.35354417344887495,1.0,53/253,10.41%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;DAB2IP;BMPR2;TGFB2;CXCL12;RAPGEF2;PDGFD;DOCK1;CAV1;NEDD9;SEMA6B;ARHGEF2;PTK2;PIK3R3;TIAM1;NOTCH1;VIL1;RIPOR1;PLCG1;RREB1;SEMA4F;GAB1;SNAI2;ACTN4;FAM107A;INSL3;ADAM10;RET;SEMA6D;RAB11A;SPAG9;TGFB1;ARHGEF7;ENPP2;PAK1;SEMA4C;ACTG1;ADAM17;CBLL1;GRB7;PDCD10
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.5829910088506457,-1.6190248253201363,0.014634146341463415,0.27631998344414765,1.0,6/24,10.91%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;COQ10A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5535525034718805,1.6180703755927457,0.010263929618768328,0.35762532581095735,1.0,24/67,12.15%,FLT1;KDR;DAB2IP;WASF2;DOCK1;ELMO1;FLT4;PTK2;PRKD1;PRKD2;PXN;ELMO2;BAIAP2;FYN;NCKAP1;PGF;CYFIP1;HSPB1;SHB;CYBB;CLEC14A;RAC1;NCF4;PIK3CB
prerank,eye morphogenesis (GO:0048592),-0.6319445711016372,-1.6163136110959873,0.022172949002217297,0.27950101726538623,1.0,9/19,13.29%,FBN1;COL5A2;COL5A1;EFEMP1;MFAP5;IFT122;FBN2;SKI;NF1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6637765148142222,-1.6161682771445343,0.010964912280701754,0.27654721043767455,1.0,8/15,20.69%,ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;ADAM8
prerank,regulation of interleukin-13 production (GO:0032656),0.7540129558899336,1.615243947957494,0.025878003696857672,0.3641542088810546,1.0,3/13,6.44%,LEF1;TNFRSF21;LGALS9
prerank,cellular response to drug (GO:0035690),0.651230958572981,1.6145561755525002,0.015544041450777202,0.3634871147616554,1.0,7/25,8.10%,TFRC;ACER2;MEF2C;KCNQ1;AIM2;KCNH2;PDE4B
prerank,regulation of plasminogen activation (GO:0010755),-0.693803019105558,-1.6102345971014358,0.020089285714285716,0.2883497885051648,1.0,6/12,19.06%,THBS1;CLEC3B;SERPINE2;CTSZ;RUNX1;SERPINE1
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.6581273673763329,-1.6101140460999208,0.026373626373626374,0.2853389760342211,1.0,5/15,8.93%,LRP1;PDPN;DDR1;FAP;DPP4
prerank,histone H3 acetylation (GO:0043966),0.6020101825830249,1.6100153975307707,0.0297339593114241,0.3764319810823202,1.0,12/40,14.76%,LEF1;TRIM16;YEATS2;BRCA2;KAT6A;JADE2;NAA60;BRD1;BRPF1;PHF14;BRPF3;POLE3
prerank,positive regulation of T cell activation (GO:0050870),0.5625512251384526,1.6092306203905782,0.013157894736842105,0.3763653524402119,1.0,17/62,17.12%,TFRC;SLC7A1;JAK3;NOD2;ZAP70;CD6;CCR7;CCDC88B;LGALS9;PNP;TNFSF11;CYRIB;IL15;NCKAP1L;VCAM1;NCK1;CCR2
prerank,ganglioside metabolic process (GO:0001573),0.6815476377799902,1.6083325205462806,0.03130434782608696,0.37633328586847803,1.0,3/20,1.09%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,neural crest cell development (GO:0014032),0.5907806980207609,1.607744651604417,0.01488095238095238,0.37494939502605973,1.0,15/44,14.26%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;CDH2;SEMA4F;SNAI2;SEMA6D;SEMA4C;PHACTR4;SOX10;SOX11;PDCD6;SEMA3G
prerank,receptor internalization (GO:0031623),0.5959151275598845,1.6074481320929286,0.0197869101978691,0.37295436013474964,1.0,12/44,8.20%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;GTF2H2;DNM2;AP2M1;CXCR2
prerank,cellular zinc ion homeostasis (GO:0006882),0.6533018590143052,1.6074316090622822,0.010362694300518135,0.37002012896245295,1.0,11/26,13.52%,SLC39A10;SLC39A8;SLC30A1;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,positive regulation of vasculogenesis (GO:2001214),0.7722966401506761,1.6073667070252504,0.032432432432432434,0.3672462105793835,1.0,3/10,1.44%,KDR;CD34;RAPGEF2
prerank,respiratory tube development (GO:0030323),-0.5583353336441017,-1.6070969566598818,0.01871657754010695,0.2901074245958437,1.0,9/28,4.69%,GLI2;PDPN;FGFR2;BMP4;FGF1;PCSK5;RBP4;LOXL3;FGF2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.6147688435386364,1.606700565754972,0.026058631921824105,0.36665316462991504,1.0,7/36,6.54%,SGMS1;DAB2IP;FAS;TPD52L1;PTPMT1;PPIA;CRADD
prerank,regulation of cardiac conduction (GO:1903779),-0.49502029392106434,-1.606181534049841,0.006006006006006006,0.2890618186469552,1.0,14/54,10.47%,ATP1A2;ANK2;ITPR1;STIM1;SLC8A3;DMPK;ASPH;ABCC9;ATP1B3;TMEM65;ATP1B2;SLC8A1;PRKACA;ITPR2
prerank,neuron remodeling (GO:0016322),0.7545132206683747,1.605525143706723,0.030965391621129327,0.3678467650153465,1.0,3/10,2.06%,APP;SCARF1;ANKS1A
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7077536850538386,1.6049360313062042,0.03063063063063063,0.36691035384651066,1.0,5/16,5.21%,NDNF;NOS3;DDAH1;NOS2;KCNC2
prerank,regulation of gastrulation (GO:0010470),-0.6712777194727426,-1.6040358456008241,0.024886877828054297,0.2912681871348111,1.0,4/14,7.49%,PHLDB2;OSR1;DAG1;PHLDB1
prerank,innate immune response (GO:0045087),0.4785605126859491,1.6038784421198895,0.0011792452830188679,0.36777744466612344,1.0,45/217,13.35%,MFHAS1;PGLYRP1;APP;FES;GCH1;TRIM25;TRIM14;B2M;PTK2;SERINC3;SP100;ADAM15;CD40;DEFA6;NOD2;IFIH1;NLRC5;ZAP70;LYN;SERINC5;IKBKB;ADAR;NOS2;CFD;TLR3;NRROS;FYN;YES1;HCK;IRF5;BST2;SHMT2;IRGM;MALT1;PTK6;AGER;CYBB;TLR8;SYK;TNK2;RNF187;SLPI;PPARG;CYLD;TRIM39
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.48994620159746116,1.6030306071391967,0.003896103896103896,0.367930449875438,1.0,31/149,11.71%,TFRC;PRKCH;APP;CAV1;TIRAP;NFKBIA;TRIM25;TNFRSF11A;TRIM14;ARHGEF2;NOD1;CD40;NOD2;PRKD1;PRKD2;IKBKB;PPIA;RPS6KA5;LGALS9;AIM2;CRNN;PIDD1;IRAK2;MALT1;UBE2V1;AGER;LAMTOR5;S100A8;TNFSF11;PRKCB;ZBTB7A
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5700747802908017,-1.6030232610122712,0.015625,0.29060339252847833,1.0,11/27,24.43%,EGFR;BMP4;DDX5;AGO2;TNRC6B;FMR1;LIMD1;EIF4G1;MAP2K1;AJUBA;STAT3
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.7052999516621075,-1.603002931641704,0.02050113895216401,0.2874853843366006,1.0,4/12,11.14%,ANK2;ANXA6;DIAPH1;PTK2B
prerank,negative regulation of epithelial cell migration (GO:0010633),0.6253380408570934,1.6016933199243877,0.021638330757341576,0.3696805311862056,1.0,9/33,5.01%,PTPRG;PTPRM;DAB2IP;MCC;SP100;ACVRL1;VASH1;EVL;DLL4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.6743643073647113,1.601397712956643,0.025466893039049237,0.3678844413159938,1.0,6/20,16.94%,FAR2;FASN;ACSL3;SLC25A1;HSD17B8;DGAT1
prerank,carbohydrate derivative transport (GO:1901264),0.7004624532635209,1.6011277303511227,0.027586206896551724,0.3659555411095203,1.0,5/18,6.50%,MFSD2A;PLTP;SCARB1;ABCG1;SLC10A7
prerank,vesicle transport along actin filament (GO:0030050),0.6948230110754838,1.6008877133925417,0.018456375838926176,0.3640780913906308,1.0,6/19,10.03%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4;MYO1F
prerank,heart morphogenesis (GO:0003007),0.580717706528807,1.6007687185931398,0.016845329249617153,0.3617336081245174,1.0,11/50,3.41%,INSR;ENG;TGFB2;NOS3;TBX1;SOX17;TBX3;PTK2;ACVRL1;ZFPM1;NOTCH1
prerank,response to axon injury (GO:0048678),-0.6288314127955587,-1.5991381281325594,0.02558139534883721,0.29365553115739657,1.0,6/18,22.37%,DPYSL3;APOD;P2RX4;SARM1;GAP43;TYROBP
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6322139609559958,1.598744530265286,0.025167785234899327,0.36572745179381466,1.0,8/27,5.25%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,modified amino acid transport (GO:0072337),-0.668400327014031,-1.598680555398543,0.03146067415730337,0.2915207877587108,1.0,4/15,6.32%,SLC6A13;SLC16A12;PDPN;SLC5A6
prerank,zinc ion transmembrane transport (GO:0071577),0.6668640184275697,1.5969906111727519,0.021015761821366025,0.36900543818770776,1.0,3/22,3.02%,SLC39A10;SLC39A8;SLC30A1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6928753965202437,1.5964385170310549,0.02413793103448276,0.3682091683949696,1.0,5/18,12.39%,PLCB1;AGRN;GNAQ;CHRM3;GNB1
prerank,regulation of transmembrane transport (GO:0034762),0.6324480640027322,1.5962588362591532,0.02622950819672131,0.36629565652943075,1.0,5/31,3.87%,OCLN;SLC2A1;CTTNBP2NL;NEDD4L;ACTB
prerank,regulation of T cell proliferation (GO:0042129),0.5576561728953051,1.596167301731021,0.01020408163265306,0.3638527769784101,1.0,12/61,16.16%,TFRC;SLC7A1;JAK3;TNFRSF21;CD6;CCDC88B;FOXP3;PNP;IL15;NCKAP1L;VCAM1;NCK1
prerank,cellular response to fatty acid (GO:0071398),-0.6979263807297224,-1.5951770416294058,0.01545253863134658,0.2975897531965696,1.0,2/12,2.42%,PID1;IRS1
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.4858839909208643,-1.5920150942726436,0.020710059171597635,0.3025812554068353,1.0,19/54,15.37%,GPC6;SDC2;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;SDC4;HS6ST2;NDST2;HEXA;GNS;NDST1;HGSNAT;B3GAT1;HPSE2
prerank,mesonephros development (GO:0001823),-0.7062263238814432,-1.5915110182613754,0.026726057906458798,0.30067562766040606,1.0,4/11,2.26%,BMP7;BMP4;OSR1;FGF1
prerank,calcium ion transmembrane transport (GO:0070588),-0.45259052836048913,-1.5906546351478763,0.003663003663003663,0.29962819608617974,1.0,25/86,12.34%,SLC24A3;TRPM3;CACNA1C;NALCN;MCU;PKD1;SLC8A3;ANO6;CACNA2D1;PKD2;TRPC3;CACNA1G;TRPM6;SLC35G1;SLC8B1;P2RX4;SLC8A1;CACNA1D;TRPC6;ITGAV;TRPM4;SLC24A5;AFG3L2;TRPC4;TRPC4AP
prerank,regulation of vasculature development (GO:1901342),0.6399974953442067,1.589592300082424,0.03709949409780776,0.38351886767918825,1.0,6/26,4.57%,ETS1;PLXND1;SP100;VASH1;CTNNB1;TSPAN12
prerank,embryonic digestive tract development (GO:0048566),-0.6074137351039886,-1.588813765937323,0.03255813953488372,0.3010738138818322,1.0,8/18,5.56%,GLI3;RARB;GLI2;PDGFRA;FGFR2;PCSK5;SALL1;RBPMS2
prerank,odontogenesis (GO:0042476),-0.5288198405448443,-1.5886649572346376,0.013888888888888888,0.29837936359351075,1.0,9/35,3.85%,COL1A2;GLI2;EDA;FGFR2;BMP4;OSR1;WNT6;FOXC1;BCOR
prerank,L-amino acid transport (GO:0015807),0.6312361348222248,1.5876610676824436,0.02875399361022364,0.3876467376169856,1.0,5/28,5.02%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC1A2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.7045064524286248,-1.5870099021646915,0.02959830866807611,0.2999360436608609,1.0,7/10,25.66%,SETD7;SETD4;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2
prerank,camera-type eye morphogenesis (GO:0048593),-0.7079225616349821,-1.586789510163586,0.022916666666666665,0.2976169192590268,1.0,6/10,19.44%,KDM2B;IFT122;SKI;NF1;LRP6;TBX2
prerank,regulation of muscle contraction (GO:0006937),-0.5658406382217007,-1.5867787168035583,0.010526315789473684,0.29470872067675,1.0,7/26,8.94%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6;KCNB2;MYL9
prerank,vasculogenesis (GO:0001570),0.6123222661552176,1.5866629198750593,0.03035143769968051,0.38831931994914254,1.0,12/32,9.09%,EGFL7;KDR;ENG;RASIP1;CAV1;SOX17;APLNR;NOTCH1;RAMP2;SOX18;TGFB1;CCM2
prerank,clathrin coat assembly (GO:0048268),0.7236314569968426,1.5862808321628656,0.04007285974499089,0.38686680613335545,1.0,5/15,12.19%,HIP1;HIP1R;FCHO2;PIK3C2A;EPS15
prerank,cotranslational protein targeting to membrane (GO:0006613),0.5277241731856606,1.5853891813282577,0.009749303621169917,0.38746568421545435,1.0,64/91,32.25%,SEC62;RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;SRP14;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;SRPRA;RPL7A;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;SSR1;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6077831005957788,1.5853381399028459,0.03241491085899514,0.38494353280197646,1.0,13/36,12.15%,NOSTRIN;NOS3;CAV1;DDAH1;GCH1;SCARB1;CALM1;DNM2;TERF2;LYPLA1;AGTR2;HIF1A;PIK3CB
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.7041150361772769,-1.5846113144448626,0.026030368763557483,0.2975219919771016,1.0,8/12,16.33%,PARP8;PARP3;TNKS2;PARP11;PARP6;PARP1;PARP12;TIPARP
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6400218910224752,-1.5832282826062547,0.034334763948497854,0.2981595333483112,1.0,7/14,20.09%,GJA1;SYDE1;AGO2;SMURF2;ACVR1B;C1QBP;ARHGDIB
prerank,positive regulation of locomotion (GO:0040017),0.6440974180016831,1.582240465022832,0.021311475409836064,0.39319728657865255,1.0,6/27,8.09%,SPOCK2;PDGFB;NTN1;STX3;CCR7;TGFB1
prerank,cytoplasmic translation (GO:0002181),0.5224830350785019,1.5822368890481477,0.007102272727272727,0.39055422637619913,1.0,63/91,32.25%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;RPS7;RPL9;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPL22L1;RPS15;RPL37;RPS28;RPS10;EIF3M;RPS25;RPL37A;EIF4A1;RPL15;RWDD1;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;RPL7A;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;DRG1;RPL36;RPS3;RPS26;RPL27A
prerank,synaptic membrane adhesion (GO:0099560),-0.6503327676766393,-1.5820694511798268,0.022675736961451247,0.2983459672482633,1.0,4/14,4.60%,GPC6;PTPRF;PTPRS;GPC4
prerank,intraciliary retrograde transport (GO:0035721),-0.6702793297233356,-1.581579466054109,0.037037037037037035,0.2967710898039517,1.0,6/12,14.69%,WDR35;DYNC2I1;DYNC2H1;IFT122;WDR19;DYNC2I2
prerank,synapse assembly (GO:0007416),0.5483460171879011,1.5811834744340654,0.008683068017366137,0.3916285633765498,1.0,14/67,9.29%,SPOCK2;DNM3;SHANK3;ADGRL3;PLXND1;FGF13;CDH2;WNT7A;GRID2;DBNL;SLITRK1;GPM6A;NRXN1;DNER
prerank,regulation of leukocyte activation (GO:0002694),0.7143250123757158,1.5801734405935846,0.039399624765478425,0.3926885758835624,1.0,3/14,3.88%,MFHAS1;CD200;LYN
prerank,positive regulation of tissue remodeling (GO:0034105),-0.7230017834051641,-1.5801505773047875,0.038636363636363635,0.2973519485464278,1.0,2/10,3.28%,ROCK2;IL18
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6273026830094969,1.5797384168177304,0.02768729641693811,0.3916364363021847,1.0,9/31,11.86%,PLCB1;TIRAP;CD40;CCR7;TLR3;LGALS9;IRF5;AGER;SYK
prerank,receptor metabolic process (GO:0043112),0.5706560231483792,1.5791102704093876,0.018433179723502304,0.39125739488944034,1.0,16/53,11.87%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;REP15;DNM2;AP2M1;TGFB1;CXCR2;SMURF1;SYK;SH3GLB1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6495282854667978,1.5785129322054499,0.029411764705882353,0.390717918020037,1.0,5/24,4.52%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,filopodium assembly (GO:0046847),0.6996185864692688,1.5777783427145233,0.04151624548736462,0.3907244047543751,1.0,5/16,3.96%,DNM3;FGD5;SRGAP2;SPATA13;PPP1R9B
prerank,respiratory system development (GO:0060541),-0.5296372231574176,-1.5769160610627388,0.030555555555555555,0.30238951937205927,1.0,8/32,4.69%,GLI2;PDPN;FGFR2;BMP4;FGF1;RBP4;LOXL3;FGF2
prerank,peptidyl-tyrosine modification (GO:0018212),0.5635826618208065,1.5765555037760344,0.021994134897360705,0.3920499177125934,1.0,15/56,6.86%,FLT1;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;TPST2;FYN;HCK
prerank,regulation of actomyosin structure organization (GO:0110020),-0.665090166708343,-1.5760709155865418,0.031746031746031744,0.30161261899644093,1.0,6/13,10.27%,ROCK2;ASAP3;ALMS1;AKAP13;FHOD1;SLC9A1
prerank,regulation of neuron migration (GO:2001222),0.6417309561475663,1.5754002835882621,0.025167785234899327,0.39352064657964436,1.0,7/26,3.39%,SEMA6A;SRGAP2;DAB2IP;RAPGEF2;ADGRG1;ARHGEF2;NTNG2
prerank,glucose transmembrane transport (GO:1904659),0.6902601973011983,1.5744337513214253,0.031746031746031744,0.3941860988143234,1.0,3/18,5.10%,SLC2A1;PPARD;SORT1
prerank,positive regulation of hydrolase activity (GO:0051345),0.487426737735857,1.5743525831277392,0.010230179028132993,0.391934687781925,1.0,26/137,8.52%,ITGA6;DOCK9;SRGAP2;RAPGEF2;ARHGAP27;NET1;CD200;BCAR3;F11R;AGRN;RAPGEF1;CD40;SNX13;RAPGEF3;TGM2;TBC1D2;CALM1;USP6NL;MAPRE2;RSU1;RAP1GDS1;RASGRP2;PKP4;PIN1;CAV2;ARHGEF7
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5252583369285437,1.5722732089629026,0.006811989100817439,0.3967778166469647,1.0,9/91,4.15%,SLC39A10;TFRC;SLC40A1;ABCG2;SLC39A8;APP;ATOX1;SLC30A1;SLC31A1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.44607584480694207,1.5721438981315612,0.0,0.3947471138544954,1.0,94/390,12.50%,PTPRG;FLT1;IGF1R;GRB14;TEK;PLCB1;MPZL1;NAMPT;PDGFB;KDR;INSR;TIE1;WASF2;RAPGEF2;PDGFD;DOCK1;RASGRP4;FES;ELMO1;ANKS1A;FLT4;BCAR3;NEDD9;PTPRJ;PTK2;MTSS1;COL4A2;KALRN;ARPC4;FOXO1;RAPGEF1;PIK3R3;TIAM1;PRKD1;PRKD2;ATP6V0A1;ZAP70;MERTK;PXN;ACTB;LYN;ELMO2;STMN1;SOCS2;GRB2;FGF16;SORT1;GAB1;CD4;EPHA4;BAIAP2;FYN;SOS1;MAPK3;RET;YES1;NCKAP1;EPHB4;HCK;SORBS1;ANKS1B;EFNA1;TIAL1;AP2M1;AP3S1;CAV2;ARHGEF7;SHC3;CD8B;ARPC3;PAK1;PGF;PLAT;ACTG1;PTK6;DDIT4;CYFIP1;PIK3C2A;GRB7;SHB;CYBB;APH1A;GRIN2B;RAC1;NCBP2;HRAS;GSK3A;SYK;NCF4;PIK3CB;TNK2;AP2B1;GDF15;EPHB1
prerank,cellular response to increased oxygen levels (GO:0036295),0.7467411613976782,1.5718808330289655,0.0364963503649635,0.39319429282441487,1.0,3/11,2.99%,CAV1;FAS;FOXO1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6611218121427698,1.5702890417240623,0.02821869488536155,0.39590308601061786,1.0,7/20,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,amino acid import across plasma membrane (GO:0089718),0.6518145639866522,1.5697375225927122,0.03511705685618729,0.39521917084787894,1.0,6/24,1.94%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A2;SLC6A5
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6438536078080803,1.5688609359971273,0.027491408934707903,0.3954323468232179,1.0,9/25,10.12%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;SHKBP1;CNOT9;PTK6
prerank,regulation of B cell proliferation (GO:0030888),0.5826280398137684,1.5669915691197769,0.019374068554396422,0.3992929512299155,1.0,7/44,5.65%,TFRC;TIRAP;MEF2C;CD40;LYN;TNFRSF21;CD38
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6591928106466793,-1.5662488531651708,0.053811659192825115,0.3232268104973672,1.0,7/13,6.56%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,negative regulation of wound healing (GO:0061045),-0.5475535872168701,-1.5656731609524164,0.017114914425427872,0.3219581318372544,1.0,9/28,8.01%,PHLDB2;TFPI;VTN;CASK;SLC12A2;FGF2;THBD;CD109;APOE
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.7027405938703171,-1.5655154916277154,0.03792415169660679,0.31947752239233257,1.0,7/11,16.33%,PARP8;PARP3;PARP4;PARP11;PARP6;PARP12;TIPARP
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.6345904566970232,1.5641484963482215,0.025996533795493933,0.40635092293132263,1.0,7/24,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.6963268712097537,1.5637172109197919,0.03486238532110092,0.4053723257512877,1.0,3/16,1.09%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5031915920270872,1.5637115592002306,0.004026845637583893,0.40297144510167016,1.0,72/110,32.25%,RPL38;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPL27;RPSA;EIF3E;RPS7;RPL9;RPL18;RPLP2;MAGOHB;RPL13A;HELZ2;RPS11;RPL8;NCBP2;RPS27;RPL19;RPS9;RPL11;PNRC2;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RBM8A;RPS18;UPF2;RPL21;RPS4X;RPL18A;NCBP1;RPS21;RPL10A;PABPC1;RPL24;RPL7A;RPL32;RPL4;UPF3B;UPF1;RPS2;RPS20;RPL6;RPS13;RPS19;PPP2R1A;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,eye photoreceptor cell differentiation (GO:0001754),0.7275850685673675,1.56295568612345,0.043243243243243246,0.40336003528745223,1.0,2/12,2.21%,PROM1;NKD1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5050772516233868,-1.5617914917462015,0.013812154696132596,0.3261445024621304,1.0,16/43,12.04%,IGF1;BMPR1A;PDGFRB;IGFBP5;BMP4;GJA1;IL18;THBS1;FGF2;RBPMS2;MMP2;FOXJ2;CCN4;CDH13;ADAMTS1;MFN2
prerank,zinc ion homeostasis (GO:0055069),0.6255592142574026,1.561158523955765,0.025597269624573378,0.4072390805102408,1.0,11/28,13.52%,SLC39A10;SLC39A8;SLC30A1;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of cell communication (GO:0010646),-0.5184802960959846,-1.5604303223978984,0.024657534246575342,0.32684494402698283,1.0,9/35,8.25%,ANK2;CXADR;GRK5;GRK3;CAMK2D;ANXA1;TBX18;SLC8A1;TSPYL2
prerank,neural crest cell migration (GO:0001755),0.5982048302123192,1.5601984278588392,0.0192,0.40798291879090653,1.0,9/36,9.47%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;SEMA4F;SEMA6D;SEMA4C;PHACTR4
prerank,positive regulation of bone mineralization (GO:0030501),-0.519695813545013,-1.5601000260134228,0.013623978201634877,0.32470207005351015,1.0,15/35,12.43%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;FBN2;PKDCC;BMP2
prerank,sodium-independent organic anion transport (GO:0043252),0.76384517979948,1.5590403850362509,0.03925233644859813,0.4094301704941256,1.0,3/10,1.67%,SLCO1C1;SLCO2B1;SLC16A2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7145147461525373,1.5573052220106693,0.04964539007092199,0.4127212451942542,1.0,2/14,6.58%,TFRC;SHLD1
prerank,regulation of T cell migration (GO:2000404),0.6751930003169149,1.5564305435554049,0.050699300699300696,0.4135952672088692,1.0,4/18,2.13%,LRCH1;CXCL12;APP;CD200
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.4740332499273249,-1.5561476083402346,0.008746355685131196,0.33246195884299307,1.0,18/46,15.49%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;RBPJ;ZNF423;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4;NRDC
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7577790835803502,1.5560379375741122,0.047058823529411764,0.4126026578473452,1.0,2/10,1.57%,SHANK3;APP
prerank,regulation of striated muscle contraction (GO:0006942),-0.5469701967582312,-1.5559237523244864,0.022388059701492536,0.33009816295893,1.0,6/27,10.12%,ATP1A2;ANK2;SLC8A3;DMD;P2RX4;PRKACA
prerank,regulation of DNA biosynthetic process (GO:2000278),0.626992068260769,1.5554890484630288,0.027257240204429302,0.41194338805376624,1.0,7/27,3.77%,DACH1;PDGFB;BMPR2;RGCC;ACVRL1;PRKD2;HMBOX1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.6138668555077067,1.554519963948961,0.03005008347245409,0.4127783979189901,1.0,8/29,5.25%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7363816222751687,1.5543166253872374,0.045774647887323945,0.411210029709479,1.0,5/12,7.16%,CAV1;GJD3;CALM1;PDE4D;SRI
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.696010561080757,-1.5525423619015268,0.041758241758241756,0.3360186564615957,1.0,1/10,0.02%,ATP1A2
prerank,intestinal absorption (GO:0050892),0.7097760327990558,1.5515733144884085,0.04878048780487805,0.41802811642691134,1.0,3/13,5.16%,TJP2;F11R;KCNQ1
prerank,modulation by symbiont of entry into host (GO:0052372),0.6874921904735238,1.5515288073140576,0.054673721340388004,0.4158463197117303,1.0,3/16,2.37%,CAV1;TRIM25;TRIM14
prerank,positive regulation of B cell proliferation (GO:0030890),0.6238290938770732,1.550834711182723,0.029595015576323987,0.4159814334916721,1.0,5/29,5.65%,TFRC;TIRAP;MEF2C;CD40;CD38
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5014556978112197,1.5497793544759875,0.00819672131147541,0.41718842702897807,1.0,17/100,6.20%,FLT1;IGF1R;TEK;PDGFB;KDR;PPP1R16B;INSR;DAB2IP;TGFB2;PDGFD;PTK2;PIK3IP1;LYN;GAB1;PIP5K1C;MAPK3;ENTPD5
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6336457669777803,1.5488521688823447,0.046822742474916385,0.4180780197793873,1.0,8/23,13.46%,FAR2;ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5676025249619813,-1.548435866845072,0.03333333333333333,0.344089404154439,1.0,8/25,8.56%,ANK2;ACTN2;SLC6A9;DMD;WNK4;ATP1B3;ATP1B2;TRPC6
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.6241003024685392,-1.5483115531782514,0.04176334106728538,0.3415080194143021,1.0,6/16,14.60%,ANK2;GBF1;SEC16B;LRRK2;SEC16A;DDRGK1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5784646222575646,1.5479924482258245,0.02564102564102564,0.4187654072239656,1.0,8/39,4.52%,TEK;NDNF;KDR;RGCC;CD40;RAMP2;PLCG1;GATA2
prerank,glycolipid metabolic process (GO:0006664),0.5605865640577504,1.547869078594328,0.023622047244094488,0.4169121570394197,1.0,12/47,13.93%,ST6GALNAC3;ST3GAL6;ST8SIA6;ESYT2;NEU4;ESYT1;GLB1;GLTP;ST6GALNAC4;B4GALNT1;CERK;NEU2
prerank,phospholipid biosynthetic process (GO:0008654),0.5945100535756354,1.5473475152428402,0.03079416531604538,0.41643930243182165,1.0,3/36,1.83%,SGMS1;SGMS2;MBOAT1
prerank,catecholamine biosynthetic process (GO:0042423),0.7326435281329136,1.546632943415785,0.053763440860215055,0.41664810155516907,1.0,4/11,7.04%,DDC;TGFB2;GCH1;INSM1
prerank,keratan sulfate catabolic process (GO:0042340),-0.6989100098432991,-1.546018581813629,0.03225806451612903,0.3448938086916137,1.0,7/11,12.24%,OGN;FMOD;PRELP;LUM;OMD;HEXA;GNS
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6620500810696912,-1.5455260513438593,0.040632054176072234,0.3432645062937581,1.0,4/13,12.43%,BMP5;DKK3;APOE;BMP2
prerank,regulation of monooxygenase activity (GO:0032768),0.6447089575765136,1.545394217079955,0.028716216216216218,0.418512945362279,1.0,7/23,8.87%,NOSTRIN;NOS3;CAV1;DDAH1;CALM1;DNM2;LYPLA1
prerank,negative regulation of angiogenesis (GO:0016525),0.5146908487257648,1.5437005558097117,0.011204481792717087,0.42173441725131167,1.0,20/84,7.37%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;EPN2;TGFB2;STAB1;RGCC;COL4A2;AMOT;VASH1;KLF2;HHEX;SARS1;CTNNB1;KLF4;STAT1;GTF2I;CD160
prerank,cardiac muscle tissue development (GO:0048738),-0.4764837093467913,-1.543303358823972,0.017045454545454544,0.34634974827374215,1.0,13/50,6.00%,NOTCH2;BMPR1A;GJB6;BMP5;SGCD;BMP7;BMP4;GJA1;RBP4;CACNA1G;NDUFV2;TBX18;AKAP13
prerank,Rap protein signal transduction (GO:0032486),0.7399217670899234,1.5427162709020579,0.04873294346978557,0.42307340342152727,1.0,4/10,7.23%,RAPGEF2;RAPGEF1;RAPGEF3;RAP1B
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.42297674024352205,-1.5417502353054904,0.004132231404958678,0.34756625498498406,1.0,27/95,9.29%,GPC6;UST;DSE;DCN;ANGPT1;SDC2;OGN;CEMIP;EXT1;FMOD;GPC3;BGN;HS3ST3A1;ST3GAL4;HS2ST1;CHST15;GPC4;PRELP;PXYLP1;CSPG4;HS3ST3B1;HS6ST1;SDC4;LUM;HS6ST2;NDST2;OMD
prerank,negative regulation of interleukin-10 production (GO:0032693),0.6808190036610041,1.5407845552629966,0.048214285714285716,0.42691029161029737,1.0,6/16,11.81%,JAK3;TNFRSF21;FOXP3;TRIB2;AGER;VSIR
prerank,sulfate transport (GO:0008272),-0.6398445012041436,-1.5407224265211839,0.03644646924829157,0.347806169654849,1.0,3/14,2.84%,SLC13A4;SLC26A7;SLC26A2
prerank,ATP transport (GO:0015867),0.7297177279331288,1.539276713813929,0.058394160583941604,0.42990589647011435,1.0,2/10,5.07%,ABCC6;SLC25A5
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.532882806607186,1.5389173930973539,0.017777777777777778,0.4290000185275684,1.0,21/65,12.42%,HIP1;DAB2IP;ITGA1;HIP1R;BCAR3;PLAUR;AFAP1L2;PTPRJ;RHBDF2;PTPN12;DUSP3;GRB2;CCDC88A;TGFA;ARHGEF7;SHKBP1;CNOT9;PTK6;CEACAM1;EPS15;HGS
prerank,glycoprotein metabolic process (GO:0009100),0.5486635972928816,1.5385894765661399,0.014992503748125937,0.4278582586541966,1.0,8/53,5.56%,ST8SIA4;ST6GALNAC3;ST8SIA6;FUT8;B4GALT5;OGA;NEU4;STT3B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.40070604483120215,-1.5380472600626987,0.004081632653061225,0.3521517247400378,1.0,27/142,12.11%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;SMAD3;CD55;CCR9;EDNRA;ADRA1B;TRPC3;SLC35G1;SLC8B1;DLG4;SLC8A1;BDKRB2;AGTR1;PTGDR;TRPC6;PTGFR;PRKACA;TRPM4;CLN3;TRPC4;ABL1;ESR1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5651943383738645,1.536282596972601,0.03559870550161812,0.4332892656565769,1.0,12/45,11.01%,TRIM16;APP;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8
prerank,cellular response to BMP stimulus (GO:0071773),-0.44305484858571015,-1.5361419554482156,0.00641025641025641,0.3546296751706216,1.0,15/66,6.76%,BMP6;TGFBR3;BMPR1A;ADAMTS12;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,negative regulation of axon extension (GO:0030517),0.5975724919400481,1.5350860982802275,0.03322259136212625,0.43524097234233383,1.0,7/30,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;DIP2B;SEMA4F;SEMA6D
prerank,N-glycan processing (GO:0006491),0.6664774259610484,1.5350451313180975,0.0429553264604811,0.4331652156096422,1.0,3/18,1.96%,ST8SIA4;ST8SIA6;FUT8
prerank,regulation of cell migration (GO:0030334),0.4356678354150061,1.5345795678033487,0.0011037527593818985,0.4328076307539505,1.0,58/382,6.48%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;LIMCH1;DACH1;PECAM1;FRMD5;SEMA6A;TJP1;CLDN5;PDGFB;KDR;SRGAP3;SRGAP2;INSR;PODXL;MACF1;ROBO4;SRGAP1;ENG;CXCL12;PDGFD;PRR5L;CAV1;NKD1;NEDD9;SEMA6B;SPATA13;PTPRJ;PTK2;PLXND1;ADAM15;PIK3R3;AMOT;ACVRL1;TIAM1;NTNG2;NOTCH1;DUSP3;VIL1;RIPOR1;TMSB4X;SMAD7;GNA12;FGF16;SEMA4F;RHOB;EPHA4;SNAI2;ACTN4;FAM107A;KIF2A;ADAM10;RET;RFFL
prerank,adherens junction organization (GO:0034332),0.5655494844843703,1.5341692188488703,0.02147239263803681,0.4320060388561853,1.0,15/48,7.00%,TJP1;CADM1;CDH2;RAMP2;ACTB;NECTIN4;CDH20;SMAD7;CTNND1;CTNNB1;CDH8;PIP5K1C;PVR;DCHS1;CDH19
prerank,regulation of interleukin-2 production (GO:0032663),0.5699007880452344,1.5338796565270996,0.0391566265060241,0.43090880638506596,1.0,11/43,11.08%,SPTBN1;CD34;PRKD2;HDAC7;HOMER2;PDE4D;CD4;PDE4B;FOXP3;MALT1;PNP
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7325564723477123,1.5336605727847554,0.07945736434108527,0.4295606319882652,1.0,3/10,4.03%,DGKH;PARD3;PRKD3
prerank,granulocyte differentiation (GO:0030851),0.6619252126655707,1.5336298027034685,0.045,0.42750925670424694,1.0,2/18,5.20%,LEF1;TAL1
prerank,cellular response to sterol (GO:0036315),-0.6588899432049199,-1.5333747305126635,0.03225806451612903,0.35949758298335005,1.0,8/13,20.36%,INSIG2;SMO;RORA;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.6450320606766786,1.532636400745165,0.03454231433506045,0.42856451843047233,1.0,3/22,5.61%,SLC7A5;NOD2;TRIL
prerank,negative regulation of anoikis (GO:2000811),0.6946036891926721,1.5324707096156096,0.05850091407678245,0.42704423173233,1.0,7/14,11.88%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5883243755781844,-1.5321480293684224,0.0547945205479452,0.36012409843459015,1.0,6/20,9.03%,SULF1;SMOC2;SULF2;THBS1;FGF2;CREB3L1
prerank,cellular response to copper ion (GO:0071280),0.6836276443333852,1.5318241665249177,0.05935251798561151,0.4270792783289262,1.0,11/16,25.24%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;DAXX;SNCA;AOC1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6726420307832169,1.530102308837963,0.0433996383363472,0.43052889182216786,1.0,2/17,6.44%,SLC7A5;LGALS9
prerank,regulation of blood circulation (GO:1903522),-0.5173828410207082,-1.5286912522904146,0.017994858611825194,0.3666626762284127,1.0,10/34,10.36%,CELF2;TPM1;DMPK;CAMK2D;KCNMB2;PER2;ACE;BDKRB2;AGTR1;DES
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.6321803620921713,-1.5279147547989735,0.03728070175438596,0.36596728592568345,1.0,5/14,10.23%,IRS1;PPARGC1A;IRS2;NNMT;SLC45A3
prerank,amino acid transport (GO:0006865),0.5512470510644214,1.5275816058538547,0.027993779160186624,0.43678614869622856,1.0,6/49,2.87%,SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC38A5;SLC43A2
prerank,regulation of chemokine production (GO:0032642),0.5884972748880901,1.5272444489907715,0.03827751196172249,0.43579086310569115,1.0,10/36,11.82%,APP;IL6R;SIGIRR;TLR3;SNAI2;LGALS9;TLR7;ADAM17;AGER;HIF1A
prerank,striated muscle cell development (GO:0055002),0.6893595042299916,1.5269231494662743,0.05989110707803993,0.43486806086052276,1.0,2/14,1.54%,FLII;PGM5
prerank,negative regulation of metabolic process (GO:0009892),-0.4498897330149585,-1.526713504491745,0.00625,0.366448827499417,1.0,18/54,15.49%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;RBPJ;ZNF423;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4;NRDC
prerank,skin development (GO:0043588),-0.45314097721524066,-1.526269043856554,0.019230769230769232,0.3650724013008623,1.0,22/65,14.74%,COL1A2;COL3A1;COL5A2;COL1A1;COL5A1;ERRFI1;PKD1;ADAM9;ANXA1;ATP7A;TXNIP;JAG1;MET;COL5A3;ITGB4;CLDN1;GATA6;SCEL;DACT2;BCR;SLC2A10;CASP3
prerank,positive regulation of integrin activation (GO:0033625),0.7244354007771948,1.5261654223238328,0.06766917293233082,0.43529399172988376,1.0,4/11,10.91%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.6214095339855468,-1.5256063826709958,0.04215456674473068,0.3614363804186219,1.0,8/16,13.58%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.6214095339855468,-1.5256063826709958,0.04215456674473068,0.3614363804186219,1.0,8/16,13.58%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7090637423669262,1.525447975116224,0.039285714285714285,0.43566791432997254,1.0,4/13,4.35%,DAB2IP;EPN2;MMRN2;HHEX
prerank,regulation of phospholipase activity (GO:0010517),-0.6917176561563083,-1.5237644404624096,0.03263403263403263,0.3642156758241276,1.0,3/10,9.06%,LRP1;FGFR2;PDPK1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5614532499688347,-1.5231906596301221,0.036057692307692304,0.36306753275895043,1.0,6/23,5.68%,WNT5B;BMP4;GJA1;SMO;FGF2;SIX1
prerank,glycerophospholipid metabolic process (GO:0006650),0.5102762231099486,1.5227189822948353,0.02463768115942029,0.4425936609931367,1.0,10/75,6.36%,GPCPD1;PLCB1;DGKH;PLA2G4B;PLCG1;SERINC5;PNPLA6;GDPD1;ABCA3;PIGM
prerank,myelination (GO:0042552),0.5577099022512482,1.522415558558656,0.02878787878787879,0.4416990188693917,1.0,20/46,19.06%,MPZ;CMTM8;MAL;B4GALT5;PLLP;PARD3;TNFRSF21;BCAS1;GAL3ST1;NFASC;EIF2B2;ABCD1;SOX10;DEGS1;MBP;PMP22;ARHGEF10;MAL2;TPPP;ABCD2
prerank,protein glycosylation (GO:0006486),0.4766653502290398,1.5221316983364175,0.014666666666666666,0.44068503188554203,1.0,36/125,17.29%,ST8SIA4;ST3GAL6;EOGT;AQP11;ST8SIA6;SLC39A8;ST3GAL1;GALNT18;FUT8;B4GALT5;ST6GALNAC2;B3GNT2;OGA;STT3B;FUT9;ENTPD5;GAL3ST1;COG3;PLOD3;NPC1;B3GALT4;MGAT4B;B3GALT2;PLOD1;DPAGT1;SERP2;NUS1;POFUT1;DAD1;GCNT2;DPM3;MGAT2;B3GNT3;POGLUT1;DOLPP1;POMGNT1
prerank,early endosome to Golgi transport (GO:0034498),-0.6839529321809014,-1.5209642040272202,0.03317535545023697,0.36649824830693356,1.0,7/11,23.00%,STX5;SNX8;RAB6A;LMAN1;TRAPPC10;SURF4;TMED9
prerank,bone development (GO:0060348),-0.4971184317651473,-1.5208360178810518,0.028328611898016998,0.36427076813403775,1.0,10/39,6.60%,RANBP3L;SULF1;FGFR2;CYP26B1;GJA1;SULF2;SH3PXD2B;AKAP13;SFRP4;GNAS
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5389460154880232,-1.5201500071596643,0.04215456674473068,0.36369320448668946,1.0,7/26,7.86%,ANK2;ACTN2;FHL1;DLG1;ATP1B3;ATP1B2;CACNA1D
prerank,positive regulation of lipid localization (GO:1905954),-0.6707263938557237,-1.5200750491582262,0.05591397849462366,0.3613572472586847,1.0,2/11,3.91%,LRP1;IKBKE
prerank,limb development (GO:0060173),-0.5393519669875518,-1.5185840300838183,0.025943396226415096,0.3626522603761654,1.0,11/28,20.36%,SMOC1;GLI3;PCSK5;SALL1;RSPO2;IFT122;IQCE;COMP;INTU;KREMEN1;PTCH1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.6903591161614099,-1.5156564907004275,0.04742268041237113,0.36795468372844886,1.0,3/10,6.35%,BMP4;SALL1;FZD7
prerank,positive regulation of DNA repair (GO:0045739),-0.48797532847267894,-1.515075894652682,0.03283582089552239,0.36695897082406564,1.0,4/46,2.10%,EYA2;EYA1;EGFR;EYA4
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6184964028469321,-1.5148777756669765,0.05324074074074074,0.364996328023977,1.0,5/14,9.96%,SEC24D;SEC24A;SAR1A;SEC31A;SEC23A
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.608204236202416,1.5146271754017298,0.04091653027823241,0.46355399784440837,1.0,5/27,1.98%,SLC7A5;SLC7A1;SLC1A1;SLC6A5;SLC38A5
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5908920165897033,1.513913553298226,0.05090311986863711,0.4639290131765259,1.0,10/29,14.31%,ELOVL7;FASN;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;SLC25A1;HACD2;HSD17B8
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6221605218444038,1.513834753075806,0.03220338983050847,0.4620569658049432,1.0,9/24,12.23%,TEK;KDR;PTPRJ;DUSP3;MAPRE2;IQSEC1;FERMT2;RAC1;MAP4K4
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5969275656420194,-1.513436193287952,0.04357798165137615,0.3664861773996988,1.0,6/17,6.33%,FSTL1;SULF1;SLIT2;CASK;TWSG1;SFRP4
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.7064533908737529,1.5129533504211246,0.06066176470588235,0.4628625697870164,1.0,4/12,11.60%,MFSD2A;ACSL3;LPCAT3;MTTP
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.6081318172438539,-1.512193862366606,0.04672897196261682,0.3672752960736174,1.0,7/15,21.31%,GGT5;ALDH4A1;PRODH;GGACT;SARDH;ABHD16A;GOT2
prerank,amino acid transmembrane transport (GO:0003333),0.5560514648832338,1.511981990616421,0.039634146341463415,0.46375325394347916,1.0,5/45,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5
prerank,cellular response to exogenous dsRNA (GO:0071360),0.7241550089728058,1.5110040132880198,0.061224489795918366,0.46486588376846794,1.0,4/12,6.98%,CAV1;IFIH1;ZCCHC3;RALB
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6431568987741783,-1.510824830927249,0.045871559633027525,0.3686633528448183,1.0,5/13,7.08%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;ATP1B2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6237665022128869,-1.5104897012049314,0.047516198704103674,0.36697889855737675,1.0,5/14,2.27%,LRP1;BMPR1A;IGFBP5;TPM1;SLIT2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5975400331959723,1.510244663387472,0.04666666666666667,0.4653730396583415,1.0,7/29,11.88%,LEF1;MEN1;CTNNB1;TCF7;TLE4;AXIN2;TLE1
prerank,positive regulation by host of viral transcription (GO:0043923),0.6686185810129666,1.5100796947471833,0.06159420289855073,0.4637691806384367,1.0,3/15,8.95%,LEF1;JUN;CHD1
prerank,regulation of interleukin-17 production (GO:0032660),0.5898256917117329,1.5096070332838296,0.058823529411764705,0.46317827742906925,1.0,9/31,14.70%,SLC7A5;NOD2;TGFB1;FOXP3;CCL1;VSIR;IL15;RFTN1;NCKAP1L
prerank,hemidesmosome assembly (GO:0031581),0.7236159360231859,1.5091451695877411,0.06336633663366337,0.4626468745148447,1.0,1/11,0.31%,ITGA6
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5956892044838138,1.5089843799871194,0.04276315789473684,0.46107651657139864,1.0,8/30,10.45%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;RFFL;FAIM;CASP8
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.6804686826274597,-1.5079299181042465,0.04743083003952569,0.37146893498482814,1.0,6/10,24.38%,EMC8;EMC7;EMC1;EMC2;EMC3;EMC4
prerank,phospholipid translocation (GO:0045332),0.6026373058348471,1.5073885548168189,0.061191626409017714,0.4642988384522027,1.0,9/28,9.75%,ATP10A;MFSD2A;ATP8A1;ATP11B;ATP11A;ABCA7;P2RX7;ATP11C;ATP10B
prerank,diol metabolic process (GO:0034311),0.6592584992049749,1.5071292276802493,0.03722504230118443,0.4631408060063639,1.0,5/19,4.35%,SGPP2;DEGS2;NOS3;GCH1;CALM1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7199593607492656,1.5064902607104962,0.07142857142857142,0.4633336373054334,1.0,3/11,3.88%,MFHAS1;TIRAP;LYN
prerank,L-serine metabolic process (GO:0006563),0.7437418392517907,1.5064292444061391,0.060836501901140684,0.46158438856209927,1.0,4/10,9.59%,SERINC3;SERINC5;SHMT2;CBS
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6682014294417965,1.5062644164650683,0.07352941176470588,0.4602200194506764,1.0,4/15,10.08%,ENTPD1;AK4;ENTPD5;CMPK1
prerank,microtubule depolymerization (GO:0007019),0.6577200821382093,1.505303984550077,0.06560283687943262,0.4616104495552218,1.0,7/17,15.68%,STMN1;NCKAP5;KIF2A;STMN3;STMN4;NCKAP5L;CKAP5
prerank,cellular response to peptide (GO:1901653),0.5342646779890748,1.504769530416297,0.02844311377245509,0.4612917326255743,1.0,12/56,6.25%,IGF1R;CACNA1A;APP;CAV1;ARHGEF2;NOD1;NOD2;CYP11B1;CYP11A1;EPHA4;FYN;ATP1A3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.5971309431837781,1.5029877891585217,0.05695142378559464,0.46522868001854023,1.0,5/29,3.73%,KANK3;SHANK3;TJP1;HIP1R;SSH2
prerank,positive regulation of ruffle assembly (GO:1900029),0.6999454764878194,1.5027270191095838,0.06428571428571428,0.46404075761221314,1.0,6/13,15.74%,EPS8;EPS8L2;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,negative regulation of DNA binding (GO:0043392),0.5941608008594927,1.5025308899865588,0.054817275747508304,0.46265620033796917,1.0,10/28,17.92%,LEF1;NFKBIA;SP100;JUN;SOX11;HEY1;HMGA2;SUMO1;SIN3A;CPNE1
prerank,glycoprotein biosynthetic process (GO:0009101),0.506410042382525,1.5021762510718575,0.03829160530191458,0.46168653634965373,1.0,11/79,7.12%,ST8SIA4;CSGALNACT1;ST3GAL6;ST8SIA6;BMPR2;B4GALT5;ST6GALNAC2;CHST11;B3GNT2;FUT9;COG3
prerank,regulation of interleukin-10 production (GO:0032653),0.5527689927642797,1.5020709129525125,0.040625,0.46005453381136485,1.0,10/44,11.86%,CD34;JAK3;NOD2;TNFRSF21;LGALS9;FOXP3;TRIB2;AGER;VSIR;SYK
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6106720163612583,-1.5011139265660014,0.04708520179372197,0.3879532234912622,1.0,7/15,16.37%,PIEZO2;ADGRV1;COL11A1;KIT;MKKS;TMEM120A;PDZD7
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5572146629883244,1.4999030692879103,0.042789223454833596,0.4651983439387711,1.0,11/39,6.17%,EPN2;TGFB2;NOS3;NOTCH4;JAG2;TSPAN5;NOD2;TSPAN14;NOTCH1;DLL4;MAML2
prerank,positive regulation of MAPK cascade (GO:0043410),0.4392073935334637,1.4995652240419217,0.004767580452920143,0.4643106817337688,1.0,34/245,6.46%,FLT1;IGF1R;TEK;SEMA7A;MFHAS1;PIK3R6;JCAD;PDGFB;KDR;INSR;DAB2IP;TGFB2;RAPGEF2;PDGFD;APP;TBX1;TIRAP;PDE8A;FLT4;BCAR3;TPD52L1;PTPRJ;CD40;NOD2;NOTCH1;PRKD2;RAMP3;CCR7;CD4;MAPK3;ADRA2B;FBXW7;LGALS9;RET
prerank,positive regulation of cell junction assembly (GO:1901890),0.5343153906430068,1.4994460314823457,0.03468208092485549,0.4627050150932377,1.0,15/56,13.19%,TEK;CLDN5;KDR;CAV1;PTPRJ;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;FERMT2;RAC1;MAP4K4;EPHB1;CNTNAP2
prerank,defense response to symbiont (GO:0140546),0.48996824461735006,1.498728033690719,0.022377622377622378,0.4630026516551083,1.0,23/92,11.42%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;BST2;TLR7;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;TLR8;RNASE1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7215444735414487,1.4986302802300289,0.06319702602230483,0.4613905644919039,1.0,3/10,1.74%,SEMA6A;DAB2IP;XDH
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6631853671606167,1.4983149418330473,0.06896551724137931,0.4605790031085164,1.0,5/15,8.41%,TGFB2;JAK3;SMAD7;TGFB1;FOXP3
prerank,JNK cascade (GO:0007254),0.5583531227211038,1.4978075730732434,0.05642633228840126,0.460371450901711,1.0,6/40,3.20%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2
prerank,neuron maturation (GO:0042551),0.6522011118798912,1.4974547320840021,0.04946996466431095,0.45962851348838785,1.0,4/18,2.10%,APP;SCARF1;ANKS1A;B4GALT5
prerank,actin filament organization (GO:0007015),0.4645483848341495,1.497114686246406,0.0063371356147021544,0.4588833870434025,1.0,27/151,7.03%,FLII;HIP1;MYO1D;MYO1E;RHOBTB1;SHROOM4;NEBL;SHROOM1;ELMO1;HIP1R;NEDD9;ARHGEF2;ARPC4;CD2AP;EVL;PLS3;ELMO2;VIL1;PPP1R9B;MYO6;RFLNB;EPS8;RHOB;TPM3;BAIAP2;ARHGAP25;ACTN1
prerank,regulation of integrin activation (GO:0033623),0.6652569097199388,1.4964782837947221,0.0693950177935943,0.4590458382526682,1.0,4/15,10.91%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,lung epithelium development (GO:0060428),-0.6876729072824728,-1.4963589928549033,0.046460176991150445,0.3984914719270943,1.0,4/10,6.13%,ERRFI1;BMP4;PKD1;RCN3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5071369312642321,1.4952814509958403,0.029914529914529916,0.4611293208754117,1.0,18/75,7.37%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;TGFB2;STAB1;RGCC;COL4A2;AMOT;VASH1;HHEX;SARS1;CTNNB1;KLF4;STAT1;GTF2I;CD160
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6296570005134152,-1.4949825686236327,0.0611353711790393,0.3997775601311509,1.0,7/13,18.22%,NUPR1;TMEM39A;LRRK2;SCFD1;PHF23;FEZ1;SMCR8
prerank,membrane organization (GO:0061024),0.4383014647987967,1.4938196152159056,0.004700352526439483,0.463988746288397,1.0,59/227,16.46%,TFRC;DNM3;CERT1;HIP1;SPTBN1;EPN2;REEP1;FNBP1L;HIP1R;AGFG1;DYSF;FZD4;ARPC4;ATP2C1;ACTB;SNX3;GRB2;CD4;PIP5K1C;OCRL;CCDC88A;CNTN2;DNM2;CHRNB1;GRIN3B;FCHO2;CHMP1B;AP2M1;TGFA;RTP4;ARPC3;NPC1;ACTG1;ATP10B;LPCAT3;PIK3C2A;LEMD3;HSPA8;LRP2;SH3GLB1;GLTP;EPS15;SNAP29;AP2B1;HGS;MITD1;IL7R;SUN1;SGCZ;M6PR;AMPH;RTP3;PLEKHA3;SH3KBP1;SYNJ1;REEP3;PDCD6IP;ANK3;SPAST
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6023085692868138,-1.492733708935441,0.05,0.4037851631814154,1.0,6/16,12.47%,ROCK2;GSN;KANK1;RIPOR2;PTK2B;BCAS3
prerank,receptor-mediated endocytosis (GO:0006898),0.47187910438653324,1.4914246868982894,0.010126582278481013,0.4698335199487793,1.0,31/132,12.31%,TFRC;DNM3;INSR;STAB1;ARHGAP27;CAV1;SCARF1;FNBP1L;HIP1R;RAB31;SCARB1;RAMP2;CALCRL;DNAJC13;GRB2;PIKFYVE;RAMP3;PIP5K1C;INPP5F;LRP1B;DNM2;FCHO2;AP2M1;CXCR2;CAV2;LRP2;AMN;CD163;SYK;EPS15;AP2B1
prerank,muscle cell differentiation (GO:0042692),0.5794540073778881,1.4908530149645456,0.054365733113673806,0.4698529733208777,1.0,7/32,2.75%,SYNE1;NEBL;TMEM204;MRTFB;TBX1;MRTFA;MEF2C
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.529775942199582,-1.490615951576005,0.04810126582278481,0.40731715535957563,1.0,9/28,14.13%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5886486297011722,-1.490487241300411,0.05620608899297424,0.4050644674432169,1.0,4/17,5.34%,PID1;NUPR1;HDAC4;PPARA
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4823633676937035,1.4904114998545932,0.013888888888888888,0.46935412828644085,1.0,19/98,8.89%,SLCO1C1;PDGFB;INSR;XDH;FASN;PPARD;NFKBIA;IFNAR1;IL10RB;WNT7A;GRB2;RAMP3;INPP5F;TBC1D5;KLF4;ACACB;NR1H2;TGFB1;GREM1
prerank,secondary palate development (GO:0062009),0.6820468205741944,1.4902192165589263,0.0743362831858407,0.46808708304120833,1.0,3/14,4.25%,LEF1;TGFB2;WNT7A
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5491992510112726,-1.490195498782187,0.05555555555555555,0.4032964536549419,1.0,7/21,8.15%,SULF1;EXT1;SULF2;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2
prerank,regulation of anoikis (GO:2000209),0.6399714179145523,1.4887414275670725,0.07504363001745201,0.4712174921949852,1.0,7/19,11.88%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,regulation of glucose import (GO:0046324),-0.51725952878583,-1.4873053503328773,0.03814713896457766,0.40895545265571276,1.0,12/30,8.52%,PID1;IGF1;PRKAG2;APPL2;ENPP1;IRS1;RHOQ;OSBPL8;PRKCI;IRS2;SELENOS;GRB10
prerank,positive regulation of cellular component organization (GO:0051130),0.4770890316464636,1.4867832228924118,0.016282225237449117,0.4758317081669822,1.0,13/107,5.96%,IGF1R;ATP10A;TFRC;SHANK3;INSR;DAB2IP;TGFB2;TIRAP;NEDD4L;RAPGEF3;FNIP2;TAL1;BIK
prerank,fat cell differentiation (GO:0045444),-0.45421650273873837,-1.4858415086349481,0.015151515151515152,0.4108611540056579,1.0,17/57,14.77%,PID1;WNT5B;SMAD6;OSBPL8;PPARGC1A;FAM120B;PER2;ATF5;C1QTNF3;CLIP3;BBS9;MKKS;MAFB;NR4A1;EP300;METRNL;TMEM120A
prerank,smoothened signaling pathway (GO:0007224),-0.5037929382501372,-1.4854335982492557,0.043701799485861184,0.4094700684332829,1.0,13/32,23.62%,GLI3;GLI2;CC2D2A;SMO;EVC2;GLI1;DYRK2;PTCH2;STIL;TMEM231;PTCH1;TMEM17;STK36
prerank,regulation of potassium ion transport (GO:0043266),-0.5156946692196741,-1.4851532258297675,0.0316622691292876,0.40763334135325524,1.0,8/31,11.14%,ANK2;ACTN2;FHL1;KCNIP3;CD63;DLG1;CACNA1D;PTK2B
prerank,positive regulation of GTPase activity (GO:0043547),0.44354575324714296,1.4847563259311236,0.013447432762836185,0.480524537533438,1.0,38/188,8.52%,ITGA6;DOCK9;TBC1D4;SRGAP2;RAPGEF2;ARHGAP27;ARHGEF15;NET1;BCAR3;F11R;TBC1D14;AGRN;TBC1D22A;RAPGEF1;SIPA1L2;CD40;SIPA1;TIAM1;ABR;RALGAPA1;TBC1D12;SNX13;RAPGEF3;TGM2;TBC1D2;CCR7;USP6NL;MAPRE2;RSU1;TBC1D5;RAP1GDS1;RASGRP2;ARHGAP25;PKP4;ARHGEF5;PIN1;CAV2;ARHGEF7
prerank,protein localization to cell-cell junction (GO:0150105),0.6631948370383297,1.484747723921193,0.06739526411657559,0.47867448463073536,1.0,5/15,3.99%,TJP1;TJP2;F11R;ACTB;LSR
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4858897974045221,1.4840882470585781,0.024691358024691357,0.4792240852045107,1.0,20/94,11.35%,PLCB1;IL1R1;NFKBIA;NOD1;NOD2;PELI1;MAP3K8;IKBKB;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;PSMD8
prerank,copper ion homeostasis (GO:0055070),0.6532389514273778,1.4840514368807225,0.06315789473684211,0.47745586848350186,1.0,4/17,5.15%,APP;ATOX1;SLC31A1;XIAP
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5777817973005598,1.4839552778571288,0.056451612903225805,0.4759815517301918,1.0,14/32,10.41%,JCAD;KDR;MMRN2;NOTCH1;HDAC9;HDAC7;STARD13;GATA2;DLL4;CARD10;KLF4;MAP3K3;PIK3C2A;PDCD10
prerank,endothelial cell proliferation (GO:0001935),0.646257661611222,1.4838894874585649,0.06368330464716007,0.47439055459124996,1.0,4/17,3.18%,TEK;CD34;BMPR2;ACVRL1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5442124093741016,-1.48371054419273,0.07363420427553444,0.4093121482565844,1.0,7/23,15.29%,PLCE1;AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,cell-cell junction organization (GO:0045216),0.5021194924263257,1.483274564752237,0.017118402282453638,0.4745811003501625,1.0,19/79,8.09%,OCLN;TJP1;CLDN5;CADM1;LIMS2;TGFB2;GJC1;TJP2;CDH2;NECTIN4;CDH20;CTNND1;CDH8;MARVELD2;PVR;DCHS1;CDH19;PKP4;TGFB1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6692560999753681,1.4832599651297493,0.07581227436823104,0.47280354984751705,1.0,4/15,6.88%,MFSD2A;SCARB1;FBXW7;NR1H2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.6420974068385275,-1.4832032092180094,0.05152224824355972,0.40817877327033086,1.0,8/13,22.68%,DDO;ASPA;ACOT8;GOT1;GLUL;QPRT;GOT2;MTHFS
prerank,anterior/posterior pattern specification (GO:0009952),-0.45976395398964415,-1.4830651745385306,0.027700831024930747,0.4060307188016558,1.0,23/53,20.30%,WLS;HOXC4;HOXC6;HOXB3;PCSK5;HOXA3;HOXA5;HOXB4;HOXB6;TGFBR1;HOXA7;HEYL;BMP2;HOXB5;SKI;HOXC5;HOXA9;HOXA6;DDIT3;HEY2;ATP6AP2;HOXD3;HES6
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.6090193488591473,1.482700446897713,0.05326460481099656,0.47296415703997496,1.0,8/26,13.79%,NOD1;NOD2;IFIH1;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3
prerank,nitrogen compound transport (GO:0071705),0.4616329426240439,1.482313271341062,0.011889035667107,0.47243602796909684,1.0,24/141,10.98%,SLC6A6;SLC7A5;SLC7A1;CERT1;ABCG2;SLC6A2;SLC38A5;ATP11B;SLC43A2;RAMP2;CALCRL;RAMP3;SLC52A2;CMTM6;SEC14L1;LRP1B;SCAMP1;CHMP1B;SLC3A2;SLC52A3;SLC18A1;ARL6IP5;LRP2;AMN
prerank,chondrocyte differentiation (GO:0002062),-0.4994917334665618,-1.4813312601865158,0.034031413612565446,0.4080334330147791,1.0,11/32,9.47%,SULF1;SOX5;WNT5B;BMP4;OSR1;SULF2;CREB3L2;SLC39A14;RUNX2;CCN3;SOX6
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4649109538946947,1.4801549713524202,0.014588859416445624,0.4774751002670371,1.0,32/140,8.84%,CHN2;MCF2L;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;SRGAP1;ARAP2;RASGRF2;NET1;PLEKHG5;ARHGEF2;KALRN;FAM13A;TIAM1;ABR;CD2AP;STARD13;TGM2;RHOB;OCRL;DEPDC7;ARHGAP23;SOS1;ARHGAP25;ARHGEF12;ARHGEF5;PREX1;ARHGEF7;OPHN1;ARHGAP4
prerank,spinal cord development (GO:0021510),-0.6439215779218342,-1.4799969250079537,0.08260869565217391,0.40949214813932,1.0,5/12,4.66%,GLI2;PKD1;VIT;LOXL3;PKD2
prerank,protein secretion (GO:0009306),-0.45113307091381477,-1.4789555356293602,0.021739130434782608,0.40989400736761705,1.0,10/56,9.51%,WLS;PCSK5;STEAP3;ABCA1;TANGO2;ANXA1;RCN3;ARFGAP3;TANGO6;CANX
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.528936630322132,1.4788183158778647,0.04579025110782865,0.4799857610938063,1.0,5/49,2.65%,SGMS1;BCL2L1;CAV1;PLAUR;PTPMT1
prerank,response to progesterone (GO:0032570),0.6495276953819213,1.4786501208111298,0.07291666666666667,0.4786630953813811,1.0,3/18,1.75%,ABHD2;TGFB2;CAV1
prerank,type I interferon signaling pathway (GO:0060337),0.5532046197102496,1.4778124598317013,0.0375,0.4777941185702221,1.0,12/41,10.15%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;XAF1;IRF9;STAT1;IRF5;BST2;OASL
prerank,cellular response to type I interferon (GO:0071357),0.5532046197102496,1.4778124598317013,0.0375,0.4777941185702221,1.0,12/41,10.15%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;XAF1;IRF9;STAT1;IRF5;BST2;OASL
prerank,neutrophil migration (GO:1990266),0.523348073914555,1.4774292841964367,0.029455081001472753,0.4772262445477759,1.0,11/58,11.86%,BSG;PECAM1;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,glucose import (GO:0046323),0.6876418884109733,1.4772558654823924,0.09340659340659341,0.4761490093546395,1.0,2/13,5.10%,SLC2A1;SORT1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7199904592368715,1.4765319650567446,0.07129094412331406,0.4767481082599795,1.0,2/11,0.22%,IGF1R;PLCB1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5162481871283919,1.4763222447321604,0.033576642335766425,0.47572111641742537,1.0,11/59,6.91%,HMCN1;PTPRM;BSG;PECAM1;CADM1;ROBO4;CDH2;DSCAML1;NECTIN4;PVR;CNTN2
prerank,camera-type eye development (GO:0043010),-0.5349202094472932,-1.4758673965400007,0.03953488372093023,0.4162684623170265,1.0,9/25,13.29%,CACNA1C;FBN1;EFEMP1;LAMA1;CYP1B1;IFT122;FBN2;SKI;NF1
prerank,cardiac atrium morphogenesis (GO:0003209),0.6513652457833815,1.4750496580980554,0.07017543859649122,0.4780436553644818,1.0,6/16,5.01%,ENG;BMPR2;TGFB2;ZFPM1;NOTCH1;DLL4
prerank,regulation of developmental growth (GO:0048638),0.5904156077264384,1.4747838040596846,0.06440677966101695,0.47717710748502495,1.0,4/29,1.57%,PLCB1;MFSD2A;INSR;APP
prerank,peptide metabolic process (GO:0006518),-0.4282327802614596,-1.4743655180688728,0.03594771241830065,0.41819801311496013,1.0,18/75,15.69%,CPQ;AEBP1;MGAT3;PCSK5;DMD;ANPEP;GSTT1;BACE2;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;IDE;PSEN1;GSTA3;GSTM2;HM13
prerank,response to exogenous dsRNA (GO:0043330),0.6407284469945127,1.473864085262549,0.06502636203866433,0.4783740798692325,1.0,6/18,8.98%,CAV1;IFIH1;TLR3;ZCCHC3;RALB;SLC3A2
prerank,calcium ion transport (GO:0006816),-0.4023701815482056,-1.4728659805773943,0.008771929824561403,0.4197125977685508,1.0,30/113,13.70%,SLC24A3;TRPM3;CACNA1C;ANK2;NALCN;ITPR1;PKD1;STIM1;SLC8A3;ANO6;CACNA2D1;RAMP1;PKD2;TRPC3;CACNA1G;TRPM6;P2RX4;SLC8A1;CACNA1D;TRPC6;ITGAV;TRPM4;SLC24A5;TRPC4;CACNB2;TRPC4AP;PSEN1;PANX1;ORAI2;CRACR2A
prerank,inorganic ion transmembrane transport (GO:0098660),-0.6285658699784843,-1.4725489491606798,0.07207207207207207,0.4181699834823092,1.0,4/12,15.15%,PKD2;ABCC9;TRPM4;KCNJ8
prerank,amino sugar metabolic process (GO:0006040),0.7260461774832333,1.4719114933596051,0.08639705882352941,0.48294125658741427,1.0,3/10,8.00%,CSGALNACT1;ST3GAL1;ST6GAL1
prerank,amide biosynthetic process (GO:0043604),0.5245862346414489,1.4712703135709182,0.054773082942097026,0.4834015450508816,1.0,11/47,15.00%,SGMS1;SGMS2;DEGS2;CERS4;TLCD3B;SPTLC2;SLC25A15;DEGS1;SPTLC1;CLN8;FA2H
prerank,positive regulation of macrophage activation (GO:0043032),-0.5643000039370948,-1.4709930303618204,0.07673267326732673,0.4201004362417272,1.0,4/17,14.75%,LBP;THBS1;TNIP2;TLR4
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6003812215362809,-1.470747393803941,0.053488372093023255,0.41834100213791625,1.0,4/16,5.34%,APPL2;APOD;ADCY7;PPARA
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.57183374214222,1.470565195055172,0.04838709677419355,0.48397060944511333,1.0,4/33,5.26%,LEF1;FES;CTNNBIP1;CD4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6426980917601935,1.4700282643133362,0.07962962962962963,0.4839772990475541,1.0,5/16,5.01%,JCAD;PPP1R16B;APLNR;GATA2;DLL4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.42983530824132743,-1.466912467242015,0.019801980198019802,0.4266733220466323,1.0,17/73,6.76%,FSTL1;SULF1;BMPR1A;FOXD1;NBL1;CRIM1;BMP4;BMPER;SMAD6;HTRA3;TWSG1;RBPJ;ZNF423;RBPMS2;SFRP4;CCN1;SMAD9
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6276193141434724,1.4667419295024642,0.08098591549295775,0.49297159908779065,1.0,2/18,0.45%,OCLN;SLC2A1
prerank,response to molecule of bacterial origin (GO:0002237),0.4981397337831148,1.4665714208390404,0.037142857142857144,0.4916910361641684,1.0,19/69,15.03%,NOS3;TIRAP;GCH1;IFNAR1;TNFRSF11A;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;IRF5;ADAM17;S100A8;CYRIB;SLPI;HMGB2;TNFAIP3;INAVA
prerank,positive regulation of dendrite extension (GO:1903861),0.642418384368801,1.4662131779484753,0.06643356643356643,0.491121607826738,1.0,10/17,20.25%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,response to muramyl dipeptide (GO:0032495),0.6790475401828906,1.465559349694128,0.10968921389396709,0.49161808531632156,1.0,4/12,7.15%,ARHGEF2;NOD1;NOD2;IRF5
prerank,regulation of Notch signaling pathway (GO:0008593),0.4922870821321412,1.465550806478855,0.021994134897360705,0.48994161040155576,1.0,16/76,6.44%,EGFL7;EPN2;TGFB2;NOS3;NOTCH4;JAG2;TSPAN5;NOD2;PRAG1;TSPAN14;NOTCH1;MFNG;GATA2;DLL4;MAML2;FBXW7
prerank,positive regulation of interleukin-17 production (GO:0032740),0.6144815802431015,1.4655221287592313,0.06335616438356165,0.4883297200667414,1.0,6/22,14.30%,SLC7A5;NOD2;TGFB1;CCL1;IL15;RFTN1
prerank,lipid modification (GO:0030258),0.5541219777117553,1.4654470142946696,0.05958132045088567,0.4869363814361919,1.0,9/37,11.93%,SGPP2;DGKH;MBOAT1;CYP2E1;PLPP6;DGKI;DGKE;LPCAT3;DGKZ
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.445892655006943,1.4651185978439796,0.015584415584415584,0.4863021949687028,1.0,19/150,6.46%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;GAB1;CCR7;FYN;RET
prerank,organic substance transport (GO:0071702),0.46419677059034214,1.4633806806235037,0.018741633199464525,0.49006667557852773,1.0,24/121,10.98%,ABCG2;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;SLC6A2;RAMP2;CALCRL;ABCG1;RAMP3;CMTM6;ABCA3;LRP1B;CHKA;SCAMP1;CHMP1B;ABCA7;TAP2;SLC18A1;ARL6IP5;LRP2;ABCD1;AMN
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6038889107683397,1.4633534444503775,0.06597222222222222,0.4884660771036412,1.0,2/25,1.75%,TMTC2;CAV1
prerank,regulation of axon extension (GO:0030516),0.5513628731479936,1.4630563352881978,0.05237315875613748,0.4877638396004657,1.0,7/37,8.14%,SEMA7A;MACF1;NTN1;DIP2B;DBNL;DNM2;TWF2
prerank,prostanoid biosynthetic process (GO:0046457),-0.6046718113942623,-1.4623763589705592,0.06818181818181818,0.437073479742591,1.0,4/15,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,negative regulation of defense response to virus (GO:0050687),-0.6669865407690156,-1.4621818172203314,0.08444444444444445,0.4351807348001946,1.0,5/10,20.58%,PPM1B;PCBP2;C1QBP;MUL1;TARBP2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6432970110224714,1.4617019937430245,0.07936507936507936,0.4903482347505004,1.0,2/15,1.56%,PRKCH;TRIM16
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6664861625694342,1.461225922246294,0.09391304347826086,0.49016768071719213,1.0,5/14,4.17%,PTK2;JAK3;PXN;LYN;SOCS2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7117919780052151,1.4608061443633067,0.08317929759704251,0.4897859131174704,1.0,3/11,4.35%,NOS3;GCH1;CALM1
prerank,cellular response to dsRNA (GO:0071359),0.6785635765468,1.4594884220851931,0.0718132854578097,0.4922757317522786,1.0,5/15,10.56%,CAV1;IFIH1;ZCCHC3;RALB;PDE12
prerank,cAMP metabolic process (GO:0046058),-0.6278932994516591,-1.4593818780467127,0.05787037037037037,0.4410771211071698,1.0,7/13,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PTHLH;ADCY6
prerank,regulation of glucose metabolic process (GO:0010906),-0.4908351395994247,-1.4581890588137085,0.04645476772616137,0.44216370762802704,1.0,8/34,10.23%,PDK1;IRS1;OGT;RORA;IRS2;PRKN;SELENOS;SLC45A3
prerank,regulation of protein localization to nucleus (GO:1900180),0.5453057336046584,1.4578432872932052,0.0405616224648986,0.49587684564837725,1.0,10/43,12.05%,TFRC;MFHAS1;WWTR1;CARD10;LIMK2;PIN1;TGFB1;LAMTOR5;FERMT2;ORMDL3
prerank,regulation of cell-cell adhesion (GO:0022407),0.5610358810194012,1.4577687582051893,0.046251993620414676,0.49443700532174845,1.0,8/39,8.09%,PTPRG;PODXL;MAGI1;PTK2;SMAD7;FUT9;PTPRR;TGFB1
prerank,MAPK cascade (GO:0000165),0.4195530809619981,1.4576283619486574,0.0034883720930232558,0.49318621402844814,1.0,50/295,9.52%,KITLG;TEK;RASGRP3;SHANK3;RASAL2;SPTBN1;PDGFB;KDR;BCL2L1;DAB2IP;RAPGEF2;RASGRF2;RASGRP4;PTK2;MEF2C;DUSP7;JAK3;FGF13;MEN1;MAP3K8;IKBKB;CALM1;GRB2;FGF16;CAMKK2;ZDHHC9;IL17RD;FYN;SOS1;MAPK3;ABHD17A;LGALS9;RET;PSMB3;LRRC7;RGL2;RASAL1;PSMD11;TGFB1;TGFA;SPTAN1;MARK3;SHC3;PSMC6;LYPLA1;CCM2;PAK1;MAP3K3;PPP1CB;PSME2
prerank,oogenesis (GO:0048477),0.6532396059644421,1.4561084058223874,0.07243816254416961,0.49655596606618824,1.0,4/15,8.49%,NANOS3;NANOS2;NANOS1;PTN
prerank,transition metal ion transport (GO:0000041),0.5621174808580054,1.4554225772126892,0.06209150326797386,0.49712233194245453,1.0,6/35,4.15%,TFRC;SLC39A8;ATOX1;SLC30A1;ATP2C1;SLC31A1
prerank,negative regulation of complement activation (GO:0045916),-0.6423599547122765,-1.4540292287112382,0.06079664570230608,0.4518504641241262,1.0,2/10,1.85%,SERPING1;CD55
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5549293211910116,-1.4538505925211342,0.061124694376528114,0.4498577563642479,1.0,9/19,21.62%,DDO;ASPA;ALDH7A1;GOT1;PHYKPL;HYKK;PIPOX;GOT2;AASS
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6712055307400369,1.4529999276887777,0.08534322820037106,0.5031514342366844,1.0,2/12,0.85%,DDC;MAOA
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6428606991320857,1.4529093621019966,0.07922535211267606,0.501721366774637,1.0,3/16,6.88%,MFSD2A;SCARB1;NR1H2
prerank,acylglycerol metabolic process (GO:0006639),0.5587772974829763,1.4520617099423012,0.05337519623233909,0.502797882752569,1.0,6/37,7.90%,ABHD2;DGKH;CAV1;DGKI;DGKE;AWAT2
prerank,regulation of dendrite extension (GO:1903859),0.6353216609009104,1.4519858410975297,0.06457242582897033,0.5013916265680276,1.0,10/18,20.25%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,lipid translocation (GO:0034204),0.6174959352420083,1.4508488144230922,0.08823529411764706,0.5034049084804891,1.0,7/21,9.75%,ATP10A;ATP8A1;ATP11B;ATP11A;ABCA7;ATP11C;ATP10B
prerank,phosphatidylcholine metabolic process (GO:0046470),0.48679131233337836,1.4506808688108392,0.04678362573099415,0.5023454304143248,1.0,14/70,13.32%,MFSD2A;MBOAT1;PLA2G4B;SLC44A5;ABCA3;NR1H2;CHKA;ENPP2;LPCAT3;LIPC;CEPT1;PNPLA8;CSNK2B;LPIN3
prerank,stabilization of membrane potential (GO:0030322),-0.5844273099547335,-1.4500917098105754,0.07226107226107226,0.4583167798701721,1.0,2/16,3.08%,KCNK2;KCNK5
prerank,regulation of interferon-gamma production (GO:0032649),0.4814200307503701,1.4499181827125573,0.03941605839416058,0.5032646274806151,1.0,14/71,12.52%,SLC7A5;IL1R1;ZFPM1;PDE4D;CCR7;TLR3;LGALS9;TLR7;PDE4B;FOXP3;EBI3;TLR8;VSIR;CYRIB
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5584138327792953,1.4475110901842614,0.06456692913385827,0.5095500071702547,1.0,15/33,12.99%,MMRN2;RGCC;MEF2C;ACVRL1;NOTCH1;VASH1;STARD13;DLL4;CARD10;KLF4;TGFB1;AGTR2;PDCD10;PPARG;CSNK2B
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5193250953544974,-1.4466775003216306,0.06345177664974619,0.46568063015501565,1.0,11/25,15.71%,ERRFI1;SLC6A9;CBLB;SNX6;PPARA;TSG101;EPHB2;CNRIP1;ZFYVE28;ACE2;GPRC5A
prerank,heart looping (GO:0001947),0.5533531522718039,1.446453677196167,0.04595879556259905,0.5112889654918108,1.0,7/39,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,BMP signaling pathway (GO:0030509),-0.42555482341904766,-1.445778615415908,0.022435897435897436,0.46567600743757465,1.0,14/62,6.76%,BMP6;TGFBR3;BMPR1A;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.460526331991985,-1.4456385680261492,0.04155124653739612,0.4635342273008293,1.0,15/46,12.50%,IGF1;PDGFRB;OGN;IGFBP5;BMP4;ELN;APOD;IL18;THBS1;RBPMS2;IGFBP3;CCN4;CDH13;MFN2;XRCC5
prerank,smooth muscle cell differentiation (GO:0051145),0.6878654478722722,1.4453556458453047,0.0852575488454707,0.5130492870494913,1.0,5/12,3.28%,TMEM204;MRTFB;MRTFA;MEF2C;APLNR
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5529122111636651,-1.4451382722617452,0.06987951807228916,0.46254999109796896,1.0,8/20,10.27%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;LACC1;ATP1B2;SLC8A1;SLC9A1
prerank,energy reserve metabolic process (GO:0006112),-0.5601053226710802,-1.4449909581583513,0.06791569086651054,0.46049549887205316,1.0,8/19,10.73%,PID1;PRKAG2;LEPR;PHKB;PYGM;GFPT1;GFPT2;PPP1R3C
prerank,regulation of endothelial cell migration (GO:0010594),0.48102299590890174,1.4437617055247645,0.02920723226703755,0.5164333979148709,1.0,17/85,5.30%,TEK;PTPRM;ETS1;KDR;DAB2IP;BMPR2;FLT4;PTK2;SP100;SCARB1;ACVRL1;PRKD1;PRKD2;VASH1;PRCP;DLL4;RHOB
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6032965581233114,1.4436883013499422,0.08747855917667238,0.5149968836349927,1.0,4/22,3.88%,MFHAS1;DAB2IP;TIRAP;LYN
prerank,lamellipodium assembly (GO:0030032),0.5883357407327338,1.4435383509366453,0.07263513513513513,0.5138467426768607,1.0,9/26,11.43%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,response to lipid (GO:0033993),0.4635306375471995,1.442667153239736,0.02857142857142857,0.5151588625093784,1.0,26/105,13.76%,NOS3;ACER2;TRIM16;PPARD;TIRAP;GCH1;IFNAR1;TNFRSF11A;FOXO1;PELI1;ABCG1;SOCS2;NOS2;CTNNB1;NOCT;PALM3;CD6;LGALS9;TGFB1;ADAM17;S100A8;PAQR7;SLPI;PPARG;SOX9;HMGB2
prerank,Rac protein signal transduction (GO:0016601),0.6319795349749115,1.4421274482533915,0.09945750452079566,0.5152198642941717,1.0,7/18,11.43%,ELMO1;TIAM1;EPS8;DBNL;NCKAP1;CYFIP1;RAC1
prerank,positive regulation of cytokine production (GO:0001819),0.4206955734338147,1.4417319450549404,0.002280501710376283,0.5149547928582634,1.0,52/292,13.02%,SLC7A5;PLCB1;SPTBN1;CADM1;CD34;APP;IL1R1;TIRAP;IL6R;FLT4;CD200;AFAP1L2;ARHGEF2;RGCC;NOD1;LRRFIP1;CD40;ZFPM1;NOD2;PRKD2;IFIH1;GBP5;NOS2;CTNNB1;PDE4D;POU2AF1;CD6;HYAL2;CCR7;CD4;TLR3;MRE11;CCDC88B;LGALS9;IRF5;TLR7;TGFB1;PDE4B;MALT1;EBI3;ADAM17;AGER;LAMTOR5;CCL1;TLR8;PNP;HIF1A;SYK;C1QTNF4;CYRIB;IL15;RAB1A
prerank,regulation of microtubule polymerization (GO:0031113),0.5329866397747673,1.4415197934453112,0.06666666666666667,0.5139943154584229,1.0,10/40,13.45%,OCLN;FES;STMN1;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;MAPRE3;CDH5
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5435989998545278,1.4413864194101627,0.0625,0.5127162134423029,1.0,9/38,10.45%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;SP100;RFFL;FAIM;CASP8
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4815458194478748,1.4412429882459385,0.041193181818181816,0.5115884385445642,1.0,17/73,10.41%,TFRC;SH2D3C;APP;CAV1;BCAR3;PRKD1;PRKD2;RAPGEF3;FNIP2;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;CNOT9;AKAP9;PDCD10
prerank,iron ion transmembrane transport (GO:0034755),0.7039642351126418,1.4409707569259191,0.09392265193370165,0.5108208525573116,1.0,2/10,1.24%,SLC40A1;SLC39A8
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5163452370960052,1.4409675124830847,0.048,0.5092407392779895,1.0,15/49,14.07%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;NOS2;HYAL2;TLR3;LGALS9;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,axon extension (GO:0048675),-0.5378213516441752,-1.4408783974860933,0.05238095238095238,0.4704249813232669,1.0,11/23,21.59%,ALCAM;AUTS2;SLIT2;ULK2;SPG11;PPP3CB;USP9X;MAP1B;SEMA5A;SEMA3F;CDK5
prerank,negative regulation of GTPase activity (GO:0034260),0.5964523078432462,1.4407989604034948,0.08417508417508418,0.5081937395403289,1.0,7/22,11.49%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;PLXNB3;HRAS
prerank,regulation of heart contraction (GO:0008016),-0.40562775355447855,-1.440396988423736,0.02857142857142857,0.4693885002873499,1.0,16/90,7.24%,ATP1A2;CELF2;ANK2;ITPR1;TPM1;STIM1;SLC8A3;DMPK;ASPH;CAMK2D;ABCC9;ATP1B3;TMEM65;ATP1B2;P2RX4;SLC8A1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.59526473861126,-1.440006390000325,0.09534883720930233,0.4680879863262023,1.0,7/13,24.90%,DDX5;PLA2R1;ATM;SPRED1;HIC1;ATR;MSX1
prerank,regulation of calcium ion import (GO:0090279),0.6054858193666355,1.4398858636714915,0.10664335664335664,0.5097149139133136,1.0,5/21,6.12%,PDGFB;CXCL12;SLC30A1;CTNNB1;FYN
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5782871325005374,1.4394383951412077,0.08771929824561403,0.5095355941328624,1.0,3/24,3.18%,DACH1;BMPR2;ACVRL1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5445286170710434,-1.4388870518060517,0.06982543640897755,0.46894313832634116,1.0,7/22,10.98%,IGF1;ROCK2;CAMK2D;P2RX4;PRKCA;SLC9A1;PARP1
prerank,glutamate receptor signaling pathway (GO:0007215),0.5516593208161373,1.4388840171853727,0.06929133858267716,0.5096740714289565,1.0,12/37,14.46%,PLCB1;APP;GNAQ;HOMER2;GRID2;HOMER1;GRIN3B;GRIA4;GRIN2B;GRIK2;GRIK1;GRM7
prerank,fatty acid biosynthetic process (GO:0006633),0.5017022787317669,1.438631813392047,0.05571847507331378,0.5089604730699138,1.0,12/63,14.31%,ABHD2;ELOVL7;TECRL;CYP2E1;ELOVL5;LIPC;ABCD1;ELOVL6;LTA4H;HACD2;DEGS1;HSD17B8
prerank,positive regulation of B cell activation (GO:0050871),0.516831437588942,1.4376686114655277,0.06580829756795423,0.5105996262320089,1.0,7/50,6.58%,TFRC;TIRAP;MEF2C;CD40;NOD2;CD38;SHLD1
prerank,heart contraction (GO:0060047),-0.46937287058654226,-1.4376414860626883,0.058823529411764705,0.4700819947055759,1.0,7/41,10.13%,ATP1A2;SGCD;TPM1;DMD;SLC8A1;ACE;GAA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6154318539983533,-1.4375145384387122,0.08281573498964803,0.4680013999332012,1.0,7/12,19.36%,DMD;WNK4;ATP1B3;ATP1B2;FXYD1;WNK1;WNK3
prerank,defense response to virus (GO:0051607),0.464728473890767,1.4369953883892577,0.034340659340659344,0.5113304593570408,1.0,23/100,11.42%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;BST2;TLR7;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;TLR8;RNASE1
prerank,B cell proliferation (GO:0042100),0.6253764535404011,1.436361226413587,0.08947368421052632,0.5117102653759258,1.0,4/17,8.21%,MEF2C;CD40;CD19;CD79A
prerank,endocrine system development (GO:0035270),-0.5492463162966996,-1.4343770945573622,0.07692307692307693,0.4751443463645571,1.0,11/21,19.53%,GLI2;WNT4;DKK3;SALL1;TGFBR1;SIX1;FOXE1;NF1;WNT11;MDK;HOXD3
prerank,negative regulation of protein processing (GO:0010955),-0.6192309481690601,-1.433471487075081,0.07777777777777778,0.4754096667259344,1.0,7/12,19.06%,GAS1;THBS1;SNX12;LRRK2;SERPINE2;CTSZ;SERPINE1
prerank,cell-cell junction assembly (GO:0007043),0.4898517462956384,1.431044544006001,0.03768115942028986,0.5270718330142953,1.0,17/63,7.09%,TJP1;CLDN5;GJD3;GJC1;CDH2;RAMP2;ACTB;CDH20;SMAD7;CTNND1;CTNNB1;CDH8;PIP5K1C;PKN2;DCHS1;CDH19;PKP4
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6419436267703789,-1.4309584952612138,0.07368421052631578,0.4799368964120493,1.0,2/10,1.89%,GLI3;BMP4
prerank,cellular response to mechanical stimulus (GO:0071260),0.5243051215251225,1.430667987029326,0.05071315372424723,0.5266458447981723,1.0,14/46,14.07%,PDE2A;FAS;F11R;CD40;MAP3K1;PIEZO1;TLR3;MAPK3;CRADD;TLR7;CASP8;TLR8;SOX9;BCL10
prerank,regulation of DNA repair (GO:0006282),-0.45577700733892157,-1.4301753065218525,0.030136986301369864,0.4797797900578783,1.0,4/44,2.10%,EYA2;EYA1;EGFR;EYA4
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.628028942767975,1.430116237294396,0.1088929219600726,0.5266996329807058,1.0,6/16,11.65%,BMPR2;DDAH1;PRCP;NPPA;KLK1;GSK3A
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5378421020577124,-1.4299316185086282,0.07126436781609195,0.4779168284062242,1.0,9/21,12.04%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2;FOXJ2;ADAMTS1;MFN2
prerank,acylglycerol catabolic process (GO:0046464),0.5546940129216088,1.4296719279209067,0.06802721088435375,0.5264652012063425,1.0,4/30,10.76%,ABHD2;LIPE;FABP5;LIPC
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5529787812286924,1.4296367493859925,0.08842443729903537,0.5249812855637128,1.0,9/35,6.71%,FLT1;PTPRM;XDH;CAV1;RGCC;MEF2C;VASH1;DLL4;STAT1
prerank,endoderm formation (GO:0001706),-0.4763282785090772,-1.4295065310671298,0.04591836734693878,0.47681065887303764,1.0,11/35,10.36%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;MMP2;ITGA5;LAMB1;ITGAV
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4702573691008474,-1.4294092078134697,0.06666666666666667,0.47470537500001336,1.0,12/37,14.69%,WDR35;IFT80;DYNC2I1;IFT81;IFT74;DYNC2H1;IFT122;IFT57;CLUAP1;PCM1;WDR19;DYNC2I2
prerank,cellular copper ion homeostasis (GO:0006878),0.6460540970245385,1.4289756031501806,0.1105072463768116,0.525449242807389,1.0,3/14,4.15%,APP;ATOX1;SLC31A1
prerank,Golgi to plasma membrane transport (GO:0006893),0.5207000560161708,1.4285470061735288,0.0662557781201849,0.5251635413227845,1.0,10/47,11.22%,SPTBN1;MACF1;EXOC6B;EXOC6;RAB31;STXBP6;RAB34;AMN;EXOC4;EXOC2
prerank,positive regulation of transferase activity (GO:0051347),0.445467948339666,1.428434512560476,0.022641509433962263,0.5239092670312299,1.0,24/142,8.09%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;CD200;DCUN1D3;HMBOX1;MERTK;SERINC5;CTNNB1;HSP90AB1;CD4;EPHA4;MRE11;MAPK3;FBXW7;KLF4;RET;EPHB4;PIN1;TGFB1
prerank,B cell activation (GO:0042113),0.4976571842159711,1.428274528423603,0.04505813953488372,0.5229221577289357,1.0,22/68,16.54%,TPD52;PTPRJ;MEF2C;JAK3;CD40;HDAC9;ZAP70;HHEX;SLC25A5;CD79A;KLF6;MALT1;ADAM17;CASP8;PRKCB;ZBTB7A;VCAM1;HDAC5;DNAJB9;MSH2;LAT2;ITGA4
prerank,regulation of isotype switching (GO:0045191),0.6481838571781771,1.4282306435989336,0.0933572710951526,0.5215151404577978,1.0,2/14,6.58%,TFRC;SHLD1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6964440471713905,1.4274807395213502,0.10218978102189781,0.5222772936341697,1.0,5/10,6.44%,CXCL12;RAPGEF2;LYN;CCR7;LGALS9
prerank,hepaticobiliary system development (GO:0061008),-0.5357354739283742,-1.4274457451946099,0.06954436450839328,0.47824034792248493,1.0,5/20,8.05%,TGFBR3;WNT4;COBL;PKD2;MET
prerank,actin filament-based transport (GO:0099515),0.6021522559331294,1.4267589721379736,0.0779436152570481,0.5230616263088378,1.0,5/21,6.03%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6815173407346907,1.4267145747549013,0.11623616236162361,0.5216724106699128,1.0,5/11,12.15%,RAPGEF2;MEF2C;LYN;LGALS9;PIK3CB
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.44761821500296506,-1.42654088433368,0.019830028328611898,0.4785005409772931,1.0,11/51,6.76%,FSTL1;FBN1;BMPR1A;NBL1;CRIM1;BMPER;SMAD6;HTRA3;GREM2;RBPMS2;SMAD9
prerank,modulation by host of symbiont process (GO:0051851),0.5504907664449302,1.425793888279568,0.08333333333333333,0.5231395226856446,1.0,1/31,0.03%,LEF1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5644350996843157,-1.4254528370921495,0.08425720620842572,0.4793552947722342,1.0,2/17,1.85%,BMP6;CD55
prerank,stress-activated MAPK cascade (GO:0051403),0.4960772102372038,1.423972186328173,0.057777777777777775,0.5271799433587929,1.0,13/61,9.77%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2;MAP3K8;IKBKB;MAPK3;LGALS9;IRAK2;CCM2;UBE2V1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.48535198244846006,1.422899954064407,0.04597701149425287,0.529134602187068,1.0,16/68,12.10%,APP;TIRAP;IL6R;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;AGER;TLR8;SYK;C1QTNF4
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.6231069309155908,1.4228399623684125,0.10211267605633803,0.5277526500974247,1.0,3/16,7.37%,CADM1;PVR;CD160
prerank,positive regulation of proteolysis (GO:0045862),-0.4377853784640932,-1.4228100374511785,0.04,0.4848247570052932,1.0,21/55,20.69%,CCBE1;CYFIP2;ASPH;OGT;ADAM9;RCN3;APOE;SNX9;PERP;BTRC;TBC1D10A;NKD2;CTSH;FBXW11;ATP5IF1;SNX33;NRDC;PACSIN3;CLN6;ADRA2A;ADAM8
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.612978336542153,1.4225800876889698,0.10332749562171628,0.5268701914796002,1.0,3/17,7.37%,CADM1;PVR;CD160
prerank,xenobiotic transport (GO:0042908),0.6276705596052549,1.4223816369998246,0.09012131715771231,0.5260246927145584,1.0,2/17,0.38%,SLC7A5;ABCG2
prerank,cellular response to insulin stimulus (GO:0032869),0.45318546667302767,1.4221913820811027,0.033288948069241014,0.5250885904734409,1.0,30/124,14.06%,IGF1R;GRB14;TBC1D4;NAMPT;INSR;BCAR3;RAB31;FOXO1;PIK3R3;HDAC9;ATP6V0A1;GRB2;GAB1;BAIAP2;DENND4C;SOS1;SLC25A33;SORBS1;PKM;AP3S1;CAV2;PIK3C2A;GRB7;GSK3A;CEACAM1;ZFP36L1;PPARG;LPIN3;SH2B2;PDE3B
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.633816354738384,-1.4217223543961777,0.07692307692307693,0.48559686521974854,1.0,5/11,19.17%,WNT4;BMP5;BMP2;NR1H4;STAR
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.564205407724595,-1.4212879539360654,0.07838479809976247,0.48456275962763884,1.0,3/18,2.31%,EGFR;BMP4;DDX5
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5579641771066579,1.4212534730135835,0.07142857142857142,0.5266522463255023,1.0,5/33,4.52%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,regulation of MAPK cascade (GO:0043408),0.4379129638568002,1.4210358975430402,0.015384615384615385,0.5258519546327625,1.0,37/157,12.68%,FLT1;IGF1R;TEK;JCAD;PDGFB;KDR;INSR;DAB2IP;CAV1;FAS;TBX1;FLT4;BCAR3;PHLPP1;PTPRJ;DUSP3;LYN;CD4;PAK5;MAPK3;ADRA2B;RET;ARHGEF5;ABCA7;IQGAP1;CAV2;P2RX7;GREM1;PAK1;DUSP1;HRAS;SYK;CEACAM1;MAP4K4;GDF15;EPHB1;WWC1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.39033448267280646,-1.4207607841461505,0.007142857142857143,0.4837529165849964,1.0,37/108,13.23%,TRABD2B;WLS;SULF1;LRP1;PTK7;FGFR2;GPC3;RNF43;DCDC2;MDFIC;RSPO3;KANK1;SULF2;WWOX;SALL1;DAAM2;RSPO2;SFRP4;FZD7;DACT1;CTNND2;PRKN;FOXL1;GRB10;NXN;AXIN1;VGLL4;CDK14;BTRC;LRRK2;CXXC4;ESR1;PSEN1;BMP2;EMD;SKI;NKD2
prerank,membrane lipid metabolic process (GO:0006643),0.5833255766093578,1.4206514487104815,0.08644067796610169,0.5256870227448256,1.0,9/22,13.84%,ST3GAL6;B4GALT4;MGST2;ACER1;GAL3ST1;CERKL;ST6GALNAC4;CERK;SPTLC1
prerank,sodium ion transport (GO:0006814),-0.39819017647335786,-1.4187493371233297,0.018315018315018316,0.48769314222231697,1.0,17/85,7.24%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;PKD2;ATP1B3;SLC5A5;SLC6A1;SLC5A6;SLC9B2;SLC8A1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6193000878735974,-1.4183441594914412,0.0744920993227991,0.486597867138085,1.0,5/11,8.27%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH
prerank,regulation of cell-substrate adhesion (GO:0010810),0.525569225599104,1.4180967549564207,0.06602254428341385,0.5323824569984792,1.0,12/42,13.54%,NDNF;PDGFB;FZD4;CORO2B;PTK2;NOTCH1;RSU1;ATXN3;SPOCK1;RAC1;PIK3CB;MINK1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6707886111193959,1.417483088731227,0.08990825688073395,0.5329100159557413,1.0,3/13,4.35%,NOS3;GCH1;CALM1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39491420300337027,1.416759492803167,0.0010683760683760685,0.5336933446267471,1.0,87/509,12.33%,FLT1;IGF1R;TFRC;KITLG;TEK;HIP1;MFHAS1;JCAD;PDGFB;KDR;INSR;BCL2L1;DAB2IP;ENG;TGFB2;RAPGEF2;TNFRSF19;PDGFD;APP;CAV1;TBX1;TIRAP;FLT4;PLEKHG5;TRIM25;BCAR3;TNFSF10;TRIM14;PTPRJ;PTK2;NOD1;CD40;NOD2;PELI1;PRKD1;PRKD2;ATP2C1;VWF;LYN;TGM2;IKBKB;GRB2;CD19;FGF16;RAMP3;HSP90AB1;GAB1;CCR7;CD4;WDR59;TLR3;ACTN4;FYN;ZCCHC3;ADRA2B;LGALS9;RET;BST2;TLR7;BIRC3;TGFB1;TGFA;IQGAP1;CAV2;MALT1;MAP3K3;NDFIP2;SCHIP1;UBE2V1;OASL;SHARPIN;AGER;CASP8;BRD4;LRP2;LAMTOR5;FERMT2;S100A8;RAC1;TNFSF11;HRAS;PRKCB;GPR89A;C1QTNF4;PIK3CB;RPTOR;GDF15
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5142235161684406,-1.416485307319527,0.07341772151898734,0.48992840664154447,1.0,7/26,15.92%,IGF1;FHL2;EFHB;SLC9A1;STIMATE;DYRK2;HOMER3
prerank,carbohydrate transport (GO:0008643),0.6780639983497874,1.4164471105059442,0.11281070745697896,0.5331737351960668,1.0,2/11,4.59%,AQP11;AQP7
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5113147632481276,1.4164293277628741,0.05732484076433121,0.5317211785279243,1.0,12/51,11.01%,TRIM16;APP;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8
prerank,regulation of macrophage cytokine production (GO:0010935),0.6704732923725363,1.4156361065464111,0.09695817490494296,0.5327240106187877,1.0,2/13,1.32%,SEMA7A;TGFB2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.43885030793172897,1.4152326895004739,0.02360248447204969,0.5325544432321304,1.0,26/159,7.00%,MPZ;HMCN1;PTPRM;BSG;PECAM1;CLDN5;CADM1;ROBO4;TGFB2;ADGRL3;CDH2;DSCAML1;ATP2C1;NECTIN4;CDH20;PCDHGB4;CD6;CDH8;GRID2;PVR;SLITRK3;FAT4;CNTN2;CLDN14;DCHS1;CDH19
prerank,hippo signaling (GO:0035329),0.5727730172217333,1.4145299449046511,0.0958904109589041,0.533339122824465,1.0,7/26,6.99%,TJP1;TEAD4;TJP2;AMOT;WWTR1;FAT4;DCHS1
prerank,cellular response to growth factor stimulus (GO:0071363),0.43610656752140703,1.4144890941016028,0.023076923076923078,0.5319860426432765,1.0,28/151,5.07%,FLT1;NDNF;SEMA6A;PDGFB;KDR;DAB2IP;BMPR2;PDE2A;RAPGEF2;TBX1;PDE8A;FLT4;MEF2C;RAPGEF1;PTPN12;ACVRL1;PRKD1;NOTCH1;PRKD2;RAMP2;DUSP3;VIL1;PLCG1;WNT7A;SMAD7;CTNNB1;DLL4;HYAL2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.575643344600932,1.4127385277927114,0.09482758620689655,0.5358909700210376,1.0,11/24,18.49%,FGF13;STMN1;NCKAP5;KIF2A;STMN3;STMN4;PIN1;NCKAP5L;CKAP5;TRPV4;TPPP
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.552793688853854,-1.4124280795264779,0.09699769053117784,0.5002226289710033,1.0,3/17,4.57%,ANK2;SNTA1;CACNA2D1
prerank,anion transmembrane transport (GO:0098656),0.48986487281309055,1.4122196048779454,0.06423357664233577,0.5360232273934659,1.0,10/67,5.07%,SLC7A5;SLC7A1;SLC1A1;SLC39A8;SLC6A5;SLC38A5;LRRC8B;LRRC8C;SLC1A2;SLC25A5
prerank,negative regulation of neuron projection development (GO:0010977),-0.4234426619613584,-1.412049719047132,0.04776119402985075,0.4989580572711335,1.0,13/56,13.58%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;MYLIP;RAB29;ADCY6;PTEN
prerank,carboxylic acid metabolic process (GO:0019752),0.5525143836584163,1.4119562384163749,0.09437086092715231,0.5352978664046705,1.0,6/33,9.51%,CSGALNACT1;SLC2A1;ST3GAL1;GLYAT;ST6GAL1;TBXAS1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5352045439282352,1.4118959154122384,0.053208137715179966,0.5340040019794505,1.0,7/42,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.6805545246313087,1.4104763234850244,0.1111111111111111,0.5370362264338565,1.0,3/11,6.88%,MFSD2A;SCARB1;NR1H2
prerank,defense response to bacterium (GO:0042742),0.45516854095510373,1.4102166027401055,0.031746031746031744,0.5364130444206204,1.0,20/105,13.76%,PGLYRP1;STAB1;TIRAP;IL6R;NOD1;DEFA6;NOD2;GBP7;GBP4;NOS2;TLR3;IRGM;PPP1R11;ADAM17;S100A8;SYK;LPO;SLPI;RAB1A;HMGB2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5322350083432013,1.4100903553016624,0.06416275430359937,0.5354037258879335,1.0,7/43,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,dendrite self-avoidance (GO:0070593),0.6387730052786408,1.4083638649997137,0.09506398537477148,0.5394963680429393,1.0,4/16,6.91%,BSG;ROBO4;DSCAML1;CNTN2
prerank,cyclooxygenase pathway (GO:0019371),-0.6277585918504234,-1.4078638182532388,0.11353711790393013,0.5092282159278637,1.0,4/10,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6072317542489742,-1.4068322002792857,0.10273972602739725,0.5097886728419064,1.0,7/13,15.12%,LARGE1;MGAT3;RENBP;PGM3;CHST3;CHST1;NAGK
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6077567437209601,1.4056515944024657,0.08506944444444445,0.5468135891789146,1.0,6/19,12.23%,TEK;KDR;PTPRJ;FERMT2;RAC1;MAP4K4
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6401511162186857,-1.4052397512864188,0.09690721649484536,0.5121814909557568,1.0,3/10,3.85%,ATP1A2;OSR1;CAMK2D
prerank,spliceosomal complex assembly (GO:0000245),-0.4371900176594201,-1.4051600790924765,0.04843304843304843,0.5100364352818864,1.0,9/46,12.49%,CELF2;SRSF5;LUC7L3;DDX1;SRSF6;GCFC2;RBM5;LUC7L2;PRPF19
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5280444941604224,1.405100129114127,0.07704654895666131,0.5471830131221285,1.0,11/35,11.49%,TEK;ESAM;TJP1;FES;F11R;RAPGEF3;BAIAP2;HCK;ARHGDIA;ABI3;HRAS
prerank,protein O-linked glycosylation (GO:0006493),0.4614330748534576,1.4048634375234492,0.04526748971193416,0.5464758541758933,1.0,11/96,4.42%,TMTC2;EOGT;ST8SIA6;ST3GAL1;GALNT18;B4GALT5;ST6GALNAC2;MUC3B;MUC3A;B3GNT2;OGA
prerank,protein autophosphorylation (GO:0046777),0.43005515919022763,1.4042262290718208,0.021822849807445442,0.5470417717917917,1.0,25/157,10.12%,FLT1;IGF1R;TEK;KDR;INSR;FES;FLT4;PTK2;PRKD1;STK10;PRKD2;LYN;PIKFYVE;CAMKK2;EPHA4;MAPK3;AATK;EPHB4;HCK;MARK3;PAK1;MAP3K3;EIF2AK4;STK33;PTK6
prerank,positive regulation of phosphorylation (GO:0042327),0.41069293742356705,1.4031180437220074,0.008225616921269096,0.5492160749663796,1.0,47/240,10.36%,FLT1;IGF1R;TFRC;TEK;ITGA6;LIMCH1;PECAM1;KDR;INSR;TIE1;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MERTK;LYN;FGF16;CD4;CAMKK2;EPHA4;MRE11;LIMK2;PPIA;MAPK3;ENTPD5;RET;EPHB4;RALB;EFNA1;PIN1;TGFB1;IRGM;P2RX7;PAK1;PGF;PFKFB3;CCND3;ADAM17;AXIN2;AGER
prerank,regulation of cellular component biogenesis (GO:0044087),0.537643578257383,1.403042339408848,0.07903225806451612,0.5480057490027,1.0,11/39,10.71%,TJP1;TIE1;DAB2IP;RAPGEF2;RAPGEF1;NOTCH1;INSM1;RAP1B;IRGM;MSN;HSPA8
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6102171983083386,-1.4025826864831006,0.09271523178807947,0.515829193936939,1.0,2/12,6.03%,INSIG2;KDELR3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.660812434454668,1.402482742792579,0.09769094138543517,0.5483536869483576,1.0,5/13,13.46%,ELOVL7;TECRL;ELOVL5;ELOVL6;HACD2
prerank,negative regulation of immune effector process (GO:0002698),-0.6005177793059651,-1.4024298043655723,0.10307017543859649,0.5139175772749274,1.0,4/13,16.97%,CD55;ENPP3;CD300A;GRN
prerank,lipid phosphorylation (GO:0046834),0.6938283570330548,1.4012610148088773,0.13172541743970315,0.5509651577841859,1.0,4/10,11.93%,DGKH;DGKI;DGKE;DGKZ
prerank,response to copper ion (GO:0046688),0.607144452073126,1.4012306523961795,0.10892857142857143,0.5495755202158543,1.0,12/20,25.24%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;LOXL2;DAXX;SNCA;AOC1
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.524174628107416,-1.401068598476245,0.08656036446469248,0.5156672494451738,1.0,6/19,17.85%,IRS1;PRKCD;PPARA;IRS2;TWIST1;ANGPTL3
prerank,regulation of metal ion transport (GO:0010959),-0.5584787612641207,-1.4009700611660936,0.0997624703087886,0.5136574040949384,1.0,7/16,7.38%,ANK2;SLC30A10;STIM1;IL16;CACNA2D1;DLG1;BCL2
prerank,negative regulation of cytokine production (GO:0001818),0.4262871409279888,1.400439897826719,0.029525032092426188,0.5505665117458446,1.0,35/163,12.02%,LEF1;CD34;CD200;TRIM25;RGCC;SRGN;JAK3;ZFPM1;IFIH1;SIGIRR;HDAC9;HDAC7;NLRC5;RNF125;TMSB4X;SARS1;HOMER2;TNFRSF21;CCR7;RPS6KA5;ATP2B1;LGALS9;KLF4;N4BP1;PIN1;CD200R1;FOXP3;PPP1R11;TRIB2;AGER;ABCD1;TLR8;RAC1;VSIR;CEACAM1
prerank,positive regulation of T cell migration (GO:2000406),0.6034151457828012,1.4002847031207162,0.11683848797250859,0.5495863711739665,1.0,4/20,9.89%,CXCL12;APP;ADAM10;ADAM17
prerank,negative regulation of chemotaxis (GO:0050922),0.5409923773382526,1.3998886138704878,0.09661016949152543,0.5494592686639498,1.0,8/31,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;NOTCH1;DUSP3;SEMA4F;SEMA6D
prerank,organophosphate ester transport (GO:0015748),0.5687967186700096,1.399355547871393,0.10613598673300166,0.5496922492214974,1.0,6/24,6.01%,PLTP;SCARB1;PITPNC1;PRELID2;PITPNA;ABCA3
prerank,T cell homeostasis (GO:0043029),0.6811787653497328,1.3991081979599607,0.14035087719298245,0.5490488951975458,1.0,4/10,14.70%,FAS;JAK3;FOXP3;NCKAP1L
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.44967278334720284,1.3983463813263086,0.05191256830601093,0.5499758033540632,1.0,21/93,10.41%,TFRC;SH2D3C;APP;CAV1;CNKSR3;BCAR3;PRKD1;PRKD2;RAPGEF3;FNIP2;SMAD7;PDE4D;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;CNOT9;AKAP9;DDIT4;PDCD10
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.5412050676466401,-1.3980990915824116,0.12018140589569161,0.5202644691526949,1.0,10/18,22.95%,ASPA;NAALAD2;ASPG;MTHFR;MTHFD1;GOT1;SLC25A12;NIT2;GOT2;NAT8L
prerank,endocardial cushion development (GO:0003197),0.5909526857824572,1.3977260819442159,0.09490333919156414,0.5504442597137987,1.0,7/21,4.36%,ENG;BMPR2;TGFB2;NOS3;ACVRL1;NOTCH1;FOXF1
prerank,cell junction organization (GO:0034330),0.4775296298171666,1.3962088332561358,0.05794947994056464,0.5538213172979057,1.0,17/71,10.91%,OCLN;TJP1;APBB2;LIMS2;TGFB2;APP;TJP2;AGRN;PPFIBP1;ACTB;MARVELD2;PIN1;TGFB1;OPHN1;ACTG1;ELFN1;FERMT2
prerank,cellular response to fluid shear stress (GO:0071498),0.6527454387680738,1.3960560734313823,0.13391304347826086,0.5528896019916659,1.0,4/12,6.45%,MTSS1;MEF2C;KLF2;KLF4
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3928919508343732,-1.3957461300211613,0.023255813953488372,0.5250855958651985,1.0,29/82,13.14%,BMP6;RANBP3L;IGF1;BMPR1A;SMOC1;WNT4;CRIM1;BMP7;FGFR2;BMP4;DDX5;SMAD6;SUFU;RUNX2;CCN1;TMEM64;YAP1;CCN4;LRP3;TWIST2;PRKACA;TRPM4;FBN2;CHRD;IFITM1;BMP2;NPNT;SKI;TWIST1
prerank,positive regulation of cell differentiation (GO:0045597),0.4107243281667837,1.3955492860530063,0.018912529550827423,0.5530451200187062,1.0,30/237,5.03%,LEF1;SLC6A6;PRKCH;KITLG;PLCB1;KDR;CD34;BMPR2;TGFB2;RAPGEF2;ZHX3;FES;PPARD;IL6R;CTNNBIP1;ARHGEF2;RGCC;MEF2C;RPS6KA1;ACVRL1;TIAM1;CDH2;PRKD1;MMD;ZBTB16;CTNNB1;NOCT;CREB1;WWTR1;HSP90AB1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5796480396360291,-1.3955215545950426,0.10888888888888888,0.5234050431782113,1.0,6/13,15.71%,ERRFI1;CBLB;SNX6;TSG101;ZFYVE28;GPRC5A
prerank,lipid oxidation (GO:0034440),0.6424702273238017,1.3954372501795131,0.14336917562724014,0.5519255213914631,1.0,3/12,11.57%,ADIPOR2;ACOX1;ADIPOR1
prerank,regulation of protein dephosphorylation (GO:0035304),0.5285458170454578,1.3950914290504466,0.09711684370257967,0.5515546113616249,1.0,11/37,13.64%,MFHAS1;PPP1R16B;CALM1;PPIA;PPP1R2;PPP2R5A;PIN1;TGFB1;NSMF;CDH5;PPP1R8
prerank,regulation of interleukin-6 production (GO:0032675),0.4508443434549933,1.3938580724871523,0.04709141274238227,0.5538916481853724,1.0,24/96,15.03%,APP;TIRAP;IL6R;CD200;AFAP1L2;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;CD200R1;AGER;TLR8;SYK;C1QTNF4;TNFAIP3;FOXJ1;BCL10;NCKAP1L;INAVA
prerank,regulation of histone methylation (GO:0031060),-0.582740555895275,-1.39349023818829,0.10583153347732181,0.5271617983528326,1.0,10/13,33.38%,CTR9;MTHFR;NNMT;PAF1;NSD1;AASS;TET1;TTLL12;PIH1D1;JARID2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.49165754626531133,-1.3932824249314333,0.09285714285714286,0.5255263835126649,1.0,6/25,5.68%,CACNA1C;ANK2;CXADR;CAMK2D;DLG1;TBX18
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6385610783983195,1.392507009406415,0.11864406779661017,0.5566546339624886,1.0,3/14,1.75%,NOTCH4;XDH;CAV1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6218192149264837,1.3923037726064718,0.13903743315508021,0.5557941412015969,1.0,2/15,1.32%,STOX2;TGFB2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5761513369708334,1.39177717525421,0.11241610738255034,0.5560270687351996,1.0,5/25,9.05%,SLC7A5;B2M;NOD2;CD160;MALT1
prerank,negative regulation of binding (GO:0051100),0.4663648925208134,1.3917095541774318,0.06857142857142857,0.5548581148351488,1.0,12/81,8.04%,LEF1;PDGFB;CAV1;NFKBIA;CTNNBIP1;NES;SP100;ZFPM1;ACTB;RALB;JUN;PIN1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4610628861506782,1.3910875422037425,0.04741980474198047,0.5554440704739703,1.0,15/84,5.30%,TEK;ETS1;PDGFB;KDR;BMPR2;NOS3;FLT4;SCARB1;CD40;PRKD1;PRKD2;TMSB4X;PLCG1;GATA2;RHOB
prerank,actin filament depolymerization (GO:0030042),-0.6020875194586264,-1.3907981437111623,0.08768267223382047,0.530473774347823,1.0,3/11,1.66%,MICAL3;GSN;MICAL2
prerank,neuron migration (GO:0001764),0.5116509010464484,1.389893661490999,0.07922272047832586,0.5577004984626333,1.0,15/48,11.43%,NDNF;RAPGEF2;ADGRL3;SH3RF1;NAV1;MEF2C;FGF13;GPM6A;SPOCK1;DNER;DISC1;DDIT4;DCX;CEP85L;RAC1
prerank,regulation of kinase activity (GO:0043549),0.4613407275398948,1.389579572701863,0.04353741496598639,0.5572997202834155,1.0,15/89,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;NLRC5;MERTK;CD4;CAMKK2;EPHA4;MRE11;RET;EPHB4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6175217602465726,-1.3892055479535586,0.11899791231732777,0.5332338079623189,1.0,5/11,24.43%,XPO5;FMR1;LIMD1;AJUBA;STAT3
prerank,regulation of interleukin-12 production (GO:0032655),0.5063440738518733,1.3889232622415022,0.07087827426810478,0.557867585829017,1.0,11/47,11.86%,PLCB1;TIRAP;JAK3;CD40;CCR7;TLR3;LGALS9;IRF5;AGER;TLR8;SYK
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5374136648838954,1.3885633281768328,0.10210696920583469,0.5575996462058995,1.0,11/36,19.12%,SHANK3;ADRA2B;FBXW7;BUD31;TGFA;GREM1;ADAM17;HIF1A;EDN1;CCR2;NRP1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4769534296964504,-1.3880279739810515,0.0792838874680307,0.5347642147659503,1.0,4/30,6.13%,IGF1;IGFBP2;IL18;IGF2
prerank,defense response to protozoan (GO:0042832),0.6575182872766867,1.3876514057858576,0.113345521023766,0.5591937539427083,1.0,3/12,3.22%,CD40;GBP7;GBP4
prerank,positive regulation of cellular process (GO:0048522),0.38480895247504854,1.386558265191022,0.0031545741324921135,0.5611566955025752,1.0,90/565,12.69%,LEF1;FLT1;IGF1R;SLC6A6;KITLG;ETS1;MFSD2A;FRMD5;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;TGFB2;CXCL12;ACER2;PDGFD;CAV1;FASN;TBX1;IL6R;FLT4;CNOT6L;TBX3;TNFRSF11A;STX3;ADGRG1;GNAI2;PTPRJ;PTK2;RPS6KA1;TIAM1;PARD3;NOTCH1;PRKD2;MERTK;LYN;TGM2;GATA2;OSMR;FGF16;RAMP3;WWTR1;HSP90AB1;SLC25A5;TAL1;CCR7;EPHA4;ACTN4;SLC25A33;ADAM10;ACACB;HCK;INSM1;TGFB1;TGFA;CXCR2;CST7;ABCA7;PTN;P2RX7;LRP5;COPS9;GREM1;PAK1;PGF;LIFR;ADAM17;PTK6;AXIN2;CDCA7L;PDCD10;CNTF;CDC6;S100A8;PPP3CA;RAC1;HRAS;BRAT1;CNOT6;RNF187;RPTOR;TGFBR2;RPS9;ZFP36L1;SOX11;IL15;DERL2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3947639884035007,1.3862348472479344,0.013377926421404682,0.5608149579212545,1.0,65/348,10.41%,TFRC;TEK;LIMCH1;PECAM1;PDGFB;SH2D3C;KDR;INSR;ENG;BMPR2;TGFB2;RAPGEF2;PDGFD;APP;CAV1;FAS;TBX1;PDE8A;IL6R;FLT4;BCAR3;LRP8;PLAUR;PTPRJ;ARHGEF2;PTK2;NIBAN1;CD40;PIK3R3;ACVRL1;APLNR;PRKD1;PRKD2;MMD;RAPGEF3;LYN;FNIP2;CALM1;FGF16;RAMP3;HSP90AB1;CCR7;CD4;CAMKK2;MRE11;LIMK2;PPIA;MAPK3;RPS6KA5;RALB;EFNA1;PIN1;TGFB1;IRGM;IQGAP1;ENPP2;PAK1;PGF;CCND3;ADAM17;CNOT9;AKAP9;AXIN2;AGER;PDCD10
prerank,positive regulation of MAP kinase activity (GO:0043406),0.48118230567707276,1.3858546151131703,0.06534954407294832,0.5606048679131853,1.0,9/66,3.20%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TPD52L1;TNFRSF11A;CD40;NOD2
prerank,regulation of inflammatory response (GO:0050727),0.41834746782974225,1.3857771153706908,0.02937576499388005,0.5594858405841286,1.0,35/190,13.79%,TEK;ETS1;SEMA7A;MFHAS1;PDE2A;APP;IL1R1;PPARD;NFKBIA;CD200;BCL6B;NOD2;TMSB4X;HYAL2;MGST2;XIAP;TLR3;KLF4;HCK;TLR7;BIRC3;NLRP6;CD200R1;LPCAT3;SHARPIN;BRD4;CCL1;S100A8;USP18;IL15;DDT;PPARG;CYLD;CDH5;TNFAIP3
prerank,positive regulation of blood coagulation (GO:0030194),-0.5577733959479406,-1.3856669546864304,0.11185682326621924,0.5397264239542298,1.0,6/17,12.30%,ST3GAL4;THBS1;F3;ANO6;THBD;DMTN
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.507014638129098,1.3851356343853938,0.0890937019969278,0.5602151414877938,1.0,8/46,7.63%,TEK;PARVB;SRGAP2;LAMA5;NTNG2;PXN;PARVG;EFNA1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.5321719697915263,1.3849342453032036,0.07487520798668885,0.5594473934623252,1.0,11/35,11.43%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;PLXND1;SEMA4F;SEMA6D;SEMA4C;ARHGDIA;PLXNB3;RAC1
prerank,cellular response to ketone (GO:1901655),-0.4601610231385842,-1.3848649548779448,0.06426735218508997,0.5398661646109559,1.0,7/35,8.86%,ROCK2;ADCY5;ADCY1;ADCY2;AR;SPP1;PTGFR
prerank,regulation of protein kinase B signaling (GO:0051896),0.4111821469517413,1.3843504170033327,0.02973977695167286,0.5598935710567877,1.0,23/193,6.46%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;XDH;PHLPP1;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;HYAL2;GAB1;CCR7;FYN;PLEKHA1;RET
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4022998400501442,-1.3831827130250072,0.028125,0.5428614066130855,1.0,21/65,14.36%,FBN1;LDLRAD4;LTBP1;SMAD3;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;SMURF2;PDPK1;SPRED1;FBN2;VASN;SKI;HTRA4;SLC2A10
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.524088607515226,1.3831620470757862,0.0989345509893455,0.5623101049993517,1.0,11/39,13.02%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4;KIF1A;MYO1F;BICDL1;SYT4;F8A1;RAB1A
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5493115823194159,1.382620723520009,0.10068259385665529,0.5625181108679048,1.0,11/31,17.11%,PPP1R13B;HIP1R;PPP3CC;YWHAH;YWHAQ;CASP8;ZNF205;GSK3A;PPP3R1;YWHAZ;YWHAB
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5763137533630271,1.3819113617052605,0.10884353741496598,0.563292620346551,1.0,10/24,14.18%,DAB2IP;EPN2;TMEM204;MMRN2;PRKD2;HHEX;PRKCB;HIF1A;HGS;PDCD6
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6280247627031453,1.3815920923378464,0.10307414104882459,0.56293600236628,1.0,4/14,10.06%,RAPGEF2;PKIG;PRKAR2B;PRKAR2A
prerank,negative regulation of lipid catabolic process (GO:0050995),0.6037877754135832,1.3814654988212953,0.13532513181019332,0.5619723272539441,1.0,1/17,0.46%,MFSD2A
prerank,positive regulation of ion transport (GO:0043270),-0.43308685922212875,-1.3801309986543842,0.05361930294906166,0.5498255413193481,1.0,12/48,13.70%,ANK2;ACTN2;FHL1;MYLK;ANO6;DLG1;P2RX4;CACNA1D;TRPC6;GPD1L;CACNB2;CRACR2A
prerank,metanephric mesenchyme development (GO:0072075),-0.6262199894718068,-1.3799767724902938,0.11255411255411256,0.5479797515700546,1.0,4/10,5.68%,WNT4;OSR1;PKD2;SIX1
prerank,regulation of bone mineralization (GO:0030500),-0.41284237478412805,-1.3798976085244103,0.07365439093484419,0.545842558890384,1.0,21/55,13.14%,BMP6;BMPR1A;WNT4;BMP7;ENPP1;BMP4;OSR1;ADGRV1;ANO6;BCOR;KL;ECM1;CCN1;SLC8A1;TGFB3;TRPM4;FBN2;PTK2B;PKDCC;BMP2;TWIST1
prerank,positive regulation of kinase activity (GO:0033674),0.44448156724130106,1.3797049043449279,0.04521276595744681,0.5661913102804671,1.0,17/107,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;RAPGEF2;FLT4;PTK2;MMD;MERTK;CCR7;CD4;EPHA4;MRE11;RET;EPHB4
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.631914269651514,1.3794088747358024,0.13114754098360656,0.5657354034059744,1.0,6/14,19.50%,DAB2IP;FICD;DNAJB9;COPS5;BFAR;BAK1
prerank,epithelial tube morphogenesis (GO:0060562),0.5326882732123501,1.3792714531824946,0.1109375,0.5647695207060835,1.0,12/32,9.22%,PODXL;RASIP1;SOX17;MTSS1;MEF2C;ACVRL1;PRKD2;CTNNB1;RHOB;COL4A1;CCM2;PAK1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5841366329826813,-1.3792237663661724,0.11513859275053305,0.5456849605484138,1.0,5/11,8.15%,ITGB5;KIT;VCL;PLEKHA7;CCN3
prerank,protein modification process (GO:0036211),0.46900058125105154,1.37874330207249,0.06232294617563739,0.565120714150242,1.0,23/76,19.23%,ST8SIA4;ST3GAL6;ST3GAL1;STK38;YES1;LCMT1;PLAT;FBXL2;CHRM3;DUSP12;UBA3;MANBA;FBXW2;MAN2B1;UBE2D3;LOXL2;MMP15;MCRS1;SEPHS1;FBXO2;ERO1A;CPE;USP25
prerank,innate immune response in mucosa (GO:0002227),0.6724897097034532,1.3786849140694384,0.1306715063520871,0.5639507409297765,1.0,2/10,4.51%,DEFA6;NOS2
prerank,activation of phospholipase C activity (GO:0007202),-0.4831249060048164,-1.3784017727996092,0.09595959595959595,0.5457415283932125,1.0,4/29,2.82%,ARHGAP6;LPAR1;EGFR;EDNRA
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.48324319358435264,-1.3774825608306924,0.11557788944723618,0.5464167647992981,1.0,12/27,19.83%,ANK2;DMD;CAMK2D;CACNB4;PRKACA;CACNB2;JPH1;CACNB1;AHNAK;JPH2;ADRA2A;CACNB3
prerank,neuron projection organization (GO:0106027),0.6224972598272441,1.3774804856498994,0.13309352517985612,0.5665965049974772,1.0,4/15,10.97%,INSR;APP;ATP1A3;ABCD1
prerank,positive regulation of protein modification process (GO:0031401),0.4144301980436016,1.3773396973301093,0.01838235294117647,0.5656930516569374,1.0,40/203,10.36%,TFRC;TEK;LIMCH1;PECAM1;KDR;PPP1R16B;INSR;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;RAPGEF3;LYN;CALM1;FGF16;CD4;CAMKK2;LIMK2;PPIA;MAPK3;PPP2R5A;RALB;EFNA1;PIN1;TGFB1;IRGM;ASPSCR1;PAK1;PGF;CCND3;ADAM17;AXIN2;AGER
prerank,embryonic limb morphogenesis (GO:0030326),-0.45995715911589646,-1.3772784055432286,0.07481296758104738,0.5446656770075341,1.0,7/34,4.36%,CACNA1C;GLI3;AFF3;OSR1;CYP26B1;SALL1;WDPCP
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.44346967736245646,1.376963840144215,0.05655172413793103,0.5655014524810281,1.0,23/101,12.53%,FLT1;PIK3R6;PDGFB;DAB2IP;RAPGEF2;PDGFD;CCNY;TPD52L1;RGCC;CD40;NOD2;CALM1;RALB;TGFB1;IRGM;CCND3;ADAM17;PDCD10;FERMT2;TNFSF11;HRAS;RPTOR;MAPRE3
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5248227240073915,1.376916256202124,0.0880503144654088,0.5643057495440956,1.0,9/39,12.15%,EFR3B;ITPKB;PIK3R3;SOCS2;SOCS5;PIK3C3;PIK3C2A;PIP4K2A;PIK3CB
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5880439847101075,1.3766456709964474,0.12802768166089964,0.563791274666063,1.0,7/18,10.26%,JCAD;KDR;HDAC9;HDAC7;GATA2;MAP3K3;PIK3C2A
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5655582056936219,1.375816765746968,0.11129568106312292,0.5650058950183634,1.0,7/25,11.08%,SPTBN1;PRKD2;PDE4D;CD4;PDE4B;MALT1;PNP
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5031725640463132,-1.3751155799796024,0.1180722891566265,0.5489204187868253,1.0,7/22,15.64%,AEBP1;MAP1S;AKAP13;APOE;EFEMP2;ABL1;MAP2
prerank,regulation of ossification (GO:0030278),0.518876472964309,1.3750022043424048,0.10894308943089431,0.566312230112246,1.0,8/36,4.55%,SGMS2;BMPR2;TGFB2;S1PR1;MEF2C;NOTCH1;ZBTB16;NOTUM
prerank,regulation of hydrolase activity (GO:0051336),0.4680265603274895,1.3740700978193507,0.05595408895265423,0.5680296482786817,1.0,17/71,11.16%,CHN2;FGD5;DAB2IP;RASIP1;ARHGAP27;CAV1;PTK2;PLXND1;PRKG1;EPHA4;OCRL;STMN3;CFAP100;ARHGEF5;FGD6;TBC1D10B;PLXNB3
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5690982050743414,-1.3738023402555604,0.13761467889908258,0.5508253534345936,1.0,4/16,5.34%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.627471291173249,1.3736381247363683,0.13457943925233645,0.5679819011436968,1.0,2/13,5.93%,ETS1;FUT9
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.584400705778442,-1.3736259330449097,0.12472647702407003,0.5467913157729689,1.0,5/12,12.30%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.584400705778442,-1.3736259330449097,0.12472647702407003,0.5467913157729689,1.0,5/12,12.30%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,positive regulation of developmental process (GO:0051094),0.4217882208168702,1.373156460651238,0.02763819095477387,0.5682363815090962,1.0,25/164,9.33%,SLC6A6;TFRC;PLCB1;SHANK3;PDGFB;KDR;INSR;DAB2IP;BMPR2;B4GALT5;LRP8;FZD4;RPS6KA1;RAPGEF3;VIL1;ZBTB16;RREB1;HSP90AB1;SHLD1;INSM1;PTN;ARHGEF7;ENPP2;NRXN1;RBM19
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.54847026655126,1.3727190826864177,0.11872909698996656,0.5682990102148203,1.0,4/26,5.43%,MFHAS1;CAV1;TIRAP;TLR3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5891361844981418,1.372395554804881,0.12365591397849462,0.5678799130261015,1.0,7/18,13.46%,ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3520116270244801,-1.3719942550179494,0.014018691588785047,0.5495121611305085,1.0,23/128,7.28%,BMP6;COL1A2;COL3A1;TGFBR3;BMPR1A;APPL2;SMAD3;BMP5;BMP7;BMP4;ITGB5;DDX5;SMAD6;RGMA;RGMB;TGFBR1;TWSG1;ADAM9;RUNX2;TMEM100;ARHGEF18;SMAD9;TGFB1I1
prerank,triglyceride biosynthetic process (GO:0019432),-0.540802015010584,-1.3718702859074783,0.10304449648711944,0.5476422526282414,1.0,6/18,15.29%,AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5460960074239121,-1.3718282142620235,0.1079136690647482,0.5455384861639373,1.0,8/17,13.39%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,positive regulation of chromatin organization (GO:1905269),0.6568659236333481,1.3717881881615375,0.13333333333333333,0.5684210547546431,1.0,6/12,21.77%,TAL1;TERF2;ACD;TERF1;SIN3A;DAXX
prerank,regulation of cholesterol efflux (GO:0010874),0.5366174662002908,1.3716792301942424,0.12836767036450078,0.5674215447742434,1.0,8/30,12.84%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;NAXE;PPARG
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5300176494863796,1.3713770790532904,0.09693053311793215,0.5670633399274447,1.0,7/33,8.09%,ETS1;PDGFB;TGFB2;GATA2;KLF4;JUN;TGFB1
prerank,somite development (GO:0061053),-0.6107917971112735,-1.3713535483802108,0.1154639175257732,0.544604673685621,1.0,4/11,8.73%,MEOX2;SMO;LOXL3;MTHFD1
prerank,hexose transmembrane transport (GO:0008645),0.5702555709121327,1.3711768603598407,0.11035653650254669,0.5664275576387168,1.0,2/21,1.88%,SLC2A1;PPARD
prerank,retinol metabolic process (GO:0042572),-0.5648927321874301,-1.3707554468452816,0.1087962962962963,0.5442365545662833,1.0,3/14,5.39%,RBP4;DHRS3;CYP1B1
prerank,membrane repolarization (GO:0086009),-0.5649441019100472,-1.370055740960516,0.10430839002267574,0.5441731588968057,1.0,4/15,7.08%,ATP1A2;KCNJ2;ATP1B3;ATP1B2
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5417898810412416,-1.3693545255611372,0.11574074074074074,0.5442328574660773,1.0,4/16,11.52%,AUTS2;BCOR;CTR9;KDM1A
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6145291869519345,1.3685418352757432,0.1280148423005566,0.5731353785466753,1.0,1/15,0.16%,PRKCH
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4585111866485415,-1.3682734642870478,0.07932011331444759,0.5456153819875832,1.0,7/38,6.15%,ANK2;ACTN2;FHL1;KCNMB2;KCNJ2;DLG1;FLNA
prerank,cell-matrix adhesion (GO:0007160),-0.38131468219117476,-1.3680921669795107,0.02181818181818182,0.5439114844266314,1.0,21/95,7.16%,ITGBL1;COL3A1;ADAMTS12;VTN;ACTN2;ITGB5;ITGB8;PKD1;ITGA10;COL13A1;FBLN5;DDR1;VCL;ECM2;CD63;ADAM9;NID2;ITGA11;THBS3;EMILIN1;MSLN
prerank,regulation of lymphocyte migration (GO:2000401),0.6712845088280078,1.3677967649766292,0.16544117647058823,0.5741910331736712,1.0,3/10,8.79%,JAM2;STK10;MSN
prerank,positive regulation of secretion (GO:0051047),0.6661866220802225,1.3676792993112334,0.14453125,0.5732821969462255,1.0,4/11,17.41%,ABCB11;ACSL3;NPR1;TRH
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6382862637261317,1.3666529276597,0.13982300884955753,0.5739130709351891,1.0,4/13,5.26%,PLCB1;JAK3;GRB2;CD4
prerank,cellular response to interleukin-15 (GO:0071350),0.6382862637261317,1.3666529276597,0.13982300884955753,0.5739130709351891,1.0,4/13,5.26%,PLCB1;JAK3;GRB2;CD4
prerank,regulation of p38MAPK cascade (GO:1900744),0.5230522096040972,1.3664450058044617,0.10339256865912763,0.5733117202842493,1.0,9/35,13.54%,MFHAS1;DAB2IP;XDH;PHLPP1;LGALS9;AGER;DUSP1;CYLD;MINK1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.49546177664477237,1.365638954214854,0.09833585476550681,0.5744283147550826,1.0,11/47,13.85%,NANOS3;APP;NFKBIA;WNT7A;KLF4;NR1H2;TGFB1;CYFIP1;EIF4E;PUM3;SSH1
prerank,heart development (GO:0007507),-0.3534018298489149,-1.3653789764910345,0.013513513513513514,0.5499648919617753,1.0,38/150,8.99%,CACNA1C;COL3A1;TGFBR3;FBN1;NTRK3;PLCE1;GLI2;CXADR;BMP5;SGCD;MICAL2;BMP7;ADAP2;GPC3;BMP4;ZFPM2;OSR1;PCSK5;PKD1;PDLIM7;RBP4;SH3PXD2B;SALL1;FOXC2;FOXC1;BCOR;TGFBR1;PKD2;SCUBE1;NDUFV2;PDLIM2;AKAP13;PDLIM4;FOXL1;KDM6B;POU6F1;MTHFD1;IFT122
prerank,alpha-amino acid catabolic process (GO:1901606),-0.47051023352969557,-1.364947090499985,0.08,0.5491951145478338,1.0,11/29,21.31%,DDO;ACADSB;ALDH4A1;PRODH;THNSL2;KYAT1;SARDH;FAH;KMO;KYNU;GOT2
prerank,positive regulation of calcium ion import (GO:0090280),0.6394882321189346,1.364387772234472,0.13944954128440368,0.5769564748283484,1.0,3/12,4.91%,PDGFB;CXCL12;RAMP3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5874114805752,1.3639797486065006,0.13805309734513274,0.5769496151339314,1.0,13/18,26.46%,UNC13B;CDH8;GRID2;GRIK5;GRIK2;GRIK1;SLC17A6;UNC13A;GRIA2;GRIK3;GRID1;SLC17A8;NAPB
prerank,positive regulation of protein import (GO:1904591),-0.4784279809935622,-1.3630129358645444,0.08616187989556136,0.5529936411894328,1.0,9/30,14.13%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.33710540156062746,-1.3626370479260563,0.0064516129032258064,0.5520210958557803,1.0,62/248,14.40%,RNF220;BICC1;RBMS3;WLS;ZEB2;EGFR;LGR4;GLI3;COL1A1;IGFBP2;PTK7;DKK3;FGFR2;GPC3;IGFBP6;LRRK1;KANK1;INVS;AMFR;LYPD6;DAB2;IGFBP4;TBL1XR1;DAAM2;PLEKHA4;SFRP4;FZD7;DACT1;GLI1;CTNND2;PFDN5;TNKS2;TMEM64;CHD8;PRKN;TLE3;APOE;PSME4;UBR5;SMURF2;MLLT3;AXIN1;CUL3;CDK14;STK11;PPM1B;FUZ;BTRC;TRPM4;PSME3;LRRK2;CAPRIN2;PSEN1;BMP2;SCEL;EMD;NKD2;DVL2;WNK1;DDX3X;LMBR1L;WNT11
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.40618687199909315,-1.3624697045130294,0.06918238993710692,0.550371636492233,1.0,11/56,4.67%,BMP6;BMPR1A;LDLRAD4;BMP5;BMP7;BMP4;BMPER;SMAD6;TGFBR1;TWSG1;DAB2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4363777079429913,1.3620887888479627,0.056910569105691054,0.5813827673410009,1.0,39/113,22.16%,TFRC;DAB2IP;RASIP1;UNC13B;TIRAP;GBP5;FNIP2;PIEZO1;TAL1;BIK;GTF2H2;RAP1B;TGFB1;PSMC6;CAPG;MMP1;FERMT2;GTF2H4;SYK;SH3GLB1;TERF1;CDH5;FSCN1;RBX1;MPP7;SUMO1;IL5;SLF1;RPA1;TPPP;SKAP1;BAK1;GTF2H3;DDB1;ERCC4;PSMC3;HRK;RACK1;SNCA
prerank,purine nucleotide catabolic process (GO:0006195),0.6185218834622617,1.362008681819818,0.1528776978417266,0.5802925497033096,1.0,4/13,11.08%,XDH;HINT1;NT5C2;PNP
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5579936150960352,1.3610852665013136,0.12479201331114809,0.5819063788176106,1.0,7/24,10.06%,PDE2A;RAPGEF2;APLNR;PEX5L;PDE4D;PRKAR2B;PRKAR2A
prerank,regulation of cellular component organization (GO:0051128),0.4300992609050639,1.3604478610038129,0.0517464424320828,0.5825550394035093,1.0,21/135,9.03%,TFRC;HIP1;TJP1;DAB2IP;LTBP4;RAPGEF2;NET1;HIP1R;RAPGEF1;SOCS2;PAK5;WFDC1;FAM107A;RASGRP2;INSM1;EGLN2;RAP1B;MARK4;IRGM;OPHN1;SPOCK1
prerank,melanocyte differentiation (GO:0030318),-0.6080531210976041,-1.3599058443220071,0.12967032967032968,0.5563964999893406,1.0,5/11,11.17%,LRMDA;ENPP1;KIT;MITF;SLC24A5
prerank,endoderm development (GO:0007492),0.6364757875801457,1.3597273916730273,0.13333333333333333,0.5835051434200929,1.0,4/13,16.13%,SOX17;SOX7;DUSP1;LHX1
prerank,artery development (GO:0060840),0.5595701998574568,1.3594609190504905,0.10689655172413794,0.5830294625065751,1.0,7/23,4.31%,ENG;BMPR2;PDE2A;TBX1;ACVRL1;APLNR;SMAD7
prerank,positive regulation of cholesterol transport (GO:0032376),0.5537085781414416,1.35940860072037,0.12175324675324675,0.5819185041704843,1.0,7/27,10.01%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;LPCAT3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6121021987889247,1.3593506917829956,0.13261648745519714,0.5808124615792434,1.0,3/16,5.99%,BCL2L1;CXCL12;SNAI2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5489488834198624,1.359209206111605,0.12248062015503876,0.5799459153621717,1.0,5/30,8.09%,FLT1;KDR;FLT4;PLD4;TGFB1
prerank,nitric oxide metabolic process (GO:0046209),0.6248393595687505,1.358270080472996,0.13953488372093023,0.5814286096565784,1.0,3/14,4.51%,NOS3;GCH1;NOS2
prerank,wound healing (GO:0042060),-0.409490818804139,-1.3582433701464267,0.04610951008645533,0.5592836690930534,1.0,13/62,6.35%,IGF1;COL3A1;PDGFRA;SMAD3;TPM1;FGF1;DCBLD2;MYOF;TGFBR1;AHNAK2;FGF2;ANXA6;FZD7
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6666048978507322,1.358115649671134,0.13419117647058823,0.5806201330044543,1.0,4/10,8.89%,FAS;LYN;MAPK3;GREM1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5176486664187447,-1.3578489496117214,0.10392609699769054,0.5583588373696063,1.0,8/21,13.67%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;GUCY1A1;ADCY6;GUCY1B1
prerank,cellular response to lipid (GO:0071396),-0.34142273209783525,-1.3577116670508318,0.010638297872340425,0.5566005781751832,1.0,27/191,8.17%,ATP1A2;PID1;EGFR;ROCK2;ADCY5;EPHA3;TFPI;PTK7;AXL;ADCY1;WNT5B;IRS1;LBP;WNT6;ADCY2;WNT9A;ADAM9;RORA;AR;CTR9;SPP1;FZD7;PABPN1;LCOR;SELENOS;ATM;TNIP2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.44255466673607585,-1.357379696584477,0.07848101265822785,0.5554480141556697,1.0,14/37,13.58%,IGF1;BMPR1A;IGFBP5;TPM1;GJA1;FGF2;MMP2;FOXJ2;SOD2;EFEMP2;TGFB3;ADAMTS1;MFN2;PTEN
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5772387619514634,1.3572650858187183,0.14166666666666666,0.5819905192797897,1.0,6/21,8.30%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4735024168464466,1.3571700494693142,0.07646176911544228,0.5809827995372361,1.0,15/55,14.07%,BCL2L1;DAB2IP;CAV1;FAS;TPD52L1;TNFSF10;HYAL2;CRADD;DEDD2;AGTR2;S100A8;TNFSF12;CYLD;TRIM39;BCL10
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6116226911409337,-1.356403925816522,0.12850467289719625,0.5541200006444456,1.0,3/10,5.34%,NUPR1;HDAC4;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),-0.6116226911409337,-1.356403925816522,0.12850467289719625,0.5541200006444456,1.0,3/10,5.34%,NUPR1;HDAC4;PPARA
prerank,histone H4 acetylation (GO:0043967),0.4918081710476777,1.356076478706561,0.11128526645768025,0.5830668756580968,1.0,10/47,16.38%,LEF1;TRIM16;PHF20;BRCA2;JADE2;NAA60;TRRAP;MCRS1;HCFC1;MSL2
prerank,cellular response to interleukin-1 (GO:0071347),0.4210924415484178,1.3554474753113341,0.0560625814863103,0.5836533586199414,1.0,25/143,11.82%,PLCB1;DAB2IP;IL1R1;NFKBIA;NOD1;CD40;NOD2;PELI1;MAP3K8;IKBKB;HYAL2;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;CCL1;PSMD8;HIF1A
prerank,positive regulation of histone deacetylation (GO:0031065),0.6327708656007778,1.3549941501506517,0.14990512333965844,0.5838280155140263,1.0,3/12,3.43%,APLNR;PRKD1;PRKD2
prerank,cellular defense response (GO:0006968),-0.43834412515193766,-1.3539886647490447,0.07446808510638298,0.5596682246668656,1.0,7/40,11.14%,DCDC2;LBP;CCR9;LSP1;ADORA2A;ZNF148;PTK2B
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6081045100783788,-1.3534316896938137,0.13991769547325103,0.5593461530262008,1.0,4/10,10.23%,IRS1;IRS2;PTH1R;SLC45A3
prerank,positive regulation of epithelial cell migration (GO:0010634),0.44825697626090677,1.3528587908346965,0.06155950752393981,0.5892143551171451,1.0,27/92,14.36%,TEK;ETS1;KDR;BMPR2;TGFB2;DOCK1;FLT4;SCARB1;PRKD1;PRKD2;VIL1;PLCG1;RREB1;RHOB;MAPRE2;INSL3;RAB11A;IQSEC1;ENPP2;RAC1;HIF1A;PIK3CB;MAP4K4;RIN2;SOX9;PDCD6;NRP2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.547485018980118,1.3528220766587933,0.09868421052631579,0.5880594979782064,1.0,6/26,6.96%,NOS3;ACER2;GCH1;NOS2;ACER1;SPTLC2
prerank,muscle organ development (GO:0007517),-0.4080549654703658,-1.3526395042438137,0.057065217391304345,0.5596704197104587,1.0,16/54,9.60%,LAMA2;IGF1;LARGE1;SGCD;COL6A3;FHL1;DMD;SPEG;ITGA11;MKX;MRAS;CHD2;VAMP5;POU6F1;SOX6;EVC
prerank,sodium ion transmembrane transport (GO:0035725),-0.3793936698868616,-1.3526285652115098,0.03180212014134275,0.5576106360514029,1.0,16/84,7.24%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;PKD2;SLC9A2;ATP1B3;SLC6A1;ATP1B2;SLC8A1
prerank,cell-substrate junction assembly (GO:0007044),0.5223466508874075,1.3521326659457988,0.13166666666666665,0.5889558675570935,1.0,6/33,10.91%,ITGA6;THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.415434653865312,1.3519480287576588,0.05063291139240506,0.588168664428776,1.0,24/151,8.30%,TEK;SEMA7A;MFHAS1;PDGFB;KDR;RAPGEF2;PDGFD;APP;TIRAP;PDE8A;FLT4;TNFRSF11A;NOD2;NOTCH1;PRKD2;RAMP3;CCR7;CD4;MAPK3;FBXW7;LGALS9;HTR2A;TGFB1;ABCA7
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5555634475389365,-1.3514360653777473,0.12354312354312354,0.5590885910274765,1.0,5/15,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,regulation of MAP kinase activity (GO:0043405),0.43939739031580227,1.3514009730435708,0.05174825174825175,0.5886495383178192,1.0,14/92,5.07%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TPD52L1;STK38;PTPRJ;DUSP7;CD40;NOD2;LYN;FGF16;HYAL2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.4244018048433873,1.3510736314830725,0.05698778833107191,0.5883485723994191,1.0,26/124,12.16%,PTPRM;FRY;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;CCR7;TBC1D24;PLEKHA1;STMN3;RAB11A;STMN4;MARK4;GPM6A;OPHN1;TBC1D23;BICDL1;CYFIP1;AGER;CEP78;RAC1;BTG2
prerank,positive regulation of chemokine production (GO:0032722),0.5006451801492681,1.3509342548559222,0.10236220472440945,0.5875373826934439,1.0,10/44,11.86%,APP;TIRAP;IL6R;TLR3;LGALS9;TLR7;ADAM17;AGER;HIF1A;SYK
prerank,regulation of intracellular signal transduction (GO:1902531),0.38429436136395756,1.3508228949970913,0.012087912087912088,0.5865977290828487,1.0,88/420,13.66%,SGMS1;CHN2;MCF2L;TEK;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;PPP1R16B;DAB2IP;SRGAP1;PPP1R13B;PDE2A;ARAP2;RASGRF2;NET1;NFKBIA;PLEKHG5;PHLPP1;PTPMT1;ARHGEF2;KALRN;FAM13A;TIAM1;ABR;PRKD2;VWF;STARD13;MOB3B;LYN;TMSB4X;PEX5L;GNA12;XIAP;RHOB;PIP5K1C;PHF20;OCRL;DEPDC7;MRE11;ARHGAP23;PAK5;SOS1;MAPK3;ENTPD5;ARHGAP25;RFFL;ARHGEF12;JMY;PRKAR2B;KAT6A;BIRC3;CRNN;ARHGEF5;PIN1;PIDD1;PREX1;ARHGEF7;OPHN1;ARHGAP4;PAK1;ARHGDIA;DNA2;PRKAR2A;DDIT4;ARHGAP17;AGER;PRKAB1;FBXL2;HSPB1;IER3;RAC1;TNFSF11;PIP4K2A;CEACAM1;MAP4K4;WWC1;TMEM127;HIPK2;CSNK2B;FGD2;CYLD;BRPF1;RPL11;STK3;MINK1;AKAP6
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5043598677970755,1.350818300163854,0.1040650406504065,0.5853534622083081,1.0,5/42,5.25%,TEK;UTRN;KDR;PTPRJ;CCR7
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5227982799375231,1.3507126755152492,0.12460063897763578,0.5844203001709012,1.0,12/33,15.74%,CACNA1A;LRP8;ABR;BTBD9;GRID2;PXK;FABP5;GRIK5;GRIK2;GRIK1;LRRC4C;NLGN1
prerank,nitric oxide biosynthetic process (GO:0006809),0.6306488097651042,1.3498388808071513,0.14695340501792115,0.5857217831176621,1.0,3/13,4.51%,NOS3;GCH1;NOS2
prerank,retinal metabolic process (GO:0042574),-0.5821342955740384,-1.349797738216571,0.1440677966101695,0.5620118755148724,1.0,7/12,34.22%,ABCA4;CYP1B1;RDH10;ALDH1A3;RDH13;ALDH8A1;DHRS13
prerank,renal water homeostasis (GO:0003091),-0.5031138614096429,-1.3493583261875004,0.10396039603960396,0.5613152276397899,1.0,8/23,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;RAB11FIP2;ADCY7;PRKACA;ADCY6
prerank,visual system development (GO:0150063),-0.4467005852783627,-1.3486095669625544,0.07948717948717948,0.5616806778424448,1.0,8/37,6.50%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5039432686658084,1.348379628806824,0.0975609756097561,0.5889542047848157,1.0,7/40,9.89%,PGLYRP1;TIRAP;DEFA6;GBP7;GBP4;PPP1R11;ADAM17
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5595208633955633,-1.3482090512134128,0.11494252873563218,0.5607587975169837,1.0,6/15,6.43%,GPC3;WNT5B;RSPO3;DAAM2;SFRP4;DACT1
prerank,development of primary male sexual characteristics (GO:0046546),0.5211593477551647,1.3477944028023179,0.12032520325203253,0.589442404202387,1.0,7/34,10.83%,KITLG;TGFB2;LHFPL2;BIK;COL9A3;NCOA4;LRP2
prerank,cellular macromolecule catabolic process (GO:0044265),0.48884295355963536,1.3477806300411264,0.08421052631578947,0.5882351569387367,1.0,18/49,21.63%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;DFFB;FBXO6;MANBA;PPP1R8;NEU2;SND1;UBE2G2;FBXO2;RNASEH2C;XRN2;NCBP1;RNASE6
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4621429019775453,1.347045004789568,0.09193776520509193,0.5891852248021977,1.0,11/70,8.64%,TEK;PARVB;SRGAP2;MEF2C;LAMA5;NTNG2;PXN;PARVG;ACTN1;EFNA1;OPHN1
prerank,icosanoid secretion (GO:0032309),0.6355386974269688,1.3468567166920926,0.15606936416184972,0.588519454697132,1.0,2/12,4.51%,ABCC4;NOS2
prerank,positive regulation of immune system process (GO:0002684),0.5945761944902928,1.3461982344720147,0.11602209944751381,0.5893248918230705,1.0,5/16,14.70%,TGFB2;LGALS9;PIK3CB;IL15;NCKAP1L
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6035536573719742,-1.3458799025591694,0.1371308016877637,0.565972844890829,1.0,5/10,24.80%,HDAC4;PIAS1;MUL1;UBA2;RWDD3
prerank,cytosolic calcium ion transport (GO:0060401),-0.46998053156073905,-1.3458001259099497,0.11382113821138211,0.5641834661383982,1.0,13/28,20.43%,CACNA1C;MCU;CACNA2D1;SLC35G1;SLC8A1;AFG3L2;JPH1;ATP2A3;ATP2B3;JPH2;ATP2A2;CACNB3;MICU1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5931556129879789,1.3453803446140575,0.13898916967509026,0.5905716441590096,1.0,6/17,12.02%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4645751648261308,1.3447164260943394,0.08794326241134752,0.5912468725468174,1.0,18/66,8.51%,PTPRM;AQP11;DAB2IP;TGFB2;XDH;CAV1;MCC;B2M;RGCC;MTSS1;VASH1;SNAI2;FBXW7;CDKN2B;STAT1;BRCA2;TGFB1;CAV2
prerank,transferrin transport (GO:0033572),0.5185700531089267,1.3446733570857439,0.14756671899529042,0.5901500666700479,1.0,5/33,7.03%,TFRC;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,telomere maintenance via recombination (GO:0000722),-0.5866433870002494,-1.3443620228871476,0.15756302521008403,0.5663655946640184,1.0,6/11,19.24%,SMC6;TEP1;ERCC1;RAD50;NSMCE2;TPRKB
prerank,nucleoside catabolic process (GO:0009164),-0.5988184005548424,-1.3440465293852975,0.13777777777777778,0.5652938793783443,1.0,6/11,15.13%,DPYD;NT5E;UPB1;UPP2;DERA;NT5C1A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6356528538974612,1.3438451286916482,0.15300546448087432,0.5913578666813226,1.0,4/11,9.66%,JAK3;SMAD7;FOXP3;SOCS5
prerank,amino sugar biosynthetic process (GO:0046349),-0.5840793688824465,-1.3434212305534445,0.15098468271334792,0.5649192373561871,1.0,8/12,28.38%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,cell chemotaxis (GO:0060326),0.4709642298499065,1.3431490950489473,0.09643916913946587,0.5923191578639326,1.0,7/60,5.25%,LEF1;DOCK4;PDGFB;CXCL12;PLEKHG5;ELMO2;CCR7
prerank,maintenance of protein location in nucleus (GO:0051457),0.5605333051873089,1.3428748759675344,0.13961605584642234,0.5919604141818499,1.0,3/20,2.92%,SYNE1;ARL2BP;SP100
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5752974982325082,-1.342751859143238,0.11392405063291139,0.5648977903046346,1.0,2/12,0.75%,NOTCH2;DOCK11
prerank,actin cytoskeleton reorganization (GO:0031532),-0.39324782215917625,-1.342418884210779,0.05217391304347826,0.5638640855708211,1.0,19/63,12.32%,AUTS2;PARVA;GSN;CXADR;PTK7;MCU;SIPA1L1;NRK;KIT;DTNBP1;ANXA1;FLNA;SYDE1;PHACTR1;PDLIM4;EZR;EFS;DMTN;S1PR2
prerank,calcium-mediated signaling (GO:0019722),-0.37296246857409504,-1.341926344123214,0.026415094339622643,0.5632947310597733,1.0,23/93,12.30%,CACNA1C;ANK2;EGFR;PLCE1;MCU;NUDT4;CCR9;ADGRL1;DMPK;P2RX4;SLC8A1;AGTR1;PTGFR;PDPK1;PRKACA;SLC9A1;TRPM4;STIMATE;LRRK2;PPP3CB;SPHK1;RCAN3;DMTN
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5126351325762597,1.3404824886055975,0.1298904538341158,0.5981949247011394,1.0,15/36,14.21%,PTPRM;DAB2IP;RGCC;MEF2C;SP100;ACVRL1;NOTCH1;VASH1;DLL4;TGFB1;AGTR2;PPARG;CSNK2B;DNAJA4;SYNJ2BP
prerank,C4-dicarboxylate transport (GO:0015740),0.6189538388208962,1.3404604601799346,0.15087719298245614,0.5970429255656797,1.0,2/14,5.02%,SLC1A1;SLC1A2
prerank,regulation of cell motility (GO:2000145),0.4280621296872415,1.340400693952672,0.06728232189973615,0.5959873056150202,1.0,28/121,12.52%,SPOCK2;FRMD5;MACF1;ROBO4;FES;NTN1;SPATA13;PLXND1;AMOT;PRAG1;TMSB4X;FGF16;CCR7;RHOB;PKN1;INPP5F;KIF2A;PKN2;TMSB10;PIN1;TGFB1;ENPP2;ABI3;PLXNB3;RAC1;SLK;CEACAM1;CYRIB
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4672709706782161,-1.3403260614931007,0.1111111111111111,0.5661197384490283,1.0,7/30,4.91%,CACNA1C;ANK2;SNTA1;GJA1;CACNA2D1;KCNJ2;CACNA1G
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4622205799188041,-1.3402397059789688,0.0835509138381201,0.5643423911340582,1.0,13/32,13.58%,PHLDB2;ARHGAP6;APOD;CASK;THBS1;HOXA7;JAG1;MYOC;SEMA3E;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.586861981026656,1.3401139978033498,0.16757741347905283,0.5956385252699635,1.0,4/17,6.46%,PODXL;TGFB2;PIEZO1;RET
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6042908509156405,-1.3396902215288717,0.1524008350730689,0.5620555401670292,1.0,5/10,18.79%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6042908509156405,-1.3396902215288717,0.1524008350730689,0.5620555401670292,1.0,5/10,18.79%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,dephosphorylation (GO:0016311),0.4171562247148046,1.3396864121740786,0.06017925736235595,0.5957163764080697,1.0,15/147,4.61%,PTPRG;PTPRM;PTPRB;SGPP2;CTTNBP2NL;PTPRJ;DUSP23;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PLPP6;PPP3CC;PPP4R1
prerank,polyol metabolic process (GO:0019751),0.4889919834807473,1.3396798079013934,0.11143695014662756,0.5945147018274033,1.0,13/46,12.48%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;IPMK;PLCH1;INPP1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.39731391218112433,1.3394315977144995,0.03308823529411765,0.5940781061169853,1.0,53/224,17.53%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A2;SLC6A5;UNC13B;RPS6KA1;CALM1;PDE7B;SLC1A2;CAMKK2;SYPL1;SLC12A6;PRKACB;ATXN3;HOMER1;CHRNB1;GABRB1;HTR2A;PRKAR2B;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;PRKAR2A;NPY5R;CHRM3;EXOC4;GRIN2B;GABRQ;PCDHB14;CPNE6;GRIK2;CPLX1;SDCBP;MINK1;GRIK1;MYCBPAP;SYNJ2BP;GABRG1;HTR4;GRM7;AMPH;NLGN1;MAPK1;GABRG3;MBP;PMP22;GABRA1;SST
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.604765643068027,1.3391633992085814,0.13392857142857142,0.5937195636831629,1.0,4/15,6.75%,IGF1R;KDR;MAPK3;AATK
prerank,protein localization to cell junction (GO:1902414),0.5521664708491549,1.3384525904825244,0.1465076660988075,0.5946565162299436,1.0,3/22,1.89%,TJP1;HEG1;TJP2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.49836856904181087,-1.3383000547563717,0.12705882352941175,0.5642788232153705,1.0,5/21,7.86%,ANK2;SNTA1;CACNA2D1;FLNA;CACNA1D
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.520509186260636,1.3374391643837291,0.11258278145695365,0.5965628467742717,1.0,7/32,13.32%,MFSD2A;SLC44A5;CHKA;LPCAT3;CEPT1;CSNK2B;LPIN3
prerank,nucleotide catabolic process (GO:0009166),0.5891614105611737,1.3373598037522771,0.15591397849462366,0.5955683219508592,1.0,5/16,11.08%,XDH;SAMHD1;NT5C2;NUDT3;PNP
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5630005307336652,1.3372132387844438,0.14751286449399656,0.5947843427208441,1.0,9/23,15.05%,MYO10;CCDC88A;CCDC88B;KIF1A;MAP6D1;TUBB;HOOK1;F8A1;TUBA1A
prerank,myotube cell development (GO:0014904),-0.602876453816552,-1.3371973955238985,0.14822546972860126,0.5656606820737862,1.0,3/10,13.00%,IGF1;SIX1;SKI
prerank,negative chemotaxis (GO:0050919),0.5167240306353077,1.3371530949927164,0.12626262626262627,0.5937831288561932,1.0,7/33,6.97%,SEMA3C;SEMA7A;SEMA6A;NTN1;SEMA6B;SEMA4F;SEMA6D
prerank,regulation of protein localization to membrane (GO:1905475),-0.4683116173910779,-1.3358041547596602,0.09571788413098237,0.5678592411915797,1.0,9/28,11.08%,GPC6;GSN;GPC3;MMP14;GPC4;AR;PRKN;SLC5A3;CLN3
prerank,regulation of phospholipid metabolic process (GO:1903725),0.6484612313510492,1.335699318810352,0.1687612208258528,0.5969100513114,1.0,4/10,15.12%,MFSD2A;ABCA3;DNAJC19;MTMR2
prerank,inositol phosphate metabolic process (GO:0043647),0.4834072322140327,1.3350043217379939,0.11918604651162791,0.5977683334723533,1.0,13/46,12.48%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;IPMK;PLCH1;INPP1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6471642870482331,1.3349249209444476,0.16512059369202226,0.5968198982586933,1.0,3/11,3.96%,SEMA6A;EPN2;KLF2
prerank,negative regulation of cartilage development (GO:0061037),-0.5659533292853776,-1.334648359267369,0.1358574610244989,0.569277083151189,1.0,4/13,4.34%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,sister chromatid segregation (GO:0000819),-0.46631980355141184,-1.3339710102523707,0.09798270893371758,0.5693230458377452,1.0,15/31,27.22%,TOP2B;KLHL22;ZWINT;SMC4;CENPK;TUBG1;LATS1;KIF18A;NUSAP1;TOP2A;KNSTRN;KIFC1;NSL1;SGO1;CDCA8
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3734919093586278,-1.3334486070821934,0.06159420289855073,0.5687341432354959,1.0,14/86,4.67%,BMP6;SULF1;ZEB2;BMPR1A;FOXD1;BMP5;BMP7;BMP4;THBS1;TGFBR1;TWSG1;RBPJ;ZNF423;DAB2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5911251357008798,-1.3332656929679672,0.1589958158995816,0.567334336541197,1.0,8/11,28.38%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,error-prone translesion synthesis (GO:0042276),0.554026306584595,1.3329230247379822,0.15345699831365936,0.6017317783346618,1.0,1/21,0.28%,POLK
prerank,positive regulation of cell growth (GO:0030307),0.43620585726863276,1.3329024831733047,0.07901907356948229,0.6006054693307756,1.0,24/96,13.66%,SEMA7A;MFSD2A;MACF1;TGFB2;NTN1;NEDD4L;ITSN2;RPS6KA1;SLC25A33;DBNL;ADAM10;RASAL1;TWF2;SMURF1;ADAM17;CPNE5;S100A8;SYT4;BRAT1;RPTOR;CPNE6;DERL2;SDCBP;AKAP6
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.46299100116262487,1.332750033451539,0.0951683748169839,0.5998425510376288,1.0,15/70,12.48%,BCL2L1;DAB2IP;TGFB2;FAS;IL6R;SORT1;TLR3;CRADD;MCL1;TGFB1;P2RX7;DEDD2;CASP8;GSK3A;TNFSF12
prerank,heme biosynthetic process (GO:0006783),0.5584566620296207,1.3318152393768405,0.16291161178509533,0.6015417002368973,1.0,3/22,8.34%,ABCG2;ALAS1;CPOX
prerank,heterochromatin organization (GO:0070828),0.6123830801221231,1.3313462336619608,0.1741472172351885,0.6017921401040636,1.0,1/14,0.11%,MECOM
prerank,regulation of macrophage migration (GO:1905521),0.6457155482758267,1.3307646467386232,0.18853974121996303,0.6022440257917263,1.0,3/10,8.06%,MTUS1;CD200;CD200R1
prerank,carnitine shuttle (GO:0006853),-0.5982512960123365,-1.3303324768281948,0.13432835820895522,0.5743994276310579,1.0,2/11,1.34%,PRKAG2;PRKAA2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5517828597699553,1.330018162499628,0.14535901926444833,0.6033822533894653,1.0,7/24,13.79%,NOD1;NOD2;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5792194499755381,-1.329721291787361,0.15812917594654788,0.5721688351309624,1.0,3/12,10.68%,IGF1;SLC9A1;STIMATE
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5792194499755381,-1.329721291787361,0.15812917594654788,0.5721688351309624,1.0,3/12,10.68%,IGF1;SLC9A1;STIMATE
prerank,sodium ion homeostasis (GO:0055078),-0.49824502703279594,-1.3296831303226786,0.12470588235294118,0.5703060724151089,1.0,6/21,10.27%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1;SLC9A1
prerank,iron ion homeostasis (GO:0055072),0.4752586201660577,1.329464901833783,0.10344827586206896,0.603899095104961,1.0,4/58,2.47%,TFRC;SLC40A1;ABCG2;B2M
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5381260219849369,1.3290821044813126,0.13815789473684212,0.6038360779765883,1.0,7/27,11.65%,EFHC2;MBOAT1;NTNG2;CCDC88A;HOMER1;DISC1;GSK3A
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.41946458286554494,1.328208503943041,0.07651715039577836,0.6053522426765623,1.0,20/124,12.39%,LEF1;PLCB1;FZD6;FZD4;TIAM1;WNT7A;CALM1;CTNNB1;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;PPP3CA;RAC1;PPP3R1;AP2B1;GNB1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4290094943598086,-1.3281006774420698,0.10427807486631016,0.5728473181517124,1.0,9/40,4.69%,ARHGAP6;LPAR1;NTRK3;EGFR;PDGFRB;PDGFRA;EDNRA;KIT;FGF2
prerank,base conversion or substitution editing (GO:0016553),0.6619597802825661,1.3280149246063795,0.17142857142857143,0.6047051112589891,1.0,5/11,23.33%,ADAR;ADAD1;NUDT16;METTL3;ADARB2
prerank,transepithelial transport (GO:0070633),0.592334232267515,1.3273399620753341,0.16,0.6054866879518496,1.0,3/15,5.02%,ABCG2;SLC1A1;SLC1A2
prerank,adipose tissue development (GO:0060612),0.64839617042032,1.3264637495184104,0.18130841121495328,0.607046099074758,1.0,3/11,8.59%,NAMPT;SPTLC2;LRP5
prerank,neural tube development (GO:0021915),-0.5346742990879945,-1.3263735939784251,0.12844036697247707,0.5761930306028202,1.0,4/15,6.43%,ALDH1A2;PKD1;PKD2;DACT1
prerank,cellular response to alcohol (GO:0097306),-0.43281188986760916,-1.3259388800192753,0.0893371757925072,0.5756001613336339,1.0,19/42,25.65%,ADCY5;ADCY1;SMO;CDH1;ADCY2;ADCY7;GRAMD1B;PTGFR;GRAMD1C;ADCY6;LRP6;SFRP1;GRAMD1A;BRCA1;PTCH1;KLF9;MLC1;SPIDR;AHR
prerank,aminoglycan catabolic process (GO:0006026),-0.46379957878059924,-1.3258789372701034,0.10498687664041995,0.5738792295421627,1.0,5/28,7.96%,GPC6;SDC2;GPC3;GPC4;SDC4
prerank,regulated exocytosis (GO:0045055),0.4011140176156443,1.3257949133150468,0.051787916152897656,0.6079246384169567,1.0,28/173,10.32%,ABCC4;PECAM1;RAB11FIP1;PDGFB;TGFB2;APP;LHFPL2;RAB31;STX1A;SRGN;SELENOP;VWF;LYN;TMSB4X;CALM1;CFD;PIP5K1C;SYT7;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;SCG3;CDC37L1;DNAJC5;ARHGAP17
prerank,neuron projection development (GO:0031175),0.4039100528424629,1.3257453055764976,0.05443037974683544,0.6068777830761384,1.0,31/168,10.36%,PTPRM;FRY;SHANK3;SRGAP2;DAB2IP;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;WNT7A;TBC1D24;EPHA4;DIP2A;DBNL;NCKAP1;STMN3;DNM2;RAB11A;STMN4;GPM6A;OPHN1;PAK1;SLC9A6;ZPR1;TBC1D23;BICDL1;AGER
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5338330045018755,-1.325418390814385,0.13990825688073394,0.5733898991621719,1.0,1/15,0.02%,ATP1A2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5118665557941992,1.325225478314948,0.12693498452012383,0.6072009560549001,1.0,11/33,12.15%,SEMA6A;TJP1;PPP1R16B;EPN2;KLF2;FGF16;KLF4;PKM;SMAD1;CEACAM1;PIK3CB
prerank,regulation of protein phosphorylation (GO:0001932),0.39090411602559755,1.3250504155629224,0.03716608594657375,0.6065146113279394,1.0,48/256,10.75%,TFRC;TEK;OCLN;LIMCH1;PECAM1;KDR;INSR;DAB2IP;ENG;APP;PRR5L;XDH;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MEN1;LYN;FNIP2;FGF16;WWTR1;CD4;CAMKK2;CCDC88A;LIMK2;PPIA;FYN;MAPK3;PPP2R5A;RALB;INSM1;EFNA1;PIN1;TGFB1;IRGM;PAK1;PGF;CCND3;ADAM17;AXIN2;AGER;BRD4;HSPB1
prerank,negative regulation of cell activation (GO:0050866),0.5911919200756728,1.3249218538981713,0.17272727272727273,0.6057663139419797,1.0,3/14,2.13%,PDGFB;NOS3;CD200
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.529708767301438,1.3246859743005128,0.15,0.6052671137018717,1.0,5/24,10.01%,AQP11;BCL2L1;NR1H2;UBXN1;LPCAT3
prerank,axon guidance (GO:0007411),0.39606906146611415,1.3240699212975782,0.038834951456310676,0.6059809526517583,1.0,39/201,9.32%,SEMA3C;PTPRM;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;NTN1;SEMA6B;KLF7;PTK2;LAMA5;PLXND1;TMEFF1;NOTCH1;DSCAML1;EVL;PLCG1;GRB2;SEMA4F;GAB1;EPHA4;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;EPHB4;CNTN2;SEMA6D;EFNA1;SPTAN1;SHC3;OPHN1;NRXN1;SEMA4C
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5805783855598203,1.3234525197593472,0.15862068965517243,0.6067173507749168,1.0,4/18,8.41%,CD34;HDAC7;HOMER2;FOXP3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.578816251061925,1.3228620458829554,0.17474048442906576,0.6073479547012263,1.0,2/18,1.49%,SLC39A8;JAM2
prerank,import into cell (GO:0098657),0.5078493960347865,1.322801470446568,0.12618296529968454,0.6063880539686878,1.0,5/41,2.53%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;LRRC8C
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5131409461966274,-1.3227981436489062,0.12614678899082568,0.5796115718336282,1.0,4/18,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,negative regulation of JNK cascade (GO:0046329),0.5198159656815795,1.3218318216058818,0.14100486223662884,0.6082535650032581,1.0,8/31,15.14%,MECOM;MEN1;DUSP3;NPPA;ZMYND11;CYLD;DNAJA1;HIPK3
prerank,positive regulation of ossification (GO:0045778),-0.4330205084245948,-1.3210454221219798,0.1132596685082873,0.5831561667190901,1.0,15/39,12.43%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;FBN2;PKDCC;BMP2
prerank,negative regulation of hormone secretion (GO:0046888),0.6336055654017847,1.320934409438498,0.17092337917485265,0.6097468725793586,1.0,1/10,0.73%,RAB11FIP1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5853230797789739,-1.3205299649151085,0.15164835164835164,0.5827254069169133,1.0,1/10,2.79%,TUT4
prerank,cellular iron ion homeostasis (GO:0006879),0.4782716260976051,1.3204595502666099,0.12536023054755044,0.6100005856180747,1.0,3/55,0.38%,TFRC;SLC40A1;ABCG2
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5233729426157366,-1.3193013323088416,0.14805825242718446,0.5844789011273694,1.0,7/17,17.63%,FGFR2;NPR3;CCN1;MN1;BMP2;SFRP1;TMEM119
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.44669695413458366,1.3187446172689345,0.11522048364153627,0.6140576995282537,1.0,11/73,11.35%,KITLG;LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5738329362457523,-1.3183916775262752,0.17400881057268722,0.5853627783082539,1.0,2/12,2.85%,DPYSL3;DPYD
prerank,neutrophil chemotaxis (GO:0030593),0.4756536780358585,1.3180714498100088,0.12557427258805512,0.6150340415844937,1.0,10/53,11.86%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,microtubule bundle formation (GO:0001578),0.49491644329582835,1.3180468772825813,0.13414634146341464,0.6139420512703099,1.0,15/42,18.49%,NAV1;CLIP1;RP1;NCKAP5;MARK4;TTLL3;CDK5RAP2;RSPH4A;DCX;RSPH1;FOXJ1;NCKAP5L;SPAST;CCDC66;TPPP
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5578357637857015,-1.3180125867248553,0.15296803652968036,0.5846492903467517,1.0,4/13,10.27%,ATP1A2;ATP1B3;ATP1B2;SLC9A1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.45081104634338975,-1.3179989160088625,0.11878453038674033,0.5827867435090237,1.0,14/33,19.26%,APPL2;PKD1;STXBP4;GLI1;PSME3;MN1;PTEN;PAF1;TCIM;PLK5;DDRGK1;ID2;PTPN6;EZH2
prerank,erythrocyte differentiation (GO:0030218),0.4831503891685573,1.3179384464591324,0.1111111111111111,0.613112498389354,1.0,8/44,5.20%,MFHAS1;ALAS1;JAK3;ZFPM1;LYN;KLF1;SLC25A5;TAL1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5370008529487931,1.3176923735107537,0.13376835236541598,0.6127558840545757,1.0,11/26,13.39%,DAB2IP;PDE8A;PTPN12;DUSP3;VIL1;PLCG1;SNAI2;IQGAP1;ZPR1;ZFP36L1;SOX9
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.623985302762277,1.3174991367638893,0.15257352941176472,0.6122195245963155,1.0,1/12,1.02%,DAB2IP
prerank,positive regulation of cellular senescence (GO:2000774),0.6281655056412306,1.3173178336524922,0.1945945945945946,0.6115748301701336,1.0,4/10,16.58%,B2M;HMGA1;ABI3;HMGA2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5376339284554895,-1.3172237289739488,0.15403422982885084,0.5831212623995266,1.0,6/16,15.13%,DPYSL3;DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4318111808216818,-1.316940844211228,0.10270270270270271,0.5821832036256323,1.0,9/38,12.08%,CACNA1C;ANK2;CAMK2D;CACNA2D1;KCNJ2;CACNA1G;CACNA1D;TRPM4;CACNB2
prerank,synaptic vesicle endocytosis (GO:0048488),0.506499831314228,1.3167211844075073,0.13694267515923567,0.6122295991643294,1.0,7/33,8.64%,DNM3;STX1A;ITSN2;PIP5K1C;DNM2;FCHO2;OPHN1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6455154285782138,1.3160617067224816,0.15917602996254682,0.6131245377566646,1.0,2/10,3.94%,PODXL;PIEZO1
prerank,histone acetylation (GO:0016573),0.4478438478338503,1.316010569471601,0.11824817518248175,0.6121147303181655,1.0,13/69,15.65%,LEF1;TRIM16;PHF20;YEATS2;BRCA2;KAT6A;JADE2;NAA60;BRD1;BRPF1;BRPF3;POLE3;TRRAP
prerank,regulation of synapse maturation (GO:0090128),0.6413533108231027,1.315939409755369,0.19373776908023482,0.6111728967926165,1.0,7/10,19.95%,DAB2IP;ARHGEF15;NRXN1;CAMK2B;YWHAZ;NEUROD2;ANAPC2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.501061539998407,1.315928207338502,0.1450381679389313,0.6100649305284299,1.0,8/36,13.08%,MECOM;FOXO1;MEN1;DUSP3;PPIA;ZMYND11;DUSP1;CYLD
prerank,positive regulation of protein processing (GO:0010954),-0.5072085136320653,-1.3155360462271772,0.1288888888888889,0.5846819531286276,1.0,3/19,3.29%,GSN;CCBE1;CLEC3B
prerank,protein oxidation (GO:0018158),-0.5959209938460779,-1.3153160345514316,0.16877637130801687,0.5835297984962696,1.0,3/11,6.71%,LOXL1;LOXL3;LOX
prerank,protein localization to cell surface (GO:0034394),-0.4702151826059278,-1.3150611916003097,0.12652068126520682,0.5824134325586573,1.0,7/26,10.34%,ANK2;ANGPT1;FBLN5;VCL;FLNA;GGA2;PRRT1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5703066300621473,-1.3149851193666093,0.14831460674157304,0.5808107477261335,1.0,5/12,13.14%,IRS1;PPARGC1A;PPARA;IRS2;TWIST1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4909566934593327,1.314756768971106,0.12557427258805512,0.6122271777118679,1.0,6/41,4.31%,TJP1;PODXL;MAGI1;PLAUR;PIEZO1;SMAD7
prerank,neuron development (GO:0048666),0.40769799519065136,1.3144690868284454,0.07692307692307693,0.6119664218189371,1.0,25/141,10.39%,PTPRM;FRY;TGFB2;RAPGEF2;APP;FRYL;B4GALT5;STX3;MEF2C;MAP4;LYN;PPP1R9B;STMN1;TBC1D24;RP1;STMN3;INSM1;RAB11A;STMN4;GPM6A;OPHN1;TBC1D23;BICDL1;AGER;DCX
prerank,regulation of cytokine production (GO:0001817),0.4182790407160021,1.3139990181331542,0.07940780619111709,0.6122914515997303,1.0,23/126,10.63%,CADM1;AFAP1L2;BCL6B;RGCC;SRGN;IFIH1;HDAC9;LYN;NOS2;MOG;CCR7;PLD4;TRIL;SNAI2;CCDC88B;RPS6KA5;ATP2B1;LGALS9;N4BP1;FOXP3;PPP1R11;CASP8;NLRP4
prerank,positive regulation of defense response (GO:0031349),0.4389621540821823,1.313622011519153,0.08659217877094973,0.6123627004542557,1.0,15/89,12.73%,ETS1;PDE2A;APP;NFKBIA;MEF2C;GBP5;HYAL2;MGST2;TLR3;TLR7;CCL1;TLR8;S100A8;IL15;DDT
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5562081825819875,-1.313301392187532,0.14376321353065538,0.5838709741136205,1.0,3/12,8.01%,ROCK2;FLOT2;APOE
prerank,positive regulation of growth (GO:0045927),0.45714310119457535,1.3129609508119777,0.11527377521613832,0.6132404490343324,1.0,16/64,14.30%,PLCB1;MFSD2A;INSR;TGFB2;RPS6KA1;SLC25A33;ADAM10;ZPR1;ADAM17;S100A8;BRAT1;RPTOR;DERL2;SDCBP;AKAP6;RFTN1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5158416859190441,-1.312416943140954,0.12354312354312354,0.5845037728129614,1.0,4/19,5.22%,IGF1;NUPR1;IL18;DAGLA
prerank,mesenchyme morphogenesis (GO:0072132),0.5785089303189755,1.3117291335043688,0.17953321364452424,0.6157944889001241,1.0,5/17,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,response to lipopolysaccharide (GO:0032496),0.4073224095478087,1.311686412019299,0.05613577023498695,0.6148076436778928,1.0,25/138,14.07%,DAB2IP;NOS3;TIRAP;GCH1;IFNAR1;TNFRSF11A;MEF2C;SCARB1;DEFA6;NOD2;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;PDE4B;IRGM;ADAM17;S100A8;SLPI;HMGB2;TNFAIP3;GIT1;BCL10
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.4956557448108387,1.3114918505413846,0.14057507987220447,0.6142850120167112,1.0,8/38,7.63%,PDGFB;APP;CAV1;LRP8;NEDD9;HYAL2;EPHA4;EFNA1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.41492755271444265,-1.3107433919752796,0.10483870967741936,0.5876542608288402,1.0,15/48,15.28%,ADCY5;AMPD3;ADCY1;ADCY9;SLC26A2;ADCY2;ADCY7;PAPSS2;GUCY1A1;DCAKD;PAPSS1;ADCY6;GUCY1B1;IMPDH2;GMPS
prerank,positive regulation of cell population proliferation (GO:0008284),0.3696062626077435,1.310603667505762,0.018498367791077257,0.6158424322902105,1.0,52/423,9.30%,LEF1;FLT1;IGF1R;PRKCH;KITLG;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;TGFB2;ACER2;PDGFD;TBX1;IL6R;FLT4;CNOT6L;TBX3;TNFRSF11A;STX3;GNAI2;PTK2;NES;MEF2C;NOD2;TIAM1;NOTCH1;LYN;OSMR;FGF16;DLL4;WWTR1;SLC25A5;SLC25A33;ADAM10;STAT1;HCK;INSM1;BST2;TGFB1;TGFA;CXCR2;PTN;LRP5;COPS9;GREM1;PAK1;PGF;MAP3K3;LIFR
prerank,activation of protein kinase A activity (GO:0034199),-0.5319109911474625,-1.310104723968438,0.11933174224343675,0.5878148871467458,1.0,7/16,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6
prerank,regulation of programmed cell death (GO:0043067),0.3970032775477766,1.3097106703910892,0.07449494949494949,0.6173071876806892,1.0,22/161,9.05%,MECOM;HIP1;PPP1R13B;ACER2;FAS;TNFRSF25;LRP8;PHLPP1;JAK3;TGM2;ACTN4;TOX3;CRADD;STAT1;ACTN1;LCMT1;MARK4;BIRC3;PIDD1;TRIM24;BNIP3L;MALT1
prerank,metal ion homeostasis (GO:0055065),0.49840023262813465,1.309295065409666,0.1234375,0.6174219383287598,1.0,6/40,9.14%,TMTC2;CAV1;SLC12A6;SLC12A9;KCNH2;LETM1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3448236448643067,-1.30915680437564,0.0502283105022831,0.5888159529571871,1.0,24/140,13.00%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CD55;CCR9;EDNRA;ADRA1B;CACNA2D1;TRPC3;DLG4;P2RX4;SLC8A1;BDKRB2;AGTR1;PTGDR;PTGFR;TRPM4;ABL1;ESR1;JPH1;LPAR4;CMKLR1
prerank,vesicle organization (GO:0016050),0.48040668246678975,1.3085652294118097,0.12612612612612611,0.6184820862456669,1.0,10/46,12.19%,CD34;CAV1;FNBP1L;ALS2CL;SRGN;DNAJC13;SORT1;CAV2;HOOK1;EPS15
prerank,potassium ion homeostasis (GO:0055075),-0.491044301411987,-1.3081349058955438,0.135,0.5900080890690571,1.0,6/23,7.08%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;SLC12A7;ATP1B2
prerank,muscle contraction (GO:0006936),-0.34462208899374824,-1.3079456322901784,0.0379746835443038,0.5887272574900257,1.0,30/126,13.21%,CALD1;ROCK2;ACTN2;MYLK;TPM1;SNTA1;ITGB5;SNTB1;EDNRA;MYOF;DMD;VCL;ASPH;PABPN1;GNAO1;SLC8A1;MYH11;BDKRB2;MYL9;LMOD1;ACTA2;TPM2;TMOD3;DES;ARHGEF11;DTNA;TLN1;MYOM1;EMD;FXYD1
prerank,photoreceptor cell development (GO:0042461),0.5852819651970277,1.307409159224385,0.2003577817531306,0.6208008539503894,1.0,3/14,10.39%,MFSD2A;RP1;DCX
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5763613804175308,1.3073302124865143,0.16548042704626334,0.6199166579479859,1.0,5/18,10.15%,RNF125;SEC14L1;ZCCHC3;BIRC3;OASL
prerank,regulation of stress fiber assembly (GO:0051492),-0.3768773501311825,-1.3069202609188462,0.0673076923076923,0.5900010925874603,1.0,24/74,10.27%,PHLDB2;ARHGAP6;LPAR1;ROCK2;ARHGAP28;PPM1E;CCN2;ARHGEF10L;ASAP3;ARAP1;TPM1;CARMIL1;TGFBR1;S100A10;ALMS1;CGNL1;ARHGEF18;FHOD1;MET;PFN2;MYOC;TGFB3;ITGB1BP1;SLC9A1
prerank,protein hydroxylation (GO:0018126),-0.531910593630171,-1.3067588186043515,0.15367483296213807,0.5886549424004428,1.0,7/15,13.28%,PLOD2;ASPH;P3H3;EGLN3;P3H2;OGFOD1;P3H1
prerank,mitochondrion morphogenesis (GO:0070584),-0.5808524024614345,-1.306642285575618,0.17011494252873563,0.5871131022174577,1.0,1/11,0.14%,PID1
prerank,I-kappaB phosphorylation (GO:0007252),0.6435777283085227,1.3064793625081101,0.1856060606060606,0.6213149229212462,1.0,3/10,7.62%,DAB2IP;TLR3;TLR7
prerank,chemical synaptic transmission (GO:0007268),0.3776987573538952,1.3063190160492475,0.03769140164899882,0.6207002274902148,1.0,66/284,17.53%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A2;SLC6A5;UNC13B;STX1A;RPS6KA1;CALM1;PDE7B;SLC1A2;CDH8;CAMKK2;TBC1D24;SYPL1;SLC12A6;PRKACB;GRID2;ATXN3;HOMER1;STXBP1;CHRNB1;GABRB1;HTR2A;PRKAR2B;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;PRKAR2A;DNAJC5;HSPA8;NPY5R;CHRM3;EXOC4;GRIN2B;SHISA6;GABRQ;PCDHB14;CPNE6;GRIK5;GRIK2;CPLX1;SDCBP;MINK1;GRIK1;MYCBPAP;SLC17A6;SYNJ2BP;GABRG1;HTR4;GRM7;ERC1;AMPH;NLGN1;FCHSD1;MAPK1;GABRG3;CRHBP;MBP;PMP22;GABRA1;SST
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6007806796818322,1.3059371564448956,0.16636528028933092,0.6207345285426016,1.0,7/14,19.69%,KDR;FLT4;GAB1;PGF;NUS1;NRP1;MYO1C
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5331985907115439,1.3054105160529648,0.1717687074829932,0.621182700124285,1.0,1/24,0.28%,POLK
prerank,retina homeostasis (GO:0001895),0.5408293263906098,1.3053314038410484,0.18055555555555555,0.620294845855679,1.0,6/23,10.75%,B2M;POTEF;ACTB;POC1B;ACTG1;HSPB1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.43372566340159413,1.3052704117337568,0.1001410437235543,0.6193483942909742,1.0,9/75,6.22%,PLCB1;RGS12;RGS3;RASGRP4;GIT2;PPP1R9B;CALM1;RAMP3;GNG7
prerank,regulation of cytoplasmic translation (GO:2000765),-0.535585295199053,-1.3052617326789566,0.17369727047146402,0.5894275617236424,1.0,6/14,22.70%,CPEB1;CPEB2;YBX3;FMR1;RBM24;CPEB4
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5186534620579087,-1.3049364248194364,0.16701902748414377,0.5885587373176291,1.0,7/17,14.67%,BMP4;FGF2;TMEM100;SFRP4;ATOH8;NKX6-1;AHI1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6035358512425575,1.304624404711267,0.1873873873873874,0.620152176137586,1.0,3/12,1.74%,SEMA6A;DAB2IP;XDH
prerank,negative regulation of cell adhesion (GO:0007162),0.44405022367815494,1.304552253759365,0.11190817790530846,0.6192836052409781,1.0,20/72,11.99%,SEMA6A;PODXL;ACER2;FZD4;CORO2B;PTK2;PLXND1;SIPA1;ACVRL1;NOTCH1;SNAI2;ADAM10;NEXMIF;TGFB1;SPOCK1;ARHGDIA;CBLL1;DUSP1;PLXNB3;RND1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.556820671000833,-1.3044099766475044,0.16703786191536749,0.5882866752707075,1.0,7/12,29.97%,ANO1;TRPM4;PPP3CB;STX4;PLA2G6;BAIAP3;GPLD1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.567770036289516,1.3035841517547453,0.17003367003367004,0.6210299437131649,1.0,3/18,4.11%,FLT1;MEF2C;PLCG1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.47245347227086154,-1.303199525408302,0.16953316953316952,0.5900076917634044,1.0,3/23,2.20%,TGFBR3;FGFR2;TPM1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3988551599596296,1.3026156514229894,0.07474226804123711,0.6228043372671759,1.0,48/163,20.06%,INPP5D;PTPRJ;MEF2C;PRKD2;ZAP70;PLCG1;IKBKB;PDE4D;TNFRSF21;MOG;CD19;CD4;CD38;FYN;PLEKHA1;PSMB3;PSMD11;PDE4B;CD79A;PSMC6;MALT1;PAK1;PSME2;EIF2B1;EIF2B2;DENND1B;PSMD8;PRKCB;SYK;PIK3CB;SH2B2;PSMB10;BCL10;RFTN1;LCP2;NCKAP1L;CARD11;PSMA8;NCK1;LAT2;PAK2;SKP1;PSMD9;SPPL3;SKAP1;RBCK1;FYB2;PLCG2
prerank,sulfur compound transport (GO:0072348),0.5306553995927145,1.3025833532526319,0.14858096828046743,0.6217952020708418,1.0,2/27,0.38%,SLC6A6;ABCG2
prerank,natural killer cell activation (GO:0030101),-0.48278829103185356,-1.3017410062779695,0.1536643026004728,0.5924439334022183,1.0,3/23,7.34%,PBX1;AXL;ELF4
prerank,peptidyl-lysine methylation (GO:0018022),-0.45804468657850095,-1.3016701193194549,0.15158924205378974,0.5908559594048837,1.0,13/26,28.74%,EHMT2;SMYD3;SETD7;SETD4;EEF2KMT;TRMT112;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;ANTKMT;METTL21C
prerank,regulation of cell growth (GO:0001558),0.3903782239578853,1.3016116884005386,0.06467065868263473,0.6236122727601139,1.0,40/204,12.23%,TFRC;MFSD2A;APBB2;LTBP4;BMPR2;TGFB2;SH3BP4;NET1;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;RPS6KA1;ACVRL1;CCDC85B;PPP1R9B;SOCS2;KIF26A;HYAL2;PAK5;WFDC1;FAM107A;SLC25A33;ADAM10;RASGRP2;EGLN2;BST2;TGFB1;NPR1;SPOCK1;ADAM17;BTG1;AGTR2;S100A8;BRAT1;NAIF1;CEACAM1;RPTOR
prerank,regulation of actin filament-based movement (GO:1903115),-0.5825412782730369,-1.3015950014466853,0.15778251599147122,0.5892627350387364,1.0,2/10,1.60%,ANK2;PDPN
prerank,vasodilation (GO:0042311),0.6105192778830423,1.301549989606117,0.17625899280575538,0.62266271267149,1.0,3/13,10.36%,NOS3;KLF2;AGTR2
prerank,mitochondrial fission (GO:0000266),0.5820451641522176,1.3015209480475165,0.19746376811594202,0.6216323141221791,1.0,2/16,7.03%,DNM3;DNM2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5594517186238154,1.3012243379241333,0.17452006980802792,0.6213852634514684,1.0,6/18,6.20%,CD200;LRP8;PRKD1;PRKD2;CRTC1;RPS6KA5
prerank,cellular response to oxidative stress (GO:0034599),-0.34796733569511545,-1.3004614707774562,0.056768558951965066,0.590728139690981,1.0,26/118,11.96%,EGFR;PDGFRA;PRKAA2;MGAT3;CPEB2;TPM1;PLA2R1;PRKCD;PPARGC1A;PKD2;STX2;SOD3;GPX8;SOD2;NOX4;SELENOS;SLC25A24;FOXO3;ARNT;CYBA;PARP1;LRRK2;TMEM161A;CHUK;MPV17;ABL1
prerank,cellular response to hexose stimulus (GO:0071331),0.5381235120352112,1.3004529541322143,0.15358361774744028,0.6226261262934846,1.0,2/23,2.00%,IGF1R;UNC13B
prerank,iron ion transport (GO:0006826),0.47507500555348364,1.300360261337623,0.13023255813953488,0.6218204230679097,1.0,6/47,7.03%,TFRC;SLC40A1;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,positive regulation of histone methylation (GO:0031062),-0.4678337792922726,-1.2997119720375523,0.1362530413625304,0.590996634917572,1.0,3/24,5.56%,AUTS2;OGT;CTR9
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5383358444022865,1.2991541304283347,0.1708542713567839,0.6240505589832909,1.0,5/22,8.89%,PDGFB;PDGFD;CALM1;MRE11;GREM1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4442752380125029,1.2990945194845938,0.12112259970457903,0.6230977949580953,1.0,9/67,5.88%,NDNF;UTRN;PDGFB;LIMS2;DOCK1;NEDD9;RREB1;CCR7;RSU1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4958434862564083,-1.2982338047703441,0.14676616915422885,0.5935911124832757,1.0,6/20,14.60%,IGF1;FOXC1;NIBAN2;TWIST1;EP300;DDRGK1
prerank,connective tissue development (GO:0061448),-0.43846830525797426,-1.2977754054580095,0.12398921832884097,0.5932221261276626,1.0,10/35,10.20%,SULF1;SOX5;ITGB8;PKD1;SULF2;CREB3L2;SH3PXD2B;ATP7A;SOX6;SLC39A13
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.6179085701367818,1.2975824829623264,0.20985401459854014,0.6264949280584855,1.0,3/11,4.69%,SLC19A3;NT5C3A;TPK1
prerank,actin filament polymerization (GO:0030041),-0.45747474372620595,-1.297520898219109,0.12,0.592162425101829,1.0,4/29,2.45%,ARHGAP6;GAS7;GSN;COBL
prerank,positive regulation of T cell proliferation (GO:0042102),0.46266304768665284,1.2974590700677382,0.12314540059347182,0.6257376431611535,1.0,15/55,17.12%,TFRC;SLC7A1;JAK3;CD6;CCDC88B;EBI3;AGER;PNP;SYK;IL27RA;IL15;NCKAP1L;VCAM1;NCK1;CCR2
prerank,negative regulation of developmental process (GO:0051093),0.44579685016970866,1.2964513524195616,0.12071535022354694,0.627613277914901,1.0,9/69,3.85%,TFRC;NOS3;NOTCH4;ARHGEF15;TBX1;KLF7;NOTCH1;VASH1;RAPGEF3
prerank,positive regulation of protein secretion (GO:0050714),-0.38073036219899553,-1.2959190095033006,0.06060606060606061,0.5950609796647478,1.0,13/69,9.52%,BMP6;WLS;IGF1;MCU;FRMD4A;NLGN2;RBP4;ADAM9;IRS2;NNAT;C1QTNF3;TGFB3;EZR
prerank,cilium-dependent cell motility (GO:0060285),0.5486856081501623,1.295899560608511,0.16817359855334538,0.6282374210052423,1.0,6/22,12.40%,EFHC2;DNAH3;DRC1;CFAP54;DNAAF2;DNAH8
prerank,regulation of cell population proliferation (GO:0042127),0.3608020639956531,1.2955073276691693,0.009424083769633508,0.6282960883657261,1.0,85/691,9.30%,LEF1;FLT1;IGF1R;TFRC;KITLG;ETS1;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;DAB2IP;ENG;BMPR2;TGFB2;NOS3;RAPGEF2;ACER2;PDGFD;SH3BP4;APP;JAG2;FES;TBX1;DDAH1;ITGA1;IL6R;FLT4;CNOT6L;CD200;TBX3;TNFRSF11A;STX3;ADGRG1;GNAI2;BCL6B;PTPRJ;ARHGEF2;RGCC;PTK2;SMARCA2;ACVRL1;TIAM1;NOTCH1;MEN1;LYN;PPP1R9B;HHEX;CTNNB1;SOX7;OSMR;FGF16;DLL4;WWTR1;SLC25A5;XIAP;IGFBP7;BTG4;ST18;CCDC88A;SLC25A33;ADAM10;KLF4;CDKN2B;STAT1;HCK;INSM1;JUN;TGFB1;TGFA;CXCR2;TMEM115;CDCA7;FOXP3;PTN;LRP5;ADAMTS8;COPS9;GREM1;HMGA1;PAK1;PGF;LIFR
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.39630714454798455,-1.295248631572533,0.10434782608695652,0.5952542112203782,1.0,22/52,22.68%,ME1;ADHFE1;ME2;ACOT8;IDH2;MTHFR;MTHFD1;MDH2;ALDH18A1;D2HGDH;GOT1;PHYH;GCLC;GPT2;MTHFD1L;L2HGDH;MTHFD2;NIT2;IDH1;GOT2;FPGS;MTHFS
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5343591629928387,1.2948840840842284,0.16808149405772496,0.628978383355617,1.0,11/25,18.87%,HSP90AB1;EPHA4;EFNA1;RPS7;OPHN1;HIPK2;F8A1;RPL11;TRIM39;PRKCG;RPL23
prerank,arachidonic acid secretion (GO:0050482),-0.5950984942030514,-1.2947111464844858,0.17142857142857143,0.5933654696066736,1.0,3/10,8.12%,ANXA1;ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5950984942030514,-1.2947111464844858,0.17142857142857143,0.5933654696066736,1.0,3/10,8.12%,ANXA1;ACE;BDKRB2
prerank,regulation of neuron projection development (GO:0010975),0.3945441480838095,1.2946207662778482,0.07870967741935483,0.6286531419671132,1.0,35/163,11.65%,ITGA6;NDNF;MFSD2A;SHANK3;DAB2IP;EFHC2;RAPGEF2;SCARF1;FES;MBOAT1;RAPGEF1;PRAG1;CDH2;PRKD1;NTNG2;LYN;SNX3;EPHA4;CCDC88A;FUT9;CSMD3;RET;KIF1A;LRRC7;TWF2;PTN;SPOCK1;PAK1;SERPINI1;DISC1;PTK6;ACP4;ABI3;PLXNB3;GSK3A
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5546214047308216,-1.293985076963855,0.1609442060085837,0.5936661339487228,1.0,8/13,28.38%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,lamellipodium organization (GO:0097581),0.5177423352204206,1.2934194901656335,0.14356435643564355,0.6310573813161304,1.0,8/29,11.43%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,cell part morphogenesis (GO:0032990),-0.5455747714985643,-1.2933088182072756,0.2054794520547945,0.5938352359299189,1.0,1/13,0.14%,PID1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5871440310022561,-1.2926862835895467,0.15982721382289417,0.5939314499327207,1.0,6/10,30.54%,ADGRV1;PDZD7;TSKU;PLS1;IFT88;WHRN
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5304957526031799,1.292521570052732,0.1683673469387755,0.6325390248729832,1.0,2/22,1.74%,MFHAS1;XDH
prerank,phagosome-lysosome fusion (GO:0090385),0.6329663355954939,1.2921923203323387,0.22791519434628976,0.6325025123092278,1.0,4/10,7.82%,PIKFYVE;SYT7;RAB39A;RAB34
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5687209904188926,1.2921567139414176,0.18035714285714285,0.6315393024053559,1.0,4/17,6.86%,TEK;FES;BAIAP2;HCK
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.39443443009487633,1.2920478486845464,0.07556675062972293,0.6307550571731211,1.0,82/168,27.87%,CNOT6L;RPL38;MTPAP;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPL27;RPSA;PAN3;EIF3E;RPS7;RPL9;RPL18;RPLP2;MAGOHB;RPL13A;CNOT9;PDE12;PAN2;HELZ2;RPS11;RPL8;DCP2;NCBP2;RPS27;RPL19;CNOT6;DXO;RPS9;ZFP36L1;DCP1B;RPL11;PNRC2;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;EXOSC10;NBAS;RPL17;RPL23;CNOT11;XRN1;RPL34;RBM8A;RPS18;EXOSC9;UPF2;XRN2;RPL21;PELO;RPS4X;RPL18A;NCBP1;RPS21;DCPS;RPL10A;EXOSC8;CNOT4;PABPC1;RPL24;RPL7A;RPL32;RPL4;UPF3B;UPF1;RPS2;ZC3H12A;RPS20;RPL6;RPS13;AGO1;RPS19;PPP2R1A;NBDY;RPL14;RPL26
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5289606889988305,-1.291976164217512,0.17002237136465326,0.5942048824493708,1.0,4/15,3.80%,GLI2;EDA;WNT6;FOXC1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.517674205046847,-1.2916473748992743,0.16371681415929204,0.5933473846674218,1.0,3/16,4.19%,AUTS2;ARHGAP24;OGT
prerank,platelet degranulation (GO:0002576),0.40748550373526454,1.2914208359801231,0.09816753926701571,0.631582933813562,1.0,21/118,9.65%,ABCC4;PECAM1;PDGFB;TGFB2;APP;LHFPL2;SRGN;SELENOP;VWF;LYN;TMSB4X;CALM1;CFD;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;SCG3;CDC37L1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.47661410963690926,-1.2911065631099705,0.16058394160583941,0.5932303702377937,1.0,11/23,25.22%,SELENOS;HSP90B1;SEC16A;SYVN1;AUP1;LMAN1;SURF4;SEC61B;DERL1;TMED9;UFD1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.519859066488403,1.290538914254541,0.16472545757071547,0.6331757824866442,1.0,9/28,15.03%,NOD1;NOD2;IRGM;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3;INAVA
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.464032687943735,1.290260253208438,0.14570552147239263,0.6329135627864693,1.0,14/54,17.70%,IVNS1ABP;CAV1;DCUN1D3;SMAD7;CTNNB1;N4BP1;COPS9;UBXN1;RPL11;TNFAIP3;DNAJA1;BAG2;SIRT7;PRKCG
prerank,protein ADP-ribosylation (GO:0006471),-0.46482718770345005,-1.290050189842955,0.15776699029126215,0.5946376162761777,1.0,11/28,16.33%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;SIRT2;PARP12;TIPARP
prerank,negative regulation of dephosphorylation (GO:0035305),0.5792942474777509,1.2890684694947927,0.18850987432675045,0.6352414364527651,1.0,2/18,0.95%,MFHAS1;PPP1R16B
prerank,synapse organization (GO:0050808),0.4075270929725021,1.288889738260848,0.10752688172043011,0.6346834531633446,1.0,23/125,10.22%,SPOCK2;DNM3;SHANK3;APBB2;APP;ADGRL3;UNC13B;AGRN;PLXND1;CDH2;PPFIBP1;DBNL;SLITRK3;CNTN2;GPHN;PIN1;SLITRK1;GPM6A;NRXN1;DNER;LRRC4B;ELFN1;CYFIP1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4994247248658398,1.2885346641167912,0.1728395061728395,0.634691989825503,1.0,2/34,3.20%,SLC7A5;NOD2
prerank,brain morphogenesis (GO:0048854),0.5952835034410762,1.2881829493839534,0.19666048237476808,0.6346730017232323,1.0,1/12,0.50%,SHANK3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5791380928855016,1.2880341879744457,0.19597069597069597,0.633964417479402,1.0,5/15,4.91%,KDR;PRKD1;PRKD2;TMSB4X;FGF16
prerank,response to cAMP (GO:0051591),0.48894167243066744,1.2875415309651927,0.17580645161290323,0.6343235122472848,1.0,11/37,13.66%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;STAT1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6
prerank,carbohydrate biosynthetic process (GO:0016051),0.5536813341821064,1.2874574646173425,0.17750439367311072,0.6335101962375321,1.0,4/21,5.93%,ST3GAL6;ST8SIA6;FUT8;FUT9
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.590462729386581,1.287342670343767,0.2060931899641577,0.6327730197374823,1.0,2/16,6.92%,CLDN5;CLDN14
prerank,alpha-amino acid metabolic process (GO:1901605),-0.409220512881485,-1.287197169305001,0.112,0.601016573071473,1.0,22/45,22.95%,ASPA;ATP7A;NAALAD2;ASPG;NOX4;MTHFR;MTHFD1;OAT;ALDH18A1;GOT1;GLUL;SLC25A12;GLS;GLS2;KYAT3;DDAH2;GPT2;KYAT1;KMO;GOT2;PYCR3;NAT8L
prerank,negative regulation of heart contraction (GO:0045822),-0.5572284906767879,-1.2871311963619763,0.1751054852320675,0.5994710608009755,1.0,1/11,0.02%,ATP1A2
prerank,response to X-ray (GO:0010165),-0.5412126457033354,-1.2858121921465802,0.1681614349775785,0.6016880062750726,1.0,5/14,12.50%,ANXA1;IKBIP;ATM;NUCKS1;XRCC5
prerank,atrioventricular valve development (GO:0003171),0.5896107321293246,1.2856521771516813,0.19065420560747665,0.6367226782729,1.0,5/14,3.41%,BMPR2;TGFB2;ZFPM1;APLNR;NOTCH1
prerank,histone lysine demethylation (GO:0070076),-0.47496472657599853,-1.285401999122806,0.16707021791767554,0.6011919091504784,1.0,12/25,23.81%,KDM7A;KDM2A;KDM3B;KDM5B;KDM6B;KDM2B;KDM1A;PHF8;RIOX2;PHF2;KDM4D;HR
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5614320077676676,1.2852338275189745,0.22631578947368422,0.6368705844075091,1.0,5/16,15.66%,FASN;DIP2A;SLC25A1;HSD17B8;ACAT1
prerank,mRNA splice site selection (GO:0006376),-0.4482336475927233,-1.285046590299407,0.12814070351758794,0.6004941084029494,1.0,6/30,13.96%,CELF2;SRSF5;LUC7L3;SRSF6;LUC7L2;PSIP1
prerank,regulation of fibrinolysis (GO:0051917),-0.5523869652246721,-1.2847773483607112,0.1673913043478261,0.599573976681871,1.0,3/13,7.12%,THBS1;FAP;THBD
prerank,regulation of protein metabolic process (GO:0051246),0.470573907394052,1.284386683488,0.1564945226917058,0.6383104024380009,1.0,8/44,8.30%,LTBP4;APP;PLAUR;NEDD4L;KLF2;HSP90AB1;KLF4;ABCA7
prerank,apoptotic DNA fragmentation (GO:0006309),0.5801213922543199,1.2843440136809894,0.1859582542694497,0.6373632787457423,1.0,8/16,19.18%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4359295116933002,-1.2842862376187731,0.13602015113350127,0.5993304934134661,1.0,10/33,13.58%,OGN;IGFBP5;TPM1;APOD;SOD2;IGFBP3;EFEMP2;TGFB3;MFN2;PTEN
prerank,potassium ion transmembrane transport (GO:0071805),-0.3362301422735793,-1.2842215179639538,0.04824561403508772,0.5978049145645373,1.0,17/135,7.22%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNT2;KCNK5;SLC12A2;PKD2;SLC9A2;KCNJ2;ABCC9;ATP1B3;KCNQ4;SLC12A7;ATP1B2;KCNB2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.37730166052039416,1.2839579621517327,0.06265060240963856,0.6374552077152589,1.0,40/234,11.71%,TFRC;PRKCH;APP;CAV1;TIRAP;NFKBIA;CD200;TRIM25;LRP8;TNFRSF11A;TRIM14;FZD4;ARHGEF2;RGCC;NOD1;CD40;NOD2;PRKD1;PRKD2;IKBKB;CTNNB1;PPIA;CRTC1;RPS6KA5;LGALS9;AIM2;BUD31;JMY;CRNN;ARHGEF5;PIDD1;IRAK2;MALT1;UBE2V1;AGER;LAMTOR5;S100A8;TNFSF11;PRKCB;ZBTB7A
prerank,negative regulation of vascular permeability (GO:0043116),0.6148287011001013,1.283839922954885,0.18928571428571428,0.636745866040663,1.0,5/12,3.52%,CLDN5;PDE2A;DDAH1;PTPRJ;RAMP2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3483467653580557,-1.2832252207268848,0.05964912280701754,0.5990083274526022,1.0,28/104,14.36%,BMPR1A;LDLRAD4;NBL1;SMAD3;CRIM1;BMPER;MAGI2;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;RBPMS2;ASPN;SMAD9;EMILIN1;TGFB1I1;CD109;CCN3;SMURF2;PDPK1;SPRED1;VASN;CHRD;BMP2;SKI;HTRA4;SLC2A10
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.48411160149217625,-1.2831009974493086,0.1783132530120482,0.5976607593629227,1.0,5/21,6.33%,ROCK2;ERRFI1;BMP4;CTSL;SFRP4
prerank,dendritic spine morphogenesis (GO:0060997),0.5736700352461214,1.2821223411095464,0.19244604316546762,0.6405633705740603,1.0,3/15,5.82%,SHANK3;WNT7A;DIP2A
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4711737081399208,-1.2821200243493622,0.141439205955335,0.598838533718285,1.0,8/24,10.73%,IGF1;ENPP1;IRS1;IRS2;IGF2;SELENOS;PPP1R3B;PPP1R3C
prerank,potassium ion transport (GO:0006813),-0.34146485544188765,-1.28135981937283,0.05952380952380952,0.599397138350938,1.0,13/120,5.51%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNK5;KCNMB2;PKD2;SLC9A2;KCNJ2;ABCC9;ATP1B3;KCNQ4
prerank,positive regulation of cellular protein localization (GO:1903829),0.43806652988741496,1.2809964376337188,0.12954876273653565,0.6429180978328168,1.0,14/69,12.05%,TFRC;STX3;WWTR1;HSP90AB1;CARD10;CCDC88A;LIMK2;FYN;MARK4;TGFB1;ABCA7;LAMTOR5;FERMT2;ORMDL3
prerank,response to interferon-gamma (GO:0034341),0.44507018973497275,1.2803669348072853,0.1487481590574374,0.6436290233009079,1.0,12/67,11.00%,GCH1;SP100;CD40;GBP7;GBP4;GBP5;LGALS9;STAT1;BST2;RPL13A;PDE12;CCL1
prerank,protein homotrimerization (GO:0070207),-0.5310147714875144,-1.2796820812996537,0.18465227817745802,0.6009311496647816,1.0,3/14,5.18%,SCARA5;SLC1A5;CLYBL
prerank,protein trimerization (GO:0070206),-0.5310147714875144,-1.2796820812996537,0.18465227817745802,0.6009311496647816,1.0,3/14,5.18%,SCARA5;SLC1A5;CLYBL
prerank,axonogenesis (GO:0007409),0.3833733972675162,1.2796296496619453,0.05474452554744526,0.6447052014861899,1.0,46/237,9.42%,SEMA3C;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;APP;B4GALT5;SEMA6B;KLF7;PTK2;LAMA5;PARD3;NTNG2;NOTCH1;DSCAML1;EVL;ACTB;PLCG1;WNT7A;GRB2;HSP90AB1;SEMA4F;GAB1;EPHA4;BAIAP2;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;EPHB4;SLITRK3;CNTN2;SEMA6D;EFNA1;SLITRK1;SPTAN1;SHC3;OPHN1;NRXN1;SEMA4C;SLC9A6
prerank,regulation of stem cell proliferation (GO:0072091),-0.5081270852604195,-1.27958901980741,0.1473922902494331,0.599542475299825,1.0,5/17,11.52%,FBLN1;GJA1;ACE;YAP1;KDM1A
prerank,Ras protein signal transduction (GO:0007265),0.3977040415216746,1.279306931782099,0.10923276983094929,0.644616480907139,1.0,33/137,10.22%,RASGRP3;ARHGEF3;RAPGEF2;NTN1;ELMO1;GRAP;PLEKHG5;ADGRG1;RAPGEF1;TIAM1;PRKD1;RAPGEF3;RIPOR1;GRB2;RREB1;EPS8;GNA12;RHOB;EPS8L2;CDC42EP3;SOS1;DBNL;RASGRP2;NCKAP1;RALB;RAP1B;RGL2;JUN;SHC3;ARHGAP4;PHACTR4;ARHGDIA;CYFIP1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6098980089733959,1.279027712531394,0.21428571428571427,0.6444209791536426,1.0,6/11,13.39%,TBX1;CTNNBIP1;STAT1;LRP5;TGFBR2;SOX9
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5157311841924705,1.2781569240513586,0.1989795918367347,0.6459832547983048,1.0,4/27,6.88%,PRKCH;NFKBIA;ABCG1;NR1H2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5530569697111377,1.2781416288633745,0.20811287477954143,0.6449773953847525,1.0,6/18,17.88%,CORO2B;CCT3;CCT5;CEP135;PTP4A3;CCT7
prerank,gland development (GO:0048732),-0.3834309852214786,-1.27716157478643,0.08841463414634146,0.6050831884177964,1.0,15/59,9.52%,TGFBR3;GLI2;WNT4;DKK3;FGFR2;COBL;SALL1;TGFBR1;PKD2;ANXA1;SIX1;IGSF3;MET;TGFB3;EZR
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3585635909110449,1.2769198120345773,0.02459893048128342,0.6475691120819053,1.0,106/532,14.05%,PLCB1;PDGFB;MAOA;BCL2L1;ADIPOR2;CXCL12;IL1R1;NFKBIA;IL6R;TNFRSF25;IFNAR1;TRIM25;LRP8;S1PR1;TNFRSF11A;INPP5D;STX3;B2M;PTPRJ;STX1A;NOD1;LAMA5;SP100;IFNAR2;FOXO1;JAK3;RAPGEF1;CD40;NOD2;PELI1;IL10RB;MAP3K8;TMSB4X;SOCS2;IRF2;IKBKB;ADAR;SAMHD1;GRB2;NOS2;OSMR;PITPNA;CD4;ST18;XAF1;PPIA;IRF9;ACTN4;FYN;SOS1;MAPK3;RPS6KA5;AIM2;MCL1;STAT1;PSMB3;HCK;IL13RA2;IRF5;RAP1B;BST2;IL4R;PSMD11;BIRC3;TGFB1;CXCR2;PSMC6;MSN;IRAK2;MAP3K3;LIFR;PSME2;CEBPD;SOCS5;EBI3;UBE2V1;ADAM17;MMP1;OASL;EIF5A;TALDO1;CNTF;TOLLIP;HSPA8;CCL1;PSMD8;TNFSF11;ADIPOR1;IL20RB;TNFRSF4;HIF1A;SYK;MID1;CEACAM1;PIK3CB;IL27RA;TNFSF12;IL15;IL7R;CSNK2B;POU2F1;FSCN1;CFL1;PLVAP;GPR75;PSMB10
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.624624419465496,1.2765413141470663,0.1996370235934664,0.6476160294505594,1.0,3/10,9.05%,SMAD7;FOXP3;MALT1
prerank,protein localization to cell periphery (GO:1990778),0.3911594444787282,1.2764861950762658,0.0978120978120978,0.6467352302638328,1.0,25/133,10.90%,EFR3B;BSG;SPTBN1;RAPGEF2;CAV1;TSPAN5;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5303814556997124,-1.276400084108446,0.15945330296127563,0.6057143516729412,1.0,6/15,10.27%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1;SLC9A1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5123118521837259,-1.2763237909704137,0.170995670995671,0.604253736703439,1.0,6/17,1.46%,IGF1;DOCK5;PDGFRB;DOCK7;IGFBP5;VTN
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.49789800007819357,1.2761389345933878,0.1669421487603306,0.6467767324014717,1.0,11/33,14.70%,TGFB2;ACER2;PTK2;LYN;SNAI2;RET;NEXMIF;EFNA1;SYK;PDE3B;NCKAP1L
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.39164038143912583,-1.2754447610312227,0.125,0.6052150889168818,1.0,8/61,6.27%,EYA2;EYA1;EGFR;PDGFRB;EYA4;SMOC2;FGF2;PARP3
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5917889708954778,1.275280217150204,0.1728395061728395,0.6483611899098243,1.0,3/13,4.51%,NOS3;DDAH1;NOS2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5182634813106555,1.275267107505671,0.18120805369127516,0.647338179737807,1.0,8/28,12.58%,SHANK3;APP;EPHA4;FAM107A;PTN;EIF2AK4;AGER;CALB2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5947609628632183,1.2746893250804487,0.19288389513108614,0.6480313090969299,1.0,3/13,15.81%,PRR5L;GTPBP1;ZC3HAV1
prerank,cellular response to cytokine stimulus (GO:0071345),0.36141587461927754,1.274631394214315,0.042951541850220265,0.6471652248009773,1.0,81/416,13.66%,LEF1;ST3GAL6;MAOA;LRCH1;BCL2L1;DAB2IP;PDE2A;CXCL12;IL1R1;IL6R;IFNAR1;LRP8;S1PR1;INPP5D;STX3;PTPRJ;ARHGEF2;STX1A;LAMA5;IFNAR2;FOXO1;JAK3;RAPGEF1;CD40;PTPN12;GBP7;GBP4;SIGIRR;GBP5;IL10RB;SOCS2;IKBKB;GRB2;NOS2;TNFRSF21;OSMR;HYAL2;CCR7;CD4;TCF7;FYN;SOS1;LGALS9;AIM2;MCL1;STAT1;HCK;IL13RA2;IRF5;IL4R;CRNN;TGFB1;IRGM;IRAK2;PTPN5;LIFR;CEBPD;SOCS5;EBI3;RPL13A;MMP1;PDE12;CNTF;HSPA8;CCL1;DUSP1;TNFSF11;GSK3A;IL20RB;HIF1A;SYK;PIK3CB;IL27RA;ZFP36L1;RO60;POU2F1;NPR2;SOX9;MT1X;FSCN1;AKAP6
prerank,erythrocyte development (GO:0048821),0.6092432708571247,1.2746277393620864,0.20802919708029197,0.6461228477177595,1.0,5/10,18.52%,ALAS1;ZBTB7A;NCKAP1L;LYAR;SH2B3
prerank,epithelial cell differentiation (GO:0030855),-0.3542852392874623,-1.2745192063504085,0.05474452554744526,0.6061604264456834,1.0,17/88,11.04%,FSTL1;MAF;FGFR2;BMP4;DAB2;SCUBE1;ANXA1;ANXA4;SIX1;FZD7;CNN3;GLI1;JAG1;KDM6B;BDH2;GATA6;TAGLN
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5427677968388862,1.2739676122745527,0.18782608695652173,0.6469179281422509,1.0,2/21,0.95%,MFHAS1;PPP1R16B
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5747565563067442,1.2739483062388326,0.19888475836431227,0.6459169950426965,1.0,5/14,19.73%,ENTPD1;ENTPD5;NUDT9;NUDT1;NUDT16
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5065840295147374,1.2738449429347052,0.173841059602649,0.6451269662747839,1.0,6/29,16.15%,CADM1;NOS2;PVR;CD160;CYRIB;AP1G1
prerank,positive regulation of DNA recombination (GO:0045911),0.5149015967635789,1.2738369847394262,0.18166383701188454,0.6441011319659052,1.0,6/27,17.43%,TFRC;SHLD1;PRDM9;WDR48;ACTR2;FANCB
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.37925562055347345,1.272957291161556,0.06690561529271206,0.6455772885498341,1.0,31/214,8.30%,TEK;SEMA7A;SEMA6A;MFHAS1;PDGFB;KDR;DAB2IP;RAPGEF2;PDGFD;APP;CNKSR3;TIRAP;PDE8A;FLT4;NOD2;NOTCH1;PRKD2;DUSP3;LYN;RAMP3;CCR7;CD4;MAPK3;FBXW7;LGALS9;PTPRR;HTR2A;ARHGEF5;PIN1;TGFB1;ABCA7
prerank,negative regulation of cell migration (GO:0030336),0.4018145232924215,1.272308792267164,0.10204081632653061,0.6464661208132637,1.0,23/137,7.36%,PTPRG;LIMCH1;DACH1;CLDN5;SRGAP3;SRGAP2;DAB2IP;SRGAP1;ENG;MCC;ADGRG1;PTPRJ;ADAM15;ACVRL1;EVL;DUSP3;SMAD7;HYAL2;RHOB;EPHA4;NEXMIF;PTPRR;BST2
prerank,regulation of membrane repolarization (GO:0060306),0.5867772190499001,1.2716049827006495,0.2164048865619546,0.6474999474129381,1.0,6/13,13.66%,CAV1;NEDD4L;KCNQ1;KCNH2;AKAP9;AKAP6
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4626470684182452,-1.2713196567771308,0.16666666666666666,0.6138393130180506,1.0,5/24,5.39%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.4687915947298912,-1.2710493543225239,0.15254237288135594,0.6129630147054852,1.0,8/24,12.28%,SOX5;ADAMTS12;EFEMP1;TGFBR1;WNT9A;SOX6;PTHLH;PKDCC
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.49910521157003696,1.2707736601447344,0.1838351822503962,0.6488110831857621,1.0,3/30,2.34%,SPTBN1;MACF1;RAB31
prerank,regulation of complement activation (GO:0030449),-0.4094657493808561,-1.270759462365146,0.1278772378516624,0.612136781290639,1.0,4/40,2.01%,SERPING1;VTN;CD55;CFH
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3664728425954936,1.2704542738061448,0.04966139954853273,0.6487090571996932,1.0,31/308,8.78%,LEF1;IGF1R;TFRC;PRKCH;PLCB1;EPAS1;PDGFB;CADM1;ADIPOR2;GATM;BMPR2;TGFB2;TRIM16;CAV1;B4GALT5;RGCC;UCP2;TIAM1;ZBTB16;RREB1;CTNNB1;WWTR1;OXTR;CCDC88B;SHLD1;YBX2;IL4R;TGFB1;ABCA7;PTN;NPR1
prerank,response to glucagon (GO:0033762),-0.4889385128960788,-1.2703803547237398,0.17675544794188863,0.6115834462968672,1.0,8/19,13.39%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,negative regulation of response to stimulus (GO:0048585),0.44335564235976466,1.2693339472195824,0.1426470588235294,0.6510925543462426,1.0,15/60,10.12%,AQP11;CD34;DDAH1;KLF7;YBX1;LYN;KIF26A;KLF4;NR1H2;TERF2;FOXP3;MAP3K3;SOCS5;LPCAT3;PTK6
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4853486200513874,-1.2690496812142806,0.18201754385964913,0.6137445053726205,1.0,1/19,0.34%,IGF1
prerank,positive regulation of vascular permeability (GO:0043117),0.6050725066658741,1.268575382892221,0.21787709497206703,0.6523497141856475,1.0,4/12,1.89%,OCLN;TJP1;PDE2A;TJP2
prerank,fatty acid elongation (GO:0030497),0.5978439086935213,1.2684634541560278,0.22003577817531306,0.6516332937196745,1.0,5/13,13.46%,ELOVL7;ELOVL5;ABCD1;ELOVL6;HACD2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6045919421524382,1.268325704331849,0.2222222222222222,0.6510028297448558,1.0,2/13,1.57%,SHANK3;APP
prerank,regulation of endocytic recycling (GO:2001135),-0.5643214534877212,-1.2682071203169942,0.18895966029723993,0.6145775517157107,1.0,5/11,16.13%,ACTN2;ATP9A;EHD1;RAB11B;EHD2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.507468063297446,-1.2674864442556182,0.1547911547911548,0.6152268581780788,1.0,8/17,13.03%,NOTCH2;BMPR1A;BMP4;RBPJ;HEYL;JAG1;BMP2;SNAI1
prerank,regulation of exosomal secretion (GO:1903541),-0.4927106169985298,-1.2674803076169492,0.1726457399103139,0.6135879729161192,1.0,5/19,7.96%,ATP9A;SMPD3;TSG101;PRKN;SDC4
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.41576947688031646,1.2673970064152427,0.13025210084033614,0.6526043948162885,1.0,26/86,18.12%,OCLN;APP;FES;EVL;VIL1;CLIP1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;FCHSD1;EDN1;NCK1;TRPV4;PROX1;PRKCE;TENM1;BIN1;WDR1;COLGALT1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5476259090491569,1.267111506449214,0.19244604316546762,0.6524058935699072,1.0,5/19,7.11%,TJP1;NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,central nervous system neuron development (GO:0021954),0.5727279621106476,1.2659848546463448,0.21314387211367672,0.6546151708505439,1.0,3/15,5.03%,RAPGEF2;B4GALT5;HSP90AB1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5170999371027066,-1.2658481959548455,0.1547085201793722,0.616703845326439,1.0,6/15,15.12%,LARGE1;MGAT3;RENBP;CHST3;CHST1;NAGK
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4700695726557719,-1.2650563958221355,0.16859122401847576,0.617433815848381,1.0,2/22,1.81%,ALDH1A2;RBP1
prerank,regulation of cell adhesion (GO:0030155),0.39857790049101954,1.2650434646773459,0.1111111111111111,0.6562721973136264,1.0,30/129,11.99%,FRMD5;PODXL;CXCL12;FES;STX3;CYTH1;ADGRG1;PTPRJ;PTK2;PLXND1;SIPA1;ACVRL1;PRKD2;LYN;TGM2;CCR7;EPHA4;RSU1;ATXN3;ADAM10;RET;PKP4;EFNA1;PPP1CB;ARHGDIA;CBLL1;DUSP1;PLXNB3;PPP3CA;RND1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4046220860004422,-1.264992284994996,0.13636363636363635,0.615953409848097,1.0,10/40,11.30%,EGFR;TIMP2;TIMP3;PTPN3;MDM4;SNX12;FLNA;SNRNP70;AZIN1;IRAK3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.44299136026296726,-1.2648972257094144,0.16756756756756758,0.6146057165205105,1.0,14/27,25.66%,DDX5;PLA2R1;ATM;SPRED1;KDM1A;SNAI1;TWIST1;CD44;HIC1;KMT5A;ATR;YJU2;MSX1;SMYD2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.49095222179126374,-1.2637295805982023,0.1678832116788321,0.6163705894236519,1.0,4/18,14.75%,LBP;THBS1;TNIP2;TLR4
prerank,endothelial tube morphogenesis (GO:0061154),0.6231455986864313,1.2631427633978674,0.23193916349809887,0.6609797196255276,1.0,7/10,12.99%,ACVRL1;PRKD2;STARD13;CTNNB1;RHOB;CCM2;CSNK2B
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.49614185171240327,1.2629065751971058,0.17609046849757673,0.6606545114846842,1.0,2/32,3.16%,PGLYRP1;DEFA6
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3911850689309855,1.2626978722201248,0.10066225165562914,0.6601711769059547,1.0,17/152,6.60%,ADGRL4;ADGRE5;WASF2;ADGRL2;PDE2A;ADGRL3;S1PR1;ADGRG1;GNAI2;RAMP2;GNAQ;CALCRL;GNA12;RAMP3;PRKACB;INSL3;ADCY4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.5271880350172625,1.2622294659079931,0.19594594594594594,0.6605045130823979,1.0,10/21,17.33%,NES;CTNNB1;DLL4;DCT;INSM1;DISC1;LRP2;DISP3;TOX;PROX1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4775823742380215,-1.2622097161342993,0.16666666666666666,0.6175679087286939,1.0,3/21,2.10%,EYA2;EYA1;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4775823742380215,-1.2622097161342993,0.16666666666666666,0.6175679087286939,1.0,3/21,2.10%,EYA2;EYA1;EYA4
prerank,positive regulation of protein kinase activity (GO:0045860),0.3909831723949716,1.2617655338610496,0.10303830911492734,0.6608320448116995,1.0,29/148,13.54%,PDGFB;INSR;DAB2IP;TGFB2;RAPGEF2;IL6R;LRP8;NEDD9;PTK2;MMD;CALM1;HSP90AB1;CCR7;CD4;EPHA4;CCDC88A;PAK5;RALB;EFNA1;IRGM;IQGAP1;PAK1;PDCD10;RPTOR;MAP4K4;TGFBR2;MAPRE3;STK3;MINK1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5403720784203045,-1.2616289936524991,0.22559652928416485,0.6175222351794892,1.0,6/11,14.53%,P4HA1;EGLN3;P4HTM;P3H2;OGFOD1;P4HB
prerank,rRNA catabolic process (GO:0016075),0.5635394151053997,1.2611130292676878,0.2127659574468085,0.6616480133542144,1.0,8/16,22.45%,DEDD2;TRIR;DIS3L;EXOSC10;XRN1;EXOSC9;PELO;EXOSC8
prerank,regulation of interleukin-1 beta production (GO:0032651),0.43224008211582543,1.2610012215866375,0.13650306748466257,0.6609494757102983,1.0,16/66,15.03%,TRIM16;APP;NOD2;GBP5;CCR7;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8;TNFAIP3;GIT1;INAVA
prerank,positive regulation of insulin secretion (GO:0032024),-0.40887994128973426,-1.2607682668690061,0.14066496163682865,0.6183932850531803,1.0,9/36,11.28%,MCU;NLGN2;RBP4;IRS2;NNAT;ANO1;TRPM4;AACS;PPP3CB
prerank,protein phosphorylation (GO:0006468),0.35400457704366334,1.26052783806224,0.034858387799564274,0.6613853157449483,1.0,101/479,15.41%,FLT1;IGF1R;PRKCH;TEK;ERG;PDGFB;KDR;INSR;DAB2IP;BMPR2;TGFB2;MAP4K2;APP;CDK17;FES;MAP4K3;FLT4;STK38;PKN3;PTK2;LIPE;SNRK;JAK3;RPS6KA1;ACVRL1;PRAG1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;SMAD7;PPP4R1;CREB1;MAST4;CAMKK2;PKN1;TLR3;STK19;EPHA4;LIMK2;PRKACB;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;RET;AATK;EPHB4;PKN2;HCK;PXK;MARK4;TLR7;TGFB1;MARK3;MAP3K6;PAK1;MAP3K3;EIF2AK4;STK33;PTK6;TRIB2;PRKAB1;ABI3;STK32C;SLK;PRKCB;GTF2H4;GSK3A;SYK;MAP4K4;TGFBR2;EPHB1;HIPK2;CSNK2B;STK24;STK3;MINK1;PIM2;VRK1;SGK1;TBCK;CAMK2B;STK26;CTBP1;GRK6;NEK3;HIPK3;SRMS;ERC1;PLK2;SGK3;SGK2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5739907609885417,1.259758781185607,0.21660649819494585,0.6625702678581507,1.0,2/15,3.26%,DDC;SMOX
prerank,regulation of transport (GO:0051049),0.48722543756807607,1.259755062584766,0.17560975609756097,0.6615524253054353,1.0,12/36,14.78%,ICA1;FES;EPB41;ACTB;MYO6;RAB11A;ACTG1;REEP5;ARL6IP5;WWC1;DISP3;DNAJA1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5777261634777859,-1.2594974951607107,0.20305676855895197,0.620391518554491,1.0,5/10,15.13%,DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,negative regulation of locomotion (GO:0040013),0.5954665306997649,1.2589908431143246,0.22365988909426987,0.6627051469786894,1.0,3/12,8.04%,FRMD5;DUSP3;PIN1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.581246240466184,1.2584037221690039,0.21981981981981982,0.6634729582610359,1.0,3/14,10.15%,TLR3;ZCCHC3;OASL
prerank,regulation of apoptotic process (GO:0042981),0.34905615920462973,1.2583521647310512,0.022750775594622543,0.6625822267200377,1.0,82/676,9.05%,LEF1;IGF1R;TFRC;MCF2L;TEK;ITGA6;HIP1;RNF144B;ARHGEF3;TJP1;KDR;BCL2L1;DAB2IP;PPP1R13B;RASGRF2;ACER2;FAS;NET1;UNC13B;NFKBIA;SH3RF1;FLT4;TBX3;HIP1R;TNFRSF25;PLEKHG5;LRP8;PHLPP1;PLAUR;DCUN1D3;TNFSF10;ARHGEF2;PTK2;MEF2C;RYBP;KALRN;FOXO1;JAK3;FOXL2;RPS6KA1;TIAM1;ABR;TGM2;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;RHOB;CAT;CD38;MRE11;PPIA;ACTN4;GRID2;SOS1;ADAM10;TOX3;CRADD;MCL1;STAT1;HCK;RNPS1;ARHGEF12;DNM2;ACTN1;EGLN2;IRF5;LCMT1;JMY;JUN;BIRC3;ARHGEF5;RHBDD1;PIDD1;PRDM9;PREX1;ARHGEF7;TRIM24;GREM1;BNIP3L;MALT1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.47160496810505703,1.2582708896359327,0.16984126984126985,0.6618037589265297,1.0,12/39,21.62%,POLK;NTHL1;GTF2H2;GTF2H4;FAN1;RBX1;RPA1;POLD1;GTF2H3;RFC2;DDB1;ERCC4
prerank,water transport (GO:0006833),0.6035407824395144,1.2581838706958737,0.22486288848263253,0.6610511240962988,1.0,2/12,4.59%,AQP11;AQP7
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.48963671293576394,1.2576728068785603,0.1984375,0.6615484983814435,1.0,8/37,6.99%,HMCN1;CADM1;NECTIN4;CD6;GRID2;PVR;FAT4;DCHS1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5338755196739542,1.257560966626105,0.21565217391304348,0.6608920048260926,1.0,5/19,4.57%,SEMA6A;JCAD;DAB2IP;XDH;TSPAN12
prerank,regulation of myelination (GO:0031641),0.5157507006010262,1.25722088473205,0.19865319865319866,0.6608439082402379,1.0,6/25,9.55%,JAM2;PARD3;TNFRSF21;CST7;PTN;ZPR1
prerank,regulation of axon regeneration (GO:0048679),0.5911106324341833,1.2568509852141783,0.22889305816135083,0.6609170492022023,1.0,6/12,13.36%,SCARF1;EPHA4;INPP5F;PTN;CNTF;STK24
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5310180519607391,-1.256847523473876,0.2100656455142232,0.6263556301120657,1.0,3/13,3.09%,CACNA1C;ANK2;GJA1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.589085398058037,1.2568250359261157,0.22586520947176686,0.6599700275478749,1.0,6/12,21.73%,CTNNB1;AXIN2;CTCF;RAD21;DDX11;WAPL
prerank,protein targeting (GO:0006605),0.3949542628079465,1.2568183032847016,0.1077127659574468,0.6589825667050018,1.0,39/118,21.23%,AQP11;RASSF9;ZDHHC14;PARD3;PIKFYVE;TOMM22;ZDHHC9;ZDHHC20;ZFAND2A;ZDHHC19;SRP14;TIMM13;RTP4;AP1S3;ZDHHC18;ZDHHC22;TIMM10;AP4S1;DNAJC19;SPCS2;RPL11;SDCBP;NACAD;EDEM1;AKAP6;HACL1;MFF;NLGN1;RTP3;ZDHHC21;PEX16;TOMM7;VPS37A;MYO1C;LONP2;VPS37B;TOMM5;SPCS1;GABARAP
prerank,miRNA metabolic process (GO:0010586),-0.4837659414756318,-1.2565980529155882,0.17,0.6254572255297093,1.0,8/20,25.60%,TUT4;AGO2;XPO5;DDX17;BCDIN3D;TARBP2;PARN;DROSHA
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.43597859210497886,-1.2565114213175685,0.14540059347181009,0.6240782251199071,1.0,7/32,5.34%,PID1;IGF1;ZBTB20;PRKAA2;NUPR1;PPARGC1A;PPARA
prerank,response to amyloid-beta (GO:1904645),0.46628262156743305,1.2561354938919278,0.18025078369905956,0.6598772370131782,1.0,7/44,6.25%,IGF1R;CACNA1A;APP;RAMP3;EPHA4;FYN;ATP1A3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5056454724219039,-1.2557199299266881,0.16702819956616052,0.6246626110304909,1.0,2/15,1.85%,GLI3;CD55
prerank,actin polymerization or depolymerization (GO:0008154),-0.38702776769581504,-1.255587412727574,0.134185303514377,0.6234191410553763,1.0,10/50,7.33%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;SVIL;VILL;DIAPH1;ABI2
prerank,granulocyte chemotaxis (GO:0071621),0.4461407816953268,1.2551966925302613,0.16467065868263472,0.6616425006774266,1.0,10/55,11.86%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5220544962931108,1.2545778561401422,0.2045060658578856,0.662437961589781,1.0,12/23,25.13%,NLRC5;HSP90AB1;STAT1;NR1H2;IRGM;PPARG;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2;PARP14
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5622267377296799,1.2545185695185417,0.22759856630824374,0.6616065808990459,1.0,1/15,0.28%,TENT4A
prerank,positive regulation of lipid transport (GO:0032370),-0.5490458448738594,-1.2544807825862583,0.21333333333333335,0.6248996880169222,1.0,3/12,8.01%,LRP1;SPP1;APOE
prerank,cellular response to zinc ion (GO:0071294),0.5737382461556879,1.2542365331978989,0.2109090909090909,0.6614305003481968,1.0,9/15,19.26%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;GLRA2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.40384216450879146,1.2540372392789758,0.12687585266030013,0.6610034399164797,1.0,13/110,6.60%,ADGRL4;ADGRE5;ADGRL2;RAPGEF2;ADGRL3;S1PR1;ADGRG1;RAMP2;GNAQ;CALCRL;RAMP3;ADRA2B;ADCY4
prerank,epithelial to mesenchymal transition (GO:0001837),0.45263744320003785,1.2539193213164417,0.1921875,0.6602989753226577,1.0,8/47,5.99%,LEF1;ENG;TGFB2;NOTCH4;TBX3;NOTCH1;CTNNB1;SNAI2
prerank,negative regulation of cell projection organization (GO:0031345),-0.39215453771702524,-1.2533786864359078,0.15126050420168066,0.6265687752033073,1.0,13/48,13.58%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;MYLIP;RAB29;ADCY6;PTEN
prerank,regulation of immune effector process (GO:0002697),-0.4081656928964228,-1.2532413673745502,0.14322916666666666,0.6252923494423887,1.0,4/41,2.01%,SERPING1;VTN;CD55;CFH
prerank,acidic amino acid transport (GO:0015800),0.5601936517284207,1.2532280033325642,0.23529411764705882,0.6612326533549757,1.0,2/17,0.40%,SLC6A6;SLC1A1
prerank,negative regulation of cell differentiation (GO:0045596),-0.3189553186527001,-1.2531211806305416,0.04807692307692308,0.6240324428319519,1.0,41/181,11.19%,RANBP3L;COL5A2;EGFR;LDLRAD4;ADAMTS12;COL5A1;EFEMP1;SMAD3;CRIM1;BMP5;BMP7;ENPP1;BMP4;ZFPM2;OSR1;SMAD6;ADGRV1;ABCA1;TGFBR1;SUFU;WNT9A;RORA;PPARA;CTR9;IGF2;DTX1;MEIS1;RUNX1T1;TMEM64;JAG1;YAP1;LRP3;SPRED1;TWIST2;ANKRD26;ITGAV;TRPM4;VASN;PTK2B;CHRD;PTHLH
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5141885076859964,-1.2524932153879658,0.2073732718894009,0.6242586774078598,1.0,3/13,8.74%,TNRC6A;AGO2;TNRC6B
prerank,anion transport (GO:0006820),0.4871682872207883,1.2520674357688069,0.19572368421052633,0.6635848531949435,1.0,4/33,2.53%,ABCG2;SLCO2B1;LRRC8B;LRRC8C
prerank,regulation of cellular respiration (GO:0043457),0.5577390957417847,1.2519058536141965,0.21754385964912282,0.6630778531500877,1.0,4/17,8.05%,IFNAR1;IL10RB;NOS2;SHMT2
prerank,establishment of epithelial cell polarity (GO:0090162),0.534412226552624,1.2518211751675676,0.2040072859744991,0.6623562414667145,1.0,5/19,8.79%,CYTH1;PARD3;CYTH3;OPHN1;MSN
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5165270622516388,-1.251821017233369,0.20554272517321015,0.6245858123629227,1.0,2/13,1.89%,GLI2;BMP4
prerank,cellular response to amyloid-beta (GO:1904646),0.47856489365825794,1.2516797351379816,0.19838709677419356,0.66178269780273,1.0,6/35,6.25%,IGF1R;CACNA1A;APP;EPHA4;FYN;ATP1A3
prerank,replicative senescence (GO:0090399),-0.548135274934815,-1.2514399963825573,0.2229580573951435,0.6241093809916903,1.0,5/12,23.65%,PLA2R1;ATM;SERPINE1;WNT16;ATR
prerank,inhibitory synapse assembly (GO:1904862),0.5945824525218005,1.250831859411217,0.22586520947176686,0.6632155227173002,1.0,6/11,25.86%,FGF13;GABRA1;GABRB2;GABRA2;CBLN4;GABRG2
prerank,carboxylic acid catabolic process (GO:0046395),-0.5426357108152362,-1.2507977666409318,0.2,0.6243956179786653,1.0,8/12,29.12%,ACOT8;PON3;RENBP;NAGK;BCKDK;NPL;GNPDA1;IL4I1
prerank,mitotic chromosome condensation (GO:0007076),0.49685292101615913,1.250456478811607,0.1830065359477124,0.6633667003365386,1.0,8/26,18.75%,TENT4A;NCAPH;MCPH1;NCAPG;CSNK2B;TTN;NCAPH2;SET
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6021162787065131,1.250236596870013,0.2342007434944238,0.6630287312014435,1.0,4/11,5.25%,CXCL12;NOD2;MERTK;CCR7
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5301378116364988,1.2500362002499292,0.20170940170940171,0.6626404061496406,1.0,5/20,15.22%,BCL2L1;FAS;MCL1;GSK3A;DCC
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.509051607837338,1.2500020818175912,0.2160392798690671,0.6617358308154795,1.0,7/25,14.70%,ETS1;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,regulation of cholesterol storage (GO:0010885),0.5650076539630633,1.2499787649779561,0.23985890652557318,0.6608083417155983,1.0,6/15,14.14%,PPARD;SCARB1;ABCG1;NR1H2;PPARG;MSR1
prerank,regulation of DNA binding (GO:0051101),0.46660245046868654,1.2496829038201414,0.1750788643533123,0.6606626780564693,1.0,11/44,13.76%,LEF1;NFKBIA;PLAUR;SP100;JUN;TGFB1;ZBTB7A;PPARG;CSNK2B;EDF1;HMGB2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5941254542402672,1.2496812947762685,0.23272727272727273,0.6596854698940939,1.0,5/11,22.25%,CAV1;ADIPOR1;HGS;SH2B3;SOCS1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.49865380140107274,1.2496552864673334,0.19936708860759494,0.6587846345367642,1.0,10/30,13.46%,ELOVL7;TECRL;ABCD4;ACOX1;ACSL6;ELOVL5;ABCD1;ELOVL6;SLC27A2;HACD2
prerank,apoptotic process (GO:0006915),0.37488844659631687,1.2496045004557699,0.10757946210268948,0.6579613303718947,1.0,23/203,6.76%,HIP1;SEMA6A;BCL2L1;TNFRSF19;APP;FAS;TBX1;PPARD;MAL;ELMO1;NFKBIA;TNFRSF25;MAGI3;FOXO1;ADAM15;ZBTB16;TNFRSF21;RHOB;PPIA;BIK;PAK5;CASP7;NCKAP1
prerank,blood circulation (GO:0008015),-0.40024638272856833,-1.2492744966957279,0.15517241379310345,0.6274247896811093,1.0,18/49,13.67%,ROCK2;SERPING1;COL4A3;SGCD;ELN;MEOX2;MYOF;SCPEP1;GUCY1A1;ACE;BDKRB2;AGTR1;ADORA2A;ITGB1BP1;ADCY6;GCLC;HTR7;GUCY1B1
prerank,glycine transport (GO:0015816),0.615906442166831,1.249145280796334,0.23032629558541268,0.6584053200278608,1.0,2/10,1.98%,SLC6A5;SLC38A5
prerank,positive regulation of response to external stimulus (GO:0032103),0.3926166276933342,1.2489236848393355,0.12169312169312169,0.658062732944593,1.0,22/128,12.73%,ETS1;PDGFB;PDE2A;APP;SCARF1;NFKBIA;STX3;GBP5;HYAL2;MGST2;TLR3;ZCCHC3;TLR7;TGFB1;PTN;OASL;CNTF;CCL1;TLR8;S100A8;IL15;DDT
prerank,negative regulation of proteolysis (GO:0045861),-0.4106191850471629,-1.2488703937264587,0.15512465373961218,0.627063087411389,1.0,9/34,13.66%,TIMP2;TIMP3;PTPN3;GAS1;SNX12;ECM1;CLN3;LRRK2;SERPINE2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.41197273438899173,-1.248228740325356,0.14084507042253522,0.6273815521386022,1.0,9/44,7.08%,ANK2;ACTN2;ANO6;WNK4;KCNMB2;KCNJ2;ATP1B3;FLNA;ATP1B2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.5230776797324537,-1.2480926074677765,0.20465116279069767,0.6262347837209797,1.0,7/14,21.13%,DPYD;NT5E;UPB1;UPP2;NT5C1A;UMPS;ERH
prerank,vasculature development (GO:0001944),0.5634374827520142,1.248082330881223,0.2333931777378815,0.6595472678807486,1.0,9/16,10.09%,BMPR2;NOTCH4;FLT4;ACVRL1;APLNR;FOXF1;FBXW7;SOX18;STRA6
prerank,positive regulation of protein depolymerization (GO:1901881),0.5955608188707211,1.2479602713508207,0.2411764705882353,0.6589330998479207,1.0,4/11,18.01%,NES;VIL1;TRPV4;WDR1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5555697919908011,1.2468339182167998,0.19851576994434136,0.6611819139421534,1.0,1/16,0.25%,ETS1
prerank,synaptic vesicle cycle (GO:0099504),0.49889189455218813,1.2464662377465663,0.18971061093247588,0.661283993185951,1.0,8/30,15.74%,STX1A;WNT7A;PIP5K1C;SYT7;DNAJC5;CPLX1;SLC17A6;NLGN1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.46513465833504397,1.2460414888869111,0.1677115987460815,0.6614924756503516,1.0,10/39,9.22%,KDR;TIE1;ENG;RASIP1;NOTCH4;CTNNB1;DLL4;COL4A1;LRP5;PAK1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4533368976480511,-1.2459837651974686,0.1717948717948718,0.6308994605817092,1.0,6/26,14.97%,ATP1A2;PKD2;THADA;GNB5;FMR1;GSTM2
prerank,cellular response to cAMP (GO:0071320),0.488888035677028,1.2457739552628992,0.20462046204620463,0.6613377956873647,1.0,10/30,13.66%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6
prerank,neuromuscular process controlling balance (GO:0050885),0.5901554503033664,1.2455471885469187,0.22281639928698752,0.6609796520359884,1.0,4/12,11.92%,PCDH15;NRXN1;CLRN1;CDH23
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4328310156459885,1.2453554525428252,0.17404129793510326,0.6605886161925189,1.0,11/67,5.98%,MYO10;PPP1R16B;PODXL;CAV1;TBC1D14;TBC1D22A;TBC1D2;CCR7;USP6NL;TBC1D24;TBC1D5
prerank,response to nitric oxide (GO:0071731),0.5870573633661509,1.2446637636730964,0.2463768115942029,0.6615762967092453,1.0,4/13,12.80%,FOXO1;KCNC2;CCR7;EGLN1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4859400019349039,-1.2443921254230463,0.1743119266055046,0.633979674187529,1.0,6/17,10.12%,ATP1A2;CACNA1C;GJA1;ATP1B2;SLC8A1;PRKACA
prerank,regulation of calcium ion transport (GO:0051924),-0.38141619430621676,-1.2442041330006617,0.12716763005780346,0.6329637743148485,1.0,13/54,8.87%,ANK2;MYLK;STIM1;IL16;CACNA2D1;PKD2;EFHB;SLC8B1;P2RX4;BCL2;CACNA1D;TRPC6;SARAF
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4579834503893714,-1.2438640373027172,0.1912442396313364,0.6324092521815339,1.0,7/22,13.75%,MDFIC;APOD;SUFU;ITGB1BP1;LRRK2;DMTN;LMAN1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.46438158351396613,1.2424949031279984,0.18153364632237873,0.6668790896130063,1.0,9/41,9.89%,PDGFB;LRP8;NEDD9;EPHA4;FYN;FBXW7;EFNA1;TGFA;ADAM17
prerank,rRNA metabolic process (GO:0016072),0.3828187773128906,1.242484095581657,0.09974093264248704,0.66594351494415,1.0,69/160,28.17%,RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;DEDD2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;MRM2;RPL11;RPS15;TRIR;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;DIS3L;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;XRN1;RPL34;WDR75;EXOSC9;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;RPL24;RPL7A;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS
prerank,negative regulation of nuclear division (GO:0051784),-0.5318063662590636,-1.2418737474770256,0.23270440251572327,0.6366857246029509,1.0,6/11,22.74%,BMP7;BMP4;TOM1L2;NME6;AURKAIP1;TOM1L1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.4018308430418357,-1.2417268907006633,0.13649025069637882,0.6355209096796816,1.0,11/41,15.79%,ATP1A2;SLC12A2;KCNJ2;ABCC9;ATP1B3;SLC12A7;ATP1B2;KCNJ13;SLC12A4;KCNJ8;KCNJ15
prerank,protein localization to plasma membrane (GO:0072659),0.38765358551066453,1.2414818576787618,0.12080536912751678,0.6678462462872686,1.0,25/129,10.90%,EFR3B;BSG;SPTBN1;RAPGEF2;TSPAN5;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;CCDC88A;DENND4C;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5793846254551824,1.241361506146184,0.23843416370106763,0.6672400987871598,1.0,4/13,16.98%,JAK3;PIGU;IL7R;CRLF2
prerank,thyroid hormone generation (GO:0006590),-0.5734124284603926,-1.2409419284831444,0.227765726681128,0.6361400248879729,1.0,3/10,13.01%,CPQ;SLC5A5;FOXE1
prerank,carbohydrate homeostasis (GO:0033500),0.42495708980258035,1.2402640865911587,0.166189111747851,0.6694162956050806,1.0,5/67,4.99%,IGF1R;INSR;ADIPOR2;KLF7;CYP11B1
prerank,positive regulation of dendritic spine development (GO:0060999),0.5251321991974133,1.2402403383134464,0.21043478260869566,0.668508750492102,1.0,3/20,6.37%,SHANK3;LRP8;DBNL
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.579282990968436,1.2401766507555134,0.2486865148861646,0.6676927883431005,1.0,4/14,9.05%,TIRAP;CARD10;TLR3;MALT1
prerank,regulation of embryonic development (GO:0045995),0.48187367070014625,1.2401156559107125,0.19773095623987033,0.6668806306726685,1.0,4/34,2.11%,PLCB1;INSR;B4GALT5;SOX17
prerank,histone modification (GO:0016570),-0.33621245609095973,-1.2400350106503728,0.08633093525179857,0.6370301142393981,1.0,22/109,15.83%,EYA2;EYA1;EYA4;HDAC4;PRKCD;BAZ1B;EHMT2;TBL1XR1;MIER3;MAP3K12;KAT6B;SGF29;MORF4L2;HUWE1;USP3;SIRT2;PRMT8;BRD8;EP300;MRGBP;UBE2B;MTA3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.477180155119899,-1.2396252010945763,0.20149253731343283,0.6365515534223339,1.0,4/19,11.34%,IGF1;FLOT2;APOE;RTN1
prerank,positive regulation of protein polymerization (GO:0032273),0.4318399699761746,1.2393325726483482,0.1696165191740413,0.6681897124846589,1.0,24/65,21.32%,OCLN;FES;EVL;CLIP1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;FCHSD1;NCK1;PRKCE;TENM1;BIN1;TPPP;DCTN1;CDC42EP1;CLASP1;BAIAP2L1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5298072956144178,1.23899378906391,0.20930232558139536,0.6681793383849329,1.0,9/18,20.23%,SAMHD1;OGA;NEU4;STT3B;FBXO6;MANBA;NEU2;FBXO2;AOAH
prerank,negative regulation of cell motility (GO:2000146),0.40082986104723844,1.2386914977361554,0.1286472148541114,0.6681211398354118,1.0,15/108,5.52%,LIMCH1;DACH1;FRMD5;CLDN5;SRGAP3;SRGAP2;SRGAP1;ENG;PTPRJ;ADAM15;ACVRL1;DUSP3;SMAD7;RHOB;EPHA4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4525152277804845,1.2380797284632317,0.2006125574272588,0.668900081828082,1.0,7/40,5.02%,LEF1;TGFB2;RGCC;TIAM1;NOTCH1;CTNNB1;WWTR1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5449402347686607,1.2375321671602053,0.2323049001814882,0.6695712414915339,1.0,6/17,12.47%,NTHL1;TERF2;SMUG1;ACD;MPG;TERF1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.46893891393058307,1.237351425591099,0.18196994991652754,0.6691228917833125,1.0,6/35,6.89%,DAB2IP;RASIP1;TGFB2;HEG1;STMN1;STMN3
prerank,positive regulation of dephosphorylation (GO:0035306),0.4964045893598024,1.2369361090862327,0.20458265139116202,0.669350611629869,1.0,8/27,13.45%,PPP1R16B;CALM1;PPIA;PPP2R5A;PIN1;TGFB1;NSMF;CDH5
prerank,positive regulation of protein binding (GO:0032092),0.4438664955415457,1.2367787948743862,0.18501529051987767,0.6688131430964531,1.0,12/56,8.28%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;B2M;EPB41;TIAM1;MEN1;RALB;PIN1;MARK3
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3558846490850761,-1.2367661503727787,0.1111111111111111,0.6431504580677802,1.0,18/79,9.03%,SULF1;BMPR1A;ADAMTS12;NBL1;CRIM1;BMPER;SLIT2;SMAD6;HTRA3;SULF2;CASK;THBS1;FGF2;RBPMS2;SMAD9;EMILIN1;SMURF2;CREB3L1
prerank,stem cell development (GO:0048864),0.5524325882401369,1.2364314947700308,0.25257731958762886,0.6688465573854023,1.0,6/16,17.63%,CDH2;WNT7A;SNAI2;SOX11;PDCD6;KBTBD8
prerank,proteoglycan biosynthetic process (GO:0030166),0.4819821431842719,1.2364037487857034,0.20770519262981574,0.6679753681814794,1.0,4/31,2.89%,CSGALNACT1;BMPR2;EXTL3;CHST11
prerank,canonical Wnt signaling pathway (GO:0060070),0.42419004436488256,1.2362991022598644,0.15460992907801419,0.6673489413039324,1.0,8/68,5.83%,LEF1;FZD6;CAV1;FZD4;WNT7A;CTNNB1;FRAT2;TCF7
prerank,T cell proliferation (GO:0042098),0.5773769276035643,1.2355232212392073,0.23674911660777384,0.6686684897809975,1.0,3/13,11.80%,CADM1;MSN;TNFRSF4
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6170484209554464,1.2353726481381,0.2338403041825095,0.6681686622018116,1.0,4/10,16.69%,CAV1;ANK3;KCNRG;SUMO1
prerank,neuron projection extension (GO:1990138),-0.4235602392708778,-1.2353613679853728,0.1556122448979592,0.6456323448318325,1.0,9/32,13.78%,ALCAM;AUTS2;IMPACT;ULK2;FLRT1;SPG11;PPP3CB;CDKL3;USP9X
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5642046504290769,1.235195410129304,0.23299319727891157,0.6677159286720009,1.0,7/14,10.41%,MMRN2;NOTCH1;STARD13;DLL4;CARD10;KLF4;PDCD10
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5092172615595878,1.232514224366295,0.23559322033898306,0.6744624123717745,1.0,2/24,2.72%,ABCG2;ALAS1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4669241403888603,1.2319728869321511,0.19448946515397084,0.6750698095701205,1.0,11/37,21.62%,POLK;NTHL1;GTF2H2;GTF2H4;RBX1;RPA1;POLD1;GTF2H3;RFC2;DDB1;ERCC4
prerank,neuropeptide signaling pathway (GO:0007218),0.43568446540501415,1.2307135619711376,0.18248175182481752,0.6776643368923114,1.0,14/58,19.26%,RAPGEF2;HCRTR1;NPPA;SORT1;SORCS1;HCRTR2;CYSLTR1;PPY;RXFP3;OPRD1;SSTR1;NTS;CPE;GLRA2
prerank,response to cytokine (GO:0034097),0.38270214184298823,1.2300973516480158,0.14088050314465408,0.678464286186269,1.0,30/141,10.45%,LEF1;BCL2L1;APP;IL1R1;MAP4K3;IL6R;GCH1;TNFRSF11A;SP100;IFNAR2;JAK3;CD40;PTPN12;SIGIRR;ADAR;OSMR;CCR7;XAF1;ADAM10;LGALS9;MCL1;STAT1;BST2;CRNN;SHMT2;IRAK2;PTPN5;LIFR;KLHL20;CASP8
prerank,regulation of immune response (GO:0050776),0.386434786085161,1.2298504417737761,0.13788487282463185,0.6781732543612382,1.0,26/135,12.66%,CD34;TGFB2;CLEC2D;TIRAP;CD200;LRP8;B2M;CD40;LYN;ICAM2;SAMHD1;CD19;PILRA;XIAP;PVR;N4BP1;CD160;BIRC3;CD200R1;FOXP3;CD8B;CASP8;DENND1B;KIR3DL2;SYK;IL15
prerank,regulation of ERAD pathway (GO:1904292),0.5889275864201056,1.2289285878622178,0.25471698113207547,0.6799583765541728,1.0,5/11,19.23%,AQP11;ATXN3;UBXN1;BAG6;USP25
prerank,sensory organ development (GO:0007423),-0.38750946974827805,-1.2288646207390275,0.13802816901408452,0.6631977424447176,1.0,8/51,6.50%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5183625984685266,1.2284569078283498,0.23679727427597955,0.6794155199768308,1.0,8/23,17.11%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5183625984685266,1.2284569078283498,0.23679727427597955,0.6794155199768308,1.0,8/23,17.11%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5018783965124054,-1.2283865882739389,0.2234762979683973,0.6630261279970242,1.0,5/15,17.88%,BMP4;SMO;SIX1;SIX4;PAX2
prerank,response to ketone (GO:1901654),0.5052160992851799,1.2275877355969367,0.233387358184765,0.6808376102791729,1.0,5/24,8.09%,ABHD2;TGFB2;CAV1;CCR7;TGFB1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5848909209588751,1.2273651545513746,0.2570888468809074,0.6805298159557371,1.0,5/10,22.39%,SVIP;DERL2;UBAC2;UBE2G2;UBE2J1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5825559625609279,1.227223186397369,0.23971377459749552,0.680013409869508,1.0,2/12,1.96%,CSGALNACT1;FUT8
prerank,entry into host (GO:0044409),0.5669311296063049,1.2271291030524065,0.27495621716287216,0.6793762998018588,1.0,6/13,10.31%,GRB2;CTNND1;CTNNB1;CD4;PPIA;CBLL1
prerank,male gonad development (GO:0008584),0.4780134477042705,1.2268222251448668,0.20949263502454993,0.6792750871932078,1.0,6/34,10.83%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.47133615070406426,1.2268199710834682,0.2090032154340836,0.6783439641540011,1.0,7/38,6.45%,INSR;CD34;CAV1;DDAH1;KLF2;HSP90AB1;KLF4
prerank,protein polymerization (GO:0051258),-0.37146869991532666,-1.2267517892691386,0.11708860759493671,0.6662237097992955,1.0,9/55,9.18%,ARHGAP6;GAS7;GSN;COBL;HDGFL3;DIAPH1;PRKN;RNF135;MAP7D3
prerank,ear morphogenesis (GO:0042471),-0.46091641154507207,-1.2266525553131857,0.18673218673218672,0.6649302734634361,1.0,5/20,7.23%,ZIC1;FGFR2;OSR1;SIX1;EPHB2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.43938244968458245,-1.2264272944934056,0.20293398533007334,0.6639778014106472,1.0,11/26,19.78%,ADCY5;EFNA5;STXBP4;ANO1;CDK16;TRPM4;PPP3CB;STX4;NR1H4;PLA2G6;ADRA2A
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3723826662100379,1.2260992145588214,0.12423873325213154,0.6794691489465576,1.0,26/182,6.45%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;APP;XDH;MEF2C;ANKRD13A;ACVRL1;APLNR;RIN3;NOTCH1;NOS2;GATA2;NOCT;DLL4;HSP90AB1;DIP2A;ADAM10;FBXW7;LGALS9;KLF4
prerank,negative regulation of MAPK cascade (GO:0043409),0.40236951116975056,1.2255822887384904,0.16455696202531644,0.6800090469888709,1.0,16/87,8.57%,SEMA6A;DAB2IP;CAV1;CNKSR3;STK38;PTPRJ;DUSP7;FOXO1;DUSP3;LYN;HYAL2;PPIA;PTPRR;PIN1;ABCA7;P2RX7
prerank,negative regulation of growth (GO:0045926),0.3905071735896994,1.2253004960873695,0.1437994722955145,0.679848964124464,1.0,30/121,13.52%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;ACVRL1;CCDC85B;NOTCH1;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2;NAIF1;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,cellular response to reactive oxygen species (GO:0034614),-0.36297296878980584,-1.2251290090222298,0.13354037267080746,0.6663105356846976,1.0,13/59,11.96%,EGFR;PDGFRA;TPM1;MAP3K5;IMPACT;PRKCD;PKD2;ANXA1;CYP1B1;FXN;CHUK;MPV17;ABL1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.49703396743202066,1.2247786343994842,0.2354948805460751,0.6803757162001683,1.0,4/23,12.55%,MBOAT1;PLA2G4B;LPCAT3;PNPLA8
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5636490948792875,1.2247677226123668,0.24236983842010773,0.6794731126491774,1.0,8/15,26.07%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;ARPC5;WHAMM
prerank,fatty acid transport (GO:0015908),0.5407564019562044,1.224564984315417,0.22043010752688172,0.6790811622226678,1.0,2/17,1.88%,MFSD2A;PPARD
prerank,ncRNA 3'-end processing (GO:0043628),-0.5077165809898788,-1.224001287799664,0.2202247191011236,0.6680244723270508,1.0,9/14,37.23%,INTS8;INTS2;ERI1;TOE1;PTCD1;INTS6L;INTS5;SSB;ELAC2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5873580480578566,1.2239934540912918,0.24729241877256317,0.6796955411440876,1.0,3/10,7.63%,DAB2IP;EPHA4;EFNA1
prerank,cellular metal ion homeostasis (GO:0006875),-0.33886271062577783,-1.2233381366659193,0.10196078431372549,0.6683844481181038,1.0,16/102,8.19%,ATP1A2;SLC24A3;ANK2;ATP13A5;SLC41A1;STIM1;SLC8A3;SLC12A2;DMPK;ATP13A3;KCNJ2;ATP1B3;SLC8B1;ATP1B2;SLC8A1;PTH1R
prerank,sterol transport (GO:0015918),0.524510591852297,1.2230860066082914,0.24263431542461006,0.6814131998353565,1.0,4/19,14.14%,CAV1;OSBP;NPC1;MSR1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5164707571461147,1.2229541517157982,0.233502538071066,0.6808528900903398,1.0,8/21,11.08%,PDE2A;XDH;HPRT1;PDE4D;HINT1;NT5C2;NUDT3;PNP
prerank,membrane fusion (GO:0061025),0.46826350696405766,1.2227607208688434,0.19543973941368079,0.6804681005994423,1.0,2/33,2.16%,DNM3;DYSF
prerank,diol biosynthetic process (GO:0034312),0.5525388575509322,1.2222429276574824,0.2508532423208191,0.6810731048355952,1.0,6/15,14.82%,ACER2;GCH1;ACER1;SPTLC2;SPTLC1;QDPR
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5913605556454442,1.2217069793904078,0.2730696798493409,0.681665445786123,1.0,3/11,7.93%,CAV1;NEDD4L;KCNH2
prerank,negative regulation of apoptotic process (GO:0043066),0.34599190788115913,1.2214854567843445,0.06896551724137931,0.6813760133686131,1.0,59/444,10.86%,LEF1;IGF1R;TFRC;PRKCH;TEK;NDNF;RNF144B;TJP1;KDR;BCL2L1;CAV1;FAS;TBX1;NFKBIA;SH3RF1;FLT4;TBX3;PLAUR;PTK2;MEF2C;FOXO1;RPS6KA1;NOTCH1;MERTK;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;CAT;CD38;MRE11;SNAI2;MAPK3;ADAM10;KLF4;TOX3;RETREG1;MCL1;HCK;POU3F4;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;FOXQ1;ARHGDIA;PTRH2;KLHL20;PDCD10;MGMT;CNTF;THOC6;HSPB1;LRP2;LAMTOR5
prerank,liver development (GO:0001889),-0.4133521103643327,-1.2214160937801484,0.1581769436997319,0.6725556242494013,1.0,7/32,10.02%,TGFBR3;WNT4;COBL;PKD2;ANXA1;MET;CEBPB
prerank,regulation of defense response (GO:0031347),0.416102075518295,1.2213375781339617,0.18641618497109827,0.6808648772319387,1.0,16/76,11.38%,SEMA7A;IL1R1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4;USP18
prerank,negative regulation of neurogenesis (GO:0050768),0.4747570729529725,1.2211397622626277,0.19831932773109243,0.6805101090506189,1.0,7/34,9.68%,RAPGEF2;B2M;NOTCH1;WNT7A;YWHAH;PTN;ARHGDIA
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5647699693869785,1.2206191260164225,0.2643253234750462,0.6809945408432094,1.0,1/14,0.33%,SEMA7A
prerank,protein localization to membrane (GO:0072657),0.3657221953749782,1.2203893354791988,0.12421580928481807,0.6808046949182195,1.0,35/187,11.87%,EFR3B;BSG;SHANK3;SPTBN1;RAPGEF2;CAV1;TSPAN5;F11R;AGRN;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;ABHD17A;MAP7;STXBP1;LRRC7;RAB11A;FCHO2;RAB34;TMEM88;PTN;NRXN1;NPC1;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C;FERMT2;NUP54;SH3GLB1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3515759680174266,-1.2201071778101025,0.10861423220973783,0.6749948994439748,1.0,17/80,15.71%,SAMD4A;PLD1;ROCK2;SLC2A13;THBS1;PRKCD;SMPD3;PLXNB2;SIRT3;FXR2;NSMAF;EIF3C;FMR1;DDX3X;CASP3;LARP6;YTHDF1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.40364479023842725,-1.2198591316181988,0.16477272727272727,0.6741157783521836,1.0,13/40,16.85%,ZBTB20;WNT4;BMP4;PPARA;APOE;CREB3L1;TGFB3;SLC5A3;CYBA;TLR4;LARP6;RUNX1;SUCO
prerank,protein O-linked mannosylation (GO:0035269),0.5246627412333377,1.2197004784743448,0.23211169284467714,0.6818529357660936,1.0,1/18,0.08%,TMTC2
prerank,positive regulation of metabolic process (GO:0009893),0.39143716225177017,1.2196984011465362,0.16779431664411368,0.6809408171754909,1.0,12/103,7.53%,IGF1R;EPAS1;INSR;ADIPOR2;GATM;CAV1;FASN;UCP2;OXTR;ACACB;YBX2;IL4R
prerank,negative regulation of lymphocyte migration (GO:2000402),0.605778837251463,1.2196131382517708,0.25475285171102663,0.6802450347914851,1.0,3/10,8.06%,LRCH1;CD200;CD200R1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4796986742678311,1.219551802649299,0.22063492063492063,0.6794885412550741,1.0,1/31,0.15%,TFRC
prerank,lymphocyte mediated immunity (GO:0002449),-0.5191855160055826,-1.2192730819951632,0.23684210526315788,0.6741565638078385,1.0,2/12,7.70%,CD55;JAG1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5062393357099868,1.21923285652045,0.24414715719063546,0.6794636693406051,1.0,8/24,19.97%,PECAM1;F11R;MSN;SYK;VCAM1;ITGA4;TNIP1;SEMA4D
prerank,protein catabolic process (GO:0030163),0.426719727002126,1.2191666479114365,0.18535127055306427,0.678737387759528,1.0,20/59,18.29%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;TRIM24;HSPA8;CEACAM1;FBXO6;MANBA;NEU2;CLN8;PSMA8;ATE1;UBE2G2;BAG6;USE1;FBXO2;SIAH1
prerank,activin receptor signaling pathway (GO:0032924),-0.4968136202165341,-1.2179397553303901,0.21559633027522937,0.6765123562440494,1.0,7/15,30.22%,SMAD3;TGFBR1;ACVR1B;INHBB;INHBA;SMAD2;AMHR2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5766832745296309,1.2175127273835211,0.26142595978062155,0.6824412051784027,1.0,6/11,20.96%,PLAUR;LYN;TNFSF11;SYK;ANK3;RDX
prerank,inorganic cation transmembrane transport (GO:0098662),-0.29324329949958655,-1.2174771604289307,0.03597122302158273,0.6763788673206934,1.0,31/268,5.61%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC41A1;SCN7A;SCARA5;SLC6A12;PKD1;SLC30A10;KCNK5;SLC8A3;SLC6A9;SLC12A2;ANO6;SLC39A14;PKD2;SLC9A2;KCNJ2;TRPC3;CACNA1G;ABCC9;ATP6V0A4;TRPM6;ATP1B3;KCNQ4;SLC6A1
prerank,endothelial cell differentiation (GO:0045446),0.5805215517630792,1.2171883490078632,0.2601054481546573,0.6824354898856612,1.0,5/12,7.19%,KDR;TIE1;BMPR2;ACVRL1;SOX18
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5238078248999052,1.2171336225020224,0.2205128205128205,0.6816919329567936,1.0,6/20,13.17%,EPAS1;DCUN1D3;HSP90AB1;UBQLN1;HIF1A;DCUN1D1
prerank,striated muscle contraction (GO:0006941),-0.3644297419047474,-1.2167994032543263,0.17058823529411765,0.6768698546549655,1.0,10/53,16.46%,ATP1A2;TPM1;DMD;SLC8A1;GAA;ARHGEF11;DTNA;STAC3;TNNT3;ALDOA
prerank,response to peptide (GO:1901652),0.4852979485816348,1.216786359405115,0.22112211221122113,0.6818437837260639,1.0,9/33,10.81%,CACNA1A;NOD2;RAMP3;FYN;STAT1;IRF5;EIF2B1;AGER;EIF2B2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.41003471486492266,1.215983097379421,0.1812778603268945,0.6832554112812583,1.0,19/72,11.43%,ARHGEF3;RASIP1;HEG1;NET1;F11R;ADGRG1;ARHGEF2;LPAR6;PRAG1;STARD13;STMN1;EPS8;EPS8L2;GPR17;OPHN1;ARHGDIA;KCTD10;PDCD10;RAC1
prerank,sphingoid metabolic process (GO:0046519),0.5958719925973541,1.2155734174008757,0.26492537313432835,0.6835541845535867,1.0,2/12,1.18%,SGPP2;DEGS2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.44926650170262455,1.2154551890898453,0.20754716981132076,0.6829663314761584,1.0,8/43,8.09%,ETS1;PDGFB;TGFB2;PPARD;GATA2;KLF4;JUN;TGFB1
prerank,T cell receptor signaling pathway (GO:0050852),0.37771673432526026,1.2147902341680479,0.13725490196078433,0.6840943141748317,1.0,45/138,23.35%,INPP5D;PTPRJ;PRKD2;ZAP70;PLCG1;IKBKB;PDE4D;TNFRSF21;MOG;CD4;FYN;PSMB3;PSMD11;PDE4B;PSMC6;MALT1;PAK1;PSME2;EIF2B1;EIF2B2;DENND1B;PSMD8;PIK3CB;PSMB10;BCL10;RFTN1;LCP2;CARD11;PSMA8;NCK1;PAK2;SKP1;PSMD9;SPPL3;SKAP1;RBCK1;FYB2;PLCG2;CUL1;PSMC3;PSMD1;TRAT1;PSMD10;TRAF6;NFKBID
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4577291444283866,1.2145292018363445,0.22442748091603054,0.6839456944128672,1.0,12/37,21.63%,ENTPD1;ENTPD5;DFFB;NUDT9;PPP1R8;SND1;NUDT1;RNASEH2C;NUDT16;XRN2;NCBP1;RNASE6
prerank,negative regulation of viral process (GO:0048525),0.43200628178705847,1.214197021140706,0.1906158357771261,0.6839835712306704,1.0,16/57,18.45%,TRIM14;IFIH1;BTBD17;PPIA;STAT1;N4BP1;BST2;BANF1;OASL;SLPI;ZC3HAV1;MBL2;TRIM26;PROX1;TNIP1;TRIM11
prerank,cardiac ventricle development (GO:0003231),0.5145445991978758,1.2141667445859308,0.23559322033898306,0.683168275136988,1.0,6/20,10.09%,ENG;PDE2A;NOTCH1;DLL4;HECTD1;STRA6
prerank,regulation of erythrocyte differentiation (GO:0045646),0.4653437838574963,1.2140408300965195,0.2224,0.682600832923012,1.0,10/35,14.70%,ETS1;ZFPM1;LYN;TAL1;STAT1;HIF1A;ZFP36L1;BRD1;HMGB2;NCKAP1L
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.587521796142019,1.2139281320175577,0.2542372881355932,0.6819922113395752,1.0,5/11,24.09%,NPPA;AKAP6;KCNIP2;ALG10B;LRRC55
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.45767843397876723,-1.2133645760973264,0.20574162679425836,0.6855713150876199,1.0,5/20,18.64%,WNT4;C1QTNF3;EP300;BCKDK;NCOR1
prerank,cellular response to glucose stimulus (GO:0071333),0.474684323816552,1.2133617833742596,0.22913256955810146,0.6826197947620231,1.0,2/30,2.00%,IGF1R;UNC13B
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4748079165423052,1.2132514904178944,0.24546952224052718,0.6820805817003002,1.0,11/32,11.43%,OCLN;WASF2;VIL1;RREB1;NCKAP1;TWF2;ARHGEF7;ENPP2;CYFIP1;CLRN1;RAC1
prerank,Golgi organization (GO:0007030),-0.3289908957813078,-1.213210982087438,0.09219858156028368,0.6843636115128583,1.0,43/112,24.16%,RAB30;GBF1;OBSL1;TANGO2;ARHGAP21;GOLGB1;FBXW8;FAM174B;DYNC2H1;GOLGA2;SEC16B;PI4K2B;STX5;COG4;CUL7;ARL1;HUWE1;LRRK2;GORASP2;PRMT5;ATP8B2;RAB29;ATP8B1;BCAS3;PLEKHM2;SEC16A;LMAN1;STX16;PLK5;SURF4;OPTN;BLZF1;GOLGA5;GOLGA8B;ATL3;TMED4;LMAN2L;SEC23IP;TMED9;MYO18A;UBXN2A;HTT;TJAP1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.47966247929996303,1.2130692562472911,0.22765598650927488,0.6816822586627762,1.0,4/29,5.03%,IFNAR2;NLRC5;SAMHD1;HSP90AB1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.49253247613656814,1.2126937938136038,0.24561403508771928,0.6818806187134109,1.0,5/26,4.22%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,negative regulation of phosphorylation (GO:0042326),-0.33861510123789745,-1.2124559993349213,0.12734082397003746,0.6850245710117371,1.0,16/85,8.16%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;BMP4;NUPR1;SLIT2;HDAC4;IMPACT;PPARA;IRS2;EPHB2;PRKN;IGFBP3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5405090975047689,1.2123122766893302,0.24773960216998192,0.6820161913680161,1.0,9/15,24.76%,ZFAND2A;SRP14;SPCS2;EDEM1;SPCS1;RAB3GAP1;RYR2;SRPRA;ZFAND2B
prerank,regulation of protein processing (GO:0070613),-0.45590994305177135,-1.212250766490538,0.21768707482993196,0.6840723430479211,1.0,8/21,16.03%,CCBE1;GAS1;SNX12;CLN3;LRRK2;NKD2;SERPINE2;RUNX1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3900620916559563,-1.2121105242606625,0.1685082872928177,0.6828833496224969,1.0,11/46,16.03%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;EMD;BAG3;PIK3R1;CAMK1
prerank,regulation of protein binding (GO:0043393),0.38678794815566336,1.2119403366853378,0.17142857142857143,0.6821752257797856,1.0,14/114,3.87%,CLDN5;PDGFB;RAPGEF2;APP;CAV1;HIP1R;CTNNBIP1;B2M;NES;EPB41;ZFPM1;TIAM1;MEN1;ACTB
prerank,protein mannosylation (GO:0035268),0.49946508761657654,1.211491640575137,0.2315270935960591,0.682492412317024,1.0,1/22,0.08%,TMTC2
prerank,positive regulation of response to wounding (GO:1903036),0.4963957671798449,1.2110301091569853,0.2345890410958904,0.682839124223238,1.0,8/24,11.49%,OCLN;SCARF1;PTK2;INSL3;PTN;ACTG1;CNTF;HRAS
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4481610569195824,-1.2096830674793264,0.21428571428571427,0.6886870908472162,1.0,4/22,7.13%,UGGT2;MAN1C1;AMFR;MAN1A2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.517677727358167,1.2093419080301517,0.24144144144144145,0.6866168842149053,1.0,6/19,11.01%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4537406175677646,-1.2093345802555149,0.1956521739130435,0.6881044311009781,1.0,3/20,1.29%,BMPR1A;GLI2;NBL1
prerank,negative regulation of cell growth (GO:0030308),0.38087812422724765,1.2092092934478467,0.15465268676277852,0.6860662367192044,1.0,22/121,10.36%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;ACVRL1;FGF13;CCDC85B;DIP2B;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2
prerank,negative regulation of viral genome replication (GO:0045071),0.4547489609967556,1.209074291710039,0.2116564417177914,0.6855143904161994,1.0,13/40,18.09%,IFIH1;BTBD17;N4BP1;BST2;BANF1;OASL;TASOR;SLPI;SETDB1;ZC3HAV1;HMGA2;PROX1;TNIP1
prerank,regulation of cellular protein localization (GO:1903827),-0.3827210395584287,-1.2089690936445323,0.195906432748538,0.6875606099293051,1.0,5/45,4.60%,GPC6;PRKAA2;GPC3;GBF1;GPC4
prerank,cellular component assembly (GO:0022607),0.3558412234702205,1.2085355685219934,0.10854503464203233,0.6861730877241735,1.0,60/253,17.36%,OCLN;SLC2A1;PARVB;SPTBN1;LIMS2;SHROOM1;FAS;MAGI1;NEDD9;CD40;PARD3;CD2AP;PLS3;ACTB;VIL1;WNT7A;EPS8;CARD10;RP1;BAIAP2;ABCA3;FAM107A;PARVG;NCKAP1;CLDN14;TTLL3;TGFB1;OPHN1;QSOX1;CAPG;ACTG1;RSPH4A;CYFIP1;DCX;PDCD10;FERMT2;ACD;PEX14;RAC1;FSCN3;CHAF1A;RANBP9;RSPH1;SOX9;FSCN1;FOXJ1;RHOV;SH3BGR;NCKAP1L;ELOB;NLGN1;APC;HAS3;CHAF1B;ANK3;GAS6;IL1RAP;YWHAZ;RAD21;BAG6
prerank,regulation of humoral immune response (GO:0002920),-0.3805977457487521,-1.2084780578512164,0.17616580310880828,0.6874611514248419,1.0,12/44,21.20%,SERPING1;VTN;CD55;CFH;GATA6;C2;C1QB;CD81;C1QBP;C4B;C3AR1;C6
prerank,cellular response to interferon-gamma (GO:0071346),0.40076868680483657,1.2082732638755358,0.1753155680224404,0.6860434037118371,1.0,17/88,11.89%,TRIM25;B2M;SP100;GBP7;GBP4;GBP5;IRF2;IRF9;LGALS9;STAT1;HCK;IRF5;RPL13A;OASL;PDE12;CCL1;MID1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.49703725963312606,1.2082700743789545,0.24190800681431004,0.6851650620746348,1.0,6/25,10.36%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.4618149351472058,-1.2079594175535868,0.22041763341067286,0.6874026352749917,1.0,6/18,11.96%,POR;ATP7A;SIRT3;AGTR1;FXN;ABL1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.472621265802536,1.2075917217087295,0.2487644151565074,0.6861577459866338,1.0,5/33,10.14%,TFRC;BCL2L1;SLC25A5;VAT1;GHITM
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5016889393302317,-1.2073727207431189,0.22666666666666666,0.6876159208646897,1.0,4/14,4.34%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,B cell differentiation (GO:0030183),0.447090889778252,1.2071306689470862,0.2199367088607595,0.686537943050176,1.0,16/46,17.84%,TPD52;PTPRJ;JAK3;HDAC9;HHEX;SLC25A5;CD79A;KLF6;ADAM17;ZBTB7A;VCAM1;HDAC5;DNAJB9;MSH2;ITGA4;ADGRG3
prerank,cobalamin metabolic process (GO:0009235),0.5351682923547106,1.2070190944920403,0.24161073825503357,0.6859675815026542,1.0,8/17,24.20%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,autonomic nervous system development (GO:0048483),0.5410963747001517,1.2068921024632142,0.25618374558303886,0.6854612170746539,1.0,5/17,12.63%,KIF26A;PHOX2A;PHACTR4;SOX10;SOX11
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4724152265858568,-1.2066544586644634,0.23113207547169812,0.6880678011177854,1.0,5/17,5.02%,ATP1A2;TFPI;BMP7;BMP4;AR
prerank,protein neddylation (GO:0045116),0.5545483006061387,1.2062243810390474,0.2658662092624357,0.6864236972996404,1.0,4/13,14.26%,DCUN1D3;UBA3;DCUN1D1;RBX1
prerank,microvillus organization (GO:0032528),0.5562107930959604,1.2057807322464238,0.26344086021505375,0.6867470283189032,1.0,5/13,14.58%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,positive regulation of embryonic development (GO:0040019),0.5191357564555361,1.205514731775039,0.25673249551166966,0.686639999092126,1.0,2/19,2.10%,PLCB1;B4GALT5
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5124519076480819,-1.2054998613191765,0.22916666666666666,0.689862405487755,1.0,4/13,11.43%,CYFIP2;ASPH;PERP;TBC1D10A
prerank,response to interferon-alpha (GO:0035455),0.5347799573541522,1.2053489034309146,0.25870646766169153,0.6861820236771887,1.0,8/16,16.47%,IFNAR1;IFNAR2;ADAR;BST2;KLHL20;PDE12;RO60;GAS6
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5850966567840266,1.2053353076164135,0.27151051625239003,0.685335617661472,1.0,4/11,8.89%,TGFB2;MEF2C;TGFB1;GREM1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.36488061978669506,-1.2053042153558942,0.17158176943699732,0.6889052225196084,1.0,8/57,6.15%,LPAR1;ADCY5;ADCY1;ADCY9;AKAP12;ADCY2;ADCY7;FLNA
prerank,phagolysosome assembly (GO:0001845),0.5688984146850954,1.2052625071099463,0.2697594501718213,0.6846710596493462,1.0,4/12,7.82%,PIKFYVE;SYT7;RAB39A;RAB34
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4844119809062335,-1.205036285174125,0.23940149625935161,0.6881147126313093,1.0,4/16,10.98%,PID1;PPARGC1A;PPARA;PARP1
prerank,urogenital system development (GO:0001655),-0.5404434394174487,-1.2048075180398,0.24608501118568232,0.6871990953120196,1.0,3/11,7.23%,OSR1;ANXA1;EPHB2
prerank,phosphorylation (GO:0016310),0.34190372424002985,1.2044967687602885,0.10886644219977554,0.6859654386150367,1.0,87/385,15.41%,PRKCH;ERG;PDGFB;INSR;BMPR2;TGFB2;MAP4K2;DGKH;APP;CDK17;MAP4K3;STK38;PKN3;LIPE;SNRK;JAK3;ACVRL1;PRAG1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;PPP4R1;CREB1;CAMKK2;DGKI;PKN1;STK19;LIMK2;PRKACB;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;RET;AATK;DGKE;PKN2;HCK;PXK;MARK4;CERKL;TGFB1;MARK3;MAP3K6;PAK1;EIF2AK4;PTK6;TRIB2;PRKAB1;TOLLIP;HK1;PRKCB;GSK3A;SYK;DGKZ;PIK3CB;TNK2;MAP4K4;TGFBR2;PANK3;HIPK2;CERK;STK24;STK3;MINK1;PIM2;VRK1;SGK1;TBCK;CAMK2B;STK26;CTBP1;GRK6;NEK3;HIPK3;PLK2;SGK3;SGK2
prerank,nucleotide metabolic process (GO:0009117),-0.44914620114807735,-1.2043532754132151,0.2078239608801956,0.6868963759566321,1.0,4/23,5.27%,FHIT;NMNAT2;ME1;ENPP3
prerank,organelle fusion (GO:0048284),-0.4395273459083572,-1.2042443298757308,0.23425692695214106,0.68567620000242,1.0,7/22,16.25%,MIGA2;EEA1;MIEF1;AFG3L2;MFN2;MIEF2;STX4
prerank,gluconeogenesis (GO:0006094),-0.3997780719769415,-1.2041292798581706,0.1909814323607427,0.6844703229411867,1.0,12/39,22.43%,RBP4;SLC39A14;PPARGC1A;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;ENO3;PGK1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5021980058290262,1.2037936252421633,0.26138279932546377,0.6862173129001837,1.0,6/22,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5021980058290262,1.2037936252421633,0.26138279932546377,0.6862173129001837,1.0,6/22,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,atrial septum morphogenesis (GO:0060413),0.5905581384831529,1.2033169896423175,0.2908745247148289,0.686666232949971,1.0,3/10,3.19%,BMPR2;TGFB2;ZFPM1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.37385843975849525,1.2033012095494386,0.14890885750962773,0.6858320796859804,1.0,29/158,11.70%,TFRC;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TNFSF10;TRIM14;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;LGALS9;BST2;BIRC3;MALT1;MAP3K3;NDFIP2;UBE2V1;SHARPIN;CASP8;BRD4;LAMTOR5;PRKCB;GPR89A
prerank,dopamine metabolic process (GO:0042417),0.5172734796992213,1.2030387851908142,0.2456445993031359,0.6856812474586886,1.0,3/18,2.19%,MAOA;TGFB2;GCH1
prerank,regulation of multicellular organismal development (GO:2000026),0.4957857146931011,1.2029056257208213,0.24190800681431004,0.6851489842804328,1.0,4/25,10.17%,INSR;SOX17;PTN;MYSM1
prerank,regulation of interleukin-8 production (GO:0032677),0.4092513725982161,1.2023438582907315,0.18556701030927836,0.6857978869000568,1.0,17/69,14.07%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;TMSB4X;NOS2;HYAL2;TLR3;LGALS9;KLF4;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.5388573478091974,-1.2020177814747348,0.2511013215859031,0.6876296564543035,1.0,4/10,25.20%,TULP1;CEP250;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.5388573478091974,-1.2020177814747348,0.2511013215859031,0.6876296564543035,1.0,4/10,25.20%,TULP1;CEP250;CNGB1;CACNA2D4
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4529146707128199,-1.2018492354281318,0.2037914691943128,0.6865851007616895,1.0,13/21,30.58%,DCDC2;SMO;GLI1;EVC;ARMC9;KIF7;SFRP1;TTC23;STK36;PDCL;TXNDC15;SHH;ULK3
prerank,protein polyglutamylation (GO:0018095),0.5864226981889551,1.2018014501452248,0.27060931899641577,0.6865077736381677,1.0,2/11,5.28%,TTLL7;TTLL5
prerank,protein localization to organelle (GO:0033365),-0.312308850712153,-1.2016757825450959,0.0794392523364486,0.6855430137717892,1.0,37/133,17.84%,ANK2;COL1A1;BMP7;BMP4;TULP3;LMNA;LAMP2;WDR35;GBF1;OBSL1;ARL3;ZNF423;SIX1;DCP1A;DDX1;IFT122;BICD1;STX5;EHD1;BBS9;ARL1;LRRK2;TOR1AIP1;RAB6A;EMD;TRAM2;AUP1;PAF1;DDX3X;DDRGK1;OPTN;SNX10;SEC61B;SIX4;VAMP2;TULP1;GET1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5620208299873655,1.2013531079242834,0.2667844522968198,0.6868674117236959,1.0,4/13,7.16%,CAV1;CALM1;PDE4D;SRI
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3883926526949673,1.2012771693498425,0.18611111111111112,0.68620758163028,1.0,25/114,15.92%,NFKBIA;TNFRSF25;TNFRSF11A;CD40;TMSB4X;IKBKB;ST18;ACTN4;AIM2;STAT1;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;ADAM17;EIF5A;PSMD8;TNFSF11;TNFRSF4;TNFSF12;PLVAP;PSMB10;EDARADD;PSMA8
prerank,negative regulation of catabolic process (GO:0009895),-0.3794672853519928,-1.2004762555771609,0.18122977346278318,0.687462804651284,1.0,10/47,13.67%,EGFR;NUPR1;HDAC4;MDM4;SNX12;PPARA;FLNA;AZIN1;IRAK3;SIRT2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4340022642875127,-1.2003750246705884,0.22137404580152673,0.6862537879240883,1.0,3/26,2.10%,EYA2;EYA1;EYA4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5337547983263092,1.2000935064045946,0.25,0.6886585484019812,1.0,8/16,27.42%,CAV1;INPP5F;ADIPOR1;HGS;SH2B3;SOCS1;PARP14;PPP2R1A
prerank,endocardial cushion morphogenesis (GO:0003203),0.524998361934487,1.2000462534728553,0.2605633802816901,0.6879231019936782,1.0,5/18,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,protein targeting to membrane (GO:0006612),0.3980449257932961,1.1990867134114087,0.2042857142857143,0.6897675968119694,1.0,25/83,19.69%,AQP11;ZDHHC14;PARD3;SEC62;PIKFYVE;ZDHHC9;ZDHHC20;ZDHHC19;SRP14;SGTB;RTP4;ZDHHC18;ZDHHC22;ABCD1;PEX14;GET3;SDCBP;NACAD;RTP3;ZDHHC21;PEX16;VPS37A;ABCD2;ACBD5;MYO1C
prerank,response to fatty acid (GO:0070542),-0.47601665126768866,-1.1989776382266055,0.22119815668202766,0.6888859918826389,1.0,2/17,2.42%,PID1;IRS1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.4851461764457589,-1.1983255969480378,0.23333333333333334,0.6893071165992772,1.0,7/15,19.26%,STXBP4;GLI1;KLHL18;CUL3;PAF1;DDRGK1;EZH2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.38100356861258655,1.197569862796015,0.18922470433639949,0.6931308249234919,1.0,32/119,17.20%,EFR3B;PIK3R6;ITPKB;INPP5D;PIK3R3;SOCS2;PIKFYVE;PIGU;PIP5K1C;OCRL;INPP5F;PLEKHA1;PIGM;MTMR6;PGAP4;PIGF;SOCS5;PIK3C3;PIK3C2A;RAB4A;PIP4K2A;PIK3CB;MTMR12;CDIPT;MTMR2;PIK3R5;DPM3;PLEKHA3;SYNJ1;TTC7B;INPP5E;INPPL1
prerank,positive regulation of programmed cell death (GO:0043068),0.34899068216562396,1.1974535290223398,0.12412993039443156,0.6925914331172214,1.0,37/272,8.96%,MCF2L;ITGA6;ARHGEF3;DAB2IP;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;NOS2;CTNNB1;RHOB;SOS1;CRADD;RNPS1;ARHGEF12;DNM2;IRF5;JMY;MARK4;JUN;ARHGEF5;PIDD1;PREX1;ARHGEF7;BNIP3L
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4903608005974544,1.1973184469099956,0.23777403035413153,0.692090081616623,1.0,6/26,10.36%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,negative regulation of programmed cell death (GO:0043069),0.34373046205102764,1.1971225544747766,0.11073825503355705,0.6917972214836601,1.0,43/355,10.83%,LEF1;IGF1R;MECOM;TFRC;TEK;RNF144B;TJP1;KDR;BCL2L1;FAS;NFKBIA;SH3RF1;FLT4;TBX3;PLAUR;PTK2;FOXO1;RPS6KA1;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;CAT;CD38;MRE11;ADAM10;MCL1;HCK;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;ARHGDIA;KLHL20;PDCD10;MGMT;THOC6;HSPB1;LRP2
prerank,neuron apoptotic process (GO:0051402),0.5088414068902062,1.1965190603955873,0.24548736462093862,0.6925753356714669,1.0,3/19,4.54%,APP;FAS;TNFRSF21
prerank,negative regulation of hydrolase activity (GO:0051346),0.4368324760650605,1.1953645075814534,0.23053892215568864,0.6948830296420488,1.0,11/49,13.03%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;CST7;TERF2;PLXNB3;HRAS;EGLN1;PPP1R35
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5724897597860096,1.1952297374672594,0.27155963302752295,0.6943725095983201,1.0,4/11,6.44%,FAS;PLAUR;ST18;LGALS9
prerank,fluid transport (GO:0042044),0.5683496368445695,1.194649494859923,0.27191413237924866,0.6951784740390857,1.0,2/12,4.59%,AQP11;AQP7
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4540278476884191,1.1946141917150883,0.235202492211838,0.6944202025198625,1.0,3/35,2.84%,FAR2;FASN;HMGCS2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.38248116544096217,-1.1944978509538273,0.1842818428184282,0.6989714111407435,1.0,6/44,5.81%,PRKAG2;CYP7B1;INSIG2;CYP27A1;PER2;ACOT8
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4510694798464152,1.1943799072888515,0.22345483359746435,0.6941893454293818,1.0,8/39,8.09%,PODXL;NOTCH4;RGCC;PTK2;NOTCH1;KLF4;NEXMIF;TGFB1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5223412177151994,1.1943527641454208,0.26791808873720135,0.6934066154062937,1.0,8/19,21.66%,TERF2;HNRNPC;ACD;DCP2;TERF1;EXOSC10;XRN1;PINX1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.47468421903582214,1.1943050601079106,0.2463295269168026,0.6926921319102242,1.0,5/30,15.03%,CD34;NOD2;LGALS9;SYK;INAVA
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.44554086023399014,-1.1929736586661766,0.2537313432835821,0.7018643624267519,1.0,5/22,8.92%,NOTCH2;FGFR2;CASK;STXBP4;SRSF6
prerank,regulation of cell differentiation (GO:0045595),0.3692080517252854,1.1927440139274146,0.16917293233082706,0.6960569069515066,1.0,20/148,9.60%,SPOCK2;SLC6A6;LTBP4;NOTCH4;FES;TBX1;BCL6B;PTK2;RPS6KA1;TIAM1;SMAD7;HSP90AB1;SNAI2;KLF4;INSM1;TGFB1;YWHAH;CDK5RAP2;GREM1;CEBPD
prerank,cognition (GO:0050890),0.4376852145725491,1.1924394494015913,0.24164133738601823,0.6959412412747783,1.0,7/42,10.22%,MFSD2A;SHROOM4;APP;GPR155;FAM107A;STRA6;CYFIP1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.531403945079576,1.1921494061493334,0.28146853146853146,0.6959205973255674,1.0,3/17,2.51%,CAV1;APOLD1;KLF7
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.49683387125108536,-1.1912541575302054,0.26048565121412803,0.7054414128142323,1.0,2/13,3.28%,AXL;IL18
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4227882520848993,1.19111081096282,0.21666666666666667,0.6980351861386308,1.0,23/59,23.35%,DAB2IP;NFKBIA;IKBKB;TLR3;TLR7;BIRC3;FAIM;IRAK2;SHARPIN;TLR8;BCL10;ERC1;CARD11;NKIRAS1;RELB;TBK1;RBCK1;AZI2;TICAM2;TBKBP1;PRDX4;TRAF6;RIPK1
prerank,glucan biosynthetic process (GO:0009250),0.5589051908085779,1.1910837467682809,0.30330882352941174,0.6964004591338607,1.0,4/12,16.05%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.5589051908085779,1.1910837467682809,0.30330882352941174,0.6964004591338607,1.0,4/12,16.05%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,regulation of peptide hormone secretion (GO:0090276),0.4067757431680634,1.1908364640790365,0.21745562130177515,0.6962019725742655,1.0,9/67,6.34%,SLC2A1;CACNA1A;STX1A;RAPGEF3;NOS2;KCNC2;SYT7;RAPGEF4;KCNG2
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.4670988621432784,-1.190727075523838,0.2376470588235294,0.705541515897722,1.0,9/18,30.18%,EHMT2;SETD7;SETD4;SETD2;EEF1AKMT2;SMYD2;SETMAR;KMT2A;SETD1B
prerank,positive regulation of inflammatory response (GO:0050729),0.39984507695103544,1.1904417558984994,0.2245762711864407,0.6965057298797462,1.0,13/86,12.73%,ETS1;PDE2A;APP;NFKBIA;OSMR;HYAL2;MGST2;TLR3;TLR7;CCL1;S100A8;IL15;DDT
prerank,vasoconstriction (GO:0042310),-0.5297595216537977,-1.190383187072237,0.2627906976744186,0.7050780495420512,1.0,3/11,9.85%,EDNRA;SLC8A1;ACTA2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4775303494496314,1.1899358779726044,0.25121555915721233,0.6970463241540308,1.0,6/29,11.00%,CXCL12;JAM2;CCR7;LGALS9;AGER;CCL1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3770993728001614,-1.1891985514162655,0.21052631578947367,0.7071590645245148,1.0,8/45,4.67%,BMP6;BMPR1A;BMP5;BMP7;BMP4;TGFBR1;TWSG1;DAB2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.538874451253631,-1.188975954141308,0.24312896405919662,0.7063210181849191,1.0,5/11,9.05%,WNT5B;RSPO3;DAB2;PLEKHA4;MLLT3
prerank,heterocycle biosynthetic process (GO:0018130),0.5420784130326171,1.1887418242876944,0.2824156305506217,0.6993689776951868,1.0,2/14,7.20%,GCH1;GPHN
prerank,glycogen catabolic process (GO:0005980),-0.47897491800803804,-1.1887121494707555,0.2638580931263858,0.7055504252264149,1.0,10/15,23.04%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,B cell receptor signaling pathway (GO:0050853),0.46654991663023493,1.1885514108429818,0.2545155993431856,0.6990839016511384,1.0,11/32,16.40%,MEF2C;CD19;CD38;PLEKHA1;CD79A;PRKCB;SYK;SH2B2;RFTN1;NCKAP1L;LAT2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.38250080748538096,-1.1884444760230741,0.23036649214659685,0.7048150079040991,1.0,15/43,12.61%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;RUNX2;CCN1;YAP1;CCN4;LRP3;FBN2;IFITM1;BMP2;NPNT
prerank,response to alcohol (GO:0097305),-0.42308319483826295,-1.1877871942122242,0.1918918918918919,0.705243466680382,1.0,3/27,3.86%,TGFBR3;SLIT2;TGFBR1
prerank,positive regulation of neuron projection development (GO:0010976),0.3931401347267041,1.1876133701763913,0.2134670487106017,0.700881841689814,1.0,19/85,10.12%,ITGA6;NDNF;DAB2IP;RAPGEF2;SCARF1;FES;LRP8;RAPGEF1;PRKD1;LYN;SNX3;FUT9;DBNL;RET;LRRC7;TWF2;PTN;SERPINI1;PTK6
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4577668869504963,-1.1874986150704374,0.24074074074074073,0.7045626048020184,1.0,8/19,16.85%,WNT4;BMP4;EMILIN1;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,regulation of glycolytic process (GO:0006110),-0.3524269714909892,-1.1870594347437964,0.17096774193548386,0.704346532408786,1.0,9/68,5.34%,IGF1;PRKAG2;ZBTB20;PRKAA2;NUPR1;HDAC4;OGT;SEH1L;PPARA
prerank,regulation of dendritic spine development (GO:0060998),0.499920877246815,1.187034282014874,0.27495621716287216,0.7016570620075585,1.0,3/19,6.87%,SHANK3;MEF2C;KIF1A
prerank,translation (GO:0006412),0.3544856487027141,1.186900331084926,0.1383495145631068,0.7011636257060544,1.0,96/208,28.90%,SARS1;SARS2;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPL27;RPSA;RPS7;RPL9;RPL18;RPLP2;GTPBP1;RPL13A;GARS1;RPS11;RPL8;RPS27;RPL19;MRPL57;RPS9;MRPL28;RPL11;EEFSEC;RPL22L1;RPS15;SRBD1;RPL37;GATC;RPS28;RPS10;EEF1D;RPS25;RPL37A;MRPS2;MRPL9;COPS5;RPL15;TNIP1;MRPL16;RWDD1;RPL17;MRPL23;RPL23;RPL34;FARSB;RPS18;APEH;RPL21;RPS4X;MRPS18A;RPL18A;DHPS;RPS21;RPL10A;GTPBP2;EEF1B2;CARS1;ABCE1;RSL24D1;RPL24;PTCD3;RPL7A;MRPL41;MRPL27;NARS1;IARS2;MRPL51;HARS1;RPL32;RPL4;RPS2;MRPS33;MRPL37;MRPL2;NDUFA7;RPS20;RPL6;RPS13;MRPS18C;RPS19;QRSL1;RPL14;VARS1;EEF1G;RPL26;MARS2;LARS2;MRPS34;MRPS12;RPS6
prerank,glutamate metabolic process (GO:0006536),-0.45255216606231674,-1.1862296168638955,0.2555831265508685,0.7054403421398803,1.0,11/19,22.68%,PRODH;OAT;ALDH18A1;GOT1;GCLC;GLUL;GLS;GLS2;GOT2;FPGS;MTHFS
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.451259497788007,-1.186072152787333,0.23648648648648649,0.7043686470778275,1.0,8/20,16.19%,HOXA5;CTR9;MEIS1;PTK2B;MAFB;PAF1;HOXA9;LDB1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.4016918085531033,1.1860118331958278,0.21075581395348839,0.7028075466130698,1.0,17/72,15.84%,KANK3;SHANK3;HIP1R;ARHGEF2;FGF13;SSH2;STMN1;TWF2;PFDN4;PFDN2;HSPA8;CYRIB;ATXN7;CDH5;SSH1;PFDN1;APC
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4949196368095854,-1.1859443996543793,0.2576419213973799,0.7032617186325588,1.0,2/14,5.56%,AUTS2;CTR9
prerank,negative regulation of signal transduction (GO:0009968),-0.2894802861813709,-1.1856495305644839,0.08695652173913043,0.7026759795945186,1.0,53/249,11.50%,PID1;TRABD2B;SULF1;LRP1;EGFR;LGR4;GLI3;ADAMTS12;DCN;IGFBP5;BMP5;DKK3;ENPP1;GPC3;KANK2;RNF43;CYP26B1;IRS1;TULP3;MMP14;APOD;KANK1;NOTCH3;SULF2;WWOX;THBS1;PRKCD;ARRB1;SUFU;FGF2;GLIS2;SFRP4;DACT1;MGRN1;EMILIN1;BCL2;IGFBP3;GRB10;TNS2;NXN;IFT122;CREB3L1;BEND6;VGLL4;PIP4K2C;QARS1;BTRC;NIBAN2;RPGRIP1L;LRRK2;IRAK3;CXXC4;WWP2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.46927781995600415,-1.1854875048029552,0.23160173160173161,0.701621179799413,1.0,3/16,7.73%,PDK1;RORA;PRKN
prerank,negative regulation of actin filament polymerization (GO:0030837),0.4938152747124039,1.1853885383613738,0.2815198618307427,0.7036855805128838,1.0,7/22,8.14%,KANK3;HIP1R;SSH2;VIL1;TMSB4X;TMSB10;TWF2
prerank,regulation of biomineral tissue development (GO:0070167),0.48116004176820176,1.185320418650759,0.2547332185886403,0.703035853503525,1.0,6/26,8.09%,SGMS2;NOS3;S1PR1;NOTCH1;NOTUM;TGFB1
prerank,gliogenesis (GO:0042063),0.5323115354335108,1.1849401988492712,0.2773722627737226,0.7032836129455671,1.0,4/15,10.01%,TGFB2;CDH2;MMP24;METRN
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.38802637325596,-1.1848230096819983,0.21052631578947367,0.7020075003178581,1.0,8/37,11.87%,PHLDB2;EPHA3;PRKAA2;EFNA5;PHLDB1;BICD1;MAP6;SKA2
prerank,protein export from nucleus (GO:0006611),-0.4228807507046987,-1.1845599645025022,0.20388349514563106,0.7013076361339585,1.0,7/27,16.48%,RANBP3L;PKD1;RANBP17;XPO5;XPO6;STRADA;XPO1
prerank,regulation of multicellular organism growth (GO:0040014),0.5387821306388181,1.1843777312135375,0.2792452830188679,0.7040246435922662,1.0,2/15,1.57%,MFSD2A;APP
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4467722923041432,-1.1842718365791576,0.24935064935064935,0.6992029924730315,1.0,7/20,12.03%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4467722923041432,-1.1842718365791576,0.24935064935064935,0.6992029924730315,1.0,7/20,12.03%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5654181788870577,1.184111108571386,0.30711610486891383,0.7038872263906248,1.0,3/11,15.78%,RTP4;LPO;RTP3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.2696455121757059,-1.1839299967008474,0.0,0.6987880385937235,1.0,126/572,16.57%,BMP6;FOXP2;PRDM6;FHL2;ZEB2;NR2F2;AEBP1;GLI3;RARB;GLI2;ZFHX3;GLIS3;SMAD3;FOXP4;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;FNIP1;NR6A1;THRB;FRK;HDAC4;CUX1;MXI1;PER3;WWOX;SALL1;IMPACT;NR1D2;ZHX2;FOXC2;DNMT3A;FOXC1;BCOR;KCNIP3;SUFU;RBPJ;HOXA7;DAB2;EHMT2;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;PPARA;CTR9;ZNF25;ZMYM5;BCL6;CBX7;IGF2;DACT1;ZEB1;ZNF568;LCOR;NFATC4;ATN1;CHD3;CHD8;PRKN;CBX5;MITF;YAP1;KDM2B;MED25;POU6F1;SMURF2;USP2;FOXO3;CXXC5;PCGF2;EZR;CEBPB;EZH1;GATA6;NR2F1;URI1;PARP1;ZNF148;CRY2;WWP2;KDM1A;RXRA;NFX1;ESR1;PSEN1;BMP2;ZNF219;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;ZNF3;ZBTB4;BAG3;SIRT2;USP9X;PAF1;PEX2;GZF1;IFI27;ZBTB1;EP300;CBX6;ZBTB7B;PHF12;MAP2K5;NFIB;MTA3;NFIL3;RUNX1;LDB1;LDB2;MDFI;ZFP37;NR1H4;JDP2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.46395369439209255,1.183812656954524,0.24440894568690097,0.7038257495618572,1.0,8/33,14.70%,ETS1;FES;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,heart trabecula morphogenesis (GO:0061384),0.5157283286983416,1.1833888023468206,0.27956989247311825,0.7041407939614404,1.0,6/18,5.01%,TEK;ENG;TGFB2;S1PR1;NOTCH1;DLL4
prerank,O-glycan processing (GO:0016266),0.4245548928136278,1.1832516880155692,0.23255813953488372,0.7036813409421017,1.0,6/54,4.22%,ST3GAL1;B4GALT5;ST6GALNAC2;MUC3B;MUC3A;B3GNT2
prerank,regulation of axonogenesis (GO:0050770),-0.36805766603102663,-1.1829519734323495,0.19318181818181818,0.700282590278314,1.0,13/51,14.09%,ROBO1;PLXNA2;TIAM2;SLIT2;SIPA1L1;KIF13B;NGF;PLXNB2;ROBO2;MAP6;CHN1;PTEN;BRSK1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.49978455082052886,1.182546311424067,0.2692307692307692,0.7048099273417189,1.0,6/22,12.02%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,positive regulation of translation (GO:0045727),-0.32793389628412983,-1.1822401285068098,0.15555555555555556,0.7009217891738946,1.0,39/94,29.51%,SAMD4A;PLD1;THBS1;PLXNB2;AGO2;YBX3;FXR2;MRPS27;RMND1;EIF3C;FMR1;HABP4;DDX3X;LARP6;YTHDF1;JMJD4;RPUSD4;C1QBP;RCC1L;USP16;RPS6KB1;FASTKD3;CIRBP;PIWIL2;FASTKD2;EIF4A3;BCL3;RPS27L;POLDIP3;ERBB2;CDC123;HNRNPD;LARP4;MPV17L2;RPUSD3;VIM;BOLL;DHX36;EIF5A2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.46705029473305737,1.1814452297383424,0.27099841521394613,0.7070390197353004,1.0,3/30,2.89%,CSGALNACT1;NDNF;CHST11
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4049196973941057,-1.181444053368712,0.2116991643454039,0.7018065569608803,1.0,15/35,22.39%,DDX5;PPARGC1B;AR;NR3C2;YAP1;UBR5;DDX17;ESR1;PGR;CALCOCO1;RNF14;ZMIZ1;ESR2;NEDD4;GPER1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4294583211675313,-1.18096490511278,0.2462686567164179,0.7017479129515504,1.0,5/25,13.00%,ITPR1;P2RX4;CDH13;LRRK2;CMKLR1
prerank,inorganic anion transport (GO:0015698),-0.36106703414893815,-1.1802969011389037,0.20426829268292682,0.7022370506178893,1.0,9/53,6.46%,SLC13A4;SLC4A10;ENPP1;SLC26A7;ANO6;CLCN2;ENPP3;SLC5A5;ANO1
prerank,synaptic vesicle recycling (GO:0036465),0.46957196949958213,1.1802231791899545,0.2576489533011272,0.7096749215179304,1.0,10/31,15.89%,STX1A;WNT7A;PIP5K1C;TBC1D24;SYT7;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,peptide biosynthetic process (GO:0043043),0.3617612667449584,1.180134214689381,0.1702127659574468,0.7090923934152895,1.0,64/153,26.75%,SARS1;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPL27;RPSA;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;MRPL28;RPL11;RPS15;SRBD1;RPL37;RPS28;RPS10;RPS25;RPL37A;MRPL9;COPS5;RPL15;TNIP1;RPL17;MRPL23;RPL23;RPL34;FARSB;RPS18;RPL21;RPS4X;MRPS18A;RPL18A;DHPS;RPS21;RPL10A;RSL24D1;RPL24;RPL7A;MRPL41;MRPL27;MRPL51;HARS1;RPL32;RPL4;RPS2;MRPS33;MRPL37;RPS20;RPL6;RPS13;MRPS18C
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5313158288468689,1.1797677776120385,0.2857142857142857,0.7092295844417074,1.0,7/16,14.67%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5064711642712398,-1.1793451720977288,0.29867256637168144,0.7035804513792874,1.0,2/12,7.33%,IL18;IL17D
prerank,fibrinolysis (GO:0042730),0.5294905322812502,1.1787127326376718,0.26373626373626374,0.7112313868823837,1.0,2/13,9.25%,PLAUR;PLAT
prerank,pancreas development (GO:0031016),0.5501653666130013,1.1780212839021456,0.27304347826086955,0.7122874080537581,1.0,2/12,4.36%,ZIC3;FOXF1
prerank,regulation of viral entry into host cell (GO:0046596),0.4660638360055438,1.1778874318124797,0.2649310872894334,0.7118467321489647,1.0,6/30,6.44%,LY6E;TRIM25;TRIM14;SNX3;CD4;LGALS9
prerank,lymphocyte differentiation (GO:0030098),0.4091765124177932,1.177860229988094,0.23760932944606414,0.7110701093067553,1.0,25/68,17.84%,JAG2;TPD52;PTPRJ;JAK3;HDAC9;ZAP70;HHEX;DLL4;SLC25A5;CD4;CD79A;KLF6;ADAM17;GPR89A;GPR89B;ZBTB7A;TOX;VCAM1;HDAC5;IKZF1;DNAJB9;MSH2;ITGA4;RELB;ADGRG3
prerank,ion homeostasis (GO:0050801),-0.4024731479984346,-1.1776282558726643,0.23684210526315788,0.7070871319757192,1.0,8/30,15.37%,SLC4A10;FHL1;WNK4;CAMK2D;SLC4A7;SLC4A2;WNK1;SLC4A3
prerank,small GTPase mediated signal transduction (GO:0007264),0.3818367570290694,1.1775775235670738,0.215633423180593,0.7109961693969876,1.0,24/103,13.29%,RASGRP3;ARHGAP31;RAPGEF2;NTN1;GRAP;TIAM1;PRKD1;ABR;GRB2;RREB1;CCDC88A;SOS1;RASGRP2;RALB;RGL2;JUN;SHC3;RAC1;HRAS;RAPGEF5;TNK2;GNB1;RIN2;SETDB1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5133880306590095,-1.1775454390505418,0.27631578947368424,0.7058485534192784,1.0,6/12,33.09%,UCK2;UPP2;UMPS;UCK1;UCKL1;DCK
prerank,monosaccharide transmembrane transport (GO:0015749),-0.472946437452804,-1.17661236645452,0.27571115973741794,0.7070870142731873,1.0,4/16,14.36%,SLC2A12;SLC5A3;SLC45A3;SLC2A10
prerank,protein autoubiquitination (GO:0051865),-0.3512818963068997,-1.1763637609815065,0.18604651162790697,0.706332754502823,1.0,12/61,11.84%,RNF220;SH3RF3;AMFR;SH3RF2;PRKN;LRSAM1;DDB2;CUL3;RNF10;WWP2;RNF181;NFX1
prerank,negative regulation of receptor internalization (GO:0002091),0.5492678141847017,1.176281295570065,0.2921146953405018,0.7137392421204994,1.0,5/12,19.35%,ANKRD13A;RIN3;SDCBP;MTMR2;LRPAP1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3911486799852945,1.1762017308568804,0.21978021978021978,0.7131502244140338,1.0,16/85,8.18%,SGPP2;TIE1;AQP11;DAB2IP;TGFB2;TBX1;MCC;B2M;MTSS1;ACVRL1;NOD2;PRKD1;FGF16;CDKN2B;TGFB1;TGFA
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5325187022978165,1.176137924498308,0.27240773286467485,0.7124907294731853,1.0,8/15,18.73%,KCNQ1;ATP1A1;KCNH2;KCNN2;KCNJ3;KCNJ5;KCNA5;KCNIP2
prerank,regulation of histone modification (GO:0031056),-0.4977295966808924,-1.175937331949726,0.2743362831858407,0.7061445723834422,1.0,7/13,18.58%,IGF2;AKAP8L;MTHFR;NNMT;SETD5;MYOCD;FLCN
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.45701149783825934,1.1752440947795213,0.2686084142394822,0.7141706375385659,1.0,12/32,14.34%,PPP1R16B;ITGA1;CALM1;HSP90AB1;PPIA;PPP2R5A;PIN1;TGFB1;AGTR2;NSMF;CDH5;PPP1R15B
prerank,cGMP metabolic process (GO:0046068),0.5485919390653564,1.17507486229917,0.27726432532347506,0.7137994967404923,1.0,4/12,13.27%,PDE2A;NPPA;NPR1;NPR2
prerank,cation transmembrane transport (GO:0098655),0.43245429536430335,1.174946293758367,0.264750378214826,0.7133301609566298,1.0,4/44,1.98%,SLC7A5;SLC7A1;SLC6A5;SLC38A5
prerank,dicarboxylic acid transport (GO:0006835),-0.40684114091438983,-1.174704761341095,0.2204724409448819,0.7082809538503577,1.0,6/28,4.51%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,positive regulation of leukocyte migration (GO:0002687),0.46137104269735535,1.1746954149410227,0.2629032258064516,0.7131456773386303,1.0,5/27,14.70%,IL6R;PTN;ADAM17;PLVAP;NCKAP1L
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5405185861291646,-1.1741096001185072,0.2930648769574944,0.7086602649749575,1.0,4/10,10.30%,GFPT1;PFKP;HK2;GFPT2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4484783094156973,1.1734591097129614,0.2747603833865815,0.7158231436862947,1.0,7/35,12.18%,HIP1;HIP1R;B2M;MKLN1;RAC1;PIK3CB;TNK2
prerank,tetrapyrrole metabolic process (GO:0033013),0.5113094557872103,1.1732040186591113,0.27860696517412936,0.7157003923281379,1.0,8/18,24.20%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.39354435941276633,1.1729797722108972,0.21852387843704776,0.7154638797319178,1.0,16/75,12.15%,DAB2IP;RASIP1;HEG1;STK38;PTPRJ;DUSP7;MEN1;PKIG;LYN;HHEX;HYAL2;PRKAR2B;LRP5;PRKAR2A;DUSP1;PIK3CB
prerank,regulation of AMPA receptor activity (GO:2000311),0.48029437353774723,1.1728916339701303,0.27240773286467485,0.7148861746298991,1.0,6/25,15.74%,SHANK3;MEF2C;SHISA6;CNIH3;MINK1;NLGN1
prerank,cellular glucose homeostasis (GO:0001678),0.43185792166168246,1.17269704039956,0.2549618320610687,0.7145942781977511,1.0,3/41,2.99%,IGF1R;UNC13B;FOXO1
prerank,microvillus assembly (GO:0030033),0.52962146697362,1.172665233096444,0.29895104895104896,0.7138307100206476,1.0,5/14,14.58%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,determination of bilateral symmetry (GO:0009855),0.4802130272611207,1.1724332556514065,0.27347611202635913,0.7136258659432112,1.0,6/24,15.27%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DNAH5
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3015753217570653,-1.172410005537606,0.10900473933649289,0.7119760054300545,1.0,35/173,15.17%,ANK2;CD55;SEC24D;CAPZB;SEC24A;GBF1;USO1;GOLGB1;COPA;NRBP2;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;GOLGA2;ERGIC3;SAR1A;SEC31A;TRAPPC3;SEC16B;STX5;COG4;CUL3;SEC23A;DYNC1I1;GOLT1A;ERGIC1;RAB29;SCFD1;SEC16A;LMAN1;CTSZ;COPB2;DCTN6
prerank,lymphocyte migration (GO:0072676),0.45453322890898434,1.1724019897031026,0.2766990291262136,0.7128675718912235,1.0,5/32,11.00%,S1PR1;ZAP70;RET;MSN;CCL1
prerank,regulation of mast cell degranulation (GO:0043304),0.5266123519657583,1.1723914709446095,0.30714285714285716,0.7120638571583418,1.0,5/14,11.86%,FES;LYN;LGALS9;UNC13D;SYK
prerank,negative regulation of gene expression (GO:0010629),0.34021155396130087,1.1721450746782158,0.13610149942329874,0.7118688553567393,1.0,58/302,13.44%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;NANOS3;APP;XDH;RGCC;MEF2C;SRGN;ACVRL1;APLNR;NOTCH1;YBX1;HDAC9;NANOS2;NOS2;GATA2;NOCT;DLL4;ENC1;MRPL13;DIP2A;NANOS1;RPS6KA5;ATP2B1;ADAM10;FBXW7;LGALS9;KLF4;PTBP3;N4BP1;HINFP;TGFB1;TERF2;FOXP3;NDFIP2;KDM4A;PPP1R11;RPL13A;CNOT9;GRB7;PTRH2;PDCD10;TASOR;DCP2;HRAS;HIF1A;BTG2;DXO;SOX11;HELLS;SETDB1;PAIP2
prerank,ion transport (GO:0006811),-0.3150186176644844,-1.1716916582083907,0.1282051282051282,0.7126984658745071,1.0,21/111,9.09%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC26A7;SLC26A2;SLC8A3;SLC12A2;ANO6;WNK4;SLC9A2;SLC5A5;SLC8B1;SLC12A7;ANO1;SLC8A1;SLC20A2;TRPC6;SLC4A2;SLC9A9;GLRB
prerank,mucosal immune response (GO:0002385),0.5283728417177777,1.1713711349260896,0.29422066549912435,0.7131843507673179,1.0,2/15,4.51%,DEFA6;NOS2
prerank,organelle disassembly (GO:1903008),-0.39212182335035894,-1.1712319006377463,0.24812030075187969,0.712625063842364,1.0,10/33,14.77%,GBF1;ULK2;ATG2B;MCTS1;GOLGA2;TEX264;STX5;PLK5;DDRGK1;UFC1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5375449904994001,1.171097264147929,0.30727272727272725,0.7130743190661355,1.0,7/13,22.00%,ATF6B;ABCA7;PPP1R15B;DNAJB9;NCK1;BFAR;RACK1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.36753744133289934,-1.1709104783373108,0.19373219373219372,0.7121154451785846,1.0,16/48,18.49%,EGFR;MDM4;SNX12;FLOT2;FLNA;PFDN5;APOE;LDLR;ITGAV;AZIN1;IRAK3;SIRT2;CRYAB;INHBB;ITGB3;MAD2L1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5713101099845685,1.1707543062860246,0.32653061224489793,0.7131277609591326,1.0,3/10,7.45%,CD40;LYN;BTLA
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4793923698281075,1.1703362021770647,0.3034825870646766,0.7134789884215251,1.0,4/23,9.22%,DAB2IP;TNFRSF11A;ARHGEF5;PAK1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.35505253193988856,-1.1701105874207385,0.1787709497206704,0.7129963389212032,1.0,18/52,24.25%,CELF2;DDX5;FXR2;SRRM4;NOVA1;SRSF6;DDX17;RBM5;FMR1;NSRP1;RBFOX1;SAP18;TRA2B;MBNL2;ZC3H10;RBM24;KHDRBS3;CELF6
prerank,positive regulation of reproductive process (GO:2000243),0.4421849242888534,1.1700454196890202,0.2619047619047619,0.7134299164998028,1.0,2/31,1.70%,PLCB1;LHFPL2
prerank,pulmonary valve morphogenesis (GO:0003184),-0.467995837032205,-1.1697866142472697,0.2819277108433735,0.7124880319218948,1.0,7/17,7.70%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.49300201231831997,-1.169557811598052,0.2946058091286307,0.7117559288280076,1.0,7/13,24.33%,IRS1;IGF2;SNX5;ECHDC3;ZBTB7B;PRKCZ;C1QTNF12
prerank,negative regulation of cellular component organization (GO:0051129),-0.33192523038983746,-1.1694950726908169,0.15432098765432098,0.7104870172070061,1.0,19/74,17.67%,BMP6;EPHA3;CARMIL1;IMPACT;AR;FAP;LRSAM1;RTEL1;IRAK3;TMEFF2;XRCC5;SCAMP5;DDX3X;SNX33;EP300;CRYAB;NR1H4;DNAJB2;PACSIN3
prerank,phosphate ion homeostasis (GO:0055062),-0.527949660979744,-1.1692443572918279,0.28016359918200406,0.7097895107228529,1.0,2/10,6.33%,ENPP1;SFRP4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.48574905555735587,1.1692301640741403,0.2687813021702838,0.7149197182989646,1.0,3/24,5.99%,BCL2L1;CXCL12;SNAI2
prerank,positive regulation of chemotaxis (GO:0050921),0.42844029235672393,1.1691373886003797,0.25,0.714325600015639,1.0,11/43,10.75%,PDGFB;KDR;IL6R;STX3;PRKD1;PRKD2;TMSB4X;TGFB1;PTN;ADAM17;HSPB1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3803907003757068,-1.1688291702104732,0.22972972972972974,0.7095457533119238,1.0,7/39,9.51%,STEAP3;ABCA1;TANGO2;RCN3;ARFGAP3;TANGO6;CANX
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5238301406465705,1.1684382824149606,0.2751798561151079,0.7145699618207872,1.0,3/15,5.88%,NANOS3;NANOS2;NANOS1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5238301406465705,1.1684382824149606,0.2751798561151079,0.7145699618207872,1.0,3/15,5.88%,NANOS3;NANOS2;NANOS1
prerank,regulation of microtubule-based process (GO:0032886),-0.3917411952482196,-1.167870986126421,0.20520231213872833,0.7109577203311904,1.0,11/36,14.87%,PHLDB2;EPHA3;PRKAA2;EFNA5;DIAPH1;ATF5;PHLDB1;BICD1;MAP6;MEMO1;KLHL42
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3497387232387549,1.1678121173499731,0.17888198757763976,0.7154482414151803,1.0,46/190,14.19%,BCL2L1;DAB2IP;PDE2A;SH3BP4;XDH;CAV1;PHLPP1;PLAUR;PTPRJ;TNFAIP8L1;APLNR;PIK3IP1;CD2AP;HDAC7;DUSP3;LYN;TMSB4X;PDE4D;HYAL2;PLEKHA1;ARHGAP25;RFFL;MCL1;STAT1;MARK3;ABCA7;P2RX7;ZMYND11;OTUD7A;DEPDC5;DDIT4;CASP8;DUSP1;ADIPOR1;GSK3A;TLE1;PIK3CB;CYRIB;WWC1;TMEM127;CYLD;TRIM39;TNFAIP3;PDE3B;PDCD6;EPM2A
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.43172330547986576,1.167204395645281,0.2578616352201258,0.7162593496251779,1.0,2/42,2.24%,POLK;TRIM25
prerank,B cell mediated immunity (GO:0019724),0.5613108964822762,1.1667052151342934,0.31153846153846154,0.7168675522167316,1.0,3/10,15.56%,CD19;TLR8;MSH2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3999651594849901,-1.1666217773787186,0.22994652406417113,0.7131779904918243,1.0,7/31,4.56%,TGFBR3;BMPR1A;FGFR2;ZFPM2;TPM1;TGFBR1;RBPJ
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.42772210432012575,-1.1665568261718662,0.24210526315789474,0.711924776451744,1.0,4/23,7.57%,NUPR1;HDAC4;PPARA;C1QTNF3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5693460752572448,1.1662275412613827,0.32879377431906615,0.7173327463464372,1.0,3/10,9.89%,FBXW7;TGFA;ADAM17
prerank,neuromuscular process (GO:0050905),0.5295927542423468,1.1659868197063208,0.30742049469964666,0.7171557062007046,1.0,3/16,10.09%,GCH1;NRXN1;STRA6
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.408157307535815,-1.1659176011582861,0.2594458438287154,0.7123077392181545,1.0,9/28,9.88%,PID1;APPL2;ENPP1;IRS1;KANK1;PRKCD;GRB10;TNS2;PIP4K2C
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4270634057458197,1.165750880115492,0.2465753424657534,0.7169535927569402,1.0,15/45,18.79%,TRIM25;B2M;SP100;IRF2;IRF9;STAT1;HCK;IRF5;OASL;MID1;CAMK2B;VCAM1;TRIM26;TRIM68;CAMK2G
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5825754134237078,1.165391935452878,0.3346456692913386,0.7171313673038469,1.0,2/10,5.97%,RNF125;SEC14L1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.4885440534693516,1.165244499364765,0.2879581151832461,0.7167321583865155,1.0,4/21,6.47%,DAB2IP;TGFB2;CD2AP;ARHGAP25
prerank,inner ear morphogenesis (GO:0042472),-0.4314163959451812,-1.165015115402694,0.26634382566585957,0.7133949453130918,1.0,6/22,7.23%,ZIC1;FGFR2;SIX1;TBX18;TTC39C;EPHB2
prerank,regulation of gluconeogenesis (GO:0006111),-0.4106554308269902,-1.1649667997556103,0.24278846153846154,0.7121195739898705,1.0,5/27,8.84%,OGT;PPARGC1A;C1QTNF3;SELENOS;NNMT
prerank,synaptic vesicle exocytosis (GO:0016079),0.43655130407373915,1.1649143316106332,0.24132492113564669,0.7168012900421403,1.0,9/40,13.19%,UNC13B;STX3;STX1A;PIP5K1C;SYT7;DNAJC5;STX19;SNAP29;CPLX1
prerank,regulation of innate immune response (GO:0045088),0.41332947862319,1.16487329484482,0.2485207100591716,0.7160863370592723,1.0,12/57,11.38%,TIRAP;LRP8;IFNAR2;GBP5;SAMHD1;HSP90AB1;XIAP;N4BP1;BIRC3;CASP8;TLR8;USP18
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5281980525137897,1.1646744517720824,0.28835489833641403,0.7158278622192211,1.0,7/13,22.39%,SVIP;DERL2;EDEM1;UBAC2;UBE2G2;BRSK2;UBE2J1
prerank,positive regulation of behavior (GO:0048520),0.5745834779480461,1.164068460687006,0.2980251346499102,0.7166580772528441,1.0,3/10,15.74%,MEF2C;STRA6;NLGN1
prerank,axoneme assembly (GO:0035082),0.4675433609523108,1.1637377273203773,0.26570048309178745,0.7167281280263111,1.0,10/30,17.66%,RP1;TTLL3;DRC1;RSPH4A;DCX;DNAAF2;RSPH1;FOXJ1;DNAAF3;TTC12
prerank,response to chemokine (GO:1990868),0.5326319529833421,1.1635085404843455,0.2787193973634652,0.7165558751325594,1.0,2/13,1.41%,LRCH1;CXCL12
prerank,mitochondrion localization (GO:0051646),-0.4531690452568309,-1.1629622945050633,0.2617283950617284,0.7166477928625147,1.0,10/19,28.49%,TRAK1;MARK1;LRRK2;MFN2;MUL1;TLE6;HAP1;MFN1;MARK2;ATCAY
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4232690287640831,1.1628900797531612,0.27134146341463417,0.7173400317002686,1.0,12/46,18.70%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4136971162581555,-1.1627737557811204,0.2656641604010025,0.7157915953618087,1.0,5/26,5.39%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,regulation of viral genome replication (GO:0045069),0.4146373906840169,1.1624881807157295,0.2529585798816568,0.7176552503237394,1.0,17/56,18.09%,IFIH1;FKBP6;ADAR;BTBD17;PPIA;PKN2;N4BP1;BST2;BANF1;OASL;PDE12;NR5A2;SLPI;ZC3HAV1;RAD23A;PROX1;TNIP1
prerank,cell proliferation in forebrain (GO:0021846),-0.5322859161796344,-1.162396208025323,0.27882599580712786,0.715544195070787,1.0,4/10,13.88%,DOCK7;NUMBL;PCM1;AKNA
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4487170731472601,1.1623860570863636,0.2734375,0.7171005327312169,1.0,5/35,5.17%,CAV1;JAK3;NOTCH1;IL10RB;PIGU
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3503284691272864,1.1619356380161194,0.18482252141982863,0.7175352647113901,1.0,36/208,11.88%,TFRC;DAB2IP;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TNFSF10;TRIM14;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;LGALS9;STAT1;BST2;BIRC3;PIDD1;MALT1;MAP3K3;NDFIP2;ZMYND11;UBE2V1;OTUD7A;SHARPIN;CASP8;BRD4;HSPB1;LAMTOR5;PRKCB;GPR89A;TLE1
prerank,regulation of myoblast fusion (GO:1901739),-0.5156543212199164,-1.1619045870301377,0.2832980972515856,0.7155448652040417,1.0,4/11,16.13%,RIPOR2;EHD1;MAPK14;EHD2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5652992534320022,1.1616173105027117,0.3014705882352941,0.7176323811168694,1.0,6/10,17.33%,CORO2B;SNX3;NDFIP2;TERF1;DNAJA1;PPM1F
prerank,cardiac cell development (GO:0055006),-0.5143624013268369,-1.1614990846476483,0.29555555555555557,0.7153490146011862,1.0,4/11,7.89%,CXADR;SLC8A1;JAG1;MYH11
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.448127611923659,-1.1613934031401625,0.25986078886310904,0.7142194170609596,1.0,6/20,6.33%,GSN;PLA2R1;THBS1;ANO6;PRKCI;SFRP4
prerank,epidermis development (GO:0008544),-0.35267509179064577,-1.1601507766547863,0.23867069486404835,0.7163298556743647,1.0,11/56,13.22%,SVEP1;CCN2;FGFR2;EMP1;FLOT2;CRABP2;GLI1;GATA6;PTHLH;SCEL;LAMC2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5214965670672627,1.159417587238946,0.30036630036630035,0.7229099047588542,1.0,3/15,11.38%,NLRC5;SAMHD1;USP18
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3375165521284392,-1.1592858918356086,0.18983050847457628,0.717409248619609,1.0,21/73,11.96%,ITGBL1;COL3A1;PLPP3;FBLN1;ITGB5;ITGB8;ITGA10;TEC;ADAM9;ITGA11;DAB2;COL16A1;ITGA5;FYB1;ITGB4;CUL3;ITGB1BP1;ITGAV;PTK2B;ADAMTS1;ABL1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3208270121751943,-1.1584423558610453,0.175,0.7185475170457774,1.0,26/95,14.57%,TGFBR3;ZEB2;LDLRAD4;SMAD3;DKK3;SMAD6;HTRA3;THBS1;SNX6;TGFBR1;DAB2;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;SMURF2;PDPK1;SPRED1;STK11;VASN;SKI;GIPC1;HTRA4;SLC2A10;EP300
prerank,postreplication repair (GO:0006301),0.4229587402001724,1.1580076114531759,0.2581143740340031,0.7259621763000579,1.0,5/45,9.77%,POLK;TRIM25;UBE2V2;USP43;UBE2V1
prerank,positive regulation of response to stimulus (GO:0048584),0.42728634497729323,1.1575109349412667,0.27472527472527475,0.7264771180346581,1.0,10/40,16.60%,TGFB2;B2M;IFIH1;HOMER1;HMGA1;ABI3;IL15;NSMCE4A;HMGA2;CDKN2AIP
prerank,protein localization to vacuole (GO:0072665),0.5390178492605187,1.1570224284522397,0.33756805807622503,0.7270772409453767,1.0,5/13,15.55%,SH3BP4;LAMTOR5;SH3GLB1;LMBRD1;LAMTOR4
prerank,mammary gland development (GO:0030879),0.4904920587845874,1.1565364828148839,0.30398671096345514,0.7276011254321779,1.0,4/21,5.76%,NOTCH4;CAV1;TBX3;OXTR
prerank,vesicle coating (GO:0006901),-0.3464307165754923,-1.1560913525876626,0.22418879056047197,0.7211129295424247,1.0,15/61,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3464307165754923,-1.1560913525876626,0.22418879056047197,0.7211129295424247,1.0,15/61,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,COPII vesicle coating (GO:0048208),-0.3464307165754923,-1.1560913525876626,0.22418879056047197,0.7211129295424247,1.0,15/61,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.4217601289136833,-1.1560775682120181,0.2677725118483412,0.7197522700067572,1.0,7/25,6.63%,SULF1;BMPR1A;FOXD1;BMP4;RBPJ;ZNF423;CCN1
prerank,regulation of actin filament polymerization (GO:0030833),0.3931066916644884,1.155512423718444,0.24597364568081992,0.729680090297029,1.0,13/69,8.14%,KANK3;ESAM;HIP1R;EVL;SSH2;VIL1;CCR7;CDC42EP3;BAIAP2;DBNL;NCKAP1;HCK;TWF2
prerank,lymphocyte chemotaxis (GO:0048247),-0.3874731842181551,-1.155407922000996,0.24866310160427807,0.7203146487261863,1.0,15/34,33.66%,CYP7B1;SLC12A2;CXCL16;CCL13;CKLF;ADAM8;PIK3CD;CCL19;CCL2;CXCL10;CCL15;CX3CL1;CCL5;GPR183;CCL11
prerank,ventricular septum morphogenesis (GO:0060412),-0.4188476981521969,-1.155350668665771,0.24083769633507854,0.7190817003415072,1.0,8/27,6.34%,ROBO1;TGFBR3;BMPR1A;BMP4;ZFPM2;SLIT2;TGFBR1;HEYL
prerank,neurotrophin signaling pathway (GO:0038179),0.4839348176068388,1.1553006578729996,0.295,0.7294186721544245,1.0,6/21,10.22%,RAPGEF2;RAPGEF1;GRB2;SORT1;SOS1;DDIT4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3347811674601708,1.1552998203108251,0.17777777777777778,0.7286048101612997,1.0,47/259,13.59%,DNM3;ABCC4;FGD5;PARVB;ABLIM1;SRGAP2;RAPGEF2;FNBP1L;NTN1;EXOC6;S1PR1;SPATA13;MTSS1;NOTCH1;CD2AP;CNGA2;CEP83;PPP1R9B;POC1B;CDC14A;CFAP52;OCRL;CCDC88A;DYNLL1;RAB11A;RAP1B;TTLL3;ARHGEF7;P2RX7;OPHN1;FGD6;DISC1;CYFIP1;KIF3B;EHD4;CFAP54;EXOC4;EXOC2;RAC1;MAP4K4;SNAP29;RAB1A;FGD2;BBIP1;SDCBP;MINK1;FSCN1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.31138493198790806,-1.1552420790303053,0.16279069767441862,0.7180194525665351,1.0,16/112,4.40%,COL1A2;COL3A1;SOX5;TGFBR3;BMPR1A;APPL2;WNT4;SMAD3;PDE3A;ITGB5;SMAD6;WWOX;CLEC3B;TGFBR1;TWSG1;ADAM9
prerank,cellular response to organic substance (GO:0071310),0.36671490099509685,1.155212449149111,0.21921515561569688,0.7280198293889881,1.0,19/116,8.14%,LEF1;SLC1A1;PDGFB;BMPR2;NCOA1;PTPN12;ACVRL1;SIGIRR;RAMP2;SOCS2;CTNNB1;RAMP3;CYP11B1;CCR7;KLF4;NCOA2;CRNN;TGFB1;TWF2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5625980903985115,1.1548683003737763,0.32007575757575757,0.7281256145225782,1.0,4/10,14.06%,ACER2;SNAI2;NEXMIF;PDE3B
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.42307172856352,1.1548364544907823,0.271889400921659,0.7274015754192107,1.0,11/45,17.80%,NANOS3;APP;NANOS1;TDRD7;CYFIP1;EIF4E;PUM3;ZC3H7A;GCNT2;ATG14;TRIM71
prerank,chromosome condensation (GO:0030261),0.435214700305728,1.154526709145061,0.27768860353130015,0.7274278736939029,1.0,10/36,18.75%,TENT4A;NCAPH;MCPH1;DFFB;NCAPG;BANF1;CSNK2B;TTN;NCAPH2;SET
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4462301487568495,-1.1543907714923716,0.2575107296137339,0.7190035479605231,1.0,11/19,33.48%,GFPT1;RENBP;GFPT2;SLC35D1;PGM3;NAGK;UAP1;UAP1L1;GNPDA1;PMM1;GMPPB
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.44792454465453196,1.154205098584611,0.270935960591133,0.7275227174021781,1.0,10/33,16.30%,PTPRJ;PRKD2;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1;BCL10;CARD11;TESPA1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4192478809887292,-1.153932341987192,0.25316455696202533,0.718892367688996,1.0,7/24,7.46%,COL5A1;PDPN;ARHGAP24;DDR1;FLNA;CCN1;ITGA5
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5527671783093215,1.1531600367575863,0.3383177570093458,0.7295439909222334,1.0,2/11,8.30%,ITM2A;ABCA7
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.523768310281114,-1.1530630386568694,0.3264367816091954,0.7198841562783134,1.0,4/11,7.70%,BMPR1A;BMP4;ZFPM2;JAG1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.39486769212397477,1.1529646312112172,0.2503681885125184,0.7292861643902981,1.0,13/75,8.64%,MFSD2A;APP;KLF7;MEF2C;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;SLITRK1;OPHN1
prerank,establishment of protein localization to membrane (GO:0090150),0.3988591000047347,1.152592768458446,0.2518740629685157,0.7295355635152588,1.0,19/66,16.37%,AQP11;REEP1;ZDHHC14;PARD3;PIKFYVE;ZDHHC9;ZDHHC20;RAB11A;GRIN3B;ZDHHC19;RTP4;NPC1;ZDHHC18;ZDHHC22;SDCBP;NACAD;RFTN1;RTP3;ZDHHC21
prerank,regulation of insulin secretion (GO:0050796),-0.31174891764749296,-1.1525715795737606,0.16296296296296298,0.7198540656296193,1.0,22/101,11.28%,CACNA1C;ADCY5;ITPR1;MCU;IRS1;EFNA5;NLGN2;RBP4;PER2;STXBP4;IRS2;SLC8B1;NNAT;PRKN;CACNA1D;CCN3;DPP4;CDK16;PRKCA;ITPR2;AACS;PPP3CB
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4546124031428622,1.1520125499924414,0.31209150326797386,0.7302737098661564,1.0,10/31,15.74%,SHANK3;LRP8;EPHA4;DBNL;KIF1A;EFNA1;ABI3;CFL1;CAMK2B;NLGN1
prerank,response to cholesterol (GO:0070723),-0.4545461938016634,-1.1519803085268552,0.2937062937062937,0.7201136189440707,1.0,10/17,26.79%,SMO;TGFBR1;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1;MLC1;PMVK;SMAD2
prerank,positive regulation of nuclear division (GO:0051785),0.4747536124948356,1.1514539846463034,0.29609929078014185,0.7310337121969006,1.0,6/25,8.59%,PDGFB;INSR;RGCC;NPM2;TGFA;LRP5
prerank,muscle cell migration (GO:0014812),-0.5273596091047197,-1.1512158174994864,0.2956521739130435,0.7210396333948066,1.0,4/10,10.01%,DDR1;SIX1;CCN3;ITGB1BP1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5040943544344031,1.1508625318449732,0.3006993006993007,0.7317808647619284,1.0,5/18,9.89%,MTUS1;IL6R;LYN;PTN;ADAM17
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4548442986140332,1.1506562026706377,0.28431372549019607,0.7315275731807745,1.0,6/29,7.79%,MFSD2A;SCARB1;CREB1;NR1H2;SORBS1;ELOVL5
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3962760578578478,1.150595812924231,0.2591549295774648,0.7308846788192701,1.0,13/69,12.73%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;C1QTNF4;DDT
prerank,histone H3-K36 demethylation (GO:0070544),-0.522730557496078,-1.14945849930316,0.29774127310061604,0.7247236234611594,1.0,5/10,16.92%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,regulation of phagocytosis (GO:0050764),0.4060189194973352,1.1491557738328588,0.2661654135338346,0.7339601236877646,1.0,14/53,17.30%,DYSF;SCARB1;MERTK;TGM2;SNX3;GATA2;SYT7;HCK;ABCA7;SYK;IL15;GAS6;DOCK2;LYAR
prerank,regulation of cell morphogenesis (GO:0022604),0.45503383383455565,1.14901691023026,0.2681744749596123,0.7335172945151864,1.0,7/30,11.20%,MFSD2A;MACF1;NTNG2;VIL1;STRIP1;FERMT2;PDZD8
prerank,transcription preinitiation complex assembly (GO:0070897),0.5434863803752134,1.1487987730376013,0.32620320855614976,0.7333043187451841,1.0,9/12,34.01%,TAF1B;TAF7L;GTF2B;BDP1;GTF2A2;TAF7;DR1;TAF11;TAF12
prerank,COPII-coated vesicle budding (GO:0090114),-0.3434871191839951,-1.1487687336015464,0.21710526315789475,0.725366230794525,1.0,16/68,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SAR1A;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,sphingosine metabolic process (GO:0006670),0.5052947738412679,1.1487094068446313,0.31864406779661014,0.7327688420475259,1.0,4/17,6.96%,SGPP2;ACER2;ACER1;SPTLC2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.482221545716068,1.1481907545547958,0.30313588850174217,0.7333553733811424,1.0,5/20,8.57%,ENTPD1;APP;HSP90AB1;ENTPD5;P2RX7
prerank,nervous system development (GO:0007399),0.3250474102459451,1.148077324613565,0.1588683351468988,0.7328664170547952,1.0,68/429,12.79%,SPOCK2;ST8SIA4;MPZ;DNM3;SLC2A1;SHANK3;SEMA6A;ZIC3;ADGRL3;MAL;PCDH1;TBX3;SEMA6B;NAV1;NES;MEF2C;PLXND1;KALRN;FGF13;CDH2;DSCAML1;EVL;MERTK;ZBTB16;PCDHA11;MOG;PCDHAC1;WWTR1;SEMA4F;ATXN3;DBNL;NCKAP1;STMN3;FAT4;DCHS1;PCDHA1;NAV2;MARK4;NFASC;DPYSL2;TGFB1;SLITRK1;GPM6A;PTN;CDK5RAP2;OPHN1;APBA2;NRXN1;SPOCK1;CAPG;DNER;SERPINI1;RITA1;DCX;THOC6;EIF2B2;VXN;CHRM3;MOBP;PCDHB12;RAPGEF5;RBM45;HMGCR;SOX10;EPHB1;PCDHB14;CPNE6;FEZ2
prerank,positive regulation of axonogenesis (GO:0050772),0.4375504339199461,1.1478731598393344,0.2929936305732484,0.7326362779834902,1.0,11/43,11.16%,SEMA7A;MACF1;NTN1;PLXND1;TIAM1;DBNL;SLITRK1;TWF2;ARHGDIA;METRN;PLXNB3
prerank,ketone body metabolic process (GO:1902224),-0.510109023459807,-1.147783754188511,0.286697247706422,0.7267572004178481,1.0,6/10,15.68%,OXCT1;ACSS3;BDH2;AACS;BDH1;HMGCLL1
prerank,cellular response to interleukin-12 (GO:0071349),0.4150456021757513,1.1476913895242207,0.27411944869831545,0.7323116106192532,1.0,12/48,18.70%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,regulation of focal adhesion assembly (GO:0051893),0.4081604681130625,1.1476084061016536,0.27474150664697194,0.7317260498044014,1.0,8/54,3.74%,TEK;LIMCH1;KDR;MACF1;PTPRJ;PTK2;ACVRL1;DUSP3
prerank,negative regulation of secretion by cell (GO:1903531),0.430258487387008,1.1474506888234608,0.29256198347107437,0.7313413356184566,1.0,8/38,14.46%,RHBDF2;SLC30A1;NOTCH1;STXBP6;PNKD;SYT4;HMGCR;GRM7
prerank,positive regulation of neurogenesis (GO:0050769),-0.33481001759820517,-1.1467841839595638,0.23127035830618892,0.7283594072735653,1.0,18/68,11.66%,ROBO1;PLXNA2;TIAM2;SLIT2;CUX1;OBSL1;NGF;FBXW8;SERPINF1;PLXNB2;FZD3;SMARCD3;CUL7;NUMBL;ROBO2;KDM1A;CAPRIN2;MAP6
prerank,organelle transport along microtubule (GO:0072384),-0.39678804476915336,-1.146411993637164,0.25,0.72810875484395,1.0,13/31,24.75%,TRAK1;ARHGAP21;MAP1S;BICD1;DYNC1I1;CLN3;RAB6A;FBXW11;RHOT1;BORCS5;COPG1;HTT;HAP1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4150685946461108,-1.1460038530103485,0.27163461538461536,0.7278811649542986,1.0,12/26,30.18%,OGT;CTR9;SETD4;KMT5C;EEF2KMT;SETD5;KMT5B;SETD2;ANTKMT;METTL21C;KMT2A;SETD1B
prerank,negative regulation of macroautophagy (GO:0016242),-0.4111887616404729,-1.1459710823598477,0.2717948717948718,0.7266075289850409,1.0,11/26,20.40%,NUPR1;NRBP2;TMEM39A;LRRK2;CLEC16A;SCFD1;PHF23;FEZ1;SMG1;SMCR8;TSC1
prerank,regulation of dephosphorylation (GO:0035303),0.5107776609174426,1.145822074666315,0.32432432432432434,0.7349985020958312,1.0,1/15,0.95%,PPP1R16B
prerank,lipoprotein transport (GO:0042953),-0.5277418844327698,-1.1454822251806356,0.33183856502242154,0.7266223411708993,1.0,1/10,0.53%,LRP1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3677082513950638,1.1453629795334406,0.24525745257452575,0.7354362207434844,1.0,13/113,4.45%,TEK;EGFL7;PDGFB;KDR;PPP1R16B;BMPR2;TBX1;FLT4;NOD2;PRKD1;PRKD2;WNT7A;RREB1
prerank,regulation of protein modification process (GO:0031399),0.41884394258989754,1.145330082302938,0.27111111111111114,0.7347256223112133,1.0,12/50,13.45%,PPP1R16B;PTK2;LYN;FNIP2;CCDC88A;PIN1;ASPSCR1;HPF1;PARG;HSPB1;PUM3;CDH5
prerank,regulation of ruffle assembly (GO:1900027),0.47903397316506574,1.1447487585531066,0.29853181076672103,0.7354612939547487,1.0,9/23,15.74%,CAV1;EVL;EPS8;EPS8L2;ABI3;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,positive regulation of telomerase activity (GO:0051973),0.440338434170542,1.1444511092141643,0.288961038961039,0.7354397943227234,1.0,15/33,27.16%,HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;MAPK1;NAF1;MAP2K7;NVL;PTGES3;MYC;PNKP;NEK7
prerank,ribosomal small subunit assembly (GO:0000028),0.5045425881234851,1.144138314551094,0.3268892794376098,0.7354796859726239,1.0,6/16,14.11%,ABT1;RPSA;RPS27;PWP2;RPS15;RPS28
prerank,postsynaptic membrane organization (GO:0001941),0.5007175659386772,1.1439490368950567,0.3345388788426763,0.73514963229136,1.0,4/17,8.93%,SHANK3;CHRNB1;GPHN;NRXN1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3628165183587103,1.1438638105997183,0.252,0.7345776286133756,1.0,28/118,13.84%,ETS1;SHANK3;TBX1;FLT4;NEDD4L;MEF2C;PLXND1;SP100;CDH2;VASH1;LZTS1;CTNNB1;TSPAN12;EPHA4;KIF1A;INF2;TGFB1;PAK1;STRIP1;FERMT2;ABI3;PDZD8;CEACAM1;CYRIB;EGLN1;NSMF;TNFAIP3;CFL1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.54577967108416,1.1432457579897277,0.3278084714548803,0.7353553515453756,1.0,6/11,18.73%,KCNQ1;ATP1A1;KCNH2;KCNJ3;KCNJ5;KCNIP2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5381325739784752,1.1432362220780103,0.3248175182481752,0.7345880293250452,1.0,3/12,9.59%,SERINC3;SERINC5;CBS
prerank,positive regulation of ERAD pathway (GO:1904294),0.5297337298007568,1.1430183804720793,0.322463768115942,0.7343725798064005,1.0,4/13,17.36%,CAV1;ATXN3;UBQLN1;BAG6
prerank,glucose homeostasis (GO:0042593),0.3808881510579044,1.1427844409326309,0.24195804195804196,0.7342250728405721,1.0,6/83,4.99%,IGF1R;INSR;ADIPOR2;KLF7;FOXO1;CYP11B1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5316588248174821,1.1427299045597077,0.32222222222222224,0.7335962507228514,1.0,4/12,3.95%,DOCK4;PDGFB;MEF2C;PRKG1
prerank,negative regulation of protein binding (GO:0032091),0.3925132968807695,1.141888265735272,0.2635431918008785,0.7350170474814129,1.0,14/71,12.78%,PDGFB;CAV1;CTNNBIP1;B2M;NES;ADAM15;ZFPM1;ACTB;RALB;PIN1;DISC1;PEX14;MITD1;SLPI
prerank,acute inflammatory response (GO:0002526),0.4578649712520083,1.1418116792241682,0.30085470085470084,0.7344353740955559,1.0,4/23,4.95%,IL6R;CTNNBIP1;SIGIRR;CD6
prerank,calcium ion transport into cytosol (GO:0060402),-0.42775489728253835,-1.1418024510711264,0.2706766917293233,0.7358810005640511,1.0,4/21,12.16%,CACNA1C;CACNA2D1;SLC8A1;JPH1
prerank,organelle fission (GO:0048285),0.4700144640076105,1.1408515666884118,0.30333333333333334,0.7363160593753562,1.0,1/24,0.16%,DNM3
prerank,translesion synthesis (GO:0019985),0.42162410725510585,1.140213359875899,0.2875,0.7372757982730783,1.0,2/42,2.24%,POLK;TRIM25
prerank,negative regulation of lipid storage (GO:0010888),0.4947755939534394,1.1400567114677331,0.3459552495697074,0.7369152625714727,1.0,4/19,6.88%,PPARD;NFKBIA;ABCG1;NR1H2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.4897689273988134,-1.140022077015587,0.314410480349345,0.7382992750940001,1.0,3/12,15.92%,FHL2;DYRK2;HOMER3
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.4897689273988134,-1.140022077015587,0.314410480349345,0.7382992750940001,1.0,3/12,15.92%,FHL2;DYRK2;HOMER3
prerank,keratan sulfate metabolic process (GO:0042339),0.44762431987325363,1.139386892175078,0.31338582677165355,0.7379144429451943,1.0,5/31,4.22%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,extracellular matrix disassembly (GO:0022617),-0.3455954493271006,-1.1390392531969435,0.2222222222222222,0.7398124565550611,1.0,12/53,8.63%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;CTSL;ADAMTS15;TLL1;MMP2;KLK2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.504830341800085,-1.1389620012534158,0.3274336283185841,0.7386527630779935,1.0,4/11,9.52%,DAB2;RAB21;PRKN;EZR
prerank,phosphate-containing compound metabolic process (GO:0006796),0.34346196292869047,1.138936137755532,0.22249388753056235,0.7383730259560948,1.0,51/198,18.95%,PLCB1;PTPRB;PLCB4;ITPKB;GPD2;INPP5D;DUSP23;PLA2G4B;DUSP3;PLCG1;CALM1;PLD4;OCRL;LIMK2;MAPK3;CERKL;PGM2L1;TGFB1;PLCH2;PAK1;PFKFB3;NUDT3;ACP4;TOLLIP;HK1;DUSP12;PPP3CA;IPMK;PLCH1;PIP4K2A;PIK3CB;TNK2;PANK3;DUSP16;INPP1;CERK;G6PC3;PFKL;DUSP8;CLN8;PLPPR4;SYNJ1;ALK;PLPP2;INPPL1;MINPP1;PRKCG;PAK2;NUDT10;GPX4;PGP
prerank,negative regulation of histone methylation (GO:0031061),-0.5227618990385351,-1.1383373318030705,0.3200836820083682,0.7391499649819303,1.0,6/10,33.38%,BCOR;KDM1A;BRCA1;AASS;MTF2;JARID2
prerank,epithelial structure maintenance (GO:0010669),-0.5104664002643177,-1.138178204835497,0.33192389006342493,0.7382785625247299,1.0,2/11,3.27%,CXADR;RBP4
prerank,response to interferon-beta (GO:0035456),0.4777070503630023,1.138140805266533,0.33389544688026984,0.739706999731849,1.0,6/22,8.17%,IFNAR2;XAF1;AIM2;STAT1;BST2;IRGM
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.4436550195757482,-1.1378879411821345,0.3080459770114943,0.7377197732153841,1.0,8/19,24.07%,ENPP1;SLC26A2;PAPSS2;PAPSS1;TPST1;ABHD14B;SLC35B2;SULT1A1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4521784532224401,1.1376225835044784,0.3153310104529617,0.7402929923836347,1.0,4/27,12.52%,ETS1;CCDC88B;TNFSF11;CYRIB
prerank,negative regulation of potassium ion transport (GO:0043267),0.5302022423429148,1.137561740219559,0.350844277673546,0.7396719339426288,1.0,3/13,7.93%,CAV1;NEDD4L;KCNH2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5522136536958903,1.13622623558655,0.3225225225225225,0.7424100374747356,1.0,3/11,14.90%,PXDN;CAT;PRDX5
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5339132730871825,1.135996427425135,0.32978723404255317,0.742262480946589,1.0,4/12,19.71%,UNC13B;SYT7;RIMS2;UNC13A
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.44000473450854993,1.1356454408900287,0.31100478468899523,0.7424294014176308,1.0,3/36,2.34%,SPTBN1;MACF1;RAB31
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5484196066604157,1.135034800948189,0.354014598540146,0.7433425244384881,1.0,4/10,25.65%,LGALS9;FOXP3;SCRIB;PRKAR1A
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4097260983009652,1.1350208811232458,0.2966360856269113,0.7425920589942153,1.0,7/46,8.04%,SEMA6A;DAB2IP;CNKSR3;DUSP3;LYN;PTPRR;PIN1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4444108262743064,1.1345741697685823,0.30833333333333335,0.7430392066938565,1.0,6/30,3.23%,ARHGEF3;NET1;F11R;ADGRG1;LPAR6;PRAG1
prerank,cellular component disassembly (GO:0022411),-0.3449354155741134,-1.134373728558545,0.23255813953488372,0.7464874758450963,1.0,12/53,8.63%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;CTSL;ADAMTS15;TLL1;MMP2;KLK2
prerank,positive regulation of apoptotic process (GO:0043065),0.32867103711792783,1.1341877750770735,0.20114942528735633,0.7433305932120352,1.0,36/293,8.52%,MCF2L;ITGA6;ARHGEF3;DAB2IP;TGFB2;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;TPD52L1;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;CTNNB1;RHOB;SOS1;CRADD;RNPS1;ARHGEF12;DNM2;IRF5;JMY;JUN;ARHGEF5;PIDD1;PREX1;ARHGEF7
prerank,regulation of B cell activation (GO:0050864),0.46090767613192885,1.1341447326942644,0.3238255033557047,0.7426582401991757,1.0,8/25,19.85%,NOD2;CD19;ZFP36L1;TNFAIP3;FOXJ1;SH3KBP1;SAMSN1;ZFP36L2
prerank,negative regulation of protein modification process (GO:0031400),0.38047135287708583,1.1337297019752468,0.27722772277227725,0.7429962945899863,1.0,13/79,8.09%,OCLN;MFHAS1;PPP1R16B;DAB2IP;PRR5L;XDH;NIBAN1;MEN1;LYN;WWTR1;PPIA;INSM1;TGFB1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.413465792227871,1.1323549835154054,0.28728414442700156,0.7458763487268409,1.0,7/44,5.07%,DAB2IP;STK38;PTPRJ;DUSP7;LYN;NPPA;HYAL2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.45949354656080016,-1.132323809917959,0.328125,0.7509758044390715,1.0,7/15,19.98%,PRKCD;SMPD3;SIRT3;NSMAF;SPHK1;PLA2G6;ORMDL2
prerank,response to iron ion (GO:0010039),-0.4862263283023538,-1.1320494709066793,0.31291028446389496,0.750407589642046,1.0,4/12,11.49%,BMP6;BCL2;FXN;ACO1
prerank,circulatory system development (GO:0072359),0.3627729419598689,1.1316919242138144,0.236,0.7469247984175613,1.0,17/118,4.36%,TEK;RBM20;PDGFB;TGFB2;NOTCH4;HEG1;TBX1;SOX17;FLT4;MEF2C;ACVRL1;ZFPM1;APLNR;NOTCH1;HDAC9;RAMP2;FOXF1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3808674083922429,1.1316433198833993,0.25591098748261476,0.7462599928478374,1.0,7/73,2.77%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1
prerank,cellular response to glucose starvation (GO:0042149),-0.36308385443616414,-1.131571244035527,0.263768115942029,0.7505113969181165,1.0,7/41,10.34%,PRKAG2;PRKAA2;IMPACT;FOXO3;NUAK1;MTMR3;PRKAG3
prerank,organic cation transport (GO:0015695),-0.43218868947287953,-1.1310975232393332,0.30403800475059384,0.7504893283528196,1.0,6/20,18.07%,SLC47A1;SLC22A4;SLC22A18;SLC5A7;SLC22A2;SLC25A29
prerank,peptidyl-lysine modification (GO:0018205),-0.3079302411280405,-1.1306204486640685,0.2029520295202952,0.7505442902316886,1.0,20/99,14.57%,EYA1;LOXL1;PLOD2;HDAC4;LOXL3;PIAS1;SEH1L;P3H3;NNAT;LOX;ATP7A;SIRT3;NUP205;TRPM4;SENP3;SENP6;PIAS2;SENP7;SIRT2;EP300
prerank,substrate-dependent cell migration (GO:0006929),0.5138738663878198,1.1305744626654572,0.3301707779886148,0.7482936278331428,1.0,4/14,8.64%,NTN1;ANKS1A;CD2AP;OPHN1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4878629483324663,1.130489274351595,0.31625441696113077,0.747713571840744,1.0,6/20,5.99%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;SNAI2
prerank,regulation of postsynapse organization (GO:0099175),0.45906953581864046,1.1303911859779034,0.33666666666666667,0.747197197043056,1.0,5/28,6.87%,SHANK3;EPHA4;ABHD17A;HOMER1;KIF1A
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4783465478329243,1.1302780111431414,0.3142361111111111,0.7467189197797123,1.0,4/21,3.74%,LIMCH1;MACF1;PTK2;DUSP3
prerank,megakaryocyte differentiation (GO:0030219),0.5389912161667678,1.12996063248671,0.34104046242774566,0.7467466785974145,1.0,3/11,6.68%,ZFPM1;TAL1;CDKN2B
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4477223439327277,-1.129172372834888,0.27880184331797236,0.7533266907277637,1.0,7/17,10.59%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;SLC9A9;SLC9A1;TRPM4
prerank,DNA dealkylation (GO:0035510),0.5603822018986646,1.1291095023644449,0.36553030303030304,0.7474631082287225,1.0,4/10,12.65%,ALKBH2;MGMT;MPG;ASCC3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5603822018986646,1.1291095023644449,0.36553030303030304,0.7474631082287225,1.0,4/10,12.65%,ALKBH2;MGMT;MPG;ASCC3
prerank,mitochondrial fusion (GO:0008053),-0.43155504261335953,-1.1288893048585515,0.28498727735368956,0.7527807634836435,1.0,5/18,14.16%,MIGA2;MIEF1;AFG3L2;MFN2;MIEF2
prerank,prostaglandin metabolic process (GO:0006693),-0.40098055135977045,-1.1287560556667362,0.2751196172248804,0.7518328056709657,1.0,5/26,9.44%,PTGDS;PTGIS;PTGS1;PTGES;PTGR2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5516329296212892,1.1287080418855988,0.3473491773308958,0.7477901867163657,1.0,3/10,6.45%,SIGIRR;PALM3;KLF4
prerank,long-chain fatty acid import into cell (GO:0044539),0.5570318708390201,1.1281675218898919,0.34026465028355385,0.7484553842041413,1.0,3/10,12.91%,SLC2A1;ACSL3;SLC27A2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.38870459694296716,-1.1280912203226618,0.3056234718826406,0.7524729784467137,1.0,7/30,8.91%,FSTL1;TGFBR3;SMAD3;DKK3;TWSG1;SFRP4;SMURF2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4245946741316404,1.1279247972943593,0.3024,0.7483130232007048,1.0,11/39,12.42%,DAB2IP;ITGA1;PTPRJ;PTPN12;DUSP3;GRB2;TGFA;ARHGEF7;ACP4;EPS15;HGS
prerank,mesenchyme development (GO:0060485),-0.4621969543740789,-1.1273455008543298,0.3051948051948052,0.7533094514169105,1.0,5/15,4.66%,BMP7;FGFR2;BMP4;TGFBR1;PKD2
prerank,negative regulation of mRNA processing (GO:0050686),-0.4670993202718352,-1.1271429991236366,0.33867276887871856,0.7525674698972289,1.0,7/15,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5228879196225519,1.1271357944832097,0.34790874524714827,0.7496241407656963,1.0,3/13,10.01%,AQP11;NR1H2;LPCAT3
prerank,embryonic digit morphogenesis (GO:0042733),-0.4389517994204665,-1.1269399812780925,0.302540415704388,0.7518034247179152,1.0,4/18,4.36%,GLI3;OSR1;SALL1;WDPCP
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.4250592584045009,-1.1269152250423748,0.28929384965831434,0.7504918273154303,1.0,6/20,11.07%,GRK3;MGRN1;MET;BICD1;GPRASP1;RPGRIP1L
prerank,L-glutamate transmembrane transport (GO:0015813),0.5570508869968294,1.1264623705773917,0.3438077634011091,0.7506692671385831,1.0,3/10,10.83%,SLC1A1;SLC1A2;ARL6IP5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.542427247274371,1.1260134666165558,0.3619402985074627,0.7511128800903603,1.0,3/10,4.54%,PDE2A;APLNR;PDE4D
prerank,peptidyl-glutamic acid modification (GO:0018200),0.46168897574847256,1.12598732474296,0.32954545454545453,0.7504114991990152,1.0,5/24,8.66%,TTLL7;TTLL5;TTLL10;TTLL3;AGBL5
prerank,homeostasis of number of cells (GO:0048872),0.5290506964554796,1.1256627904667535,0.3227016885553471,0.7504633891290248,1.0,3/12,10.01%,NOS3;NOTCH1;LPCAT3
prerank,ethanol metabolic process (GO:0006067),-0.4861202675340953,-1.12523586098661,0.3068181818181818,0.7540829769008152,1.0,1/12,0.31%,ALDH1A1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.38555099254306463,1.1250698396356988,0.3058470764617691,0.7513320256811381,1.0,15/64,13.75%,CYP2E1;PLA2G4B;ACSL5;CPT1A;ACOX1;ACSL6;ELOVL5;ACSL3;AIG1;ABCD1;ELOVL6;PNPLA8;SLC27A2;LTA4H;HACL1
prerank,negative regulation of inflammatory response (GO:0050728),0.3402660160120061,1.125010593754117,0.24257425742574257,0.7507317199303307,1.0,36/182,14.39%,TEK;MFHAS1;PPARD;CD200;RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;KLF4;ADCY4;YES1;HCK;PRKAR2B;CD200R1;NPS;CALCB;ADAM17;LPCAT3;PRKAR2A;SHARPIN;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1;PPARG;CDH5;TNFAIP3;GIT1;HTR4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3597921909577785,1.1247711777666634,0.276510067114094,0.7505808905789509,1.0,25/105,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,rRNA processing (GO:0006364),0.3405289381061397,1.1247417138126916,0.2475,0.7498805408903267,1.0,79/172,29.83%,RPL38;RPL13;RPL36A;MAK16;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;RIOK1;MRM2;RPL11;RPS15;RRP15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;NHP2;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;RPL34;WDR75;EXOSC9;THUMPD1;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;RIOK3;RPL24;MRPL1;RPL7A;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS;DCAF13;RPS6;LSM6;POP5;TFB1M;DDX27;RPS14
prerank,negative regulation of cellular process (GO:0048523),0.3164573912567727,1.1245078600910186,0.1929637526652452,0.7497517018821104,1.0,78/521,11.25%,ETS1;SRGAP2;PODXL;AQP11;DAB2IP;CD34;APBB2;BMPR2;PPP1R13B;TGFB2;NOS3;NOTCH4;RAPGEF2;JAM2;SH3BP4;APP;TBX1;DDAH1;PDE8A;ITGA1;SOX17;CD200;DYSF;CTTNBP2NL;DCUN1D3;ADGRG1;PTPRJ;RGCC;SMARCA2;PLXND1;SP100;ADAM15;SIPA1;ACVRL1;CCDC85B;PRKD1;NOTCH1;MEN1;LYN;PPP1R9B;SNX3;CTNNB1;TNFRSF21;SOX7;PIWIL1;DLL4;HYAL2;IGFBP7;BTG4;RHOB;ST18;WFDC1;ADAM10;KLF4;CDKN2B;NR1H2;ACTN1;INSM1;BST2;TGFB1;TMEM115;FOXP3;ADAMTS8;NPR1;BNIP3L;HMGA1;ARHGDIA;LPCAT3;AXIN2;BTG1;CBLL1;AGTR2;PDE12;CDC6;FERMT2;DUSP1;PLXNB3;CTCF
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4383536808597083,1.124454325442284,0.32459016393442625,0.74912430773045,1.0,9/33,16.12%,IGF1R;PLEKHA1;CD160;HTR2A;PIK3C2A;PIK3CB;ZFP36L1;PIK3R5;EDN1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5171602413532166,1.1239026260314553,0.34615384615384615,0.7498529756607866,1.0,6/12,24.79%,PCGF3;RBM15;RLIM;METTL3;CDYL;PCGF5
prerank,cellular response to lectin (GO:1990858),0.3612585429453594,1.1234351034920396,0.28222523744911804,0.7495560043982143,1.0,25/104,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3612585429453594,1.1234351034920396,0.28222523744911804,0.7495560043982143,1.0,25/104,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,positive regulation of autophagy (GO:0010508),0.3753535232782821,1.122525142115733,0.2796143250688705,0.7512621003725202,1.0,21/81,15.36%,KDR;SH3BP4;TRIM14;FOXO1;PRKD1;CAMKK2;SESN3;IRGM;BNIP3L;EIF2AK4;PIK3C2A;GSK3A;SH3GLB1;ORMDL3;PIK3CB;SVIP;TFEB;EPM2A;PIM2;TMEM59;PLK2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5200726792695322,1.1218191283050962,0.35359116022099446,0.7523236928302094,1.0,5/13,12.34%,NOTCH1;FOXF1;NPY5R;GSK3A;TGFBR2
prerank,positive regulation of DNA replication (GO:0045740),-0.4490917043063274,-1.1218087614210421,0.3140877598152425,0.7626911115894464,1.0,3/16,6.56%,EGFR;GLI2;GLI1
prerank,lipoprotein localization (GO:0044872),-0.5008738329206501,-1.1216634776590586,0.3252212389380531,0.7617319742757459,1.0,1/11,0.53%,LRP1
prerank,negative regulation of cilium assembly (GO:1902018),0.5312440170756425,1.1212363033060984,0.3442028985507246,0.7531321373861596,1.0,5/12,11.60%,MAP4;LIMK2;CCP110;ODF2L;TBC1D30
prerank,positive regulation of T cell differentiation (GO:0045582),0.4317972963238849,1.1209126904800653,0.31045241809672386,0.7532352513457662,1.0,5/36,11.81%,LEF1;ZAP70;SOX12;PNP;VSIR
prerank,blood vessel diameter maintenance (GO:0097746),-0.3795141578346517,-1.120223308956797,0.31313131313131315,0.764537808855821,1.0,12/34,15.39%,ROCK2;EDNRA;KCNMB2;PER2;SCPEP1;ACE;BDKRB2;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,vitamin transport (GO:0051180),0.4497052064977263,1.1201075696795255,0.3238255033557047,0.7546028753111957,1.0,5/29,10.98%,ABCG2;SLC52A2;SLC25A32;SLC52A3;AMN
prerank,regulation of small molecule metabolic process (GO:0062012),-0.3929718518601,-1.1200172939400965,0.2857142857142857,0.7637501093965011,1.0,5/28,8.01%,PDK1;RORA;PPARA;PRKN;APOE
prerank,RNA destabilization (GO:0050779),-0.44174946814661664,-1.119601596264515,0.3073286052009456,0.7636038661189737,1.0,5/18,24.65%,ROCK2;YTHDF1;RBM24;ZC3H18;MEX3D
prerank,positive regulation of binding (GO:0051099),0.37997533935083205,1.1195241613145193,0.28851963746223563,0.7553519602573181,1.0,12/84,4.05%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;PLAUR;B2M;EPB41;TIAM1;MEN1;HMBOX1;STMN1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3875849309903097,-1.118762178185698,0.28809523809523807,0.7647070517562794,1.0,4/27,5.09%,CACNA1C;ANK2;CAMK2D;DLG1
prerank,positive regulation of endocytosis (GO:0045807),-0.35367539592449543,-1.118076543938719,0.2877094972067039,0.7653525075345254,1.0,11/45,9.19%,LRP1;APPL2;VTN;AXL;GPC3;ANO6;DAB2;RAB21;APOE;CLIP3;BICD1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4399419904165959,-1.1179308544710935,0.30260047281323876,0.7644248806384163,1.0,7/17,16.50%,ARRB1;ANXA1;ANXA4;SSC5D;PTPN22;MAP2K5;MAPKBP1
prerank,cellular response to radiation (GO:0071478),0.42002105000760287,1.1175492824666844,0.3161993769470405,0.7597419604757285,1.0,13/40,22.80%,NET1;GRB2;RHOB;OPN5;GPR52;OPN3;EEF1D;HUS1;RRH;NSMCE3;RAD9B;RAD1;INO80
prerank,regulation of platelet activation (GO:0010543),0.4653442100422865,1.1175341410667206,0.3415061295971979,0.7590086701274157,1.0,3/21,3.88%,PDGFB;NOS3;LYN
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.40026618393977786,-1.1172439857719247,0.30484988452655887,0.7650235060262465,1.0,8/24,9.33%,PHLDB2;ARHGAP6;ARHGAP28;ARAP1;CGNL1;ARHGEF18;MET;MYOC
prerank,regulation of lamellipodium organization (GO:1902743),-0.46677279603188593,-1.1171869115686917,0.3479212253829322,0.7638264600196366,1.0,3/14,2.69%,PDPN;CARMIL1;CAPZB
prerank,negative regulation of ion transport (GO:0043271),-0.4018900442513239,-1.1170417326919957,0.3146341463414634,0.7629064192647304,1.0,10/24,25.25%,ACTN2;WNK4;PTK2B;WNK1;HTR1B;PACSIN3;WNK3;ADRA2A;NEDD4;STC1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4558401391813802,1.116964921083622,0.332220367278798,0.7597797512428717,1.0,6/25,15.12%,APP;ANKRD13A;RIN3;RAC1;SDCBP;MTMR2
prerank,tryptophan metabolic process (GO:0006568),-0.504120628402769,-1.1168027436114887,0.3271889400921659,0.7622601997903117,1.0,6/11,30.37%,ATP7A;KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4331540593681851,-1.1167424052226747,0.30120481927710846,0.7611138725787757,1.0,7/19,17.10%,IL34;CAMK1D;THBS1;CMKLR1;MPP1;RARRES2;MDK
prerank,artery morphogenesis (GO:0048844),0.43358242365686595,1.1162667272012572,0.3104575163398693,0.7609225591889239,1.0,7/30,4.36%,ENG;BMPR2;TGFB2;TBX1;NOTCH1;SMAD7;FOXF1
prerank,regulation of cell cycle process (GO:0010564),0.35960453650628776,1.115918694985302,0.2776243093922652,0.7610549633791659,1.0,26/104,17.15%,BCL2L1;DCUN1D3;CALM1;CTNNB1;CDKN2B;CCP110;INSM1;RAB11A;MARK4;PIN1;CETN2;CAV2;RAB11FIP4;PIK3C3;SH3GLB1;SOX9;GIT1;TTL;SPAG5;PLK2;SND1;RPRD1B;APC;PRPF40A;HMGA2;CEP85
prerank,SNARE complex assembly (GO:0035493),0.5471737527312985,1.1156963684710395,0.36185383244206776,0.7608258233014358,1.0,5/10,22.16%,STXBP6;STXBP1;UVRAG;VAMP8;SNCA
prerank,protein K48-linked deubiquitination (GO:0071108),0.4544455739896408,1.115516257869226,0.3383838383838384,0.7605102410762256,1.0,8/23,19.24%,MINDY1;ATXN3;OTUD7A;MINDY2;TNFAIP3;OTUD4;USP25;OTUD7B
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4381495662268453,1.115249638103939,0.3435897435897436,0.7604210208898331,1.0,5/27,4.05%,SHANK3;TJP1;WASF2;F11R;STMN1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4550331517741919,-1.1150644219804955,0.31910112359550563,0.7647701154167371,1.0,5/16,12.11%,DDX5;PPARGC1B;AR;DDX17;ESR1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4287634458925595,1.1149208200118297,0.32038834951456313,0.760517684486089,1.0,11/35,15.74%,ATP2C1;CDH20;PCDHGB4;CDH8;DCHS1;CDH19;CDH10;CDH23;PCDHB14;CDH5;NLGN1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.400276370331771,-1.1148732617657457,0.2936708860759494,0.7639765845257562,1.0,6/24,11.45%,ITPR1;PKD2;FGF2;ANXA6;ITPR2;IBTK
prerank,exit from mitosis (GO:0010458),0.528682475664277,1.114797044562198,0.34954954954954953,0.7600698346044568,1.0,5/12,25.97%,EPS8;SIRT7;SPAST;CLASP1;CLASP2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5305244744736228,1.1142966440891093,0.3685152057245081,0.7606808975513346,1.0,6/11,21.34%,UQCRB;CYC1;UQCRC1;CYCS;UQCRQ;UQCR11
prerank,mRNA metabolic process (GO:0016071),-0.311724624565751,-1.1141357158483605,0.21323529411764705,0.764898990096292,1.0,27/90,22.91%,DDX5;PPARGC1A;SON;SRSF5;SRSF11;PCF11;AKAP8L;SRRM4;CPSF3;PRKACA;SRSF4;RNASE4;HNRNPR;NONO;HNRNPA2B1;PRMT9;PCBP2;PRPF18;LSM10;PRPF3;U2AF2;U2AF1;LSM3;TCERG1;CSTF3;AURKAIP1;TBRG4
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4648363773455737,-1.113458066294027,0.3333333333333333,0.7655721615066182,1.0,2/13,3.08%,KCNT2;KCNK5
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4939490368336555,1.1133821499023495,0.35130434782608694,0.7623171623842921,1.0,5/16,10.26%,PDGFB;PDGFD;PTPRJ;PLAT;PIK3C2A
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3649961732537512,1.1131630180095549,0.29160935350756534,0.7621290155935598,1.0,14/90,12.19%,IGF1R;EPAS1;ADIPOR2;GATM;CAV1;UCP2;OXTR;YBX2;IL4R;FABP5;PRKAB1;ADIPOR1;SYK;ELOVL6
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3656286439055525,1.112979427300973,0.29098360655737704,0.7618092658074124,1.0,24/107,13.52%,SLC39A10;SLC39A8;CXCL12;CAV1;SLC30A1;CD40;ATP2C1;SLC24A2;SLC24A4;ATP2B1;SLC10A7;HTR2A;CALCB;CCL1;CSRP3;CDH5;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,protein dephosphorylation (GO:0006470),0.3500309103760395,1.1128893391351602,0.2846054333764554,0.7612994840550433,1.0,21/135,11.40%,PTPRG;PTPRM;PTPRB;CTTNBP2NL;PTPRJ;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PPP3CC;PPP4R1;PPP2R5A;PTPRR;MTMR6;PTPN5;PPP1CB;SSU72;DUSP12;DUSP1;PPP3CA
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2840866573434878,-1.11286425342386,0.18592964824120603,0.7658592534163344,1.0,26/166,8.84%,SAMD4A;IGF1;ZEB2;EGFR;PLD1;PDGFRB;GLI2;SMAD3;IRS1;SMOC2;THBS1;SLC6A9;PPARGC1A;PKD2;FGF2;IRS2;IGF2;GLI1;PLXNB2;ATP7A;P2RX4;PTH1R;LPGAT1;FXR2;LDLR;NNMT
prerank,myeloid leukocyte differentiation (GO:0002573),0.39352603164336064,1.1125760210738476,0.29873772791023845,0.7613702741500726,1.0,12/65,13.46%,LEF1;TNFRSF11A;CCR7;CD4;PIR;LGALS9;CASP8;TNFSF11;TGFBR2;IL15;PPARG;MT1G
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5013881923249677,1.1125586410010821,0.3679417122040073,0.7606625498562345,1.0,4/15,11.82%,NOD2;GBP5;CD6;HIF1A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4288886142304099,1.1123660025639128,0.3252032520325203,0.7604031798886934,1.0,4/34,5.43%,MFHAS1;DAB2IP;LYN;TLR3
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2855722648642862,-1.1123508041706645,0.18018018018018017,0.7660687341145481,1.0,35/150,13.67%,PID1;PTPN13;PRKAG2;NTRK3;LDLRAD4;PLPP3;ERRFI1;PPM1E;FBLN1;ENPP1;SLIT2;SMAD6;DEPTOR;IMPACT;DMD;RASSF2;PRKCD;DTNBP1;EMILIN1;EPHB2;PRKN;IGFBP3;PDPK1;SPRED1;QARS1;ITGB1BP1;PPEF2;LRRK2;IBTK;GPD1L;DMTN;TWIST1;NF1;PTEN;SIRT2
prerank,cellular protein modification process (GO:0006464),0.3043546835537707,1.1120981172798712,0.16938775510204082,0.7603554527317906,1.0,222/983,18.28%,PTPRG;ST8SIA4;PRKCH;PTPRM;ST3GAL6;PTPRB;ERG;EPAS1;PDGFB;INSR;ST8SIA6;BMPR2;TGFB2;LMO7;MAP4K2;KLHL5;KLHL2;APP;CDK17;ST3GAL1;MAP4K3;B4GALT5;CTTNBP2NL;DCUN1D3;ST6GALNAC2;STK38;PKN3;SPARCL1;PTPRJ;VWA1;PPM1L;LIPE;SNRK;DUSP7;JAK3;PTPN12;ACVRL1;PRAG1;MAP3K1;CDH2;PRKD1;STK10;PRKD2;MEN1;CDK19;ZAP70;SSH2;MERTK;LYN;FNIP2;PRKG1;ZBTB16;TGM2;SOCS2;B3GNT2;PPP3CC;IKBKB;OGA;NOTUM;PPP4R1;CREB1;PIGU;IGFBP7;CAMKK2;PKN1;STK19;STT3B;LIMK2;PRKACB;FUT9;KLHL25;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;FBXW7;RET;PPP2R5A;YES1;AATK;PSMB3;GOLM1;PKN2;HCK;RAB11A;COG3;LCMT1;PTPRR;PXK;MARK4;FBXO41;PDIA6;MTMR6;PSMD11;TGFB1;RHBDD1;MARK3;ABCA7;MAP3K6;QSOX1;PIGK;PSMC6;FEM1C;NPC1;PTPN5;KLHL3;PAK1;PGGT1B;PLAT;PPP1CB;PSME2;SCG3;EIF2AK4;SOCS5;PIK3C3;PTK6;TRIB2;KLHL20;PRKAB1;FBXL2;JMJD7;CHRM3;DUSP12;DUSP1;PSMD8;PPP3CA;PRKCB;GSK3A;WSB1;UBA3;HIF1A;SYK;B3GALT4;FBXO6;MAP4K4;TGFBR2;DUSP16;HIPK2;ASB13;RAB1A;EVA1A;DCUN1D1;B3GALT2;MANBA;STK24;STK3;MINK1;FBXW2;SSH1;METAP2;ASB5;PSMB10;FBXO21;SERP2;RBX1;PIM2;MAN2B1;DUSP8;VRK1;SGK1;TBCK;CAMK2B;STK26;SERPINC1;NUS1;FBXL8;CTBP1;DAD1;UBE2D3;GRK6;FBXL15;MTMR2;NEK3;HIPK3;ELOB;ASB15;LOXL2;LORICRIN;PLK2;SGK3;SGK2;GCNT2;MMP15;MCRS1;ZC3HAV1;PROC;DCAF5;PSMA8;ASB7;MAPK1;B3GNT3;ATE1;COPS5;ACVR1;SIRT7;GAS6;SEPHS1;YWHAZ;PTPRZ1;TMEM132A;SIK2;GPS1;FN3K;PPM1F;MAP3K11;SCG2;PRKG2;KBTBD8;WDR45;FBXO2;PRKCG;PRKCE;RCE1;TBK1;PAK2;SKP1;WNK2;PTPRK;RSKR;CDK11B;PSMD9
prerank,negative regulation of synaptic transmission (GO:0050805),0.46446315475560623,1.1120094254870874,0.32432432432432434,0.7598375517991068,1.0,7/23,15.36%,SLC30A1;SLC24A2;STXBP1;PNKD;TMEM25;MTMR2;PLK2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5133340187059595,1.1120069831907375,0.35154826958105645,0.7590888067340302,1.0,6/13,23.90%,ARID1A;SMARCD1;SPI1;ZMIZ2;SERTAD2;PADI2
prerank,epithelium development (GO:0060429),-0.3058681139950681,-1.1119259861398667,0.24497991967871485,0.765849191839053,1.0,22/107,8.99%,ALDH1A2;ERRFI1;WNT4;FGFR2;KANK2;OSR1;PKD1;MEOX2;SMO;SALL1;VCL;LOXL3;DAG1;PKD2;ANXA4;SIX1;RCN3;DACT1;CNN3;BDH2;MTHFD1;IFT122
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4826377570197663,1.111545706068456,0.3418181818181818,0.7595078343560494,1.0,4/18,11.65%,HIP1R;SLC25A5;ZNF205;GSK3A
prerank,regulation of fibroblast migration (GO:0010762),0.4682886576295115,1.1111300955088181,0.3367003367003367,0.7599159674071719,1.0,8/20,11.43%,PRR5L;PTK2;GNA12;HYAL2;RFFL;TGFB1;ARHGEF7;RAC1
prerank,amyloid-beta metabolic process (GO:0050435),-0.4498699876904929,-1.111101378055932,0.3462414578587699,0.7669215600950212,1.0,5/16,12.41%,MGAT3;BACE2;ACE;IDE;PSEN1
prerank,ribosome biogenesis (GO:0042254),0.3322330332046795,1.1110803106519358,0.2648845686512758,0.7592980345794162,1.0,78/187,28.90%,RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;NOP16;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;GTF3A;NOL9;RIOK1;MRM2;RPL11;RPS15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;NOL8;LYAR;RPL15;NAF1;RRP12;EXOSC10;RPL17;RPL23;RPL34;WDR75;EXOSC9;NOC2L;PAK1IP1;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;SURF6;ABCE1;RPL24;RPL7A;MRPL22;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS;DHX29;RAN;DCAF13;RPS6
prerank,hydrogen peroxide metabolic process (GO:0042743),0.48368378457238687,1.1108094119611909,0.33962264150943394,0.7592727751434597,1.0,5/19,14.90%,PXDN;CAT;ACOX1;MAOB;PRDX5
prerank,negative regulation of lyase activity (GO:0051350),0.4855580842724018,1.1107204521703935,0.3517857142857143,0.758741973201809,1.0,2/16,2.58%,PALM;GNAI2
prerank,arachidonic acid metabolic process (GO:0019369),-0.3725933205173364,-1.1098782495257054,0.3075,0.7691216290876229,1.0,6/35,5.75%,PTGDS;PTGIS;PTGS1;DAGLA;CYP1B1;PTGES
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3791006121270571,1.1098018029783592,0.3065187239944521,0.760401956464482,1.0,14/73,14.07%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;C1QTNF4;DDT;BCL10
prerank,outflow tract septum morphogenesis (GO:0003148),0.4605601747954363,1.1097457814103557,0.3344316309719934,0.7598020065795333,1.0,5/24,1.88%,SEMA3C;ENG;BMPR2;TGFB2;TBX1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.45814200284375867,-1.1096781213403524,0.3623853211009174,0.7683721200350216,1.0,4/14,23.10%,IL18;IL17D;CD84;CD80
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.35937669203211864,-1.1094166222551542,0.2734584450402145,0.7678243620226745,1.0,12/43,11.73%,PID1;ENPP1;IRS1;KANK1;PRKCD;OGT;IGF2;GRB10;TNS2;PIP4K2C;NUCKS1;SNX5
prerank,activation of protein kinase activity (GO:0032147),-0.3016042862927185,-1.1093845535960898,0.2366412213740458,0.7666112305133717,1.0,26/106,13.69%,IGF1;NTRK3;ADCY5;ANGPT1;ADCY1;FGF1;ADCY9;NRK;IL18;PRKCD;ADCY2;OSBPL8;ADCY7;CARD14;PDPK1;AXIN1;ITGB1BP1;STK11;PRKACA;PTK2B;ABL1;ADCY6;PRLR;PIBF1;GHR;STRADA
prerank,regulation of response to cytokine stimulus (GO:0060759),0.48047862142025294,1.1092440567941444,0.3503521126760563,0.7603544565384746,1.0,5/19,10.94%,IFIH1;KLF4;IRAK2;LIFR;CBFB
prerank,modulation by symbiont of host process (GO:0044003),0.5376722794007026,1.1091981541048284,0.36242884250474383,0.7597097749038108,1.0,2/10,12.42%,B2M;HGS
prerank,negative regulation of multicellular organismal process (GO:0051241),0.33238727228164733,1.1091642526860466,0.25744934445768775,0.7590493952040946,1.0,35/199,12.68%,PTPRG;RAB11FIP1;DAB2IP;BMPR2;NOS3;NOVA2;MCC;ID1;KLF7;RGCC;MEF2C;SRGN;NOTCH1;HDAC9;EVL;SMAD7;IL17RD;RPS6KA5;ATP2B1;NR1H2;N4BP1;PTPRR;BRCA2;EFNA1;TGFB1;FOXP3;PPP1R11;ADAM17;AGER;ADIPOR1;GSK3A;HMGCR;GDF15;IL15;WWC1
prerank,negative regulation of protein polymerization (GO:0032272),0.43858965479720713,1.1090336127502527,0.3293718166383701,0.758639624210135,1.0,8/27,13.85%,KANK3;HIP1R;SSH2;STMN1;TWF2;CYRIB;CDH5;SSH1
prerank,positive regulation of coagulation (GO:0050820),-0.49769297627043074,-1.1089263021452995,0.3411016949152542,0.7654282986650064,1.0,5/10,22.31%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.49769297627043074,-1.1089263021452995,0.3411016949152542,0.7654282986650064,1.0,5/10,22.31%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,regulation of cell aging (GO:0090342),-0.4796005364541106,-1.1087582941672582,0.34146341463414637,0.7645724883152133,1.0,3/11,9.42%,LMNA;NEK6;NUAK1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3752671198986931,1.108735320009636,0.32554744525547447,0.7587058703075095,1.0,30/80,17.99%,OCLN;WASF2;FNBP1L;PALM;AGRN;EPS8;CCR7;EPS8L2;CCDC88A;CDC42EP3;CCP110;NCKAP1;MARK4;GPM6A;TWF2;P2RX7;CYFIP1;CLRN1;PLEKHM1;RAC1;HRAS;FSCN1;FAM98A;ANLN;NLGN1;APC;RALA;ACTR2;TENM1;KCTD17
prerank,rRNA transcription (GO:0009303),0.4975630128333271,1.1086961266765285,0.34458259325044405,0.7580882365035716,1.0,6/17,22.62%,TAF1B;GTF3A;GTF3C5;SIRT7;SPIN1;GTF3C1
prerank,positive regulation of cellular respiration (GO:1901857),0.5362219545193713,1.1085534329441742,0.375,0.7577044802356129,1.0,2/11,3.56%,IFNAR1;IL10RB
prerank,negative regulation of protein kinase activity (GO:0006469),0.3635945294754985,1.1083167056652792,0.3029891304347826,0.7576095386112165,1.0,17/88,12.34%,PTPRB;DAB2IP;CAV1;GNAQ;DUSP3;ADAR;WWTR1;HYAL2;PPIA;LRP5;PTK6;TRIB2;ACP4;HSPB1;CEACAM1;PTPRQ;DBNDD1
prerank,Golgi ribbon formation (GO:0090161),-0.46952428596370593,-1.1081308757194743,0.3284823284823285,0.765009857934708,1.0,6/13,29.07%,GOLGA2;PRMT5;STX16;OPTN;MYO18A;TRIP11
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3712627417818057,1.1079690726834703,0.2926829268292683,0.7577916464192881,1.0,23/76,18.01%,TEK;FES;NES;EVL;VIL1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;P2RX7;PFDN2;HRAS;NCKAP1L;SPAG5;FCHSD1;EDN1;NCK1;PROX1;PRKCE;TENM1;BIN1;WDR1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4792732289134051,1.107630577391282,0.34683098591549294,0.7580031385893745,1.0,3/20,5.93%,ST3GAL6;FUT8;FUT9
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.4722333481113227,-1.1075382535145744,0.3271889400921659,0.7654724675586827,1.0,7/14,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4535478633302215,1.106502611316768,0.3415061295971979,0.7602554302878168,1.0,8/24,13.59%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;RAC1;FSCN1
prerank,regulation of protein secretion (GO:0050708),0.35095066753663284,1.1064755133749076,0.2878787878787879,0.759575591208061,1.0,15/119,6.34%,SLC2A1;CACNA1A;TGFB2;UNC13B;STX1A;RHBDF2;CD2AP;RAPGEF3;ABCG1;NOS2;KCNC2;SYT7;PPIA;RAPGEF4;KCNG2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3778903155221738,1.1062791201492304,0.29929078014184396,0.7593527623705342,1.0,13/75,9.42%,SLC39A10;SLC39A8;SLC24A2;SLC9A5;SLC12A6;ATP1A4;ATP1A1;ATP1A3;SLC9A3;SLC12A9;KCNH2;SLC9A7;SLC9A6
prerank,cholesterol transport (GO:0030301),0.41058417493051497,1.1062156817220112,0.3348694316436252,0.758765980530185,1.0,9/45,14.49%,CAV1;SCARB1;OSBP;ABCG1;ABCA7;NPC1;LIPC;MSR1;STARD4
prerank,nuclear body organization (GO:0030575),0.5062311367987822,1.1061034707424384,0.36298932384341637,0.758329309799148,1.0,4/12,14.13%,ETS1;ZPR1;HIPK2;SERBP1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4529227473804065,1.106096941172091,0.3449367088607595,0.7576135853797514,1.0,10/26,11.81%,LYN;EPHA4;FYN;AIM2;EFNA1;PSME2;AGER;APH1A;GRIN2B;VSIR
prerank,macrophage activation (GO:0042116),0.4328387790139866,1.106021081012743,0.33063209076175043,0.7570794386930018,1.0,11/34,22.16%,APP;DYSF;CD93;AGER;SYK;NMI;SBNO2;PLCG2;FOXP1;IFNGR1;SNCA
prerank,muscle cell development (GO:0055001),-0.37781465952700255,-1.1058030854215735,0.30434782608695654,0.7691306680217869,1.0,8/30,9.11%,ANK2;IGF1;CXADR;MYOF;DMD;SLC8A1;MYH11;EFEMP2
prerank,actomyosin structure organization (GO:0031032),0.3748253233335473,1.1054350076430604,0.3171745152354571,0.7578427968488355,1.0,6/75,3.01%,FLII;FRMD5;TJP1;PGM5;F11R;EPB41
prerank,positive regulation of wound healing (GO:0090303),-0.37056947072708574,-1.105419981353029,0.29508196721311475,0.768895415387374,1.0,9/36,5.24%,PLPP3;VTN;MYLK;ST3GAL4;KANK1;SMOC2;THBS1;FOXC2;ANXA1
prerank,cell-cell junction maintenance (GO:0045217),0.5249116169529486,1.1053970231157255,0.375,0.7572072632668393,1.0,5/11,19.90%,TJP1;FERMT2;INAVA;CSF1R;F2R
prerank,regulation of cell-matrix adhesion (GO:0001952),0.38690114080485627,1.1046427288572178,0.31635802469135804,0.7584844374466256,1.0,13/64,12.23%,LIMCH1;UTRN;MACF1;ACER2;PTK2;ADAM15;DUSP3;CCR7;NEXMIF;ACTG1;SLK;PIK3CB;MAP4K4
prerank,transcription by RNA polymerase III (GO:0006383),0.4545305694100059,1.10452435192136,0.3430034129692833,0.7580711751670742,1.0,6/27,15.25%,IVNS1ABP;GTF3A;GTF3C5;RO60;SNAPC1;CRCP
prerank,negative regulation of nervous system development (GO:0051961),0.4755928154973515,1.1044977428225686,0.3603448275862069,0.7574206086917534,1.0,3/17,4.25%,B2M;NOTCH1;WNT7A
prerank,negative regulation of platelet activation (GO:0010544),0.48717037518010675,1.103840296897701,0.344954128440367,0.7584295665165467,1.0,3/16,3.95%,PDGFB;NOS3;PRKG1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4256872486487337,1.1034668435096389,0.3276661514683153,0.7586923473192483,1.0,6/32,14.00%,NANOS3;APP;CYFIP1;EIF4E;PUM3;PGAM1
prerank,hyaluronan metabolic process (GO:0030212),-0.40069239532116396,-1.1033157683147117,0.3349875930521092,0.7735493202741955,1.0,12/23,27.44%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;ABCC5;CD44;LYVE1;HAS1;HMMR;GUSB;HYAL3
prerank,lipid homeostasis (GO:0055088),-0.3280611522870621,-1.1026959060376609,0.26380368098159507,0.7740574042232179,1.0,10/57,9.80%,ZBTB20;PRKAA2;RBP1;NR1D2;ABCA1;THADA;IRS2;RCN3;APOE;TLCD2
prerank,neural tube closure (GO:0001843),-0.37257994925700944,-1.102690901673135,0.3323943661971831,0.7727598139850043,1.0,15/34,17.88%,LMO4;COBL;PLXNB2;KDM2B;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,neural crest cell differentiation (GO:0014033),0.47931009002734826,1.1024610467627058,0.3587521663778163,0.7606233637088907,1.0,6/18,17.63%,MEF2C;CDH2;SNAI2;SOX11;PDCD6;KBTBD8
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.48322049137597034,1.1020652908547652,0.35563380281690143,0.760953799477226,1.0,3/17,4.26%,CLDN5;F11R;IKBKB
prerank,sterol metabolic process (GO:0016125),-0.331009340920117,-1.1015622999984984,0.2724358974358974,0.7746930338388712,1.0,15/60,18.12%,PRKAG2;CYP7B1;CYP26B1;INSIG2;CYP27A1;ABCA1;CYP1B1;APOE;OSBPL5;RXRA;TSKU;FDX1;ANGPTL3;SQLE;CLN6
prerank,positive regulation of DNA binding (GO:0043388),-0.383130794288959,-1.1010447511775132,0.3153846153846154,0.7748713892573018,1.0,8/31,13.67%,IGF1;FOXC1;NGF;PRKN;NIBAN2;SKI;TWIST1;SIRT2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.4922796886768767,-1.1007405460829944,0.3404710920770878,0.7744788767618673,1.0,8/10,50.80%,APOC1;SHH;NFKB1;ABCA2;SREBF2;ABCG5;APOA2;PLA2G10
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.34911454826540583,-1.1006812859074004,0.27297297297297296,0.7733456018856676,1.0,9/49,16.16%,LDLRAD4;SMAD6;IMPACT;DACT1;ANKRD27;DDX3X;EP300;NLRP2B;CRYAB
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.44620417126107287,-1.1005051173530676,0.33181818181818185,0.772593933775157,1.0,7/16,16.85%,WNT4;BMP4;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3799608571896751,-1.100462658052855,0.33064516129032256,0.7714315232596085,1.0,12/30,21.84%,DDX5;DAB2;AR;HEYL;KLK2;KDM1A;PIAS2;EP300;SFRP1;NCOR1;RNF14;SAFB2
prerank,glucan catabolic process (GO:0009251),-0.44215093159468105,-1.099655391674585,0.3550561797752809,0.7725977730310176,1.0,10/15,23.04%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.40275909269017796,-1.0996390140892396,0.3348519362186788,0.7713460677510819,1.0,1/23,0.34%,IGF1
prerank,stress fiber assembly (GO:0043149),-0.45897235364341565,-1.0995510760710414,0.3477272727272727,0.7690440977895967,1.0,5/15,15.61%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),-0.45897235364341565,-1.0995510760710414,0.3477272727272727,0.7690440977895967,1.0,5/15,15.61%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,negative regulation of phagocytosis (GO:0050765),0.4804232865713254,1.0994175611413488,0.33879781420765026,0.7671558509660538,1.0,2/17,4.37%,DYSF;SNX3
prerank,lymphocyte proliferation (GO:0046651),0.462681877145387,1.0993820577030244,0.3433333333333333,0.7665227041770967,1.0,6/22,12.86%,MEF2C;CD40;CD79A;MSN;TNFRSF4;HELLS
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.41958497485206137,-1.099237076803324,0.34793187347931875,0.7686632039735943,1.0,8/19,20.57%,PLCE1;NFAT5;NFATC4;PPP3CB;INPP5A;NFATC2;NFATC3;HRH1
prerank,focal adhesion assembly (GO:0048041),0.4673212325655621,1.0988621493278063,0.36952714535901926,0.7671793685545522,1.0,5/21,10.91%,THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.34092188213986385,-1.0988091246995797,0.2849162011173184,0.7686050472987482,1.0,15/51,10.01%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;SYNPO;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3532887943344405,1.0986707106916804,0.3081155433287483,0.7669771823880972,1.0,25/110,16.69%,TFRC;DAB2IP;TIRAP;FNIP2;TAL1;BIK;HCK;STXBP1;RALB;INSM1;LCMT1;TGFB1;IRGM;MMP1;HSPA8;SYK;SH3GLB1;SVIP;CDH5;BBS10;GFAP;MPP7;OPRD1;HCFC1;SUMO1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3809461158152882,1.0984923523845396,0.31976744186046513,0.7666986444903746,1.0,14/63,14.07%,ITGA6;CAV1;FAS;SH3RF1;TNFSF10;SP100;HYAL2;DEDD2;ZMYND11;AGTR2;CASP8;TNFSF12;CYLD;BCL10
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5034596252562973,1.098408793185436,0.35985533453887886,0.766182878347581,1.0,2/13,2.58%,PALM;GNAI2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4819261693911693,1.0980546009365455,0.3615257048092869,0.7664000946805097,1.0,4/18,6.44%,CD34;TGFB2;CD200;LGALS9
prerank,snRNA processing (GO:0016180),-0.43122521206125897,-1.0979838697004372,0.34598214285714285,0.7697611609537915,1.0,9/16,30.02%,INTS8;INTS2;INTS4;TUT1;INTS10;INTS3;TOE1;INTS6L;INTS5
prerank,negative regulation of cell death (GO:0060548),0.3679228565448135,1.0978324517030045,0.31432748538011696,0.7662575442241086,1.0,12/88,11.17%,MECOM;SRGAP2;CD34;PDE8A;CD200;PRKD1;FYN;CD200R1;BNIP3L;PDE12;FERMT2;KIR3DL2
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.35731235642903386,-1.0975753303598594,0.32,0.7696835835757025,1.0,10/45,8.19%,SMAD3;BMP7;BMP4;PTPN3;GAS1;FOXC1;BCL6;FZD3;PRCC;ZWINT
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3525701529094194,-1.0973507250922965,0.28532608695652173,0.7690715011149862,1.0,14/44,10.01%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4717059631244623,1.0967496744691598,0.36515912897822445,0.7683360810212942,1.0,7/20,12.53%,PDGFB;CCNY;RGCC;HSP90AB1;CCND3;ADAM17;MAPRE3
prerank,negative regulation of receptor binding (GO:1900121),0.5425107131620317,1.0965394753685573,0.38294010889292196,0.7681822862778773,1.0,2/10,3.05%,B2M;ADAM15
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4746105446810915,-1.0960561409477116,0.37636761487964987,0.7714485858355783,1.0,5/12,21.67%,NINL;BICD1;PCM1;CEP19;BBS4
prerank,negative regulation of leukocyte migration (GO:0002686),-0.4946429275997196,-1.0952283047349916,0.3624733475479744,0.7725505693531936,1.0,5/10,11.81%,BMP5;SLIT2;HOXA7;EMILIN1;CD300A
prerank,negative regulation of blood coagulation (GO:0030195),0.4122883779870719,1.0951831870967474,0.3481848184818482,0.7710257509891416,1.0,4/38,2.28%,PDGFB;CD34;NOS3;PLAUR
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.359663540832487,-1.0950565751145929,0.307909604519774,0.7717599561322421,1.0,15/40,27.39%,FBH1;RTEL1;NUCKS1;TIPIN;ZRANB3;TRAIP;PRIMPOL;DONSON;WRN;ATR;BOD1L1;THOC1;CDK9;MCM9;SETMAR
prerank,Notch signaling pathway (GO:0007219),0.3774947679281965,1.0949984237848696,0.3217893217893218,0.7707625806664646,1.0,11/59,6.71%,SORBS2;NOTCH4;JAG2;PLXND1;NOTCH1;YBX1;DLL4;SNAI2;MAML2;ADAM10;STAT1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.30854223609536024,1.0949062169836323,0.2459546925566343,0.7702396346271654,1.0,83/476,14.38%,LEF1;MECOM;PLCB1;ETS1;FLI1;PDGFB;NOTCH4;TRIM16;ZIC3;TBX1;PPARD;SOX17;AFAP1L2;FZD4;MEF2C;RYBP;NCOA1;SMARCA2;SP100;FOXO1;FOXL2;RPS6KA1;ACVRL1;NOTCH1;KLF2;ZBTB16;WNT7A;IKBKB;HHEX;FOXF1;RREB1;CTNNB1;CREB1;MRPL12;KLF1;TAL1;CD4;CAMKK2;CD38;KLF4;RET;STAT1;NR1H2;DNM2;SOX18;BRCA2;HINFP;KAT6A;JUN;KCNH2;TGFB1;YWHAH;KLF6;FOXP3;LRP5;CDK5RAP2;ARID1A;HMGA1;UBE2V1;ELF2;SMAD5;BRD4;NR5A2;CTCF;HIF1A;SOX10;RNF187;RAI1;TFEB;MAPRE3;SOX11;NAA16;PPARG;HIPK2;EDF1;BRPF1;SOX9;HMGB2;NAT14;BCL10;SP1;PIM2;BICRA
prerank,aorta development (GO:0035904),-0.4544664131026136,-1.0945019786410408,0.34966592427616927,0.7720360554646959,1.0,7/14,10.98%,ROBO1;LRP1;PDGFRB;PKD2;JAG1;EFEMP2;ROBO2
prerank,aerobic respiration (GO:0009060),-0.41995033378621405,-1.094276255990587,0.3566265060240964,0.7714139130257883,1.0,9/20,20.26%,SIRT3;SDHC;MDH2;SDHB;MTFR1;SLC25A14;SURF1;MTFR2;UQCRC2
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4089184751840315,-1.0940456169721262,0.3268765133171913,0.7708113979725458,1.0,6/21,12.43%,CXADR;AKAP13;SLC8A1;MYH11;KDM6B;BMP2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.23750466882606544,-1.0939765951844123,0.0,0.7697508598516615,1.0,343/1668,16.32%,BMP6;AUTS2;PID1;FOXP2;PBX1;PRDM6;IGF1;SOX5;MAF;FHL2;ZIC1;NFIA;ZEB2;EGFR;NR2F2;ZIC4;AEBP1;BMPR1A;GLI3;ZBTB7C;DCN;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;SSBP2;BMP5;HOXC4;FGFR2;HOXC6;ZNF462;BMP4;KANK2;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;FGF1;DDX5;PPARGC1B;FNIP1;SMAD6;NR6A1;RGMA;HOXA3;HOXA5;NFAT5;PKD1;MEOX2;THRB;TNRC6A;FRK;HDAC4;GABPB2;CUX1;TRAK1;MXI1;PER3;IKZF2;HOXB4;WWOX;PRRX2;CREB3L2;TEF;IL18;SALL1;RHOQ;IMPACT;NR1D2;HOXB6;ZHX2;CCNT2;KIT;FOXC2;DNMT3A;FOXC1;CAMK2D;BCOR;ARRB1;TBX15;KCNIP3;HIVEP2;MLXIP;OGT;SUFU;VGLL3;PLAGL1;CDK8;PPARGC1A;RBPJ;HOXA7;BAZ1B;PKD2;DAB2;FGF2;PIAS1;MKX;ZNF367;KDM7A;EHMT2;RORA;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;ANXA4;HDGFL3;PPARA;KAT6B;PBX4;HIF3A;RUNX2;KLF3;PURG;MED23;CTR9;SIX1;TBX18;EBF4;ZNF25;CRTC3;ZMYM5;IKZF4;BCL6;TEAD3;CBX7;IGF2;TSHZ1;SSBP3;CHD2;HEYL;HOXC8;NR3C2;PAXBP1;DACT1;MEIS1;PBX3;SMARCC2;GLI1;CCN1;ZEB1;SMAD9;KDM2A;CCNL1;ZNF568;KDM3B;LCOR;FOXJ2;NFATC4;ATF5;EBF2;AGO2;ELF4;ZSCAN29;SOD2;KLF15;ATN1;CHD3;JAG1;CHD8;PRKN;CBX5;RFX7;SMARCD3;FHOD1;MITF;FBXL19;KDM5B;APOE;FOXL1;MET;KDM6B;ATM;AKAP8L;TNIP2;YAP1;SMARCB1;RBBP8;KDM2B;MED25;POU6F1;RBAK;CHD4;TNRC6B;HSF2;ATOH8;SMURF2;CREB3L1;USP2;STAT5A;ZNF23;FOXO3;CXXC5;SOX6;PCGF2;MGA;TGFB3;EZR;SLC30A9;PPM1D;BRD9;TWIST2;DDX17;ZNF483;ZKSCAN7;ARNT;ELP3;CDH13;ITGB1BP1;CEBPB;ELK1;SLC9A1;CCNC;SP140;ZNF507;NOP2;EZH1;GATA6;ZNF697;SMARCA1;ZNF182;RNF10;ZBTB38;CCNH;NR2F1;URI1;ARID3A;PARP1;ZNF148;CRY2;PPP3CB;NUCKS1;CHUK;ETV1;MED14;WWP2;KDM1A;CAPRIN2;CREBRF;TFCP2L1;RXRA;PHF8;NFX1;RFXAP;ABL1;CDK7;ESR1;PIAS2;PGR;PSEN1;BMP2;BCAS3;ZNF219;HOXB5;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5;MED15;ZNF3;DVL2;SP3;PTEN;ZBTB4;SIRT2;MAFB;CAMTA2;USP9X;PAF1;PEX2;AKNA;SMARCA5;PSIP1;BRD8;MTF1;PIK3R1;GZF1;HOXA9;MAPK14;DDX3X;ATF2;IFI27;NR4A1;ZBTB1;EP300;DDRGK1;AHI1;MRGBP;CBX6;TSHZ3;TLR4;LAGE3;ZBTB7B;PHF12;ZFP64;E2F3;RFX5;ZSCAN20;CD81;LRP6;ELP4;MAP2K5;SAP18;SREBF1;GTF2F1;NFIB;IKBKG;MYBL2;ZSCAN2;PROX2;MTA3;NFIL3;RUNX1;CAMK1;HIVEP3;FOXJ3;ATMIN;LDB1;LDB2;MDFI;ZSCAN21;ATAD2B;MED30;ZBTB26;ZFP37
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.44484980010220987,1.093748500464354,0.33663366336633666,0.7725298529558732,1.0,8/26,16.18%,SHANK3;APP;WNT7A;NRXN1;TMEM25;MTMR2;NLGN1;RIMS2
prerank,negative regulation of cyclase activity (GO:0031280),0.4980865786062665,1.0933958226589189,0.3588342440801457,0.7727018601164872,1.0,2/14,2.58%,PALM;GNAI2
prerank,negative regulation of cell development (GO:0010721),-0.40405897732197604,-1.0930714649977178,0.3526448362720403,0.7710776608480264,1.0,3/25,1.30%,IGF1;FBN1;APPL2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.397505083450701,-1.0926980494202148,0.3573200992555831,0.7708224951333656,1.0,5/23,10.06%,UACA;BMP7;C1QTNF3;CCN3;PPM1B
prerank,glycosphingolipid metabolic process (GO:0006687),0.4079771448130369,1.0926777759181174,0.34294871794871795,0.7739193723716273,1.0,9/42,13.93%,ST6GALNAC3;ESYT2;NEU4;ESYT1;GLB1;GLTP;B4GALNT1;CERK;NEU2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3196800061830481,-1.0920743496436163,0.30824372759856633,0.7713183564471635,1.0,30/80,23.65%,PLPP3;ATP9A;GBF1;COPA;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;ERGIC3;COG4;ERGIC1;RAB6A;STX18;SCFD1;COPB2;SURF4;RACGAP1;ATP9B;ERGIC2;KIF18A;KIF15;CENPE;SCYL1;COPZ1;TMED9;KIF3C;COPG1;RER1;HTT
prerank,regulation of macrophage differentiation (GO:0045649),-0.4385755759992588,-1.0914861305264911,0.367032967032967,0.7717031214350119,1.0,9/15,36.36%,IL34;PRKCA;INHA;ID2;INHBA;FADD;LIF;HSF1;PF4
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.39717213915048666,-1.0913527863613204,0.3309002433090024,0.7708414060847655,1.0,6/23,8.93%,CAMK1D;MCU;SLIT2;RIPOR2;DAPK2;DPP4
prerank,microtubule anchoring at centrosome (GO:0034454),-0.4992078412508911,-1.0906362600625887,0.3763440860215054,0.7715768401029628,1.0,4/10,21.67%,NINL;PCM1;CEP19;BBS4
prerank,nerve growth factor signaling pathway (GO:0038180),0.5253537551241364,1.0902442988369678,0.3829787234042553,0.7795396101896174,1.0,2/10,3.02%,RAPGEF2;RAPGEF1
prerank,excitatory postsynaptic potential (GO:0060079),0.4716082037618598,1.0900573239616427,0.3641114982578397,0.7792957709067938,1.0,4/19,11.65%,MEF2C;GRID2;GRIN2B;GSK3A
prerank,tube closure (GO:0060606),-0.37393172171853734,-1.090014850455589,0.3252032520325203,0.7719451175651743,1.0,14/31,17.88%,LMO4;COBL;PLXNB2;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,lysine metabolic process (GO:0006553),-0.46271927268419466,-1.0898544618268244,0.3832199546485261,0.7698935440062217,1.0,8/12,34.93%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS;DLST;OGDH;CRYM
prerank,lysine catabolic process (GO:0006554),-0.46271927268419466,-1.0898544618268244,0.3832199546485261,0.7698935440062217,1.0,8/12,34.93%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS;DLST;OGDH;CRYM
prerank,regulation of protein autophosphorylation (GO:0031952),0.4131801920783669,1.0895407431738942,0.3281004709576138,0.7799284730935443,1.0,6/36,6.61%,PDGFB;ENG;PDGFD;CALM1;MRE11;PPP2R5A
prerank,histone H2B ubiquitination (GO:0033523),-0.49576552291369,-1.0892058225801267,0.3537117903930131,0.7705692059519846,1.0,4/10,13.81%,CTR9;UBE2E1;RNF20;PAF1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4693332185640503,-1.0891141142801117,0.3683127572016461,0.7695967595454837,1.0,6/12,24.33%,IRS1;IGF2;SNX5;ZBTB7B;PRKCZ;C1QTNF12
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5259577592485373,1.0884479785125678,0.38461538461538464,0.7820902306364418,1.0,4/10,7.11%,NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,macrophage chemotaxis (GO:0048246),-0.4886088102886773,-1.088217318873477,0.38065843621399176,0.7709161578709446,1.0,7/10,48.45%,CKLF;CCL2;CCL5;TAFA4;CXCL17;CCL3;LGALS3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.42834503133944746,1.0881849564975974,0.3792,0.7820302717213967,1.0,3/30,5.99%,BCL2L1;CXCL12;SNAI2
prerank,membrane depolarization (GO:0051899),0.4234594836711063,1.0880143055926121,0.3530377668308703,0.7816951567017166,1.0,6/32,8.57%,CACNA1A;CAV1;SCN1A;KCNH2;YWHAH;P2RX7
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3649861490243399,-1.0876548644625896,0.3268698060941828,0.7712882210953984,1.0,3/34,2.04%,IGF1;ROCK2;SLC2A13
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.37703585705296055,1.0871204874145342,0.34226190476190477,0.7832895611270747,1.0,13/60,12.22%,PDGFB;RGCC;PRKD2;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;CCT3;CCT5;ACD;POLG2
prerank,aorta morphogenesis (GO:0035909),-0.4313927494786713,-1.086711096609371,0.3613861386138614,0.7727350188386045,1.0,7/17,9.11%,LRP1;BMPR1A;PDGFRB;MYLK;RBPJ;JAG1;EFEMP2
prerank,neutrophil activation involved in immune response (GO:0002283),0.30858754349514544,1.0863935911507556,0.26973684210526316,0.7845623258694481,1.0,98/428,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;SYK;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5242553639890001,1.086364635612413,0.37142857142857144,0.7838988612276822,1.0,3/10,12.55%,ENPP2;LIPC;PNPLA8
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4327876624125809,-1.0863224068418844,0.3642691415313225,0.7726306048944461,1.0,6/16,22.50%,KLHL22;SEH1L;CLEC16A;RRAGA;FLCN;LARS1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5092450930745352,1.0861810256870106,0.3761467889908257,0.7836489473540716,1.0,3/13,8.30%,STX3;HSP90AB1;ABCA7
prerank,RNA catabolic process (GO:0006401),0.39779023048626727,1.0861240190075532,0.3522388059701492,0.7830560822103871,1.0,16/46,24.13%,NANOS2;ZPR1;DNA2;DCP2;DXO;PPP1R8;SND1;RNASEH2C;NUDT16;ZFP36L2;XRN2;METTL3;NCBP1;RNASE6;RIDA;NUDT12
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5072707718372067,1.0860976641118234,0.3677536231884058,0.7823997024426262,1.0,2/13,1.88%,PDGFB;PPARD
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.40023684639389867,-1.0859518539476631,0.3647959183673469,0.7724595882226939,1.0,7/24,10.21%,SEC24D;SEC24A;ACE;SEC31A;CANX;SEC23A;IDE
prerank,hexose biosynthetic process (GO:0019319),-0.3520938619390346,-1.0855074711075925,0.3269230769230769,0.7724460819849994,1.0,14/42,22.43%,RBP4;SLC39A14;CHST15;PPARGC1A;AKR1B1;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;ENO3;PGK1
prerank,regulation of telomerase activity (GO:0051972),0.40019838945211406,1.0854540341475347,0.33766233766233766,0.7833606371770839,1.0,19/45,25.84%,MEN1;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;TERF1;MAPK1;NAF1;MAP2K7;NVL;ERCC4;PINX1;PTGES3;MYC;NABP2;PNKP
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.42686021098286087,-1.085404097712498,0.35,0.7714705748217655,1.0,6/18,12.43%,HDAC4;FRS2;FZD7;CCN3;SOX6;BMP2
prerank,primary neural tube formation (GO:0014020),-0.3780311537915601,-1.0853735273750047,0.3379501385041551,0.7703447758599745,1.0,14/30,17.88%,LMO4;COBL;PLXNB2;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3858218872453983,-1.0852937777854785,0.35,0.7693617392734761,1.0,10/29,23.27%,COPA;COPZ2;COPB1;TRAPPC3;RAB6A;TRAPPC10;COPB2;GOLGA5;COPZ1;COPG1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3712727315454986,1.0851015838880045,0.33234859675036926,0.7835210241846311,1.0,13/62,5.48%,ARHGEF3;RASGRP4;NET1;F11R;ADGRG1;LPAR6;RAPGEF1;PRAG1;NOTCH1;LYN;GRB2;MAPRE2;STK19
prerank,renal filtration (GO:0097205),0.5319378313834204,1.084928478237615,0.40038684719535783,0.7832205082974284,1.0,2/10,1.05%,MYO1E;CD34
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.23073355177053587,-1.084825408443474,0.0,0.769478289172964,1.0,333/1646,16.32%,FOXP2;BNC2;PBX1;IGF1;SOX5;MAF;ZIC1;NFIA;ZEB2;EGFR;NR2F2;ZIC4;GLI3;DENND4A;COL1A1;ZBTB7C;PRRX1;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;EFEMP1;GLIS3;FOXD1;WNT4;HLF;SMAD3;PKNOX2;FOXP4;SSBP2;IL31RA;HOXC4;DKK3;BMP7;HOXC6;BMP4;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;DDX5;PPARGC1B;SMAD6;NR6A1;TULP3;MDFIC;HOXA3;HOXA5;NFAT5;MEOX2;RGMB;LBH;HDAC4;CUX1;TRAK1;MXI1;IKZF2;HOXB4;PRRX2;CREB3L2;TEF;SALL1;MAP3K5;FZD2;SNX6;SHC1;NR1D2;HOXB6;ZHX2;CCNT2;KIT;CDH1;FOXC2;LOXL3;FOXC1;CAMK2D;BCOR;TGFBR1;ARRB1;TBX15;HIVEP2;MLXIP;OGT;SUFU;VGLL3;PLAGL1;PPARGC1A;RBPJ;ZNF423;HOXA7;BAZ1B;FGF2;PIAS1;MKX;ZNF367;KDM7A;RORA;TBL1XR1;MDM4;AR;PER2;GLIS2;MAP3K12;ANXA4;HDGFL3;PPARA;KAT6B;PBX4;HIF3A;RUNX2;KLF3;PURG;MED23;CTR9;SIX1;TBX18;EBF4;ZNF25;SPP1;IKZF4;BCL6;TEAD3;NFXL1;IGF2;TSHZ1;CRABP2;POLR2A;CHD2;HEYL;FZD7;HOXC8;NR3C2;MEIS1;PBX3;SMARCC2;GLI1;ZEB1;SMAD9;ILF2;KDM2A;CCNL1;ZFAT;ZNF568;KDM3B;LCOR;FOXJ2;NFATC4;ATF5;EBF2;TGFB1I1;ELF4;ZSCAN29;GPBP1L1;PHC2;SOD2;KLF15;RUNX1T1;PFDN5;CHD3;CHD8;CBX5;VSX1;RFX7;SMARCD3;MITF;FBXL19;KDM5B;APOE;FOXL1;YAP1;SMARCB1;RBBP8;ZMYND15;KDM2B;TP53INP2;POU6F1;ACTR8;RBAK;CHD4;HSF2;ATOH8;SMURF2;SFMBT1;CREB3L1;MLLT3;AXIN1;STAT5A;ZNF23;PML;FOXO3;CDK16;SOX6;MGA;TGFB3;REXO4;VGLL4;BRD9;TWIST2;DDX17;GCFC2;ZNF483;ACTA2;ZKSCAN7;QARS1;ARNT;ELP3;CEBPB;CDK14;ELK1;CCNC;BTRC;SP140;TSC22D4;MBTD1;NIBAN2;ARHGEF11;NOP2;GATA6;ZNF697;SMARCA1;ZNF182;RNF10;CBFA2T2;ZBTB38;CCNH;NR2F1;URI1;NSD2;ARID3A;SETD5;ZNF148;CRY2;PRDM11;PBXIP1;PPP3CB;NUCKS1;CHUK;MTERF3;PRMT5;ETV1;MED14;WWP2;KDM1A;CREBRF;RNF20;TFCP2L1;SNX5;RXRA;PHF8;BCL7A;NFX1;TGFBRAP1;RFXAP;ABL1;ESR1;SBNO1;PIAS2;PGR;ATP8B1;PSEN1;BMP2;XRCC5;ZNF219;HOXB5;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5;PCBD2;ZNF3;DVL2;SP3;GCLC;ZBTB4;SIRT2;MAFB;CAMTA2;FBXW11;SMARCA5;ACVR1B;PSIP1;MTF1;GZF1;HOXA9;MAPK14;TCIM;ATF2;WNT11;NR4A1;ZBTB1;SPTY2D1;EP300;NONO;MRGBP;TSHZ3;ZBTB7B;PHF12;E2F3;RFX5;ZSCAN20;LRP6;ELP4;SAP18;SREBF1;NFIB;MYBL2;ZSCAN2;SPINDOC;PROX2;MTA3;LIMD1;TLE2;NFIL3;CCAR1;CDKN1C;RUNX1;MAP3K2;HIVEP3;FOXJ3;CRYAB;ATMIN;LDB1;APBB3;ZSCAN21;PSPC1;MED30;ZBTB26;ZFP37
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.47843937695278743,-1.0842247720942448,0.38478747203579416,0.7699521990053113,1.0,8/11,36.46%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4568424951667482,1.084171292394761,0.38250428816466553,0.7845605080143764,1.0,10/22,17.80%,SLC16A2;NES;GATA2;DLL4;INSM1;DISP3;TOX;PTPRZ1;PROX1;TRIM71
prerank,second-messenger-mediated signaling (GO:0019932),0.36166864065217125,1.0841131895999438,0.31874145006839943,0.784006062296764,1.0,9/82,5.27%,NDNF;NOS3;DDAH1;PLA2G4B;PPP1R9B;PLCG1;NOS2;CCR7;CAMKK2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4709940676203283,-1.083733381023804,0.3752808988764045,0.7701213386627381,1.0,4/12,6.13%,IGF1;IRS1;IRS2;IGF2
prerank,glycogen metabolic process (GO:0005977),-0.38296907996870805,-1.0832545570038152,0.3458646616541353,0.7701500728480746,1.0,9/27,11.70%,PRKAG2;PYGB;PHKB;PER2;PYGM;GAA;PHKA2;PPP1R3C;AGL
prerank,peptidyl-methionine modification (GO:0018206),0.5130412939438571,1.0829125346981232,0.3912280701754386,0.7864542486584436,1.0,3/12,13.94%,NAA60;NAA16;METAP2
prerank,aortic valve morphogenesis (GO:0003180),-0.37633484728397815,-1.082322270975079,0.31451612903225806,0.7714448324195451,1.0,9/30,7.70%,ROBO1;ROCK2;BMP4;ELN;SLIT2;SMAD6;HEYL;EMILIN1;JAG1
prerank,regulation of secretion (GO:0051046),0.5073245437813325,1.082153282289812,0.3904761904761905,0.7876836192211315,1.0,4/13,14.50%,MYO6;KCNQ1;ACSL3;SGK1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.49174130940325134,-1.0821190870523358,0.3822314049586777,0.7708109930287591,1.0,2/10,2.33%,ACTN2;CARMIL1
prerank,defense response to tumor cell (GO:0002357),-0.497011010795107,-1.0820500770576489,0.35294117647058826,0.7697890076048178,1.0,1/10,0.11%,RBMS3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3020985299103141,-1.0820391311239297,0.2993421052631579,0.7686312021792707,1.0,27/84,24.25%,CELF2;DDX5;SON;RBM39;FXR2;SRRM4;NOVA1;SRSF6;DDX17;SRSF4;RBM5;FMR1;NSRP1;RBFOX1;PCBP4;SAP18;C1QBP;U2AF2;TRA2B;CIRBP;MBNL2;ZC3H10;SRSF10;RBM24;SF1;KHDRBS3;CELF6
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.44379989185288593,-1.082029277683606,0.3411214953271028,0.7674693723237347,1.0,5/15,8.73%,PDGFRA;FGFR2;TGFBR1;SIX1;MTHFD1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.44476146459739035,1.0816209974038706,0.3686868686868687,0.7883437596681651,1.0,5/25,11.65%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A
prerank,neutrophil degranulation (GO:0043312),0.3071917843700056,1.0815168016760435,0.28399122807017546,0.7879075471407798,1.0,97/425,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,long-term memory (GO:0007616),-0.41989679483342224,-1.081442243242848,0.34966592427616927,0.7679511739033773,1.0,5/19,15.21%,NFATC4;APOE;PJA2;LDLR;RASGRF1
prerank,embryonic organ development (GO:0048568),0.3820067918644732,1.0813856187134536,0.35450516986706054,0.7875211078385655,1.0,8/61,3.19%,KITLG;MFSD2A;KDR;TGFB2;TEAD4;SOX17;NES;ZFPM1
prerank,response to glucocorticoid (GO:0051384),-0.38698239412859564,-1.0813294675494112,0.3542168674698795,0.7670996031566998,1.0,4/26,11.72%,SLIT2;ADAM9;ANXA1;GOT1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.35755133482091894,1.0808714925657728,0.33627019089574156,0.7881635669554964,1.0,18/86,10.41%,DAB2IP;TGFB2;DENND3;RASGRP4;ARHGEF2;RAPGEF1;NOTCH1;STARD13;LYN;GRB2;EPS8;STK19;EPS8L2;DENND4C;OPHN1;ARHGDIA;ARHGAP17;PDCD10
prerank,catecholamine metabolic process (GO:0006584),0.49256527456349825,1.0807028668284344,0.3672014260249554,0.7878809879807145,1.0,1/14,0.61%,DDC
prerank,regulation of extracellular matrix organization (GO:1903053),-0.43781096068240105,-1.0805528132479194,0.3372093023255814,0.7681087688101104,1.0,5/15,9.11%,LRP1;AEBP1;DDR1;FAP;EFEMP2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.41367610333315785,1.0805393038730569,0.3467094703049759,0.7875651310642534,1.0,13/36,19.23%,AQP11;RYBP;HSP90AB1;N4BP1;OPHN1;UBXN1;F8A1;RPL11;TRIM39;SDCBP;BAG6;PRKCG;USP25
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.5235619926326586,1.0805155315150348,0.38697318007662834,0.7868962034543747,1.0,4/10,8.10%,CALM1;NPPA;SRI;PDE4B
prerank,lytic vacuole organization (GO:0080171),-0.37435395482440087,-1.0801426077973162,0.3178082191780822,0.7680219885913886,1.0,12/32,18.25%,ABCA1;HOOK2;ARSB;GAA;CLN3;LRRK2;AKTIP;ACP2;GNPTAB;GRN;CLN6;MBTPS1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3957373633608594,-1.079960151950913,0.36387434554973824,0.7673346682574161,1.0,9/22,25.92%,ANK2;PKD2;SLC9A1;GSTM2;STAC3;JPH2;HTT;HAP1;GSTO1
prerank,negative regulation of protein secretion (GO:0050709),0.4035240467582061,1.0798899112737663,0.35927152317880795,0.787784285516832,1.0,3/38,2.95%,RAB11FIP1;CD200;RHBDF2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.27239624244954413,-1.0797365381960455,0.26344086021505375,0.766767327002455,1.0,50/186,17.47%,BICC1;RBMS3;TRABD2B;LRP1;GLI3;IGFBP2;DKK3;RNF43;IGFBP6;WWOX;INVS;AMFR;DAB2;IGFBP4;SFRP4;DACT1;GLI1;PFDN5;TMEM64;CHD8;PRKN;TLE3;APOE;PSME4;GRB10;NXN;MLLT3;AXIN1;VGLL4;CUL3;STK11;FUZ;PSME3;CXXC4;BMP2;EMD;NKD2;DVL2;LMBR1L;WNT11;LRP6;LIMD1;TLE2;MDFI;TSKU;MDK;SFRP1;LATS1;HIC1;DDIT3
prerank,mesenchymal cell differentiation (GO:0048762),0.38656151690317686,1.0796862760183963,0.3411949685534591,0.7875929920877337,1.0,8/51,5.99%,LEF1;ENG;TGFB2;NOTCH4;MEF2C;NOTCH1;CTNNB1;SNAI2
prerank,protein-containing complex subunit organization (GO:0043933),0.34981271817430337,1.0793056445958025,0.3382157123834887,0.7878763401178768,1.0,10/109,6.92%,OCLN;SLC2A1;FAS;MAGI1;CD40;PARD3;CD2AP;VIL1;CARD10;CLDN14
prerank,regulation of establishment of protein localization (GO:0070201),0.5000888660013606,1.0791169018597668,0.3914656771799629,0.7876058726593199,1.0,4/13,16.25%,CORO2B;CEP135;DNAJA1;PTP4A3
prerank,regulation of cellular senescence (GO:2000772),0.43022278976136885,1.0781955018072011,0.36902800658978585,0.7892557004919977,1.0,9/28,16.58%,B2M;YBX1;VASH1;TERF2;HMGA1;MAP3K3;ABI3;RBL1;HMGA2
prerank,rRNA methylation (GO:0031167),-0.3980035015162351,-1.0780914790375402,0.3380952380952381,0.7702043487030803,1.0,14/22,39.27%,NOP2;MTERF4;NSUN3;NSUN4;EMG1;FDXACB1;TRMT112;DIMT1;MRM3;MRM1;FTSJ3;BUD23;NSUN5;FBLL1
prerank,sphingosine biosynthetic process (GO:0046512),0.5158013892125342,1.0780432854643998,0.40608228980322003,0.7881666159867999,1.0,3/11,6.96%,ACER2;ACER1;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.5158013892125342,1.0780432854643998,0.40608228980322003,0.7881666159867999,1.0,3/11,6.96%,ACER2;ACER1;SPTLC2
prerank,protein-containing complex assembly (GO:0065003),0.3146525331149171,1.0778608258154163,0.3033175355450237,0.7879127067574956,1.0,42/259,14.70%,LEF1;OCLN;SLC2A1;CXCL12;FAS;MAGI1;CD40;TIAM1;PARD3;CD2AP;MEN1;CTSC;VIL1;CTNNB1;CARD10;TCF7;DBNL;ADAM10;AIM2;CLDN14;TLE4;AP2M1;TGFA;P2RX7;CAPG;RSPH4A;AXIN2;CASP8;SAMM50;FERMT2;PEX14;TLE1;RANBP9;CSNK2B;RAB1A;CNIH3;SOX9;PDCD6;RBX1;TSPAN33;SH3BGR;NCKAP1L
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.40973332294449993,-1.07772849574553,0.34782608695652173,0.7700501076467385,1.0,3/20,3.85%,ACTN2;OSR1;CAMK2D
prerank,monocyte differentiation (GO:0030224),-0.48713173959162426,-1.0776731525884118,0.3774403470715835,0.7690029128254171,1.0,2/10,1.89%,IL31RA;BMP4
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4767153045768889,1.077586463750734,0.3893653516295026,0.7878918443070534,1.0,3/17,1.88%,ADIPOR2;CAV1;PPARD
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4024649270936158,-1.0772302662988618,0.3645320197044335,0.7678478118163281,1.0,11/23,18.58%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;SLC2A10;EP300;CDKN1C;CITED2;FLCN
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4024649270936158,-1.0772302662988618,0.3645320197044335,0.7678478118163281,1.0,11/23,18.58%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;SLC2A10;EP300;CDKN1C;CITED2;FLCN
prerank,cardiac myofibril assembly (GO:0055003),-0.44702164946576084,-1.0771974174911982,0.38344226579520696,0.7667623624918366,1.0,3/15,3.88%,PDGFRB;PDGFRA;OBSL1
prerank,neutrophil mediated immunity (GO:0002446),0.3053989440766146,1.0769935932026082,0.2891566265060241,0.7887502948630887,1.0,98/432,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;ADAM17;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,response to glucose (GO:0009749),0.39332645978204694,1.0766649994890285,0.3427230046948357,0.7888912095600367,1.0,2/46,2.00%,IGF1R;UNC13B
prerank,tryptophan catabolic process (GO:0006569),-0.4798025053944757,-1.076559382218873,0.3986636971046771,0.7673590113701892,1.0,6/11,30.37%,AFMID;KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,zymogen activation (GO:0031638),-0.3445322680036926,-1.076514796104398,0.31891891891891894,0.7663149262706065,1.0,8/39,13.45%,CYFIP2;MMP14;ASPH;CTSL;KLK2;PERP;TBC1D10A;CTSH
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5239734907563506,1.0758630342965585,0.4047186932849365,0.7901989904914344,1.0,5/10,13.39%,TBX1;STAT1;LRP5;TGFBR2;SOX9
prerank,regulation of dendrite development (GO:0050773),0.40865368370781935,1.0754704834676887,0.36867862969004894,0.7905394604427455,1.0,7/37,8.49%,MFSD2A;DAB2IP;LRP8;NEDD4L;LZTS1;CSMD3;PTN
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.3874335805700172,-1.0752354890073643,0.3399014778325123,0.7686750404327829,1.0,4/27,7.09%,IGF1;PDGFRA;S100A6;PDGFC
prerank,proteolysis (GO:0006508),-0.2658872385395023,-1.0751035010600758,0.23308270676691728,0.7678345098506836,1.0,46/252,15.77%,TRABD2B;CPQ;AEBP1;ADAMTS12;PCSK5;MMP14;HTRA3;ADGRV1;MMP16;F3;ANPEP;OGT;SUFU;FAP;GGT5;BACE2;CTSL;MMP2;NAALAD2;ACE;ENPEP;ADAM19;NPEPPS;CPXM1;DPP4;CPXM2;ADAM33;CUL7;IDE;ATG4A;CLN3;MMP19;AFG3L2;SENP6;PSEN1;HTRA1;CTSH;HTRA4;HTRA2;CTSZ;CAPN1;CASP3;SDE2;ADAMTS9;HM13;ZMPSTE24
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4682268496429321,-1.075010423116848,0.3807531380753138,0.7669252053224594,1.0,4/11,13.30%,CAMK2D;CACNA2D1;CACNB2;CACNB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4676109753053456,1.0749925690368858,0.3732142857142857,0.7910534074864252,1.0,3/18,8.93%,SHANK3;NPS;NRXN1
prerank,cellular amino acid catabolic process (GO:0009063),-0.30173914014903563,-1.0745624268963574,0.3545816733067729,0.7670156356316731,1.0,30/87,21.62%,DDO;ACADSB;ASPA;ALDH7A1;IVD;HNMT;MCCC2;AUH;HIBADH;ABAT;ALDH4A1;BCKDHB;PRODH;GOT1;HIBCH;GLUL;GLS;GLS2;HMGCLL1;KYAT1;PHYKPL;HYKK;SARDH;PIPOX;BCKDK;FAH;KMO;KYNU;GOT2;AASS
prerank,calcium ion import (GO:0070509),-0.3842598557631867,-1.074484349765787,0.34413965087281795,0.7660673556217847,1.0,8/28,12.08%,CACNA1C;MCU;CACNA1G;SLC8A1;CACNA1D;AFG3L2;TRPC4;CACNB2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4531914905864198,-1.0739487729823571,0.3870246085011186,0.7664546332348329,1.0,4/13,6.13%,IGF1;IRS1;IRS2;IGF2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.43906188577414007,1.0738749692707839,0.36348408710217756,0.7932031253000891,1.0,3/25,5.96%,PLAUR;TNFSF10;BIK
prerank,cristae formation (GO:0042407),0.4430990518953923,1.0737085993112463,0.3990228013029316,0.7928993285464238,1.0,9/27,19.22%,ATP5F1E;ATP5MC2;LETM1;ATP5PO;SAMM50;ATP5F1A;ATP5MF;ATP5PF;CHCHD3
prerank,positive regulation of cell cycle (GO:0045787),0.3765401980334209,1.0736770039671608,0.3495702005730659,0.7922516096711418,1.0,12/62,10.12%,PDGFB;TGFB2;APP;TBX3;CCNY;RGCC;DUSP3;TAL1;PKN2;CCND3;ADAM17;PTK6
prerank,regulation of blood coagulation (GO:0030193),-0.38679424322127115,-1.0736074851643498,0.3541147132169576,0.7662987207961613,1.0,8/27,8.01%,TFPI;VTN;ST3GAL4;THBS1;FAP;THBD;EPHB2;APOE
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.41328919342126536,-1.073316087999915,0.3629807692307692,0.7659397710811875,1.0,7/18,19.78%,IRS1;PRKN;CCN3;KCNB1;SFRP1;INHBB;ADRA2A
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.431664558709258,-1.07303739821058,0.3865336658354115,0.7655745369519432,1.0,3/17,11.34%,IGF1;APOE;RTN1
prerank,oligodendrocyte development (GO:0014003),0.49962686499006037,1.0723490541191658,0.39928698752228164,0.7948815353889793,1.0,9/15,28.61%,B4GALT5;EIF2B1;EIF2B2;SOX10;TPPP;EIF2B4;PLP1;MYRF;HES5
prerank,activation of GTPase activity (GO:0090630),0.34891735930918005,1.072337986603086,0.3610719322990127,0.7941870986771941,1.0,15/89,6.47%,TBC1D4;ARHGEF15;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;TIAM1;ABR;RALGAPA1;TBC1D12;TBC1D2;CCR7;USP6NL;TBC1D5;ARHGAP25
prerank,transition metal ion homeostasis (GO:0055076),0.4314420181919596,1.0720124142889897,0.36867862969004894,0.7942473106543821,1.0,3/28,5.15%,SLC40A1;B2M;XIAP
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5130035200983474,1.0717705193746019,0.38691588785046727,0.7941611059362155,1.0,4/11,10.45%,ARHGEF2;PELI1;BIRC3;CASP8
prerank,regulation of cellular component movement (GO:0051270),0.39024898465113017,1.0716821027678696,0.37910447761194027,0.7936328574699993,1.0,10/49,7.03%,ETS1;FES;SP100;PRAG1;LYN;PKN1;INPP5F;ACTN4;PKN2;ACTN1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.399491441477974,-1.071078414047317,0.35308056872037913,0.7698505406516049,1.0,8/21,22.96%,SLC30A10;PPARA;PRKN;TRAP1;SIRT2;PAX2;BRCA1;AATF
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4255536402352902,-1.0705597663293454,0.38288288288288286,0.7701294279711837,1.0,9/15,32.35%,BCL2;PRKN;KDM1A;CD44;TAF9B;TAF9;ARMC10;SIRT1;MUC1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.45684552077448465,-1.069465182081629,0.3857758620689655,0.7719686280613202,1.0,6/12,28.15%,PLK5;SDE2;WAC;RPS27L;CCND1;PLK3
prerank,myoblast differentiation (GO:0045445),-0.44821269711820044,-1.0693764444874951,0.3827956989247312,0.7710667249167852,1.0,5/14,9.76%,IGF1;DDX5;JAG1;PLEKHM3;DDX17
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2974712479343631,-1.0689021313232858,0.3166023166023166,0.7712154026944332,1.0,22/101,15.71%,SAMD4A;PLD1;CYFIP2;THBS1;ASPH;OGT;ATG10;DACT1;PLXNB2;AGTR1;FXR2;PERP;EZR;VGLL4;BTRC;TBC1D10A;EIF3C;FMR1;FBXW11;DDX3X;LARP6;YTHDF1
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4060373642260915,-1.0686149472692645,0.3738095238095238,0.7708032586262382,1.0,4/18,17.17%,EGFR;LCOR;ESR1;SFRP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.38485370142889797,1.06848307696048,0.35303265940902023,0.801224199701911,1.0,16/51,19.88%,CXCL12;IL6R;PTK2;CCR7;MAPK3;LGALS9;PTN;PGF;ADAM17;CCL1;MAPK1;GAS6;CCR2;CSF1R;MOSPD2;AKIRIN1
prerank,regulation of response to external stimulus (GO:0032101),0.33746023736817454,1.0683944361381579,0.3641160949868074,0.8007235416094453,1.0,22/121,13.94%,SEMA7A;IL1R1;CAV1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;CALM1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4;USP18;CYRIB;CYLD;STK24;METAP2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4216010735616826,-1.067897356356861,0.3681710213776722,0.7716017762186383,1.0,2/17,2.25%,ANK2;SNTA1
prerank,phagosome maturation (GO:0090382),0.41813317769249825,1.0678489763666081,0.38041733547351525,0.8014413503547578,1.0,6/35,7.82%,RAB31;ATP6V0A1;MCOLN1;PIKFYVE;RAB39A;RAB34
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5095005830319748,1.0674711828485879,0.39849624060150374,0.8016943600944381,1.0,5/11,23.90%,ARID1A;SMARCD1;ZMIZ2;SERTAD2;PADI2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.38597349812125464,-1.0674509278735804,0.35368956743002544,0.7717082586358929,1.0,3/26,5.14%,LGR4;APPL2;FLOT2
prerank,glutathione biosynthetic process (GO:0006750),0.5152876889180461,1.0672143217322672,0.427255985267035,0.8016659522663374,1.0,2/11,5.09%,GCLM;MGST2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.45579037211002477,-1.0668411781474914,0.40176600441501104,0.7722924083825442,1.0,4/12,13.58%,CDC14B;GOLGA2;BTRC;PTEN
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.43111002203923826,1.0666073759729875,0.37110016420361247,0.8025492052860288,1.0,8/28,15.10%,DAB2IP;PTK2;CTSC;FBXW7;PSMC6;SMURF1;RNF139;BAG2
prerank,response to interleukin-1 (GO:0070555),0.3602787134295885,1.0660639193734878,0.34017595307917886,0.8031924333469043,1.0,11/73,13.39%,DAB2IP;APP;IL1R1;TNFRSF11A;CD40;HYAL2;LGALS9;IRAK2;CCL1;HIF1A;SOX9
prerank,positive regulation of catabolic process (GO:0009896),0.3679245710720383,1.0654244979100995,0.3768545994065282,0.8041630746942329,1.0,15/65,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;SMURF1;GSK3A;VSIR;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;APC
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.45212435272174684,-1.0650875891866676,0.4031890660592255,0.7759154681370654,1.0,4/13,15.19%,SAR1A;SEC16B;SEC16A;CD81
prerank,regulation of biosynthetic process (GO:0009889),0.5185844120685423,1.0648553147397848,0.41100917431192663,0.8048401651035595,1.0,2/11,6.23%,PIKFYVE;SLC25A33
prerank,cellular protein catabolic process (GO:0044257),0.3776301414333037,1.0647273116176739,0.3789004457652303,0.8044674058971659,1.0,23/59,23.75%,DAB2IP;DENND3;CTSC;CTSW;CTSK;CTSO;UBE2G1;AP2M1;BNIP3L;MALT1;CASP8;AP2B1;AFG1L;CTSS;UBE2G2;CAPN2;RSPRY1;PISD;AP2S1;BNIP3;LGMN;RIPK1;LONP1
prerank,bicarbonate transport (GO:0015701),0.43972698268812316,1.064256618119104,0.38651315789473684,0.8049600463407697,1.0,2/25,1.24%,CA4;SLC39A8
prerank,inflammatory response (GO:0006954),0.32355911467785536,1.0637150610163941,0.35625,0.8055909433254355,1.0,26/195,11.80%,MFHAS1;LY75;ADGRE5;AFAP1L2;F11R;NOD1;CD40;PLA2G4B;HDAC9;IL10RB;IKBKB;NOS2;CCR7;NRROS;LGALS9;PXK;TGFB1;CXCR2;SIGLEC1;AGTR2;CYBB;TAC4;CCL1;S100A8;RAC1;TNFRSF4
prerank,negative regulation of viral transcription (GO:0032897),0.5040804414517512,1.0633780316566086,0.39107142857142857,0.8057564094131163,1.0,1/13,2.37%,TRIM14
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4509176683478177,-1.06333076788466,0.41002277904328016,0.7796799216678125,1.0,4/12,19.09%,SEH1L;CENPC;RMDN1;CENPE
prerank,regulation of TORC1 signaling (GO:1903432),-0.35683856881082854,-1.0629025811652317,0.3674540682414698,0.779828824662973,1.0,9/33,18.58%,RNF152;KLHL22;SEH1L;ATM;STK11;CLEC16A;RRAGA;SMCR8;FLCN
prerank,positive regulation of protein metabolic process (GO:0051247),0.3410457119409206,1.0628050729300231,0.35607094133697137,0.8064490059713268,1.0,24/110,15.84%,DAB2IP;APP;NFKBIA;NKD1;NEDD4L;FOXO1;KLF2;WNT7A;KLF4;NR1H2;EGLN2;OAZ1;TGFB1;SMURF1;GSK3A;TNFSF12;RANBP9;RAB1A;TNFAIP3;ASB5;BCL10;AREL1;PLK2;APC
prerank,reverse cholesterol transport (GO:0043691),0.4851280833242341,1.062514318981923,0.3902877697841727,0.8064855226448346,1.0,3/13,10.76%,SCARB1;ABCG1;LIPC
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3868138362477401,-1.0624335012704662,0.3612565445026178,0.779974400509792,1.0,8/25,11.13%,SLIT2;CAPZB;ARHGAP24;KANK1;PRKCD;YAP1;PFN2;ARHGAP44
prerank,cellular response to light stimulus (GO:0071482),0.3692870815320575,1.0620997768711737,0.37300435413642963,0.8068219151433429,1.0,18/66,21.62%,POLK;N4BP1;OPN5;RHBDD1;GPR52;COPS9;EIF2AK4;GNB1;OPN3;TRIAP1;RRH;PTPRK;NSMCE3;BAK1;NOC2L;POLD1;METTL3;ERCC4
prerank,regulation of cellular localization (GO:0060341),-0.3397700688935942,-1.0619515346561696,0.36,0.7801729078439316,1.0,14/46,16.50%,ADCY5;GSN;PARD6G;EFNA5;CAMK2D;STXBP4;PRKN;CDK16;PARP1;LRRK2;KDM1A;BRSK1;MAP2;NR1H4
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3409348334961569,1.0607335443738537,0.3821138211382114,0.8096727855792359,1.0,37/109,21.88%,MAP3K1;LYN;PLCG1;IKBKB;CALM1;GRB2;SOS1;MAPK3;PSMB3;JUN;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;PPP3CA;RAC1;SYK;PPP3R1;PIK3CB;PSMB10;BCL10;LCP2;CARD11;PSMA8;MAPK1;LAT2;PAK2;SKP1;PSMD9;PLCG2;MAP2K7;VAV1;CUL1;PSMC3;PSMD1
prerank,hyaluronan catabolic process (GO:0030214),-0.414023850575126,-1.060714663850272,0.39655172413793105,0.7824200020617544,1.0,10/18,27.44%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;CD44;LYVE1;HMMR;GUSB;HYAL3
prerank,positive regulation of glucose import (GO:0046326),0.4482911385639109,1.0605530847350932,0.4056291390728477,0.8094241046820077,1.0,2/21,0.95%,OCLN;INSR
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4526559215513374,1.0603074859978951,0.4114671163575042,0.8093530008116704,1.0,3/20,5.09%,GATM;GCLM;MGST2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.41798720035009806,1.0602417235238515,0.367816091954023,0.8087989544463127,1.0,6/29,8.09%,ENG;S1PR1;ZFPM1;NOTCH1;SMAD7;TGFB1
prerank,signal transduction by p53 class mediator (GO:0072331),0.41104427482151285,1.0601595546785294,0.38287560581583197,0.8082495042003507,1.0,6/30,8.89%,PPP1R13B;ACER2;MYO6;HINT1;JMY;GREM1
prerank,positive regulation of cell projection organization (GO:0031346),0.3392490839424075,1.0598896590656908,0.3617886178861789,0.8082535449010997,1.0,23/115,10.12%,ITGA6;NDNF;DAB2IP;RAPGEF2;SCARF1;FES;FZD4;PLXND1;RAPGEF1;TIAM1;PRKD1;LYN;SNX3;FUT9;RET;LRRC7;SLITRK1;TWF2;PTN;SERPINI1;ARHGDIA;METRN;PTK6
prerank,acute-phase response (GO:0006953),0.48963690985930897,1.0595706073924234,0.41208791208791207,0.8083818506419477,1.0,2/12,3.44%,IL6R;SIGIRR
prerank,ephrin receptor signaling pathway (GO:0048013),0.3544399665192705,1.0595148715526024,0.3715083798882682,0.8078117432820727,1.0,26/82,14.03%,ANKS1A;PTK2;KALRN;ARPC4;TIAM1;ACTB;LYN;EPHA4;FYN;YES1;EPHB4;ANKS1B;EFNA1;AP2M1;ARHGEF7;ARPC3;PAK1;ACTG1;APH1A;GRIN2B;RAC1;HRAS;AP2B1;EPHB1;SDCBP;GIT1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3417156742450697,-1.059349730392877,0.36,0.7851508384938639,1.0,8/41,11.45%,ITPR1;SLC8A3;CACNA2D1;PKD2;FGF2;SLC8A1;ITPR2;IBTK
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.4255578663993667,1.0593350452217236,0.3889763779527559,0.8075446869756003,1.0,8/29,18.18%,HSP90AB1;MRE11;PPIA;TERF2;ACD;TERF1;NHP2;RPA1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.33367500147492407,1.0586698981713696,0.35968379446640314,0.80853188886812,1.0,11/122,3.59%,NAMPT;PDGFB;KDR;INSR;TGFB2;BCAR3;RGCC;NIBAN1;NOD2;PRKD2;NLRC5
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3225765432998801,-1.058271356427019,0.3475783475783476,0.7869978291988686,1.0,11/51,8.50%,GAS7;DCLK1;NBL1;BMP7;NRK;DTNBP1;NGF;MAP1S;ATP7A;EPB41L3;ANKRD27
prerank,protein monoubiquitination (GO:0006513),-0.3467695104746783,-1.0579810827028933,0.34472934472934474,0.7867003104438208,1.0,11/36,15.38%,KLHL22;CTR9;UBE2R2;MGRN1;PRKN;UBE2E1;CUL3;HUWE1;RNF20;PAF1;UBE2B
prerank,actin filament bundle assembly (GO:0051017),-0.3627916798919715,-1.057890585342705,0.35170603674540685,0.7858295782974201,1.0,3/33,0.50%,CALD1;DPYSL3;PAWR
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.4488882844417146,-1.0578577381524088,0.4088888888888889,0.7847755446373293,1.0,3/13,4.32%,MDFIC;APOD;SUFU
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.506009745522714,1.0578111220591844,0.3973384030418251,0.8100288185369209,1.0,4/12,7.36%,PTK2;LYN;MAPK3;BST2
prerank,positive regulation of signal transduction (GO:0009967),0.31232753732471763,1.0577188711134307,0.36893203883495146,0.8095462361791704,1.0,27/238,6.54%,TEK;SHANK3;JCAD;DAB2IP;MACF1;LIMS2;EPN2;TGFB2;NOS3;NOTCH4;TRIM16;JAG2;TSPAN5;FAS;TPD52L1;NOD2;TSPAN14;NOTCH1;PRKD2;VWF;KLF2;WNT7A;HHEX;DLL4;MAML2;HOMER1;CRADD
prerank,response to reactive oxygen species (GO:0000302),-0.318432329680432,-1.0572040011401267,0.3323076923076923,0.7854746433906555,1.0,10/54,11.92%,EGFR;PDGFRA;TPM1;APOD;ADAM9;PKD2;SOD2;APOE;CHUK;MPV17
prerank,supramolecular fiber organization (GO:0097435),0.3046876565430106,1.0569313788221077,0.3348623853211009,0.8108533044544622,1.0,59/333,11.52%,ITGA6;FLII;HIP1;COLGALT2;MYO1D;MYO1E;RHOBTB1;SHROOM4;TGFB2;SHROOM1;PGM5;APP;TSPAN5;ELMO1;HIP1R;B2M;ARHGEF2;COL4A2;FGF13;TSPAN14;CD2AP;EVL;PXDN;ELMO2;PPP1R9B;MYO6;STMN1;CCDC13;NPPA;CLIP1;HSP90AB1;RHOB;TPM3;CCDC88A;NCKAP5;CCDC88B;KIF2A;ADAM10;ARHGAP25;STMN3;ACTN1;COL4A1;STMN4;KLHL24;PIN1;PLOD3;GREM1;COL9A3;TMOD1;MYO1F;ARHGAP17;CLRN1;CRIPT;HOOK1;APH1A;TPM4;RAC1;MAP10;SLK
prerank,peptidyl-proline modification (GO:0018208),-0.3819072130272554,-1.0563726221587744,0.37817258883248733,0.7866620418135638,1.0,8/25,18.35%,FKBP5;PPIC;FKBP10;PPIL2;P3H2;OGFOD1;PPIH;NKTR
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.45389347600904395,1.056370126812905,0.39783001808318263,0.811563814663519,1.0,3/18,4.05%,RASIP1;HEG1;STMN1
prerank,histone methylation (GO:0016571),-0.38584974206569633,-1.056231796647904,0.37851662404092073,0.7858988989206107,1.0,17/26,39.45%,EHMT2;SMYD3;PRMT5;PRMT8;EZH2;TRMT112;NSD1;SETD6;SMYD2;CREBBP;PRMT2;CARM1;PRMT1;NTMT1;PRMT6;FBLL1;NSD3
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5081174340258714,1.0555868154117625,0.4257246376811594,0.812934747423224,1.0,3/12,9.63%,LAMA5;ACTB;ACTG1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3727492251807539,1.0546774697210577,0.3782608695652174,0.8145221358492001,1.0,7/62,6.64%,BCL2L1;CXCL12;PLAUR;ARHGEF2;PPIA;SNAI2;MCL1
prerank,ERBB signaling pathway (GO:0038127),0.3656346188817886,1.054553778689998,0.38705035971223023,0.814121621653184,1.0,17/64,10.31%,PTK2;PTPN12;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;PTPRR;TGFB1;TGFA;IQGAP1;SHC3;ADAM17;PTK6;PIK3C2A;GRB7
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.462100744302326,1.0545215881869894,0.4342560553633218,0.8134837037128657,1.0,2/18,5.07%,BCL2L1;SLC25A5
prerank,cholesterol efflux (GO:0033344),0.44954772690748535,1.0545191435093557,0.40436241610738255,0.8127702819357622,1.0,4/20,8.94%,SCARB1;ABCG1;ABCA7;NPC1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4871214450525514,1.0544291323739823,0.4203152364273205,0.8122797816469521,1.0,4/13,14.68%,LCMT1;CDK5RAP2;DUSP1;DYNC1LI1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.38118305727263624,-1.0543220200798513,0.3932038834951456,0.7898750008882826,1.0,6/23,12.32%,PRKAG2;CEMIP;BMP7;AXIN1;SPHK1;S1PR2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4385144760841956,1.0538049862685035,0.4077834179357022,0.813112747978736,1.0,4/21,4.54%,CAV1;CNKSR3;SMAD7;PDE4D
prerank,positive regulation of lyase activity (GO:0051349),-0.4328424084212842,-1.0537040319527538,0.42417061611374407,0.790537127426172,1.0,5/14,13.29%,CACNA1C;STIM1;CACNA1D;FXN;NF1
prerank,mononuclear cell differentiation (GO:1903131),-0.38833682232104666,-1.0533157989338988,0.38235294117647056,0.7905071910215652,1.0,3/24,1.89%,IL31RA;AXL;BMP4
prerank,regulation of T cell cytokine production (GO:0002724),0.4736612043045864,1.0530427236983975,0.4010416666666667,0.814349482471785,1.0,4/15,9.05%,B2M;SMAD7;FOXP3;MALT1
prerank,inositol lipid-mediated signaling (GO:0048017),0.3795301249164371,1.0528421802784387,0.3888048411497731,0.8141510017036658,1.0,3/50,0.56%,IGF1R;PLCB1;PLCB4
prerank,actin crosslink formation (GO:0051764),-0.4562369924546765,-1.0524044180342478,0.41435185185185186,0.7919999879408922,1.0,2/12,6.15%,DPYSL3;FLNA
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.4731370685912404,1.0520546845213186,0.4031141868512111,0.8155274825550324,1.0,6/16,18.32%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,regulation of JUN kinase activity (GO:0043506),0.4103768335146198,1.051450760664819,0.39389067524115756,0.8163954586030355,1.0,9/33,17.39%,DAB2IP;TNFRSF11A;NPPA;ARHGEF5;PAK1;DNAJA1;HIPK3;EDN1;MAP3K11
prerank,regulation of feeding behavior (GO:0060259),-0.4591971570659905,-1.0513539715965547,0.41318681318681316,0.79391098788952,1.0,1/11,1.10%,LEPR
prerank,regulation of cell development (GO:0060284),-0.3478318642339807,-1.051098749855526,0.3697916666666667,0.793493937874622,1.0,5/36,8.25%,NOTCH2;DOCK7;PER2;HEYL;YAP1
prerank,histone ubiquitination (GO:0016574),-0.3963195193180792,-1.051058436839694,0.3915211970074813,0.7924863063596861,1.0,7/21,15.79%,CTR9;UBE2E1;HUWE1;RNF20;PAF1;UBE2B;UBR2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.23490104024309588,-1.050956236911883,0.16666666666666666,0.7916264849470604,1.0,177/807,16.32%,BMP6;FOXP2;PRDM6;FHL2;ZEB2;NR2F2;AEBP1;GLI3;RARB;GLI2;ZFHX3;GLIS3;FOXD1;WNT4;SMAD3;FOXP4;DKK3;BMP7;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;FNIP1;NR6A1;MDFIC;THRB;LBH;FRK;HDAC4;CUX1;MXI1;PER3;WWOX;SALL1;SNX6;SHC1;IMPACT;NR1D2;ZHX2;FOXC2;LOXL3;DNMT3A;FOXC1;BCOR;KCNIP3;SUFU;RBPJ;ZNF423;HOXA7;DAB2;EHMT2;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;PPARA;KAT6B;RUNX2;CTR9;ZNF25;ZMYM5;IKZF4;BCL6;CBX7;IGF2;FLNA;HEYL;DACT1;SMARCC2;ZEB1;KDM2A;ZNF568;LCOR;ATF5;PHC2;RUNX1T1;PFDN5;ATN1;CHD3;CHD8;PRKN;CBX5;MITF;YAP1;ZMYND15;KDM2B;MED25;POU6F1;RBAK;ATOH8;SMURF2;SFMBT1;CREB3L1;USP2;PML;FOXO3;CXXC5;PCGF2;EZR;VGLL4;TWIST2;GCFC2;QARS1;CEBPB;BTRC;TSC22D4;MBTD1;NIBAN2;EZH1;GATA6;CBFA2T2;ZBTB38;NR2F1;URI1;PARP1;ZNF148;CRY2;PRDM11;PBXIP1;MTERF3;WWP2;KDM1A;RXRA;BCL7A;NFX1;ESR1;ATP8B1;PSEN1;BMP2;XRCC5;ZNF219;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;ZNF3;SP3;GCLC;ZBTB4;SIRT2;USP9X;PAF1;PEX2;FBXW11;GZF1;WNT11;IFI27;ZBTB1;EP300;NONO;CBX6;TSHZ3;ZBTB7B;PHF12;MAP2K5;SAP18;SPINDOC;MTA3;LIMD1;TLE2;NFIL3;CDKN1C;RUNX1;CRYAB;LDB1;LDB2;MDFI;PSPC1;ZFP37
prerank,regulation of interferon-alpha production (GO:0032647),0.4362146143082254,1.0508380551755667,0.42114384748700173,0.8172114393005233,1.0,6/23,11.01%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.39084399914642076,1.050320124915403,0.3898305084745763,0.8178269179607349,1.0,6/47,6.44%,CD34;RAPGEF2;CAV1;SNAI2;FYN;FBXW7
prerank,cellular response to cadmium ion (GO:0071276),0.433028104549505,1.048648398927424,0.40483870967741936,0.8213337932896909,1.0,12/24,16.69%,MAPK3;JUN;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MAPK1;SUMO1
prerank,ventricular septum development (GO:0003281),-0.3510031439192638,-1.0480957876828967,0.36363636363636365,0.7983910490934846,1.0,9/37,6.34%,ROBO1;TGFBR3;BMPR1A;ZFPM2;SLIT2;SALL1;TGFBR1;MDM4;HEYL
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.41946367719819394,-1.047892879523215,0.40420560747663553,0.7977567275923233,1.0,10/16,23.04%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3606415607996048,1.0475352084935579,0.3854014598540146,0.8235821199527833,1.0,14/69,12.55%,IGF1R;PLCB1;PLCB4;INPP5F;PLEKHA1;PIRT;CD160;HTR2A;PLCH2;PIK3C3;PIK3C2A;PLCH1;PIK3CB;ZFP36L1
prerank,regulation of type I interferon production (GO:0032479),0.34898728309004096,1.0473555932083547,0.39154929577464787,0.823308851240634,1.0,15/84,15.25%,TIRAP;TRIM25;LRRFIP1;IFIH1;NLRC5;RNF125;CTNNB1;MRE11;IRF5;PIN1;NLRP4;CYLD;TNFAIP3;G3BP1;CRCP
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.45287516153070845,1.0472713046893052,0.4272890484739677,0.8228218062032543,1.0,2/19,1.99%,CSGALNACT1;EXTL3
prerank,regulation of cytokinesis (GO:0032465),0.35001807653247946,1.0471492708443846,0.3883495145631068,0.8224034405303422,1.0,20/78,16.46%,BCL2L1;CALM1;CDC14A;CCP110;PKN2;RAB11A;PKP4;PIN1;CETN2;RAB11FIP4;PIK3C3;CDC6;KIF23;MAP10;SH3GLB1;GIT1;PLK2;RXFP3;PRPF40A;SPAST
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.36902808559039235,-1.0471446492143035,0.4046997389033943,0.7987016863154753,1.0,6/26,11.45%,ITPR1;PKD2;FGF2;SLC8B1;ITPR2;IBTK
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.39491447100777144,-1.0466565072573286,0.397196261682243,0.796617112987804,1.0,13/20,33.33%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.39491447100777144,-1.0466565072573286,0.397196261682243,0.796617112987804,1.0,13/20,33.33%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.39491447100777144,-1.0466565072573286,0.397196261682243,0.796617112987804,1.0,13/20,33.33%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4422378165436655,1.04657555467071,0.40978077571669475,0.8232338746415759,1.0,9/21,25.97%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.507171723461685,1.046234837954688,0.4106813996316759,0.8233830903078653,1.0,2/10,8.00%,ST3GAL1;ST6GAL1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.44005127884893336,-1.0459169316955086,0.4105263157894737,0.7976349357626406,1.0,9/14,28.26%,MRPS27;RMND1;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2;MPV17L2;RPUSD3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3519299365537829,1.045728798862634,0.3849431818181818,0.8239836656606676,1.0,10/74,6.64%,ITGA6;BCL2L1;NOS3;FAS;SH3RF1;TNFSF10;ARHGEF2;SNAI2;RFFL;MCL1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4637760129515268,-1.0456530908343673,0.4175824175824176,0.7972602495325366,1.0,3/11,13.15%,GRK3;ARRB1;ADM
prerank,spermatid development (GO:0007286),0.4063399895226168,1.0456383558117026,0.4069952305246423,0.823525361515142,1.0,5/32,15.21%,JAM2;PIWIL1;RSPH1;YTHDC2;RNF8
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.28365213216478335,-1.0456221028790453,0.33584905660377357,0.7962323858112107,1.0,28/102,14.43%,ADCY5;ENPP1;ADCY1;CPEB1;CPEB2;ADCY9;IRS1;SLC30A10;INSIG2;RHOQ;PRKCD;SLC39A14;ADCY2;PRKCI;ADCY7;MYO5A;IRS2;SELENOS;PDPK1;PRKACA;EPRS1;SYAP1;PARP1;GOT1;ADCY6;CYSLTR2;PIK3R1;NR4A1
prerank,endothelial cell migration (GO:0043542),0.3975047006828067,1.0455344308223204,0.4097331240188383,0.8230731143350736,1.0,8/37,7.19%,NOS3;PLEKHG5;ID1;PLXND1;STARD13;PXN;STAT1;SOX18
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3719282302809641,-1.0447075872343703,0.3904282115869018,0.7976153964890473,1.0,9/26,22.21%,KANK2;DAB2;HEYL;CRY2;PIAS2;SFRP1;NCOR1;BRCA1;PER1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4928639398383047,1.0445943876836763,0.42028985507246375,0.8247801089700744,1.0,2/13,5.25%,PLCB1;CCR7
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4471915958991679,1.0444075227159215,0.3960216998191682,0.8245578403988725,1.0,6/20,9.70%,IMPDH1;HPRT1;NT5C2;AK4;ADSS2;GART
prerank,sensory perception of sound (GO:0007605),0.3444436595144116,1.044282276065383,0.38812154696132595,0.8241618631534229,1.0,19/88,10.83%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;KCNQ1;EPS8L2;SNAI2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2
prerank,axonal fasciculation (GO:0007413),-0.44865274522033016,-1.044200351324188,0.4166666666666667,0.7978254603802524,1.0,2/12,7.23%,EPHA3;EPHB2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3772393285952246,-1.0441294047103518,0.3981264637002342,0.7969187176871271,1.0,3/22,3.05%,CACNA1C;STIM1;ADGRV1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5146412734340381,1.0439100997683715,0.4300884955752212,0.8244317470968386,1.0,3/10,14.70%,SH3RF1;CBFB;NCKAP1L
prerank,calcium ion import across plasma membrane (GO:0098703),-0.43896781607836927,-1.0437151778581388,0.413716814159292,0.7970697787681168,1.0,3/14,7.24%,SLC8A3;CACNA2D1;SLC8A1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.40671426127239435,-1.0436432041692822,0.3934065934065934,0.7961473396936459,1.0,3/17,12.09%,LPGAT1;LCLAT1;PLA2G12A
prerank,protein modification by small protein conjugation (GO:0032446),-0.241168722720836,-1.0425299335112344,0.30851063829787234,0.7980551643785707,1.0,94/361,21.38%,RNF220;PDZRN3;EYA1;RNF152;FBXL7;RNF43;SPSB1;AMFR;ARRB1;ASB2;FBXL17;PIAS1;DTX4;DTX3;SEH1L;TRIM23;FBXO10;HIF3A;CTR9;FBH1;ZSWIM8;ATG10;FBXW8;DTX1;UBE2R2;MGRN1;PRKN;SELENOS;PJA2;UBE2E1;KLHL18;SMURF2;RNF135;FBXO45;UBE2M;NUP205;CUL7;CUL3;BTRC;TRIM63;TRPM4;KLHL13;HUWE1;ARRDC4;WWP2;MYLIP;RNF20;DCUN1D5;RNF181;NFX1;UBE2E3;PIAS2;TRPC4AP;UBA1;SYVN1;USP9X;PAF1;PEX2;FBXW11;DDRGK1;LZTR1;UFC1;SDE2;RRAGA;RNF144A;ATG3;UBE2B;SPSB4;DTX2;UBR2;UBR3;MKRN1;RCHY1;FBXO4;TRAIP;NUB1;CAND1;FBXO9;NSMCE2;MUL1;CDC16;HECW2;UBA6;BRCA1;TRIM17;OTULIN;RNF14;BRAP;RAE1;FBXW5;DCAF15;RNF34;UBA2;KLHL21
prerank,pulmonary valve development (GO:0003177),-0.4100991167305125,-1.042301453594655,0.41975308641975306,0.7975713095988837,1.0,7/18,7.70%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,amyloid fibril formation (GO:1990000),0.3731430782333007,1.0422462515663906,0.4093655589123867,0.8279691624292099,1.0,6/51,6.41%,APP;TSPAN5;B2M;TSPAN14;NPPA;ADAM10
prerank,digestive tract morphogenesis (GO:0048546),-0.4278651620956253,-1.042024655328153,0.4035476718403548,0.7971602310525762,1.0,4/14,6.56%,PDGFRA;FGFR2;RBPMS2;GLI1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4608360371489385,1.0417505052817606,0.42905982905982903,0.8284918362823865,1.0,6/17,18.32%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,regulation of response to biotic stimulus (GO:0002831),0.4138344468370115,1.041732922791756,0.415973377703827,0.8278192101102788,1.0,7/28,10.45%,TIRAP;LRP8;SAMHD1;XIAP;N4BP1;BIRC3;CASP8
prerank,cellular response to gamma radiation (GO:0071480),-0.4124426522254765,-1.0413602556008315,0.4216589861751152,0.7978832091651074,1.0,7/17,23.65%,ATM;YAP1;KDM1A;XRCC5;CRYAB;WRN;ATR
prerank,glial cell development (GO:0021782),0.4338683556368391,1.0411618037418566,0.4176182707993475,0.8285405894084578,1.0,6/25,12.63%,APP;NRROS;EIF2B1;EIF2B2;SOX10;SOX11
prerank,organonitrogen compound catabolic process (GO:1901565),-0.31974706534119013,-1.0410969103089154,0.40540540540540543,0.7975153021794104,1.0,10/57,10.79%,CPQ;ANPEP;PDXDC1;ACE;ENPEP;NPEPPS;LRSAM1;RENBP;IDE;GGACT
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3825512324347068,1.0405112499770568,0.4106583072100313,0.8295139928158074,1.0,15/46,17.12%,SHANK3;MEF2C;CDH2;TPRG1L;DGKI;HOMER1;NPS;OPHN1;NRXN1;DGKZ;GRIK1;GRM7;NLGN1;GRM8;CCR2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.41824567725191547,-1.0404693797719637,0.42376681614349776,0.7981085693198854,1.0,7/15,25.22%,SELENOS;HSP90B1;SYVN1;AUP1;SEC61B;DERL1;UFD1
prerank,cell differentiation in spinal cord (GO:0021515),0.5088464369937739,1.039920590153458,0.4232209737827715,0.8303796352434637,1.0,6/10,26.91%,SOX13;MDGA2;LHX1;DRAXIN;ISL1;ZC4H2
prerank,regulation of immunoglobulin production (GO:0002637),-0.37394026695641513,-1.0395211588167002,0.3969465648854962,0.7996794819453392,1.0,5/23,21.01%,RBP4;EPHB2;STX4;PTPRC;VAMP3
prerank,regulation of microtubule nucleation (GO:0010968),0.4956526549716119,1.0394629477948218,0.44,0.8308510799029065,1.0,6/10,19.94%,ARHGEF7;PAK1;GIT1;CKAP5;DCTN1;MECP2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4970189692342293,1.0392697161177085,0.41312741312741313,0.830624642829536,1.0,4/11,19.12%,STMN1;PAK1;RAC1;NRP1
prerank,response to UV-A (GO:0070141),-0.43585043948562496,-1.0392513327250357,0.4178082191780822,0.799324251019232,1.0,2/14,6.54%,EGFR;MMP2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2722043831201913,-1.0390782627506707,0.3067226890756303,0.7986880659839919,1.0,26/138,12.24%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;TEAD3;POLR2A;NR3C2;YAP1;CCNH;NR2F1;RXRA;TAF8;CDK7;ESR1;PGR
prerank,response to cadmium ion (GO:0046686),0.4211586979277774,1.0388444968017827,0.41798107255520506,0.8309892538382048,1.0,12/26,16.69%,MAPK3;JUN;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MAPK1;SUMO1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.45251927305682327,-1.0387774807605712,0.4327354260089686,0.7983732795323423,1.0,3/12,3.43%,APOD;CBLB;F3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.3105153200402116,-1.0385557509417105,0.38461538461538464,0.7977999373664881,1.0,6/59,5.81%,ALDH1A2;CYP7B1;ABCD3;CYP27A1;PER2;ACOT8
prerank,protein stabilization (GO:0050821),-0.2617282661935221,-1.0383571898963424,0.3188405797101449,0.7972159737753651,1.0,45/168,18.80%,ANK2;IGF1;PARVA;PLPP3;LAMP2;PER3;RASSF2;PRKCD;PPARGC1A;MDM4;FLOT2;ATP1B3;RAB21;STXBP4;AAK1;FLNA;ATP1B2;PRKN;TNIP2;PFN2;USP2;BAG1;CCNH;CDK7;SEC16A;SYVN1;P3H1;NCLN;PTEN;BAG3;OTUD3;USP9X;MORC3;PIK3R1;EP300;UBE2B;CCT2;CRYAB;GRN;TAF9B;GET1;ATF7IP;CCT6A;USP19;MUL1
prerank,regulation of mitochondrial fusion (GO:0010635),0.49826864428537665,1.0377681203682996,0.43272727272727274,0.8330335770958072,1.0,1/11,0.15%,TFRC
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4793316921319253,1.0377002979175824,0.43462246777163904,0.8324958768914225,1.0,4/13,13.39%,TBX3;NOTCH1;TGFB1;SOX9
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.40848619287050303,1.037616929591544,0.4135702746365105,0.8319971610340042,1.0,6/32,8.57%,CAV1;APLNR;PLCG1;CD19;RAMP3;P2RX7
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4318173968304011,1.0375496515406033,0.425,0.831446569809328,1.0,2/24,1.56%,PRKCH;TRIM16
prerank,clathrin-dependent endocytosis (GO:0072583),0.4264070242876191,1.0375351168661915,0.4302134646962233,0.8307794628616073,1.0,9/26,14.60%,FNBP1L;ITSN2;PIP5K1C;INPP5F;FCHO2;AP2M1;SIGLEC1;AP2B1;LMBRD1
prerank,cellular response to interleukin-6 (GO:0071354),0.4257639435203621,1.037260099482431,0.41147540983606556,0.8307762048774546,1.0,4/26,6.71%,ST3GAL6;IL6R;ST18;STAT1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5003119689911704,1.0368847027899193,0.44935543278084716,0.8309703895154894,1.0,2/11,4.54%,LYN;TNFRSF21
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.36861470987660716,-1.0366725298232977,0.4020100502512563,0.8008217623987843,1.0,8/27,9.88%,PID1;ENPP1;IRS1;KANK1;PRKCD;GRB10;TNS2;PIP4K2C
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.43522884590428246,1.0366058708271826,0.4265975820379965,0.8309790347020799,1.0,7/23,11.82%,PDGFB;INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4508085292131183,1.0365462603154745,0.42759795570698467,0.8304299287714849,1.0,2/18,3.87%,SPTBN1;ACTB
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.44472996306806634,1.0364777159308851,0.41308089500860584,0.8299084150663804,1.0,2/19,2.62%,KDR;PTPRJ
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4499877529857304,1.036474117227664,0.40034965034965037,0.8292107827161221,1.0,5/19,7.63%,BMPR2;TGFB2;ZFPM1;NOTCH1;EFNA1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3687476416438488,1.036293617778646,0.40483383685800606,0.8289744974376764,1.0,7/52,8.24%,PRKCH;SPTBN1;STX3;ATP2C1;RAMP3;SORBS1;ACSL3
prerank,cAMP-mediated signaling (GO:0019933),0.4275001073072272,1.0360936251475041,0.418212478920742,0.8287703507507088,1.0,5/24,5.00%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;PDE7B
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.34192015406484394,1.035401315584034,0.40793201133144474,0.8298041449695821,1.0,19/88,16.69%,TFRC;DAB2IP;TIRAP;RGCC;FNIP2;VIL1;TAL1;BIK;TGFB1;MMP1;SYK;SH3GLB1;HGS;SDCBP;CDH5;HAS3;MPP7;PDCD6IP;SUMO1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29098664192230234,1.0352462850275832,0.40064102564102566,0.8295063012608673,1.0,85/497,15.26%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;BMPR2;NANOS3;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;ACVRL1;SOX13;CCDC85B;NOTCH1;MEN1;YBX1;HDAC9;HMBOX1;ZBTB16;HHEX;NANOS2;CTNNB1;SOX7;GATAD2A;ENC1;MRPL13;CD38;NANOS1;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;L3MBTL4;KAT6A;JUN;TGFB1;FOXP3;ZBTB14;CIART;DEDD2;HMGA1;KDM4A;ZMYND11;YWHAQ;RPL13A;CNOT9;GRB7;HSPA8;CDC6;PEX14;CTCF;EID2;GSK3A;ZBTB7A;LHX9;TNFRSF4;TLE1;BTG2;RCOR2;TERF1;PPARG;ZBTB33;POU2F1;SOX9;PAIP2;HMGB2;NR3C1;ID3;CIC;CTBP1;RIOX1;HDAC5;YAF2;RNF139;IKZF1;LOXL2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.45096665620084403,1.0351731995442754,0.4322916666666667,0.8289959138486716,1.0,7/18,18.54%,CCT3;CCT5;DCP2;NHP2;CCT7;NAF1;EXOSC10
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.29347886150774816,-1.0350026190874697,0.3644859813084112,0.804332387710679,1.0,19/76,20.94%,LPAR1;PLCE1;ACTN2;ADRA1B;ANO1;PTH1R;AGTR1;ESR1;LPAR4;CMKLR1;GNA14;CHRM2;GPR157;OPRK1;HTR2C;CCKBR;ADRA2A;HRH1;C3AR1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.38776209507908455,-1.0348608758080253,0.39436619718309857,0.803627023309296,1.0,13/21,33.33%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,protein processing (GO:0016485),-0.2831146016883972,-1.0345748722071688,0.36329588014981273,0.8033309728234237,1.0,27/102,20.74%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;CTSL;ADAM19;CPXM1;KLK2;CPXM2;FXN;CLN3;AFG3L2;PSEN1;CTSH;HTRA2;SDE2;HM13;ZMPSTE24;PRSS12;PARL;CASP4;PCSK6;PTCH1;EEF1AKMT4-ECE2;XPNPEP3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4873439073013678,1.0345559989265805,0.4280155642023346,0.8298815670556565,1.0,3/12,11.84%,SEC62;SGTB;GET3
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.4107931500955296,-1.0339917900950752,0.41402714932126694,0.8038520575082283,1.0,7/17,16.85%,WNT4;BMP4;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.47218079944632707,1.0339821583086553,0.42066420664206644,0.8305991628563716,1.0,1/13,0.77%,NAMPT
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.49370503212382766,1.033559319046308,0.44485294117647056,0.8310134282586439,1.0,1/10,0.34%,CSGALNACT1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3342556736894536,1.0335520825646143,0.40599455040871935,0.8303355036316376,1.0,29/107,16.74%,CACNA1A;APP;LRP8;MEF2C;CDH2;ABR;CLSTN1;TPRG1L;DGKI;BTBD9;GRID2;HOMER1;PXK;OPHN1;AKAP9;AGER;DGKZ;GRIK5;GRIK2;CPLX1;GRIK1;GRM7;DLGAP3;LRRC4C;NLGN1;RIMS2;GRM8;LGI1;CNTNAP4
prerank,generation of neurons (GO:0048699),0.314672281505209,1.033524887737023,0.409035409035409,0.829724325089608,1.0,34/190,12.71%,NDNF;TGFB2;RAPGEF2;ADGRL3;SH3RF1;FZD4;NAV1;MEF2C;FGF13;WNT7A;CTNNB1;BTG4;FUT9;INSM1;PIN1;GPM6A;ACSL3;OPHN1;SPOCK1;DNER;DISC1;DDIT4;ATOH7;DCX;CEP85L;LHX5;VXN;IER2;RAC1;LHX9;LHX6;EML1;SOX11;OLIG1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.42574092717557555,-1.0333348073640258,0.43448275862068964,0.804611161395942,1.0,6/15,16.13%,RIPOR2;ADAM9;EHD1;MAPK14;CAMK1;EHD2
prerank,ceramide catabolic process (GO:0046514),0.45700934296013446,1.0332324990534572,0.4205128205128205,0.8297807376342651,1.0,3/14,5.39%,ACER2;ACER1;NEU4
prerank,histone monoubiquitination (GO:0010390),-0.3754564893305397,-1.033086457690856,0.41975308641975306,0.8041752684048967,1.0,13/24,29.88%,BCOR;CTR9;UBE2E1;KDM2B;DDB2;RNF20;PAF1;TRIM37;CUL4B;WAC;RNF40;RNF168;UHRF1
prerank,apical protein localization (GO:0045176),0.5138267574187476,1.0329444720679177,0.42226487523992323,0.8298004804962973,1.0,2/10,3.87%,MAL;ACTB
prerank,negative regulation of developmental growth (GO:0048640),0.40535515672337025,1.0328778656398765,0.41776315789473684,0.8292660787215603,1.0,9/30,16.96%,NKD1;FGF13;DIP2B;GDF15;WWC1;MAG;SEMA3G;DCC;WWC2
prerank,respiratory electron transport chain (GO:0022904),0.47001013397967206,1.0328151763863722,0.4381625441696113,0.8287385176529507,1.0,3/14,9.79%,GPD2;ETFRF1;ETFB
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.40437737821846953,-1.0325216568379485,0.3932038834951456,0.8046554965398979,1.0,10/17,34.64%,CPEB1;CTR9;RNF20;NELFE;ZC3H3;CDK9;RNF40;ZC3H14;VIRMA;HSF1
prerank,regulation of cholesterol transport (GO:0032374),-0.3958036661653748,-1.0323935641629078,0.4527363184079602,0.8038965254000445,1.0,1/20,0.53%,LRP1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4742884815942423,1.0323857006238835,0.42162162162162165,0.8291111868679761,1.0,7/15,26.06%,SMAD7;RPS7;RPL11;BAG2;RPL23;BAG5;DTX3L
prerank,peptidyl-threonine modification (GO:0018210),-0.30092940462836987,-1.0321098124048818,0.3546325878594249,0.8035797866673631,1.0,24/66,25.37%,ROCK2;PRKCD;CAMK2D;TGFBR1;MAP3K12;PDPK1;PRKCA;LRRK2;GALNTL6;GALNT16;WNK1;ACVR1B;DYRK2;CDC42BPG;SBK1;WNK3;CSNK2A1;CDK5;MAP2K1;GALNT1;CDK10;TNKS;CIT;GALNT3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.43763086438136894,1.0320708071849904,0.4204152249134948,0.8291958517490274,1.0,4/20,10.81%,IL1R1;B2M;MALT1;DENND1B
prerank,response to steroid hormone (GO:0048545),0.4134685218711547,1.0317668761973993,0.40584415584415584,0.8292515762683832,1.0,6/31,8.09%,ABHD2;TGFB2;CAV1;ATP1A1;ATP1A3;TGFB1
prerank,cellular response to organonitrogen compound (GO:0071417),0.3310698304825121,1.0314528986997527,0.40290620871862615,0.8293249801401004,1.0,27/99,18.57%,PDE2A;RAPGEF2;SH3BP4;MEF2C;RAPGEF1;RAPGEF3;ACTB;CTNNB1;KCNQ1;RAP1B;GABRB1;P2RX7;AKAP9;LAMTOR5;RPTOR;ZFP36L1;NSMF;HCN2;SOX9;AKAP6;SSH1;LAMTOR4;CRHBP;CAPN2;SLC26A3;CIB2;GABRB2
prerank,RNA metabolic process (GO:0016070),-0.2731472640777144,-1.031411136038334,0.375,0.8044102455847907,1.0,43/127,28.92%,CELF2;RBMS1;HNRNPH1;HNRNPUL1;POLR2A;PABPN1;AGO2;RBM39;NOVA1;BICD1;DDX17;HNRNPH2;RBM5;RNASE4;ALKBH1;HNRNPR;TENT2;DDX3X;SIDT2;LAGE3;HNRNPA2B1;PABPC4;GTF2F1;DDX39B;PCBP2;FASTKD1;TP53RK;PAPOLG;FASTKD2;TBRG4;POLR2L;PARN;THOC1;DROSHA;LSM8;POLR2I;HNRNPD;RNASEH2B;ATXN1;TFIP11;SYNCRIP;POLR2K;DHX36
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3407668320128248,-1.0313453522596567,0.41025641025641024,0.8034852579188028,1.0,5/41,6.15%,ANK2;ACTN2;KCNMB2;KCNJ2;FLNA
prerank,regulation of myoblast differentiation (GO:0045661),0.4056494743048325,1.031263810440109,0.43720190779014306,0.8290896158079074,1.0,4/32,3.41%,PLCB1;TBX3;MEF2C;NOTCH1
prerank,plasma membrane organization (GO:0007009),-0.30918505086967113,-1.0310955535882096,0.40064102564102566,0.8031170720787942,1.0,13/61,11.08%,ANK2;COL5A1;MYOF;ANO6;AHNAK2;A4GALT;ANXA6;STX2;PLSCR2;EPB41L3;SNX9;TLCD2;CLN3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.41379661415562224,1.0308957330254402,0.4228295819935691,0.8293168038405025,1.0,2/26,0.95%,OCLN;INSR
prerank,Rho protein signal transduction (GO:0007266),0.3687787230653206,1.0303231101833046,0.4209726443768997,0.8300180497987883,1.0,13/53,9.68%,ARHGEF3;NTN1;PLEKHG5;ADGRG1;RIPOR1;EPS8;GNA12;RHOB;EPS8L2;CDC42EP3;ARHGAP4;PHACTR4;ARHGDIA
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.40032801976733823,1.030304584298717,0.424,0.8293761340157548,1.0,9/34,12.43%,PTPRB;PTPRJ;DUSP7;PTPN12;DUSP3;ACP4;DUSP1;PTPRQ;DUSP16
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.36708009360747207,-1.0302608427400137,0.42053789731051344,0.8043333182240942,1.0,10/25,16.89%,AMPD3;PAICS;MTHFD1;PRPS2;GMPR2;PRPSAP1;GMPS;DGUOK;PRPSAP2;ADSL
prerank,cellular response to nutrient levels (GO:0031669),0.35913977557388127,1.0302294766097972,0.41185185185185186,0.828881089513996,1.0,16/62,17.67%,MFSD2A;BMPR2;FOXO1;RIPOR1;FAM107A;CDKN2B;RALB;MAP1LC3B;HSPA8;RPTOR;TFEB;STK24;STK26;ATG14;MAP1LC3A;WDR45
prerank,regulation of lamellipodium assembly (GO:0010591),0.3910715918034376,1.0301103560737517,0.40789473684210525,0.8285030766890059,1.0,9/34,11.43%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;ABI3;PLXNB3;RAC1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4123480375588484,1.0300617857802887,0.43167701863354035,0.8279515252488381,1.0,6/29,14.41%,DCUN1D3;SMAD7;FBXW7;PIN1;DCUN1D1;BMI1
prerank,reticulophagy (GO:0061709),-0.44331864738198684,-1.0293058963617254,0.43043478260869567,0.8058492376340822,1.0,5/12,14.77%,ULK2;ATG2B;TEX264;DDRGK1;UFC1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4441358896903732,-1.0292248472079382,0.4370860927152318,0.8049631388490391,1.0,9/13,30.69%,ABCA1;LDLR;CD9;CDH13;CD81;FCER1G;ITGB1;LPL;CD36
prerank,in utero embryonic development (GO:0001701),-0.36913638064379406,-1.0291020311301187,0.4344660194174757,0.80419605441244,1.0,8/25,12.43%,FGFR2;ARNT2;PKD1;TGFBR1;IGF2;ZNF568;TGFB3;BMP2
prerank,regulation of cellular pH (GO:0030641),-0.354897260580639,-1.0290620878125274,0.39385474860335196,0.8032153207971428,1.0,8/29,11.08%,SLC4A10;SLC9A2;LACC1;SLC4A7;SLC4A2;SLC9A9;SLC9A1;CLN3
prerank,positive regulation of bone resorption (GO:0045780),0.4961065090714576,1.028096873820744,0.44313725490196076,0.8321995369014008,1.0,4/11,11.86%,TNFRSF11A;PLEKHM1;TNFSF11;SYK
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2696555638141908,-1.0280794981874244,0.3936651583710407,0.8048025521854709,1.0,24/133,12.41%,SLC24A3;ANK2;ATP13A5;MCU;STIM1;SLC8A3;DMPK;ATP13A3;CAMK2D;TRPC3;SLC35G1;ANXA6;SLC8B1;SLC8A1;BCL2;PTH1R;TRPC6;PML;PRKACA;CLN3;SLC24A5;AFG3L2;TRPC4;PSEN1
prerank,cardiac muscle cell development (GO:0055013),-0.39282604425784656,-1.0277338786651198,0.4423963133640553,0.8046129248444727,1.0,6/20,7.89%,PDGFRB;PDGFRA;CXADR;OBSL1;SLC8A1;MYH11
prerank,regulation of organelle organization (GO:0033043),0.346089021718255,1.0274823943256324,0.41983695652173914,0.8330158574717271,1.0,13/80,11.08%,TJP1;PDE2A;F11R;PTK2;USP6NL;MAPK3;STMN3;ARHGEF5;MSN;CLIC4;AKAP9;PDCD10;S100A8
prerank,nuclear envelope organization (GO:0006998),-0.38058975419334107,-1.0273940956798955,0.40232558139534885,0.804472576828412,1.0,9/20,26.04%,DMPK;TMEM170A;TOR1AIP1;EMD;SUN2;VPS4A;TMEM43;LEMD2;NUP155
prerank,brain development (GO:0007420),0.3204698999751193,1.0271922610285502,0.4174135723431498,0.8330301380032838,1.0,23/136,13.19%,MFSD2A;SHANK3;ADGRL2;SHROOM4;RAPGEF2;ADGRL3;ADGRG1;NES;CDH2;DSCAML1;AATK;COL4A1;DHX37;CDK5RAP2;TBC1D23;DDIT4;AGTR2;GRIN2B;UFM1;UTP3;TGFBR2;EML1;CNTNAP2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.28321536326467084,1.027174837707955,0.4,0.8323751933230213,1.0,96/834,8.89%,LEF1;ETS1;ITGA6;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;BMPR2;TGFB2;LMO7;NOTCH4;MRTFB;APP;ZIC3;TBX1;PPARD;MRTFA;NFKBIA;SOX17;TBX3;KLF7;AGRN;ARHGEF2;RGCC;MEF2C;MOSPD1;NCOA1;SMARCA2;PLXND1;FOXO1;CD40;RPS6KA1;ACVRL1;ZFPM1;NOD2;PRKD1;NOTCH1;PRKD2;MEN1;YBX1;NLRC5;KLF2;MYO6;PRDM2;IRF2;ASXL3;WNT7A;IKBKB;SMAD7;HHEX;FOXF1;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;SPAG8;WWTR1;HYAL2;TAL1;ST18;TLR3;CRTC1;MAML2;MAPK3;RPS6KA5;KLF4;TOX3;NKX2-8;CDKN2B;STAT1;MAX;NR1H2;IRF5;NCOA2;SOX18;PHOX2A;NFIC;SOX12;HINFP;KAT6A;JUN;PIN1;TGFB1;ATF6B;TCF12;KLF6;FOXP3;ELK4;LRP5;NFATC2IP;GREM1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.4247822544502792,1.0270745455368495,0.4056761268781302,0.8319299711410999,1.0,4/21,10.01%,MBOAT1;PLA2G4B;OSBPL10;LPCAT3
prerank,cochlea morphogenesis (GO:0090103),0.5012531444881031,1.0267217022087198,0.45692883895131087,0.8321159054853297,1.0,3/10,13.39%,TBX1;POU3F4;SOX9
prerank,organophosphate biosynthetic process (GO:0090407),0.3915983182839591,1.0266748083307289,0.4328125,0.8315411364903412,1.0,4/37,7.20%,ITPKB;MBOAT1;TPK1;GPHN
prerank,protein transport (GO:0015031),0.29474800080214264,1.0265763283186542,0.41685393258426967,0.8311160942144061,1.0,46/332,11.60%,TFRC;TBC1D4;SPTBN1;MACF1;STX3;RAB31;TBC1D14;ARHGEF2;STX1A;TBC1D22A;RAMP2;TBC1D12;ATP6V0A1;CALCRL;SNX13;MYO6;ABCG1;MCOLN1;TBC1D2;ARF5;RAMP3;USP6NL;CMTM6;TBC1D5;REP15;LRP1B;SLC10A7;STXBP1;DNM2;ARL4A;SCAMP1;RAB34;CHMP1B;YWHAH;RAB3B;KIF3B;ARL6IP5;LRP2;TBC1D10B;ACD;AMN;PPY;STX19;PRKCB;MTTP;TBC1D30
prerank,regulation of tau-protein kinase activity (GO:1902947),0.508740936777454,1.0265210030850889,0.45300751879699247,0.8305598013872529,1.0,1/10,5.03%,HSP90AB1
prerank,Fc receptor signaling pathway (GO:0038093),0.32972132654427144,1.0263492230848588,0.44037940379403795,0.8303306958758405,1.0,37/110,21.88%,MAP3K1;LYN;PLCG1;IKBKB;CALM1;GRB2;SOS1;MAPK3;PSMB3;JUN;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;PPP3CA;RAC1;SYK;PPP3R1;PIK3CB;PSMB10;BCL10;LCP2;CARD11;PSMA8;MAPK1;LAT2;PAK2;SKP1;PSMD9;PLCG2;MAP2K7;VAV1;CUL1;PSMC3;PSMD1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.45907760998424996,1.0261253439905524,0.45315487571701724,0.8302136920483362,1.0,4/14,7.37%,RGCC;CD40;PLCG1;CD160
prerank,regulation of cation transmembrane transport (GO:1904062),-0.35638867010323794,-1.025900701427103,0.39080459770114945,0.8075010054880835,1.0,6/29,8.55%,SNTA1;KCNIP3;CD63;DLG1;CACNA1D;SLMAP
prerank,response to acidic pH (GO:0010447),-0.4282296610375593,-1.0256732630381058,0.4401805869074492,0.80696936628527,1.0,3/13,15.76%,IMPACT;SLC9A1;RAB11B
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.40799339147341884,-1.0254503541022129,0.4288990825688073,0.8064811601776952,1.0,4/17,4.69%,ROBO1;EFNB2;SLIT2;FGF2
prerank,sarcomere organization (GO:0045214),-0.3669992428218954,-1.0251986059587614,0.4094488188976378,0.8060794775508119,1.0,7/27,21.25%,ACTN2;TPM1;TNNT3;SIX4;MYOM2;CSRP2;KRT19
prerank,cellular response to metal ion (GO:0071248),-0.270801809373506,-1.0246103056680573,0.4017094017094017,0.8066294175308054,1.0,16/123,8.33%,BMP6;EGFR;PRKAA2;SLC41A1;ADCY1;ADGRV1;SLC12A2;CDH1;CAMK2D;PKD2;ADCY7;DLG4;P2RX4;PRKN;SYT9;SLC25A24
prerank,regulation of vesicle-mediated transport (GO:0060627),0.333901560496989,1.024252329713334,0.4349593495934959,0.834194785581811,1.0,20/91,16.87%,HIP1;FES;HIP1R;SCARB1;DNAJC13;SYT7;INPP5F;MAPK3;HCK;RAB11A;OPHN1;RAB3B;RAB4A;SYK;LGI3;CPLX1;RNF139;MAPK1;RIMS2;RALA
prerank,skeletal muscle tissue development (GO:0007519),0.40465151572004815,1.0237367708745588,0.4558359621451104,0.8347706759510559,1.0,6/32,12.12%,CAV1;MEF2C;FOXL2;MYH14;CAV2;CSRP3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3401879887916593,1.0232391538737207,0.4188626907073509,0.8352898954925612,1.0,19/85,10.83%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;KCNQ1;EPS8L2;SNAI2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2
prerank,positive regulation of organelle assembly (GO:1902117),0.38003146816406286,1.0230967088311822,0.4456692913385827,0.834968096299878,1.0,16/44,17.99%,CNOT6L;CCDC88A;CCP110;RALB;MARK4;CAPG;SH3GLB1;PIP4K2A;CNOT6;SDCBP;FSCN1;G3BP1;SPAG5;PDCD6IP;IL5;KCTD17
prerank,metal ion export (GO:0070839),-0.35458128668301725,-1.02296660272853,0.4387755102040816,0.8099512084194967,1.0,6/31,7.08%,ATP1A2;KCNT2;KCNK5;ATP1B3;ATP7A;ATP1B2
prerank,epithelial cell development (GO:0002064),-0.38806239285596356,-1.0227728443939557,0.43559718969555034,0.8093754486063125,1.0,7/20,19.72%,WNT5B;SLC4A7;ACTA2;DACT2;RILPL2;PDZD7;BFSP1
prerank,stem cell differentiation (GO:0048863),-0.32918259731735955,-1.0225083528392944,0.431266846361186,0.8090124801043622,1.0,17/39,21.50%,FGFR2;OSR1;HOXB4;KIT;FBXL17;ACE;MLLT3;LMBR1L;LRP6;SFRP1;PAX2;BATF;PTPRC;SP7;EEF1AKMT4-ECE2;SETD2;SETD6
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.42162141397111946,-1.0223505580689385,0.4331896551724138,0.8083027502273367,1.0,5/14,19.36%,DMD;WNK4;SLC9A1;WNK1;WNK3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.445390354501614,1.0221341113711915,0.4273356401384083,0.8366986030193295,1.0,3/18,8.93%,SHANK3;WNT7A;NRXN1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4071100848876623,1.0219632020337361,0.4708904109589041,0.8364284454284895,1.0,9/29,14.07%,CAV1;TNFSF10;HYAL2;RET;DEDD2;AGTR2;TNFSF12;CYLD;BCL10
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.49809821701469,1.0219020857156058,0.44029850746268656,0.8358785340842949,1.0,6/10,29.44%,PDE8A;STK26;TXN;RIPK1;NFE2L2;PARK7
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.39318670026246316,-1.021702836153997,0.45305164319248825,0.8089982667323157,1.0,6/18,16.03%,SMAD3;PDPN;EMILIN1;EFEMP2;BMP2;RUNX1
prerank,T cell differentiation in thymus (GO:0033077),-0.42006998882837127,-1.0216570232031943,0.43675417661097854,0.8080293583597923,1.0,1/14,0.65%,GLI3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3742015626885934,-1.0212692397510537,0.4314214463840399,0.8079775212079559,1.0,5/22,10.43%,NTRK3;MAGI2;NGF;ACAP2;EHD1
prerank,cellular protein-containing complex assembly (GO:0034622),0.3144004371165785,1.0209158502117075,0.41466498103666244,0.8376247550015791,1.0,39/159,19.02%,HIP1;HIP1R;TIAM1;STXBP6;PXN;POMP;HSP90AB1;RPL38;EIF4H;STXBP1;FCHO2;PSMD11;DRC1;AP2M1;TGFB1;PIK3C2A;SMAD1;SAMM50;DNAAF2;EID2;EPS15;GTF2B;HIGD1A;CSNK2B;BBS10;ANLN;OMA1;DNAAF3;IMMP2L;NCK1;TESPA1;TBCEL;POGZ;TTC12;BIN1;NUP153;CHCHD4;GPX4;FKBP1A
prerank,positive regulation of phospholipase activity (GO:0010518),-0.374755547856375,-1.0203375023334884,0.43532338308457713,0.8094376238274001,1.0,10/22,12.11%,NTRK3;PDGFRB;PDGFRA;FGFR2;KIT;FGF2;AGTR1;PDPK1;ARL1;ESR1
prerank,negative regulation of cell population proliferation (GO:0008285),0.2936630457798121,1.0189804848117654,0.4260089686098655,0.8417947238146568,1.0,43/351,9.22%,ETS1;AQP11;DAB2IP;BMPR2;TGFB2;NOS3;RAPGEF2;SH3BP4;APP;SLC16A2;DDAH1;MCC;ITGA1;CD200;TBX3;CTNNBIP1;B2M;ADGRG1;PTPRJ;RGCC;MTSS1;SMARCA2;ACVRL1;NOTCH1;MEN1;LYN;CTNNB1;GATA2;SOX7;DLL4;IGFBP7;BTG4;ST18;KLF4;CDKN2B;INSM1;TGFB1;TMEM115;FOXP3;ADAMTS8;GREM1;HMGA1;PAK1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.46983960930946295,1.0185885330478168,0.43956043956043955,0.842028206699497,1.0,6/14,17.33%,DUSP1;PPP3CA;PPP1R15B;PPP2R2C;NCK1;PPM1F
prerank,endodermal cell fate commitment (GO:0001711),0.5056515379929662,1.0184836287199635,0.47580645161290325,0.8415837619287098,1.0,1/10,2.11%,SOX17
prerank,sprouting angiogenesis (GO:0002040),0.3597484838986264,1.0180495169964796,0.4268292682926829,0.8420019708959785,1.0,7/51,3.52%,TEK;KDR;ENG;FLT4;PIK3R3;ACVRL1;RAMP2
prerank,protein lipidation (GO:0006497),0.35928871556488307,1.0177197593599852,0.42746913580246915,0.8421662448767591,1.0,19/59,21.77%,ZDHHC14;PIGU;ZDHHC9;ZDHHC20;PIGM;PGAP4;PIGF;ZDHHC18;ZDHHC22;PIK3C3;ATG12;DPM3;ZDHHC21;WDR45;ATG7;ZDHHC17;PIGO;PIGV;PIGQ
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3179039115311653,1.0176863906336882,0.4269081500646831,0.8415595704733955,1.0,24/136,14.63%,DAB2IP;FZD6;NFKBIA;CD200;CTNNBIP1;ID1;SP100;SIGIRR;MEN1;NLRC5;TMSB4X;SMAD7;KLF4;AIM2;FOXP3;IRAK2;EIF2AK4;PEX14;TNFRSF4;EGLN1;CYLD;TNFAIP3;FOXJ1;ID3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4403705639759612,-1.0171863536729955,0.4531590413943355,0.8169874449262514,1.0,9/12,42.15%,TIPIN;WDR18;NBN;METTL4;GMNN;TICRR;NUGGC;CDT1;KAT7
prerank,positive regulation of receptor internalization (GO:0002092),-0.3797002825095867,-1.0171342126000416,0.41784037558685444,0.8160673828484604,1.0,5/22,6.33%,ANGPT1;MAGI2;ARRB1;CD63;SFRP4
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4433334431155296,-1.0169295376145076,0.4369747899159664,0.8155794276019852,1.0,6/11,33.17%,UGGT2;AUP1;DERL1;UFD1;UGGT1;POMT2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4596789859199234,1.0168988045840823,0.45390070921985815,0.842895077673146,1.0,6/17,12.53%,PDGFB;CCNY;RGCC;CCND3;ADAM17;MAPRE3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.31108573849372395,1.0168277291686398,0.4360613810741688,0.8423883701813685,1.0,27/175,12.55%,DAB2IP;NFKBIA;TNFRSF25;TNFRSF11A;ARHGEF2;CD40;TMSB4X;IKBKB;TNFRSF21;HYAL2;ST18;ACTN4;AIM2;STAT1;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;ADAM17;EIF5A;CCL1;PSMD8;TNFSF11;TNFRSF4;TNFSF12;ZFP36L1
prerank,regulation of protein sumoylation (GO:0033233),-0.39980824746494525,-1.0167191348797886,0.43820224719101125,0.8150708476837062,1.0,8/17,26.68%,HDAC4;PIAS1;MUL1;UBA2;ZMIZ1;RWDD3;EGR1;GNL3L
prerank,establishment of melanosome localization (GO:0032401),-0.3885624126669584,-1.0164454507311589,0.42548596112311016,0.8146807160222715,1.0,14/19,40.57%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.408486297597956,-1.016276718274023,0.42953020134228187,0.8140666840811944,1.0,3/16,3.80%,SOX5;HOXB4;FOXC1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.37194210246939935,1.0161676039085055,0.4148606811145511,0.8433403331076776,1.0,10/50,17.70%,IVNS1ABP;CAV1;SMAD7;N4BP1;UBXN1;TNFAIP3;DNAJA1;BAG2;SIRT7;PRKCG
prerank,positive regulation of immune response (GO:0050778),0.3513222684704602,1.0161648456911974,0.4269005847953216,0.8426607331050306,1.0,8/64,12.66%,TGFB2;NOD2;GBP5;CCR7;LGALS9;EIF2AK4;TLR8;IL15
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3485389384691928,-1.015685128852445,0.4314214463840399,0.8145324763704765,1.0,10/31,13.14%,RANBP3L;CRIM1;SMAD6;SUFU;TMEM64;TWIST2;TRPM4;CHRD;SKI;TWIST1
prerank,diacylglycerol metabolic process (GO:0046339),0.41759237184656,1.015634072441105,0.4317032040472175,0.8432825649592511,1.0,7/23,16.94%,DGKH;LIPE;DGKI;DGKE;DGKZ;MOGAT2;DGAT1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.49799985271118163,1.0154443206299397,0.4744525547445255,0.8430577113928701,1.0,2/10,3.88%,JAK3;LYN
prerank,visual perception (GO:0007601),-0.2906629318990354,-1.0153246121170438,0.40425531914893614,0.8144650567783198,1.0,9/84,5.12%,COL1A1;SLC4A10;EFEMP1;EYA4;COL18A1;ADGRV1;COL11A1;DHRS3;EML2
prerank,negative regulation of cellular component movement (GO:0051271),0.4584993200535199,1.0150502288869545,0.463768115942029,0.8433782464352354,1.0,4/15,8.04%,FRMD5;SP100;ACTN1;PIN1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3452577519321532,-1.0147394755571184,0.44545454545454544,0.8150174493933638,1.0,5/32,8.01%,PRKAG2;ZBTB20;PRKAA2;PPARA;APOE
prerank,vitamin D metabolic process (GO:0042359),0.4642104764532927,1.0146323922620015,0.43856332703213613,0.843740846786597,1.0,4/13,22.48%,CYP11A1;LRP2;CYP24A1;LGMN
prerank,calcium ion import into cytosol (GO:1902656),-0.42152919901865465,-1.0146043287544593,0.4469525959367946,0.8143179592874681,1.0,3/15,7.24%,SLC8A3;CACNA2D1;SLC8A1
prerank,positive regulation of vasoconstriction (GO:0045907),0.4725687678203233,1.014123009741625,0.4606946983546618,0.844276332118189,1.0,2/13,5.76%,CAV1;OXTR
prerank,nucleocytoplasmic transport (GO:0006913),0.384210127412309,1.01410346115316,0.44952681388012616,0.8436483257338553,1.0,22/40,31.72%,BACH2;SNRPF;NXT1;MALT1;SNRPE;RITA1;NCBP2;SNRPB;RSRC1;SNRPD2;NCBP1;NXT2;DDX20;SNRPD1;SMN1;NUTF2;HNRNPA1;GEMIN5;ANP32A;HTATIP2;SNRPG;SNRPD3
prerank,transcription by RNA polymerase II (GO:0006366),-0.2401376991664052,-1.0138205170175714,0.3484848484848485,0.8153313449129839,1.0,65/305,18.64%,NOTCH2;SOX5;MAF;PRRX1;RARB;GLIS3;CCN2;TEAD1;DDX5;NR6A1;THRB;NOTCH3;NR1D2;CCNT2;PHAX;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;CTR9;TEAD3;POLR2A;NR3C2;DTX1;PABPN1;PCF11;RPRD2;YAP1;MLLT3;INTS8;CPSF3;CCNH;NR2F1;PARP1;RXRA;NFX1;TAF8;CDK7;ESR1;PGR;TSC22D1;AFF4;INTS2;PAF1;NR4A1;ZBTB1;ZBTB7B;E2F3;ELP4;NELFE;GTF2F1;INTS4;NR1H4;ERCC6;RARA;INTS10;TAF9B;NRBP1;RPAP1;LSM10;HSF2BP;NCOR1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.40660010944587904,-1.0135858083573994,0.4439252336448598,0.8148424061189832,1.0,2/16,8.01%,LRP1;APOE
prerank,neuronal action potential (GO:0019228),-0.3760817940992576,-1.0135448093390156,0.43287037037037035,0.8139064338139104,1.0,3/22,4.91%,SCN7A;KCNMB2;CACNA1G
prerank,protein insertion into membrane (GO:0051205),0.3981759816161812,1.0133862680668886,0.44126984126984126,0.8447352726041432,1.0,5/32,8.56%,APP;REEP1;STX1A;GRIN3B;RTP4
prerank,regulation of macrophage activation (GO:0043030),0.3949106749189194,1.012508085825143,0.4504201680672269,0.8462106486013462,1.0,2/30,2.13%,MFHAS1;CD200
prerank,cholesterol metabolic process (GO:0008203),0.34718455279571,1.0124040704830062,0.4431977559607293,0.8457914012093248,1.0,7/68,5.41%,SCARF1;PPARD;OSBPL1A;PLPP6;ABCG1;CYP11B1;CYP11A1
prerank,regulation of lymphocyte activation (GO:0051249),0.4711177570583188,1.0123938207870995,0.45925925925925926,0.8451348587359141,1.0,2/12,5.26%,CD19;CD4
prerank,secondary alcohol metabolic process (GO:1902652),0.37596712372505575,1.0122212572227218,0.4611872146118721,0.8448637273374958,1.0,6/42,6.49%,PPARD;OSBPL1A;ABCG1;CYP11B1;CYP11A1;IDH3A
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.29090036967207294,-1.0120547289851596,0.4612794612794613,0.8167327369107462,1.0,10/72,10.29%,FGFR2;FGF1;FRS2;KL;FGF2;HNRNPH1;POLR2A;FLRT1;SPRED1;FGFBP1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4424971327304318,-1.0119753143726151,0.4512471655328798,0.815897093698025,1.0,5/12,18.64%,DAB2;HEYL;PIAS2;SFRP1;NCOR1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.47232193446179904,1.0119268517323867,0.46083788706739526,0.844894898290348,1.0,4/12,12.26%,STX3;STX1A;STX19;SNAP29
prerank,water-soluble vitamin metabolic process (GO:0006767),0.34481398725818274,1.0118981664133835,0.4265536723163842,0.8442902510917272,1.0,11/68,11.50%,SLC2A1;SLC19A3;ABCD4;TPK1;SLC52A2;SLC25A32;SHMT2;PDXK;SLC52A3;AMN;MMAA
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.38248294789223536,-1.011295422921612,0.42606516290726815,0.8166126301331545,1.0,9/20,31.16%,TNRC6A;AGO2;TNRC6B;LIMD1;HELZ;AJUBA;MOV10;CNOT1;AGO4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.46013785184054123,1.0111276538698768,0.42911153119092627,0.8455119252590476,1.0,2/13,6.20%,ENTPD1;ENTPD5
prerank,glycerol metabolic process (GO:0006071),-0.439387837605022,-1.0109481827975741,0.46436285097192226,0.8165255688464651,1.0,4/10,17.85%,GK;GOT1;COQ2;ANGPTL3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4094771054753927,1.0107935050384391,0.4400684931506849,0.845706464557842,1.0,6/26,12.23%,PLCB1;RGCC;CCND3;ADAM17;CDC6;RPTOR
prerank,pore complex assembly (GO:0046931),-0.38831029418360985,-1.0107775861045674,0.4642857142857143,0.8159667482052683,1.0,6/19,14.43%,ANO6;PLEKHA7;AFDN;NUP205;TMEM170A;GSDMD
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.3318769065419222,-1.010515020698785,0.45161290322580644,0.8155989291379147,1.0,5/39,6.29%,MCU;NLGN2;RBP4;IRS2;NNAT
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3465583325808671,1.0103067039026163,0.445095168374817,0.8462753964204135,1.0,10/70,11.35%,LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,regulation of endopeptidase activity (GO:0052548),0.3567279809253577,1.0090755271062666,0.4538690476190476,0.8487397508422029,1.0,10/59,11.81%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;BIRC3;SPOCK1;SERPINI1;PSME2;APH1A;VSIR
prerank,positive regulation of protein transport (GO:0051222),0.35104170274603963,1.0090600886353902,0.45156482861400893,0.8480971978206089,1.0,12/67,8.24%,TGFB2;PRR5L;UNC13B;CD2AP;ATP2C1;RIPOR1;ABCG1;PPIA;OAZ1;ARHGEF5;TGFB1;ACSL3
prerank,peptidyl-amino acid modification (GO:0018193),-0.4478350388079798,-1.0086971411358945,0.44490644490644493,0.8195043183424449,1.0,2/10,10.72%,ATP7A;FKBP10
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.28664179543133433,1.0084367066512827,0.4696969696969697,0.8488877850154828,1.0,69/417,15.46%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;SOX13;CCDC85B;NOTCH1;MEN1;HDAC9;HMBOX1;ZBTB16;HHEX;CTNNB1;SOX7;GATAD2A;CD38;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;L3MBTL4;KAT6A;JUN;TGFB1;FOXP3;ZBTB14;CIART;DEDD2;HMGA1;KDM4A;ZMYND11;YWHAQ;HSPA8;PEX14;CTCF;EID2;ZBTB7A;LHX9;TNFRSF4;TLE1;RCOR2;PPARG;ZBTB33;POU2F1;SOX9;HMGB2;NR3C1;ID3;CIC;CTBP1;RIOX1;HDAC5;YAF2;IKZF1;LOXL2;ARID4A
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.47911113690815105,1.0081859512341564,0.44076655052264807,0.8488144855499864,1.0,4/12,12.84%,NFKBIA;ABCG1;NR1H2;PPARG
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.437973858186817,-1.0081210190571743,0.4793577981651376,0.8199723864258451,1.0,8/12,36.46%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,cellular response to hormone stimulus (GO:0032870),0.34763101215326514,1.0076614579747358,0.4544159544159544,0.8494295588196485,1.0,14/69,9.46%,LMO2;CAV1;MEF2C;NCOA1;RAMP2;SOCS2;RAMP3;CYP11B1;CYP11A1;ATP1A1;ATP1A3;NCOA2;TRIM24;NCOA4
prerank,positive regulation of cell death (GO:0010942),0.35941099559168643,1.0075984562343734,0.45864661654135336,0.8488966657959419,1.0,8/59,11.28%,SLC6A6;ACER2;RAMP3;FYN;MARK4;DDIT4;AXIN2;GRIN2B
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.36268462473332636,1.0074642201104311,0.4356589147286822,0.8485428639292593,1.0,14/45,10.31%,PTK2;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;TGFB1;TGFA;IQGAP1;SHC3;ADAM17;PIK3C2A;GRB7
prerank,proteoglycan metabolic process (GO:0006029),0.39548368399300593,1.0073945564503555,0.4315068493150685,0.8480534313139457,1.0,3/26,2.89%,CSGALNACT1;BMPR2;CHST11
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.34848650736886383,1.0072536887100902,0.43851851851851853,0.8477483724451739,1.0,12/66,12.05%,TFRC;WWTR1;HYAL2;CARD10;LIMK2;TGFB1;CCT3;ZPR1;CCT5;LAMTOR5;FERMT2;ORMDL3
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42595124819481045,1.006972575292415,0.4653130287648054,0.8477688574508677,1.0,2/21,2.89%,CSGALNACT1;CHST11
prerank,melanosome transport (GO:0032402),-0.3894067465979155,-1.0069221778917141,0.45454545454545453,0.8211752332629813,1.0,14/18,40.57%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,pigment granule transport (GO:0051904),-0.3894067465979155,-1.0069221778917141,0.45454545454545453,0.8211752332629813,1.0,14/18,40.57%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,regulation of viral life cycle (GO:1903900),0.4266706880192952,1.0068268052954892,0.4610169491525424,0.847446018090056,1.0,3/21,5.94%,TRIM25;TRIM14;PPIA
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4261111236804317,1.0066885525900142,0.4568106312292359,0.8470955748307917,1.0,3/21,5.68%,CAV1;CTNNB1;FRAT2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.372131061613529,1.0066501618855324,0.438871473354232,0.8465032759153583,1.0,6/47,9.50%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;SPOCK1;SERPINI1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.45408505055036186,1.0065421508089647,0.46716697936210133,0.8460851586737048,1.0,2/14,5.76%,NOS3;OXTR
prerank,calcium ion homeostasis (GO:0055074),0.33366812023287606,1.006542115592074,0.4418918918918919,0.8454152575187771,1.0,11/95,7.55%,TMTC2;CXCL12;CAV1;SLC30A1;CD40;ATP2C1;SLC24A2;SLC24A4;ATP2B1;SLC10A7;HTR2A
prerank,negative regulation of catalytic activity (GO:0043086),0.41037579394747997,1.0064077843038874,0.4312080536912752,0.8451059674022194,1.0,2/24,3.41%,NES;NOTCH1
prerank,acetyl-CoA metabolic process (GO:0006084),0.4568987351117777,1.0063781846255009,0.4809437386569873,0.8445131134366293,1.0,6/15,22.50%,HMGCS2;DIP2A;ACACB;ACAT1;HMGCS1;ACLY
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.30566350030967515,1.0060387198139042,0.4419475655430712,0.844647157331536,1.0,48/172,21.29%,MFSD2A;PIK3R6;DGKH;INPP5D;PIK3R3;PLA2G4B;SLC44A5;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;CDS2;DGKE;CHKA;MTMR6;SELENOI;PIK3C3;LPCAT3;PIK3C2A;RAB4A;PIP4K2A;DGKZ;PIK3CB;CEPT1;CPNE6;CSNK2B;LPIN3;MTMR12;CDIPT;MTMR2;PIK3R5;PLEKHA3;SYNJ1;CPNE3;ETNPPL;INPP5E;INPPL1;CPNE1;PIP5K1B;MTMR1;PGS1;PLCG2;ETNK1;MBOAT7;PISD;INPP5K;LPCAT2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3375234526756306,1.0054531735679286,0.461864406779661,0.84541690273015,1.0,17/72,20.08%,ACER2;CNOT6L;RGCC;SP100;MYO6;CRADD;PIDD1;CNOT9;CNOT6;BTG2;HIPK2;PLK2;TRIAP1;NDRG1;CNOT11;TFAP4;E2F4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.34173237995313804,1.0053648332747716,0.4474053295932679,0.844964102701564,1.0,16/74,12.34%,LEF1;DAB2IP;TGFB2;RGCC;TIAM1;SMAD7;CTNNB1;WWTR1;IL17RD;EFNA1;TGFB1;GREM1;AXIN2;FERMT2;ADIPOR1;TGFBR2
prerank,protein depolymerization (GO:0051261),-0.3602183360829807,-1.0053188117993852,0.43765281173594134,0.8246014459591999,1.0,3/27,1.66%,MICAL3;GSN;MICAL2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.44102488680184676,-1.004879277537006,0.4730290456431535,0.8247383119790224,1.0,6/12,22.38%,CLN3;LRRK2;GRN;CLN6;ATP6AP2;TMEM9
prerank,negative regulation of transport (GO:0051051),0.3604348371083502,1.004857397347289,0.4561933534743202,0.8455688717099018,1.0,10/51,10.83%,DYSF;CTTNBP2NL;PRKD1;SNX3;NR1H2;BST2;PXK;ABCA7;NDFIP2;ARL6IP5
prerank,regulation of cilium assembly (GO:1902017),0.3528230451339497,1.0048198447202865,0.45454545454545453,0.8449971152914822,1.0,19/62,17.99%,TBC1D14;TBC1D22A;TBC1D2;USP6NL;TBC1D24;CCDC88A;LIMK2;TBC1D5;CCP110;MARK4;ODF2L;TBC1D10B;TBC1D30;CYLD;TBC1D1;TBC1D22B;TBC1D15;IFT140;KCTD17
prerank,positive regulation of RNA splicing (GO:0033120),0.40282245888733115,1.0047983337265536,0.4375,0.8443744944142365,1.0,1/29,0.46%,RBM20
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4742892783681633,1.0046652788184025,0.47950089126559714,0.8440417081262013,1.0,5/14,11.18%,ABCG1;ADAM10;ABCA7;ADAM17;APH1A
prerank,regulation of mononuclear cell migration (GO:0071675),-0.36562713249622103,-1.0044466068456894,0.4348894348894349,0.8248597990736324,1.0,4/23,3.29%,IL34;BMP5;SLIT2;THBS1
prerank,regulation of cytoskeleton organization (GO:0051493),0.32038877395924475,1.0039000054851757,0.438957475994513,0.8452042710849761,1.0,26/108,11.99%,TJP1;RHOBTB1;HIP1R;F11R;CORO2B;PTK2;RHOB;CCDC88A;BAIAP2;FAM107A;MAPK3;STMN3;BST2;MAP6D1;ARHGEF5;TWF2;IQGAP1;TRIM36;P2RX7;CLIC4;PFDN2;PAK1;ARHGAP17;S100A8;RAC1;RND1
prerank,serine family amino acid metabolic process (GO:0009069),0.4415405272508419,1.0038135374932742,0.4577205882352941,0.8447696603797592,1.0,4/16,9.59%,SARS1;GLYAT;SHMT2;CBS
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.33020801471285516,1.003766182880016,0.4342105263157895,0.8441983913562408,1.0,21/87,11.99%,ESAM;RHOBTB1;HIP1R;F11R;CORO2B;RAPGEF3;EPS8;RHOB;CCDC88A;BAIAP2;FAM107A;BST2;ARHGEF5;TWF2;IQGAP1;PAK1;ARHGDIA;ARHGAP17;ABI3;RAC1;RND1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.27426625928817067,1.0036944608890452,0.4798387096774194,0.8437224146106785,1.0,116/1082,8.90%,LEF1;MECOM;PLCB1;ETS1;ITGA6;FLI1;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;BMPR2;LMO7;NOTCH4;MRTFB;TRIM16;APP;ZIC3;TBX1;PPARD;MRTFA;NFKBIA;SOX17;TBX3;AFAP1L2;FZD4;KLF7;AGRN;ARHGEF2;RGCC;MEF2C;MOSPD1;RYBP;NCOA1;SMARCA2;SP100;FOXO1;CD40;FOXL2;RPS6KA1;ACVRL1;ZFPM1;NOD2;PRKD1;NOTCH1;PRKD2;MEN1;YBX1;NLRC5;KLF2;ZBTB16;MYO6;PRDM2;IRF2;ASXL3;WNT7A;IKBKB;SMAD7;HHEX;FOXF1;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;MRPL12;SPAG8;KLF1;WWTR1;HYAL2;TAL1;CD4;CAMKK2;ST18;TLR3;CD38;CRTC1;MAML2;MAPK3;RPS6KA5;KLF4;RET;TOX3;NKX2-8;CDKN2B;STAT1;MAX;NR1H2;DNM2;IRF5;NCOA2;SOX18;PHOX2A;NFIC;BRCA2;SOX12;HINFP;KAT6A;JUN;KCNH2;PIN1;TGFB1;ATF6B;YWHAH;TCF12;KLF6;FOXP3;ELK4;LRP5;CDK5RAP2;NFATC2IP;GREM1;ARID1A
prerank,epithelial cell migration (GO:0010631),0.3798051058372236,1.0036041112371483,0.46511627906976744,0.8432971190059784,1.0,10/37,6.84%,NOS3;PLEKHG5;PKN3;PLXND1;STARD13;PXN;PKN1;NANOS1;STAT1;PKN2
prerank,necroptotic process (GO:0070266),0.4455888736125415,1.0034256382266054,0.46735395189003437,0.8430348509398563,1.0,5/16,23.35%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3147679598481579,1.0026110839620002,0.47192513368983957,0.8442972108775676,1.0,26/128,15.94%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;DNM2;LCMT1;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP135;CEP72;FBXL8;TUBB4B;TUBA1A;FBXL15;CKAP5;CEP70;PPME1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.41138011593574714,1.002545071498684,0.4718543046357616,0.8438020842815825,1.0,2/25,1.57%,ITGA6;APP
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4915270703362337,1.0024522958162347,0.4794007490636704,0.8433646218630774,1.0,3/11,6.44%,CD34;CD200;LGALS9
prerank,myeloid cell development (GO:0061515),0.43454823237110385,1.0022387357234732,0.45768566493955093,0.8432404991440379,1.0,3/18,5.46%,APP;ALAS1;NRROS
prerank,regulation of G0 to G1 transition (GO:0070316),0.3758856986037852,1.001899190864781,0.4501557632398754,0.8433753366825101,1.0,5/38,6.73%,DAB2IP;RYBP;PHC1;CDKN2B;MAX
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.35560389598923203,-1.0016275596121726,0.43842364532019706,0.8312477185642629,1.0,8/26,10.27%,ROCK2;ASAP3;ALMS1;SYNPO;PRKN;FHOD1;PFN2;SLC9A1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.33944277152895513,1.0014308722706082,0.47435897435897434,0.843818192876171,1.0,15/74,15.92%,EPAS1;NOTCH1;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.43294697233316876,1.001291132837988,0.4427350427350427,0.8434584861050848,1.0,3/18,6.71%,IL6R;ST18;STAT1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.42270974282895774,1.000533265221952,0.47442680776014107,0.8446058149752267,1.0,6/21,17.44%,JAK3;DUSP3;SOX11;TNFAIP3;FOXJ1;SAMSN1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.39835330134169966,1.0002322728516044,0.4513888888888889,0.8446503013522666,1.0,7/28,17.12%,NOD2;CCDC88B;TNFSF11;CYRIB;NCKAP1L;SH3KBP1;CCR2
prerank,nucleotide biosynthetic process (GO:0009165),-0.38478600339607244,-0.9998820641847286,0.43414634146341463,0.8349372161937451,1.0,8/18,18.64%,NMNAT2;ME1;MTHFD1;PRPS2;PRPSAP1;PRPSAP2;ADSL;NMNAT1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.45319321163718096,0.9994953446180351,0.46153846153846156,0.8457964950544181,1.0,2/16,2.75%,PLCB1;MEF2C
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.359707372259867,0.9987942569040009,0.45933734939759036,0.8468380424759469,1.0,17/51,21.66%,HMBOX1;CTNNB1;MAPK3;TERF2;HNRNPC;CCT3;CCT5;ACD;DCP2;TERF1;MAPK1;CCT7;NAF1;EXOSC10;XRN1;MAP2K7;PINX1
prerank,male meiosis I (GO:0007141),-0.40687205991015013,-0.9987668569435998,0.4593406593406593,0.836785755106024,1.0,7/16,28.69%,FOXJ2;FOXJ3;ZSCAN21;HSF2BP;MYBL1;TDRD9;DDX4
prerank,motor neuron axon guidance (GO:0008045),0.4558305733173054,0.9987667581570496,0.4782608695652174,0.846242780960854,1.0,4/15,11.43%,NTN1;TMEFF1;EPHA4;RAC1
prerank,axon development (GO:0061564),0.3416927747834546,0.9982925080571572,0.4761215629522431,0.8467108081212551,1.0,21/78,20.79%,APP;KLF7;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;SLITRK1;ZPR1;GRM7;DCC;PLPPR4;NRCAM;ANK3;CTNNA2;CAMSAP2;RAB8A;ZDHHC17;BRSK2
prerank,translational elongation (GO:0006414),0.32714672901319064,0.998165735194191,0.4763231197771588,0.8463586456344028,1.0,45/101,28.70%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GTPBP1;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;EEFSEC;MRPL19;EEF1D;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;RACK1;GTPBP2;EEF1B2;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C;EEF1G;MRPL15;MRPS34;MRPS12
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.46849968079760074,0.9976547440273883,0.48269581056466304,0.8469980799941198,1.0,4/12,10.94%,LYN;CD19;ELF2;CBFB
prerank,positive regulation of protein acetylation (GO:1901985),0.4717150206721563,0.9976137416957933,0.46938775510204084,0.8464256547177073,1.0,3/12,5.82%,DIP2B;RAPGEF3;DIP2A
prerank,negative regulation of organelle assembly (GO:1902116),-0.3303076053991382,-0.997613406636472,0.4305177111716621,0.83891619441416,1.0,14/35,19.93%,NUPR1;TMEM39A;YAP1;LRRK2;SCFD1;MDM1;TESK1;PHF23;FEZ1;SMCR8;TCHP;TRIM37;TBC1D7;BRCA1
prerank,muscle tissue development (GO:0060537),0.4673715591437677,0.9975190992319238,0.4774436090225564,0.8459908956995286,1.0,4/13,12.12%,ENG;PGM5;STRA6;CSRP3
prerank,negative regulation of response to external stimulus (GO:0032102),0.3261265638874654,0.9974927988085275,0.4757412398921833,0.8454076347918837,1.0,9/105,6.45%,TEK;MFHAS1;PPARD;SIGIRR;DUSP3;EPHA4;INPP5F;GRID2;KLF4
prerank,response to prostaglandin E (GO:0034695),-0.45956692793912407,-0.9974651416762793,0.47123893805309736,0.8382236846448188,1.0,1/10,0.41%,TGFBR3
prerank,Notch signaling involved in heart development (GO:0061314),-0.4430541766166904,-0.997151364058947,0.5011441647597255,0.8380189120002653,1.0,4/11,7.70%,NOTCH2;RBPJ;HEYL;JAG1
prerank,protein heterotetramerization (GO:0051290),-0.4151932029028854,-0.9970432000979812,0.4752252252252252,0.8372734306207301,1.0,2/13,4.66%,PKD1;PKD2
prerank,cellular lipid catabolic process (GO:0044242),0.39863384483980707,0.9970125281917764,0.45901639344262296,0.8459225259910576,1.0,9/27,20.60%,PPARD;MGST2;ACOX1;ENPP2;LPIN3;SMPDL3B;ACBD5;AOAH;FAAH
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3961263022902989,-0.9964170792962926,0.46651785714285715,0.8380113680573582,1.0,2/15,5.34%,OSBPL8;PPARA
prerank,pyruvate metabolic process (GO:0006090),0.35825335127461577,0.9960792234680848,0.46048632218844987,0.847579819560645,1.0,9/52,14.41%,BSG;PDHB;PKM;HK1;PDHX;PGAM4;PGAM1;TPI1;PFKL
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35813631926305844,0.9955391562958794,0.4688427299703264,0.8482543206142066,1.0,13/52,18.88%,PPP1R13B;PPP3CC;FBXW7;YWHAH;YWHAQ;CASP8;GSK3A;SH3GLB1;PPP3R1;UBE2D3;YWHAZ;YWHAB;TOMM7
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4825488476886964,0.9953743767046801,0.48717948717948717,0.847966983687846,1.0,1/12,1.71%,IL1R1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3165293698260311,0.9948560595640736,0.462059620596206,0.8485187810194654,1.0,21/108,14.18%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1;FOXL2;SOX7;ST18;LGALS9;CRADD;PIDD1;MALT1;CASP8;ARL6IP5;S100A8;SYK;PPARG;BCL10;PDCD6
prerank,sterol homeostasis (GO:0055092),0.3399030553623827,0.9948495920367135,0.48546511627906974,0.8478834025044452,1.0,11/65,11.60%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LRP5;NPC1;LIPC;ABCD1;MTTP
prerank,macrophage differentiation (GO:0030225),-0.42563581353109403,-0.9947577821107092,0.4766355140186916,0.8414405530134526,1.0,2/13,1.89%,IL31RA;BMP4
prerank,regulation of B cell apoptotic process (GO:0002902),-0.43337071105129776,-0.9947063489015995,0.4855769230769231,0.8405179726856696,1.0,3/12,6.04%,FNIP1;IRS2;BCL6
prerank,muscle filament sliding (GO:0030049),-0.3239965711327658,-0.9945737199208142,0.4555256064690027,0.8387118469263347,1.0,5/38,10.36%,ACTN2;TPM1;DMD;TPM2;DES
prerank,actin-myosin filament sliding (GO:0033275),-0.3239965711327658,-0.9945737199208142,0.4555256064690027,0.8387118469263347,1.0,5/38,10.36%,ACTN2;TPM1;DMD;TPM2;DES
prerank,response to peptide hormone (GO:0043434),-0.31919977243362246,-0.9942060122845956,0.4699140401146132,0.8386326927450692,1.0,6/43,5.24%,TGFBR3;ROCK2;IGFBP5;IRS1;OGT;ANXA1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.42360662166610974,-0.9940062797462769,0.47415730337078654,0.8381550733386083,1.0,5/13,22.65%,SLC4A10;CLN3;SYP;SHISA7;PPFIA3
prerank,copper ion transport (GO:0006825),0.4658467619103962,0.9937052732079757,0.4765625,0.8499996967099576,1.0,2/11,4.15%,ATOX1;SLC31A1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33920165118288576,0.993362787092424,0.4692982456140351,0.8501791859591252,1.0,22/72,21.63%,POLK;MRE11;EDC3;GTF2H2;DNA2;PDE12;RNASE1;GTF2H4;DXO;DCP1B;FAN1;PNRC2;RBX1;RPA1;DICER1;POLD1;XRN2;GTF2H3;RFC2;DDB1;ERCC4;RNASE6
prerank,regulation of coagulation (GO:0050818),0.47494376739591637,0.9931950006101204,0.47843137254901963,0.8498976799337219,1.0,1/11,1.75%,CAV1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.46613399480988293,0.9931802638596844,0.46455223880597013,0.8492879925680085,1.0,2/12,6.45%,TIRAP;KLF4
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.28521000348818065,0.9928584364042478,0.49337748344370863,0.8494041105816422,1.0,56/348,13.45%,LEF1;TFRC;ETS1;OCLN;CLDN5;PDGFB;INSR;CD34;NOS3;PDE2A;APP;RGCC;MEF2C;PIK3R3;NOTCH1;RAMP2;KLF2;GATA2;TCF23;FGF16;RAMP3;DLL4;TLR3;INPP5F;TBC1D5;MAPK3;LGALS9;KLF4;HINFP;TGFB1;TERF2;RPS7;P2RX7;MSN;GREM1;ZPR1;ACTG1;PDCD10;SMAD1;PRKAB1;CNTF;LAMTOR5;TASOR;CTCF;GSK3A;VSIR;HIF1A;TLE1;PIK3CB;HGS;SOX11;DNAJA4;SETDB1;RPL11;SOX9;CDH5
prerank,histone H3-K9 demethylation (GO:0033169),-0.44567356235364547,-0.9927970272427051,0.49780701754385964,0.8404350783582702,1.0,6/11,23.81%,KDM7A;KDM3B;KDM1A;PHF8;KDM4D;HR
prerank,female gamete generation (GO:0007292),0.395688627468666,0.9925309696484915,0.46116504854368934,0.8495904708735482,1.0,5/29,8.49%,NANOS3;NANOS2;NANOS1;PRDM9;PTN
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4732178067763382,0.9924585544137063,0.4821763602251407,0.8491130952688515,1.0,4/11,22.85%,SP100;HIPK2;TFAP4;ING4
prerank,mRNA methylation (GO:0080009),0.45051688930475436,0.9916675390862254,0.46869409660107336,0.8503973470722646,1.0,7/15,23.95%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.28699761526045675,0.9915569028527007,0.48607888631090485,0.8499972916092825,1.0,50/291,14.07%,PDGFB;DAB2IP;PDE2A;RAPGEF2;SH3BP4;FES;TBX1;TIRAP;FZD4;MEF2C;FOXO1;RAPGEF1;DEFA6;NOD2;PRKD1;PXN;RAPGEF3;ACTB;LYN;TGM2;CREB1;RAMP3;KCNQ1;KCNC2;CAMKK2;MAPK3;RET;RAP1B;JUN;PDE4B;TWF2;IRGM;P2RX7;BRINP3;AKAP9;PTK6;LAMTOR5;BRINP2;RPTOR;GNB1;ZFP36L1;NSMF;HCN2;SOX9;AKAP6;HMGB2;TNFAIP3;SSH1;GIT1;BCL10
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4019848831051155,0.9910499986353742,0.48092868988391374,0.8505382861905849,1.0,4/23,10.56%,TOMM22;TIMM13;TIMM10;SAMM50
prerank,response to organophosphorus (GO:0046683),0.43803490849477356,0.9909945920262416,0.47186932849364793,0.8500215563551933,1.0,3/16,8.57%,TRIM16;STAT1;P2RX7
prerank,T cell mediated immunity (GO:0002456),0.4599663282178368,0.9908773467184063,0.48807339449541287,0.8496535126801998,1.0,1/13,0.97%,CADM1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4777418919493888,0.9908704280832972,0.4685714285714286,0.8490220131099849,1.0,4/10,22.85%,SP100;HIPK2;TFAP4;ING4
prerank,purine-containing compound catabolic process (GO:0072523),0.45222529402219724,0.990263435726351,0.4648648648648649,0.8498266886016581,1.0,3/13,11.08%,XDH;NT5C2;PNP
prerank,primary alcohol metabolic process (GO:0034308),-0.3555482517351826,-0.990062799699914,0.450261780104712,0.8467829974753922,1.0,6/25,10.14%,IGF1;RBP4;DHRS3;CYP1B1;NAAA;PECR
prerank,apoptotic nuclear changes (GO:0030262),0.40826307513318894,0.9898403365507367,0.48154657293497366,0.8502297244127442,1.0,9/24,19.18%,FOXL2;CECR2;DFFB;DEDD2;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,icosanoid metabolic process (GO:0006690),-0.32638488557436945,-0.9897569602267281,0.4768392370572207,0.8466095678683352,1.0,6/40,6.72%,PTGIS;PTGS1;DAGLA;CYP1B1;GGT5;PON3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2904085953635824,-0.9896790378102355,0.4575757575757576,0.845749739297407,1.0,12/63,9.09%,SLC1A3;SLC26A2;GABRA3;SLC12A2;ANO6;SLC5A5;SLC6A1;SLC12A7;SLC5A6;ANO1;SLC20A2;GLRB
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3179352001134363,0.9895359111623159,0.4676354029062087,0.8502781131210191,1.0,23/117,12.39%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1
prerank,gonad development (GO:0008406),0.3692139256416057,0.9895227195802484,0.4821705426356589,0.8496618681280446,1.0,6/41,10.83%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.31373945065725695,-0.9891414481652119,0.4604904632152589,0.8460585802851687,1.0,18/48,18.36%,DOCK5;CARMIL1;CUX1;OBSL1;S100A10;FBXW8;FLNA;MYOC;CUL7;CAPRIN2;ABL1;DMTN;CDKL3;P4HB;TESK1;MDK;MYADM;C1QBP
prerank,negative regulation of histone acetylation (GO:0035067),0.47412876380489505,0.9890761644297452,0.49433962264150944,0.8501032200881737,1.0,6/11,22.35%,CTBP1;SIN3A;SET;NOC2L;SNCA;SPI1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3184329414028165,0.9889969569720781,0.47354497354497355,0.849638221341484,1.0,23/116,12.39%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.4623936509736934,0.9889351390365169,0.4757630161579892,0.8491348779607527,1.0,9/12,31.80%,STK33;CDC6;ORC1;HUS1;RAD17;TOPBP1;HUS1B;CHEK2;NAE1
prerank,epiboly involved in wound healing (GO:0090505),-0.3967957916498527,-0.9887450360493637,0.4652777777777778,0.8460943132725917,1.0,5/16,11.79%,PDPN;DDR1;FLNA;CCN1;TMEFF2
prerank,negative regulation of defense response (GO:0031348),0.3327561153687643,0.9884889635723138,0.48667601683029454,0.8495901637924879,1.0,3/77,1.88%,TEK;MFHAS1;PPARD
prerank,ncRNA processing (GO:0034470),0.2954839457215788,0.9884037512735708,0.48946716232961585,0.8491808851533418,1.0,57/200,21.52%,ADAR;SARS1;RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;INTS11;PDCD11;RPL13A;SMAD1;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;MRM2;RPL11;RPS15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;MRPL44;RPL37A;RPP21;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;RPL34;DICER1;WDR75;EXOSC9;XRN2;NVL;RPL21;DDX54;RPP30;METTL3;RPL18A
prerank,response to purine-containing compound (GO:0014074),-0.3919129183413329,-0.9883600930857893,0.4852607709750567,0.8460445761895534,1.0,3/17,7.23%,TRPC3;ABCC9;P2RX4
prerank,peptide hormone secretion (GO:0030072),0.3999398666271664,0.9879420724866509,0.47884940778341795,0.8496675334983376,1.0,6/26,19.30%,LTBP4;RAB1A;EDN1;RIMS2;CAMK2G;CYB5R4
prerank,phosphatidylserine metabolic process (GO:0006658),0.38121625215017374,0.9878728209568484,0.4599686028257457,0.8491931666186967,1.0,5/32,10.01%,MBOAT1;PLA2G4B;SERINC5;OSBPL10;LPCAT3
prerank,homotypic cell-cell adhesion (GO:0034109),-0.32626442497947516,-0.987835179767167,0.47191011235955055,0.8464103743273163,1.0,7/39,8.94%,PLPP3;PDGFRA;MEGF11;VCL;FLNA;GNAS;MYL9
prerank,T cell migration (GO:0072678),0.4589428148768511,0.9876822762500329,0.4732965009208103,0.8489895332693578,1.0,3/13,8.79%,S1PR1;ZAP70;MSN
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4513576111888646,0.9875848614311435,0.475177304964539,0.8485674580693924,1.0,3/14,10.97%,MFSD2A;ABCB11;ABCD1
prerank,cellular response to organic cyclic compound (GO:0071407),0.30678844116533227,0.9875496464606299,0.4901185770750988,0.8480256826420167,1.0,30/141,13.85%,SLC1A1;PDGFB;PDE2A;RAPGEF2;FES;MEF2C;RAPGEF1;RAPGEF3;ACTB;TGM2;CTNNB1;RAMP3;KCNQ1;ATP1A1;ATP1A3;CASP7;RAP1B;GABRB1;TGFB1;P2RX7;MSN;NCOA4;AKAP9;PDE12;ARL6IP5;GNB1;ZFP36L1;HCN2;AKAP6;SSH1
prerank,regulation of signal transduction (GO:0009966),0.29638286439140027,0.9874975305013208,0.4785276073619632,0.8475090753174256,1.0,29/190,10.19%,PLCB1;RGS12;TMEM204;RGS3;APP;RASGRP4;GIT2;SP100;PRAG1;PRKD1;PXN;MFNG;SOCS2;SNX3;KIF26A;TSPAN12;WWTR1;IGFBP7;PPIA;FYN;GNG7;HOMER1;TGFB1;FOXP3;IRAK2;LIFR;SOCS5;PTK6;SHARPIN
prerank,establishment of vesicle localization (GO:0051650),0.4302209259308327,0.9868242116681181,0.4791666666666667,0.8484731228850774,1.0,6/18,18.50%,LIMK2;DNM2;RAB11A;F8A1;SYNJ1;CCDC186
prerank,toxin transport (GO:1901998),-0.43977389736044004,-0.9865696156962753,0.5218295218295218,0.848909364557005,1.0,3/10,13.99%,ANTXR2;RAB29;SLC22A2
prerank,melanosome localization (GO:0032400),-0.369895893956279,-0.9863477295051106,0.4878587196467991,0.8484565243113737,1.0,15/21,40.57%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;VPS33A;BLOC1S3;RAB27B
prerank,regulation of chemotaxis (GO:0050920),-0.3416514353532009,-0.9862065020898789,0.472,0.8477572116049304,1.0,6/30,7.23%,PDGFRB;PDGFRA;EFNB2;THBS1;ZSWIM8;P2RX4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4683645117113574,0.9857449261272669,0.5072202166064982,0.8503354458741013,1.0,4/11,17.88%,CCT3;CCT5;TERF1;CCT7
prerank,telomere capping (GO:0016233),0.44541854095285904,0.9856739471106448,0.4822064056939502,0.8498516790178401,1.0,4/16,12.47%,MRE11;TERF2;ACD;TERF1
prerank,cell cycle G2/M phase transition (GO:0044839),0.30888401881188154,0.9854651839471114,0.5106951871657754,0.8497100802816766,1.0,26/129,15.94%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;DNM2;LCMT1;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP135;CEP72;FBXL8;TUBB4B;TUBA1A;FBXL15;CKAP5;CEP70;PPME1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3595303118534993,-0.9853492327692378,0.4909090909090909,0.8489797409138452,1.0,4/25,13.14%,IGF1;PER2;NIBAN2;TWIST1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3278503602260711,-0.9848491241131702,0.4785100286532951,0.8492331161186556,1.0,5/41,9.42%,PRKAG2;OGT;SEH1L;LACC1;NUP205
prerank,regulation of vacuole organization (GO:0044088),0.4279402999228076,0.9844382290879201,0.5103092783505154,0.8514960215274089,1.0,3/20,4.82%,TBC1D14;TBC1D12;PIKFYVE
prerank,regulation of macroautophagy (GO:0016241),-0.27111519876075,-0.9841440998372787,0.5179282868525896,0.8500021962811899,1.0,35/105,23.77%,PRKAG2;DCN;PRKAA2;SNX6;NRBP2;PRKACA;PRKAG3;CLN3;LRRK2;ATP6V1C1;SNX5;RHEB;ATP6V1G2;CLEC16A;LAMTOR3;CAPN1;CASP3;RRAGA;GNAI3;IKBKG;SMG1;ATP6V1E1;SNX32;SCOC;SMCR8;GPSM1;TSC1;ATP6V0D2;CDK5;NEDD4;PRKAB2;ATP13A2;VPS26A;WAC;SLC38A9
prerank,positive regulation of synapse assembly (GO:0051965),0.40328781348935727,0.9838383121154035,0.48032786885245904,0.852208763700256,1.0,9/27,16.49%,AGRN;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;EPHB1;NLGN1;IL1RAP
prerank,aortic valve development (GO:0003176),0.3814201780941628,0.9836763855540959,0.470125786163522,0.8519256637483767,1.0,9/34,8.09%,TIE1;BMPR2;NOS3;NOTCH1;NPPA;DLL4;SNAI2;EFNA1;TGFB1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.4145681430058223,-0.9836585000522311,0.48,0.8503019967925213,1.0,2/14,5.27%,ENPP1;ENPP3
prerank,steroid biosynthetic process (GO:0006694),-0.29444788767249896,-0.9835650691600961,0.4880239520958084,0.8495371661457463,1.0,5/56,5.81%,PRKAG2;CYP7B1;INSIG2;CYP27A1;ACOT8
prerank,regulation of fibroblast proliferation (GO:0048145),-0.31419980577591383,-0.9833673601152177,0.48717948717948717,0.8490537159392555,1.0,12/45,14.01%,IGF1;PDGFRA;S100A6;PDGFC;MED25;SPHK1;CD300A;EMD;SKI;NF1;PEX2;MORC3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.38969717937729026,0.9833663592225336,0.47796610169491527,0.8520287986521538,1.0,7/30,5.48%,RASGRP4;RAPGEF1;NOTCH1;LYN;TGM2;GRB2;STK19
prerank,negative regulation of ossification (GO:0030279),-0.36630165018481864,-0.9832065130055945,0.4660633484162896,0.8484751906297816,1.0,10/23,17.17%,ENPP1;SMAD6;BCOR;RBPJ;ECM1;TRPM4;PTK2B;CHSY1;MDK;SFRP1
prerank,cellular protein localization (GO:0034613),0.2839974046935632,0.9831445494411895,0.49193548387096775,0.8519382618034307,1.0,40/285,11.15%,OCLN;ESAM;TBC1D4;REEP1;STX3;RAB31;ID1;TBC1D14;ARHGEF2;STX1A;TBC1D22A;AMOT;TBC1D12;SNX13;MYO6;TBC1D2;HHEX;CTNNB1;ARF5;CEP68;PIGU;USP6NL;MESD;TBC1D5;GRID2;ABHD17A;STXBP1;CNTN2;COG3;GRIN3B;ARL4A;YWHAH;RTP4;PIGK;SMURF1;AXIN2;FERMT2;TBC1D10B;ACD;STX19
prerank,negative regulation of interferon-beta production (GO:0032688),-0.44083941443857577,-0.9829950604439106,0.48717948717948717,0.8480110519062124,1.0,6/10,38.04%,PTPRS;PPM1B;PYCARD;LILRB1;NLRC3;REL
prerank,regulation of tube diameter (GO:0035296),-0.41625487796206484,-0.9827716694476458,0.4890829694323144,0.8465466938872908,1.0,8/13,15.39%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,vascular process in circulatory system (GO:0003018),-0.41625487796206484,-0.9827716694476458,0.4890829694323144,0.8465466938872908,1.0,8/13,15.39%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,lysosome organization (GO:0007040),-0.3257893501779924,-0.9826706313024605,0.4477211796246649,0.8457740907481884,1.0,12/36,18.25%,ABCA1;HOOK2;ARSB;GAA;CLN3;LRRK2;AKTIP;ACP2;GNPTAB;GRN;CLN6;MBTPS1
prerank,actin filament capping (GO:0051693),0.4342577769608963,0.9826700834520451,0.47810858143607704,0.8518187320836296,1.0,5/18,9.26%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,barbed-end actin filament capping (GO:0051016),0.4342577769608963,0.9826700834520451,0.47810858143607704,0.8518187320836296,1.0,5/18,9.26%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.474712193929268,0.9824749885519385,0.4990990990990991,0.8516418167115987,1.0,3/11,12.02%,SMAD7;FOXP3;CEACAM1
prerank,negative regulation of kinase activity (GO:0033673),-0.28770475341920426,-0.9821071273433637,0.48125,0.8462112628673134,1.0,16/62,20.58%,PRKAG2;PPM1E;DEPTOR;DTNBP1;IRS2;PDPK1;SPRED1;QARS1;ITGB1BP1;NF1;LRP6;CDKN1C;PTPRC;SMCR8;THY1;TARBP2
prerank,glycine metabolic process (GO:0006544),0.4641641598545918,0.9817210210777325,0.4982014388489209,0.8527923901264122,1.0,5/12,23.81%,GLYAT;SHMT2;SDSL;RIDA;GCSH
prerank,stress granule assembly (GO:0034063),-0.3710917792603866,-0.9815428693984107,0.4806763285024155,0.8466664816096181,1.0,8/20,24.23%,UBAP2L;BICD1;OGFOD1;DDX3X;YTHDF1;ATXN2L;CIRBP;CSDE1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.48161405186572404,0.9814505486661724,0.4892086330935252,0.8527565994378355,1.0,3/10,17.12%,ADAM10;ADAM17;CCR2
prerank,regulation of cell death (GO:0010941),-0.2736522055920911,-0.981403904708164,0.5087108013937283,0.8460206267233653,1.0,22/94,16.16%,LRP1;CCN2;BMP7;BMP4;ACER3;IMPACT;FGF2;CCN5;CCN1;PRKN;CCN3;PRODH;SLC25A24;SRSF6;CCN4;LRRK2;RAB29;DUS2;WNT11;CTSZ;SARM1;CRYAB
prerank,regulation of lipase activity (GO:0060191),-0.415582124675719,-0.9811522846203644,0.4769874476987448,0.8456885332500822,1.0,4/13,18.62%,PCSK5;LMF1;ANGPTL3;PCSK6
prerank,membrane repolarization during action potential (GO:0086011),0.45970595104468426,0.9810183689151442,0.4851301115241636,0.8531543344345037,1.0,3/13,7.93%,KCNQ1;ATP1A1;KCNH2
prerank,mRNA destabilization (GO:0061157),-0.31978117294026676,-0.9809091208689165,0.47277936962750716,0.8453572458289187,1.0,2/38,2.79%,ROCK2;TUT4
prerank,iron-sulfur cluster assembly (GO:0016226),0.4000256591694517,0.9803729435527738,0.48576214405360135,0.8540026767971974,1.0,15/24,29.81%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;BOLA2;NUBPL;GLRX3;LYRM4;NFU1;ISCA1;ISCA2;NUBP1;NUBP2;ISCU
prerank,basement membrane organization (GO:0071711),0.4422759483161133,0.9802096867158582,0.4802065404475043,0.8537699417411868,1.0,4/14,7.04%,NTNG2;RAMP2;PXDN;COL4A1
prerank,protein palmitoylation (GO:0018345),0.3844071737817197,0.9800565214118935,0.47611464968152867,0.853509018491123,1.0,6/30,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,intracellular lipid transport (GO:0032365),0.41031506558789144,0.979300875509797,0.4753521126760563,0.8546283295957625,1.0,4/21,6.80%,CERT1;ABCD4;CPT1A;ACACB
prerank,DNA modification (GO:0006304),0.4074173317472295,0.9792293464618581,0.4904679376083189,0.8541617203177846,1.0,6/22,12.47%,NTHL1;TERF2;SMUG1;ACD;MPG;TERF1
prerank,regulation of presynapse organization (GO:0099174),-0.38109810775019964,-0.9790661730134967,0.5122549019607843,0.8483027386476079,1.0,2/18,4.60%,GPC6;GPC4
prerank,regulation of presynapse assembly (GO:1905606),-0.38109810775019964,-0.9790661730134967,0.5122549019607843,0.8483027386476079,1.0,2/18,4.60%,GPC6;GPC4
prerank,protein localization to lysosome (GO:0061462),0.39886529932590936,0.9788713710550141,0.5025380710659898,0.8544105520939674,1.0,8/28,17.46%,SH3BP4;NCOA4;LAMTOR5;HGS;M6PR;LMBRD1;LAMTOR4;AP3M1
prerank,microtubule-based transport (GO:0099111),-0.4204146135559027,-0.9787517530801981,0.48086124401913877,0.8481224612575001,1.0,9/12,33.83%,DYNC1I1;ROPN1L;HTT;ADCY10;SPAG17;SPA17;DYNC1I2;CCDC40;DNAAF4
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3700774579880928,-0.9785653099935814,0.47074468085106386,0.8475813844415545,1.0,7/23,13.62%,KIT;CYP1B1;OCIAD1;PTK2B;PRLR;PIBF1;GHR
prerank,"phagocytosis, engulfment (GO:0006911)",0.3725800915250992,0.9785323512218972,0.48856209150326796,0.8545624386369735,1.0,4/36,6.47%,RHOBTB1;DOCK1;ELMO1;ARHGAP25
prerank,muscle tissue morphogenesis (GO:0060415),-0.3891290947503383,-0.9785119952743667,0.4854586129753915,0.8467080216704752,1.0,3/16,2.08%,TGFBR3;BMP4;MYLK
prerank,androgen receptor signaling pathway (GO:0030521),-0.433999316557376,-0.9785082365691823,0.48156182212581344,0.8456997067511952,1.0,5/11,21.53%,DDX5;AR;DDX17;RNF14;ZMIZ1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3252806252238746,0.9784036580621553,0.4901685393258427,0.8542570074939965,1.0,10/78,8.09%,PRKCH;SPTBN1;BCL2L1;STX3;ACTB;RAMP3;PPP2R5A;SORBS1;AP2M1;TGFB1
prerank,cytoskeleton organization (GO:0007010),0.3103463922519905,0.9774194859794808,0.49728260869565216,0.8559950929739361,1.0,24/114,13.84%,FGD5;SEMA6A;ARAP3;RHOBTB1;FMNL3;NEDD9;SIPA1;MAST4;RHOB;PAK5;CECR2;DPYSL2;ARHGAP4;RANBP10;FGD6;STRIP1;KLHL20;PDZD8;RAC1;RND1;RANBP9;FGD2;TNFAIP3;CFL1
prerank,axonemal dynein complex assembly (GO:0070286),0.3912269779872837,0.9773101789912852,0.4847972972972973,0.8556218251226559,1.0,9/27,17.66%,ZMYND10;LRRC49;CFAP100;DRC1;DNAAF2;DNAH8;DNAAF3;DNAH5;TTC12
prerank,central nervous system development (GO:0007417),0.28793825413471774,0.9772287676384552,0.5134502923976608,0.8551774484647066,1.0,45/250,14.06%,SLC2A1;MFSD2A;ADGRL2;SHROOM4;ZIC3;ADGRL3;MAL;TBX3;SEMA6B;ADGRG1;NES;CDH2;DSCAML1;ZBTB16;LSR;MOG;AATK;NCKAP1;COL4A1;SOX12;DHX37;CDK5RAP2;SPOCK1;CAPG;DNER;SERPINI1;ZPR1;TBC1D23;DDIT4;AGTR2;DCX;THOC6;EIF2B2;GRIN2B;UFM1;UTP3;SOX10;TGFBR2;EML1;SOX11;CNTNAP2;SOX9;GRIK1;FOXJ1;HAPLN2
prerank,regulation of wound healing (GO:0061041),0.36174129104788905,0.9771207257961446,0.47702060221870046,0.8548359152492633,1.0,5/42,6.30%,OCLN;CAV1;PTK2;VIL1;INSL3
prerank,inner mitochondrial membrane organization (GO:0007007),0.35340259304050814,0.9770934085764587,0.4970414201183432,0.8542742607726492,1.0,15/47,22.97%,ATP5F1E;TIMM13;ATP5MC2;LETM1;ATP5PO;GHITM;TIMM10;SAMM50;ATP5F1A;HSPA9;ATP5MF;ATP5PF;CHCHD3;TMEM11;MTX1
prerank,positive regulation of nervous system process (GO:0031646),0.42701912279794885,0.9768834824431766,0.49732620320855614,0.8541163716996101,1.0,6/18,19.18%,UNC13B;PARD3;CST7;RIMS2;TPPP;DICER1
prerank,protein acylation (GO:0043543),0.3744248696545363,0.9764584711770753,0.5031055900621118,0.8544752285557918,1.0,8/38,12.54%,ZDHHC14;FOXO1;ZDHHC9;ZDHHC20;KAT6A;ZDHHC18;ZDHHC22;GTF2B
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4415758369664303,-0.9748117112155321,0.49223946784922396,0.8544001486721928,1.0,4/10,9.92%,VTN;ITGA5;GRB10;ARNT
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.44302364709386194,-0.9742494069790745,0.5092783505154639,0.854918478216307,1.0,5/11,24.87%,FBH1;TIPIN;ZRANB3;DONSON;LIG3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.3454045084929491,-0.974225724364308,0.5087281795511222,0.8539686879079343,1.0,3/23,2.73%,IGF1;EFNB2;MMP14
prerank,negative regulation of response to wounding (GO:1903035),-0.377035820244534,-0.9740973010035987,0.5,0.8532398844818659,1.0,8/19,21.79%,CASK;PTPRS;FGF2;CD109;MDK;CERS2;SERPINE1;RTN4R
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.43853342098652937,-0.9739031483949666,0.5020576131687243,0.8527723796443185,1.0,2/10,7.88%,OGT;SELENOS
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3505002459162466,0.973845519711518,0.5070202808112324,0.8598803691319107,1.0,5/52,4.91%,PRKCH;SPTBN1;STX3;EPB41;RAMP3
prerank,synaptic vesicle membrane organization (GO:0048499),0.42567979182465404,0.9731935416989738,0.5008849557522124,0.8608022437237708,1.0,4/17,12.26%,STX3;STX1A;STX19;SNAP29
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4260264234990484,0.9731830719481127,0.49333333333333335,0.8601944577972298,1.0,6/18,20.96%,DAB2IP;MSN;RGP1;PTTG1IP;NELL1;RDX
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3780937124069591,0.9724934259425849,0.5103092783505154,0.8611837632356983,1.0,4/31,10.71%,DAB2IP;ATXN3;RHBDD1;HSPA8
prerank,regulation of membrane depolarization (GO:0003254),-0.38746706625634886,-0.9722889199082949,0.47845804988662133,0.8560327505418183,1.0,5/18,11.81%,FHL1;PTPN3;CAMK2D;LRRK2;GPD1L
prerank,positive regulation of cell aging (GO:0090343),0.45602413915605033,0.9722367769452244,0.518783542039356,0.8611520155356579,1.0,4/11,16.58%,B2M;HMGA1;ABI3;HMGA2
prerank,positive regulation of macroautophagy (GO:0016239),0.3509069564437393,0.9719745945280428,0.49846625766871167,0.861111422473763,1.0,13/48,14.19%,KDR;SLC25A5;SESN3;SPTLC2;RALB;IRGM;FYCO1;BNIP3L;VPS13D;SH3GLB1;PIP4K2A;SPTLC1;EPM2A
prerank,central nervous system neuron axonogenesis (GO:0021955),0.46286923342481745,0.9717400011371665,0.5134649910233393,0.8610160958722547,1.0,3/12,12.50%,B4GALT5;HSP90AB1;EPHB1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4368140647643479,0.9716555272942764,0.508637236084453,0.8605990505129408,1.0,2/15,1.41%,KDR;CXCL12
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.33780951432925305,-0.9716252140122488,0.49742268041237114,0.8567323241782037,1.0,2/28,1.34%,PRKAG2;PRKAA2
prerank,regulation of phospholipase C activity (GO:1900274),0.43458363501768466,0.9715980362702941,0.5086206896551724,0.8601057206442845,1.0,2/15,4.11%,FLT1;PLCG1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3485657633868952,0.9715508070345872,0.5,0.8596116333180529,1.0,9/50,12.10%,APP;NOD1;NOD2;TLR3;ACTN4;LGALS9;TLR7;AGER;C1QTNF4
prerank,pentose-phosphate shunt (GO:0006098),-0.42532956355774926,-0.9713999645411627,0.5168776371308017,0.8563442424259693,1.0,4/11,14.58%,PGLS;H6PD;PGD;DERA
prerank,positive regulation of cell development (GO:0010720),-0.33563666520844926,-0.9710158020552677,0.47435897435897434,0.8563381303806256,1.0,7/31,15.19%,PDE3A;BMP4;SERPINF1;NUMBL;NIBAN2;NKX6-1;NAP1L1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.31137651103846453,0.9707584600039872,0.522911051212938,0.8608185363984246,1.0,25/109,17.29%,PLCB1;PIK3R6;INPP5D;PIK3R3;PLCG1;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;MTMR6;PIK3C3;PIK3C2A;RAB4A;PIP4K2A;PIK3CB;MTMR12;CDIPT;MTMR2;PIK3R5;PLEKHA3;SYNJ1;INPP5E;INPPL1;CSF1R
prerank,regulation of centriole replication (GO:0046599),-0.38571863874537593,-0.9704299480319527,0.5070754716981132,0.8568398766759353,1.0,8/17,23.20%,ALMS1;MDM1;SPICE1;STIL;CEP295NL;TRIM37;BRCA1;CEP76
prerank,mitochondrial membrane organization (GO:0007006),0.3765495563828456,0.9702086169526667,0.502454991816694,0.8614379093603326,1.0,11/32,24.74%,BCL2L1;SLC25A5;GHITM;SAMM50;HSPA9;CHCHD3;BAK1;BNIP3;TMEM11;MTX1;PMAIP1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4255429444349496,0.9702060303508152,0.4700854700854701,0.8608156569268249,1.0,1/17,0.99%,BCL2L1
prerank,regulation of mitotic nuclear division (GO:0007088),0.34189414677014895,0.9694074607325297,0.5114503816793893,0.8619976850481172,1.0,9/55,8.63%,PDGFB;INSR;RGCC;LCMT1;PIN1;TGFA;CAV2;LRP5;CDK5RAP2
prerank,response to thyroid hormone (GO:0097066),0.444638516250606,0.9693546610032086,0.5095320623916811,0.8614848788682312,1.0,1/13,0.76%,LMO2
prerank,skeletal muscle organ development (GO:0060538),0.39496671167218605,0.9691048889112576,0.49589490968801314,0.8614737629862761,1.0,6/26,12.12%,CAV1;MEF2C;FOXL2;MYH14;STRA6;CSRP3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3205905687050289,0.9690279905453748,0.5131396957123098,0.8610289732700277,1.0,19/88,12.42%,EXOC6B;APP;EXOC6;STXBP6;AP1S2;SORT1;SORCS1;DNM2;SCAMP1;CLINT1;AP1S3;KLHL20;CLVS2;HSPA8;EXOC4;EXOC2;AP4S1;EPS15;HGS
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.39069396765353814,-0.9687675054047536,0.4928909952606635,0.8602730928076444,1.0,3/16,9.76%,DDX5;SRSF6;DDX17
prerank,morphogenesis of an epithelium (GO:0002009),-0.348226271119392,-0.9684096654249997,0.5025125628140703,0.8602145844050746,1.0,8/25,15.26%,FGFR2;VCL;DAG1;TBX18;KDM2B;ARHGAP12;AHI1;LRP6
prerank,phospholipid dephosphorylation (GO:0046839),0.36782754569419124,0.9683108906602876,0.5030769230769231,0.8620311272093941,1.0,10/37,17.06%,SGPP2;PLPP6;OCRL;INPP5F;MTMR6;MTMR12;MTMR2;PLPPR4;SYNJ1;PLPP2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.36371244291603366,0.9674418584733603,0.5299837925445705,0.8633775424867461,1.0,5/38,6.22%,XDH;PHLPP1;PTPRJ;HYAL2;PLEKHA1
prerank,pharyngeal system development (GO:0060037),0.4321747822249675,0.9665075159671632,0.5095652173913043,0.8649325122668347,1.0,3/15,1.88%,BMPR2;TGFB2;TBX1
prerank,regulation of filopodium assembly (GO:0051489),0.36589294197545125,0.9662840417153608,0.4878048780487805,0.8648419815939272,1.0,6/38,5.25%,MYO10;PPP1R16B;FNBP1L;PALM;AGRN;CCR7
prerank,endomembrane system organization (GO:0010256),-0.2469244656041979,-0.9661740472398649,0.565,0.8649839194948253,1.0,68/178,26.36%,RAB30;MYOF;GBF1;DMPK;OBSL1;TANGO2;ARHGAP21;GOLGB1;A4GALT;FBXW8;FAM174B;DYNC2H1;GOLGA2;HOOK2;SEC31A;SEC16B;PI4K2B;COG4;CUL7;TLCD2;PLEKHF1;TMEM170A;ARL1;ARFGEF2;HUWE1;LRRK2;GORASP2;AKTIP;ATP8B2;RAB29;ATP8B1;SPTSSB;BCAS3;PLEKHM2;SEC16A;LMAN1;SNX33;WASHC5;SURF4;OPTN;SNX10;USP50;SYP;SUN2;BLZF1;GOLGA5;GOLGA8B;RAB22A;VPS4A;ATL3;TMED4;DNM1;LMAN2L;SEC23IP;TMED9;MYO18A;UBXN2A;ALS2;HTT;LEMD2;TJAP1;OTOF;WASHC4;NUP155;ANXA8;ANXA8L1;EIF2AK3;PHETA2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.45202596253046934,0.9657824744933546,0.49471830985915494,0.865371931787901,1.0,1/12,0.76%,LMO2
prerank,regulation of cartilage development (GO:0061035),-0.3792867423327962,-0.96552374479895,0.5100671140939598,0.8657031049741765,1.0,7/18,17.10%,SOX5;BMP4;SOX6;PTHLH;BMP2;WNT11;MDK
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3571505588587599,-0.9654904665043839,0.5057736720554272,0.864749397744473,1.0,6/20,14.30%,ADGRV1;AKAP12;AKAP7;PJA2;LRRK2;TCIM
prerank,nucleotide-excision repair (GO:0006289),0.3180335763326622,0.9654785430782338,0.5350140056022409,0.8654451551444702,1.0,35/101,26.33%,POLK;ATXN3;GTF2H2;BRCA2;CETN2;GTF2H4;POLB;FAN1;RBX1;AQR;COPS5;RAD23A;GPS1;ISY1;HUS1;POLR2J;RPA1;TCEA1;POLL;POLD1;ERCC8;GTF2H3;POLA1;COPS6;RFC2;DDB1;ERCC4;RAD23B;PPIE;XPC;RFC4;COPS2;PNKP;POLD4;USP45
prerank,cellular protein metabolic process (GO:0044267),0.27517985707560777,0.9653212304754119,0.5686059275521405,0.8651979414161278,1.0,98/396,19.60%,ST8SIA4;ST3GAL6;DAB2IP;DENND3;APP;ST3GAL1;STK38;SPARCL1;VWA1;CDH2;MEN1;SARS1;NOTUM;ZAR1L;RPL38;IGFBP7;MRPL13;RPL13;RPS29;ABCA3;MRPL10;ADAM10;RPL36A;YES1;RPL3;GOLM1;UBE2G1;MSRB2;YARS2;LCMT1;MSRB3;RPL27;RPSA;PDIA6;RPS7;QSOX1;RPL9;RPL18;RPLP2;PLAT;SCG3;ADAM17;RPL13A;MMP1;FBXL2;CHRM3;RPS11;DUSP12;APH1A;RPL8;RPS27;RPL19;UBA3;RPS9;MRPL28;SPCS2;EVA1A;MANBA;RPL11;LTA4H;FBXW2;RPS15;SRBD1;RPL37;RPS28;MAN2B1;SERPINC1;RPS10;OMA1;UBE2D3;LOXL2;MMP15;RPS25;MCRS1;PROC;RPL37A;MRPL9;COPS5;GAS6;SEPHS1;TMEM132A;UBE2G2;SCG2;FBXO2;RPL15;SFTPC;TNIP1;SPPL3;ERO1A;CPE;RPL17;MRPL23;RPL23;RPL34;USP25;LMCD1;FARSB;RPS18
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3438398018537047,0.9651838995293684,0.5388059701492537,0.8648896956369577,1.0,6/57,5.96%,KDR;HIP1R;PLAUR;TNFSF10;CAMKK2;BIK
prerank,limb morphogenesis (GO:0035108),-0.36686978239238605,-0.9649123487546653,0.517162471395881,0.8652330064504177,1.0,3/20,2.40%,GLI3;CYP26B1;PCSK5
prerank,negative regulation of peptidase activity (GO:0010466),0.35387548403354535,0.96466147752585,0.522273425499232,0.8654567875809265,1.0,8/47,9.85%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;CST7;SPOCK1;SERPINI1;UBXN1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.22478471967270058,-0.9634830355478169,0.6578947368421053,0.8679546750158424,1.0,72/327,16.52%,BNC2;NFIA;DENND4A;ZFHX3;EFEMP1;SSBP2;ARNT2;PPARGC1B;TULP3;PRRX2;NR1D2;FOXC1;TGFBR1;SUFU;PPARGC1A;ZNF423;RORA;KAT6B;MED23;CTR9;SIX1;NFXL1;IGF2;CRABP2;POLR2A;FZD7;ZFAT;ATF5;GPBP1L1;PFDN5;CHD3;VSX1;MITF;ACTR8;RBAK;PML;SOX6;REXO4;GCFC2;CEBPB;ZBTB38;NSD2;PRMT5;RNF20;NFX1;TGFBRAP1;ABL1;ESR1;SBNO1;BMP2;ZNF219;DVL2;SP3;ZBTB4;MAFB;ACVR1B;GZF1;ATF2;SPTY2D1;EP300;NONO;PHF12;MYBL2;LIMD1;NFIL3;CCAR1;LDB1;APBB3;ZSCAN21;PSPC1;ZFP37;NFATC2
prerank,ganglion development (GO:0061548),0.45512766287708195,0.9634086237317938,0.5176470588235295,0.8676322003862875,1.0,4/11,19.12%,CTNNB1;INSM1;NRP2;NRP1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4061103852082647,-0.9632085358978819,0.5,0.8676863009946216,1.0,7/13,18.29%,PKD1;SUFU;PKD2;FLNA;MDFI;LATS1;DBN1
prerank,Golgi inheritance (GO:0048313),-0.4244571103400203,-0.9630867486847586,0.5090497737556561,0.866973852956115,1.0,4/11,14.52%,GBF1;GOLGA2;STX5;PLK5
prerank,metal ion transport (GO:0030001),0.3253850327984612,0.962955351572574,0.5267605633802817,0.8680557555636585,1.0,15/86,11.92%,CACNA1A;SLC39A8;CAV1;SLC30A1;NIPAL3;RAMP2;ATP2C1;CALCRL;RAMP3;FYN;SLC3A2;NIPAL4;NDFIP2;LRP2;CDH23
prerank,response to muscle stretch (GO:0035994),0.42847986821719064,0.9627618612665626,0.49912739965095987,0.8678702219380454,1.0,4/15,4.86%,PTK2;CDH2;CTNNB1;NPPA
prerank,regulation of protein kinase C signaling (GO:0090036),0.4435301413349757,0.9623657566382732,0.5119266055045871,0.8681422604883551,1.0,2/14,3.06%,FLT4;CD40
prerank,blood vessel endothelial cell migration (GO:0043534),0.4032881073848393,0.9621811565917807,0.5008547008547009,0.8679278246557082,1.0,6/22,8.89%,KDR;ID1;PIK3R3;EPHB4;SOX18;GREM1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.39178814040027,-0.9621621441698041,0.4931506849315068,0.8684090045509325,1.0,8/15,25.26%,TNKS2;ATM;RTEL1;PARP1;ERCC1;RAD50;NBN;TNKS
prerank,regulation of cellular component size (GO:0032535),0.37788821856227905,0.9621614137510623,0.5199362041467305,0.8673552135615188,1.0,9/30,15.55%,RIN3;EPS8;AP2M1;MSN;RAB3B;LAMTOR5;RAC1;RPTOR;LAMTOR4
prerank,T cell differentiation (GO:0030217),0.36004935735164767,0.962076324335034,0.5232383808095952,0.866913490428047,1.0,10/40,12.55%,JAG2;SOX13;ZAP70;DLL4;CD4;TCF7;ADAM17;GPR89A;GPR89B;ZFP36L1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.3508189852480348,-0.9620577671957626,0.5012406947890818,0.8676524393581548,1.0,5/24,4.23%,DPYSL3;DOCK11;ARAP1;RHOQ;RIPOR2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.32648089393763025,0.9619215505532617,0.5191489361702127,0.8666357743358348,1.0,21/72,23.22%,TIRAP;CARD10;TLR3;PSMB3;PSMD11;BIRC3;PSMC6;MALT1;PSME2;PSMD8;PSMB10;PSMA8;RELB;SKP1;PSMD9;DICER1;CUL1;PSMC3;PSMD1;PSMD10;TRAF6
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4132676517780771,-0.9619116412458952,0.49572649572649574,0.8669828251706928,1.0,4/12,17.88%,SMO;SIX1;SIX4;PAX2
prerank,mRNA stabilization (GO:0048255),0.36416829244108334,0.9617560702360232,0.524031007751938,0.8663744192292538,1.0,7/40,14.77%,TIRAP;YBX1;NOCT;HNRNPC;AXIN2;PAIP1;ELAVL1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2670782377317257,-0.9606770518081859,0.5370370370370371,0.8693740383899486,1.0,17/94,10.31%,ITPR1;FHIT;PDK1;DDX5;MAP3K5;PRKCD;IKBKE;CYP1B1;TMEM117;BCL2;ATM;PRODH;PML;CUL3;CEBPB;STK11;CRIP1
prerank,carbohydrate catabolic process (GO:0016052),0.36409367285713334,0.9604696957277382,0.5072,0.8687657199536516,1.0,12/38,18.47%,NEU4;PKM;HK1;MANBA;NEU2;PGAM4;PGAM1;TPI1;MAN2B1;PFKL;NEU1;LDHA
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.33693347456340683,0.9604467605577918,0.516566265060241,0.8682018039512667,1.0,1/60,0.03%,LEF1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.35667329920564134,0.960135350091799,0.5147744945567652,0.8682772856022869,1.0,12/41,12.63%,ENG;TGFB2;MEF2C;NOTCH1;SMAD7;FOXF1;DLL4;TGFB1;NPY5R;GSK3A;TGFBR2;SOX11
prerank,primary miRNA processing (GO:0031053),-0.42796582281382006,-0.9598938942736988,0.4966442953020134,0.8705091329003243,1.0,3/10,14.96%,SMAD3;PUS10;HNRNPA2B1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.35771145129552534,0.9597335040341871,0.5226917057902973,0.8685892466052295,1.0,4/40,5.96%,BCL2L1;PLAUR;TNFSF10;BIK
prerank,secretion (GO:0046903),-0.3942323095218777,-0.9596489784122263,0.49336283185840707,0.8701585331781925,1.0,4/14,4.51%,FBLN5;SLC22A4;PRKCI;SLC22A6
prerank,snRNA 3'-end processing (GO:0034472),-0.3730644260596423,-0.9595204081053705,0.5279069767441861,0.8694707901835587,1.0,7/19,30.02%,INTS8;INTS2;TUT1;EXOSC2;TOE1;INTS6L;INTS5
prerank,positive regulation of protein ubiquitination (GO:0031398),0.32309556393939337,0.9590553649954461,0.5403899721448467,0.8695066289509636,1.0,22/80,19.21%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;PIN1;MALT1;NDFIP2;UBQLN1;GSK3A;DCUN1D1;BCL10;PDCD6;RBX1;BMI1;INAVA;PTTG1IP;UBE2D1;FKBP1A;NSMCE3
prerank,indolalkylamine catabolic process (GO:0046218),-0.4359177063884866,-0.9589997152605119,0.5277161862527716,0.8697996450137103,1.0,5/10,30.37%,KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,extracellular matrix assembly (GO:0085029),-0.3553921552506686,-0.9585902421592837,0.5289672544080605,0.8698591365357519,1.0,8/23,11.27%,TNXB;FBLN5;ATP7A;EMILIN1;MYH11;LAMB1;EFEMP2;MFAP4
prerank,protein K11-linked ubiquitination (GO:0070979),-0.33469496655263664,-0.9584766137574565,0.5163043478260869,0.8691444614865076,1.0,9/27,26.18%,UBE2E2;ANAPC5;PRKN;UBE2E3;UBE2B;CDC16;UBE2S;ANAPC4;ANAPC13
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.301467184583211,0.9584026518948133,0.5376486129458389,0.8703208326271133,1.0,18/121,10.58%,PECAM1;PDGFB;IL6R;LRP8;NEDD9;ARL2BP;PTPRJ;ARHGEF2;CD40;LYN;EPHA4;STAP2;EFNA1;TGFB1;ENPP2;GREM1;PTK6;CNTF
prerank,regulation of cell cycle (GO:0051726),0.2806373029462874,0.9582964701155062,0.5570934256055363,0.869953469762207,1.0,28/271,8.39%,MECOM;DAB2IP;APBB2;PPP1R13B;TGFB2;NANOS3;TBX3;AFAP1L2;DCUN1D3;RGCC;SIPA1;NOTCH1;MEN1;PPP1R9B;HSP90AB1;CDC14A;XIAP;BTG4;RHOB;TTC28;ADAM10;CDKN2B;INSM1;JMY;JUN;BIRC3;TGFB1;IQGAP1
prerank,mitotic cell cycle phase transition (GO:0044772),0.28664082185136125,0.9581126297645407,0.5661764705882353,0.8697742064594893,1.0,54/203,22.49%,PLCB1;CCNY;TPD52L1;NES;EPS8;DYNLL1;CDKN2B;CCP110;MAX;DNM2;LCMT1;CCNI;PRKAR2B;HINFP;CETN2;TUBB;CDK5RAP2;PPP1CB;CCND3;AKAP9;HAUS6;CEP78;EIF4E;CEP135;CEP72;PIM2;FBXL8;TUBB4B;TUBA1A;FBXL15;PLK2;CKAP5;CEP70;PPME1;ACVR1;ANAPC7;SPAST;TRIM71;SKP1;USP29;CDK6;DCTN1;SFI1;BRSK2;TAF2;CLASP1;NDE1;HAUS2;CDK4;NASP;CUL1;CCNJL;CDC23;ENSA
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.30337753202067147,-0.9580537895496064,0.5488505747126436,0.8691521223836775,1.0,17/47,18.36%,DOCK5;FBLN1;PDPN;CARMIL1;EFNA5;KANK1;S100A10;FLNA;MYOC;ITGB1BP1;ABL1;DMTN;P4HB;TESK1;MDK;MYADM;C1QBP
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3804206370224045,0.9576407143540178,0.4915254237288136,0.870216641766391,1.0,3/27,8.88%,TIRAP;MAP3K1;IRAK2
prerank,regulation of necroptotic process (GO:0060544),0.40385398614107476,0.9575369690223866,0.5221088435374149,0.8698342882514378,1.0,7/23,16.43%,ARHGEF2;PELI1;BIRC3;CASP8;CYLD;SDCBP;PDCD6IP
prerank,peptide cross-linking (GO:0018149),0.39124681724715193,0.9574535337878355,0.4838160136286201,0.8694092842447091,1.0,3/25,8.30%,NDNF;TGM2;ABCA7
prerank,negative regulation of cellular protein localization (GO:1903828),0.3726534442949112,0.9574138932896679,0.5187713310580204,0.8688963988208926,1.0,3/34,3.12%,MFHAS1;NEDD4L;ANKRD13A
prerank,immunoglobulin mediated immune response (GO:0016064),0.4688413793359299,0.9573586152405484,0.5166340508806262,0.8683914307649208,1.0,2/10,11.01%,CD19;TLR8
prerank,regulation of store-operated calcium entry (GO:2001256),-0.444743407553714,-0.9571700965385791,0.5330396475770925,0.8704354258000366,1.0,4/10,8.87%,STIM1;EFHB;SLC8B1;SARAF
prerank,regulation of neuron death (GO:1901214),0.3223960528503128,0.9570547289711545,0.5397727272727273,0.8684712171662459,1.0,16/82,15.22%,CD34;CD200;MEF2C;GRID2;FYN;EGLN2;CD200R1;DDIT4;KIR3DL2;GRIN2B;EPHB1;NSMF;GPR75;TRIM2;BTBD10;DCC
prerank,regulation of astrocyte differentiation (GO:0048710),0.4535943489479741,0.956956938175422,0.5308411214953271,0.8680756643955507,1.0,2/12,5.52%,NOTCH1;EPHA4
prerank,sensory perception of light stimulus (GO:0050953),-0.27028507191548884,-0.9569475336029659,0.5409252669039146,0.8699489640284916,1.0,9/87,5.12%,COL1A1;SLC4A10;EFEMP1;EYA4;COL18A1;ADGRV1;COL11A1;DHRS3;EML2
prerank,pinocytosis (GO:0006907),-0.43474943420449824,-0.9567769160847264,0.5350877192982456,0.8694261303171305,1.0,7/10,29.49%,CARMIL1;MAPKAPK3;SNX5;SNX33;PYCARD;AHSG;MAPKAPK2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3082552640434997,0.9566050796782093,0.5300400534045394,0.8682645994973351,1.0,16/112,13.79%,CD34;APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;VSIR;SYK;C1QTNF4;DDT;TNFAIP3
prerank,histone H3-K4 trimethylation (GO:0080182),-0.42366170745749226,-0.9562754818420411,0.5291750503018109,0.8697308069789789,1.0,2/11,5.56%,OGT;CTR9
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3588478215760671,0.9555940400215143,0.5138888888888888,0.8699952054063548,1.0,2/40,1.98%,SLC7A5;SLC38A5
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.41330816109412394,-0.9548765390726062,0.5483870967741935,0.8723951747591564,1.0,2/12,4.68%,BMP4;PTPN14
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.4059263123209431,0.9545752045458621,0.5017241379310344,0.8717333905259125,1.0,5/17,6.71%,NOTCH4;PLXND1;NOTCH1;MAML2;STAT1
prerank,detection of mechanical stimulus (GO:0050982),0.41448974033049024,0.9544519657701224,0.512998266897747,0.871392484661674,1.0,4/19,4.52%,PTK2;CDH2;PIEZO1;CTNNB1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3515476144565739,0.9544424657821214,0.5116279069767442,0.8708016960440841,1.0,7/44,12.55%,NANOS3;PRR5L;NANOS2;NANOS1;GTPBP1;BTG2;ZFP36L1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.34438633969332155,-0.953886327566922,0.486810551558753,0.8739606171732569,1.0,6/24,12.30%,PID1;RHOQ;DAB2;ITGB1BP1;LZTFL1;DMTN
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3742946534634558,0.9535098942697816,0.5252525252525253,0.872377653294988,1.0,10/29,25.84%,PLA2G4B;NR1H2;LPCAT3;PNPLA8;MBOAT7;LPCAT2;MBOAT2;LPCAT4;TMEM86B;LPCAT1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4261692936686589,0.9530687597008909,0.5290102389078498,0.8728020488650813,1.0,4/17,10.22%,PARD3;SMAD7;CALM1;DDIT4
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3150543811182815,0.9523695231442219,0.5343406593406593,0.8737926141990897,1.0,21/88,17.97%,DAB2IP;NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PLAT;RPL13A;CNOT9;GRB7;BTG2;PAIP2;CLN8;RNF139;EDN1;CSTB;RGP1;BAG6;TRIM71;NELL1
prerank,nuclear export (GO:0051168),-0.27184895546976023,-0.9522351911567505,0.5353535353535354,0.8772168365050489,1.0,26/80,26.87%,RANBP3L;PKD1;PHAX;RANBP17;SRSF5;SRSF11;XPO5;SRSF6;XPO6;SRSF4;STRADA;DDX39B;XPO1;THOC2;THOC7;U2AF2;U2AF1;RAE1;DDX39A;EIF4A3;POLDIP3;THOC1;WASHC4;NUP155;TPR;ATXN1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3648588665473933,-0.9513924583164458,0.513317191283293,0.87831667897818,1.0,2/20,1.57%,WNT4;BMP5
prerank,cellular response to calcium ion (GO:0071277),0.32653128253436076,0.9513748367945531,0.5213068181818182,0.8754052172006987,1.0,17/67,17.95%,ITPKB;MEF2C;MCOLN1;ACER1;SYT7;CPNE8;RASGRP2;IQGAP1;CLIC4;CPNE5;SYT4;CPNE6;NLGN1;CPNE3;CRHBP;CPNE1;NEUROD2
prerank,genitalia development (GO:0048806),0.4483877609721925,0.9512722088002569,0.5274102079395085,0.8750097053402826,1.0,4/12,16.48%,TBX3;STRA6;DNAJC19;FOXF2
prerank,cholesterol homeostasis (GO:0042632),0.32653769218762563,0.9510190657980843,0.543731778425656,0.874987286730173,1.0,10/64,11.60%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LRP5;NPC1;LIPC;MTTP
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4085069563624596,-0.9504192109014008,0.5209713024282561,0.8797784946895508,1.0,3/12,10.59%,CACNA1C;DLG1;TRPM4
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.40988606833038477,-0.9501549861815219,0.5382932166301969,0.879439066149233,1.0,4/12,16.49%,GLI2;EPHB2;NFIB;TSKU
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3736414318068245,0.9500821648377111,0.5016835016835017,0.8765216196434952,1.0,15/28,30.46%,STMN1;MAPRE2;STMN3;STMN4;MAPRE3;CAMSAP2;CLASP1;GAS2L1;CAMSAP1;ARL2;CLASP2;PRUNE1;STMN2;SKA3;FKBP4
prerank,positive regulation of myelination (GO:0031643),0.4523999025594319,0.9499555615950257,0.5443037974683544,0.8761716806466319,1.0,4/11,19.18%,PARD3;CST7;TPPP;DICER1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.45095259849629005,0.9498457974109391,0.5421903052064632,0.8758321844266664,1.0,1/12,0.22%,PLCB1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.43787900057223855,0.9498133607943186,0.5243055555555556,0.8752928579538224,1.0,4/14,19.78%,TIRAP;HNRNPC;ELAVL1;DAZL
prerank,cellular response to unfolded protein (GO:0034620),0.37680762053873657,0.9497091428183196,0.5195911413969335,0.874907606745652,1.0,3/26,10.71%,DAB2IP;RHBDD1;HSPA8
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.40983475570446687,-0.9494775356819714,0.535377358490566,0.8782839070978863,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.40983475570446687,-0.9494775356819714,0.535377358490566,0.8782839070978863,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.40983475570446687,-0.9494775356819714,0.535377358490566,0.8782839070978863,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,anterior/posterior axis specification (GO:0009948),-0.38523190503424176,-0.9493031140908074,0.5054945054945055,0.8777626052895259,1.0,1/15,0.25%,WLS
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3578511910386242,0.948632528300177,0.5522151898734177,0.8766940996948112,1.0,20/39,31.33%,RPSA;SNU13;RPS7;RPS27;PWP2;RIOK1;RPS15;RPS28;RPS25;SURF6;RIOK3;ERAL1;RPS19;UTP4;RPS6;LSM6;RPS14;RPS24;WDR3;RPS16
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.31832256602190945,0.9485508620046035,0.546831955922865,0.8762573720878422,1.0,6/77,6.64%,ITGA6;BCL2L1;SH3RF1;PLAUR;SLC25A5;MCL1
prerank,microglial cell activation (GO:0001774),0.40342936000624113,0.948529960258248,0.5346020761245674,0.8756824251295021,1.0,8/21,30.78%,APP;AGER;IFNGR1;SNCA;ITGB2;CX3CR1;CLU;AIF1
prerank,plasma membrane repair (GO:0001778),-0.4006439683722434,-0.9483156310833672,0.5320088300220751,0.8793921102241822,1.0,3/13,5.39%,MYOF;AHNAK2;ANXA6
prerank,telomere maintenance via telomerase (GO:0007004),0.3849598588745729,0.9481748019178146,0.530448717948718,0.8759187407629918,1.0,9/28,24.06%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1;PTGES3
prerank,positive regulation of cilium assembly (GO:0045724),0.40711454462556285,0.9475308661896025,0.5278745644599303,0.8768132497460757,1.0,6/18,17.99%,ZMYND10;CCDC88A;CCP110;MARK4;CEP135;KCTD17
prerank,regulation of water loss via skin (GO:0033561),0.42240263226715735,0.9474165430050333,0.5277777777777778,0.875856502140246,1.0,6/15,24.27%,LSR;STMN1;FA2H;HRNR;TMEM79;SFN
prerank,establishment of skin barrier (GO:0061436),0.42240263226715735,0.9474165430050333,0.5277777777777778,0.875856502140246,1.0,6/15,24.27%,LSR;STMN1;FA2H;HRNR;TMEM79;SFN
prerank,positive regulation of nervous system development (GO:0051962),0.3536656538158164,0.9470841701471737,0.5407066052227343,0.8759995709063276,1.0,12/42,16.49%,TGM2;WNT7A;CLSTN1;GRID2;FAIM;NRXN1;LRRC4B;LRP2;EPHB1;SOX11;NLGN1;IL1RAP
prerank,Wnt signaling pathway (GO:0016055),0.3099150022792726,0.9469957193321377,0.5531034482758621,0.8755760380357028,1.0,7/92,5.83%,LEF1;FZD6;FZD4;WNT7A;SNX3;CTNNB1;TCF7
prerank,sulfur compound biosynthetic process (GO:0044272),0.3081824616720241,0.9469807181466617,0.5545087483176312,0.8749973195451084,1.0,16/104,10.19%,CSGALNACT1;ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;CHST11;GCLM;B3GNT2;TPK1;MGST2;GSTA4;SLC10A7;MAT2A;CBS;HPGDS;GSTK1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4213283546098039,-0.9469540311603496,0.5142231947483589,0.8819940807775377,1.0,3/11,8.15%,NBL1;SLIT2;CCN3
prerank,regulation of spindle organization (GO:0090224),-0.3649379024346897,-0.9469157276283728,0.5155131264916468,0.8810867881201842,1.0,9/18,38.06%,PARP3;GPSM2;SENP6;RAE1;TPX2;NUMA1;PSRC1;TACC3;NUP62
prerank,positive regulation of gene expression (GO:0010628),0.2678673395751731,0.9465008010707047,0.6141479099678456,0.8755189374396319,1.0,31/442,6.45%,LEF1;TFRC;ETS1;OCLN;TENT4A;RBM20;CLDN5;PDGFB;CADM1;CD34;NOS3;PDE2A;APP;RGCC;MEF2C;NIBAN1;PIK3R3;NOTCH1;RAMP2;ACTB;GATA2;TCF23;FGF16;RAMP3;DLL4;TLR3;TAF1B;MAPK3;CCDC88B;LGALS9;KLF4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.42618473718757666,-0.9463037603339407,0.5343347639484979,0.881721807601364,1.0,5/11,12.43%,EFNB2;FRS2;FZD7;SOX6;BMP2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3351106123806769,-0.9462628432591746,0.5469613259668509,0.8808302769746046,1.0,6/29,14.96%,SMAD3;TUT4;ZC3H7B;AGO2;PUS10;HNRNPA2B1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3398988323922304,-0.9462175422322838,0.5281173594132029,0.8799240566924496,1.0,10/23,19.75%,ERRFI1;CBLB;SNX6;TSG101;ZFYVE28;SRCIN1;GPRC5A;MVP;PTPRC;THY1
prerank,inner dynein arm assembly (GO:0036159),0.46146675053626446,0.9460769475746311,0.536178107606679,0.8758955331930689,1.0,2/10,7.43%,ZMYND10;CFAP100
prerank,actin filament network formation (GO:0051639),-0.42192143474911137,-0.9458384370890044,0.5543237250554324,0.8799037155826026,1.0,3/11,7.91%,CARMIL1;COBL;FHOD1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3174589393048995,0.9455878110118539,0.5352517985611511,0.8763721913068288,1.0,33/87,27.04%,NDUFAF3;NDUFA2;NDUFA8;SLC25A33;SCO2;NDUFAF7;DMAC2;SAMM50;TMEM126B;SCO1;OMA1;IMMP2L;NDUFA12;NDUFB3;NDUFAF8;SDHAF4;CHCHD4;COA3;SDHAF1;NDUFC1;SMIM20;NUBPL;SDHAF2;NDUFA10;COX20;COX17;ECSIT;DMAC1;PET100;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,response to interleukin-6 (GO:0070741),0.47360742694686997,0.945132444731894,0.5608856088560885,0.8768369408586777,1.0,1/10,0.37%,ST3GAL6
prerank,negative regulation of chemokine production (GO:0032682),0.42110580268643133,0.9450959084598767,0.5311909262759924,0.876309227267099,1.0,3/14,6.45%,SIGIRR;LGALS9;KLF4
prerank,regulation of leukocyte migration (GO:0002685),-0.3721478298422888,-0.9444457368819237,0.5460829493087558,0.882398456501012,1.0,4/16,19.98%,HOXA7;ANXA1;CD81;RHOH
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3074726405982199,-0.9443825688049926,0.5429362880886427,0.8815512905817036,1.0,10/37,13.67%,PRKAG2;CEMIP;BMP7;AXIN1;SPRED1;PPEF2;SPHK1;DMTN;S1PR2;SIRT2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2994324145266818,-0.9443527501416985,0.5470085470085471,0.8806228402074501,1.0,9/48,12.16%,ANK2;CEMIP;DMD;CAMK2D;DIAPH1;PDPK1;PRKACA;PTK2B;JPH1
prerank,cellular response to acid chemical (GO:0071229),0.3876867201171279,0.9439694307373356,0.5551894563426688,0.8782439268672975,1.0,8/27,19.26%,SH3BP4;KLF2;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.41979984059504566,0.9439002473946124,0.5250431778929189,0.8778099635698396,1.0,4/15,10.22%,GRB2;SORT1;SOS1;DDIT4
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4654376424716433,0.9436889177712459,0.5264150943396226,0.8776773137838978,1.0,2/10,12.02%,LGALS9;CEACAM1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3820634842155821,0.9434267134048889,0.5320623916811091,0.8776905466744881,1.0,7/26,14.67%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3658812478872854,0.943414129929415,0.5548489666136724,0.877114368070662,1.0,13/32,25.97%,ARHGEF2;FGF13;STMN1;ATXN7;CDH5;APC;CAMSAP2;DYRK1A;CLASP1;SNCA;CAMSAP1;NAV3;CLASP2
prerank,negative regulation of viral life cycle (GO:1903901),0.43068639337088394,0.9430066946667891,0.5235602094240838,0.8774280607152029,1.0,4/15,7.36%,LY6E;SNX3;PPIA;BST2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.428939132656894,0.9428819119553944,0.5371024734982333,0.8771226828917409,1.0,1/14,0.99%,BCL2L1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3447157428026071,-0.9428548300643598,0.538083538083538,0.8834784154582109,1.0,8/23,18.36%,AXL;TLR4;NR1H4;RARA;DDIT3;INHA;LAPTM5;C1QBP
prerank,determination of left/right symmetry (GO:0007368),0.363359097034785,0.9426412954131863,0.5514469453376206,0.8770671062977626,1.0,7/36,15.27%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DAND5;DNAH5
prerank,proteasome assembly (GO:0043248),0.4445780364889139,0.9426002076632428,0.5294117647058824,0.8765536784095009,1.0,5/11,27.29%,POMP;PSMD11;PSMD9;PSMD10;ADRM1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3919730731835867,0.9425227025003975,0.5250431778929189,0.8761155992495013,1.0,14/21,31.34%,SCO2;SCO1;COA6;COA3;SMIM20;COX10;COX20;COX17;COX15;PET100;TIMM21;COA5;BCS1L;COA8
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4265852264718315,-0.9421026018346677,0.5416666666666666,0.8843850333311661,1.0,3/10,11.81%,APPL2;ANO6;CD300A
prerank,sphingolipid catabolic process (GO:0030149),0.4197295266064082,0.9416684225316138,0.526595744680851,0.8774592124343222,1.0,3/15,8.63%,ACER2;ACER1;ENPP2
prerank,response to tumor necrosis factor (GO:0034612),0.30968069524387876,0.9415622253754435,0.5454545454545454,0.8770838088228392,1.0,10/91,6.41%,DAB2IP;MAP4K3;GCH1;TNFRSF11A;ARHGEF2;CD40;IKBKB;TNFRSF21;HYAL2;ADAM10
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4141024927561859,0.9415400887263667,0.5619694397283531,0.8765314057538189,1.0,5/18,11.18%,ABCG1;ADAM10;TMCC2;ADAM17;APH1A
prerank,protein localization to centrosome (GO:0071539),-0.3699138638625205,-0.9412819617507809,0.5342465753424658,0.8854709247536245,1.0,11/17,29.48%,GOLGB1;CCDC14;PIBF1;PCM1;SNX10;STIL;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.31188666952003014,0.940658715589121,0.5842696629213483,0.8778907457003247,1.0,20/87,12.34%,CLDN5;ENG;TGFB2;F11R;ID1;PTK2;ACVRL1;PARD3;PXN;SMAD7;NRROS;JUN;TGFB1;SMURF1;SMAD5;SMAD1;FERMT2;EID2;GDF15;TGFBR2
prerank,triglyceride metabolic process (GO:0006641),-0.29457345081072706,-0.9403650941844557,0.5591397849462365,0.8869154933175228,1.0,8/48,15.29%,AGMO;MOGAT3;GK;APOE;LPGAT1;LMF1;GPAT3;PNPLA3
prerank,positive regulation of phospholipid transport (GO:2001140),0.45562857242404264,0.9402370407653347,0.5266055045871559,0.8782262975339737,1.0,4/10,17.31%,ABCA3;ABCA7;TMEM30A;TRIAP1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2855384359111891,0.9401382206321118,0.5835411471321695,0.8778375039178173,1.0,34/161,14.80%,DAB2IP;FZD6;CAV1;ANKRD6;MCC;SOX17;NKD1;FZD4;SOX13;ZNRF3;CTNND1;NOTUM;WWTR1;SNAI2;PSMB3;TLE4;PSMD11;TMEM88;PSMC6;GREM1;PSME2;AMER2;AXIN2;PSMD8;GSK3A;SHISA6;TLE1;CYLD;STK3;SOX9;PSMB10;RBX1;TPBG;TMEM131L
prerank,regulation of lipid kinase activity (GO:0043550),0.4462246409046481,0.9400051560683312,0.5457875457875457,0.8775138070779676,1.0,3/11,15.45%,PIK3R3;PPP2R5A;RBL1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.37191394989253374,0.9397730141734221,0.5182119205298014,0.8774271243619218,1.0,11/32,24.87%,CDK17;HINFP;ZPR1;BRD4;CDC6;ORC1;CDK18;POLA1;DHFR;KLF11;TYMS
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3601587325655726,0.9397698772188118,0.536115569823435,0.8768337729557738,1.0,11/38,19.24%,DAB2IP;STAT1;ZMYND11;OTUD7A;CASP8;TLE1;TRIM39;TNFAIP3;TRIM59;TNIP1;OTUD7B
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4216866519751669,0.9392425732275425,0.5709156193895871,0.8773739702053551,1.0,1/18,0.20%,TEK
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3241187743340621,-0.9390760525148567,0.5286103542234333,0.8892845266450335,1.0,12/33,21.84%,DDX5;AR;KLK2;AXIN1;KDM1A;ESR1;EP300;DDRGK1;RUNX1;LATS1;RNF14;SAFB2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.3437713552539443,-0.9386647157219338,0.5526932084309133,0.8893574495840803,1.0,2/22,1.89%,BMP7;BMP4
prerank,positive regulation of sodium ion transport (GO:0010765),0.440982797372163,0.9383340019169392,0.5390334572490706,0.8788910002155905,1.0,1/12,2.01%,CNKSR3
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2567879800766727,-0.9374986337266865,0.5789473684210527,0.8913508131535292,1.0,29/107,19.12%,ITPR1;CREB3L2;THBS1;MAP3K5;ATG10;TMEM117;RCN3;BCL2;TMEM259;PRKN;SELENOS;CREB3L1;CEBPB;GORASP2;HSP90B1;SCAMP5;SEC16A;SYVN1;PIK3R1;P4HB;DDRGK1;UFC1;RASGRF1;ATP2A3;DDIT3;CASP4;MBTPS1;USP19;ATP2A2
prerank,mesenchymal cell development (GO:0014031),0.4130905936484679,0.9374002626603052,0.541095890410959,0.8804087237960314,1.0,6/18,17.63%,CDH2;NOTCH1;SNAI2;SOX11;PDCD6;KBTBD8
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.39113104150515643,-0.9373533119346548,0.5072463768115942,0.890717640793093,1.0,3/13,10.04%,RNF152;ATM;STK11
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3773592808607389,0.9371797429288177,0.5771812080536913,0.8803251994235763,1.0,5/28,10.45%,DAB2IP;SORT1;CRADD;DEDD2;CASP8
prerank,regulation of exit from mitosis (GO:0007096),0.35501941873991577,0.9370338157974406,0.5553745928338762,0.8800531696864271,1.0,15/38,23.32%,RGCC;PPP1R9B;CDC14A;NPM2;BUB3;ANLN;ANAPC16;ANAPC7;ANAPC10;UBE2D1;ZW10;ANAPC2;CDC23;CDC26;CDC27
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3270750585000975,0.9368694252216427,0.5720461095100865,0.8798270802547261,1.0,4/63,2.62%,MFSD2A;DAB2IP;RASIP1;TBC1D14
prerank,mitochondrial translational elongation (GO:0070125),0.3108473182864987,0.9367494862141351,0.5532212885154062,0.879491593575532,1.0,35/88,26.75%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C
prerank,actin nucleation (GO:0045010),0.39991407552803343,0.9367209264032623,0.5361344537815126,0.8789607455161955,1.0,8/21,26.07%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;ARPC5;WHAMM
prerank,glutamine family amino acid metabolic process (GO:0009064),0.36388375332694395,0.9358310901846348,0.5295031055900621,0.8803530200401163,1.0,3/33,3.70%,SLC39A8;DDAH1;GCLM
prerank,cellular response to chemokine (GO:1990869),0.3390110826412247,0.9357956310543335,0.5503875968992248,0.8798347023611839,1.0,2/46,1.41%,LRCH1;CXCL12
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4558677836664686,0.9354191372170539,0.5509433962264151,0.8800684895547503,1.0,1/11,1.17%,ITPKB
prerank,regulation of muscle cell differentiation (GO:0051147),0.3657892829589572,0.9354122421997685,0.5404120443740095,0.8794795561026078,1.0,6/31,7.40%,MEF2C;CDH2;HDAC9;CTNNB1;TCF23;SPAG9
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4560491614046417,0.9353572013885786,0.5478927203065134,0.8790178599318872,1.0,3/10,14.70%,FOXP3;VSIR;NCKAP1L
prerank,cell differentiation in hindbrain (GO:0021533),0.4449839411808838,0.9345779916504281,0.5361216730038023,0.8801300082696125,1.0,4/11,17.33%,GRID2;OPHN1;LHX1;PROX1
prerank,embryonic heart tube development (GO:0035050),0.4298361711592643,0.9341300910353958,0.5571955719557196,0.8805448120373328,1.0,2/14,7.19%,SOX17;SOX18
prerank,protein autoprocessing (GO:0016540),-0.3683426990100508,-0.9339545560847367,0.5486111111111112,0.8986010798188719,1.0,5/17,17.71%,CTSL;FXN;AFG3L2;HTRA2;CASP4
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.37092470902932206,0.9332072530533538,0.5436573311367381,0.8820425615494609,1.0,8/28,13.14%,EGFL7;GATA2;DLL4;FBXW7;RITA1;DLK2;ZBTB7A;ARRDC1
prerank,"phototransduction, visible light (GO:0007603)",0.41957244921787634,0.9326727854949088,0.5452865064695009,0.8826124424747066,1.0,3/14,12.39%,GNAQ;RP1;GNB1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.36793628797561434,0.9325331754460964,0.565359477124183,0.8823330398578809,1.0,5/34,8.59%,PDGFB;INSR;RGCC;TGFA;LRP5
prerank,protein methylation (GO:0006479),-0.3032433324290921,-0.9324403767343756,0.5621468926553672,0.9013705018388284,1.0,13/40,23.33%,PCMT1;EHMT2;EEF2KMT;PRMT5;RAB6A;PRMT8;METTL22;FAM98B;EZH2;TRMT112;GSPT1;NSD1;EEF1AKMT2
prerank,DNA conformation change (GO:0071103),-0.36856807309211603,-0.9322587355255546,0.5619047619047619,0.900796190917652,1.0,4/17,11.96%,TOP2B;TOP1;HAT1;ABL1
prerank,negative regulation of autophagy (GO:0010507),-0.2817021767471044,-0.932241399136613,0.6072507552870091,0.8998466570630641,1.0,18/54,20.40%,LEPR;NUPR1;KLHL22;NRBP2;SNRNP70;DAPL1;BCL2;GOLGA2;MET;PTPN22;LRRK2;SIRT2;RRAGA;SMG1;CTSA;SMCR8;EIF4G1;TSC1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.31186070408069505,0.9322041368085151,0.5900709219858156,0.882470798488295,1.0,9/76,8.88%,DAB2IP;NFKBIA;CD200;NLRC5;TMSB4X;KLF4;AIM2;FOXP3;IRAK2
prerank,detection of calcium ion (GO:0005513),-0.39641893253500393,-0.9321307140753221,0.5786924939467313,0.8991692782171815,1.0,2/13,4.49%,STIM1;KCNMB2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3697254266483314,0.9318962295143489,0.5565068493150684,0.8825256177251272,1.0,11/29,23.35%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3;TICAM2;RIPK1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3882140378702257,0.9315374839505143,0.5514184397163121,0.8827068010392478,1.0,8/23,19.18%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,activation of protein kinase B activity (GO:0032148),0.36769800933974983,0.9315263085571582,0.5595432300163132,0.8821309890688606,1.0,5/29,6.32%,PDGFB;INSR;CCDC88A;PPIA;ADRA2B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4135510031256836,0.931425827700011,0.5373134328358209,0.8817491089359922,1.0,7/14,20.67%,CHKA;SELENOI;CEPT1;LPIN3;ETNPPL;ETNK1;PISD
prerank,central nervous system neuron differentiation (GO:0021953),0.3627481369850347,0.9306243255663782,0.5621019108280255,0.8829351347947195,1.0,10/33,19.35%,CTNNB1;MDGA2;GRID2;OPHN1;SPOCK1;TOX;LHX1;PROX1;SIN3A;DRAXIN
prerank,neuron differentiation (GO:0030182),-0.23936550239105192,-0.930507303469689,0.6451612903225806,0.9021627071108765,1.0,19/165,8.81%,PBX1;GLI2;WNT4;WNT5B;WNT6;FZD2;TGFBR1;WNT9A;PBX4;RUNX2;NRBP2;FZD7;TDP2;PBX3;HS6ST1;FZD3;VSX1;MET;ATOH8
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.42574698347260787,0.9300773029121934,0.5377697841726619,0.8835415594839457,1.0,7/14,24.01%,PRKD2;BCL10;CARD11;TESPA1;KCNN4;TRAT1;NECTIN2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.36385820058200075,-0.9300659806226105,0.5600961538461539,0.9022598451915111,1.0,2/18,2.04%,ROCK2;SLC2A13
prerank,regulation of Golgi organization (GO:1903358),0.4100103417716695,0.9300280988894299,0.5498220640569395,0.8830552851780588,1.0,6/17,17.98%,USP6NL;MAPK3;AKAP9;PDCD10;MAPK1;CAMSAP2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3188390219188999,0.9298544064460948,0.5761494252873564,0.8828548746580283,1.0,28/72,25.37%,IFNAR2;SIGIRR;IKBKB;PALM3;HSP90AB1;STAT1;BIRC3;IRAK2;LIFR;SHARPIN;CASP8;CBFB;USP18;SYK;CYLD;TNFAIP3;GAS6;SUMO1;SPPL2A;RBCK1;IFNGR1;RACK1;SOCS1;ABCE1;RIPK1;IFNGR2;TRAF1;TRADD
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3499384474615605,-0.9297105768713226,0.5491071428571429,0.9022172952153551,1.0,9/22,19.83%,DMD;CACNB4;CACNB2;GNB5;FMR1;CACNB1;STAC3;AHNAK;CACNB3
prerank,cellular response to interferon-beta (GO:0035458),0.4277226027988982,0.9296270099147373,0.5393258426966292,0.8827690128320475,1.0,3/14,8.17%,AIM2;STAT1;IRGM
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.34791948451541094,-0.9294429187351411,0.5477855477855478,0.9019147079870203,1.0,2/21,2.79%,SAMD4A;TUT4
prerank,cellular response to misfolded protein (GO:0071218),-0.3569135697840725,-0.9292675915050895,0.5629820051413882,0.9013540355859121,1.0,8/20,25.22%,UGGT2;CUL3;KLHL15;AUP1;DNAJC18;DNAJB14;DERL1;UFD1
prerank,negative regulation of cell cycle (GO:0045786),-0.2731485313085262,-0.9292268074326732,0.5936507936507937,0.9004383948531225,1.0,8/73,3.80%,NR2F2;SMAD3;BMP7;BMP4;NUPR1;PTPN3;GAS1;FOXC1
prerank,regulation of sensory perception of pain (GO:0051930),-0.4121093875911698,-0.9291007462307164,0.5498938428874734,0.8997623522047297,1.0,2/11,8.15%,TMEM100;CCN3
prerank,response to ATP (GO:0033198),-0.3626804933435912,-0.9289343735661106,0.5601851851851852,0.8992395084808108,1.0,4/18,12.78%,TRPC3;ABCC9;P2RX4;HSP90B1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3696003056105277,0.9288876281471106,0.5665529010238908,0.8837933425643238,1.0,2/28,1.41%,ESAM;CXCL12
prerank,cellular response to superoxide (GO:0071451),0.4592462281270999,0.9284612158483879,0.553875236294896,0.8841342590613865,1.0,1/10,1.35%,NOS3
prerank,mitochondrion distribution (GO:0048311),-0.39512470333910726,-0.9283075219737984,0.5635491606714629,0.899837031341571,1.0,2/12,11.11%,TRAK1;LRRK2
prerank,peptidyl-serine modification (GO:0018209),0.2833162716858651,0.927956742623389,0.5959595959595959,0.8846247475121874,1.0,33/166,18.02%,PRKCH;NDNF;PDGFB;STK38;PKN3;RPS6KA1;PRKD1;PRKD2;IKBKB;MAST4;PKN1;RPS6KA5;PKN2;MARK3;HPF1;STK32C;PRKCB;TGFBR2;HIPK2;NAA11;VRK1;SGK1;HIPK3;PLK2;SGK3;SGK2;MAPK1;GAS6;POGLUT1;PRKCG;PRKCE;TBK1;PAK2
prerank,toll-like receptor signaling pathway (GO:0002224),0.30610048642514365,0.9274600122343961,0.565406976744186,0.8851552830954044,1.0,24/84,20.16%,TIRAP;MAP3K1;IKBKB;TLR3;TRIL;LGALS9;CTSK;TLR7;BIRC3;IRAK2;PIK3C3;CASP8;TLR8;S100A8;BCL10;RFTN1;UBE2D3;CTSS;TNIP1;UBE2D1;TRAF3;NMI;PLCG2;RPS6KA3
prerank,regulation of fat cell differentiation (GO:0045598),0.31368237654110864,0.9273467863061808,0.5670103092783505,0.8848078329174528,1.0,16/74,12.84%,PPARD;FOXO1;ZFPM1;CCDC85B;ZBTB16;GATA2;NOCT;CREB1;WWTR1;TGFB1;LRP5;TRIB2;FERMT2;PTPRQ;ZFP36L1;PPARG
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.4049896744935062,-0.9272446297149756,0.5711060948081265,0.9014571491705101,1.0,11/12,53.58%,CDC45;MCM3;MCM4;MCM5;CDC7;MUS81;MCMDC2;MCM2;MCM7;GINS4;GINS2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3510876659708358,-0.9271029252355621,0.5447941888619855,0.90084668425826,1.0,4/19,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,substantia nigra development (GO:0021762),0.3555983342273116,0.9268247370747792,0.56120826709062,0.8853761533580805,1.0,16/37,24.34%,ACTB;CALM1;INA;DYNLL1;YWHAH;YWHAQ;MAOB;SYPL2;GNB4;MBP;ATP5PF;BASP1;SUDS3;RAD1;PADI2;TTBK1
prerank,positive regulation of macrophage migration (GO:1905523),-0.356974572141648,-0.9265783282017127,0.5844748858447488,0.9011847823876766,1.0,6/19,17.10%,IL34;THBS1;P2RX4;CMKLR1;RARRES2;MDK
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.34677378911732504,0.9264308228562738,0.5460526315789473,0.8856620611051195,1.0,8/39,9.03%,ACER2;FZD4;CORO2B;ADAM15;NOTCH1;ACTN4;NEXMIF;SPOCK1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.44064885141881904,0.9262555115903324,0.5274336283185841,0.8848588050642097,1.0,1/11,1.39%,NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.44064885141881904,0.9262555115903324,0.5274336283185841,0.8848588050642097,1.0,1/11,1.39%,NOTCH4
prerank,negative regulation of hemostasis (GO:1900047),-0.4009274967437157,-0.9261732316921804,0.5582959641255605,0.9012009969692192,1.0,4/12,8.01%,TFPI;VTN;THBD;APOE
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.4388368635840315,0.9260326973182238,0.56353591160221,0.8847431238728214,1.0,2/12,5.09%,GCLM;MGST2
prerank,chromatin organization (GO:0006325),0.2936199129912462,0.9257304615588977,0.6154891304347826,0.8848402983714471,1.0,24/132,16.58%,MECOM;SMARCA2;NPM3;BAZ2B;NPM2;PWWP3A;FOXP3;ARID1A;CHD1;HCFC2;PAK1;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;SETDB1;SOX9;HMGB2;HDAC5;LOXL2;SMARCAD1;HCFC1;HMGA2
prerank,positive regulation of cell communication (GO:0010647),-0.3203334515492362,-0.9256273017363107,0.5466321243523317,0.9015982462156183,1.0,3/28,7.03%,WLS;CLSTN2;DLG4
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.2338152311365947,-0.9255782890877706,0.6787330316742082,0.9007268581841112,1.0,36/166,17.91%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;TEAD3;POLR2A;NR3C2;YAP1;CCNH;NR2F1;RXRA;TAF8;CDK7;ESR1;PGR;SMARCA5;TAF1D;NR4A1;E2F3;GTF2F1;NR1H4;POLR1C;RARA;TAF9B;NRBP1
prerank,cation transport (GO:0006812),0.28493492744974874,0.9250673760512574,0.6081081081081081,0.8856647693012607,1.0,19/167,10.87%,SLC6A6;SLC7A1;SLC1A1;SLC38A5;NEDD4L;FGF13;PIEZO1;MCOLN1;ATP1A4;KCNK6;KCNG2;CHRNB1;SCN1A;KCNN2;SLC3A2;NDFIP2;KCNV1;LRP2;KCNA4
prerank,regulation of protein ubiquitination (GO:0031396),0.29859667734844847,0.9250338742060793,0.571619812583668,0.8851448511231841,1.0,28/108,19.64%,IVNS1ABP;CAV1;SMAD7;HSP90AB1;XIAP;FAM107A;FBXW7;N4BP1;BIRC3;MALT1;NDFIP2;UBXN1;UBQLN1;GSK3A;DCUN1D1;TNFAIP3;BCL10;DNAJA1;INAVA;BAG2;SIRT7;FOXF2;PTTG1IP;PRKCG;UBE2D1;FKBP1A;NSMCE3;PRR7
prerank,endochondral bone morphogenesis (GO:0060350),0.4464524383725572,0.9249147751750296,0.5482142857142858,0.8848203805198762,1.0,2/11,2.75%,BMPR2;MEF2C
prerank,regulation of hormone secretion (GO:0046883),-0.3749366065398766,-0.9246435287346941,0.5620915032679739,0.9021473848733942,1.0,7/15,33.60%,SNX6;ANXA1;VAMP2;VAMP3;SCG5;IL11;LIF
prerank,positive regulation of phosphatase activity (GO:0010922),0.3875057139729294,0.9244221146994949,0.560067681895093,0.885305822948604,1.0,4/21,5.03%,ITGA1;MEF2C;CALM1;HSP90AB1
prerank,regulation of intracellular transport (GO:0032386),-0.30561497264793414,-0.924386469079861,0.5558739255014327,0.9018577613816511,1.0,9/38,16.16%,ATP9A;GAS1;GRIPAP1;LRRK2;SCFD1;NEFH;MAP2;RAB11B;CRYAB
prerank,female gonad development (GO:0008585),-0.3561616725901696,-0.9242756199361993,0.5584415584415584,0.901149711305279,1.0,5/19,17.72%,NR2F2;KIT;CEBPB;INHBB;INHA
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.362933244375895,0.9240457976144354,0.543918918918919,0.8855564166965058,1.0,9/30,19.03%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3
prerank,regulation of vasoconstriction (GO:0019229),0.3644337098270857,0.9240156020374699,0.5658783783783784,0.8850285366506605,1.0,4/27,6.35%,BMPR2;CAV1;OXTR;ATP2B1
prerank,protein K63-linked deubiquitination (GO:0070536),0.36428635387890096,0.9239801315522482,0.547077922077922,0.8845195044430634,1.0,10/31,19.24%,ATXN3;SHMT2;OTUD7A;BABAM1;CYLD;TNFAIP3;BRCC3;OTUD4;USP25;OTUD7B
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.31134438927725144,-0.9239018308781215,0.583547557840617,0.9011101870904454,1.0,7/33,11.96%,MAP3K5;IMPACT;PRKCD;ANXA1;CYP1B1;FXN;ABL1
prerank,dendritic cell migration (GO:0036336),0.4252528784765661,0.9235135446991843,0.571917808219178,0.8849293040079552,1.0,3/16,8.20%,EPS8;CCR7;CXCR2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.4636090018041016,0.9233619517999896,0.5310734463276836,0.8846626491795729,1.0,2/10,1.75%,ENG;CAV1
prerank,B cell activation involved in immune response (GO:0002312),0.42596545399508734,0.9231825933293916,0.544256120527307,0.8844567168544091,1.0,3/13,15.56%,CD19;RNF8;MSH2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.34336920003517146,-0.9230858288371818,0.5458937198067633,0.9021583555702308,1.0,7/22,19.75%,BMP7;FLOT2;WNK1;MAP2K5;CD44;MYADM;THY1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3737095146705718,-0.9225040701258646,0.5886214442013129,0.902607082395876,1.0,7/14,26.82%,IL18;ANXA1;RARA;CD80;PRKCZ;CCL19;CD86
prerank,cilium organization (GO:0044782),-0.22772442378767316,-0.9224431568269229,0.7258064516129032,0.9017785824115707,1.0,41/209,14.69%,PARVA;GSN;CYS1;CC2D2A;DCDC2;PKD1;WDR35;IFT80;GBF1;DYNC2I1;IFT81;WDPCP;ARL3;PKD2;CDC14B;DZIP1;DZIP1L;IFT74;CCDC57;TTC39C;FLNA;PTPDC1;DYNC2H1;CFAP44;TTC8;IFT122;CEP164;FUZ;ARMC9;EHD1;BBS9;LZTFL1;TRAPPC14;CLUAP1;MKKS;PIBF1;PCM1;RILPL2;WDR19;AHI1;DYNC2I2
prerank,regulation of actin nucleation (GO:0051125),-0.41294363771526127,-0.9223979693330127,0.5711252653927813,0.9009167075276612,1.0,5/12,21.04%,GSN;ARFIP2;WASHC5;ARF1;CORO1B
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2932154328649583,-0.922321581339277,0.5942408376963351,0.9001163320208512,1.0,9/44,11.14%,GSN;FCHSD2;CARMIL1;CDC42EP4;CDC42EP5;SNX9;PFN2;LMOD1;PTK2B
prerank,nuclear membrane organization (GO:0071763),-0.35642754400442994,-0.9221342916894731,0.5858823529411765,0.8996399715928417,1.0,7/19,23.94%,AKAP8L;TOR1AIP1;EMD;VPS4A;GPER1;UBXN2A;TMEM43
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.40970926779483124,0.9221299061898026,0.549645390070922,0.8861789073357387,1.0,4/15,10.43%,TJP1;KLF4;PKM;SMAD1
prerank,positive regulation of viral transcription (GO:0050434),-0.33569321314397993,-0.9214709674600339,0.5845410628019324,0.9001941810540905,1.0,8/25,28.84%,MDFIC;POLR2A;NELFE;GTF2F1;POLR2L;CDK9;POLR2I;POLR2K
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3831360234936359,0.9213737494193908,0.5435540069686411,0.8872523843174231,1.0,6/23,12.63%,ENG;LTBP4;SMAD7;TGFB1;EID2;SOX11
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3668556243015514,-0.9212225983046236,0.5587583148558758,0.8998546169970477,1.0,5/15,13.15%,IRS1;PPARA;IRS2;SLC45A3;ADM
prerank,negative regulation of coagulation (GO:0050819),-0.38275998266510225,-0.9209442078995943,0.5604395604395604,0.8995295694355535,1.0,4/14,8.01%,TFPI;VTN;THBD;APOE
prerank,fatty acid transmembrane transport (GO:1902001),0.40283596621567624,0.9205942980898064,0.5577981651376147,0.8883619298118539,1.0,4/19,6.80%,SLC2A1;ABCD4;CPT1A;ACACB
prerank,UV protection (GO:0009650),-0.41072992861154256,-0.9203831650378952,0.5612472160356348,0.8999253658530522,1.0,2/10,11.27%,SCARA3;MFAP4
prerank,regulation of response to interferon-gamma (GO:0060330),0.42219253834218595,0.9201341767280792,0.5644283121597096,0.8888063663226098,1.0,7/14,24.58%,HSP90AB1;STAT1;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4377759260096591,0.9201033774350877,0.5557586837294333,0.888270786489965,1.0,2/12,3.96%,TRIM16;KLF2
prerank,cellular respiration (GO:0045333),-0.29522683960638574,-0.920070967855105,0.6028169014084507,0.899752221505387,1.0,17/41,25.63%,PPARGC1A;SIRT3;SDHC;MDH2;SDHB;COQ10A;UQCRFS1;MTFR1;SLC25A14;NDUFS1;SURF1;MTFR2;COQ10B;UQCRC2;NR4A3;LYRM7;NDUFS8
prerank,neuron projection morphogenesis (GO:0048812),0.2903145266548867,0.919987898859547,0.603448275862069,0.887928329688544,1.0,23/137,9.61%,SHANK3;SRGAP2;DAB2IP;APP;KLF7;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;CTNNB1;BAIAP2;DIP2A;DBNL;NCKAP1;SLITRK3;DNM2;SLITRK1;GPM6A;IQGAP1;PAK1;SLC9A6;EIF2AK4
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.27243211382047156,-0.9199347488139396,0.6,0.8991440693727795,1.0,10/66,6.43%,EGFR;APPL2;KANK2;FHL1;UBE2E2;PKD1;PKD2;DLG1;ANXA1;DACT1
prerank,regulation of intracellular pH (GO:0051453),-0.3170783939355359,-0.9196825000248251,0.5895316804407713,0.8987884622397024,1.0,8/34,11.11%,SLC4A10;SLC9A2;SLC4A7;SLC4A2;SLC9A9;SLC9A1;CLN3;LRRK2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.36334288916892526,-0.9194868230455014,0.5892018779342723,0.8982712303526241,1.0,2/18,3.76%,UGGT2;AMFR
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.41859477981084064,0.919435293103272,0.5749063670411985,0.8885083774825301,1.0,7/15,23.12%,HOMER2;HOMER1;GRM7;GRM8;GRM2;GRM3;GRIK3
prerank,regulation of neuron apoptotic process (GO:0043523),-0.25384551236559894,-0.9193033198143719,0.6586345381526104,0.8977214025686999,1.0,20/96,11.14%,EPHA7;NUPR1;SLC30A10;SNX6;PRKCI;PPARGC1A;NGF;SIX1;NRBP2;EGLN3;NFATC4;BCL2;SOD2;PRKN;APOE;KDM2B;FOXO3;TGFB3;CLN3;PTK2B
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.32731360391517106,0.9190891898336084,0.6100917431192661,0.8886866551588106,1.0,14/56,17.09%,SPTBN1;EFHC2;STMN1;RHOB;CECR2;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;ANK3;SPAST;MYH10
prerank,response to growth factor (GO:0070848),0.34550164960751645,0.919065465421976,0.5804878048780487,0.8881572329998475,1.0,8/41,12.34%,PDGFB;BMPR2;ACVRL1;CTNNB1;KLF4;TWF2;LRP2;TGFBR2
prerank,antibacterial humoral response (GO:0019731),0.4081180872078539,0.9188674779307782,0.5578583765112263,0.8879603510789283,1.0,4/16,21.63%,DEFA6;SLPI;JCHAIN;RNASE6
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.30531504988800895,0.9187992348968119,0.5901408450704225,0.8875333221904782,1.0,28/85,25.03%,RNF144B;DAB2IP;SMAD7;ATXN3;FBXW7;PSMC6;HECTD1;SOCS5;TRIB2;GSK3A;RBX1;BAG2;ELOB;RAD23A;SUMO1;BAG6;RNF19A;CBFA2T3;GABARAP;PSMC3;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;OSBPL7;KEAP1
prerank,signal peptide processing (GO:0006465),-0.40648460685691323,-0.9186918731919522,0.5744234800838575,0.8982102381197897,1.0,3/11,17.16%,PCSK5;HM13;PARL
prerank,regulation of monocyte differentiation (GO:0045655),0.42085974320048775,0.9185520537877747,0.5736568457538995,0.8874994853857641,1.0,3/14,5.26%,FES;CTNNBIP1;CD4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.37936419795891085,-0.918328196336664,0.5743243243243243,0.8981714313682331,1.0,5/13,21.90%,SAR1A;SEC16B;SEC16A;CD81;EDEM2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.28413916769112957,-0.9176011436521628,0.6005747126436781,0.8980479180045531,1.0,17/50,29.32%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,regulation of gene silencing by RNA (GO:0060966),-0.28413916769112957,-0.9176011436521628,0.6005747126436781,0.8980479180045531,1.0,17/50,29.32%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,presynaptic endocytosis (GO:0140238),0.3816386076983164,0.9175911133930434,0.5611015490533563,0.8890205526133643,1.0,7/24,15.89%,STX1A;PIP5K1C;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3391850772310374,0.9174712805342947,0.5834609494640123,0.8886661103373092,1.0,10/43,12.42%,DAB2IP;ITGA1;PTPRJ;DUSP3;GRB2;TGFA;ARHGEF7;SOCS5;EPS15;HGS
prerank,cellular response to chemical stress (GO:0062197),-0.2537216917572093,-0.9171375342783865,0.6088560885608856,0.8982388592521409,1.0,22/96,14.30%,PRKAA2;MGAT3;CPEB2;PPARGC1A;PKD2;STX2;SOD3;GPX8;SOD2;NOX4;SELENOS;ATM;SLC25A24;FOXO3;CYBA;PARP1;LRRK2;TMEM161A;ABL1;SIRT2;HTRA2;DDX3X
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.32850420721081136,-0.9168702081564364,0.5760598503740648,0.8979217921135031,1.0,5/26,6.49%,ERRFI1;CBLB;SNX6;SHC1;TSG101
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3462627192556022,0.9165426147733094,0.5581761006289309,0.8900515828004993,1.0,4/36,6.73%,DAB2IP;RYBP;PHC1;MAX
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.32216243521147647,-0.9164749406029162,0.5815085158150851,0.8979389103776229,1.0,6/27,11.15%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.4205812856263648,0.9162364021974778,0.5378927911275416,0.8901164066653475,1.0,2/11,10.44%,TIMM13;TIMM10
prerank,positive regulation of cyclase activity (GO:0031281),-0.3816310864967428,-0.9157127560489989,0.5563380281690141,0.8988625057448889,1.0,5/14,14.21%,CACNA1C;STIM1;CACNA1D;NF1;MAPK14
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.29983247466519214,-0.91568756932786,0.5798969072164949,0.8979761674186449,1.0,11/38,18.52%,PRKN;NPEPPS;RNF31;HUWE1;LRRK2;LMAN1;ATP5IF1;HTRA2;SREBF1;PARL;ABLIM3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3230315436674945,0.9156632575242364,0.5862068965517241,0.8907548958240974,1.0,1/59,0.03%,LEF1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.346526741559165,-0.9156483123649098,0.5858823529411765,0.8971386096988394,1.0,9/21,28.92%,MITF;MED14;TWIST1;MED30;BCLAF1;MED4;MED24;MED16;DHX36
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4250967612040357,0.9155444650282335,0.5851063829787234,0.8904148291660284,1.0,1/13,0.30%,ABHD2
prerank,mitochondrial translation (GO:0032543),0.2949950221221473,0.9154328404605037,0.6136054421768707,0.8900864688787369,1.0,45/104,28.70%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MTIF3;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;GATC;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;IARS2;MRPL51;HARS1;MRPL49;MRPS33;MRPL37;MRPL2;NDUFA7;MRPS18C;QRSL1;MRPL15;LARS2;MRPS34;MRPS12
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.29627313307828634,-0.9148908806303808,0.6151898734177215,0.8980528259445656,1.0,8/39,13.21%,ANK2;FHL1;PTPN3;CACNA1D;TRPC6;WWP2;GPD1L;FXYD1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.27388019237374384,-0.9148379493136604,0.6337579617834395,0.8972117635986517,1.0,20/59,25.34%,ROCK2;PRKCD;CAMK2D;TGFBR1;MAP3K12;PDPK1;PRKCA;LRRK2;WNK1;ACVR1B;DYRK2;CDC42BPG;SBK1;WNK3;CSNK2A1;CDK5;MAP2K1;CDK10;TNKS;CIT
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.38465969923386695,0.9147941883286413,0.5598006644518272,0.8908733354265432,1.0,8/22,14.25%,LYN;ABCG1;EPHA4;EFNA1;AGER;GSK3A;RANBP9;SP1
prerank,cell projection assembly (GO:0030031),0.3830690707775668,0.9146909987454359,0.5641025641025641,0.8905193038126576,1.0,8/22,14.70%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,regulation of protein localization to cell surface (GO:2000008),0.3538080046803164,0.9146848390472112,0.5779967159277504,0.8899541734428874,1.0,6/33,11.56%,STX3;NEDD4L;CTNNB1;HSP90AB1;ABCA7;KCNAB2
prerank,chloride transport (GO:0006821),0.303256005753118,0.9145894660020779,0.609129814550642,0.8895549551734321,1.0,18/74,19.47%,CLIC5;SLC1A1;SLC12A6;GABRB1;SLC12A9;CLCN3;CLIC4;TTYH3;GABRQ;GABRG1;CLIC1;GABRG3;PACC1;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,chemical homeostasis (GO:0048878),-0.27228248232603264,-0.914579340469052,0.6054216867469879,0.8968929414243041,1.0,14/61,15.37%,ZBTB20;SLC4A10;RBP1;NR1D2;WNK4;THADA;IRS2;SLC4A7;SLC4A2;TLCD2;WNK1;DDX3X;PNPLA3;SLC4A3
prerank,GPI anchor biosynthetic process (GO:0006506),0.3608241746243194,0.9142303358351046,0.5777027027027027,0.8897095609342787,1.0,10/30,21.77%,PIGU;PIGM;PGAP4;PIGK;PIGF;DPM3;PIGS;PIGO;PIGV;PIGQ
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4134435646919966,-0.9141356668520261,0.5865168539325842,0.8969701727712259,1.0,4/10,26.10%,DDIT3;QRICH1;CCL2;EIF2AK3
prerank,icosanoid biosynthetic process (GO:0046456),0.44364451643395486,0.9141181191104818,0.5605214152700186,0.8893743668672965,1.0,2/10,13.41%,MGST2;LTA4H
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3962648568690743,0.9139219783670957,0.5724508050089445,0.8892057798633065,1.0,5/17,15.44%,HDAC9;SORT1;NR1H2;LIPC;ANGPTL4
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.41620647624657425,0.9139093853910161,0.5978456014362658,0.8886591597117555,1.0,5/15,18.10%,CCT3;CCT5;NHP2;CCT7;NAF1
prerank,T cell activation (GO:0042110),0.3149003856382732,0.9137130474816837,0.5814606741573034,0.8885353801233699,1.0,14/69,11.80%,JAG2;ZAP70;DLL4;CCR7;CD4;FOXP3;CD8B;MSN;EIF2AK4;CASP8;PPP3CA;GPR89A;GPR89B;TNFRSF4
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.2653320964819043,0.913536260200373,0.669327251995439,0.8883400264346135,1.0,104/306,26.50%,B4GALT5;ALAS1;PTMA;SARS1;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;RPS29;MRE11;FUT9;MRPL10;RPL36A;NKX2-8;RPL3;RNPS1;YARS2;RPL27;RPSA;RPS7;PWP1;RPL9;RPL18;RPLP2;GTPBP1;MCM10;DNA2;RPL13A;CDC6;RPS11;RECQL4;RPL8;RPS27;RPL19;RPS9;MRPL28;ORC1;RPL11;EEFSEC;RPS15;SRBD1;RPL37;RPS28;RPS10;POLE3;EEF1D;RPS25;RPL37A;MRPL9;COPS5;HUS1;RPL15;POLR2J;TNIP1;RPA1;SET;RPL17;MRPL23;RPL23;RPL34;FARSB;RPS18;RAD9B;POLL;POLD1;GRWD1;RPL21;POLA1;RPS4X;MRPS18A;RFC2;RPL18A;RAD1;DHPS;RPS21;RPL10A;GTPBP2;EEF1B2;ING4;RAD17;RSL24D1;RPL24;RPL7A;ING5;TOPBP1;MRPL41;MRPL27;MRPL51;TYMS;HARS1;RFC4;RPL32;RMI1;RPL4;UPF1;RPS2;MRPS33;BLM;MEF2A;MRPL37;RPS20;RPL6;RPS13
prerank,regulation of actin filament-based process (GO:0032970),0.30913467555592683,0.9133848840141596,0.6002994011976048,0.8881002035466687,1.0,16/70,11.99%,RHOBTB1;HIP1R;F11R;CORO2B;RHOB;CCDC88A;BAIAP2;FAM107A;BST2;ARHGEF5;TWF2;IQGAP1;PAK1;ARHGAP17;RAC1;RND1
prerank,neurotransmitter transport (GO:0006836),0.31175889542450147,0.9129438257649793,0.59375,0.8885094128051834,1.0,9/73,10.71%,SLC1A1;SLC6A2;UNC13B;STX1A;SLC1A2;STXBP1;NRXN1;DNAJC5;HSPA8
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.36676720915379474,-0.912840417541309,0.5623529411764706,0.8990344846360783,1.0,4/14,15.19%,CD55;IL18;PTPN22;CD81
prerank,meiosis I (GO:0007127),-0.3384352886937079,-0.9127895964456761,0.5962877030162413,0.8981959382254251,1.0,10/23,30.21%,FOXJ2;FOXJ3;ZSCAN21;HSF2BP;MYBL1;ZCWPW1;SGO1;TDRD9;DDX4;MEIOB
prerank,positive regulation of viral life cycle (GO:1903902),-0.3309622891602523,-0.9125866137475946,0.6009732360097324,0.8977036346000735,1.0,6/22,18.69%,AXL;LGALS1;TSG101;FMR1;P4HB;VPS4A
prerank,intestinal lipid absorption (GO:0098856),-0.398605729426204,-0.9125807410264426,0.5748373101952278,0.8967752548857801,1.0,7/11,49.31%,LDLR;CD36;SOAT2;AKR1C1;ABCG5;UGCG;NPC1L1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3530198985973137,0.9124928526826054,0.5721311475409836,0.8889489623829376,1.0,7/34,11.43%,LIMS2;DOCK1;NEDD9;RREB1;ARHGEF7;FERMT2;RAC1
prerank,signal release from synapse (GO:0099643),0.33378048546063727,0.9124634150854186,0.5792880258899676,0.8884315486250367,1.0,7/43,13.19%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.41639198399152394,0.9122655338683311,0.573943661971831,0.8882670706732211,1.0,1/15,1.82%,REEP1
prerank,mitotic cytokinesis (GO:0000281),0.33280876654601615,0.9122320701876103,0.6090342679127726,0.887768468964242,1.0,13/47,17.09%,SPTBN1;EFHC2;STMN1;RHOB;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;ANK3;SPAST;MYH10
prerank,response to sterol (GO:0036314),-0.4023378514619563,-0.9120399896468327,0.5642105263157895,0.8971082085156183,1.0,2/11,4.86%,TGFBR1;RORA
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.32984123826823464,0.911662430172935,0.6003039513677811,0.8884137286147977,1.0,6/50,6.48%,SH3RF1;PLAUR;RPS6KA1;XIAP;KLF4;RFFL
prerank,negative regulation of immune system process (GO:0002683),-0.36462191533331,-0.9112519128484263,0.5835294117647059,0.898112799299919,1.0,3/16,7.33%,COL3A1;HOXA7;IL17D
prerank,regulation of mast cell activation (GO:0033003),0.4537946007472565,0.910963363217471,0.555765595463138,0.8893010525233632,1.0,3/10,16.98%,LYN;MILR1;CRLF2
prerank,motile cilium assembly (GO:0044458),0.4239229060976698,0.9105254586822484,0.5659050966608085,0.8896245389448556,1.0,3/12,20.08%,ZMYND10;DNAAF3;E2F4
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.35731601370090704,-0.9104540112301416,0.5704225352112676,0.899157514072634,1.0,4/17,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,melanosome organization (GO:0032438),-0.32775548107474234,-0.9099368885768513,0.5857843137254902,0.899472513437822,1.0,16/26,38.32%,DTNBP1;AP3B1;RAB29;BLOC1S2;LYST;BLOC1S6;BLOC1S5;HPS4;HPS1;BLOC1S4;KIF13A;RAB38;PMEL;GPR143;AP1M1;RAB32
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3808178322357777,-0.9098820570583875,0.5748987854251012,0.8986704992201215,1.0,4/13,10.71%,ACSL1;ANO6;CLIP3;AZIN1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.44419424203374436,0.9096143492129579,0.579136690647482,0.8910036049168714,1.0,3/10,11.99%,ATP5MC2;ATP5PO;ATP5F1A
prerank,regulation of microtubule depolymerization (GO:0031114),0.3650122915636217,0.909023724513371,0.576797385620915,0.8916673269482597,1.0,10/25,25.97%,ARHGEF2;FGF13;ATXN7;APC;TRPV4;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,GTP metabolic process (GO:0046039),0.4088158679529006,0.9089952231385481,0.5595026642984015,0.8911632373989686,1.0,3/15,9.07%,IMPDH1;AK4;GTPBP1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3280744840269326,-0.9087716279180663,0.6092233009708737,0.9004209175401878,1.0,5/25,13.44%,UGGT2;FBXL17;CUL3;KLHL15;AUP1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.40354612450202415,-0.9084523030429958,0.5847826086956521,0.9001776237909731,1.0,4/10,18.39%,IMPACT;BAG3;SIRT2;CITED2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.357326011203538,-0.9083889837311061,0.5954022988505747,0.8993732880234636,1.0,8/17,25.22%,SELENOS;HSP90B1;SYVN1;AUP1;HM13;SEC61B;DERL1;UFD1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2408253817368815,-0.9078632843477359,0.7032520325203252,0.8997027966277874,1.0,19/117,9.79%,IGF1;ALDH1A2;CYP26B1;ACADSB;ME1;PER2;PPARA;CPT1C;GGT5;ME2;MCCC2;SLC5A6;SCPEP1;ACOT11;ABAT;CKB;ALDH4A1;NAAA;AMACR
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3694296248782766,0.9077271870652526,0.5747899159663865,0.8933818078179686,1.0,4/24,6.64%,TGFB2;CTNNB1;FBXW7;MCL1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.40061564253371507,0.9077209155451295,0.5905923344947736,0.8928153057744704,1.0,7/16,28.80%,SNRPC;NCBP2;DCPS;WBP11;SRSF12;SFSWAP;SRSF1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.32955057372750485,-0.9074995581270849,0.5990220048899756,0.8996225820163355,1.0,2/25,1.47%,ANK2;CEMIP
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3459925305598162,0.9072027449731326,0.5791139240506329,0.8932819262574367,1.0,7/34,8.10%,SMAD7;CALM1;PDE4D;NPPA;KCNQ1;SRI;PDE4B
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.32110670865601315,-0.907188539525261,0.599009900990099,0.8985166854501901,1.0,8/29,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,CENP-A containing chromatin organization (GO:0061641),-0.32110670865601315,-0.907188539525261,0.599009900990099,0.8985166854501901,1.0,8/29,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,embryonic appendage morphogenesis (GO:0035113),0.4250742198196828,0.906993183067561,0.568738229755179,0.8931389397206259,1.0,1/12,1.32%,TGFB2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2969531319240915,0.9067511361627285,0.6135734072022161,0.8931002850824113,1.0,7/86,2.67%,PECAM1;PDGFB;APP;IL6R;LRP8;PTPRJ;ARHGEF2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.333904925048969,0.9064157888152149,0.5663026521060842,0.8932646381956759,1.0,4/42,8.17%,IL6R;DEFA6;NOS2;IRGM
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.34465471889884625,0.9059754415664539,0.6060606060606061,0.8935730999140139,1.0,13/40,20.02%,PTK2;GNA12;FBXW7;RPS7;SMURF1;HIPK2;RPL11;TRIM39;RNF139;RAD23A;FOXF2;RPL23;DESI1
prerank,superoxide metabolic process (GO:0006801),0.3633938254027468,0.9057503560442692,0.6077441077441077,0.8934634268407378,1.0,7/29,12.57%,NOS3;NOS2;NRROS;PREX1;CYBB;NCF4;NOX3
prerank,regulation of inclusion body assembly (GO:0090083),-0.403231390114103,-0.9057490987114456,0.5948827292110874,0.9009935925321689,1.0,1/11,0.93%,SNCAIP
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4133995291019543,-0.905447643431125,0.5891304347826087,0.900800353037221,1.0,2/10,2.82%,LRP1;APOD
prerank,keratinocyte differentiation (GO:0030216),-0.3105490548427276,-0.9050173302948796,0.5927710843373494,0.9008862508643615,1.0,9/29,19.51%,ADAM9;ANXA1;TXNIP;JAG1;SCEL;BCR;CASP3;DSP;WNT16
prerank,response to insulin (GO:0032868),0.3031134848372742,0.904878393426802,0.6160458452722063,0.8948017327748253,1.0,17/80,14.97%,TBC1D4;INSR;RAB31;FOXO1;HDAC9;SORT1;DENND4C;SLC25A33;SORBS1;PKM;GSK3A;CEACAM1;ZFP36L1;PPARG;LPIN3;PDE3B;HDAC5
prerank,positive regulation of organelle organization (GO:0010638),-0.31036982285116377,-0.9042851029278968,0.6098191214470284,0.9017006089991098,1.0,11/32,20.23%,ANXA2;PPARGC1A;ANXA1;STX18;LMAN1;HTRA2;SURF4;RAB3GAP2;SMCR8;C2CD5;ATL3
prerank,negative regulation by host of viral transcription (GO:0043922),0.42688299426604426,0.9042234519527643,0.5954198473282443,0.895582917040117,1.0,5/12,21.70%,JUN;HMGA2;TFAP4;INPP5K;PSMC3
prerank,mammary gland epithelium development (GO:0061180),-0.3799192583294665,-0.9039187674420063,0.5827338129496403,0.9016331200440182,1.0,6/14,32.42%,WNT4;LATS1;ID2;WNT2;WNT3;IRF6
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.30024169663276656,-0.9035935456677401,0.6297297297297297,0.9014785554791701,1.0,9/38,21.33%,BMP6;PRKCA;CYBA;SLC15A4;POLR3G;GRN;PLSCR1;ADAM8;USP15
prerank,cellular response to purine-containing compound (GO:0071415),-0.40047983757128947,-0.9034679050982529,0.5862831858407079,0.9008400568242384,1.0,5/10,33.72%,SLC8A1;GSTM2;RYR3;P2RY1;CASQ2
prerank,regulation of receptor binding (GO:1900120),0.4559280557805482,0.9034141701148996,0.5947955390334573,0.8966782340081934,1.0,2/10,3.05%,B2M;ADAM15
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3487352965996572,0.9032701325451312,0.5811688311688312,0.8964113319748235,1.0,13/34,25.86%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A;GABRG1;GABRG3;GABRA1;RAB3GAP1;GABRA2;GRIN1;GLRA1;GABRG2
prerank,mitochondrial transport (GO:0006839),0.32093926910078563,0.9027699930192422,0.616191904047976,0.8968998652395535,1.0,11/53,21.97%,BCL2L1;TOMM22;SLC25A5;TIMM13;TIMM10;DNAJC19;MFF;TOMM7;BAK1;TOMM5;BNIP3
prerank,renal absorption (GO:0070293),-0.4128311819197027,-0.9027654746375982,0.603448275862069,0.901543825063858,1.0,2/10,3.67%,GSN;WNK4
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2317681783375711,-0.9025824454105763,0.7342342342342343,0.9010713675821361,1.0,22/170,11.19%,PRDM6;IGF1;ROCK2;AFF3;AFF2;ZNF462;CDH1;SLC8A1;YBX3;AFF1;APOE;KDM6B;FUBP1;LDLR;NOVA1;MTMR3;CRIP1;ZNF507;STX1B;IGF2BP2;PRDM11;PTHLH
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.44674359242075407,0.9022672854087156,0.5757009345794393,0.8973813019891891,1.0,1/11,1.47%,NOVA2
prerank,snRNA metabolic process (GO:0016073),-0.3554158010657445,-0.9020394239938366,0.5638766519823789,0.9013593675080324,1.0,5/17,17.38%,INTS8;INTS2;INTS4;TUT1;INTS10
prerank,regulation of nervous system process (GO:0031644),0.3954411748903074,0.9018549552062463,0.5974729241877257,0.8976991385298421,1.0,2/18,1.57%,NOS3;APP
prerank,proteasomal protein catabolic process (GO:0010498),0.2665083907026593,0.9017918346365038,0.6638452237001209,0.8972803734385443,1.0,65/201,24.81%,ZNRF1;NEDD4L;PELI1;CTNNB1;ENC1;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;RHBDD1;PSMC6;FEM1C;PSME2;SMURF1;UBXN1;KCTD10;SHARPIN;KLHL20;UBE3D;PSMD8;GSK3A;RNF187;MAEA;PSMB10;NHLRC1;RBX1;TRIM2;UBE2D3;AREL1;RNF139;PSMA8;ATE1;ARMC8;RAD23A;BAG6;GID8;BFAR;TRIM71;TRIM3;KCTD17;PSMD9;SIAH1;RNF4;RBCK1;NSFL1C;PLAA;ANKRD9;BRSK2;ERCC8;DDB1;PSMC3;PSMD1;RAD23B;RNF126;PSMD10;HECW1;CRBN;RNF216;PMAIP1;UBXN2B;ZFAND2B;MTA1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.30612194896610967,0.9014870806842163,0.6214689265536724,0.8973356170005844,1.0,13/78,12.53%,PDGFB;CCNY;RGCC;MEN1;ACTB;HHEX;CDKN2B;CCNI;CCND3;ADAM17;CDC6;CCNK;MAPRE3
prerank,positive regulation of calcium ion transport (GO:0051928),0.33509650744582226,0.9013521003301834,0.6,0.8970499511789329,1.0,3/36,1.75%,PDGFB;CXCL12;CAV1
prerank,cortical cytoskeleton organization (GO:0030865),0.33356104534760245,0.9012899923053443,0.6064,0.8966007898196583,1.0,11/41,16.62%,RHOBTB1;FMNL3;IKBKB;RHOB;NCKAP1;STRIP1;RAC1;RND1;NCKAP1L;NLGN1;TRPV4
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3747153879392124,0.9012606475668329,0.5837742504409171,0.8961019135780346,1.0,6/21,15.98%,KDR;MAPK3;LGALS9;ZFP36L1;SOX9;MAPK1
prerank,photoperiodism (GO:0009648),-0.3146415369637523,-0.9008801094726561,0.5759036144578313,0.9030784230174038,1.0,6/28,11.15%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,central nervous system myelination (GO:0022010),0.4363108001108645,0.9006918434997802,0.5821167883211679,0.8967125050831711,1.0,2/11,12.11%,B4GALT5;SOX10
prerank,neutrophil activation (GO:0042119),0.4188539075285329,0.9005072687343533,0.5916824196597353,0.8965290525818279,1.0,4/12,12.66%,CXCR2;PREX1;SYK;IL15
prerank,negative regulation of cation channel activity (GO:2001258),-0.32089003184638604,-0.900503552464799,0.6039603960396039,0.9030503186083959,1.0,7/26,15.68%,SLC6A9;PKD2;EPHB2;GNB5;FMR1;GSTM2;KCNAB1
prerank,positive regulation of cell cycle process (GO:0090068),0.29746729349732964,0.9003616142144658,0.6205923836389281,0.8962615379296165,1.0,21/91,18.30%,PDGFB;INSR;RGCC;CDC14A;PKN2;PKP4;NPM2;TGFA;LRP5;CDC6;KIF23;MAP10;DYNC1LI1;SPAG5;RXFP3;RCC2;EDN1;SPAST;RAD21;PRKCE;DDX11
prerank,AMP metabolic process (GO:0046033),0.41553665103570875,0.9002002651163029,0.5891472868217055,0.8960303749766042,1.0,3/13,7.35%,XDH;AK4;ADSS2
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.26027148478020123,-0.899558336996929,0.6771929824561403,0.9043049883011555,1.0,16/69,11.14%,SLC30A10;SNX6;PRKCI;PPARGC1A;NGF;SIX1;NRBP2;NFATC4;BCL2;SOD2;PRKN;APOE;KDM2B;TGFB3;CLN3;PTK2B
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3764690184866078,0.8994668695529705,0.5960264900662252,0.8970218434440936,1.0,9/24,21.66%,TERF2;HNRNPC;ACD;DCP2;TERF1;EXOSC10;XRN1;ERCC4;PINX1
prerank,striated muscle tissue development (GO:0014706),0.3663412550643323,0.8994423658538783,0.5759075907590759,0.896505974019031,1.0,4/29,2.75%,BMPR2;PGM5;CAV1;MEF2C
prerank,regulation of hippo signaling (GO:0035330),0.38993348790634963,0.8994324491423888,0.5793357933579336,0.8959560992485215,1.0,6/17,16.96%,MOB3B;MARK3;SCHIP1;SOX11;WWC1;WWC2
prerank,regulation of aerobic respiration (GO:1903715),0.40551282350957696,0.8990624187517119,0.5737122557726465,0.8961958894768088,1.0,4/15,10.97%,AK4;SLC25A33;SHMT2;ABCD1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.38421352200653924,-0.8987467002636158,0.6,0.9052653996751893,1.0,4/12,19.87%,AR;SELENOS;TMEFF2;AP2A1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4054707852557309,0.8986279411896392,0.5555555555555556,0.8965251203527413,1.0,3/14,9.47%,LIMS2;PRKD1;PHACTR4
prerank,purine nucleotide metabolic process (GO:0006163),0.3659740383558079,0.8982704736645382,0.5941780821917808,0.8966944187284287,1.0,5/24,11.08%,XDH;HPRT1;NT5C2;GART;PNP
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.34627715893914507,-0.8981306599700533,0.6097560975609756,0.9058189172366529,1.0,6/21,15.69%,DAG1;ADAM9;BACE2;ADAM19;PSEN1;HM13
prerank,response to retinoic acid (GO:0032526),0.3176911914698917,0.8980460395733858,0.6168639053254438,0.896606134373897,1.0,11/59,11.20%,ACER2;TRIM16;TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,mitochondrial translational termination (GO:0070126),0.2968092518928959,0.8980303637555385,0.6321678321678321,0.8960707305134085,1.0,34/88,26.75%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.35881845092444664,-0.8976760855271424,0.6146788990825688,0.9059728129043163,1.0,3/17,7.70%,CD55;IL18;JAG1
prerank,negative regulation of cellular senescence (GO:2000773),0.415013180094527,0.8972599253819598,0.5798165137614679,0.8971134311146992,1.0,7/13,23.00%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,histone H2A acetylation (GO:0043968),-0.3486661992543176,-0.896865263039586,0.6034858387799564,0.9070328561632397,1.0,6/16,30.24%,MORF4L2;BRD8;NAA40;EPC1;MSL3;SPHK2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3380128377861039,0.8961873643443037,0.6236044657097288,0.898757399501992,1.0,5/37,11.08%,BCL2L1;CAV1;RPS7;EIF5A;S100A8
prerank,positive regulation of neutrophil migration (GO:1902624),-0.34467809430489504,-0.896007123670084,0.6111111111111112,0.9081538409309378,1.0,4/18,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,electron transport chain (GO:0022900),0.40342106922003884,0.8958293067066337,0.5940246045694201,0.8989413591552656,1.0,4/15,9.79%,ETFRF1;ENOX2;CYB561;ETFB
prerank,ERBB2 signaling pathway (GO:0038128),0.3517037049172369,0.8956580939585169,0.6040688575899843,0.8987211049887872,1.0,7/31,10.31%,PTPN12;GRB2;GAB1;SOS1;PTPRR;PTK6;GRB7
prerank,sterol biosynthetic process (GO:0016126),-0.30455182503314493,-0.8953261922654323,0.6145552560646901,0.9088072229765976,1.0,2/33,2.95%,PRKAG2;INSIG2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3600914804191674,0.8949866155026975,0.5829228243021346,0.8995126789032547,1.0,2/27,2.89%,CSGALNACT1;CHST11
prerank,smooth muscle tissue development (GO:0048745),-0.4025716700741945,-0.8948252375103543,0.5908141962421712,0.9090574106914268,1.0,5/10,13.29%,BMP4;MYLK;SMO;EFEMP2;NF1
prerank,intracellular sterol transport (GO:0032366),0.4148088604631387,0.8943170063863864,0.5909090909090909,0.9002930575023862,1.0,4/13,14.49%,OSBP;ABCG1;NPC1;STARD4
prerank,positive regulation of signaling (GO:0023056),-0.29051373605901654,-0.8941160939255554,0.6428571428571429,0.9097944248742486,1.0,4/37,7.03%,WLS;ANXA2;CLSTN2;DLG4
prerank,polyamine metabolic process (GO:0006595),0.4086601884046868,0.8940751718110308,0.5918762088974855,0.9002226998146912,1.0,8/13,29.42%,SMOX;AMD1;SMS;OAZ2;DHPS;AOC1;SRM;HDAC6
prerank,regulation of hemopoiesis (GO:1903706),0.4353785518586848,0.8940461146839096,0.6067415730337079,0.8997099961153441,1.0,4/10,11.53%,PTN;MYSM1;CBFB;PRKCB
prerank,regulation of oxidative phosphorylation (GO:0002082),0.40090451990166054,0.8936033939529227,0.5985915492957746,0.9000924289138772,1.0,5/16,10.97%,AK4;SLC25A33;SHMT2;PDE12;ABCD1
prerank,regulation of gene expression (GO:0010468),0.24634793517873121,0.8932101819931116,0.8294177732379979,0.900363752647618,1.0,122/903,13.45%,LEF1;SLC7A5;TFRC;ETS1;OCLN;RBM20;CLDN5;PDGFB;KDR;INSR;CD34;APBB2;SLC39A8;ENG;TGFB2;NOS3;PDE2A;NOVA2;APP;XDH;SOX17;TRIM14;BCL6B;RGCC;MEF2C;RYBP;SMARCA2;PIK3R3;ACVRL1;SOX13;APLNR;NOTCH1;YBX1;RAMP2;LYN;PRDM2;IRF2;RREB1;NOS2;GATA2;SOX7;NOCT;MOG;HINT1;TCF23;FGF16;RAMP3;DLL4;KLF1;WWTR1;SORT1;TLR3;DIP2A;TCF7;NANOS1;CAVIN4;SNAI2;MAPK3;RPS6KA5;ADAM10;FBXW7;LGALS9;KLF4;PTBP3;DNM2;INSM1;NCOA2;SOX18;YBX2;BRCA2;SOX12;HINFP;CRNN;TDRD7;PIN1;TGFB1;TERF2;FOXP3;RPS7;PRDM9;P2RX7;MSN;HCFC2;HMGA1;NDFIP2;KDM4A;ZPR1;ACTG1;UBE2V1;BTG1;PTRH2;PDCD10;SMAD1;CASP8;PRKAB1;CNTF;ZNF205;NR5A2;LAMTOR5;ADNP;CTCF;HRAS;GSK3A;ONECUT1;VSIR;HIF1A;TLE1;PIK3CB;RNF187;HGS;TFEB;ZFP36L1;SOX11;WWC1;RO60;EDF1;DNAJA4;SETDB1;RPL11;TRIM39;SOX9;CDH5
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.37018757882988795,0.8931918001317798,0.60580204778157,0.8998322286222974,1.0,4/24,7.40%,MEF2C;CDH2;CTNNB1;SPAG9
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.42174638138542864,0.8931836377133471,0.5971223021582733,0.899281686535816,1.0,3/11,11.65%,FOXO1;NOTCH1;GSK3A
prerank,apoptotic cell clearance (GO:0043277),-0.31200889248522506,-0.8926790756066603,0.5906862745098039,0.9122538328856209,1.0,7/30,10.36%,LRP1;THBS1;XKR4;ANXA1;RHOBTB2;TXNDC5;ITGAV
prerank,cellular response to lipopolysaccharide (GO:0071222),0.28680039551193237,0.8923789445203083,0.6488340192043895,0.9003729125045532,1.0,10/101,8.17%,DAB2IP;MEF2C;DEFA6;NOD2;LYN;CD6;HCK;TGFB1;PDE4B;IRGM
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.42257640183460277,0.892148936360919,0.5877862595419847,0.9003072527911478,1.0,3/11,19.40%,ABCG1;LIPC;AGT
prerank,homocysteine metabolic process (GO:0050667),-0.392712274391094,-0.8920640640948261,0.6016597510373444,0.9127289753934485,1.0,2/11,8.66%,NOX4;MTHFR
prerank,negative regulation of type I interferon production (GO:0032480),0.3335716391994493,0.8919640699842034,0.6107692307692307,0.9001472382008286,1.0,9/40,17.96%,TRIM25;IFIH1;NLRC5;RNF125;PIN1;CYLD;TNFAIP3;RELB;TBK1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3346610655387613,-0.8917286950899972,0.5955056179775281,0.9125988252594858,1.0,4/22,11.15%,ROCK2;PPP4R4;PTPA;CRY2
prerank,regulation of axon guidance (GO:1902667),-0.40349368823975784,-0.8915033375428822,0.5911949685534591,0.9121834923369798,1.0,3/10,16.70%,ZSWIM8;YTHDF1;TUBB2B
prerank,response to estradiol (GO:0032355),-0.2987514183549006,-0.8914626309232305,0.6202185792349727,0.9113387807027417,1.0,4/31,6.99%,EGFR;ANXA1;GGT5;LCOR
prerank,fatty acid catabolic process (GO:0009062),0.30734581742808254,0.8914201294726105,0.6366237482117311,0.9007443481768231,1.0,12/67,15.66%,ABHD2;PPARD;ABCD4;ACOX1;AIG1;ABCD1;MMAA;SLC27A2;LPIN3;HACL1;ECI2;ACAT1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.29907750865587357,0.891373173955331,0.6273653566229985,0.9002759828847587,1.0,25/76,25.03%,RNF144B;PTK2;SMAD7;FBXW7;HECTD1;SOCS5;SMURF1;TRIB2;GSK3A;RBX1;RNF139;BAG2;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1
prerank,protein localization to synapse (GO:0035418),-0.3804019970703364,-0.8910955630089924,0.6031042128603105,0.9113007571446611,1.0,2/12,7.03%,NLGN2;DLG4
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2780156622008078,-0.8909952279485374,0.6219839142091153,0.9105895336690463,1.0,10/47,15.39%,PID1;PDGFRB;THBS1;PRKCD;AGTR1;SLC5A3;CYBA;MAPK14;TLR4;ACE2
prerank,positive regulation of heart contraction (GO:0045823),-0.34803605628993606,-0.8909000809756564,0.6111111111111112,0.9098946055519701,1.0,1/19,0.02%,ATP1A2
prerank,negative regulation of bone mineralization (GO:0030502),-0.3826534711096274,-0.8906012289583757,0.5886214442013129,0.9096473759819788,1.0,5/13,11.14%,ENPP1;BCOR;ECM1;TRPM4;PTK2B
prerank,sympathetic nervous system development (GO:0048485),0.40278885992702707,0.890495991955648,0.6048237476808905,0.9015434733794476,1.0,5/15,19.12%,CTNNB1;INSM1;SOX11;NRP2;NRP1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3928707424218914,0.8903887741619392,0.5989010989010989,0.9011668663072511,1.0,5/17,16.69%,NPPA;AKAP6;ANK3;KCNRG;SUMO1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3715314667208726,0.8897201443996878,0.5979202772963604,0.9019855159792138,1.0,7/21,20.60%,PPARD;ACOX1;LDHD;LPIN3;AGXT;ACBD5;FAAH
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3898607762587332,0.8895466897898621,0.6003430531732419,0.9017783272713515,1.0,4/18,7.93%,CAV1;NEDD4L;SLC43A2;KCNH2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3162657262365848,-0.8892830962185718,0.6262135922330098,0.9117831044544559,1.0,4/25,10.36%,PARVA;CXADR;ITGA5;ITGAV
prerank,positive regulation of neuron death (GO:1901216),-0.2857873464684098,-0.8891545216899401,0.6586102719033232,0.9111473408708209,1.0,10/46,17.47%,EPHA7;EFNB2;NUPR1;MAP3K5;FOXO3;NF1;TLR4;SARM1;GRN;DDIT3
prerank,regulation of phosphatase activity (GO:0010921),-0.32612505179732965,-0.88895944039816,0.6354679802955665,0.9106835354120587,1.0,10/24,28.68%,SH3RF2;PTPA;URI1;BMP2;HSP90B1;SH2D4A;TSC1;HTT;ZCCHC9;MTMR9
prerank,negative regulation of RNA splicing (GO:0033119),-0.3454147151641487,-0.888494082496783,0.6122448979591837,0.9109086053200748,1.0,8/19,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;PTBP2;SRSF10
prerank,long-chain fatty acid transport (GO:0015909),0.3530970452897871,0.8884912022081994,0.6177474402730375,0.9034771379817499,1.0,9/30,12.91%,MFSD2A;ABCD4;CPT1A;ACACB;ACSL3;FABP5;ABCD1;PPARG;SLC27A2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.40770306780214904,-0.8877229950370358,0.6213389121338913,0.9117997990212712,1.0,5/10,30.71%,GALNT16;POGLUT2;GALNT1;GALNT3;MGAT5B
prerank,oxoacid metabolic process (GO:0043436),-0.3220706615542011,-0.8875302415256497,0.628140703517588,0.9113337839001474,1.0,2/27,1.67%,DDO;ENPP1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.3864758230409004,-0.8874269540606307,0.6217948717948718,0.9106623505608014,1.0,3/12,19.11%,PPP1R3B;PPP1R3C;PPP1R3F
prerank,regulation of T cell chemotaxis (GO:0010819),0.4279264902806893,0.8874061416168987,0.5855855855855856,0.9051807689101947,1.0,3/11,17.12%,ADAM10;ADAM17;CCR2
prerank,B cell homeostasis (GO:0001782),0.43099816540381086,0.887082155414489,0.5918003565062389,0.9052978190991638,1.0,4/10,14.70%,MEF2C;LYN;TNFAIP3;NCKAP1L
prerank,actin filament bundle organization (GO:0061572),0.3483660733541728,0.8870092312377295,0.6205211726384365,0.9048868992182566,1.0,7/33,6.17%,SHROOM1;NEDD9;PLS3;RFLNB;EPS8;BAIAP2;FAM107A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.30346002895240887,-0.8870035316721826,0.6327543424317618,0.910707881010821,1.0,5/31,6.43%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3677070357604935,0.8866459998974046,0.6135593220338983,0.9050455316196804,1.0,13/22,29.81%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;NUBPL;LYRM4;NFU1;ISCA1;ISCA2;NUBP1;NUBP2;ISCU
prerank,atrial septum development (GO:0003283),0.4120302907760841,0.886575636661407,0.5882352941176471,0.9046252140472358,1.0,3/13,3.19%,BMPR2;TGFB2;ZFPM1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.28762138052712366,0.8864137269764567,0.6466480446927374,0.9043745357853107,1.0,36/100,25.71%,RNF144B;RYBP;SMAD7;GNA12;HSP90AB1;N4BP1;HECTD1;SOCS5;UBXN1;TRIB2;GSK3A;RPL11;TRIM39;SDCBP;RBX1;BAG2;ELOB;RAD23A;FOXF2;SUMO1;BAG6;RNF19A;CBFA2T3;DESI1;GABARAP;EIF3H;RACK1;RAD23B;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1;BAG5;CAMLG
prerank,alcohol catabolic process (GO:0046164),0.42608891435324325,0.8863263963638072,0.5879120879120879,0.9039821733514222,1.0,1/10,1.76%,SCARF1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.41755672820600065,0.8858783870762842,0.6074074074074074,0.9043400203246977,1.0,1/12,3.41%,NOTCH1
prerank,regulation of T cell activation (GO:0050863),0.3307999458544559,0.8858208099126615,0.6491228070175439,0.9038847863602719,1.0,6/42,12.52%,JAK3;DUSP3;CD4;CCDC88B;TNFSF11;CYRIB
prerank,nuclear pore organization (GO:0006999),-0.3703820487700688,-0.8856316762205995,0.6144859813084113,0.9128068305370202,1.0,7/14,31.05%,SEH1L;NUP205;TMEM170A;NUP35;NDC1;TPR;RTN4
prerank,positive regulation of interferon-beta production (GO:0032728),0.34849048271385386,0.8851052111972926,0.6277495769881557,0.9047891078672665,1.0,14/33,27.40%,IFIH1;TLR3;IRF5;TLR7;TLR8;TBK1;POLR3F;FLOT1;RIOK3;POLR3B;ISG15;POLR3C;IRF7;TOMM70
prerank,regulation of translation (GO:0006417),0.272706407998659,0.8850964165500819,0.7088607594936709,0.9042470424512035,1.0,30/173,13.59%,NANOS3;APP;NIBAN1;RPS6KA1;YBX1;MTG1;NANOS2;EIF4H;ENC1;MRPL13;NANOS1;KLHL25;YBX2;SHMT2;EIF3E;EIF2AK4;RPL13A;CNOT9;EIF3D;CYFIP1;GRB7;HSPB1;EIF2B2;NCBP2;BTG2;EIF4E;PUM3;PAIP2;PAIP1;EIF3B
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3628386909084555,-0.8850116546049911,0.5918367346938775,0.9133478072442407,1.0,1/16,1.30%,APPL2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4050357682698288,-0.8850027751858773,0.6137931034482759,0.9124685797994903,1.0,2/10,13.81%,CPEB1;PAF1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4185264544387186,0.8845162974199573,0.5984848484848485,0.9048813146493248,1.0,1/11,0.99%,BCL2L1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2881196198843742,0.8845127313451719,0.6559571619812584,0.9043285952657354,1.0,13/98,11.94%,PRKCH;SPTBN1;PPP1R13B;STX3;PPP3CC;RAMP3;FYN;SORBS1;YWHAH;YWHAQ;CASP8;HRAS;PPP3R1
prerank,regulation of ion transmembrane transport (GO:0034765),0.34054129590298177,0.884461329842842,0.6152647975077882,0.9038822821014174,1.0,10/33,18.39%,NEDD4L;KCNQ1;KCNH2;P2RX7;AKAP9;CHRM3;AKAP6;KCNJ3;KCNJ5;KCNJ6
prerank,leukocyte tethering or rolling (GO:0050901),0.3936641535028341,0.884230097006891,0.5818505338078291,0.9037797515234465,1.0,1/17,1.49%,JAM2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.37415624827282706,0.8841038965331355,0.6055846422338569,0.9035123983207248,1.0,7/20,14.85%,BCL2L1;PPP2R5A;AP2M1;TGFB1;ABI3;MRAP;TMEM59
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.36004673197985626,0.8840326540767193,0.6186440677966102,0.9030992601965883,1.0,4/26,10.75%,PDE8A;PPIA;FYN;HSPB1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.388060372035237,-0.8832639680880828,0.6004228329809725,0.9156086008926978,1.0,2/11,10.12%,IL34;PRKCA
prerank,positive regulation of dendrite development (GO:1900006),0.42750459929439905,0.8831189966977471,0.6211849192100538,0.9044314394490124,1.0,3/10,8.49%,DAB2IP;LRP8;PTN
prerank,programmed necrotic cell death (GO:0097300),0.3878963009347903,0.8830228178202197,0.6219931271477663,0.9040731256047306,1.0,5/18,23.35%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,positive regulation of vacuole organization (GO:0044090),-0.39989190676848124,-0.8825209188625083,0.6123711340206186,0.9163366148682605,1.0,5/10,16.97%,ANXA2;LRSAM1;PIP4K2C;RAB3GAP2;GRN
prerank,neurotransmitter secretion (GO:0007269),0.3231189219817624,0.8824745893527645,0.6319218241042345,0.9046358208480528,1.0,12/44,24.10%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1;RIMS2;UNC13A;SNCA;PTPRN2;SYN1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.292089458879924,-0.8822805037643642,0.65,0.9159576157204045,1.0,10/38,19.99%,CENPC;HAT1;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4;UBN1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.29319782498893365,-0.8817236662896771,0.6314285714285715,0.9163553227716228,1.0,4/41,9.42%,PRKAG2;OGT;SEH1L;NUP205
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.38908447015479414,-0.8814993654752029,0.6115879828326181,0.9159702408465321,1.0,3/11,11.85%,SLC30A10;PPARA;TRAP1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3744988714489762,0.8813528485714821,0.6047700170357752,0.9063750764059623,1.0,6/20,12.14%,DIP2B;DIP2A;MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.29384642955635065,0.8810916746649903,0.672316384180791,0.9063399293664883,1.0,15/86,15.92%,EPAS1;KLF2;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,C-terminal protein amino acid modification (GO:0018410),0.4215163677365521,0.8810150312120051,0.6126629422718808,0.9059365308309342,1.0,7/11,31.34%,LCMT1;ATG12;TTL;ATG7;AGBL4;FOLH1;AGTPBP1
prerank,regulation of establishment of planar polarity (GO:0090175),0.29076757070061726,0.8802731505574366,0.6509695290858726,0.9069008281712176,1.0,13/88,12.31%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;RAC1;AP2B1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.37288737106825465,0.8801371389483127,0.6340640809443507,0.9066237157773113,1.0,3/20,6.32%,RAPGEF2;PDE4D;ADRA2B
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3455634320543421,0.8799762184491567,0.6191222570532915,0.9064171135082922,1.0,9/33,24.06%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1;PTGES3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.33066122120299324,0.8791539433421611,0.6203703703703703,0.9074817404599087,1.0,3/40,2.47%,HIP1;INSR;B2M
prerank,negative regulation of inclusion body assembly (GO:0090084),0.43101683599354573,0.8791182997628608,0.5963302752293578,0.9069858461739984,1.0,3/10,17.78%,SACS;DNAJA4;DNAJB6
prerank,regulation of amyloid fibril formation (GO:1905906),0.395240025794952,0.878182015280633,0.5955882352941176,0.9083116304164457,1.0,3/15,9.20%,APP;PFDN4;PFDN2
prerank,protein kinase B signaling (GO:0043491),0.3650537901457529,0.8781373532905917,0.6146010186757216,0.9078554802861735,1.0,3/23,8.09%,KDR;PIK3R3;TGFB1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2842143614593254,0.8777615416844067,0.6775956284153005,0.9080499173261898,1.0,12/95,14.07%,DAB2IP;TIRAP;MEF2C;DEFA6;NOD2;PDE4B;IRGM;CYRIB;HMGB2;TNFAIP3;GIT1;BCL10
prerank,neuromuscular junction development (GO:0007528),-0.3187144665164837,-0.8776452709508413,0.6601466992665037,0.9237766065984669,1.0,7/24,13.30%,PDZRN3;UNC13C;PPFIBP2;CACNB4;LRRK2;CACNB2;CACNB1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3008574162892315,0.8776019961371087,0.6534508076358296,0.9078271148836152,1.0,18/72,21.62%,POLK;GTF2H2;GTF2H4;RBX1;AQR;COPS5;GPS1;ISY1;POLR2J;RPA1;TCEA1;POLD1;ERCC8;GTF2H3;COPS6;RFC2;DDB1;ERCC4
prerank,response to organic cyclic compound (GO:0014070),0.31263274852786893,0.8775082221325543,0.656060606060606,0.9074598979883015,1.0,7/52,11.91%,SLC1A1;SOCS2;CTNNB1;TLR3;TGFB1;ARL6IP5;PAQR7
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3622605848487862,0.8774883749296688,0.6295681063122923,0.9069497670187432,1.0,2/26,2.10%,ST8SIA6;B4GALT5
prerank,gene expression (GO:0010467),0.2508824655471394,0.8772887108635002,0.7667410714285714,0.9067922703367809,1.0,112/348,26.77%,TSPAN5;AGFG1;TSPAN14;ADAR;PTMA;HHEX;SARS1;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;RPS29;MRPL10;RPL36A;NKX2-8;RPL3;RNPS1;YARS2;RPL27;RPSA;RPS7;PWP1;RPL9;RPL18;RPLP2;NXT1;DEDD2;CPSF1;MAGOHB;RPL13A;THOC6;RPS11;RPL8;NUP54;MPHOSPH10;RBPMS;NCBP2;RPS27;RPL19;RPS9;MRPL28;EIF4E;NOL9;ADAD1;ZC3H11A;RPL11;RPS15;SRBD1;RPL37;RPS28;TSPAN33;RPS10;NUP160;RPS25;MRPL44;RPL37A;MRPL9;COPS5;PRPF4;RPL15;POLR2J;TNIP1;NUP153;NUP50;RPL17;MRPL23;RPL23;RPL34;RBM8A;RBMS2;FARSB;RPS18;UPF2;XRN2;RPL21;RPS4X;MRPS18A;DDX54;RPL18A;NCBP1;DHPS;RPS21;NUP42;DUSP11;RPL10A;ADARB2;RSL24D1;RPL24;RPL7A;NUP85;MRPL41;MRPL27;NUP210;MRPL51;HARS1;RPL32;DHX38;RPL4;UPF3B;UPF1;RPS2;MRPS33;MEF2A;NUP188;MRPL37;CHTOP;RPS20;RPL6;RPS13;MRPS18C;DNAJB11
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3453376385321545,-0.8766943435328871,0.6384976525821596,0.9250245562128364,1.0,3/17,12.48%,NSA2;WDR12;LAS1L
prerank,cellular glucan metabolic process (GO:0006073),-0.38304951528187103,-0.8766330208383334,0.6322314049586777,0.9242222919714531,1.0,4/11,10.73%,PRKAG2;PHKB;PYGM;PPP1R3C
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.35736543983576025,0.875220434969722,0.6198347107438017,0.9104152421782775,1.0,4/24,12.55%,PLA2G4B;ABCA3;CDS2;PNPLA8
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3817156479445209,0.8750737156838169,0.6342342342342342,0.9101744064722922,1.0,1/18,0.69%,MFHAS1
prerank,polyol biosynthetic process (GO:0046173),-0.3540050847476147,-0.87485513964141,0.625,0.9272560008200244,1.0,5/16,11.06%,CYP27A1;ACER3;FGF2;ISYNA1;PPIP5K2
prerank,autophagosome maturation (GO:0097352),0.34288224734329364,0.8742555461632021,0.6634615384615384,0.9112561198476617,1.0,15/32,23.67%,CALM1;TECPR1;MAP1LC3B;UBQLN1;SNAP29;ATG14;VPS16;MAP1LC3A;VAMP7;UVRAG;GABARAP;VMP1;RUBCNL;VAMP8;GABARAPL2
prerank,regulation of interferon-beta production (GO:0032648),0.31823746925210505,0.8742160681508859,0.6405529953917051,0.91077172139802,1.0,18/46,27.40%,TIRAP;IFIH1;TLR3;IRF5;TLR7;TLR8;RELB;TBK1;TRAF3;POLR3F;FLOT1;RIOK3;POLR3B;RNF216;ISG15;POLR3C;IRF7;TOMM70
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2923409095706291,0.8740549682254315,0.6412103746397695,0.9105421906904763,1.0,23/78,25.03%,RNF144B;CAV1;SMAD7;HECTD1;SOCS5;TRIB2;UBQLN1;GSK3A;RBX1;BAG2;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.2871473041302437,0.8740271160117336,0.6843575418994413,0.910039125189289,1.0,8/87,7.78%,NDNF;TBX1;GRB2;FGF16;DLL4;HYAL2;MAPK3;TIAL1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3697848255976365,0.8735365028424895,0.6056338028169014,0.9104406301276087,1.0,7/20,14.85%,BCL2L1;PPP2R5A;AP2M1;TGFB1;ABI3;MRAP;TMEM59
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3600862606973394,0.8734021592426384,0.6429809358752167,0.9101785320337709,1.0,3/25,5.93%,CSGALNACT1;B3GNT2;FUT9
prerank,nuclear pore complex assembly (GO:0051292),-0.39570060703166193,-0.8732790872097436,0.6213151927437641,0.9298951309845206,1.0,8/10,45.00%,NUP205;TMEM170A;NDC1;TPR;RTN4;NUP98;NUP107;AHCTF1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.34572452927684405,-0.8731643350945519,0.6514423076923077,0.9292162848286618,1.0,6/18,14.16%,DCN;MCU;PRKN;MIEF1;DDHD1;MIEF2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3880090555254674,-0.8730514408493061,0.6210526315789474,0.9285494159852752,1.0,2/10,6.13%,DNMT3A;IGF2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.42112573250726476,0.8726323365414742,0.6055555555555555,0.911165404222633,1.0,3/10,9.62%,CTNNB1;DCT;DISC1
prerank,dendrite morphogenesis (GO:0048813),0.3343207493804399,0.8724953540951266,0.6415410385259631,0.9109105503263608,1.0,5/35,8.49%,SHANK3;KLF7;WNT7A;DIP2A;PTN
prerank,mitotic DNA replication (GO:1902969),-0.39507545021350754,-0.8722539668100576,0.6157112526539278,0.9293872237078273,1.0,6/10,34.71%,CDC45;LIG1;MCM3;MCM4;GINS1;GINS3
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3900805374038606,-0.8719743348954102,0.6183035714285714,0.9290940744032127,1.0,7/10,32.90%,GAR1;RPUSD4;RPUSD1;TSR3;RPUSD2;RPUSD3;NOP10
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3319950924371248,0.8715482458088338,0.6158833063209076,0.9122595570023982,1.0,6/35,5.00%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;NPPA;PDE7B
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4181335410852589,0.871473449027858,0.5939278937381404,0.9118492409093643,1.0,4/11,8.63%,VIL1;RREB1;ARHGEF7;ENPP2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2841224416219352,-0.87111904613668,0.6745562130177515,0.9300579470425999,1.0,9/41,12.70%,RNF152;UBE2E2;TRAF3IP2;PRKN;RNF135;WWP2;UBE2E3;PRPF19;PELI3
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3872181428842123,0.8709938269974403,0.6113074204946997,0.9122426775425266,1.0,4/15,4.06%,PRKD1;NOTCH1;PRKD2;TMSB4X
prerank,nucleosome organization (GO:0034728),0.30320218262237136,0.8709837256746941,0.649331352154532,0.9117165246274535,1.0,24/55,25.82%,PRDM9;ARID1A;HMGA1;CTCF;CHAF1A;NAA60;SMARCD1;SOX9;HMGB2;VPS72;POLE3;RNF8;CHAF1B;SET;SRCAP;GRWD1;NASP;DAXX;LIN54;INO80;NAP1L4;ARID2;SMARCA4;SART3
prerank,receptor signaling pathway via STAT (GO:0097696),-0.31494782482401096,-0.8708535167728739,0.6381909547738693,0.9297329251129068,1.0,6/25,9.16%,IL31RA;PKD1;PKD2;PIAS1;CTR9;STAT5A
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.36493465071774406,-0.8702357964773867,0.620137299771167,0.9302053906469722,1.0,1/13,0.65%,GLI3
prerank,negative regulation of protein depolymerization (GO:1901880),0.35804106672450575,0.8698492020854452,0.6389351081530782,0.9134301838792309,1.0,9/24,25.97%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,cellular amide metabolic process (GO:0043603),-0.2374995389900981,-0.8698441326182342,0.7898550724637681,0.930122181688673,1.0,22/102,18.30%,AEBP1;PLPP3;ACOT8;SMPD3;MCCC2;SLC5A6;ACOT11;CPXM1;MTHFR;MTHFD1;NNMT;NAAA;CPXM2;ACSF2;NSMAF;PCCB;NIT1;BTD;DBI;MTHFD1L;OXSM;MTHFD2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3384552637030532,-0.8688112532627831,0.6389548693586699,0.9315586364475087,1.0,6/18,15.19%,DACT1;APOE;EZR;VGLL4;ATP5IF1;CD81
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.41890509369931767,0.8687650241881141,0.6191304347826087,0.9150720505113167,1.0,3/13,4.51%,NOS3;TMSB4X;NOS2
prerank,negative regulation of endocytosis (GO:0045806),0.36161549434400725,0.8687031466015948,0.6427320490367776,0.9146411045105531,1.0,5/24,11.43%,CAV1;PRKD1;NR1H2;ABCA7;RAC1
prerank,negative regulation of translation (GO:0017148),-0.24709797534221567,-0.8685294018908979,0.7582417582417582,0.9312602857375655,1.0,5/87,2.18%,SAMD4A;ROCK2;IGFBP5;CPEB1;CPEB2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3876622975224472,0.8678642922371175,0.6225749559082893,0.915775080747694,1.0,4/16,18.18%,HMGA1;RECQL4;TWNK;RPA1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3486043198496404,0.8678073259975181,0.65,0.9153515564124662,1.0,7/29,12.66%,IFNAR1;IFNAR2;JAK3;SOCS2;STAT1;PTK6;IL15
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.3644621510948122,-0.8671636869614064,0.6377777777777778,0.9333475541889308,1.0,6/13,26.85%,CBLB;KPNA3;KPNB1;KPNA6;NUP35;KPNA1
prerank,proton transmembrane transport (GO:1902600),-0.2863127920307426,-0.8668895278370091,0.6649484536082474,0.9330269702549726,1.0,2/36,5.04%,ATP1A2;ATP6V0A4
prerank,response to UV (GO:0009411),0.28449226089878826,0.8667539214392556,0.6893333333333334,0.9168821454046401,1.0,10/95,9.61%,POLK;MAP4K3;DCUN1D3;MEN1;CAT;GTF2H2;N4BP1;RHBDD1;COPS9;EIF2AK4
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3761848938845995,0.8666298963343056,0.6287744227353463,0.9165846830957511,1.0,2/18,3.74%,JAK3;DUSP3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.336607173125215,0.8664912455789727,0.624390243902439,0.916306469891112,1.0,6/33,12.23%,PLCB1;RGCC;CRNN;CCND3;ADAM17;RPTOR
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.32991612801822817,-0.8661661279695175,0.6428571428571429,0.9337020268959805,1.0,6/22,17.83%,DDX5;PLA2R1;ATM;SPRED1;HIC1;CHD5
prerank,protein destabilization (GO:0031648),-0.2965237029825204,-0.8660333622577404,0.6701030927835051,0.9330749065038527,1.0,8/32,14.57%,GSN;PRKN;CUL3;BTRC;CTSH;PEX2;FBXW11;EP300
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3365278741549286,-0.8657970565570705,0.6699266503667481,0.9326686302501361,1.0,5/20,12.41%,CAMK2D;THADA;BCL2;PML;PSEN1
prerank,response to estrogen (GO:0043627),0.3400585014568716,0.8657641693474568,0.6464,0.9172119139117507,1.0,4/31,9.46%,CAV1;TRIM25;TRIM24;NCOA4
prerank,translational termination (GO:0006415),0.2821552505827343,0.8657081745200411,0.6831955922865014,0.9167705393896793,1.0,35/95,26.03%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;APEH;MRPL21;MRPS18A;ABCE1;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3657596738128548,0.8656780208409526,0.6201680672268908,0.9162779910352059,1.0,3/21,6.18%,MTUS1;PTK2;MAPK3
prerank,regulation of microglial cell activation (GO:1903978),-0.3542828717764197,-0.8655976510770157,0.6431924882629108,0.9321925518819878,1.0,4/15,17.98%,LDLR;SPHK1;GRN;PTPRC
prerank,regulation of myotube differentiation (GO:0010830),0.354217596059058,0.8655059263136138,0.6455906821963394,0.9160644621051586,1.0,4/24,4.77%,NOTCH1;HDAC9;PIEZO1;ATP11A
prerank,zinc ion transport (GO:0006829),0.3615666881107237,0.8651785573696789,0.6405451448040886,0.9161744093081216,1.0,2/21,3.02%,SLC39A8;SLC30A1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2874357273856178,0.8648670895544358,0.6775106082036775,0.9162647944713397,1.0,13/85,12.31%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;RAC1;AP2B1
prerank,protein-containing complex disassembly (GO:0032984),0.3074199703137211,0.8644455550368904,0.6656716417910448,0.9165456151011728,1.0,20/54,24.71%,CAV1;CTNNB1;TECPR1;FRAT2;MAP1LC3B;HSPA8;UBQLN1;SNAP29;APC;VPS16;MAP1LC3A;VAMP7;RPL23;UVRAG;GABARAP;RUBCNL;VAMP8;CSNK1A1;GABARAPL2;MYC
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3431685882482893,-0.8643341671405944,0.6599552572706935,0.934086621744745,1.0,7/17,24.38%,EMC8;EMC7;GET1;EMC1;EMC2;EMC3;EMC4
prerank,positive regulation of translational initiation (GO:0045948),-0.32940124995072734,-0.864267634045718,0.6492027334851936,0.9333158919498012,1.0,7/18,32.93%,HABP4;DDX3X;YTHDF1;RPS6KB1;CDC123;BOLL;CCL5
prerank,positive regulation of immune effector process (GO:0002699),-0.3004439036012988,-0.8641452474437953,0.672544080604534,0.9326541403086286,1.0,2/27,2.68%,APPL2;LBP
prerank,negative regulation of bone remodeling (GO:0046851),0.40893922885658546,0.8640109473883294,0.6238532110091743,0.9168831068272739,1.0,4/11,21.75%,P2RX7;GREM1;TNFAIP3;GPR137
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3881391326350829,0.8630148143515921,0.6425992779783394,0.9183245099984709,1.0,5/17,18.27%,STX1A;UNC13D;SYT4;NLGN1;CACNA1I
prerank,GPI anchor metabolic process (GO:0006505),0.3498870115255699,0.8627029586622867,0.6369982547993019,0.9183655387776929,1.0,8/26,21.77%,PIGU;PIGM;PGAP4;PIGF;DPM3;PIGO;PIGV;PIGQ
prerank,myotube differentiation (GO:0014902),0.3727652096987499,0.8626857148095083,0.6101083032490975,0.9178519942629686,1.0,3/17,5.10%,JAM2;MEF2C;SORT1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.33651872477734945,-0.862550059015517,0.6351039260969977,0.9351979333013056,1.0,1/18,0.45%,FBN1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2627394562425926,-0.8621027967746518,0.7053824362606232,0.9352343521034009,1.0,11/52,13.05%,LMNA;SHC1;KDELR3;ARFGAP1;GFPT1;TSPYL2;SEC31A;CUL7;FKBP14;TLN1;SYVN1
prerank,positive regulation of type I interferon production (GO:0032481),0.29047104594460427,0.8620644136806641,0.6910688140556369,0.9185085555987849,1.0,8/73,7.62%,LRRFIP1;IFIH1;CTNNB1;TLR3;MRE11;STAT1;IRF5;TLR7
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.32055255987244136,-0.8616993848634116,0.6231884057971014,0.9352014659733101,1.0,9/23,28.15%,PRCC;ZWINT;ZWILCH;PLK5;CHMP4C;VPS4A;INTS3;SETMAR;PLK3
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3806724323543513,-0.8614636198224133,0.6530172413793104,0.9348180679026821,1.0,3/12,14.17%,PRCC;ZWINT;ZWILCH
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.30028580713696873,-0.861069462730194,0.6576354679802956,0.9347790209708473,1.0,8/28,17.71%,ITPR1;MAP3K5;TMEM117;BCL2;CEBPB;ATP2A3;DDIT3;CASP4
prerank,mitotic recombination (GO:0006312),-0.3534108326030161,-0.8604869151977346,0.6482300884955752,0.9350908943750266,1.0,7/15,19.24%,SMC6;TEP1;ERCC1;RAD50;NSMCE2;DMC1;TPRKB
prerank,positive regulation of synaptic transmission (GO:0050806),0.2918998683755796,0.8603469566492528,0.6773255813953488,0.9213235466385349,1.0,15/72,17.12%,SHANK3;APP;SLC24A2;CLSTN1;NPS;NRXN1;EIF2AK4;AGER;GRIN2B;GRIK2;PLK2;NLGN1;RIMS2;LGI1;CCR2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.31511534902849075,0.8603005317870106,0.6778625954198473,0.9208514563370807,1.0,6/47,4.72%,PPARD;SOX13;ZBTB16;RREB1;NOCT;CREB1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4032163081138691,-0.860239544713681,0.6568848758465011,0.9347096556778833,1.0,3/10,10.12%,ABCA1;APOE;PRKACA
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.3990830886551454,0.8597787938175354,0.630188679245283,0.9213709801129881,1.0,1/13,2.06%,PDE8A
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.41541231426788766,0.8593046019304714,0.6216730038022814,0.9217166594691684,1.0,1/10,2.03%,TIRAP
prerank,"transcription, DNA-templated (GO:0006351)",0.25628961663093947,0.859293128078655,0.7560975609756098,0.9211920963351693,1.0,50/207,19.85%,IVNS1ABP;PTMA;RREB1;NOCT;MRPL12;PIR;TAF1B;IRF9;SLC25A33;NKX2-8;GTF2H2;ABT1;RNPS1;YBX2;NFIC;PWP1;KLF13;TRIM24;CEBPD;PKNOX1;CBFB;NCBP2;GTF2H4;NELFCD;CCNK;GTF2B;GTF3A;MLLT1;GTF3C5;RO60;NAT14;HIPK3;ELOB;CRCP;TWNK;UBTF;TAF4B;LHX1;TAF4;MNT;POLR2J;DEK;TAF5;TCEA1;CCNT1;TBPL1;EAF1;THRA;GTF2E2;BRF2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3848319067583325,0.8590327157674913,0.6290322580645161,0.9211594823358353,1.0,4/15,12.84%,PPARD;NR1H2;ELOVL5;PPARG
prerank,manganese ion transport (GO:0006828),0.3933382932864749,0.8586518371060661,0.639344262295082,0.9213251273729633,1.0,2/14,3.60%,SLC39A8;ATP2C1
prerank,negative regulation of cell aging (GO:0090344),0.3794585806710299,0.8585502416887897,0.6548672566371682,0.9209757502249515,1.0,7/16,23.00%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3118118919029041,0.8584895215116402,0.7008797653958945,0.9205545753108061,1.0,20/46,30.85%,TOMM22;TIMM13;TIMM10;HK1;DNAJC19;MFF;TOMM20L;RALA;CHCHD4;TOMM7;TOMM5;TIMM21;TIMM50;TOMM70;BCAP31;TIMM9;AIFM1;FIS1;GRPEL2;AKT1
prerank,protein complex oligomerization (GO:0051259),0.28275846345497796,0.8584683281574571,0.7187060478199718,0.9200545135833523,1.0,17/85,16.56%,AQP11;LRRC8C;KCNC2;HOMER1;SHMT2;MAT2A;LETM1;EHD4;LRRC8D;BCL10;ELAVL1;TRMT61B;CARD11;TWNK;PDCD6IP;SPAST;NLRC4
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3239554918525556,-0.8584348303805465,0.6651480637813212,0.9376685047941504,1.0,2/19,2.73%,AXL;MMP14
prerank,positive regulation of cartilage development (GO:0061036),0.38176353942219377,0.8579784974754485,0.6401515151515151,0.920503521495519,1.0,3/17,3.97%,BMPR2;ACVRL1;ZBTB16
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3028308235746434,0.8578689355900612,0.6676514032496307,0.9201854965907463,1.0,9/57,12.66%,IL6R;ARL2BP;CD40;LYN;INPP5F;STAP2;PTK6;CNTF;IL15
prerank,myofibril assembly (GO:0030239),0.31324605066400035,0.8576559673477038,0.6691729323308271,0.9200701665314832,1.0,2/42,1.54%,FLII;PGM5
prerank,protein deubiquitination (GO:0016579),0.25188279921725326,0.8576539877882009,0.7646356033452808,0.9195259781557181,1.0,86/242,27.39%,MINDY1;NFKBIA;IFIH1;ACTB;SMAD7;SNX3;ATXN3;CCP110;EIF3F;PSMB3;PSMD11;BIRC3;SHMT2;PSMC6;PSME2;OTUD7A;MYSM1;BABAM1;SMAD1;MINDY2;PSMD8;USP18;HIF1A;TADA2B;POLB;HGS;ATXN7;WDR48;CYLD;TNFAIP3;PSMB10;WDR20;TRRAP;MCRS1;APC;PSMA8;COPS5;HCFC1;RAD23A;USP49;RCE1;TNIP1;PSMD9;JOSD2;USP32;USP29;UBE2D1;BRCC3;TRAF3;OTUD4;ASXL1;USP25;USP21;OTUD7B;DESI2;JOSD1;SUDS3;KAT2B;MBD5;PSMC3;PSMD1;STAMBP;RAD23B;INO80;PSMD10;TRAF6;ENY2;RIPK1;USP30;VCPIP1;FOXO4;MYC;KEAP1;KDM1B;ZC3H12A;USP38;PSME1;USP45;TAB1;ACTR5;ADRB2;UBB;PSMD2;PSMA1;ADRM1;NFRKB
prerank,negative regulation of T cell activation (GO:0050868),0.3294179130777937,0.8573580222944925,0.670906200317965,0.9195502913819743,1.0,6/35,14.70%,JAK3;DUSP3;TNFRSF21;FOXP3;CEACAM1;NCKAP1L
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.40073797653702914,0.8570997607101922,0.6299638989169675,0.9194972683630234,1.0,5/13,18.60%,STAT1;EBI3;OASL;IL27RA;IL27
prerank,epidermal cell differentiation (GO:0009913),-0.27798845211453627,-0.8570287168163867,0.7225274725274725,0.939693804926606,1.0,11/41,19.51%,ADAM9;ANXA1;GLI1;TXNIP;JAG1;GATA6;SCEL;BCR;CASP3;DSP;WNT16
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3570224473411532,0.8570077502133833,0.6384742951907131,0.9191244805450708,1.0,1/21,0.99%,BCL2L1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3336479616555268,-0.8569877213063474,0.6713947990543735,0.9388740206954358,1.0,4/18,15.47%,FCHSD2;DTNA;SLC5A7;STAC3
prerank,regulation of phosphorylation (GO:0042325),0.2758989100863411,0.8568495027663854,0.716,0.9188850170204128,1.0,23/120,15.38%,ITGA6;APP;PTK2;NLRC5;LYN;FNIP2;IKBKB;CCDC88A;DYNLL1;CDKN2B;PIN1;HSPB1;NUP54;ZBTB7A;HIF1A;KCTD20;SDCBP;CDH5;PGAM1;BCL10;NCKAP1L;BTBD10;NUP160
prerank,response to hexose (GO:0009746),-0.30237134276516664,-0.8567544017784313,0.6783216783216783,0.9384548516734648,1.0,3/25,7.88%,THBS1;IRS2;SELENOS
prerank,glycoprotein catabolic process (GO:0006516),0.3709477667576561,0.8567303796773224,0.6278260869565218,0.9185722554846398,1.0,7/17,13.93%,OGA;NEU4;STT3B;FBXO6;MANBA;EDEM1;NEU2
prerank,response to laminar fluid shear stress (GO:0034616),0.41524485192564586,0.8566635534181538,0.6394316163410302,0.9181546388873806,1.0,3/10,6.45%,KLF2;SMAD7;KLF4
prerank,positive regulation of TOR signaling (GO:0032008),-0.2788259811058764,-0.8564147023644422,0.7307692307692307,0.9382461585674483,1.0,9/40,18.58%,FNIP1;KLHL22;SEH1L;RHEB;CLEC16A;LAMTOR3;RRAGA;SMCR8;FLCN
prerank,regulation of response to stress (GO:0080134),0.42629636633993956,0.8562295464218503,0.6355140186915887,0.9184694696987493,1.0,1/10,2.60%,CORO2B
prerank,positive regulation of keratinocyte migration (GO:0051549),0.4224901227040573,0.8558184807139577,0.6188679245283019,0.9187212270977649,1.0,3/10,12.23%,MAPRE2;IQSEC1;MAP4K4
prerank,membrane raft organization (GO:0031579),-0.34460480978591435,-0.8556549764804365,0.6438053097345132,0.9390307404551289,1.0,4/15,11.08%,ANXA2;S100A10;FLOT2;CLN3
prerank,negative regulation by host of viral process (GO:0044793),0.4091687148089415,0.8556189996201522,0.6349206349206349,0.9185370169381294,1.0,5/10,25.67%,EIF2AK4;CCNK;PSMC3;PTX3;ZC3H12A
prerank,glycolipid biosynthetic process (GO:0009247),-0.28007011347165445,-0.8555245155745559,0.7219387755102041,0.9384117998731686,1.0,10/38,15.65%,LARGE1;ST3GAL4;A4GALT;ST3GAL5;PIGN;GBGT1;B4GALT6;ST6GALNAC5;PIGA;PIGP
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2624676150691466,0.8555031850141257,0.7272727272727273,0.9182062953445559,1.0,13/153,6.84%,PRKCH;PDGFB;STK38;PKN3;RPS6KA1;PRKD1;PRKD2;IKBKB;PIKFYVE;MAST4;PKN1;RPS6KA5;PKN2
prerank,cell projection organization (GO:0030030),0.33045333967755613,0.8554238268277439,0.6666666666666666,0.91779966170139,1.0,8/30,14.70%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,cellular senescence (GO:0090398),0.33935685324963283,0.8554062354283881,0.661641541038526,0.9172892495493519,1.0,6/27,11.49%,TBX3;CDKN2B;KAT6A;TERF2;HMGA1;HRAS
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3024212695866733,-0.8551767326239719,0.6921119592875318,0.9382581236269922,1.0,14/28,32.62%,GJA1;GPSM2;FBXW11;NUSAP1;MAD2L1;MISP;HTT;KPNB1;SPDL1;NUMA1;ITGB1;PLK1;ESPL1;PKHD1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3037361000851477,0.8551541882808682,0.6773211567732116,0.9172426628842266,1.0,18/50,28.16%,PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3426880212343854,-0.8550956887871526,0.6605080831408776,0.9375305795700648,1.0,5/17,19.66%,GJA1;KDM1A;PTPRC;PDCD2;LTBP3
prerank,pseudouridine synthesis (GO:0001522),-0.35978040691019875,-0.8549746258352603,0.642369020501139,0.9369204567035927,1.0,3/13,15.09%,PUS7;PUS10;GAR1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2772967706252703,-0.8545492239522281,0.7214484679665738,0.9369387854103864,1.0,9/41,18.91%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;NR1H4;RARA;PTPN6
prerank,positive regulation of transporter activity (GO:0032411),-0.36423755281596837,-0.8545492079574537,0.6894273127753304,0.9360464627576146,1.0,7/13,31.29%,TRPC6;RXRA;KCTD7;WNK3;SYNGR3;KMT2A;PDZK1
prerank,regulation of neuroblast proliferation (GO:1902692),0.38560597503805505,0.854437065877038,0.6325411334552102,0.9181137055806037,1.0,4/15,9.62%,CTNNB1;DCT;PTN;DISC1
prerank,regulation of mitochondrial fission (GO:0090140),-0.30944235497873396,-0.854275554951264,0.6774193548387096,0.9356904912380323,1.0,7/24,14.16%,DCN;MCU;PRKN;MIEF1;LRRK2;DDHD1;MIEF2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.35602811672455026,0.8536848298652552,0.6655172413793103,0.9190586575844935,1.0,9/23,27.36%,CYP2E1;ELOVL6;LTA4H;GPX4;HPGD;GSTM1;LTC4S;ACSBG1;ASAH2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.33624002453805596,0.8533461013040498,0.6644067796610169,0.9191917982226698,1.0,8/30,13.42%,RYBP;HSP90AB1;N4BP1;UBXN1;SVIP;RPL11;TRIM39;SDCBP
prerank,regulation of autophagy (GO:0010506),-0.21516882358273232,-0.8528283616414303,0.9277777777777778,0.9377560938678029,1.0,49/216,18.58%,PRKAG2;DCN;ITPR1;LEPR;PRKAA2;RNF152;NUPR1;SNX6;KLHL22;DAPK2;DAPL1;BCL2;GOLGA2;PRKN;MET;ATM;FOXO3;PTPN22;PLEKHF1;PIP4K2C;MTMR3;STK11;PRKACA;PRKAG3;LRRK2;ATP6V1C1;SNX5;ABL1;RHEB;ATP6V1G2;TPCN1;SIRT2;HTRA2;LAMTOR3;EP300;CAPN1;CASP3;RRAGA;WDR41;SREBF1;OPTN;CISD2;ATP6V1E1;SNX32;DDIT3;CTSA;PSAP;SMCR8;FLCN
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3252265584085135,-0.8527836228561775,0.676056338028169,0.9369502860026662,1.0,4/20,7.91%,ROCK2;RHOQ;DLG1;FHOD1
prerank,response to calcium ion (GO:0051592),0.27741394920237505,0.8521344156198981,0.7249666221628839,0.9210123571126693,1.0,23/102,17.95%,ITPKB;CAV1;MEF2C;MCOLN1;CALM1;ACER1;SYT7;CPNE8;RASGRP2;HOMER1;IQGAP1;CLIC4;CPNE5;PPP3CA;SYT4;CPNE6;PDCD6;NLGN1;CPNE3;CRHBP;TTN;CPNE1;NEUROD2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.35387686446656375,-0.8519690503998091,0.6666666666666666,0.9378942684804593,1.0,3/15,7.96%,SMPD3;TSG101;SDC4
prerank,macrophage migration (GO:1905517),-0.35778586210255303,-0.851767869247199,0.6701461377870563,0.9374468002987055,1.0,8/13,44.82%,P2RX4;CKLF;CCL2;CCL5;P2RY12;TAFA4;CXCL17;CCL3
prerank,NAD biosynthetic process (GO:0009435),0.3548803503807668,0.8516082888196068,0.6745362563237775,0.9214754573373163,1.0,1/20,0.77%,NAMPT
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.27328213152091985,-0.8514459428085753,0.7071240105540897,0.9372007699309595,1.0,7/40,13.91%,PID1;SLC25A36;BCL2;PPA2;LRRK2;ABL1;ATP5IF1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3727811257822395,0.8512313915873408,0.6490299823633157,0.9216686515290339,1.0,1/18,1.02%,DAB2IP
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3087092449117863,-0.8511296586991388,0.6844783715012722,0.93699138852399,1.0,2/26,1.34%,PRKAG2;PRKAA2
prerank,DNA methylation (GO:0006306),-0.31837200022142087,-0.8509100390318646,0.6689342403628118,0.9366164872027073,1.0,10/23,30.13%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15;PICK1;ZFP57;METTL4;FOS;BAZ2A
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.37713588089193983,-0.8506992732588591,0.6347826086956522,0.9361802500207702,1.0,4/10,17.48%,ALDH7A1;HNMT;COMT;SARDH
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.272837078701336,-0.8506205049095719,0.7183098591549296,0.9354506367678155,1.0,9/43,18.91%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;NR1H4;RARA;PTPN6
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3886227109254214,0.84981154096546,0.6471698113207547,0.9239002270996263,1.0,6/14,25.56%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3273239030053199,0.8492335335585622,0.6645264847512039,0.9245113476167286,1.0,10/32,20.09%,HMBOX1;CTNNB1;MAPK3;CCT3;CCT5;ACD;MAPK1;CCT7;NAF1;MAP2K7
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3228217830209697,-0.8491522463478444,0.6833333333333333,0.9376606933160521,1.0,5/20,18.35%,FKBP5;PPIC;PPIL2;PPIH;NKTR
prerank,regulation of receptor internalization (GO:0002090),0.32590948425249716,0.8480817924163399,0.6738056013179572,0.9261428253026819,1.0,6/35,8.89%,INSR;ANKRD13A;RIN3;TBC1D5;MKLN1;GREM1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.3018657542876072,-0.8476460120789557,0.7088948787061995,0.939891519931433,1.0,7/28,18.24%,CEMIP;MIEF1;ITGB1BP1;DMTN;MIEF2;KCNB1;C2CD5
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3241945151937876,-0.8475635764375611,0.6666666666666666,0.9391844606111078,1.0,6/19,13.53%,CUX1;OBSL1;FBXW8;CUL7;CAPRIN2;CDKL3
prerank,oligodendrocyte differentiation (GO:0048709),0.371942597725485,0.847515186889814,0.6615384615384615,0.926701606144113,1.0,7/19,18.49%,SOX13;EIF2B1;EIF2B2;SOX10;SOX9;PTPRZ1;TPPP
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3994893893412592,0.8472090165990763,0.651685393258427,0.9267462449558365,1.0,3/12,9.70%,IMPDH1;ADSS2;GART
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.35193355523970543,-0.8472025755050373,0.6659192825112108,0.9390409530552456,1.0,5/14,17.10%,IL34;THBS1;CMKLR1;RARRES2;MDK
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3074038627205478,-0.8470463249524403,0.6949152542372882,0.9384373094258733,1.0,9/24,17.51%,PKD1;APOE;PRKACA;PSME3;PTK2B;ATP5IF1;RHBDF1;LATS1;NUB1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.27758296550540185,-0.8469001075628462,0.725,0.9378789558085695,1.0,5/41,5.81%,ACSL1;PTGS1;DAGLA;CYP1B1;ACOT8
prerank,fatty acid metabolic process (GO:0006631),0.2682953085446038,0.8460335246653905,0.7343124165554072,0.9284391850084753,1.0,19/115,15.00%,ADIPOR2;FASN;PPARD;ACSL5;CPT1A;CRAT;ACOX1;ABCB11;ACSL6;ACSL3;LIPC;ADIPOR1;PNPLA8;PPARG;SLC27A2;LPIN3;HACL1;HSD17B8;FA2H
prerank,rRNA 3'-end processing (GO:0031125),-0.3851800999120283,-0.8459352348323878,0.6533333333333333,0.9389962219406047,1.0,4/10,25.05%,ERI3;ERI2;EXOSC2;ERI1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.392197337840989,0.8458723470679386,0.6401515151515151,0.9282115405220344,1.0,6/13,25.56%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,nucleoside salvage (GO:0043174),0.4145785519112508,0.8457808022399692,0.6330097087378641,0.9278530614292034,1.0,1/10,3.05%,HPRT1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26618817622282687,-0.8457294987754058,0.7017543859649122,0.9385540869018935,1.0,10/46,15.57%,PLD1;AGPAT4;LCLAT1;GPD1L;PLA2G12A;ACP6;GPAT3;DDHD1;PNPLA3;SLC27A1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2884326076533524,0.8452856874686174,0.7126436781609196,0.9282616666337382,1.0,20/76,19.21%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;MALT1;NDFIP2;UBQLN1;GSK3A;WDR48;DCUN1D1;BCL10;INAVA;PTTG1IP;TNIP1;UBE2D1;FKBP1A;NSMCE3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.33896761691464095,-0.8450692997759796,0.6550976138828634,0.9389824416815207,1.0,3/16,11.39%,SLC39A14;PRKCA;PRMT5
prerank,positive regulation of cellular catabolic process (GO:0031331),0.26325762328299745,0.8442862359763466,0.751937984496124,0.929654260809872,1.0,23/132,12.45%,INSR;SH3BP4;APP;PRR5L;TRIM14;FOXO1;PRKD1;ENTPD5;IRGM;P2RX7;MSN;GTPBP1;PFKFB3;PIK3C2A;ABCD1;GSK3A;HIF1A;SH3GLB1;ORMDL3;PIK3CB;SVIP;DXO;TFEB
prerank,cellular response to amino acid stimulus (GO:0071230),0.32870306711057495,0.844192522126259,0.6817472698907956,0.9292843671213177,1.0,9/33,19.26%,SH3BP4;SESN3;FYN;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2
prerank,cardiocyte differentiation (GO:0035051),0.41630070230596283,0.8441771882838618,0.6450381679389313,0.9287693798794204,1.0,1/10,1.32%,TGFB2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.36728140214099914,-0.8437723424450634,0.6959619952494062,0.9407600125043609,1.0,2/13,6.78%,PLXNA2;PLXNB2
prerank,plasma membrane tubulation (GO:0097320),0.39580200963898,0.8435568945248229,0.6243194192377496,0.9293831784270385,1.0,2/13,9.16%,FNBP1L;CAVIN2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.33070210657989885,-0.8432861310248697,0.6852678571428571,0.9408613666826728,1.0,8/16,40.92%,TOP2B;TOP2A;HFM1;MEIOB;EME1;SHOC1;CENPS;MUS81
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3641061106775043,0.8430463884497358,0.6541889483065954,0.9298020643359005,1.0,3/19,6.44%,TIRAP;TRIL;LGALS9
prerank,protein localization to nucleus (GO:0034504),-0.2328176198359799,-0.8430391769483807,0.848605577689243,0.94045847785822,1.0,29/102,27.08%,COL1A1;APPL2;BMP7;BMP4;LMNA;RANBP17;SIX1;PML;TOR1AIP1;TAF8;PAF1;MORC3;E2F3;FAM53B;SIX4;CNEP1R1;IPO7;BBS4;WRN;GBP2;BCL3;STAT3;KPNB1;MSX1;HIKESHI;NUP155;IPO8;TPR;NOP53
prerank,negative regulation of cell communication (GO:0010648),0.35537093151201454,0.842592241566293,0.643598615916955,0.9301069525020444,1.0,5/21,16.32%,KIF26A;SOCS5;PTK6;SRMS;ACVR1
prerank,methylguanosine-cap decapping (GO:0110156),0.41490171775518364,0.8420495626417022,0.6642599277978339,0.9306413156112818,1.0,4/10,13.62%,EDC3;DCP2;DCP1B;PNRC2
prerank,mesoderm formation (GO:0001707),0.3695850377545461,0.8414449603583265,0.6613475177304965,0.9312179428065605,1.0,1/17,1.29%,BMPR2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.333032801973973,-0.8410565764164715,0.673773987206823,0.9435933103218994,1.0,7/16,17.12%,AMPD3;PAICS;LHPP;IMPDH2;GMPS;ADSL;ATIC
prerank,peroxisome organization (GO:0007031),-0.30446288772901187,-0.8406046755138509,0.6774193548387096,0.9435830850211593,1.0,7/25,18.07%,ABCD3;ACOT8;SEC16B;PEX7;PEX2;TMEM135;PEX11A
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.38441671755729284,-0.8403329827481759,0.6814345991561181,0.943217103015814,1.0,2/10,3.85%,OSR1;CAMK2D
prerank,regulation of platelet aggregation (GO:0090330),0.36660617557287345,0.8400940455540631,0.6491862567811935,0.9332429038122757,1.0,5/17,12.02%,F11R;LYN;PRKG1;SYK;CEACAM1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3361299199675668,-0.839968258541522,0.6942528735632184,0.9430468403706044,1.0,4/16,11.85%,SLC30A10;PPARA;EMILIN1;TRAP1
prerank,regulation of mitochondrion organization (GO:0010821),-0.2681049109748113,-0.8397037217562932,0.7723076923076924,0.9426701987351688,1.0,12/47,18.93%,PID1;PPARGC1A;PRKN;LRRK2;HTRA2;MIEF2;EP300;SREBF1;PARL;FLCN;MUL1;RHOT1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3731209179511586,0.8394934995983216,0.6539855072463768,0.9338660566811505,1.0,4/16,18.03%,VPS36;TMEM50A;VPS25;LEPROTL1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.36987771147816567,-0.839455115755233,0.6828193832599119,0.9423115403063569,1.0,5/11,37.06%,SIRT1;CIITA;TMEM106A;PF4;IL4
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3274923002924104,-0.8383794728796542,0.6888361045130641,0.9435795037260742,1.0,15/19,46.12%,APOE;SLC5A7;NQO1;CHRNA4;CHRNB2;ACHE;COLQ;CHRFAM7A;CHRNA7;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;RAPSN
prerank,positive regulation of cell division (GO:0051781),-0.28399116135377656,-0.8373730638328537,0.7247956403269755,0.9446644226677058,1.0,9/38,16.08%,FGFR2;FGF1;SVIL;CDC14B;CUL3;CDC25B;GIPC1;SIRT2;RACGAP1
prerank,positive regulation of glycolytic process (GO:0045821),0.3599897063899529,0.837327415323547,0.6813559322033899,0.9369001355368649,1.0,6/20,11.82%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3599897063899529,0.837327415323547,0.6813559322033899,0.9369001355368649,1.0,6/20,11.82%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.31674048530277493,-0.8370905906100994,0.6985645933014354,0.9443430164440366,1.0,3/20,5.80%,MCU;SLC8A3;SLC8B1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2845728260836633,-0.8370767965048137,0.7240506329113924,0.9434947122924281,1.0,5/33,6.43%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,regulation of TOR signaling (GO:0032006),0.28872822162746,0.8370399740415583,0.7359050445103857,0.9369120741963651,1.0,16/67,16.47%,SH3BP4;TNFAIP8L1;GNA12;WDR59;RFFL;DEPDC5;DDIT4;LAMTOR5;GSK3A;RPTOR;TMEM127;PDCD6;EPM2A;TBCK;LAMTOR4;GAS6
prerank,protein maturation (GO:0051604),-0.23300322221316197,-0.8367733838149494,0.8737541528239202,0.9432202550218177,1.0,15/95,12.41%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;NAA35;NNAT;ADAM19;CPXM1;CPXM2;CLN3;AFG3L2;LMF1;PSEN1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2852098108758787,0.8366896835132251,0.7403708987161198,0.937028788928608,1.0,20/70,23.03%,B2M;IKBKB;PSMB3;PSMD11;MFSD6;TAP2;PSMC6;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;PSMC3;PSMD1;VAMP8;PSMD10;CALR
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24026548112839172,0.8365637885945726,0.8437146092865232,0.9367317172082151,1.0,95/341,23.32%,RNF144B;ZNRF1;TRIM25;NEDD4L;PELI1;RNF125;ZNRF3;CTNNB1;KLHL25;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;RNF215;PSMD11;PSMC6;FEM1C;KLHL3;NDFIP2;PSME2;PPP1R11;SMURF1;UBXN1;KCTD10;OTUD7A;SHARPIN;KLHL20;RNF130;TOLLIP;UBE3D;UBQLN1;PSMD8;GSK3A;RNF187;ARRDC1;MAEA;BUB3;TNFAIP3;PSMB10;FBXO21;NHLRC1;RBX1;PTTG1;ANAPC16;TRIM2;UBE2D3;AREL1;RNF8;PSMA8;ATE1;ARMC8;RAD23A;ANAPC7;UBE2G2;BAG6;GID8;BFAR;RNF19A;TRIM71;TRIM3;KCTD17;ANAPC10;PSMD9;SIAH1;CBL;RNF4;UBE2D1;VPS37A;OTUD7B;RBCK1;RNF166;FBXO8;ANAPC2;NSFL1C;PLAA;ANKRD9;VPS37B;ERCC8;MIB1;RLIM;DDB1;PSMC3;UBL7;PSMD1;CDC23;RAD23B;RNF126;VPS37C;CNOT4;PSMD10;CDC26;FBXL14;CDC27
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3533123621342523,-0.8361463274702774,0.6762114537444934,0.9436483291858735,1.0,2/12,5.81%,ACSL1;ACOT8
prerank,regulation of urine volume (GO:0035809),-0.3806285207261138,-0.8357666941239882,0.6707317073170732,0.9435730805312482,1.0,3/10,13.15%,NPR3;ADCY6;ADM
prerank,negative regulation of signaling (GO:0023057),0.34099639741695903,0.8355606670152397,0.6789297658862876,0.9380629103013871,1.0,9/25,24.90%,KIF26A;SOCS5;PTK6;SRMS;AP1AR;ACVR1;TRAT1;OPRM1;GLRA1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.34713963921526503,-0.8351653550171912,0.6976744186046512,0.9438961958384722,1.0,2/14,4.11%,NMNAT2;ME1
prerank,acyl-CoA metabolic process (GO:0006637),0.32424753533033746,0.8344798480261945,0.6853932584269663,0.9395795756072038,1.0,5/35,7.77%,HMGCS2;ACBD6;GLYAT;ACACB;ACSL6
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4120245631213726,0.8343672613883054,0.6602687140115163,0.9392394934253703,1.0,6/10,31.00%,INPP5F;SH2B3;SOCS1;PARP14;PPP2R1A;NF2
prerank,long-term synaptic potentiation (GO:0060291),-0.3153537095971588,-0.833849167859895,0.6810933940774487,0.9455864134377426,1.0,9/21,27.37%,SLC8A3;NFATC4;PTK2B;TSHZ3;STX4;VAMP2;PRKCZ;GRIN2D;SLC8A2
prerank,ubiquinone metabolic process (GO:0006743),-0.33684955249453225,-0.8337856681675565,0.6906976744186046,0.9448416939526146,1.0,5/15,19.93%,COQ10A;AIFM2;COQ2;COQ8B;COQ10B
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.3015195424429641,-0.833742928023662,0.7461538461538462,0.9440632219864628,1.0,8/26,18.80%,TRAFD1;PPM1B;IRAK3;SIRT2;MAPKBP1;PCBP2;C1QBP;MUL1
prerank,regulation of protein polymerization (GO:0032271),-0.2755408480389383,-0.8332915963493622,0.7365591397849462,0.9440761076524052,1.0,10/35,18.29%,ARHGAP28;FCHSD2;PLEKHG2;ARHGAP18;PFN2;ABL1;MAP2;CTTN;LATS1;DBN1
prerank,positive regulation of actin nucleation (GO:0051127),-0.3706191000253717,-0.833031567328623,0.6936936936936937,0.9436925693618027,1.0,3/11,7.33%,GSN;FCHSD2;ABI2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.23741522918306215,-0.8325762421764712,0.8129251700680272,0.9437551632639785,1.0,27/80,26.63%,DENND2A;SGSM2;SNX6;GBF1;SNX12;STX5;ARL1;TBC1D10A;SNX5;SNX8;RAB29;RAB6A;LMAN1;STX16;TRAPPC10;SURF4;SNX32;VPS54;BET1L;VAMP3;TMED9;VPS26A;RAB9A;BAIAP3;PHETA2;VPS26B;RHOBTB3
prerank,multivesicular body organization (GO:0036257),0.3239084271006134,0.8323235355465416,0.6891447368421053,0.9424611419413946,1.0,13/31,28.32%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C;CHMP2B;VPS4B;RAB27A;VPS28
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.29271156843955254,0.8320050514986965,0.7318181818181818,0.9425264164446027,1.0,18/57,19.90%,TNFSF10;NOD1;FOXL2;SOX7;FYN;AIM2;MALT1;CASP8;ARL6IP5;GRIN2B;SYK;BCL10;PDCD6;NLRC4;PPM1F;BAK1;CYCS;F2R
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.3355307241086817,0.8318797532017927,0.6706896551724137,0.9422027162068595,1.0,2/27,2.59%,UTRN;NEDD4L
prerank,cytoplasmic microtubule organization (GO:0031122),0.2958765491692371,0.8318765847590753,0.7166921898928025,0.9416637814996862,1.0,18/54,21.14%,CCDC13;CLIP1;CCDC88A;LIMK2;CCDC88B;STMN3;RAB11A;CRIPT;HOOK1;MAP10;SLK;SPAST;TRPV4;CLIP2;CAMSAP2;TPPP;DCTN1;CLASP1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3783457419448026,-0.8311267577017739,0.689873417721519,0.9457619231419566,1.0,3/10,12.28%,SOX5;SOX6;PKDCC
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2714868236862477,0.8310238909866088,0.7551299589603283,0.9427305250696337,1.0,16/104,12.42%,DAB2IP;ACTB;CALM1;FGF16;CDKN2B;RALB;CCNI;IRGM;LRP5;CCND3;TRIB2;PDCD10;CDC6;CCNK;RPTOR;HGS
prerank,RNA polyadenylation (GO:0043631),0.3311897875525803,0.8305301778813162,0.7003484320557491,0.9425770929167542,1.0,4/26,10.84%,APP;MTPAP;CPSF1;SSU72
prerank,mRNA polyadenylation (GO:0006378),0.3311897875525803,0.8305301778813162,0.7003484320557491,0.9425770929167542,1.0,4/26,10.84%,APP;MTPAP;CPSF1;SSU72
prerank,bone morphogenesis (GO:0060349),-0.3434920906964277,-0.8305234939754051,0.6890380313199105,0.9461012921090233,1.0,5/14,15.26%,FGFR2;CYP26B1;SFRP4;SKI;LRP6
prerank,negative regulation of transposition (GO:0010529),-0.3331500291033973,-0.8299448879817299,0.7116279069767442,0.9463343623781753,1.0,8/16,28.69%,TUT4;UBR2;TEX15;PIWIL2;MYBL1;TDRD9;MOV10;DDX4
prerank,mitotic nuclear division (GO:0140014),-0.23817859960075485,-0.8295206692620695,0.8338557993730408,0.9462690501581091,1.0,31/71,32.28%,KLHL22;FLNA;GOLGA2;ZWINT;SMC4;PIBF1;CENPK;TUBG1;KLHDC8B;STAG2;SPICE1;KIF18A;NUSAP1;CCDC61;MISP;TPX2;KNSTRN;KIFC1;NSL1;UBE2S;KPNB1;KIF11;SGO1;CDCA8;CEP192;ABRAXAS2;BCCIP;PLK1;ABRAXAS1;TOGARAM2;ESPL1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3439075816488396,0.8294919561508736,0.6984924623115578,0.9439379792177972,1.0,5/22,14.02%,PPARD;CREB1;SORBS1;PPARG;DISP3
prerank,protein homotetramerization (GO:0051289),0.30148644515537887,0.8291616641018027,0.7237410071942446,0.9440538570508518,1.0,7/49,8.05%,B2M;HPRT1;GBP5;SAMHD1;MCOLN1;ACACB;SHMT2
prerank,protein import into peroxisome membrane (GO:0045046),-0.30029213696126944,-0.8290976781539452,0.6945107398568019,0.946270009360635,1.0,6/22,23.80%,ABCD3;PXMP2;PEX2;ALDH3A2;ATAD1;PEX13
prerank,plasma membrane invagination (GO:0099024),0.3262055586101935,0.8286712042607428,0.6774193548387096,0.9444384735131851,1.0,3/29,6.47%,DOCK1;ELMO1;ARHGAP25
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.30250694924547095,0.8280100799175018,0.7080062794348508,0.9445665881557614,1.0,18/56,27.04%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;ECSIT;DMAC1;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.30250694924547095,0.8280100799175018,0.7080062794348508,0.9445665881557614,1.0,18/56,27.04%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;ECSIT;DMAC1;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,positive regulation of neuron differentiation (GO:0045666),0.31145331352358563,0.8278819673071991,0.7151515151515152,0.9442748781810687,1.0,12/40,17.95%,ARHGEF2;MEF2C;MMD;ADRA2B;BRINP3;BRINP2;SOX11;NRCAM;PROX1;SIN3A;CPNE1;NEUROD2
prerank,lipoprotein catabolic process (GO:0042159),0.39230771830851635,0.8271289193190214,0.649812734082397,0.9451306875362785,1.0,3/11,8.87%,NOTUM;ABHD17A;LYPLA1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3159827398617845,-0.8268500533505632,0.6997742663656885,0.9496568472522636,1.0,6/20,17.34%,NR2F2;CDK5RAP1;PTEN;CDKN1C;LATS1;MYOCD
prerank,macrophage activation involved in immune response (GO:0002281),0.3876923565400119,0.8266466853185098,0.6630434782608695,0.9454904255975203,1.0,5/13,20.06%,DYSF;SYK;NMI;SBNO2;PLCG2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3339006447252635,-0.8265647730165486,0.7122641509433962,0.9493093927769453,1.0,5/16,14.96%,TNKS2;ATM;RTEL1;PARP1;HNRNPA2B1
prerank,cellular response to inorganic substance (GO:0071241),0.35226365601219745,0.8264860025980744,0.6888888888888889,0.9452339899391549,1.0,2/21,5.21%,FOXO1;KCNC2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2790334123490378,0.826454332163124,0.7470588235294118,0.9447505387758535,1.0,14/76,13.08%,APP;NFKBIA;NOD1;NOD2;HDAC7;TMSB4X;TLR3;ACTN4;LGALS9;TLR7;AGER;ADIPOR1;C1QTNF4;CYLD
prerank,regulation of proteolysis (GO:0030162),0.29958161953642515,0.826207329670459,0.7214814814814815,0.9446543639576273,1.0,3/48,2.28%,LTBP4;CAV1;PLAUR
prerank,transport along microtubule (GO:0010970),-0.34768283666636035,-0.8259509568956052,0.7133333333333334,0.9495866288613639,1.0,8/13,23.27%,ARHGAP21;CLIP3;DYNC1I1;SPG11;BAG3;APBA1;BORCS5;COPG1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3157171896280529,0.8259241708582269,0.7018425460636516,0.9446264714281873,1.0,9/37,13.42%,RYBP;HSP90AB1;N4BP1;RPS7;UBXN1;HIPK2;RPL11;TRIM39;SDCBP
prerank,kinetochore organization (GO:0051383),-0.3447732512808209,-0.8257733641628481,0.6808035714285714,0.9490733078867266,1.0,8/13,41.13%,CENPC;CENPE;CENPF;DLGAP5;NUF2;CENPW;CENPH;CDT1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3485016887679503,0.8255185940762656,0.6678321678321678,0.9448451620091172,1.0,9/22,26.98%,GTF2H2;CETN2;GTF2H4;RBX1;GTF2H3;DDB1;RAD23B;XPC;UBB
prerank,regulation of DNA replication (GO:0006275),-0.2575203083908506,-0.8253343131234586,0.8060941828254847,0.9490298929917201,1.0,7/49,11.32%,EGFR;GLI2;EHMT2;GLI1;TSPYL2;ZBTB38;NUCKS1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.40185067386347995,0.8245301298872749,0.6944444444444444,0.9461375384849177,1.0,3/10,17.88%,CCT3;CCT5;CCT7
prerank,tRNA modification (GO:0006400),-0.24455129990551353,-0.8241919714570809,0.7908496732026143,0.9503424157455443,1.0,18/62,20.25%,THADA;TRMT9B;THUMPD3;NSUN2;OSGEP;ALKBH1;METTL6;PUS7;ELP5;DUS2;PUS10;TRIT1;TPRKB;DTWD1;TRMT112;ANKRD16;TYW5;BCDIN3D
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.36778010664374,0.823901624669781,0.6757741347905283,0.9467403848159179,1.0,3/15,12.18%,HIP1R;PIK3CB;TNK2
prerank,macromolecule catabolic process (GO:0009057),0.33083758914118294,0.8234291313947569,0.6851851851851852,0.9471373400704778,1.0,13/26,27.66%,TGFB1;TRIM24;SMURF1;SH3GLB1;CLN8;USE1;SIAH1;UVRAG;LGMN;SNX25;MTOR;PPT1;BECN1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2996192558328119,0.8234200359200464,0.7134052388289677,0.9466155576624884,1.0,8/49,12.66%,IL6R;ARL2BP;CD40;LYN;STAP2;PTK6;CNTF;IL15
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.35112995934721936,-0.8233622870358711,0.697986577181208,0.9510654060161597,1.0,5/13,21.27%,ATG10;SENP6;UBA1;UBA6;UBA2
prerank,regulation of tissue remodeling (GO:0034103),0.3669201533820121,0.8232994848952576,0.6756302521008404,0.9462843700817921,1.0,5/18,12.66%,FLT4;SYT7;TGFB1;CEACAM1;IL15
prerank,regulation of protein acetylation (GO:1901983),0.3785908611575127,0.8232519597381964,0.6961538461538461,0.9458355951060233,1.0,1/12,3.85%,RAPGEF3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.2803777919578589,0.8231746393686868,0.7344632768361582,0.9454511669780471,1.0,19/67,23.03%,B2M;IKBKB;PSMB3;PSMD11;TAP2;PSMC6;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;PSMC3;PSMD1;VAMP8;PSMD10;CALR
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.32869952361790433,0.8223668660566704,0.7175324675324676,0.9463989416696992,1.0,2/31,7.20%,GCH1;GPHN
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.32510419549777203,0.8220845508408994,0.6985413290113452,0.9463667706032194,1.0,9/32,22.58%,TAF1B;MAPK3;GTF2H2;GTF2H4;RRN3;UBTF;POLR1A;GTF2H3;TAF1C
prerank,cGMP-mediated signaling (GO:0019934),0.374810477159632,0.821633917529453,0.6605166051660517,0.9466481101199369,1.0,3/13,5.21%,PDE2A;NPPA;KCNC2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3079703134873367,-0.8211687340047679,0.745958429561201,0.9544193492717418,1.0,6/22,17.34%,NR2F2;CDK5RAP1;PTEN;CDKN1C;LATS1;MYOCD
prerank,RNA 3'-end processing (GO:0031123),0.2783419603372243,0.8207130473539987,0.7525035765379113,0.9477915564096415,1.0,9/69,13.09%,TENT4A;MTPAP;RNPS1;CSTF2;CPSF1;MAGOHB;THOC6;NCBP2;ZC3H11A
prerank,regulation of stem cell differentiation (GO:2000736),0.27138143867399234,0.8197271747635685,0.7742382271468145,0.9491103381702893,1.0,12/89,11.35%,LMO2;NOTCH1;GATA2;TAL1;PSMB3;PSMD11;TCF12;PTN;PSMC6;PSME2;CBFB;PSMD8
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.30192533623019696,-0.8195493648876219,0.7297297297297297,0.9565870615207939,1.0,11/23,32.62%,GJA1;GPSM2;FBXW11;MAD2L1;MISP;HTT;SPDL1;NUMA1;ITGB1;PLK1;PKHD1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3099821271206623,-0.8192400781355759,0.7188264058679706,0.9563155864217591,1.0,7/20,18.67%,RBPJ;RUNX2;SMAD9;BMP2;EP300;CHD6;CREB3
prerank,regulation of mitotic cell cycle (GO:0007346),0.25081010184005176,0.8192137072776675,0.8156565656565656,0.9495283492523319,1.0,53/171,23.54%,APP;AFAP1L2;DUSP3;TAL1;BTG4;TTC28;PSMB3;PKN2;PSMD11;HECA;PIN1;TGFB1;IQGAP1;CAV2;PSMC6;PSME2;BRINP3;BTG1;BRINP2;PSMD8;BTG2;EIF4E;CYLD;SDCBP;MAEA;BUB3;PSMB10;PIM2;TTL;ANAPC16;PSMA8;ANAPC7;SKP1;ANAPC10;CDK11B;PSMD9;UBE2D1;PIM3;TFAP4;ANAPC2;BTG3;ASNS;DDB1;CUL1;PSMC3;PSMD1;CDC23;SCRIB;LGMN;PSMD10;CDC26;CDC27;CDKN1B
prerank,positive regulation of viral genome replication (GO:0045070),0.3286903218884292,0.8188331394948973,0.7291338582677165,0.9496926969194339,1.0,6/29,10.78%,FKBP6;ADAR;PPIA;PKN2;PDE12;NR5A2
prerank,RNA splicing (GO:0008380),0.2664976659313245,0.8185475831565415,0.7842876165113183,0.9496501844765586,1.0,34/95,29.86%,IVNS1ABP;PPP1R9B;RNPS1;SNRPF;HNRNPC;MAGOHB;SNRPN;ZCRB1;MPHOSPH10;NCBP2;SNRPB;PRPF4;RSRC1;SCNM1;SMU1;LSM4;SNRPD2;RBM8A;SF3B3;NCBP1;PRPF8;SMNDC1;USB1;SCAF11;SNRNP48;PPP2R1A;NOL3;SNRPD1;SRSF7;LSM6;PPIG;BCAS2;PRPF6;ZRSR2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.378140788910456,0.8183750031968714,0.6918819188191881,0.9494206168885415,1.0,3/14,9.70%,IMPDH1;ADSS2;GART
prerank,protein import into peroxisome matrix (GO:0016558),0.3821264418987703,0.8183262750515652,0.7043010752688172,0.9489825806015632,1.0,5/12,23.89%,PEX5L;PEX14;PEX16;PEX6;PEX1
prerank,spliceosomal snRNP assembly (GO:0000387),0.30847691155019735,0.8181829257062467,0.7281553398058253,0.9487130702519418,1.0,21/38,31.72%,SNRPF;SNRPC;SNRPE;SNRPB;AAR2;PRMT7;LSM4;SNRPD2;WDR77;PRPF8;SART3;DDX20;SNRPD1;SRSF12;SMN1;PRPF31;COIL;GEMIN5;PRPF6;SNRPG;SNRPD3
prerank,regulation of protein kinase activity (GO:0045859),-0.2215628607780853,-0.8180303043868626,0.9083665338645418,0.9576341972929152,1.0,18/106,13.29%,PRKAG2;PLCE1;PPM1E;DEPTOR;RASSF2;DTNBP1;CCN1;TSPYL2;SNX9;PDPK1;SPRED1;QARS1;ITGB1BP1;PTK2B;JTB;XRCC5;ANKRD54;NF1
prerank,cellular response to nitrogen compound (GO:1901699),-0.31837986404002305,-0.8179592819707607,0.7012048192771084,0.9569059803175568,1.0,1/20,0.65%,ROCK2
prerank,cellular response to retinoic acid (GO:0071300),0.303770455526506,0.8177183379268947,0.7151515151515152,0.9490122203915605,1.0,9/42,11.20%,TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,cGMP biosynthetic process (GO:0006182),0.39438879405305804,0.8174236958984538,0.6616541353383458,0.949037576679119,1.0,3/10,13.27%,NPPA;NPR1;NPR2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3709990948290078,0.8173691259997246,0.6878402903811253,0.9486201433165047,1.0,5/15,23.39%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,detection of visible light (GO:0009584),0.36243485766329564,0.8165812446151254,0.6830122591943958,0.9495461118308087,1.0,2/16,5.49%,GNAQ;RP1
prerank,cell junction maintenance (GO:0034331),-0.3453328355515925,-0.816182819631217,0.7228381374722838,0.9593322189949559,1.0,5/14,25.83%,NLGN2;CLDN1;MYADM;CBLN2;PRTN3
prerank,regulation of cation channel activity (GO:2001257),-0.23253481155152478,-0.8159182786977367,0.8615916955017301,0.958978043326323,1.0,22/89,18.42%,ANK2;ACTN2;NLGN2;DMD;CAMK2D;DLG1;DLG4;SLMAP;CACNB4;PRKACA;PRRT1;PTK2B;GRIA3;CACNB2;JPH1;CACNB1;CAPN1;FGF11;KCNAB1;VAMP2;AHNAK;JPH2
prerank,positive regulation of cation channel activity (GO:2001259),0.30588338144285426,0.8159079673911733,0.7260479041916168,0.9502590251719597,1.0,4/40,6.96%,SHANK3;TMSB4X;CALM1;PIRT
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2706619198673625,0.8157731741099196,0.7713884992987378,0.9499777447959253,1.0,21/80,20.16%,SH3RF1;TNFSF10;NOD1;FOXL2;RPS6KA1;SOX7;XIAP;KLF4;MALT1;ARL6IP5;LAMTOR5;SYK;BCL10;PDCD6;GAS6;TRIAP1;PPM1F;DNAJB6;CYCS;F2R;RPS6KA3
prerank,chloride transmembrane transport (GO:1902476),0.29378092073234263,0.8156518809083592,0.7472698907956318,0.9496649008740624,1.0,13/48,19.47%,SLC1A1;SLC12A6;GABRB1;SLC12A9;CLCN3;GABRQ;GABRG1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2875599122208019,0.81496487993863,0.7510853835021708,0.9503372866591127,1.0,11/65,12.89%,NDNF;EPAS1;RGCC;AK4;EGLN2;BNIP3L;UBQLN1;HIF1A;ZFP36L1;EGLN1;HIPK2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3580070258479144,-0.814733347000687,0.695364238410596,0.9603380207552891,1.0,3/11,24.33%,C1QTNF3;EP300;C1QTNF12
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3680492994973549,-0.8142637586429711,0.7142857142857143,0.9603342554806934,1.0,2/10,6.79%,ZEB2;ATP7A
prerank,regulation of protein catabolic process (GO:0042176),0.2660980567677947,0.814219750700902,0.7850208044382802,0.9511880401662856,1.0,19/99,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;SNX3;EGLN2;OAZ1;PIN1;SMURF1;GSK3A;HMGCR;HGS;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;GFAP;APC
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.36388731449888734,-0.8139411335642868,0.695067264573991,0.9600215086201931,1.0,2/10,1.67%,BMP5;BMP7
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.37728065561481383,-0.8132693360205507,0.7092050209205021,0.9603839139386674,1.0,4/10,31.50%,TLR4;TLR6;CD36;CD68
prerank,tRNA wobble base modification (GO:0002097),-0.3419741315819732,-0.8128912771905327,0.6882217090069284,0.9602333695752588,1.0,4/14,15.33%,TRMT9B;ELP3;ALKBH1;ELP4
prerank,regulation of mitochondrial depolarization (GO:0051900),0.39031955349210995,0.812823638555836,0.6833976833976834,0.9531767632757957,1.0,1/10,0.90%,KDR
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.33547787880612256,0.8127714987480915,0.7159863945578231,0.952745816977842,1.0,4/26,6.84%,APP;DUSP3;TAL1;PKN2
prerank,axonal transport of mitochondrion (GO:0019896),-0.35669501619411326,-0.8124111750467812,0.7197452229299363,0.9602332232511963,1.0,1/11,2.97%,TRAK1
prerank,regulation of cell killing (GO:0031341),-0.3269943700482264,-0.8123114546114881,0.7402597402597403,0.959545384459403,1.0,5/16,13.37%,CD55;CFH;FZD7;CYBA;DVL2
prerank,prostanoid metabolic process (GO:0006692),-0.3361460063166626,-0.8116724893137135,0.7192224622030238,0.9598035075317686,1.0,5/13,20.54%,PTGS1;PTGES;PTGR2;CYP2S1;PTGR1
prerank,myoblast fusion (GO:0007520),0.3778150499755021,0.8116292151727522,0.6737588652482269,0.9542801234144918,1.0,3/12,13.82%,JAM2;PTGFRN;ADAM12
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2893852101093874,-0.8110180884062491,0.7275064267352185,0.9601618628349713,1.0,6/26,17.72%,FBN1;HOXA7;MAFB;TLR4;RARA;INHA
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3671150045802146,-0.8105517665502323,0.6991341991341992,0.9601521578931583,1.0,5/10,36.76%,KDM1A;BRCA1;SIRT1;JARID2;MYB
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.28562817082044906,0.8104368760105778,0.7420814479638009,0.9559119995490042,1.0,18/53,28.16%,PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,DNA methylation or demethylation (GO:0044728),-0.31590395234630286,-0.8103612618277682,0.7024608501118568,0.9587748904109362,1.0,5/19,19.69%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,DNA alkylation (GO:0006305),-0.31590395234630286,-0.8103612618277682,0.7024608501118568,0.9587748904109362,1.0,5/19,19.69%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,protein N-linked glycosylation (GO:0006487),0.27566212453775235,0.8103510145280296,0.7665706051873199,0.9555295787330655,1.0,7/66,8.00%,SLC39A8;ST3GAL1;FUT8;STT3B;ENTPD5;GAL3ST1;ST6GAL1
prerank,regulation of nervous system development (GO:0051960),-0.26949076052953147,-0.8100566608725355,0.8005390835579514,0.9584811454360324,1.0,6/37,13.98%,DOCK7;PER2;HEYL;YAP1;SIRT2;LGI4
prerank,response to unfolded protein (GO:0006986),0.29294436017655007,0.8100065138889525,0.7304625199362041,0.9556060745927262,1.0,6/48,10.75%,DAB2IP;HSP90AB1;STT3B;RHBDD1;HSPA8;HSPB1
prerank,chromatin remodeling at centromere (GO:0031055),-0.2786858314604258,-0.8096862572508108,0.7587064676616916,0.9582768361983404,1.0,8/31,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,positive regulation of protein catabolic process (GO:0045732),0.2688464641420962,0.8092494786207748,0.7567567567567568,0.9563984367250816,1.0,15/84,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;MSN;SMURF1;GSK3A;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;APC
prerank,positive regulation of catalytic activity (GO:0043085),0.3091430994179878,0.8087040256518664,0.722488038277512,0.9567743945273643,1.0,9/37,17.11%,CAV1;NOD2;MAPK3;PHACTR4;APH1A;B3GAT3;MSH3;MSH2;YWHAB
prerank,positive regulation of secretion by cell (GO:1903532),0.2780697681843239,0.8086596671957907,0.7576642335766424,0.9563108737516527,1.0,9/70,8.09%,TGFB2;UNC13B;RGCC;STX1A;CD2AP;ABCG1;PPIA;UNC13D;TGFB1
prerank,global genome nucleotide-excision repair (GO:0070911),0.3331227939974059,0.8086119854517729,0.6994727592267135,0.9558699241410555,1.0,11/26,26.98%,GTF2H2;CETN2;GTF2H4;RBX1;GTF2H3;DDB1;ERCC4;RAD23B;XPC;USP45;UBB
prerank,ether lipid metabolic process (GO:0046485),-0.33770431849394245,-0.8085259534717768,0.7242152466367713,0.959583077372289,1.0,5/14,23.05%,AGMO;PEX7;PLA2G6;AGPS;GNPAT
prerank,piRNA metabolic process (GO:0034587),0.3444662798353148,0.8083964797995032,0.6891891891891891,0.9557352144934544,1.0,2/19,4.89%,FKBP6;PIWIL1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3036467128270651,-0.8083294179811858,0.7396593673965937,0.9590875214221105,1.0,8/22,25.47%,ERI3;ERI2;WDR12;NOP14;EXOSC2;NOP9;ERI1;UTP20
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2856969756497255,0.8082718870989122,0.7613104524180967,0.9554165182559881,1.0,14/56,20.16%,NOD1;NOD2;TLR3;CTSK;TLR7;IRAK2;TLR8;S100A8;BCL10;INAVA;CTSS;TRAF3;PLCG2;RPS6KA3
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2533505326023251,-0.8082242494311284,0.7928994082840237,0.9584276613737127,1.0,10/48,15.57%,PLD1;AGPAT4;LCLAT1;GPD1L;PLA2G12A;ACP6;GPAT3;DDHD1;PNPLA3;SLC27A1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3735963727762268,0.8080393905873732,0.7019748653500898,0.9552918086231179,1.0,4/13,26.57%,PVR;CYRIB;NECTIN2;IL12A
prerank,mitochondrion organization (GO:0007005),0.24824083238412803,0.8079304328828882,0.8423028785982478,0.9549432476307605,1.0,24/165,15.54%,DNM3;BCL2L1;NOS3;ALAS1;TOMM22;BIK;SLC25A33;DNM2;MYH14;TIMM13;CAV2;BNIP3L;FANCG;TIMM10;SAMM50;VPS13D;DNAJC19;POLG2;HIGD1A;AFG1L;OMA1;MFF;IMMP2L;TWNK
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3937739327889713,0.8078232066603341,0.7037735849056603,0.954615375162673,1.0,3/10,10.97%,NR1H2;ELOVL5;ABCD1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3583509159451515,-0.8075354020047713,0.7117516629711752,0.9588199917583751,1.0,6/10,41.13%,DBF4;E2F7;E2F8;WIZ;CDC7;CDT1
prerank,neurogenesis (GO:0022008),-0.262405672185252,-0.8075032154883534,0.8162729658792651,0.9580270205156466,1.0,5/43,5.68%,LPAR1;TRAK1;DAGLA;ANXA1;SIX1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3100535275333651,0.8071573146005784,0.7216666666666667,0.9552628598868925,1.0,8/34,10.91%,FOXO1;ZFPM1;CCDC85B;GATA2;WWTR1;TGFB1;TRIB2;FERMT2
prerank,protein targeting to mitochondrion (GO:0006626),0.28575632440502174,0.8070599206104604,0.7442196531791907,0.9549154601744578,1.0,20/52,30.76%,TOMM22;TIMM13;PMPCA;TIMM10;SAMM50;DNAJC19;MFF;IMMP2L;TOMM20L;CHCHD4;TOMM7;TOMM5;TIMM21;TIMM50;TOMM70;BCAP31;TIMM9;AIFM1;FIS1;GRPEL2
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3648046039685606,-0.8068294487031755,0.7065217391304348,0.9583609172142021,1.0,6/10,27.79%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;MTHFS;SHMT1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.2952477807262054,-0.8064297583243976,0.7424242424242424,0.9582116888533894,1.0,6/25,16.99%,CCNT2;WDR43;SETD5;DDX39B;LDB1;ERCC6
prerank,regulation of lipid storage (GO:0010883),0.3424065184566479,0.8061923185791806,0.705574912891986,0.9558874442242793,1.0,2/22,6.44%,NFKBIA;FBXW7
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.38762847825460606,0.8058713348441903,0.6948176583493282,0.9559209904259357,1.0,5/11,16.32%,TGFB2;SMAD7;TGFB1;TGFBR2;ACVR1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.27376083530180034,-0.8051180466333191,0.7506631299734748,0.9596535978658339,1.0,22/33,44.92%,FBN1;CEBPB;MAFB;TLR4;FSTL3;CAMK4;LILRB3;CARTPT;LRRC17;POU4F1;BGLAP;CCR1;IL4;UBASH3B;OCSTAMP;IL23A;TNF;IL23R;PRXL2A;TCTA;CCL3;IL12B
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3412380841978421,0.8050637748754854,0.7135593220338983,0.9568131724351285,1.0,10/20,25.98%,ADAM10;TGFB1;RHBDD1;ADAM17;APH1A;SPPL2A;APH1B;TRAF6;MBTPS2;NCSTN
prerank,cellular response to heat (GO:0034605),-0.2749963075269305,-0.8048877094579654,0.7741935483870968,0.9592060074290871,1.0,14/35,26.78%,FGF1;THBS1;ANO1;PRKACA;BAG3;HTRA2;TCIM;HSBP1;CLPB;RBBP7;HIKESHI;HSPA1A;HMOX1;TPR
prerank,heart process (GO:0003015),-0.34084734854249965,-0.8042963256074698,0.7393258426966293,0.9594158616792493,1.0,3/14,7.82%,SGCD;ACE;NOX4
prerank,engulfment of apoptotic cell (GO:0043652),0.3590665423818213,0.8042828865399688,0.7109515260323159,0.9576655846734969,1.0,1/15,1.07%,RHOBTB1
prerank,negative regulation of axonogenesis (GO:0050771),0.325652500947042,0.8040320084866699,0.7294117647058823,0.9576014753990205,1.0,6/27,15.22%,FGF13;DIP2B;ARHGDIA;MAG;SEMA3G;DCC
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.285787970470411,0.8036560696967872,0.7752293577981652,0.9577193279827071,1.0,20/57,24.02%,APP;MEF2C;LRRC7;GRIA4;AKAP9;GRIN2B;SHISA6;CNIH3;MINK1;CAMK2B;DLGAP3;NLGN1;CRHBP;NPTX1;GRIA2;NPTXR;CACNG2;OPRM1;GSG1L;GRIN1
prerank,placenta development (GO:0001890),0.3742347153553367,0.803563188748575,0.711304347826087,0.9573584486752085,1.0,2/12,12.84%,PTK2;PPARG
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3261824039123426,-0.8031906953042243,0.7146017699115044,0.9605024190809685,1.0,10/15,29.48%,CCDC14;PIBF1;PCM1;SNX10;STIL;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.31137652413728567,0.8030415111378193,0.7037617554858934,0.9577488391199108,1.0,4/32,4.79%,APLNR;PLCG1;CALM1;CD19
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3127940032711167,-0.8025955462996665,0.7464114832535885,0.9606840264533619,1.0,8/18,28.84%,FLNA;WDR43;PHF8;POLR2L;RASL11A;ERBB2;EIF2AK3;POLR2K
prerank,mitochondrial genome maintenance (GO:0000002),-0.3510731075690968,-0.8024802797543015,0.7075892857142857,0.9600457967852704,1.0,3/11,11.92%,SLC25A36;PARP1;MPV17
prerank,protein targeting to peroxisome (GO:0006625),-0.2742761290673794,-0.802459034610283,0.7729591836734694,0.9592399344055401,1.0,5/29,13.81%,ABCD3;ZFAND6;PXMP2;PEX7;PEX2
prerank,fatty acid oxidation (GO:0019395),0.28426496911521293,0.8022584258964534,0.7558823529411764,0.958554097092393,1.0,14/57,19.06%,ADIPOR2;PPARD;ABCD4;ACOX1;ABCD1;ADIPOR1;SLC27A2;HACL1;ADH5;ECI2;ACAT1;CYP24A1;ACAD11;ABCD2
prerank,multivesicular body assembly (GO:0036258),0.3161206289837485,0.8021136923083627,0.7312186978297162,0.9582784975256771,1.0,12/30,28.32%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C;CHMP2B;VPS4B;VPS28
prerank,cellular response to UV (GO:0034644),0.27642005423909044,0.8020771448481284,0.7792397660818714,0.9578066994540413,1.0,19/76,21.62%,POLK;HYAL2;N4BP1;OPN5;RHBDD1;COPS9;EIF2AK4;MMP1;OPN3;TRIAP1;PTPRK;NSMCE3;BAK1;NOC2L;POLD1;HYAL1;METTL3;DDB1;ERCC4
prerank,negative regulation of interleukin-12 production (GO:0032695),0.36158521904894086,0.8019874354646975,0.6875,0.9574249476650961,1.0,3/14,11.01%,JAK3;CCR7;TLR8
prerank,bile acid biosynthetic process (GO:0006699),-0.2898627049393897,-0.8019651700183971,0.7444168734491315,0.9592621682545417,1.0,4/24,9.79%,CYP7B1;CYP27A1;ACOT8;AMACR
prerank,protein polyubiquitination (GO:0000209),0.2323731633632273,0.801903579064626,0.9054209919261822,0.9570419400411534,1.0,84/297,23.32%,RNF144B;LMO7;ZNRF1;TRIM14;NEDD4L;PELI1;RNF125;CTNNB1;UBE2V2;FBXW7;RFFL;PSMB3;UBE2G1;FBXO41;PSMD11;TRIM36;PSMC6;KLHL3;PSME2;HECTD1;UBE2V1;SMURF1;SHARPIN;KLHL20;UBOX5;HERC6;CBFB;UBE3D;PSMD8;ZNRF2;WSB1;FBXO6;RNF187;TRIM69;FBXW2;TNFAIP3;PSMB10;FBXO21;NHLRC1;RBX1;FBXL8;TRIM2;UBE2D3;AREL1;FBXL15;RNF8;UBE2Q2;PSMA8;ANAPC7;UBE2G2;BFAR;TRIM68;FBXO2;RNF19A;TRIM71;TRIM3;SKP1;ANAPC10;PSMD9;SIAH1;FBXW9;RNF4;UBE2D1;FBXO28;TRAF3;TMEM129;RBCK1;RNF166;ANAPC2;ERCC8;RLIM;CUL1;PSMC3;PSMD1;CDC23;UBE2J1;RNF126;UNKL;PSMD10;FBXO32;CDC26;TRAF6;FBXL14;CDC27
prerank,regulation of lipid metabolic process (GO:0019216),0.26789102790587793,0.8016363760057802,0.7971631205673759,0.9569952610689054,1.0,18/88,14.25%,CAV1;FASN;PPARD;NCOA1;ACACB;NCOA2;ZFP69;ABCA7;OPA3;HELZ2;LACTB;ADIPOR1;HMGCR;ELOVL6;PPARG;EDF1;DISP3;SP1
prerank,regulation of cellular response to stress (GO:0080135),-0.21621753744071576,-0.801358525672114,0.875,0.9594579775929348,1.0,35/115,26.78%,ROCK2;NUPR1;AMFR;CAMK2D;NEK6;SEH1L;PRKN;ATM;NUAK1;NUP205;BAG1;CEBPB;CLN3;AIFM2;ABL1;ARMT1;BAG3;EP300;CRYAB;SMG1;SLC38A2;HSBP1;USP19;EIF4G1;RAE1;AJUBA;CASP9;ATR;HIKESHI;HSPA1A;NUP155;CREBBP;NUP35;NDC1;TPR
prerank,DNA packaging (GO:0006323),0.3600563859410738,0.8013204991504265,0.7250470809792844,0.9569989078723993,1.0,5/16,20.07%,KAT6A;BANF1;CHAF1A;CHAF1B;NOC2L
prerank,regulation of primary metabolic process (GO:0080090),0.2514113352330477,0.8012847707080968,0.8064085447263017,0.9565369328654741,1.0,30/126,18.72%,FASN;PPARD;NCOA1;PSMB3;ACACB;NCOA2;OAZ1;PSMD11;ZFP69;ABCA7;PSMC6;OPA3;PSME2;PRKAB1;HELZ2;LACTB;PSMD8;ADIPOR1;HMGCR;ELOVL6;PPARG;EDF1;PSMB10;SP1;PSMA8;IDI1;SIN3A;DHCR7;PSMD9;HMGCS1
prerank,mitotic metaphase plate congression (GO:0007080),-0.24772933558065835,-0.8012620419325691,0.8220858895705522,0.9587930016307934,1.0,11/51,19.09%,EML4;SEH1L;CENPC;CUL3;PIBF1;RMDN1;CHMP4C;KIF18A;EML3;VPS4A;CENPE
prerank,nuclear membrane disassembly (GO:0051081),-0.3338642608705736,-0.8012524611289578,0.7314410480349345,0.957971322081979,1.0,5/14,22.47%,NEK6;AKAP8L;PRKCA;CNEP1R1;CCNB2
prerank,negative regulation of neuron death (GO:1901215),0.2664629123218297,0.8001692962117791,0.7969821673525377,0.9579910363649428,1.0,18/93,18.75%,NDNF;CD34;CD200;MEF2C;TOX3;RETREG1;CD200R1;FOXQ1;CNTF;KIR3DL2;MAG;BTBD10;UNC5B;MSH2;PTPRZ1;PRKCG;PM20D1;SET
prerank,positive regulation of protein maturation (GO:1903319),-0.3518264384518829,-0.7998441027189643,0.7358870967741935,0.9595084441002961,1.0,1/11,1.62%,CCBE1
prerank,organelle organization (GO:0006996),0.22928379702665638,0.7992243112132139,0.9235095613048369,0.9591055837644062,1.0,53/388,13.84%,FGD5;SEMA6A;ARAP3;SYNE1;NOS3;CAV1;FNBP1L;FMNL3;RAB31;NEDD9;ALAS1;SIPA1;PRKD1;MCOLN1;ABCD4;PIKFYVE;SORT1;MAST4;USP6NL;PPIA;ABCA3;PAK5;SLC25A33;CECR2;COG3;MARK4;RAB34;CHMP1B;DPYSL2;CAV2;ARHGEF7;ARHGAP4;FANCG;RANBP10;FGD6;STRIP1;REEP5;KLHL20;ABCD1;PEX14;CEP78;VPS13D;PDZD8;EPS15;POLG2;ATXN7;RANBP9;RAB1A;FGD2;TSGA10IP;AFG1L;TNFAIP3;CFL1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.2061311772612371,-0.7987852296435773,0.9166666666666666,0.9605101537437779,1.0,52/148,29.19%,PRKAG2;PRKAA2;EHMT2;MDM4;CHD3;ATM;RBBP8;CHD4;PDPK1;USP2;PML;NUAK1;STK11;PRKAG3;NOP2;PRMT5;DYRK2;MAPK14;EP300;RAD50;ATRIP;TAF9B;CHD5;RBBP4;BOP1;TP53RK;RFC3;CSNK2A1;BRCA1;KMT5A;RNF34;CDK5;TBP;WRN;PRKAB2;TPX2;PIP4K2B;NBN;RBBP7;ATR;MAPK11;TAF9;PPP1R13L;SMYD2;EXO1;RFC5;NOP53;PRR5;PLK3;TTC5;PRDM1;HDAC1
prerank,chromatin assembly or disassembly (GO:0006333),0.38440740396148726,0.7984947312807332,0.7034220532319392,0.959857726363079,1.0,4/11,20.07%,CHAF1A;CHAF1B;HIRIP3;NOC2L
prerank,negative regulation of biomineral tissue development (GO:0070168),0.337617560845371,0.7983577892528719,0.7231833910034602,0.9595706706728767,1.0,8/21,16.47%,NOS3;SRGN;NOTCH1;TGFB1;GREM1;SOX9;HEY1;GAS6
prerank,cellular response to hypoxia (GO:0071456),0.25405720581387126,0.7982025975907802,0.8198433420365535,0.9593084281823019,1.0,22/126,16.11%,NDNF;EPAS1;RGCC;AK4;PSMB3;EGLN2;PSMD11;PSMC6;BNIP3L;PSME2;UBQLN1;PSMD8;HIF1A;ZFP36L1;HIGD1A;EGLN1;HIPK2;PSMB10;RBX1;ELOB;PSMA8;OPRD1
prerank,mitochondrial protein processing (GO:0034982),0.380270166557269,0.7980862869699951,0.6990654205607477,0.9589796996488729,1.0,3/11,15.12%,PMPCA;OMA1;IMMP2L
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.33845457698597037,0.7979695382384895,0.7377622377622378,0.9586402094071534,1.0,6/19,14.21%,PARD3;LRRC7;CLIC4;FSCN1;FOXJ1;SYNJ2BP
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.349113837102662,0.7966090404984522,0.7103918228279387,0.9605366886076887,1.0,6/18,15.98%,SNX3;DNAJC13;MAPK3;MSN;MTMR2;MAPK1
prerank,DNA catabolic process (GO:0006308),-0.3415838716947142,-0.7965914145542914,0.6978260869565217,0.9634517612009446,1.0,2/11,9.55%,FBH1;REXO4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3841217883731781,0.7961240150369705,0.6837294332723949,0.9608144735524501,1.0,3/11,11.81%,LGALS9;CBFB;VSIR
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2618584610355909,0.7961145666191553,0.7900709219858156,0.9603040792439919,1.0,25/87,21.88%,DCUN1D3;RGCC;FAM107A;KLF4;CDKN2B;PSMB3;PSMD11;PSMC6;PSME2;PSMD8;ZFP36L1;PSMB10;RBX1;RBL1;APC;PSMA8;SKP1;PSMD9;CDK6;ZFP36L2;CDK4;PINX1;CUL1;PSMC3;PSMD1
prerank,regulation of organelle assembly (GO:1902115),0.27336125941786277,0.7960887057136964,0.7795620437956204,0.9598214360406312,1.0,19/72,18.50%,TBC1D14;TBC1D22A;TBC1D12;TBC1D2;PIKFYVE;USP6NL;TBC1D24;TBC1D5;HCK;MSN;TBC1D10B;CYLD;PLK2;TBC1D1;PDCD6IP;TBC1D22B;TBC1D15;IFT140;RNF4
prerank,transcription by RNA polymerase I (GO:0006360),0.31308083092029115,0.7953146408124083,0.7165605095541401,0.9606648724767137,1.0,9/34,22.58%,TAF1B;MAPK3;GTF2H2;GTF2H4;RRN3;UBTF;POLR1A;GTF2H3;TAF1C
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2913118316643956,-0.7951957782602085,0.7480916030534351,0.9649262209448218,1.0,6/24,18.24%,CEMIP;MIEF1;ITGB1BP1;MIEF2;KCNB1;C2CD5
prerank,negative regulation of transferase activity (GO:0051348),0.3185765203505319,0.794892973182601,0.7224080267558528,0.9608288974332856,1.0,14/28,31.41%,MEN1;SMAD7;GSK3A;TERF1;INPP5K;ERCC4;PINX1;CDKN1B;BAG5;DTX3L;PARK7;TP53;GSK3B;SRC
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.34024925646472964,-0.7941390549465155,0.7051282051282052,0.9658812986687498,1.0,1/12,1.67%,BMP7
prerank,negative regulation of immune response (GO:0050777),0.2469043125616979,0.7941086894651382,0.850253807106599,0.961645928391473,1.0,32/154,17.44%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;FOXP3;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1;TNFAIP3;HTR4;PLK2;RXFP2;GLP1R;CCR2;LYAR;SAMSN1
prerank,cilium assembly (GO:0060271),0.22793857972661355,0.7940740800912197,0.9156214367160775,0.9611785575119502,1.0,49/296,15.76%,ABCC4;ABLIM1;FNBP1L;EXOC6;NOTCH1;CNGA2;CEP83;POC1B;CCDC13;ZMYND10;CDC14A;RP1;CFAP52;OCRL;DYNLL1;CCP110;RAB11A;PRKAR2B;MARK4;TTLL3;CETN2;TUBB;CDK5RAP2;DISC1;AKAP9;RSPH4A;DCX;HAUS6;KIF3B;EHD4;TBC1D32;CFAP54;CEP78;EXOC4;EXOC2;SNAP29;RAB1A;RSPH1;BBIP1;BBS10;CEP135;FOXJ1;CEP72;DNAAF3;TUBB4B;TUBA1A;DNAH5;CKAP5;CEP70
prerank,organelle assembly (GO:0070925),0.22609077668924882,0.7937428867306875,0.9183445190156599,0.9612103208079673,1.0,41/384,11.25%,ABCC4;FLII;ABLIM1;CD34;PGM5;FNBP1L;EXOC6;STARD9;NOTCH1;CNGA2;CEP83;POC1B;CDC14A;MAPRE2;CFAP52;OCRL;DYNLL1;ABCA3;DBNL;EDC3;CDS2;RAB11A;SAC3D1;TTLL3;CHMP1B;IRGM;MAP1LC3B;DHX37;TMOD1;DISC1;PIK3C3;ATG12;GRB7;VPS36;HAUS6;KIF3B;EHD4;CFAP54;EXOC4;EXOC2;UBQLN1
prerank,triglyceride homeostasis (GO:0070328),-0.2847848870441784,-0.7926376687218005,0.7701149425287356,0.9675158016409448,1.0,4/26,8.01%,IL18;RORA;C1QTNF3;APOE
prerank,regulation of cellular catabolic process (GO:0031329),-0.23547523845223067,-0.7916101561059499,0.8317757009345794,0.9683399066237449,1.0,27/62,29.24%,ITPR1;NUPR1;DAPK2;PRKN;ATM;PIP4K2C;MTMR3;LRRK2;ABL1;EP300;RRAGA;WDR41;CISD2;DDIT3;PSAP;SMCR8;USP13;RAB39B;PIP4K2B;TYSND1;USP10;KAT8;WDR91;MTMR4;WDR24;USP33;PIK3R2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.3303183828008153,-0.7913450604450261,0.7224669603524229,0.9679297207071308,1.0,1/13,1.94%,GAB2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.34397614343601884,0.7911637220387036,0.7158469945355191,0.9651818402732053,1.0,4/18,17.36%,LYN;CD19;SH2B2;BAG6
prerank,intracellular protein transport (GO:0006886),-0.18833056568663564,-0.7908493162220085,0.9918032786885246,0.9678582013937745,1.0,72/304,21.28%,RANBP3L;WLS;APPL2;SGSM2;PKD1;LAMP2;TRAK1;SNX6;USO1;KIF13B;SIL1;RANBP17;COPA;TRIM23;RAB21;STX2;COPZ2;ARFGAP3;GRTP1;GGA2;AP3B1;SAR1A;XPO5;SNX9;SEC31A;CLIP3;STX5;SNX15;AP4M1;XPO6;EHD1;ARL1;STX1B;TBC1D10A;SNX8;RAB29;RAB6A;SCFD1;SEC16A;ARFIP2;GIPC1;BAG3;STRADA;LMAN1;STX16;RABGAP1;COPB2;E2F3;SURF4;RAB3GAP2;CTTN;HOMER3;STX4;XPO1;TBC1D2B;FAM53B;LAPTM5;CTSA;C2CD5;RAB22A;VPS26C;RPGR;LTBP2;AP2A1;TBC1D9B;ARL5C;COX18;ARF1;RAB14;SNX17;COPZ1;IPO7
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.29360414865780926,0.7908218655473916,0.7636054421768708,0.9652218858021522,1.0,3/39,3.22%,UTRN;NEDD4L;FGF13
prerank,purine ribonucleotide metabolic process (GO:0009150),0.27526524116578516,0.7905484491359028,0.8089080459770115,0.9651403366156143,1.0,10/68,9.07%,HPRT1;HINT1;NT5C2;ACBD6;GLYAT;AK4;TPST2;ADSS2;ACSL6;GTPBP1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.36756207920891326,-0.7905006105800843,0.7551020408163265,0.9676226533833967,1.0,5/10,18.58%,PRKAA2;KLF15;SETD5;MYOCD;FLCN
prerank,microtubule anchoring (GO:0034453),-0.3460467207906371,-0.7902445583373688,0.7608200455580866,0.9671971594370202,1.0,3/12,13.57%,DAG1;BICD1;PCM1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2667840519332147,0.7900615713441335,0.7959183673469388,0.9654498362126425,1.0,14/79,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;MFSD6;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,ncRNA metabolic process (GO:0034660),-0.26183635454729176,-0.7899360371689569,0.8099173553719008,0.9669057046378128,1.0,14/37,28.69%,TUT4;AGO2;XPO5;DDX17;EXD1;DTD1;BCDIN3D;TARBP2;PIWIL2;PARN;DROSHA;TDRD9;DTD2;DDX4
prerank,regulation of cell cycle phase transition (GO:1901987),0.2595896510535589,0.7899134259503002,0.8240343347639485,0.9651861239979681,1.0,29/91,24.43%,FBXW7;PSMB3;PSMD11;PSMC6;PSME2;PSMD8;TRIM39;BUB3;PSMB10;ANAPC16;PSMA8;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;TFAP4;ANAPC2;ATP2B4;DDB1;CUL1;PSMC3;PSMD1;CDC23;PSMD10;CDC26;CDC27;CDKN1B;XPC
prerank,nucleus organization (GO:0006997),0.28994704938808924,0.7895873477503806,0.7929447852760736,0.9652040158494483,1.0,10/47,18.00%,SYNE1;CHMP1B;LEMD3;NUP54;ATXN7;SUN1;REEP3;PDCD6IP;PITPNB;BIN1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.3500620376287754,0.7892818330024507,0.7172774869109948,0.9651810919501234,1.0,5/17,22.48%,CXCL12;CCL1;CCR2;MOSPD2;LGMN
prerank,mitochondrial gene expression (GO:0140053),0.2955591403149409,0.7892506212007208,0.7680722891566265,0.964700311417178,1.0,21/42,30.67%,MRPL12;SLC25A33;MRPL57;GATC;TWNK;MRPS2;MRPL16;MRPL23;MRPS18A;PTCD3;IARS2;MRPL51;HARS1;MRPL2;NDUFA7;QRSL1;LARS2;MRPS34;MRPS12;MRPS28;MRPS24
prerank,platelet aggregation (GO:0070527),0.30363680486282296,0.7887954471333042,0.7721311475409836,0.9649376173510956,1.0,8/33,12.38%,ACTB;PPIA;STXBP1;ACTN1;ACTG1;HSPB1;PIK3CB;MYL12A
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3299089691992601,0.7886975060241281,0.7269565217391304,0.96459619325601,1.0,4/20,8.09%,LYN;CD6;HCK;TGFB1
prerank,ncRNA catabolic process (GO:0034661),0.3155309733143287,0.787801593372755,0.71900826446281,0.9655951895771877,1.0,9/28,22.45%,DEDD2;TRIR;SND1;DIS3L;EXOSC10;XRN1;NUDT16;EXOSC9;EXOSC8
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3031191080675555,-0.7874296122432082,0.754424778761062,0.9701853546179833,1.0,5/18,17.10%,IL34;DAAM2;SLC45A3;NF1;MDK
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3266506223540015,-0.7874288494249815,0.7336343115124153,0.9693476668990971,1.0,1/13,1.61%,AXL
prerank,protein K48-linked ubiquitination (GO:0070936),0.2857822791694672,0.7872724203813486,0.8033282904689864,0.9659437826478917,1.0,16/54,18.63%,ZNRF1;NEDD4L;PELI1;RFFL;UBE2G1;KLHL3;RNF187;TNFAIP3;RBX1;UBE2D3;RNF8;UBE2Q2;UBE2G2;BFAR;RNF4;UBE2D1
prerank,DNA metabolic process (GO:0006259),0.22970387946032275,0.7862923102655331,0.9194476409666283,0.96705910627859,1.0,61/270,21.64%,POLK;SP100;MEN1;SAMHD1;NTHL1;MRE11;UBE2V2;HINFP;TERF2;PWWP3A;DFFB;FANCG;CBS;MCM10;DNA2;AXIN2;PARG;SMUG1;MGMT;CDC6;ACD;RECQL4;GTF2H4;MPG;FBXO6;BTG2;POLB;TERF1;HELLS;ORC1;FAN1;HMGB2;NSMCE4A;POLE3;MSH3;SMARCAD1;MSH2;TSN;TRRAP;DNASE2;SIRT7;SUMO1;RAD21;UHRF2;HUS1;NUDT1;ENDOG;RPA1;ADPRS;NSMCE3;RAD9B;POLL;POLD1;UVRAG;GTF2H3;POLA1;PARP2;RFC2;DDB1;ERCC4;RAD1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.34169899266637616,-0.7859574589654046,0.7420718816067653,0.9708767059119996,1.0,2/11,8.01%,ATG10;APOE
prerank,ruffle organization (GO:0031529),-0.308300848592073,-0.7859283326313579,0.7577777777777778,0.9700974040145856,1.0,2/16,2.33%,TPM1;CARMIL1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3680777564748637,0.785801468663124,0.7375,0.9673570981281643,1.0,5/14,16.18%,CRAT;ACOX1;ABCD1;ECI2;DECR2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.30893625836331673,0.7857498584806846,0.7540453074433657,0.9669252666346096,1.0,8/29,23.49%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1;NBAS;TENT5C;PABPC1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3618456387520058,-0.7856677437270296,0.7537154989384289,0.9697176290870491,1.0,3/10,8.93%,FAP;EMILIN1;DPP4
prerank,mRNA catabolic process (GO:0006402),0.29046183601513426,0.7849981733248254,0.7848297213622291,0.9676339180497484,1.0,18/44,27.43%,NANOS2;PDE12;DCP2;DXO;EXOSC10;NBAS;XRN1;NUDT16;ZFP36L2;EXOSC9;XRN2;METTL3;RIDA;NUDT12;UPF1;NUDT16L1;AGO1;NBDY
prerank,positive regulation of transport (GO:0051050),-0.21797670732968885,-0.7849775068775353,0.902027027027027,0.9700150904275245,1.0,13/85,12.85%,LRP1;GPC3;CAMK1D;ANXA2;DAB2;ANXA1;IL15RA;APOE;CLIP3;BID;CYBA;RXRA;FMR1
prerank,glial cell differentiation (GO:0010001),0.3184766630265483,0.7848680779921292,0.7491749174917491,0.9673378381028274,1.0,8/28,18.49%,CDH2;MMP24;METRN;SOX10;SOX11;SOX9;PTPRZ1;TPPP
prerank,regulation of NMDA receptor activity (GO:2000310),0.30767035002710796,0.7840675150701265,0.7550387596899225,0.9681556503060355,1.0,9/32,17.12%,APP;MEF2C;LRRC7;GRIA4;GRIN2B;CAMK2B;NLGN1;CRHBP;CCR2
prerank,chromatin remodeling (GO:0006338),0.2535880132996115,0.7839481164513357,0.8457300275482094,0.9678300315382365,1.0,22/100,16.58%,SMARCA2;NPM3;ACTB;BAZ2B;CECR2;NPM2;FOXP3;ARID1A;HNRNPC;HCFC2;PAK1;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;SOX9;POLE3;HDAC5;SMARCAD1;HCFC1;HMGA2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.32673500408596534,0.7834557108335393,0.7585616438356164,0.9681195229419707,1.0,5/23,9.42%,SLC12A6;SLC12A9;KCNH2;CLCN3;SLC9A7
prerank,protein alkylation (GO:0008213),-0.2896628762705951,-0.7825491275448918,0.8313253012048193,0.972984812993022,1.0,9/22,28.74%,PCMT1;EEF2KMT;PRMT8;METTL22;FAM98B;GSPT1;EEF1AKMT2;PRMT2;METTL21C
prerank,ether lipid biosynthetic process (GO:0008611),-0.35764028046510604,-0.7825189075707185,0.7484276729559748,0.9722072219850109,1.0,4/10,30.33%,PEX7;AGPS;GNPAT;FAR1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.27630453766150803,0.7819691538358596,0.8133333333333334,0.9700851040712231,1.0,24/69,27.63%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COA6;COX6C;NDUFA12;NDUFB3;CYCS;NDUFC1;UQCRQ;COX10;UQCR11;SDHAF2;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.37241097655380784,0.7818037057549468,0.7266187050359713,0.9698152944866975,1.0,3/11,12.20%,STAT1;EBI3;IL27RA
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.223375627564167,0.7815060282183223,0.9309173272933182,0.969786252977004,1.0,93/314,24.81%,ZNRF1;TRIM25;NEDD4L;PELI1;CTNNB1;STT3B;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;SGTB;PSMC6;FEM1C;DMAC2;PSME2;SMURF1;UBXN1;KCTD10;SHARPIN;KLHL20;FBXL2;UBE3D;UBQLN1;PSMD8;GSK3A;FBXO6;RNF187;DERL2;MAN1B1;MAEA;EDEM1;BUB3;PSMB10;NHLRC1;RBX1;PTTG1;FBXL8;ANAPC16;TRIM2;UBE2D3;AREL1;FBXL15;DNAJB9;TMUB2;PSMA8;ARMC8;RAD23A;ANAPC7;UBE2G2;BAG6;GID8;BFAR;FBXO2;TRIM71;TRIM3;KCTD17;SKP1;ANAPC10;PSMD9;SIAH1;RNF4;UBE2D1;TMEM129;RBCK1;ANAPC2;NSFL1C;PLAA;ANKRD9;ERCC8;ANKZF1;DDB1;CUL1;PSMC3;TMUB1;PSMD1;CDC23;RAD23B;UBE2J1;RNF126;PSMD10;CDC26;FBXL14;CDC27;HECW1;CRBN;FBXL3;RNF216;UBXN2B;ZFAND2B;MTA1
prerank,extracellular transport (GO:0006858),-0.33871868684679135,-0.7813779377240025,0.7534883720930232,0.973172403652852,1.0,8/12,33.83%,TSG101;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.29643554887058177,-0.7809784036302456,0.7858880778588808,0.9729549228584988,1.0,3/20,5.14%,NUPR1;OGT;FLOT2
prerank,cellular response to UV-A (GO:0071492),0.3710565038859842,0.7808876023348229,0.6992619926199262,0.970310040744421,1.0,3/11,15.23%,OPN5;MMP1;OPN3
prerank,tyrosine metabolic process (GO:0006570),0.3689301437158956,0.7805138126494533,0.7153558052434457,0.9704183427030771,1.0,3/11,23.82%,DCT;HGD;THAP4
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.3420758108211297,-0.780502729052363,0.7741228070175439,0.9728471515532304,1.0,4/12,16.16%,PFDN5;APOE;LDLR;CRYAB
prerank,regulation of protein transport (GO:0051223),0.3167907175183002,0.7800417365603418,0.7619047619047619,0.9706580305260225,1.0,6/27,17.33%,RHBDF2;SNX3;NDFIP2;HSPA8;DNAJA1;PPM1F
prerank,post-translational protein modification (GO:0043687),0.22445616688459605,0.7800367509184072,0.9257990867579908,0.9701454085148811,1.0,67/332,18.43%,EPAS1;LMO7;KLHL5;KLHL2;APP;DCUN1D3;SPARCL1;VWA1;CDH2;MEN1;ZBTB16;SOCS2;NOTUM;IGFBP7;STT3B;KLHL25;ADAM10;FBXW7;PSMB3;GOLM1;RAB11A;FBXO41;PDIA6;PSMD11;RHBDD1;QSOX1;PSMC6;FEM1C;KLHL3;PSME2;SCG3;SOCS5;KLHL20;PSMD8;WSB1;UBA3;HIF1A;FBXO6;ASB13;RAB1A;EVA1A;DCUN1D1;FBXW2;ASB5;PSMB10;FBXO21;RBX1;SERPINC1;FBXL8;FBXL15;ELOB;ASB15;PROC;DCAF5;PSMA8;ASB7;COPS5;GAS6;TMEM132A;GPS1;FN3K;SCG2;KBTBD8;FBXO2;SKP1;PSMD9;FBXW9
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2990510656629446,-0.7798192044894378,0.7892156862745098,0.9730630915858614,1.0,8/19,24.68%,CDIP1;PML;DYRK2;EP300;PHLDA3;PYCARD;BCL3;RPS27L
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.3564491252590769,0.7798021853010062,0.7078853046594982,0.9699936274921406,1.0,2/14,4.06%,NFKBIA;TMSB4X
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.31203351514447897,0.7795649283410743,0.7745762711864407,0.9698899498779733,1.0,11/29,29.64%,RNF212B;PRDM9;SIRT7;RAD21;BAG6;SYCP2;REC8;TEX12;IHO1;TERB1;P3H4
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.3690573687548545,0.7787427698385491,0.7286527514231499,0.9707931273129188,1.0,2/12,5.41%,CYP11B1;CYP11A1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.2798398215444619,-0.7780766908866115,0.7892156862745098,0.9749276548670628,1.0,6/26,14.75%,SLC30A10;PPARA;SLC5A3;CYBA;TRAP1;TLR4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.28319151629914835,0.7779267070086474,0.8123123123123123,0.9716098961891598,1.0,6/44,10.86%,SH3RF1;RPS6KA1;XIAP;KLF4;CST7;LAMTOR5
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3120365949882461,0.7779257324081662,0.7484472049689441,0.9710888937605873,1.0,4/29,7.63%,DAB2IP;SMAD7;IL17RD;EFNA1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3493371201873603,0.7778629558888784,0.7250437828371279,0.9706608634142802,1.0,10/17,31.46%,NDUFA4;AFG1L;COX6C;CYCS;COX10;COX15;COX7A2L;COX5B;COX4I1;COX8A
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.36795307018210693,0.7776960284600466,0.7231638418079096,0.9704239947194605,1.0,3/12,15.03%,NOD2;SOX9;INAVA
prerank,aggrephagy (GO:0035973),0.3144608900727765,0.7776050691704808,0.7699836867862969,0.9700548834228667,1.0,12/27,29.53%,DYNLL1;WDFY3;UBE2V1;UBQLN1;DYNC1LI1;ACBD5;ARL13B;UBB;PCNT;HDAC6;PARK7;DYNC1H1
prerank,maturation of SSU-rRNA (GO:0030490),0.3016120804458578,0.7773519507423999,0.7475247524752475,0.9699515621021947,1.0,7/34,14.11%,SNU13;DHX37;PWP2;NOL10;UTP3;RIOK1;RPS28
prerank,negative regulation of cell division (GO:0051782),-0.34936963731933224,-0.7772337512571683,0.7607758620689655,0.9753419407344125,1.0,7/11,39.89%,TXNIP;CHMP4C;VPS4A;E2F7;E2F8;ORC6;AURKB
prerank,histone H2A ubiquitination (GO:0033522),-0.30271857858377776,-0.7770341703452043,0.7620137299771167,0.974833526751151,1.0,7/17,21.71%,BCOR;KDM2B;DDB2;UBE2B;UBR2;TRIM37;CUL4B
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2670174220450604,-0.7767454536637353,0.8186666666666667,0.9744716988829961,1.0,13/31,26.60%,TNKS2;ATM;PML;RTEL1;HNRNPA2B1;ERCC1;RAD50;NBN;SIRT6;TNKS;PKIB;HNRNPD;MAP3K4
prerank,osteoclast differentiation (GO:0030316),-0.2877288249038505,-0.7761889902243647,0.788659793814433,0.9744995743883893,1.0,2/22,2.21%,GAB2;ANXA2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2974629445271114,0.7760345637183962,0.7544715447154472,0.9715830665322724,1.0,7/33,13.02%,CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;SNRPB
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.36984495637436443,0.7754698049659146,0.7490566037735849,0.9720201000004002,1.0,11/11,63.04%,MALT1;NFKBID;PRKCQ;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3345695878710094,0.7752853225304154,0.7504553734061931,0.9718026445207667,1.0,11/18,31.34%,SCO2;SCO1;COA3;SMIM20;COX20;COX17;PET100;TIMM21;COA5;BCS1L;COA8
prerank,calcineurin-mediated signaling (GO:0097720),-0.35562474521929927,-0.7752589541652194,0.7601809954751131,0.9743204584489175,1.0,5/10,19.56%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.35562474521929927,-0.7752589541652194,0.7601809954751131,0.9743204584489175,1.0,5/10,19.56%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,leukotriene metabolic process (GO:0006691),-0.29971043252856133,-0.7743410703537514,0.7981220657276995,0.9748933902257477,1.0,10/19,33.57%,GGT5;ABCC10;MGST3;PTGR1;ABCC1;PLA2G5;MAPKAPK2;ALOX12;DPEP1;GGT1
prerank,membrane assembly (GO:0071709),-0.25700222339997036,-0.7740921929569856,0.8199445983379502,0.9744288126063311,1.0,5/34,5.95%,ANXA2;NLGN2;S100A10;FLOT2;STX2
prerank,centromere complex assembly (GO:0034508),-0.259370319742831,-0.7739296537485612,0.8077922077922078,0.9738433787682959,1.0,11/36,23.99%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4;CENPE;RBBP7;CENPF
prerank,lipid biosynthetic process (GO:0008610),-0.2217079996595218,-0.7739187188449422,0.9281045751633987,0.9730325037553085,1.0,4/77,3.79%,ABCD3;PRKAA2;ACSL1;PAM
prerank,positive regulation of cytokinesis (GO:0032467),0.30127175353845587,0.7737539768095998,0.7807570977917981,0.9737327340123898,1.0,9/32,17.83%,CDC14A;PKN2;PKP4;CDC6;KIF23;MAP10;RXFP3;SPAST;PRKCE
prerank,thymus development (GO:0048538),0.36066842074294697,0.7733502213419264,0.7531305903398927,0.9738902416143295,1.0,1/13,1.88%,TBX1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.2775674267724274,-0.7732518326201125,0.8132992327365729,0.9732119858989382,1.0,8/26,19.68%,ANAPC5;NEK6;RIOK2;CUL3;NSMCE2;CENPE;CDC16;HECW2
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.23283696499697992,-0.7730903525879846,0.9030303030303031,0.9726323959453849,1.0,20/62,29.32%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;LIMD1;EIF4G1;RAE1;AJUBA;POLR2L;STAT3;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,regulation of myeloid cell differentiation (GO:0045637),0.26885444070942344,0.7725133327312705,0.8212703101920237,0.9746751267800385,1.0,5/62,3.97%,FES;MEF2C;ZFPM1;LYN;ZBTB16
prerank,striated muscle cell differentiation (GO:0051146),0.3406174878880902,0.7722782565192826,0.7232472324723247,0.9745367410999186,1.0,2/16,5.10%,MEF2C;SORT1
prerank,regulation of defense response to virus (GO:0050688),-0.32271625181566976,-0.7717652957241111,0.7733644859813084,0.9738075234063864,1.0,4/14,18.36%,PPM1B;ZMPSTE24;PCBP2;C1QBP
prerank,regulation of cell division (GO:0051302),0.25917228154802596,0.7717406036665513,0.8330914368650217,0.9749151353416305,1.0,13/72,16.22%,BCL2L1;CALM1;TAL1;CCP110;RAB11A;PIN1;CETN2;RAB11FIP4;PIK3C3;SH3GLB1;GIT1;PLK2;PRPF40A
prerank,regulation of endocytosis (GO:0030100),0.2685595126112725,0.771604115137506,0.8227272727272728,0.9746082512681132,1.0,4/61,3.37%,HIP1;HIP1R;NEDD4L;PRKD1
prerank,ribosome assembly (GO:0042255),0.28312706283748307,0.7713981482639595,0.8186046511627907,0.9744182986306632,1.0,19/47,28.37%,RPL3;RPSA;DHX37;RPS27;PWP2;MRPL20;RPL11;RPS15;RPS28;MRPS2;RSL24D1;RPL24;ERAL1;MRPL22;RPL6;RPS19;TRAF7;SBDS;DHX29
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.34078858673852075,0.7713698558393955,0.7598627787307033,0.9739587754982176,1.0,2/17,6.32%,RAPGEF2;ADRA2B
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3778016573301898,0.770840788441486,0.7523105360443623,0.9742509291686449,1.0,1/10,4.52%,CTNNB1
prerank,DNA replication checkpoint signaling (GO:0000076),0.3459270455004657,0.7705180006134338,0.7415929203539823,0.9742280124029273,1.0,9/16,29.22%,DNA2;CDC6;ORC1;HUS1;RAD9B;RAD17;TOPBP1;TIMELESS;HUS1B
prerank,negative regulation of neuron differentiation (GO:0045665),0.3213440540258637,0.7700125808664463,0.7583187390542907,0.9744954710131657,1.0,5/22,16.14%,B2M;EIF2AK4;SOX9;DISP3;HEY1
prerank,insulin secretion (GO:0030073),-0.2943974913109727,-0.769401886445919,0.800453514739229,0.97649894919338,1.0,2/19,5.24%,RAB11FIP2;ANXA1
prerank,positive regulation of cell killing (GO:0031343),0.3583848402977954,0.7693915324781182,0.7282809611829945,0.9749220109116381,1.0,3/13,11.86%,NOS2;RAC1;SYK
prerank,sensory perception of smell (GO:0007608),0.3707801892465765,0.7692136772495763,0.7423423423423423,0.9746684620740583,1.0,1/11,4.01%,SLC24A4
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3158234829104668,-0.7686453864643578,0.7761194029850746,0.9767917781089508,1.0,7/15,38.23%,CPEB2;DDX3X;GSTO1;DHX36;ZFAND1;HSF1;VCP
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3638729548097263,0.7681548647501395,0.7210144927536232,0.9758189082316765,1.0,7/12,32.99%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;TRIM28;PPHLN1
prerank,nucleic acid-templated transcription (GO:0097659),0.2866761018411444,0.7679867549912803,0.8077544426494345,0.9755603145218639,1.0,5/42,8.47%,PTMA;TAF1B;NKX2-8;RNPS1;PWP1
prerank,mitochondrial transcription (GO:0006390),0.37860395287649523,0.7679755433894393,0.7357512953367875,0.975059693349532,1.0,3/10,15.54%,MRPL12;SLC25A33;TWNK
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.2284140580600652,-0.7678096254756778,0.8746268656716418,0.9772464520076817,1.0,22/64,28.84%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;ELP4;NELFE;GTF2F1;SETD2;GTF2H1;POLR2L;CDK12;EAF2;CDK9;POLR2I;ELOA;TCEA2;ERCC2;POLR2K
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.28944341907833143,0.7673433247617499,0.8035714285714286,0.9755535346705859,1.0,7/37,11.82%,NOD2;GBP5;NOS2;CD6;PLD4;ABCD1;HIF1A
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.27625997695548077,0.7667469199019409,0.8242245199409158,0.9759931837787984,1.0,15/54,19.16%,CAV1;NEDD4L;KCNQ1;KCNH2;KCNN2;KCNN3;KCNAB2;GNB1;AKAP6;KCNJ3;KCNJ5;BIN1;KCNJ6;KCNIP2;KCNN4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3312872324543409,0.7666086255821146,0.75,0.975169450436155,1.0,4/20,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),0.3312872324543409,0.7666086255821146,0.75,0.975169450436155,1.0,4/20,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.2746534839868539,-0.7665332457067766,0.8248730964467005,0.9783268248088348,1.0,6/27,15.78%,GBF1;OBSL1;VPS13A;ARL1;RAB6A;OPTN
prerank,rRNA modification (GO:0000154),-0.2814179360338008,-0.7663636795681947,0.7805486284289277,0.977746681199867,1.0,7/21,22.12%,MTERF4;GAR1;NSUN3;NSUN4;TRMT112;DIMT1;TSR3
prerank,glycolytic process (GO:0006096),0.3045210739354842,0.7660504379001983,0.768595041322314,0.9755539496923381,1.0,7/28,18.47%,PKM;HK1;PGAM4;PGAM1;TPI1;PFKL;LDHA
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.22004652462565322,0.7653838603583004,0.9563758389261745,0.976059076228439,1.0,47/366,13.22%,INSR;APBB2;SLC39A8;ENG;NANOS3;APP;SOX17;MEF2C;RYBP;SMARCA2;ACVRL1;SOX13;NOTCH1;YBX1;PRDM2;IRF2;RREB1;SOX7;HINT1;KLF1;WWTR1;CCDC88A;TCF7;SNAI2;RPS6KA5;DNM2;NCOA2;SOX18;BRCA2;SOX12;HINFP;FOXP3;HCFC2;HMGA1;UBE2V1;CYFIP1;BTG1;ZNF205;NR5A2;ONECUT1;HIF1A;TFEB;SOX11;WWC1;EIF4E;EDF1;PUM3
prerank,establishment of spindle localization (GO:0051293),0.3493366983539933,0.7653715799961086,0.756007393715342,0.9755589739402342,1.0,2/14,13.84%,MAP4;CFL1
prerank,negative regulation of cell cycle process (GO:0010948),0.266981089390052,0.7650951446801733,0.8090379008746356,0.9754665225541391,1.0,7/61,8.29%,DAB2IP;RYBP;NANOS2;PHC1;CCP110;MAX;TERF2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3353704998273149,0.7646493100373485,0.7646017699115044,0.9756522131769262,1.0,5/18,23.39%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,regulation of cellular response to heat (GO:1900034),0.2594701957212776,0.7646043136206527,0.8388969521044993,0.9752054908380761,1.0,25/77,26.36%,CD34;HSP90AB1;MAPK3;HSPA8;NUP54;RPTOR;CAMK2B;BAG2;NUP160;DNAJC7;MAPK1;DNAJB6;RPA1;NUP153;NUP50;CAMK2G;IER5;NUP42;PTGES3;NUP85;MTOR;NUP210;BAG5;NUP188;BAG4
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3688809751105152,0.7645559101877417,0.7504761904761905,0.9742451264507971,1.0,3/11,17.88%,CCT3;CCT5;CCT7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3688809751105152,0.7645559101877417,0.7504761904761905,0.9742451264507971,1.0,3/11,17.88%,CCT3;CCT5;CCT7
prerank,histone H4-K8 acetylation (GO:0043982),0.34350831516291946,0.7643692095208761,0.7642725598526704,0.9735150350104493,1.0,4/15,16.34%,PHF20;JADE2;MCRS1;HCFC1
prerank,histone H4-K5 acetylation (GO:0043981),0.34350831516291946,0.7643692095208761,0.7642725598526704,0.9735150350104493,1.0,4/15,16.34%,PHF20;JADE2;MCRS1;HCFC1
prerank,negative regulation of insulin secretion (GO:0046676),-0.3031780758406672,-0.7638000375398579,0.7765237020316027,0.9807340912557638,1.0,7/17,19.78%,IRS1;PRKN;CCN3;KCNB1;SFRP1;INHBB;ADRA2A
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.35194734845366205,0.7637936132259416,0.7538167938931297,0.9739378235544888,1.0,3/13,9.98%,TLR7;IRAK2;PIK3C3
prerank,regulation of interleukin-1 production (GO:0032652),0.35003871364692274,0.7635345434776659,0.7314814814814815,0.973797070720421,1.0,5/15,20.10%,CCR7;CEACAM1;GAS6;F2R;FOXP1
prerank,regulation of response to oxidative stress (GO:1902882),-0.33577097718836374,-0.7632728713711426,0.7649667405764967,0.9807373340428108,1.0,9/11,43.54%,PRKN;AIFM2;ACOX2;HEBP2;STOX1;MCTP1;SELENON;ALOX5;PINK1
prerank,regulation of synapse assembly (GO:0051963),0.28602261557065783,0.7626266085809814,0.7954545454545454,0.9747176397185778,1.0,9/46,9.94%,APP;MEF2C;WNT7A;CLSTN1;GRID2;SLITRK3;SLITRK1;NRXN1;LRRC4B
prerank,early endosome to late endosome transport (GO:0045022),-0.29039802513272384,-0.76238495265502,0.7990196078431373,0.9812412130633089,1.0,12/20,35.75%,EEA1;ANKRD27;HOOK2;AKTIP;WDR81;WDR91;EMP2;SNF8;PTPN23;SNX16;RILP;RAB5A
prerank,outer dynein arm assembly (GO:0036158),0.34272435520615013,0.7612770595956218,0.7343453510436433,0.9762678627686352,1.0,4/14,15.27%,ZMYND10;LRRC49;DNAH8;DNAH5
prerank,serine family amino acid catabolic process (GO:0009071),0.3693793132288162,0.7609231208848951,0.7312614259597806,0.9763229070408017,1.0,2/10,9.59%,SHMT2;CBS
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.24380632199112195,-0.7606930434212654,0.8579545454545454,0.982792484252319,1.0,13/42,18.14%,SMARCC2;CHD3;CHD8;SMARCB1;ACTR8;CHD4;SMARCA1;SMARCA5;SPTY2D1;ERCC6;MBD2;SMARCC1;RBBP4
prerank,regulation of neuron differentiation (GO:0045664),0.2572405847628563,0.7602777132990657,0.8410689170182841,0.9768201942664989,1.0,20/76,18.00%,ARHGEF2;MEF2C;TIAM1;MMD;ADRA2B;YWHAH;CDK5RAP2;EIF2AK4;BRINP3;BRINP2;SOX11;DISP3;NLGN1;HEY1;NRCAM;ALK;SIN3A;CPNE1;NEUROD2;BIN1
prerank,regulation of histone acetylation (GO:0035065),0.2933374996116842,0.7601455391243863,0.7789968652037618,0.9764997701054213,1.0,11/33,22.35%,RAPGEF3;MAPK3;RPS6KA5;FOXP3;TADA2B;CTBP1;HDAC5;SET;NOC2L;SNCA;SPI1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3392217862429092,-0.7599709044993109,0.7610619469026548,0.9830459495598389,1.0,2/11,8.17%,SCARA3;TNIP2
prerank,negative regulation of protein transport (GO:0051224),0.3081988717391658,0.7595491830023884,0.788235294117647,0.9768397818912924,1.0,4/25,12.09%,RHBDF2;SNX3;NDFIP2;HMGCR
prerank,dendritic cell differentiation (GO:0097028),0.32042159940727827,0.7594978553135763,0.7661691542288557,0.9764002590891286,1.0,5/22,16.47%,LYN;CCR7;LGALS9;TGFBR2;GAS6
prerank,negative regulation of transmembrane transport (GO:0034763),0.3661554150024612,0.7593934126945301,0.746268656716418,0.9760572169627044,1.0,2/10,11.53%,CTTNBP2NL;PRKCB
prerank,body fluid secretion (GO:0007589),-0.31122256646315843,-0.7592074199903189,0.7720090293453724,0.9832850036120308,1.0,4/15,14.82%,SLC22A4;PRLR;SLC22A2;ZBTB7B
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3217308889338755,-0.7589167560870232,0.7811158798283262,0.982843028502601,1.0,1/13,1.67%,ENPP1
prerank,response to zinc ion (GO:0010043),0.31288957063231204,0.7587991287693907,0.770940170940171,0.97642237676144,1.0,10/25,20.32%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;GLRA2;SLC30A4
prerank,regulation of autophagosome assembly (GO:2000785),0.2954421964260377,0.7587568159427924,0.7945859872611465,0.9759827029628996,1.0,7/33,12.79%,TBC1D14;TBC1D12;PIKFYVE;RALB;SH3GLB1;PIP4K2A;FEZ2
prerank,negative regulation of T cell proliferation (GO:0042130),0.30338298235237515,0.7586801512202673,0.797716150081566,0.9755895701012368,1.0,3/28,8.41%,TNFRSF21;LGALS9;FOXP3
prerank,regulation of protein export from nucleus (GO:0046825),0.3097236658645598,0.7585916194553608,0.7832167832167832,0.9752100831461733,1.0,2/23,3.85%,SP100;RAPGEF3
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23497488561080565,-0.7582074160659696,0.8711484593837535,0.9830531056516227,1.0,16/45,25.08%,EGFR;BMP4;DDX5;POLR2A;RIOK2;WDR43;HABP4;PIK3R1;SLC38A2;U2AF2;TRMT112;DIMT1;MAP2K1;ZC3H18;GRSF1;HSPA1A
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.26723635557977854,0.758168074140938,0.8291970802919708,0.9753347060933105,1.0,7/56,12.23%,PLCB1;RGCC;RAB11A;CCND3;ADAM17;BRD4;RPTOR
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.275476768959543,0.757885098183985,0.8105939004815409,0.9752714627420394,1.0,6/48,6.88%,SIGIRR;NLRC5;SAMHD1;PALM3;RFFL;NR1H2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.34195859961362135,-0.7576358914186728,0.7671232876712328,0.9830133568844895,1.0,3/10,15.19%,CD55;ZBTB7B;CD81
prerank,regulation of autophagosome maturation (GO:1901096),-0.32087701181341133,-0.7570345024086366,0.7582938388625592,0.9830564898465212,1.0,5/13,18.22%,TMEM39A;CLN3;CLEC16A;PHF23;SMCR8
prerank,phospholipid homeostasis (GO:0055091),-0.3260319891904554,-0.7569293449335398,0.786036036036036,0.9823884260647711,1.0,3/11,9.80%,ABCA1;RCN3;TLCD2
prerank,glutathione metabolic process (GO:0006749),0.2861226356713305,0.756664088895913,0.8108527131782945,0.9766538911967533,1.0,5/38,10.19%,GCLM;MGST2;GSTA4;HPGDS;GSTK1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2700774886998051,0.756274080637327,0.8450292397660819,0.9767363594649248,1.0,12/53,17.70%,DAB2IP;GNA12;HSP90AB1;FBXW7;OPHN1;PSMC6;PSME2;F8A1;BAG2;RAD23A;FOXF2;PRKCG
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3216008108352758,0.7562232477104877,0.788135593220339,0.9763007673958707,1.0,2/20,5.41%,CYP11B1;CYP11A1
prerank,cellular response to starvation (GO:0009267),0.23544588314982592,0.7561684121449574,0.9102564102564102,0.975873545508649,1.0,20/147,12.45%,MFSD2A;BMPR2;FAS;FOXO1;PRKD1;RIPOR1;WDR59;XPR1;SESN3;MAPK3;RALB;MAP1LC3B;EIF2AK4;PIK3C3;DEPDC5;HSPA8;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,response to metal ion (GO:0010038),0.26292622457171755,0.7561066480782258,0.8361823361823362,0.9754525708935274,1.0,13/67,17.65%,CAV1;NEDD4L;CALM1;HOMER1;GPHN;PPP3CA;HIF1A;MT1X;MT1A;PDCD6;LOXL2;TTN;NDRG1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.31531953914657795,0.7560187078823591,0.7858347386172007,0.9750884432045319,1.0,9/23,22.85%,TGM2;KCNQ1;MAPK3;PDE4B;GNB1;MAPK1;ATP2B4;SNCA;RYR2
prerank,positive regulation of ATPase activity (GO:0032781),-0.24243687807807748,-0.7554491665503792,0.8608695652173913,0.9836868982360685,1.0,8/41,17.81%,TPM1;ATP1B3;ATP1B2;PFN2;TOR1AIP1;TNNT3;DNAJB2;PLSCR1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.30011801638769225,-0.7552990836555883,0.7815315315315315,0.9830586823148525,1.0,1/16,0.93%,SNCAIP
prerank,histone mRNA catabolic process (GO:0071044),-0.3036377318976439,-0.7549110471124447,0.7705627705627706,0.9827870040718869,1.0,4/15,16.24%,TUT4;ATM;TENT2;TUT1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.22806131809797778,0.7546557875388977,0.9245283018867925,0.9766457974653113,1.0,54/184,23.32%,RGCC;PPP1R9B;CDC14A;DYNLL1;CCP110;PSMB3;NPM2;PRKAR2B;PSMD11;CETN2;TUBB;CDK5RAP2;PSMC6;PSME2;AKAP9;HAUS6;CDC6;CEP78;PSMD8;ZFP36L1;BUB3;CEP135;PSMB10;CEP72;ANLN;ANAPC16;TUBB4B;TUBA1A;CKAP5;CEP70;PSMA8;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;ZW10;ZFP36L2;TFAP4;DCTN1;ANAPC2;SFI1;CLASP1;NDE1;HAUS2;DDB1;CUL1;PSMC3;PSMD1;CDC23;INO80;PSMD10;CDC26;CDC27
prerank,regulation of stem cell population maintenance (GO:2000036),0.3309397628910183,0.7543024879500901,0.7937384898710865,0.9766716627861315,1.0,7/18,25.12%,PTN;ELAVL1;LOXL2;ZC3H13;HMGA2;MYC;TAF5L
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24797049130571283,0.7540285158008329,0.8782234957020058,0.9765590687956744,1.0,24/94,21.27%,CEP83;DYNLL1;CCP110;RAB11A;PRKAR2B;MARK4;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP135;CEP72;TUBB4B;TUBA1A;CKAP5;CEP70;CEP97;DCTN1;SFI1;CLASP1;NDE1;HAUS2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2684942895303242,-0.7538399145704646,0.8232445520581114,0.9834719459325925,1.0,6/27,20.94%,LPAR1;AGTR1;LPAR4;GPR157;HTR2C;C3AR1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2413629950201729,-0.7535915354237894,0.8508771929824561,0.9829955950293119,1.0,3/48,5.18%,PRKAG2;OGT;SEH1L
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.23136677472005204,0.753585728671828,0.9232736572890026,0.9766891172157499,1.0,39/145,21.88%,DYNLL1;CCP110;PSMB3;RAB11A;PRKAR2B;PSMD11;CETN2;TUBB;CDK5RAP2;PSMC6;PSME2;AKAP9;HAUS6;BRD4;CEP78;PSMD8;CEP135;PSMB10;CEP72;RBX1;TUBB4B;TUBA1A;RCC2;CKAP5;CEP70;PSMA8;SKP1;PSMD9;DCTN1;MECP2;SFI1;CLASP1;NDE1;HAUS2;CDK4;PINX1;CUL1;PSMC3;PSMD1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.26529539172393685,0.7534551537870603,0.8628318584070797,0.9763663062956525,1.0,5/55,6.23%,PDGFB;XDH;GRB2;PIKFYVE;SLC25A33
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2808322535424965,-0.752859194082547,0.812987012987013,0.9832064192529244,1.0,4/22,11.97%,PPM1E;PPM1D;PPM1B;DUSP10
prerank,intracellular cholesterol transport (GO:0032367),0.3370478387527637,0.7527244343311408,0.7660311958405546,0.9769530132334405,1.0,4/15,14.49%,OSBP;ABCG1;NPC1;STARD4
prerank,Golgi to endosome transport (GO:0006895),-0.29821171009681385,-0.7525286438715596,0.8127962085308057,0.9828573284226009,1.0,7/16,23.45%,GBF1;VPS13A;AP4M1;MON2;AP2A1;RAB14;CORO7
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3144152455685616,0.7523008704024465,0.7758913412563667,0.9770374818485514,1.0,12/22,33.78%,ENC1;PSMB3;PSMB10;PSMA8;PSMA1;NFE2L2;PSMB8;PSMA7;PSMB9;PSMB1;PSMA4;PSMB7
prerank,regulation of lipid catabolic process (GO:0050994),0.32404305897873026,0.7520934955911617,0.7653239929947461,0.9768514909638008,1.0,6/19,22.21%,ABCB11;ABCD1;PDE3B;ALK;LONP2;PRKAA1
prerank,regulation of chromatin organization (GO:1902275),-0.3114679859808079,-0.7520357207286659,0.7880952380952381,0.9826951838222838,1.0,3/14,10.99%,IGF2;MLLT3;SETD5
prerank,neuron projection regeneration (GO:0031102),0.3591456726304777,0.751626414904545,0.7380073800738007,0.9770681545185687,1.0,2/10,23.20%,PTN;DHFR
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31942927122967124,0.7514301912176532,0.7701543739279588,0.9768592646822932,1.0,5/21,11.20%,MCUB;TGM2;RAP1GDS1;LETM1;PDZD8
prerank,regulation of RNA export from nucleus (GO:0046831),-0.32554194094430167,-0.75138808574294,0.7825112107623319,0.9827504202680998,1.0,4/11,26.78%,AKAP8L;NSUN2;SETD2;TPR
prerank,neuron cell-cell adhesion (GO:0007158),0.34535025111718,0.7513688633960708,0.7734513274336283,0.976445113304343,1.0,4/14,15.74%,RET;NCAM2;NRXN1;NLGN1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2901075537074777,0.7512731884674989,0.808130081300813,0.9760738271208469,1.0,13/35,25.96%,NTHL1;PARG;SMUG1;MPG;POLB;RPA1;ADPRS;POLL;POLD1;RFC2;RFC4;PNKP;POLD4
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.32757647914346755,0.7507868377518944,0.7816901408450704,0.976272117379625,1.0,5/17,14.34%,ITGA1;CALM1;HSP90AB1;AGTR2;PPP1R15B
prerank,receptor catabolic process (GO:0032801),0.30656123681124425,0.7507860852086093,0.7893030794165316,0.9757678464752445,1.0,6/24,12.31%,ZNRF3;AP2M1;TGFB1;SMURF1;SH3GLB1;AP2B1
prerank,histone exchange (GO:0043486),-0.2517673305561918,-0.7500801498165112,0.8491048593350383,0.983817915790255,1.0,9/37,18.14%,CENPC;CENPP;CENPK;SMARCA5;SPTY2D1;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,protein import (GO:0017038),-0.21342886823782303,-0.7495005506862352,0.9411764705882353,0.9837592900818118,1.0,21/84,26.78%,ABCD3;APPL2;LAMP2;RANBP17;HSPA4;APOE;PXMP2;PEX2;SNX33;E2F3;FAM53B;ALDH3A2;IPO7;ATAD1;PEX13;STAT3;KPNB1;HIKESHI;NUP155;IPO8;TPR
prerank,response to light stimulus (GO:0009416),0.269170843498756,0.7494846033963679,0.8326055312954876,0.9771917008710975,1.0,6/55,8.66%,MAP4K3;MEN1;DCT;GTF2H2;OPN5;GPR52
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.2655399878760939,-0.7494641294508336,0.8429319371727748,0.9830015618078064,1.0,8/29,19.93%,KANK2;YAP1;AXIN1;ESR1;DDRGK1;RUNX1;LATS1;BRCA1
prerank,protein deacylation (GO:0035601),0.30893287154876886,0.7491288103422811,0.7915936952714536,0.9772427155768266,1.0,7/23,17.62%,HDAC7;NOTUM;ABHD17A;LYPLA1;HDAC5;SIRT7;SIN3A
prerank,pre-miRNA processing (GO:0031054),-0.3100804765147028,-0.7489567658980699,0.7845433255269321,0.9828821122576464,1.0,2/14,7.30%,TUT4;AGO2
prerank,covalent chromatin modification (GO:0016569),0.3426460952122101,0.7484487106661039,0.7653239929947461,0.9777843564010829,1.0,5/14,21.06%,CHD1;HELLS;SIRT7;HLCS;PARP2
prerank,aerobic electron transport chain (GO:0019646),0.2651819440553688,0.7484045192628441,0.849925705794948,0.9773487653279276,1.0,24/68,28.50%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COX6C;NDUFA12;NDUFB3;CYCS;NDUFC1;UQCRQ;COX10;UQCR11;SDHAF2;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B;NDUFAB1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3110561213946435,0.7478373180945054,0.7860696517412935,0.977690904823323,1.0,5/24,11.06%,CXCL12;LYN;GREM1;CCL1;DUSP1
prerank,triglyceride catabolic process (GO:0019433),0.31039972751735967,0.7476716098384725,0.7945945945945946,0.9774217263870727,1.0,2/19,10.76%,FABP5;LIPC
prerank,protein-DNA complex assembly (GO:0065004),0.23787654512939632,0.7474712902780251,0.8797814207650273,0.9771882857982215,1.0,37/116,28.16%,GTF2H2;PSMB3;PSMD11;CETN2;PSMC6;PSME2;CDC6;PSMD8;GTF2H4;CHAF1A;NAA60;ORC1;SOX9;HMGB2;PSMB10;RBX1;PSMA8;CHAF1B;RPA1;PSMD9;GRWD1;GTF2H3;DDB1;PSMC3;DAXX;PSMD1;RAD23B;PSMD10;NAP1L4;XPC;SART3;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,hexose metabolic process (GO:0019318),0.28092052260469047,0.7472757441263113,0.8077544426494345,0.9769488311112672,1.0,6/39,14.74%,SORD;PPARD;HK1;BRAT1;HECTD4;OMA1
prerank,positive regulation of rRNA processing (GO:2000234),-0.3337809425725062,-0.7471921953121468,0.8016528925619835,0.9844245629170442,1.0,4/10,21.58%,RIOK2;WDR43;TRMT112;DIMT1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.3523982037591405,0.7468500548679602,0.7643979057591623,0.9770445879483849,1.0,2/12,4.37%,LY6E;SNX3
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.31708801853375107,-0.7461790243576869,0.7484276729559748,0.9849724766110823,1.0,4/12,18.25%,CLCN2;H6PD;SREBF1;MBTPS1
prerank,positive regulation of heart rate (GO:0010460),0.3284285305777511,0.7461322469650241,0.800711743772242,0.9775786529344073,1.0,3/17,5.16%,PDE4D;NPPA;KCNQ1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.32199946594703704,-0.7460545999997193,0.7668067226890757,0.984344792262376,1.0,5/11,30.73%,STX4;TYROBP;MAVS;CAMK4;ITGAM
prerank,protein insertion into ER membrane (GO:0045048),0.2877694857624015,0.7455417932946474,0.8142857142857143,0.9779498022998654,1.0,2/37,2.69%,APP;STX1A
prerank,regulation of dopamine secretion (GO:0014059),-0.2721503341627894,-0.7455114889483719,0.8567708333333334,0.9842294766092071,1.0,5/25,16.89%,DTNBP1;PRKN;SYT9;SYT13;SYT3
prerank,import into nucleus (GO:0051170),0.25420816972376475,0.7452122532961779,0.8658892128279884,0.9779242251549157,1.0,30/73,31.72%,BACH2;IPO11;SNRPF;NXT1;SNRPE;RANBP6;SYK;SNRPB;PTTG1IP;SNRPD2;NUP153;NUP50;IPO4;CSE1L;NXT2;NUP85;FAM53A;NUP188;DDX20;RAN;SNRPD1;SMN1;NUTF2;HNRNPA1;GEMIN5;HTATIP2;AKT1;RPAIN;SNRPG;SNRPD3
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2518477151077785,0.7449713808709348,0.8454172366621067,0.9772787228356413,1.0,13/78,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2518477151077785,0.7449713808709348,0.8454172366621067,0.9772787228356413,1.0,13/78,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,protein ubiquitination (GO:0016567),0.20841050097929092,0.7446735290640834,0.9902597402597403,0.9772010763175842,1.0,95/471,18.63%,RNF144B;EPAS1;LMO7;ZNRF1;KLHL2;SH3RF1;TRIM25;TRIM14;NEDD4L;KLHL7;PELI1;RNF125;ZNRF3;CTNNB1;ENC1;KLHL25;UBE2V2;ABCB11;FBXW7;PHC1;PSMB3;UBE2G1;FBXO41;PSMD11;KLHL24;TRIM36;TRIM24;PSMC6;KLHL3;PSME2;UBE2V1;SMURF1;KCTD10;CBLL1;KLHL20;FBXL2;UBOX5;HERC6;CBFB;PEX14;UBE3D;PSMD8;ZNRF2;WSB1;HIF1A;FBXO6;RNF187;TRIM69;ARRDC1;TRIM39;FBXW2;RNF38;RNF208;ASB5;PSMB10;BCL10;FBXO21;NHLRC1;RBX1;FBXL8;ANAPC16;TRIM2;UBE2D3;AREL1;FBXL15;RNF139;ELOB;RNF8;UBE2Q2;PSMA8;MSL2;ANAPC7;HERC2;UBE2G2;TRIM26;TRIM47;UHRF2;UBE2Z;BFAR;KBTBD8;TRIM68;FBXO2;RNF19A;TRIM71;TRIM3;NEUROD2;SKP1;HLTF;PSMD9;SIAH1;CBL;FBXW9;TRIM11;RNF4;UBE2D1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.31192161643869026,-0.7445068725064345,0.8200455580865603,0.9847326129340422,1.0,5/15,17.74%,EGFR;RBPJ;CDH13;RHBDF1;MVB12A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.223443035732529,-0.7443593579510553,0.9251497005988024,0.9841147390749669,1.0,21/62,28.84%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;ELP4;NELFE;GTF2F1;SETD2;GTF2H1;POLR2L;CDK12;EAF2;CDK9;POLR2I;ELOA;ERCC2;POLR2K
prerank,protein modification by small protein removal (GO:0070646),0.218699409639664,0.74418055970834,0.9627403846153846,0.9774058840213041,1.0,86/252,27.39%,NFKBIA;IFIH1;ACTB;SMAD7;SNX3;ATXN3;CCP110;EIF3F;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;OTUD7A;MYSM1;BABAM1;SMAD1;PSMD8;USP18;HIF1A;TADA2B;POLB;HGS;ATXN7;WDR48;CYLD;TNFAIP3;PSMB10;WDR20;TRRAP;MCRS1;APC;PSMA8;COPS5;HCFC1;RAD23A;GPS1;USP49;RCE1;TNIP1;PSMD9;JOSD2;USP32;USP29;UBE2D1;BRCC3;TRAF3;OTUD4;ASXL1;USP25;USP21;OTUD7B;DESI2;DESI1;JOSD1;SUDS3;COPS6;KAT2B;MBD5;PSMC3;PSMD1;STAMBP;RAD23B;INO80;PSMD10;TRAF6;RIPK1;USP30;VCPIP1;FOXO4;MYC;KEAP1;COPS2;KDM1B;ZC3H12A;USP38;PSME1;USP45;TAB1;ACTR5;ADRB2;UBB;PSMD2;PSMA1;ADRM1;NFRKB
prerank,synaptic vesicle localization (GO:0097479),0.3442305208000367,0.7437883228444232,0.7620751341681574,0.9774626223846227,1.0,3/13,15.89%,DNM2;NLGN1;SYNJ1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3433849516112114,0.7435015560928573,0.7670753064798599,0.9773792970595061,1.0,3/12,17.88%,CCT3;CCT5;CCT7
prerank,regulation of RNA metabolic process (GO:0051252),0.26338140542510763,0.7434119000264864,0.8556998556998557,0.9770110065942846,1.0,2/59,1.47%,RBM20;NOVA2
prerank,positive chemotaxis (GO:0050918),-0.28552944637246896,-0.7433849240935545,0.8095238095238095,0.9845244753342333,1.0,2/17,8.05%,ANGPT1;MET
prerank,modification-dependent protein catabolic process (GO:0019941),0.226648937865225,0.7432663700275479,0.9288389513108615,0.9767270104416476,1.0,51/193,23.32%,RNF144B;TRIM25;NEDD4L;RNF125;ZNRF3;KLHL25;ATXN3;RFFL;UBE2G1;RNF215;PSMD11;FEM1C;KLHL3;NDFIP2;PPP1R11;SMURF1;KCTD10;RNF130;TOLLIP;UBQLN1;ARRDC1;BUB3;FBXO21;RBX1;PTTG1;ANAPC16;AREL1;RNF8;ANAPC7;UBE2G2;BAG6;BFAR;RNF19A;ANAPC10;PSMD9;SIAH1;CBL;UBE2D1;RNF166;FBXO8;ANAPC2;MIB1;RLIM;DDB1;UBL7;CDC23;RNF126;CNOT4;CDC26;FBXL14;CDC27
prerank,regulation of intracellular protein transport (GO:0033157),0.29599975488873564,0.7430744260081749,0.8125,0.9764924904432526,1.0,9/32,19.68%,PRR5L;RIPOR1;OAZ1;TGFB1;PDCD10;B3GAT3;SIRT7;TENM1;OAZ2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3311170510102135,0.7420864901495274,0.7839721254355401,0.977410635271753,1.0,3/16,12.52%,AGER;CEACAM1;CYRIB
prerank,regulation of pH (GO:0006885),0.34713367753508084,0.7419959513753299,0.7568058076225045,0.9770270479164486,1.0,3/11,9.42%,ATP1A4;CLCN3;SLC9A7
prerank,regulation of protein localization to centrosome (GO:1904779),0.36495942570544176,0.7414883436090907,0.7727272727272727,0.9772460992502485,1.0,5/10,24.75%,MARK4;CEP72;APC;NSFL1C;UBXN2B
prerank,negative regulation of TOR signaling (GO:0032007),0.279282915549158,0.7412802249487219,0.8284313725490197,0.9770619116954672,1.0,9/36,14.19%,SH3BP4;TNFAIP8L1;SESN3;DEPDC5;DDIT4;GSK3A;TMEM127;PDCD6;EPM2A
prerank,vacuolar acidification (GO:0007035),-0.2783599130731028,-0.7411976827158139,0.8238095238095238,0.9864979311507034,1.0,8/21,22.38%,ATP6V0A4;CLN3;GRN;CLN6;ATP6AP2;TCIRG1;ATP6V0D2;TMEM9
prerank,regulation of smooth muscle contraction (GO:0006940),-0.2830446836382494,-0.7411111348193784,0.8317535545023697,0.9858093352925157,1.0,6/20,17.34%,PLCE1;KCNB2;SPHK1;CHRM2;CTTN;MYOCD
prerank,response to hydrogen peroxide (GO:0042542),0.27343020430429243,0.7405082902447261,0.8190184049079755,0.9776293069789098,1.0,9/45,14.58%,NET1;RHOB;CAT;FYN;PLEKHA1;PDCD10;STK24;TNFAIP3;STK26
prerank,monoacylglycerol metabolic process (GO:0046462),-0.31290523828535155,-0.7403955795344865,0.825287356321839,0.9859570402124609,1.0,1/13,1.74%,MOGAT3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3423498870270491,0.7398343388383842,0.7685352622061483,0.9780665676086974,1.0,4/13,17.62%,TMSB4X;SOX11;HEY1;SIN3A
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3329837332703625,-0.7391076719980098,0.7983014861995754,0.9868972265629481,1.0,2/11,9.99%,P2RX4;CDH13
prerank,cellular response to pH (GO:0071467),-0.2899975083823596,-0.7388061376358008,0.8236714975845411,0.9865133421890592,1.0,3/17,15.76%,IMPACT;SLC9A1;RAB11B
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.29644963126548074,-0.7382369544875538,0.8137472283813747,0.9864756834041633,1.0,5/15,19.68%,NEK6;RIOK2;CENPE;CDC16;HECW2
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.33240904831470774,-0.7377815687252535,0.7837837837837838,0.9862802505472169,1.0,6/10,37.06%,IL18;RARA;PRKCZ;SPHK2;GATA3;IL4
prerank,regulation of keratinocyte migration (GO:0051547),0.3561377876939379,0.7375264790762137,0.7560975609756098,0.9808243994288063,1.0,3/12,12.23%,MAPRE2;IQSEC1;MAP4K4
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3046944012148863,-0.737350927676996,0.8240534521158129,0.9852592288840878,1.0,6/15,21.85%,DTNBP1;AP3B1;BLOC1S2;AP3S2;BLOC1S6;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3046944012148863,-0.737350927676996,0.8240534521158129,0.9852592288840878,1.0,6/15,21.85%,DTNBP1;AP3B1;BLOC1S2;AP3S2;BLOC1S6;BLOC1S5
prerank,protein tetramerization (GO:0051262),0.2551989963521311,0.7371081398321786,0.8689655172413793,0.98090483113885,1.0,8/67,8.05%,B2M;HPRT1;GBP5;SAMHD1;MCOLN1;HOMER1;ACACB;SHMT2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2895155854189122,0.7370358064194213,0.8020477815699659,0.9805203164552931,1.0,5/29,11.86%,ABT1;DHX37;PWP2;NOL10;UTP3
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.26393790655253135,-0.7365431580469868,0.849624060150376,0.9854441036277561,1.0,13/27,33.08%,KAT6B;SGF29;MORF4L2;BRD8;EP300;MRGBP;TAF6L;NAA50;CREBBP;KAT8;MSL3;KAT5;TAF6
prerank,response to gamma radiation (GO:0010332),0.3077941611920747,0.7363789092238637,0.8027210884353742,0.9809165825939465,1.0,2/24,3.46%,DCUN1D3;MEN1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3546105452902708,0.7357908853642892,0.7663551401869159,0.9812522085676524,1.0,4/10,20.44%,AKAP9;DLGAP3;NPTX1;NPTXR
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.26194006733389624,0.7355240971423106,0.8377581120943953,0.9811156190201713,1.0,15/57,20.83%,RPL38;NOP16;RPS7;DHX37;WDR74;GTF3A;RIOK1;RPL11;RPS15;RPS28;RPS25;NAF1;NOC2L;PAK1IP1;NVL
prerank,regulation of nuclear division (GO:0051783),-0.2775177696342783,-0.7350454829079694,0.8521939953810623,0.9865151079664252,1.0,3/20,11.39%,OBSL1;CUL7;PRMT5
prerank,response to ionizing radiation (GO:0010212),0.2514253321814732,0.7346881374706853,0.8809869375907112,0.9817727691769524,1.0,26/70,27.78%,NET1;DCUN1D3;MEN1;GRB2;RHOB;BABAM1;BRAT1;RNF8;MSH2;EEF1D;HUS1;BRCC3;RAD9B;RAD1;PRKAA1;INO80;TOPBP1;MYC;MTA1;SMPD1;NABP2;BLM;CLOCK;XRRA1;GADD45A;RFWD3
prerank,regulation of synapse organization (GO:0050807),0.2989872818635486,0.7339050191711595,0.8122977346278317,0.9823315800352114,1.0,6/26,17.93%,MEF2C;EPHA4;ABHD17A;CAMK2B;YWHAZ;CTNNA2
prerank,positive regulation of phagocytosis (GO:0050766),0.2645778590130054,0.7336726583498898,0.8353846153846154,0.9821658777222172,1.0,10/47,17.30%,RAB31;PTPRJ;MERTK;GATA2;ABCA7;IL15;NCKAP1L;GAS6;DOCK2;LYAR
prerank,regulation of exocytosis (GO:0017157),0.2671157207755411,0.7332791973855822,0.8513302034428795,0.9821862452073155,1.0,13/46,22.16%,STXBP6;UNC13D;RAB3B;LGI3;CPLX1;CADPS;RIMS2;RALA;CADPS2;RAB8A;CLASP1;ATP6AP1;SNCA
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3395801529042112,0.7326100710178912,0.7858407079646018,0.9826131098550839,1.0,7/13,29.61%,CIAO2B;BOLA2;GLRX3;YAE1;NFU1;ISCA1;ISCA2
prerank,regulation of centrosome duplication (GO:0010824),-0.2558554328757817,-0.7321648815165523,0.8664921465968587,0.9893573841548524,1.0,8/29,23.20%,ALMS1;SPICE1;STIL;CHMP4C;CEP295NL;FBXW5;CEP131;CEP76
prerank,carnitine metabolic process (GO:0009437),0.3417561209452721,0.7320990623517207,0.7838827838827839,0.9827922661938598,1.0,2/12,5.58%,CPT1A;CRAT
prerank,regulation of adaptive immune response (GO:0002819),-0.2854777005905841,-0.731700684817388,0.8256880733944955,0.989133454001093,1.0,8/18,30.76%,ADCY7;PYCARD;IL6ST;AHR;IRF1;FADD;IL4I1;SIRT1
prerank,mRNA modification (GO:0016556),0.31146043830986636,0.7316284026925698,0.787085514834206,0.9829250926134985,1.0,7/22,23.95%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2650407336528247,-0.7315663078731826,0.8317757009345794,0.9884996180544053,1.0,2/21,5.31%,EPHA7;NGF
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2614007035142966,0.7312265547931455,0.8807069219440353,0.9829983344779267,1.0,23/54,27.87%,MAK16;RPL3;SNU13;NOP16;WDR74;MRPL20;GTF3A;RPL11;RRP15;NHP2;NOC2L;PAK1IP1;NVL;RPL10A;SURF6;RSL24D1;RPL24;MRPL1;RPL7A;RPL6;TRAF7;RPL14;RPL26
prerank,DNA repair (GO:0006281),0.2141669332714856,0.731139987636603,0.9802555168408827,0.982613046474346,1.0,63/284,22.36%,TENT4A;POLK;MEN1;MRE11;UBE2V2;ATXN3;GTF2H2;ALKBH2;BRCA2;HINFP;CETN2;PWWP3A;FANCG;KDM4A;HPF1;UBE2V1;UBXN1;DNA2;BABAM1;SMUG1;MGMT;RECQL4;GTF2H4;MPG;FBXO6;BTG2;POLB;ASCC3;WDR48;FAN1;NSMCE4A;FANCF;MSH3;RNF8;MSH2;TRRAP;RAD23A;HERC2;HMGA2;SUMO1;RAD21;FANCB;HUS1;NUDT1;RPA1;ADPRS;BRCC3;NSMCE3;RAD9B;POLL;POLD1;UVRAG;ERCC8;GTF2H3;POLA1;PARP2;RFC2;DDB1;ERCC4;RAD1;DCLRE1C;PARP9;RAD23B
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.3191109541676086,-0.7306267718653651,0.8095238095238095,0.9889246862886192,1.0,1/12,1.07%,B3GALT1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.28538344471544247,0.730305694010454,0.829153605015674,0.9832715674476232,1.0,6/31,14.41%,DCUN1D3;FBXW7;PIN1;RAB1A;DCUN1D1;BMI1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2669181668478782,0.7300398538049706,0.8638426626323752,0.9831352283118964,1.0,7/50,12.11%,ACTB;HSP90AB1;CDKN2B;CCNI;CCND3;CDC6;CCNK
prerank,negative regulation of macrophage activation (GO:0043031),0.32721653084017394,0.7299712093976864,0.7901234567901234,0.9827279507603796,1.0,2/16,8.24%,CD200;CST7
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3070005958079086,0.7297198756069619,0.8198347107438017,0.9825536834286303,1.0,5/22,16.57%,ASXL3;PPP2R5A;CEACAM1;PDE3B;ALK
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2766277994564141,0.7287424976618724,0.8537360890302067,0.9833805394838525,1.0,9/35,15.74%,ITGA1;CALM1;HSP90AB1;PPP1R2;PPP1R11;AGTR2;CSNK2B;PPP1R15B;BOD1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2800672343628645,0.7286877782554108,0.842443729903537,0.982946688037871,1.0,10/35,20.09%,HMBOX1;CTNNB1;MAPK3;CCT3;CCT5;ACD;MAPK1;CCT7;NAF1;MAP2K7
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24366513153577335,0.7280873899524164,0.9065550906555091,0.9832620791286492,1.0,15/84,13.44%,NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PIN1;ABCA7;RPL13A;CNOT9;GRB7;ORMDL1;ORMDL3;BTG2;PAIP2
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.31723528590408806,-0.7280273176199263,0.7962184873949579,0.9912730114225261,1.0,6/10,40.95%,DDX39B;THOC1;FEM1B;ETAA1;CCAR2;THOC5
prerank,DNA duplex unwinding (GO:0032508),0.2618946703809372,0.7275184335850525,0.8644578313253012,0.983483279982123,1.0,14/50,22.36%,MRE11;GTF2H2;CETN2;HMGA1;RECQL4;GTF2H4;ASCC3;RBX1;TWNK;RPA1;DDX11;GTF2H3;DDB1;RAD23B
prerank,microtubule nucleation (GO:0007020),-0.2849151277443615,-0.7272567972387556,0.8571428571428571,0.9914408381922242,1.0,5/19,16.29%,CCDC57;GOLGA2;TUBGCP2;TUBGCP4;TUBG1
prerank,protein homooligomerization (GO:0051260),0.2332180037281697,0.7266121227478447,0.9336801040312094,0.9841876607419253,1.0,19/114,16.56%,AQP11;B2M;HPRT1;GBP5;SAMHD1;MCOLN1;SLC1A2;KCNC2;ACACB;SHMT2;LETM1;EHD4;BCL10;ELAVL1;TRMT61B;CARD11;PDCD6IP;SPAST;NLRC4
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3403172789542539,0.7264832869159542,0.780952380952381,0.9838531510966656,1.0,5/12,22.16%,STMN1;ARHGEF7;CDH5;DYRK1A;SNCA
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2868145383386736,0.7262966791956282,0.8262987012987013,0.9835841820264867,1.0,6/30,16.02%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.30740228172050404,0.7253170482377151,0.8093525179856115,0.9838999600340667,1.0,7/21,21.62%,GTF2H2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.30740228172050404,0.7253170482377151,0.8093525179856115,0.9838999600340667,1.0,7/21,21.62%,GTF2H2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;ERCC4
prerank,negative regulation of ATPase activity (GO:0032780),-0.2942533390166048,-0.7250484593911165,0.8329621380846325,0.9933172098913269,1.0,3/16,20.40%,THADA;ATP5IF1;TSC1
prerank,endoplasmic reticulum organization (GO:0007029),0.2494852592597077,0.7247913155350976,0.8944365192582026,0.9841262770552125,1.0,6/72,10.33%,APP;REEP1;STX1A;CAV2;LPCAT3;REEP5
prerank,DNA-dependent DNA replication (GO:0006261),0.22696709619000302,0.7245847292126861,0.9357798165137615,0.9838983817243324,1.0,39/128,28.64%,PSMB3;PSMD11;PSMC6;HMGA1;PSME2;MCM10;DNA2;CDC6;RECQL4;PSMD8;POLB;POLG2;ORC1;PSMB10;POLE3;TWNK;PSMA8;SIRT7;RPA1;PSMD9;REV3L;POLD1;POLA1;RFC2;PSMC3;PSMD1;PSMD10;TOPBP1;RFC4;PNKP;BLM;POLD4;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7;WRNIP1
prerank,autophagosome assembly (GO:0000045),0.26167571061556333,0.7244475277333436,0.8763197586726998,0.9835792524051304,1.0,23/52,27.66%,IRGM;MAP1LC3B;SMURF1;PIK3C3;ATG12;UBQLN1;RAB1A;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;NSFL1C;GABARAP;VMP1;ATG2A;GABARAPL2;UBXN2B;ULK1;RAB1B;UBQLN2;RAB7A;BECN1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.28100807504711284,-0.7236652217878231,0.8476190476190476,0.9940797610751232,1.0,7/19,22.68%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;GGH;FPGS;MTHFS
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2534705534770407,0.7233537383637998,0.9125364431486881,0.9845382485455345,1.0,7/54,12.16%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2
prerank,regulation of neurogenesis (GO:0050767),0.2562474186264918,0.7233211367672605,0.8818181818181818,0.9840972903386451,1.0,9/55,13.76%,B2M;NOTCH1;TGM2;WNT7A;CTNNB1;FAIM;LRP2;SOX11;HMGB2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3610820121716384,0.7232802592337642,0.7767175572519084,0.9836623551832844,1.0,4/10,16.06%,TBX1;ACTN4;PPARG;RXRB
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.29731388683200494,0.7231774224003377,0.8178807947019867,0.9833130500409579,1.0,4/24,11.82%,NOTCH1;KLF2;ATF6B;HIF1A
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.33067507164159143,0.7227624061723245,0.7905282331511839,0.983377687947919,1.0,3/14,8.24%,CD200;CD200R1;CST7
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.27644413215585323,0.7226612833770913,0.8335974643423137,0.9830248221304465,1.0,13/36,26.63%,NLRC5;IRGM;ADAM17;HIF1A;C1QTNF4;EDN1;GAS6;CPNE1;PARP9;TICAM2;RIPK1;PARP14;AGPAT2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3296127285491408,0.7224518576996394,0.8210526315789474,0.9828095294810786,1.0,3/14,17.12%,ADAM10;ADAM17;CCR2
prerank,embryonic axis specification (GO:0000578),0.332794195922294,0.722302090450798,0.7860869565217391,0.982491715011121,1.0,3/15,10.96%,TBX3;WNT7A;TASOR
prerank,regulation of chromatin binding (GO:0035561),0.357150316259382,0.7222093780859837,0.7834862385321101,0.9821367859455438,1.0,5/10,26.06%,HMBOX1;DDX11;WAPL;PARP9;DTX3L
prerank,regulation of cytoplasmic transport (GO:1903649),0.34751112796965067,0.721850741146422,0.7754716981132076,0.9820992154849139,1.0,2/11,6.18%,DNAJC13;MAPK3
prerank,snRNA transcription (GO:0009301),-0.21174058367652235,-0.7215080388230153,0.9425981873111783,0.995857418139979,1.0,23/70,30.57%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;USPL1;TBP;POLR2L;TAF9;SNAPC2;CDK9;POLR2I;INTS3;POLR2K;ZC3H8;INTS5;SNAPC4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.2860294743129385,0.7212762733902446,0.8477508650519031,0.9823623575475221,1.0,6/27,16.47%,CD200;CD200R1;TNFAIP3;FOXJ1;NCKAP1L;GAS6
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2906207191057134,-0.7210382766920395,0.8412017167381974,0.9955853250061744,1.0,7/16,24.26%,PIGN;PIGA;PIGP;PIGX;PIGB;PIGH;PIGL
prerank,response to amino acid (GO:0043200),0.2839776287565136,0.7210217483063986,0.8644338118022329,0.9822009664451331,1.0,10/31,24.90%,SH3BP4;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2;GRIN1;MTOR;GLRA1
prerank,peptidyl-asparagine modification (GO:0018196),0.2825473821645814,0.7205412457703085,0.8327974276527331,0.9823209277964272,1.0,6/31,16.02%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.30850828376027206,-0.7197694470199355,0.8237885462555066,0.9963109563747393,1.0,1/13,1.07%,B3GALT1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.32632878032991885,0.7197638601459404,0.8135283363802559,0.9828398926515824,1.0,1/15,0.99%,BCL2L1
prerank,membrane protein proteolysis (GO:0033619),-0.24063989831305227,-0.7194358578162303,0.8956043956043956,0.9959329613779359,1.0,10/37,18.25%,DAG1;ADAM9;BACE2;ADAM19;AFG3L2;PSEN1;CTSH;HM13;PARL;MBTPS1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.2828844182522596,0.7193702770373267,0.8195364238410596,0.9828605676265774,1.0,8/27,21.67%,MAP3K8;IKBKB;MAPK3;CCM2;MAPK1;SKP1;MAP2K7;CUL1
prerank,cardiolipin metabolic process (GO:0032048),0.3312084092374888,0.7190094785620565,0.7939068100358423,0.982804602176905,1.0,2/13,12.55%,PTPMT1;PNPLA8
prerank,pre-replicative complex assembly (GO:0036388),0.2481169163389206,0.7185497001803632,0.8742424242424243,0.982906390271898,1.0,19/64,28.16%,PSMB3;PSMD11;PSMC6;PSME2;CDC6;PSMD8;ORC1;PSMB10;PSMA8;PSMD9;PSMC3;PSMD1;PSMD10;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,nucleic acid metabolic process (GO:0090304),-0.2065882554385275,-0.7185395972955403,0.9585987261146497,0.9961956543119156,1.0,11/69,17.09%,ENPP1;NT5E;HNRNPH1;POLR2A;DDX1;HNRNPH2;HNRNPR;HNRNPA2B1;GTF2F1;RAD50;PCBP2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.34484264657619235,0.7183001861693715,0.7927927927927928,0.9827477281523095,1.0,1/11,4.52%,CTNNB1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.23735803263237118,-0.7172501911016855,0.8931506849315068,0.9969150936170784,1.0,12/35,31.68%,PARP3;GPSM2;CHMP4C;EML3;RAE1;TPX2;HSPA1A;CCSAP;TPR;NUMA1;PLK1;PSRC1
prerank,DNA replication (GO:0006260),-0.19543933303691194,-0.7167171506096441,0.9826839826839827,0.996762375410127,1.0,40/105,32.26%,TOP1;RBMS1;REV1;ATM;RBBP8;TIPIN;HELB;IGHMBP2;NAP1L1;RAD50;BAZ1A;CLSPN;DUT;ATRIP;POLD2;RFC3;BRCA1;PCLAF;DONSON;CDC45;DBF4;WRN;NBN;MCM3;ATR;MCM4;POLE2;MCM5;MCM9;EXO1;RFC5;ORC2;ORC5;TOP1MT;TBRG1;PIF1;FEN1;KAT5;TICRR;MCMBP
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.30058285389337625,0.7164351684082089,0.8137254901960784,0.984663429702821,1.0,2/22,3.56%,NOTCH1;IL10RB
prerank,chromatin assembly (GO:0031497),0.26791142818114794,0.7163828972632426,0.8672,0.9842354095953884,1.0,14/38,24.04%,PRDM9;CTCF;CHAF1A;NAA60;SOX9;HMGB2;POLE3;CHAF1B;HMGA2;NOC2L;GRWD1;DAXX;LIN54;NAP1L4
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3086877061420816,0.7160953026370416,0.7962328767123288,0.9841311317244748,1.0,6/18,20.06%,DYSF;SYK;DOCK2;NMI;SBNO2;PLCG2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.34203632502047104,0.7140314111448042,0.8051001821493625,0.9863011143542633,1.0,4/11,22.42%,NCBP2;ZFP36L1;NCBP1;PAPOLA
prerank,response to nutrient levels (GO:0031667),-0.2800515059380746,-0.7136936236472688,0.8611764705882353,0.9994856758707812,1.0,4/17,19.95%,PRKAA2;KCNB1;RPS6KB1;EIF4G1
prerank,protein deacetylation (GO:0006476),-0.2336396654401774,-0.7136560375670669,0.9010695187165776,0.9987261986312659,1.0,6/41,9.15%,HDAC4;TBL1XR1;MIER3;FLNA;SIRT3;MORF4L2
prerank,steroid hormone biosynthetic process (GO:0120178),0.282340595315243,0.7132731709726723,0.8497576736672051,0.986791674291787,1.0,6/29,19.63%,CYP11B1;CYP11A1;HSD17B7;HSD17B8;DHCR7;STARD3NL
prerank,sensory perception of chemical stimulus (GO:0007606),-0.29407625884883043,-0.7131572577424659,0.8495370370370371,0.998478735680701,1.0,5/15,22.35%,GNAS;MKKS;UBR3;BBS4;GNAL
prerank,nuclear transport (GO:0051169),0.31806910852656944,0.712717199754296,0.8059964726631393,0.9870171527024899,1.0,4/16,17.07%,NXT1;HMGA1;BANF1;RSRC1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.27940417758665914,0.7124264183150262,0.8360927152317881,0.9868876147074331,1.0,4/31,11.78%,STX1A;SYT7;STXBP1;SYT4
prerank,dopaminergic neuron differentiation (GO:0071542),0.30575945195380694,0.7122995729915323,0.8076923076923077,0.9865485446823175,1.0,2/19,7.32%,CTNNB1;PHOX2A
prerank,telomere organization (GO:0032200),0.265037361112457,0.7119017486192669,0.8790199081163859,0.9865557292745439,1.0,14/43,25.96%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1;HUS1;RPA1;POLD1;ERCC4;PTGES3;BLM;POLD4
prerank,histone H3-K4 methylation (GO:0051568),-0.250063378906763,-0.7116046666455761,0.8557919621749409,0.9994671330834995,1.0,3/26,6.37%,OGT;CTR9;SETD4
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2824056677394657,-0.711486948814781,0.8318181818181818,0.998782574685425,1.0,4/15,13.94%,MAGI2;DACT1;SKI;ACVR1B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.309767771118525,-0.7113364632185167,0.8170212765957446,0.9981650658322723,1.0,6/12,30.07%,ESR1;NCOR1;BCDIN3D;ZC3H10;STAT3;TERT
prerank,regulation of oxidoreductase activity (GO:0051341),0.33416643271103885,0.7110501307439894,0.7956204379562044,0.9871055799896087,1.0,1/13,3.20%,NOD2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.28017135905140544,0.7109521226871899,0.8414239482200647,0.9867433661714835,1.0,4/30,10.12%,CAV1;HYAL2;INPP5F;PTK6
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2735186056277298,0.7109474722708865,0.8464106844741235,0.986260368405364,1.0,3/32,4.12%,RAPGEF2;NEDD4L;LZTS1
prerank,regulation of ion transport (GO:0043269),0.24371770468619394,0.7106732552273227,0.9152542372881356,0.9861140767877148,1.0,16/76,18.53%,B2M;NEDD4L;NKAIN2;SYT7;ATP1A1;PXK;YWHAH;P2RX7;NKAIN1;SYT4;ANK3;KCNJ3;KCNJ5;CA2;KCNJ6;KCNA5
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.2947198680303647,0.7106150499194317,0.8446280991735537,0.9856973793937466,1.0,3/25,10.72%,SORT1;CHMP1B;TMEM50A
prerank,signal transduction in response to DNA damage (GO:0042770),0.2558705015694965,0.7105915495193349,0.8843226788432268,0.9852376069439815,1.0,10/49,19.36%,ACER2;MYO6;GRB2;HINFP;STK33;FBXO6;TRIAP1;HUS1;NDRG1;CDC5L
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.3064719202892322,-0.7104142193639854,0.8311688311688312,0.9984311424734048,1.0,4/12,22.47%,NEK6;PRKCA;CNEP1R1;CCNB2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.34770078502175766,0.7097896770723303,0.8134328358208955,0.9857370195423487,1.0,1/10,4.35%,CALM1
prerank,action potential (GO:0001508),0.2599805128178624,0.709737009944331,0.8736176935229067,0.9853161313572357,1.0,7/44,8.33%,GNAQ;KCNQ1;SRI;SCN1A;MYH14;KCNH2;YWHAH
prerank,mRNA 3'-end processing (GO:0031124),-0.20430260437770525,-0.7096824963491012,0.9463087248322147,0.9984835718523056,1.0,27/78,25.41%,SRSF5;PABPN1;SRSF11;PCF11;RPRD2;SRSF6;CPSF3;SRSF4;TENT2;PAF1;DDX39B;PAPOLB;TUT1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;CSTF3;PAPOLG;FIP1L1;DDX39A;EIF4A3;GRSF1;POLDIP3;THOC1;SYMPK
prerank,Golgi localization (GO:0051645),0.33792134291336096,0.7096291151750287,0.7779816513761468,0.9849575474751474,1.0,6/11,27.10%,RIPOR1;PDCD10;YWHAZ;UVRAG;CDC42;HOOK3
prerank,regulation of transferase activity (GO:0051338),0.31957841385715224,0.7095251666734215,0.8315217391304348,0.984596822748419,1.0,2/17,3.77%,NLRC5;HMBOX1
prerank,regulation of peptidase activity (GO:0052547),0.314393060629491,0.7092553693645814,0.8180242634315424,0.984427422933676,1.0,2/19,8.24%,CAV1;CST7
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3107708580674984,0.7089098161419607,0.8217993079584776,0.9843434111052741,1.0,5/17,19.17%,CTCF;BUB3;BOD1;ZW10;IK
prerank,leukotriene biosynthetic process (GO:0019370),-0.2901187646723171,-0.7084629718781332,0.8133333333333334,0.9990567972477115,1.0,3/14,15.64%,GGT5;GGTA1;MGST3
prerank,acylglycerol homeostasis (GO:0055090),-0.272614743039043,-0.7072812014063559,0.8813186813186813,0.9995711913766098,1.0,3/20,8.01%,IL18;RORA;APOE
prerank,myelination in peripheral nervous system (GO:0022011),-0.2991134924810908,-0.7069229290222871,0.8559322033898306,0.9991783939505804,1.0,8/13,27.75%,MYOC;SKI;NF1;SIRT2;LGI4;NCMAP;PRX;CNTNAP1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2338303011880567,0.7067506548615907,0.9221311475409836,0.9865369056581685,1.0,24/83,24.87%,CDK17;MAX;HINFP;BRD4;CDC6;EIF4E;ORC1;PIM2;PLK2;ACVR1;TRIM71;USP29;CDK18;CDK6;POLA1;CDK4;NASP;CUL1;DHFR;CDKN1B;KLF11;MYC;CDKN2C;TYMS
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.32413597123881077,0.7061663766765764,0.8149532710280374,0.9867875094029941,1.0,3/13,18.27%,STX1A;SYT4;CACNA1I
prerank,integrated stress response signaling (GO:0140467),-0.28719997902825906,-0.7057422019156467,0.8179775280898877,0.9997074995475068,1.0,5/14,26.10%,IMPACT;DDIT3;QRICH1;CCL2;EIF2AK3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2825547502281576,-0.7055908599565919,0.8626126126126126,0.9990887919027744,1.0,3/16,14.03%,FBH1;KLHL15;HELB
prerank,midbody abscission (GO:0061952),0.3078583980729539,0.7046928382521869,0.8102836879432624,0.9880211922474603,1.0,6/17,28.95%,CHMP1B;MITD1;PDCD6IP;CHMP2B;VPS4B;CEP55
prerank,non-motile cilium assembly (GO:1905515),-0.2458302398015387,-0.7041476103868417,0.8837837837837837,0.9999284116394839,1.0,11/30,24.39%,TTC8;IFT122;FUZ;RPGRIP1L;IFT57;PIBF1;PCM1;CEP250;BBS4;TMEM17;C2CD3
prerank,bile acid metabolic process (GO:0008206),0.2847699184187219,0.7031314064049764,0.8387622149837134,0.9893322502206437,1.0,5/27,12.91%,OSBPL1A;OSBP;ABCB11;NPC1;SLC27A2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.33688722798381093,0.7031192552084047,0.8059149722735675,0.9888647250326118,1.0,4/11,20.98%,NEDD4L;GOPC;LEPROTL1;GPM6B
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23722264352723085,0.7030137242948232,0.9051094890510949,0.9885223811482751,1.0,17/71,17.36%,CTSC;ATXN3;CTSW;CTSK;CTSO;RHBDD1;MALT1;OTUD7A;CASP8;TNFAIP3;OMA1;PSMA8;ATE1;PDCD6IP;CTSS;CAPN2;BAG6
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2589691304374335,-0.7022096212953806,0.8862433862433863,1.0,1.0,6/24,14.97%,DMD;CAMK2D;PKD2;PRKACA;JPH1;GSTM2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2745151288086272,0.7020289016701827,0.8663446054750402,0.9891806417485424,1.0,4/31,12.63%,LYN;TNFRSF21;FOXP3;SOX11
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3365349668622639,0.7019511867322445,0.8075539568345323,0.988307610099777,1.0,2/11,7.16%,CALM1;SRI
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3365349668622639,0.7019511867322445,0.8075539568345323,0.988307610099777,1.0,2/11,7.16%,CALM1;SRI
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.22595626676933828,-0.7017938148836824,0.9401041666666666,1.0,1.0,11/42,27.38%,FBH1;RTEL1;PARP1;KDM1A;KLHL15;HELB;ERCC6;SETD2;SIRT6;SPIDR;RAD51AP1
prerank,glycerolipid metabolic process (GO:0046486),0.33556531647359206,0.7016391185036394,0.795880149812734,0.9881983042450864,1.0,3/11,18.95%,GAL3ST1;DGKZ;PGP
prerank,protein sumoylation (GO:0016925),-0.21971358581349337,-0.7009064160278109,0.9528301886792453,1.0,1.0,6/49,12.17%,EYA1;PIAS1;SEH1L;NUP205;TRPM4;PIAS2
prerank,glucose metabolic process (GO:0006006),0.24715515155242948,0.700555099033802,0.9113149847094801,0.9890229755615777,1.0,10/58,14.74%,SORD;PPARD;LRP5;BRAT1;SLC25A1;G6PC3;HECTD4;PGAM1;TPI1;OMA1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2925746747313714,0.7000120335366985,0.8370883882149047,0.9891443025985512,1.0,10/23,26.98%,CETN2;RBX1;COPS5;GPS1;COPS6;DDB1;RAD23B;XPC;COPS2;UBB
prerank,secretory granule organization (GO:0033363),-0.3143117412477199,-0.6993398265840529,0.8390557939914163,1.0,1.0,2/10,5.16%,ABCA1;DTNBP1
prerank,regulation of RNA splicing (GO:0043484),0.23849264992969854,0.6992295058680345,0.9380281690140845,0.9895938283605636,1.0,2/69,1.59%,RBM20;QKI
prerank,N-terminal protein amino acid modification (GO:0031365),0.3235903279615382,0.6973480090870472,0.8165137614678899,0.9913302992262402,1.0,4/14,13.94%,NAA60;NAA16;NAA11;METAP2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2756267751323377,-0.6971133483486094,0.8584686774941995,1.0,1.0,8/18,34.71%,POLD2;RFC3;LIG1;MCM3;MCM4;LIG3;GINS1;GINS3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.21712994609262132,0.6968987309010515,0.9667519181585678,0.9913622612468114,1.0,27/144,17.11%,PPP1R13B;PRR5L;RAPGEF3;RIPOR1;PPP3CC;HYAL2;FYN;FBXW7;OAZ1;TGFB1;YWHAH;ZPR1;YWHAQ;PDCD10;CASP8;HRAS;GSK3A;SH3GLB1;PPP3R1;B3GAT3;TMEM30A;MFF;UBE2D3;ANK3;GAS6;YWHAZ;YWHAB
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3101861741579616,0.6965387266830583,0.8494623655913979,0.9912933193402567,1.0,3/17,10.22%,WASF2;NCKAP1;CYFIP1
prerank,tRNA methylation (GO:0030488),-0.23055538344921023,-0.6955412419262816,0.9263157894736842,1.0,1.0,7/34,12.55%,THADA;PRORP;DALRD3;THUMPD3;TRMT1L;NSUN2;METTL6
prerank,autophagosome organization (GO:1905037),0.25282174818829667,0.6953252906672716,0.9009009009009009,0.9922395984629884,1.0,22/50,27.66%,IRGM;MAP1LC3B;PIK3C3;ATG12;UBQLN1;RAB1A;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;NSFL1C;GABARAP;VMP1;ATG2A;GABARAPL2;UBXN2B;ULK1;RAB1B;UBQLN2;RAB7A;BECN1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.32380640181489884,0.6952537730404021,0.8085867620751341,0.9918358635170166,1.0,2/13,4.45%,SOX13;RREB1
prerank,regulation of ATP metabolic process (GO:1903578),-0.21588883294778122,-0.695236404166647,0.9454022988505747,1.0,1.0,5/54,9.42%,PRKAG2;OGT;SEH1L;ATP7A;NUP205
prerank,sensory perception (GO:0007600),-0.22353986996831232,-0.695048899783536,0.956989247311828,1.0,1.0,6/45,8.63%,ADGRV1;PTGES;GNAS;P2RX4;TTC8;ADORA2A
prerank,negative regulation of phosphatase activity (GO:0010923),0.2842836831350939,0.6948455754652659,0.8414023372287145,0.9918166602653566,1.0,6/25,19.97%,TGFB2;PPP1R11;PPP1R35;BOD1;FKBP1A;SEMA4D
prerank,maturation of LSU-rRNA (GO:0000470),-0.24830825352900626,-0.6942410041710037,0.8900255754475703,1.0,1.0,4/26,12.48%,NSA2;WDR12;NOP2;LAS1L
prerank,cellular response to virus (GO:0098586),0.2739105204633012,0.6934698052571584,0.8610169491525423,0.992904911411135,1.0,6/30,11.82%,IFIH1;POU2AF1;LGALS9;IRGM;EIF5A;HIF1A
prerank,lipid catabolic process (GO:0016042),0.3031986982105275,0.6930189210415456,0.8493647912885662,0.9929059232021338,1.0,2/18,10.76%,LIPE;LIPC
prerank,histone H4 deacetylation (GO:0070933),0.33624173897399834,0.6925769200570205,0.8147448015122873,0.9929320784807675,1.0,3/10,16.91%,HDAC9;SMARCAD1;RCOR1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.2786256280041856,-0.692380436382458,0.8544600938967136,1.0,1.0,6/15,28.72%,COQ10A;COQ2;COQ8B;COQ10B;NDUFA9;COQ6
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2928039652256681,0.6922646700099478,0.8505154639175257,0.9927872105591313,1.0,8/23,21.28%,OCRL;INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1;INPP5K
prerank,mRNA processing (GO:0006397),-0.1634122312032481,-0.6920925128375349,1.0,1.0,1.0,80/287,27.74%,DDX5;SRRM2;PPARGC1A;HNRNPH1;HNRNPUL1;SON;SRSF5;POLR2A;RNPC3;PABPN1;SNRNP70;SRSF11;PRCC;RAVER2;PCF11;RPRD2;AKAP8L;SRRM4;NOVA1;SRSF6;CPSF3;GCFC2;PRKACA;SUGP1;CCNH;HNRNPH2;SRSF4;PNN;CDK7;RBM5;PRPF19;HNRNPR;RBM41;NONO;HNRNPA2B1;PRMT9;GTF2F1;PPIH;DDX39B;CCAR1;PSPC1;RAMAC;PCBP2;THOC2;PRPF18;PRPF3;THOC7;U2AF2;U2AF1;TRA2B;LSM3;TCERG1;CPSF2;CSTF3;FIP1L1;SRSF10;DDX39A;RBMX2;AURKAIP1;SF1;TBRG4;RBM10;EIF4A3;GTF2H1;DBR1;PPIL1;POLR2L;POLDIP3;CWF19L1;THOC1;RNMT;SYMPK;LSM8;POLR2I;HNRNPD;SNRPA1;SF3B5;DHX35;CRNKL1;TFIP11
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3433723529595901,0.6915281705225929,0.8075471698113208,0.9926618365417431,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.3433723529595901,0.6915281705225929,0.8075471698113208,0.9926618365417431,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,DNA geometric change (GO:0032392),-0.2493395019631096,-0.6914506615446917,0.8734177215189873,1.0,1.0,14/24,32.83%,ANXA1;DDX1;RTEL1;ZRANB3;HNRNPA2B1;RAD50;WRN;NBN;MCM9;HMGB1;RECQL;DHX36;PIF1;SUPV3L1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.2935872477952639,-0.6913364766572483,0.852112676056338,1.0,1.0,6/14,21.80%,AR;BCAS3;SFRP1;RARA;PELP1;SRA1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27277233051045413,-0.6904759688653418,0.8709677419354839,1.0,1.0,5/18,14.62%,SOD2;PRKN;TRAP1;HTRA2;NONO
prerank,regulation of protein localization (GO:0032880),0.24271696129524284,0.6898690134127772,0.8967551622418879,0.9940033631437715,1.0,5/58,6.44%,TRIM25;TRIM14;MMD;HSP90AB1;FBXW7
prerank,regulation of histone deacetylation (GO:0031063),0.32362100778145425,0.6892518471150346,0.8257713248638838,0.994215817421734,1.0,3/13,14.86%,APLNR;FOXP3;CTBP1
prerank,protein-DNA complex disassembly (GO:0032986),0.30557552127081494,0.688890961240928,0.8167259786476868,0.9941277025085336,1.0,9/16,25.08%,ARID1A;HMGA1;SMARCD1;SET;RPL23;GRWD1;ARID2;MYC;SMARCA4
prerank,steroid metabolic process (GO:0008202),-0.20009797980506855,-0.6883111661285031,0.9793103448275862,1.0,1.0,4/72,5.39%,CYP7B1;CYP26B1;CYP27A1;CYP1B1
prerank,lysosome localization (GO:0032418),0.2668538000377099,0.6879442968669855,0.9003215434083601,0.9946543564316679,1.0,7/37,14.10%,SPAG9;RAB34;MILR1;PLEKHM1;TFEB;KXD1;FAM98A
prerank,synaptonemal complex organization (GO:0070193),0.3101916186317877,0.6874700960797845,0.8458646616541353,0.9942261377641278,1.0,6/15,29.64%,RAD21;BAG6;SYCP2;REC8;TEX12;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.3101916186317877,0.6874700960797845,0.8458646616541353,0.9942261377641278,1.0,6/15,29.64%,RAD21;BAG6;SYCP2;REC8;TEX12;P3H4
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3189250681060037,0.6865458919721753,0.825136612021858,0.9947048767698744,1.0,3/14,10.96%,BRCA2;TERF2;ACD
prerank,DNA double-strand break processing (GO:0000729),0.29725798307562695,0.6854696299914594,0.8386524822695035,0.9953748987941905,1.0,4/18,15.43%,MRE11;UBE2V2;DNA2;SMARCAD1
prerank,sulfur amino acid catabolic process (GO:0000098),0.3342607943449163,0.6850955455982609,0.8314814814814815,0.9953237310575019,1.0,2/10,18.90%,CBS;TXN2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.20191887212858162,-0.684824026619198,0.9539877300613497,1.0,1.0,22/69,30.57%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;TBP;POLR2L;TAF9;SNAPC2;CDK9;POLR2I;INTS3;POLR2K;ZC3H8;INTS5;SNAPC4
prerank,histone H4-K16 acetylation (GO:0043984),0.2893385959944217,0.6844726639129086,0.831304347826087,0.9954945495932698,1.0,5/19,16.38%,PHF20;JADE2;MCRS1;HCFC1;MSL2
prerank,selective autophagy (GO:0061912),-0.2115382400142995,-0.6842542110793624,0.9451219512195121,1.0,1.0,11/56,14.77%,LGALS8;ULK2;ATG2B;PRKN;ATM;TEX264;DYNC1I1;AUP1;AMBRA1;DDRGK1;UFC1
prerank,histone mRNA metabolic process (GO:0008334),0.2726406800940256,0.6836026160901746,0.8925619834710744,0.9959408980662432,1.0,9/27,21.57%,MTPAP;SNRPF;SNRPE;DCP2;NCBP2;SNRPB;EXOSC10;XRN1;NCBP1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.19820204032864938,-0.6835035519048124,0.9635761589403974,1.0,1.0,15/73,19.26%,HDAC4;DNMT3A;BAZ1B;IGF2;TDG;PPM1D;SMARCA5;TAF1D;EP300;POLR1C;ERCC6;RBBP4;EED;PHF2;EZH2
prerank,magnesium ion transport (GO:0015693),-0.2994558593101044,-0.6834743441415416,0.823394495412844,1.0,1.0,4/12,19.77%,SLC41A1;NIPAL2;MAGT1;TUSC3
prerank,regulation of mitochondrial translation (GO:0070129),-0.25851089076679995,-0.6829017386227,0.8857808857808858,1.0,1.0,9/21,22.00%,MRPS27;RMND1;ALKBH1;NSUN3;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2880357486564889,-0.682081377783106,0.8783783783783784,1.0,1.0,4/13,20.90%,RHOQ;LRRK2;GNAI3;ENTPD7
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.23680809984718537,-0.6818474570837295,0.9345088161209067,1.0,1.0,5/31,9.52%,PRKCI;PARD3B;DLG1;MYO9A;EZR
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24094337844902605,-0.6817006521751153,0.9291139240506329,1.0,1.0,7/30,16.99%,FBH1;UBR5;KLHL15;TWIST1;HELB;TRIP12;ERCC6
prerank,cellular response to DNA damage stimulus (GO:0006974),0.1959309055920794,0.6813653547078871,0.9988532110091743,0.9978938399157576,1.0,71/336,21.64%,POLK;BCL2L1;ACER2;FOXO1;MEN1;LYN;FNIP2;SAMHD1;GRB2;CCDC13;RNF169;XIAP;MRE11;MAPK3;MCL1;HINFP;PIDD1;PWWP3A;FANCG;PAK1;HPF1;MCM10;STK33;MGMT;RECQL4;GTF2H4;BRAT1;CCNK;FBXO6;BTG2;POLB;WDR48;FAN1;NSMCE4A;FANCF;POLE3;MSH3;RNF8;MSH2;TRRAP;APC;SIRT7;HERC2;CDKN2AIP;SUMO1;GNL1;ALKBH8;HUS1;NUDT1;CBX1;SLF1;RPA1;DDX11;ADPRS;NSMCE3;BAK1;RAD9B;FOXP1;POLD1;UVRAG;TIGAR;ERCC8;GTF2H3;POLA1;PARP2;RBBP5;RFC2;METTL3;DDB1;ERCC4;RAD1
prerank,cellular response to amino acid starvation (GO:0034198),0.2348002311733861,0.6809780992787642,0.9384835479256081,0.9978249202831586,1.0,11/71,12.45%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;DEPDC5;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,anterograde axonal transport (GO:0008089),-0.22152164037072156,-0.680601444798644,0.9390581717451524,1.0,1.0,4/37,7.83%,TRAK1;DTNBP1;RAB21;AP3B1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.29302368155410763,0.6800735515559693,0.8585858585858586,0.998301279782169,1.0,1/17,3.45%,PLA2G4B
prerank,response to amino acid starvation (GO:1990928),0.23407072936508802,0.6799070153338647,0.9373219373219374,0.9979927455327615,1.0,11/72,12.45%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;DEPDC5;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.2844872227788588,0.6793473195007125,0.8662207357859532,0.998090947644631,1.0,3/22,12.52%,B2M;MALT1;CYRIB
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2702103981561018,0.6791797254422233,0.8717504332755632,0.9977867187049674,1.0,8/27,20.67%,CHKA;SELENOI;CEPT1;PNPLA8;LPIN3;ETNPPL;ETNK1;PISD
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3134220987418575,0.6791401469150457,0.8385899814471243,0.9973417405063512,1.0,1/14,4.60%,OSMR
prerank,spindle assembly (GO:0051225),0.23493726757412492,0.6789039185664874,0.9266467065868264,0.9971059702846623,1.0,9/67,12.53%,STARD9;MAPRE2;KIF2A;RAB11A;SAC3D1;MZT1;HAUS6;KIF3B;MAPRE3
prerank,regulation of sodium ion transport (GO:0002028),0.26086598536738725,0.6787642008251095,0.9019933554817275,0.9967719387442227,1.0,6/34,11.33%,CNKSR3;NKAIN2;ATP1A1;YWHAH;P2RX7;NKAIN1
prerank,positive regulation of peptidase activity (GO:0010952),-0.2604563712810417,-0.6783003858023393,0.8942065491183879,1.0,1.0,5/20,16.97%,RCN3;PSME3;CTSH;DDRGK1;GRN
prerank,regulation of cellular metabolic process (GO:0031323),0.2459248705288136,0.6774568116106453,0.9129770992366413,0.9976107493470581,1.0,5/45,8.23%,FASN;ABCG1;ABCB11;ACACB;MKLN1
prerank,heterochromatin assembly (GO:0031507),0.2899634782131564,0.6774212016922885,0.8586387434554974,0.9971745059391431,1.0,5/20,16.58%,ZNFX1;HMGA1;HELLS;POLE3;HMGA2
prerank,histone H2A monoubiquitination (GO:0035518),-0.2669769691713153,-0.6770611149374323,0.8793503480278422,1.0,1.0,4/17,9.81%,BCOR;KDM2B;PCGF2;DDB2
prerank,cytoplasmic translational initiation (GO:0002183),0.2974333380809817,0.6768458071571474,0.8568807339449541,0.9972805607868158,1.0,6/17,23.52%,EIF4H;EIF3D;EIF3M;EIF4A1;EIF4B;EIF2S2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.29788455294222116,-0.6765224769986952,0.8645833333333334,1.0,1.0,3/12,14.75%,SLC5A3;CYBA;TLR4
prerank,linoleic acid metabolic process (GO:0043651),-0.2676730420697849,-0.6762493579360197,0.8738532110091743,1.0,1.0,1/17,1.89%,ACSL1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.33505362064130245,0.6762104309608291,0.8295880149812734,0.9974634010397447,1.0,2/10,10.96%,TERF2;ACD
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.32312788219417216,0.6761749455193096,0.8451730418943534,0.9970152110592823,1.0,3/11,14.58%,FYN;UBQLN1;STK26
prerank,negative regulation of DNA recombination (GO:0045910),-0.21902630264583928,-0.6746513651137723,0.9559228650137741,1.0,1.0,7/43,14.03%,FBH1;PARP3;POLR2A;RTEL1;KLHL15;ZRANB3;HELB
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.27435652345758016,-0.6742205596948161,0.8764568764568764,1.0,1.0,4/16,21.77%,PARP3;KMT5C;KMT5B;KDM4D
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.27647665226879015,-0.6738407436712817,0.8647342995169082,1.0,1.0,6/15,30.37%,KYAT1;FAH;KMO;KYNU;IL4I1;HAAO
prerank,regulation of T cell differentiation (GO:0045580),0.2688092956152598,0.6734835676188112,0.8818040435458787,0.9992500909454153,1.0,4/33,10.94%,ZAP70;TCF7;FOXP3;CBFB
prerank,endocytic recycling (GO:0032456),-0.2085701248738733,-0.6734430302767033,0.9593023255813954,1.0,1.0,16/50,24.67%,SNX12;ENTR1;ACAP2;ANKRD27;VPS35L;EHD1;RAB11B;EHD2;VPS26C;RAB13;ANKRD50;RAB14;SNX17;CCDC22;VPS26A;VPS39
prerank,dendritic cell chemotaxis (GO:0002407),0.3168063841672555,0.6718900294296335,0.8376511226252159,1.0,1.0,2/14,8.20%,CCR7;CXCR2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2673786595410612,0.6705728235637465,0.8794567062818336,1.0,1.0,9/29,24.43%,GTF2H2;CETN2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;RAD23B;XPC
prerank,membrane lipid catabolic process (GO:0046466),-0.30122273742928257,-0.6704189182797848,0.841541755888651,1.0,1.0,3/10,13.89%,CYP1B1;PDXDC1;NAGA
prerank,positive regulation of hormone secretion (GO:0046887),-0.2618795880004868,-0.6696573709530651,0.8886255924170616,1.0,1.0,2/17,7.57%,SPP1;C1QTNF3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2587424197276016,-0.669582792179687,0.9027149321266968,1.0,1.0,4/18,17.76%,PABPN1;DDX19B;MCM3AP;THOC2
prerank,mitotic sister chromatid segregation (GO:0000070),0.21982954581374775,0.6695772992314817,0.9678770949720671,1.0,1.0,17/98,19.15%,TENT4A;NCAPH;RAB11A;MCPH1;CHMP1B;NCAPG;KIF23;CSNK2B;SPAG5;BOD1;PDCD6IP;TTN;RAD21;POGZ;NCAPH2;SET;ZW10
prerank,peptidyl-arginine modification (GO:0018195),-0.2696004551804782,-0.6688620909793337,0.8849557522123894,1.0,1.0,10/15,44.77%,PRMT5;PRMT8;ART3;KRTCAP2;PRMT1;ART1;PADI1;PADI4;ART4;ART5
prerank,regulation of double-strand break repair (GO:2000779),-0.21725209352670113,-0.6683067066062075,0.9462915601023018,1.0,1.0,13/39,27.38%,UBR5;PML;RTEL1;KDM1A;TWIST1;TRIP12;SETD2;SLF2;OTUB1;SIRT6;ZCWPW1;SPIDR;RAD51AP1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2241866261046273,0.6676139781672592,0.9580318379160637,1.0,1.0,20/82,21.27%,DYNLL1;CCP110;PRKAR2B;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP135;CEP72;TUBB4B;TUBA1A;CKAP5;CEP70;DCTN1;SFI1;CLASP1;NDE1;HAUS2
prerank,negative regulation of hippo signaling (GO:0035331),-0.29137263684873466,-0.6675242877678927,0.8755274261603375,1.0,1.0,6/12,25.34%,VGLL4;MAPK14;LIMD1;MAP2K3;AJUBA;CIT
prerank,cellular response to osmotic stress (GO:0071470),0.2763976741809338,0.6674830351206672,0.8726003490401396,1.0,1.0,5/21,16.62%,ARHGEF2;RCSD1;ZFP36L1;LRRC8D;TRPV4
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.22521331396803318,0.6674103551418672,0.9556509298998569,1.0,1.0,18/69,22.39%,TRIM25;STT3B;SGTB;PSMC6;UBQLN1;FBXO6;DERL2;MAN1B1;EDEM1;DNAJB9;TMUB2;UBE2G2;BAG6;FBXO2;TMEM129;ANKZF1;TMUB1;UBE2J1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2806109527651409,-0.6666835787393252,0.888402625820569,1.0,1.0,3/12,17.10%,PPARA;WNK1;MDK
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3158011149748156,0.6666644080909099,0.8462962962962963,1.0,1.0,2/12,9.70%,HPRT1;GART
prerank,intracellular pH reduction (GO:0051452),0.25922842998881657,0.6665613938655791,0.9074380165289256,1.0,1.0,5/33,11.70%,ATP6V0A1;RAB39A;CLCN3;GPR89A;GPR89B
prerank,regulation of neurotransmitter secretion (GO:0046928),0.26050717427244835,0.6663328830752883,0.9040650406504065,1.0,1.0,7/32,18.11%,MEF2C;SLC30A1;PNKD;CPLX1;RIMS4;RIMS2;PREPL
prerank,secondary alcohol biosynthetic process (GO:1902653),0.26167244236500276,0.6655841070241523,0.9105691056910569,1.0,1.0,7/30,18.72%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,quinone biosynthetic process (GO:1901663),-0.272139668623345,-0.6649064289727925,0.9061784897025171,1.0,1.0,4/14,19.93%,COQ10A;COQ2;COQ8B;COQ10B
prerank,regulation of cholesterol esterification (GO:0010872),0.3218853713479582,0.6644261603709086,0.8445297504798465,1.0,1.0,3/10,19.40%,ABCG1;STARD4;AGT
prerank,ncRNA transcription (GO:0098781),0.30736611016473714,0.6641514005976198,0.8516483516483516,1.0,1.0,5/13,27.64%,GTF3A;SIRT7;SPIN1;GTF3C1;SNAPC3
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3049527785305693,0.6640918526523839,0.8657718120805369,1.0,1.0,2/14,6.23%,MRPL12;SLC25A33
prerank,regulation of neutrophil migration (GO:1902622),0.3142974489440497,0.6636065452009245,0.843065693430657,1.0,1.0,2/10,14.70%,RAC1;NCKAP1L
prerank,TOR signaling (GO:0031929),0.26843721952542277,0.6633440728835541,0.8964401294498382,1.0,1.0,4/26,15.35%,PRR5L;CCDC88A;RPTOR;CARD11
prerank,regulation of brown fat cell differentiation (GO:0090335),0.2952177771418704,0.6618287462042807,0.8599290780141844,1.0,1.0,2/16,4.45%,SOX13;RREB1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2900732085370159,-0.6618054196681611,0.8818181818181818,1.0,1.0,5/11,21.38%,SHC1;STAT5A;PTK2B;STAT5B;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),-0.2900732085370159,-0.6618054196681611,0.8818181818181818,1.0,1.0,5/11,21.38%,SHC1;STAT5A;PTK2B;STAT5B;JAK1
prerank,receptor clustering (GO:0043113),0.2655066535509597,0.6612793861406203,0.9004893964110929,1.0,1.0,7/27,16.54%,AGRN;LRRC7;PTN;NRXN1;SYNJ2BP;NLGN1;ITGA4
prerank,gastrulation (GO:0007369),-0.2739408418159515,-0.6608151161424578,0.8714596949891068,1.0,1.0,1/15,1.79%,GPC3
prerank,cholesterol biosynthetic process (GO:0006695),0.2582886946380559,0.6603809531796204,0.9197431781701445,1.0,1.0,7/31,18.72%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,regulation of mRNA stability (GO:0043488),-0.17421524304613065,-0.658889859729008,0.9955357142857143,1.0,1.0,31/145,25.40%,SAMD4A;ROCK2;PRKCD;TENT5A;DCP1A;CSDC2;PSME4;FXR2;PRKCA;PSME3;IGF2BP2;FMR1;PCBP4;YTHDF1;XPO1;FASTKD1;EXOSC2;FASTKD3;EIF4G1;PSMD7;CIRBP;PSMA3;EXOSC1;PSMD14;SAMD4B;RBM24;TBRG4;PARN;MEX3D;HSPA1A;TNFSF13
prerank,negative regulation of myotube differentiation (GO:0010832),-0.28802829315376055,-0.6587486813606372,0.8832271762208068,1.0,1.0,2/12,8.15%,HDAC4;CCN3
prerank,apoptotic mitochondrial changes (GO:0008637),0.25806377628741356,0.6587442932337327,0.8930817610062893,1.0,1.0,2/32,5.96%,BCL2L1;BIK
prerank,regulation of steroid metabolic process (GO:0019218),0.27273159789605267,0.658627375476869,0.878839590443686,1.0,1.0,2/23,6.18%,ABCG1;ABCB11
prerank,tRNA metabolic process (GO:0006399),0.2807061068586423,0.6577605886473231,0.8852173913043478,1.0,1.0,2/17,7.22%,SARS1;YARS2
prerank,ERAD pathway (GO:0036503),0.2186276975353758,0.6575777982191726,0.9737991266375546,1.0,1.0,23/83,22.39%,TRIM25;STT3B;ATXN3;SGTB;RHBDD1;PSMC6;UBQLN1;FBXO6;DERL2;MAN1B1;EDEM1;RNF139;DNAJB9;TMUB2;UBE2G2;BAG6;GET4;FBXO2;TMEM129;BRSK2;ANKZF1;TMUB1;UBE2J1
prerank,regulation of viral release from host cell (GO:1902186),0.27587639375482015,0.6569506225400877,0.8963210702341137,1.0,1.0,6/21,23.50%,TRIM25;TRIM26;TRIM11;VPS37B;DDB1;MID2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.2903664044912625,0.655904782400946,0.8654867256637168,1.0,1.0,6/15,23.21%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.26091415094940007,0.6557965369913852,0.9120521172638436,1.0,1.0,16/31,32.21%,PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;TIMM21;TIMM50;TOMM70;PEX12;AIFM1;PEX5;GRPEL2;GRPEL1;PEX10
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.29236117673517625,0.6553743142172972,0.8810810810810811,1.0,1.0,2/17,3.95%,MEF2C;PRKG1
prerank,response to UV-B (GO:0010224),-0.28495117593637664,-0.655274286472173,0.8801742919389978,1.0,1.0,3/12,11.27%,STK11;CRIP1;MFAP4
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2559537836527952,0.6550595815560023,0.8859504132231405,1.0,1.0,6/29,14.55%,APP;ACP4;SHISA6;NSMF;GRIK2;CAMK2B
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.31279976104820145,0.6546723072228472,0.8707360861759426,1.0,1.0,7/11,32.99%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;TRIM28;PPHLN1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.29187490586165443,-0.6546685581147155,0.8784648187633263,1.0,1.0,3/10,13.66%,PRKCD;CD9;SERPINE2
prerank,peroxisomal membrane transport (GO:0015919),-0.22642806513948074,-0.6545444967427301,0.945679012345679,1.0,1.0,7/27,23.80%,ABCD3;PXMP2;PEX7;PEX2;ALDH3A2;ATAD1;PEX13
prerank,regulation of B cell differentiation (GO:0045577),-0.2575453765328988,-0.6544047246208738,0.9129411764705883,1.0,1.0,4/17,18.74%,MMP14;SFRP1;INHA;ID2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.23893853427150935,0.6542428709607708,0.926040061633282,1.0,1.0,13/48,23.90%,ACTB;TAF1B;ARID1A;HMGA1;SMARCD1;DEK;POLR1A;MYO1C;KAT2B;TAF1C;ZMIZ2;SERTAD2;PADI2
prerank,protein acetylation (GO:0006473),0.2603925557368195,0.6533691231473767,0.9066666666666666,1.0,1.0,6/30,13.40%,FOXO1;KAT6A;NAA60;GTF2B;NAA16;NAA11
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.21142267866651734,-0.6525906710072149,0.967032967032967,1.0,1.0,19/42,29.67%,PPA2;QARS1;EPRS1;YARS1;HARS2;VARS2;WARS2;RARS2;DARS2;DARS1;FARS2;EARS2;FARSA;LARS1;TARS1;AIMP1;PPA1;RARS1;KARS1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.27748569551588426,0.6520321251613879,0.8732876712328768,1.0,1.0,3/19,11.65%,CAMKK2;FBXW7;GSK3A
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3209430848211439,0.6519062480522271,0.8283018867924529,1.0,1.0,3/10,15.14%,NPPA;DNAJA1;HIPK3
prerank,microtubule polymerization (GO:0046785),0.2626992478840672,0.6518286139138442,0.8912,1.0,1.0,10/28,21.21%,FGF13;PIN1;AKAP9;RANBP9;CKAP5;TRPV4;TPPP;CLASP1;TUBG2;NDE1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.302695445095831,0.6516800594327014,0.8696498054474708,1.0,1.0,3/12,14.77%,TGFB1;PPARG;ELAVL1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.2869878655818229,0.651635435355053,0.8856088560885609,1.0,1.0,5/19,21.77%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.2869878655818229,0.651635435355053,0.8856088560885609,1.0,1.0,5/19,21.77%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,cytosolic transport (GO:0016482),-0.17932433295830685,-0.651126462719262,0.9957264957264957,1.0,1.0,17/108,12.33%,DENND2A;SNX6;GBF1;VPS13A;EEA1;ANKRD27;HOOK2;STX5;AP4M1;ARL1;CLN3;AKTIP;TBC1D10A;MON2;SNX5;RAB29;RAB6A
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2926399683659913,0.6508992596711236,0.8664323374340949,1.0,1.0,6/14,23.21%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,negative regulation of leukocyte activation (GO:0002695),0.29341205756577793,0.6506405303736593,0.8656987295825771,1.0,1.0,1/15,2.13%,CD200
prerank,mitotic nuclear membrane organization (GO:0101024),-0.19745243748200283,-0.6505845111510912,0.9638888888888889,1.0,1.0,15/51,29.32%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1;NUP43
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.19745243748200283,-0.6505845111510912,0.9638888888888889,1.0,1.0,15/51,29.32%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1;NUP43
prerank,mismatch repair (GO:0006298),-0.23769441709100947,-0.6505467707461298,0.9251870324189526,1.0,1.0,9/27,25.96%,TDG;ABL1;ERCC1;MLH3;POLD2;SETD2;LIG1;MCM9;EXO1
prerank,inositol phosphate catabolic process (GO:0071545),0.30428936576420323,0.6505278438833463,0.8560606060606061,1.0,1.0,6/12,25.08%,OCRL;NUDT3;INPP1;SYNJ1;INPP5K;IMPA1
prerank,regulation of telomere maintenance (GO:0032204),-0.23815643452751137,-0.6494748931552577,0.9324675324675324,1.0,1.0,11/26,31.27%,PML;RTEL1;XRCC5;ERCC1;RAD50;SMG1;NBN;SIRT6;HNRNPD;DHX36;PIF1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.26908722447477723,0.6494604283169719,0.8866906474820144,1.0,1.0,9/24,27.40%,AIM2;STAT1;EIF2AK4;SIN3A;PARP9;ZC3H12A;CGAS;DTX3L;TOMM70
prerank,regulation of catabolic process (GO:0009894),0.27868123033326564,0.6487308366790137,0.8866906474820144,1.0,1.0,1/18,2.59%,NEDD4L
prerank,calcium import into the mitochondrion (GO:0036444),0.3123769354328132,0.6479067431145982,0.8615664845173042,1.0,1.0,1/10,2.82%,MCUB
prerank,protein targeting to lysosome (GO:0006622),-0.2437973792491458,-0.6477369214275621,0.9114219114219114,1.0,1.0,6/20,22.12%,LAMP2;AP4M1;GNPTAB;LAPTM5;VPS4A;NEDD4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.24083812837419538,-0.6476438350125507,0.9170616113744076,1.0,1.0,7/22,28.92%,MED14;ESR1;MED30;MED4;MED24;MED16;DHX36
prerank,nucleosome disassembly (GO:0006337),-0.27084398691365347,-0.6475074313706805,0.9098901098901099,1.0,1.0,3/14,8.30%,SMARCC2;SMARCD3;SMARCB1
prerank,chromatin disassembly (GO:0031498),-0.27084398691365347,-0.6475074313706805,0.9098901098901099,1.0,1.0,3/14,8.30%,SMARCC2;SMARCD3;SMARCB1
prerank,protein heterooligomerization (GO:0051291),-0.25278392424556045,-0.647500078444457,0.892018779342723,1.0,1.0,2/17,4.66%,PKD1;PKD2
prerank,vesicle transport along microtubule (GO:0047496),0.2683795801516735,0.6470877120769924,0.9087947882736156,1.0,1.0,5/23,13.02%,KIF1A;FYCO1;BICDL1;KIF3B;RAB1A
prerank,RNA modification (GO:0009451),-0.1964698269376954,-0.6465761949487894,0.9656160458452722,1.0,1.0,16/54,23.95%,TRMT9B;NOP2;NSUN2;ALKBH1;PUS7;ELP5;NSUN3;TRIT1;NSUN4;DTWD1;ANKRD16;TYW5;BCDIN3D;TSR3;LCMT2;PARN
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2395256163406238,0.6465065079921991,0.9300476947535771,1.0,1.0,7/42,20.92%,CXCL12;CCL1;GPR75;CCR2;SH2B3;CCL25;RBM15
prerank,endosome organization (GO:0007032),0.2397929629552395,0.6460023584979665,0.9481946624803768,1.0,1.0,5/41,10.88%,ALS2CL;SNX3;DNAJC13;CLCN3;HOOK1
prerank,macroautophagy (GO:0016236),0.20329159196269725,0.6459379016468345,0.9818652849740933,1.0,1.0,36/118,22.48%,TOMM22;TECPR1;DYNLL1;TBC1D5;TOMM6;MAP1LC3B;KLHL3;PIK3C3;ATG12;VPS36;PRKAB1;UBQLN1;PLEKHM1;PIP4K2A;SNAP29;HGS;CSNK2B;VPS25;TMEM74;ATG14;VPS16;MAP1LC3A;VAMP7;TOMM7;VPS37A;ATG7;ACBD5;PLAA;UVRAG;VPS37B;TOMM5;GABARAP;RUBCNL;VAMP8;PRKAA1;VPS37C
prerank,RNA transport (GO:0050658),-0.18486596667892397,-0.6457343146449795,0.986159169550173,1.0,1.0,22/71,26.78%,SIDT1;SRSF5;SRSF11;XPO5;SRSF6;SRSF4;FMR1;RBFOX1;SIDT2;HNRNPA2B1;DDX39B;THOC2;THOC7;U2AF2;U2AF1;RAE1;DDX39A;EIF4A3;POLDIP3;THOC1;NUP155;TPR
prerank,positive regulation of glial cell differentiation (GO:0045687),0.28584562105014455,0.6454901588651422,0.9043321299638989,1.0,1.0,6/17,19.18%,NOTCH1;TGFB1;PTN;PTPRZ1;BIN1;DICER1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3038365318226271,0.6451494802149285,0.8535262206148282,1.0,1.0,5/11,25.08%,PWP1;SIRT7;DDX11;MTOR;SMARCA4
prerank,superoxide anion generation (GO:0042554),0.29567042005253963,0.6450844147844058,0.8661710037174721,1.0,1.0,3/13,12.57%,CYBB;NCF4;NOX3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.22036801437260423,0.6450332576592012,0.9642857142857143,1.0,1.0,7/63,12.16%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2
prerank,modulation by host of viral genome replication (GO:0044827),0.29499786557738145,0.6448148853226207,0.8546845124282982,1.0,1.0,4/13,14.87%,EIF2AK4;FBXL2;CCNK;YTHDC2
prerank,histone deacetylation (GO:0016575),-0.2075266486045791,-0.6434197619279959,0.9603174603174603,1.0,1.0,16/43,30.76%,HDAC4;TBL1XR1;MIER3;PER2;MORF4L2;SIRT2;MTA3;RCOR3;PER1;SIRT6;MIER2;HDAC1;MSL3;BAZ2A;RBM14;SIRT1
prerank,negative regulation of B cell activation (GO:0050869),0.2698071985662104,0.6433700035981612,0.9054054054054054,1.0,1.0,5/21,17.44%,LYN;TNFRSF21;TNFAIP3;FOXJ1;SAMSN1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.21739955078122397,-0.6431653506568867,0.9466019417475728,1.0,1.0,15/32,35.57%,CDC14B;ATM;BRSK1;CLSPN;BRCA1;DONSON;NBN;DTL;TAOK3;NOP53;PLK1;ABRAXAS1;TICRR;TAOK2;UIMC1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.23056695968251087,0.6431411433474996,0.9663093415007658,1.0,1.0,9/52,13.07%,CNOT6L;EDC3;PAN3;CNOT9;PDE12;PAN2;DCP2;CNOT6;DCP1B
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.2912226480332042,-0.6426613683580401,0.8798283261802575,1.0,1.0,5/10,28.94%,GATA6;TSKU;CDH3;TYROBP;LILRB1
prerank,positive regulation of innate immune response (GO:0045089),0.2570331597871422,0.6423772201006861,0.8996655518394648,1.0,1.0,11/30,27.28%,GBP5;NLRC5;TLR8;NMI;POLR3F;SPI1;RIOK3;POLR3B;POLR3C;IFI35;RPS19
prerank,aminoglycan metabolic process (GO:0006022),0.3088093142045718,0.6413850239954235,0.8432835820895522,1.0,1.0,6/10,29.59%,XYLT2;B3GAT3;CHST9;B3GAT2;GAL3ST3;XYLT1
prerank,fatty acid beta-oxidation (GO:0006635),0.23279543932558594,0.6410876456211846,0.9428152492668622,1.0,1.0,13/51,19.06%,PPARD;ABCD4;CRAT;ACOX1;ETFB;ABCD1;SLC27A2;ECI2;ACAT1;DECR2;ACAD11;ETFDH;ABCD2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2716116399876064,-0.6404374455503765,0.900709219858156,1.0,1.0,5/14,23.17%,PELI3;NLRP2B;TRAIP;GPS2;CCDC3
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.28313109655891433,-0.64018079375632,0.8876404494382022,1.0,1.0,3/11,19.99%,HAT1;RBBP4;UBN1
prerank,cellular response to interleukin-7 (GO:0098761),0.2875368314434919,0.6395323665205724,0.8797250859106529,1.0,1.0,8/17,25.08%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;IL2RG;SMARCA4
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.2875368314434919,0.6395323665205724,0.8797250859106529,1.0,1.0,8/17,25.08%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;IL2RG;SMARCA4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.2782484892724266,0.6388600670162041,0.895,1.0,1.0,10/19,26.51%,RPTOR;PRDX5;TENM1;BRF2;POLR3F;ZNF76;MAF1;ICE1;MTOR;POLR3C
prerank,presynapse organization (GO:0099172),-0.29193277391170713,-0.6381380470332713,0.8967032967032967,1.0,1.0,1/10,2.73%,NLGN2
prerank,gene silencing by miRNA (GO:0035195),0.2488927914658456,0.6380648319065159,0.9120521172638436,1.0,1.0,2/32,4.27%,NOTCH4;ADAR
prerank,regulation of lymphocyte differentiation (GO:0045619),0.28035501032130605,0.6374794345616958,0.8852173913043478,1.0,1.0,5/18,21.50%,ZFP36L1;NCKAP1L;CCR2;ZFP36L2;METTL3
prerank,skeletal muscle contraction (GO:0003009),0.27519096885841426,0.6368335103870164,0.87893864013267,1.0,1.0,2/19,8.31%,MYH14;RCSD1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.24256616566587286,-0.6364919358803987,0.949238578680203,1.0,1.0,5/21,18.49%,CDC14B;GOLGA2;BTRC;PTEN;MAD2L1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.21692458006465568,0.6358600303055238,0.9606986899563319,1.0,1.0,20/61,28.16%,CAV1;PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;SIRT5;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,DNA biosynthetic process (GO:0071897),0.2818438087085548,0.6353370427949222,0.8700361010830325,1.0,1.0,7/16,28.64%,PPIA;POLL;POLD1;POLA1;TYMS;POLD4;WRNIP1
prerank,DNA strand elongation (GO:0022616),-0.24495443031820877,-0.6352212393803075,0.9209932279909706,1.0,1.0,8/18,30.27%,RAD50;POLD2;RFC3;NBN;MCM3;MCM4;TERT;GINS1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.26551422311317086,-0.634847345642528,0.9030837004405287,1.0,1.0,3/13,9.06%,FGF2;IGF2;PDPK1
prerank,lipid droplet organization (GO:0034389),0.2654079038311102,0.6339322758372292,0.9103448275862069,1.0,1.0,2/22,6.74%,PPIA;CDS2
prerank,RNA processing (GO:0006396),0.1906487651772688,0.6332788883834357,0.9975698663426489,1.0,1.0,18/176,13.02%,TENT4A;IVNS1ABP;PPP1R9B;ADAR;MTPAP;RNPS1;SNRPF;HNRNPC;DEDD2;MAGOHB;SNRPN;ZCRB1;MPHOSPH10;RBPMS;NCBP2;NOL9;ADAD1;SNRPB
prerank,cellular response to ionizing radiation (GO:0071479),0.2307632441663851,0.6326503451974016,0.9415384615384615,1.0,1.0,3/47,5.30%,NET1;GRB2;RHOB
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.24255121048635533,0.631770513220131,0.9411764705882353,1.0,1.0,7/32,17.36%,PPP1R13B;HINT1;JMY;DDIT4;HIPK2;MSH2;BAG6
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.27485878746011116,0.6315267540177371,0.891459074733096,1.0,1.0,8/18,25.81%,RAP1B;RIMS4;NLGN1;RIMS2;PREPL;RAB3GAP1;SYN1;RIMS1
prerank,nuclear membrane reassembly (GO:0031468),-0.1900266293755903,-0.6311004893892053,0.988795518207283,1.0,1.0,15/54,27.62%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;UBXN2A;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1
prerank,regulation of receptor recycling (GO:0001919),0.2768198347556839,0.6290821549461867,0.8917089678510999,1.0,1.0,8/16,27.00%,RAMP3;INPP5F;AP1AR;SNCA;SCRIB;TRAT1;NSF;ECE1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.2814967183591852,0.6289697949610489,0.909710391822828,1.0,1.0,4/14,14.04%,OPHN1;MSN;FSCN1;FOXJ1
prerank,protein deneddylation (GO:0000338),0.3057988219115986,0.627649601443585,0.8860294117647058,1.0,1.0,4/10,25.22%,COPS5;GPS1;COPS6;COPS2
prerank,maintenance of protein localization in organelle (GO:0072595),0.2653326006222475,0.6273904462444607,0.9140893470790378,1.0,1.0,2/19,10.89%,ARL2BP;HK1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.2659621945804905,-0.6272479523022852,0.9140271493212669,1.0,1.0,2/13,12.68%,ALG1;MPDU1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.2791887705085616,0.6265648851292354,0.8987783595113438,1.0,1.0,3/17,11.25%,PPIA;HSPB1;UBQLN1
prerank,regulation of cell size (GO:0008361),0.2608621112181688,0.6259812074675789,0.9198606271777003,1.0,1.0,10/23,24.53%,MSN;LAMTOR5;RAC1;RPTOR;LAMTOR4;EDN1;RDX;VAV1;RAP1GAP2;MTOR
prerank,Golgi to lysosome transport (GO:0090160),0.29374735384593464,0.6249028333460221,0.8931159420289855,1.0,1.0,3/11,20.91%,SORT1;AP1G1;ANKFY1
prerank,protein kinase A signaling (GO:0010737),-0.2703244019717116,-0.6247654908871055,0.9144893111638955,1.0,1.0,4/12,19.00%,EZR;PRKACA;MYOM1;RAB13
prerank,negative regulation of histone modification (GO:0031057),0.2890651912765563,0.6246591815528411,0.8824561403508772,1.0,1.0,5/14,22.16%,FOXP3;CTBP1;SET;NOC2L;SNCA
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.26531424097511036,0.6246138939065118,0.9183333333333333,1.0,1.0,4/21,13.44%,PGM2L1;TALDO1;HK1;G6PC3
prerank,regulation of defense response to virus by host (GO:0050691),0.24755628510291258,0.6241090604145239,0.9261168384879725,1.0,1.0,11/30,27.40%,AIM2;STAT1;EIF2AK4;TNFAIP3;SIN3A;PARP9;RNF216;ZC3H12A;CGAS;DTX3L;TOMM70
prerank,regulation of regulated secretory pathway (GO:1903305),0.24706851016041953,0.6238449207229685,0.9523026315789473,1.0,1.0,11/34,26.31%,SYT7;UNC13D;SYT4;RIMS4;RIMS2;PREPL;DOC2A;SYN1;SYT17;RIMS1;SYT15
prerank,folic acid metabolic process (GO:0046655),-0.24815111876515755,-0.6227922534606422,0.927536231884058,1.0,1.0,9/18,32.80%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;FPGS;MTHFS;SHMT1;ALDH1L1;PM20D2
prerank,tRNA transport (GO:0051031),0.24579065490335145,0.6221429114732429,0.9238249594813615,1.0,1.0,11/35,26.01%,YBX1;NUP54;NUP160;TOMM20L;NUP153;NUP50;XPOT;NUP42;NUP85;NUP210;NUP188
prerank,positive regulation of histone modification (GO:0031058),0.24447335759736968,0.6214154235688162,0.9428104575163399,1.0,1.0,6/33,14.86%,APLNR;MAPK3;RPS6KA5;FOXP3;TADA2B;CTBP1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.2085604998095251,0.6212214376158512,0.9783549783549783,1.0,1.0,27/84,28.16%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;BUB3;PSMB10;PTTG1;ANAPC16;PSMA8;ANAPC7;ANAPC10;PSMD9;UBE2D1;ANAPC2;PSMC3;PSMD1;CDC23;PSMD10;CDC26;CDC27;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,positive regulation of type 2 immune response (GO:0002830),0.28441061963284764,0.6208783145038356,0.8819188191881919,1.0,1.0,2/14,10.81%,NOD2;DENND1B
prerank,sensory perception of taste (GO:0050909),0.3069922169219181,0.6208757918627292,0.8533834586466166,1.0,1.0,10/10,69.32%,TAS1R1;PKD2L1;ASIC2;ASIC1;PKD1L3;TAS1R3;GNAT3;TAS1R2;ASIC3;CD36
prerank,sulfur amino acid metabolic process (GO:0000096),-0.2201482958845949,-0.62061983937096,0.9378109452736318,1.0,1.0,4/24,13.47%,NOX4;MTHFR;MTHFD1;GCLC
prerank,'de novo' posttranslational protein folding (GO:0051084),0.24201127859957597,0.6197631404462244,0.9446254071661238,1.0,1.0,7/30,18.69%,ENTPD5;HSPA8;DNAJC7;HSPA9;HSPE1;CHCHD4;ERO1A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.27565095586364285,-0.6193808372706742,0.9323467230443975,1.0,1.0,4/11,15.58%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.27565095586364285,-0.6193808372706742,0.9323467230443975,1.0,1.0,4/11,15.58%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.23298594232377334,-0.6182128186343002,0.941320293398533,1.0,1.0,6/22,25.19%,CCNT2;DDX39B;ERCC6;TCERG1;CDK12;THOC1
prerank,homologous chromosome segregation (GO:0045143),0.2672807479852037,0.6181992283667692,0.91005291005291,1.0,1.0,4/20,16.41%,RNF212B;PRDM9;PTTG1;SIRT7
prerank,positive regulation of protein deacetylation (GO:0090312),0.28468444588012115,0.6169539282726126,0.8961038961038961,1.0,1.0,3/14,19.42%,APLNR;CTBP1;DYRK1A
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2487766033383378,-0.6169318868787431,0.9314159292035398,1.0,1.0,5/16,20.96%,PLEKHM2;VAMP2;RAET1E;LYST;ULBP1
prerank,DNA recombination (GO:0006310),0.23422062855733525,0.6153930160177464,0.9346092503987241,1.0,1.0,9/37,18.18%,RAD54B;MRE11;RECQL4;MSH3;MSH2;TSN;RAD21;ENDOG;RPA1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.285529860263001,0.6151618636177135,0.88909426987061,1.0,1.0,2/13,10.50%,NTHL1;SMUG1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.28163334493695796,0.6138315731318329,0.8950381679389313,1.0,1.0,1/15,3.49%,GBP5
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.29698428232894236,0.6137896271414208,0.9042357274401474,1.0,1.0,2/10,12.31%,AP2M1;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.29698428232894236,0.6137896271414208,0.9042357274401474,1.0,1.0,2/10,12.31%,AP2M1;AP2B1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.17029708144901776,-0.613765894717416,1.0,1.0,1.0,30/95,27.38%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;CDC45;PSMD14;WRN;KDM4D;SEM1;NBN;MCM3;AP5Z1;MCM4;ZSWIM7;LIG3;SPIDR;RAD54L;MCM5;MCM9;RECQL;ZFYVE26;RAD51AP1
prerank,regulation of DNA metabolic process (GO:0051052),0.2233990206146841,0.6136811900344219,0.9492868462757528,1.0,1.0,14/44,25.57%,UBE2V2;TERF2;UBE2V1;PARG;IL7R;SMARCAD1;YLPM1;SIRT7;RADX;SUB1;WDR70;MYC;UPF1;KDM1B
prerank,calcium-ion regulated exocytosis (GO:0017156),0.24976417072046378,0.6135531381994921,0.9433656957928802,1.0,1.0,8/27,26.31%,SYT7;ARHGAP17;SYT4;RIMS2;VAMP7;SYT17;RIMS1;SYT15
prerank,negative regulation of DNA replication (GO:0008156),-0.25937713702621856,-0.6126468035512257,0.9309576837416481,1.0,1.0,7/13,31.03%,TSPYL2;CDAN1;S100A11;ATR;GMNC;PDS5A;GMNN
prerank,error-free translesion synthesis (GO:0070987),-0.22456820410869133,-0.6120261175874143,0.945679012345679,1.0,1.0,7/22,32.74%,REV1;RCHY1;RFC3;UFD1;RFC5;SPRTN;POLDIP2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2309954721278564,-0.6115616962970696,0.9533169533169533,1.0,1.0,9/20,31.82%,HSPA4;MKKS;CCT2;PSMG1;PTGES3L;HSPA1A;HOPX;TMEM35A;PSMG2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.18353337186302923,-0.611115565388769,0.9793510324483776,1.0,1.0,17/57,27.08%,CDC14B;ATM;TIPIN;BRSK1;ATF2;SDE2;CLSPN;FANCD2;BRCA1;DONSON;NBN;WAC;DTL;RPS27L;CCND1;TAOK3;NOP53
prerank,axonal transport (GO:0098930),0.22826724456683722,0.6101405475868691,0.968944099378882,1.0,1.0,8/36,19.90%,AP3M2;KIF1A;AP3S1;KIF3B;HIF1A;SPAST;AP3M1;DCTN1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3055260019081375,0.6098774420609239,0.898635477582846,1.0,1.0,4/10,19.18%,TSNAX;TSN;MRPL44;DICER1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.28888674804026254,0.6085556108358531,0.9065934065934066,1.0,1.0,6/10,25.86%,GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,regulation of mRNA processing (GO:0050684),0.23735341930312906,0.6082401311318436,0.9488817891373802,1.0,1.0,1/32,1.59%,QKI
prerank,phosphate ion transport (GO:0006817),0.26429581280844816,0.6081430037506925,0.9271758436944938,1.0,1.0,5/16,23.80%,XPR1;SLC37A3;SLC37A2;SLC34A3;SLC37A1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2580284368198629,0.6071413382533684,0.947986577181208,1.0,1.0,4/22,11.81%,SOX12;FOXP3;CBFB;VSIR
prerank,base-excision repair (GO:0006284),0.22273550778098952,0.606955725536038,0.9566563467492261,1.0,1.0,12/48,21.33%,NTHL1;DNA2;PARG;SMUG1;MPG;POLB;HMGA2;RPA1;ADPRS;POLL;POLD1;RFC2
prerank,intracellular protein transmembrane transport (GO:0065002),0.22714625481163003,0.6057251857607681,0.9584615384615385,1.0,1.0,20/42,32.21%,SEC62;PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;ZFAND2B;TIMM21;TIMM50;TOMM70;SEC63;AKT2;PEX12;AIFM1;PEX5;GRPEL2;GRPEL1;PEX10
prerank,canonical glycolysis (GO:0061621),0.2490736583155621,0.6056252443539336,0.9393939393939394,1.0,1.0,5/24,14.41%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2490736583155621,0.6056252443539336,0.9393939393939394,1.0,1.0,5/24,14.41%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,termination of RNA polymerase I transcription (GO:0006363),0.24294235784335771,0.6055754107648011,0.9509001636661211,1.0,1.0,7/30,22.58%,TAF1B;GTF2H2;GTF2H4;UBTF;POLR1A;GTF2H3;TAF1C
prerank,positive regulation of viral process (GO:0048524),-0.18571197590593994,-0.6052894465456878,0.9806451612903225,1.0,1.0,9/60,15.81%,AXL;MDFIC;PPARA;POLR2A;TMEM39A;DDX3X;NELFE;GTF2F1;PPIH
prerank,synaptic vesicle transport (GO:0048489),0.2867214267955095,0.6052825714989993,0.8911070780399274,1.0,1.0,2/11,15.89%,DNM2;SYNJ1
prerank,purine-containing compound salvage (GO:0043101),-0.266950855298124,-0.6051924290579936,0.9364406779661016,1.0,1.0,3/12,16.15%,AMPD3;GMPR2;DGUOK
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.24091376713676008,-0.6049846131170474,0.9308035714285714,1.0,1.0,6/16,26.34%,NAA35;NAA80;EP300;NAA40;NAA50;CREBBP
prerank,recombinational repair (GO:0000725),-0.1730056690232562,-0.6042169519428053,0.9867549668874173,1.0,1.0,25/77,27.38%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;PSMD14;WRN;KDM4D;SEM1;NBN;AP5Z1;ZSWIM7;LIG3;SPIDR;MCM9;RECQL;ZFYVE26;RAD51AP1
prerank,histone H3 deacetylation (GO:0070932),0.27236723464872437,0.6036461561393726,0.9189686924493554,1.0,1.0,4/15,16.41%,HDAC9;ELK4;SMARCAD1;SIRT7
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2699575336580302,-0.6034124769129735,0.9209401709401709,1.0,1.0,3/11,17.47%,CREB3L1;CEBPB;DDIT3
prerank,t-circle formation (GO:0090656),0.2914783216674678,0.6033733974217349,0.8685714285714285,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.2914783216674678,0.6033733974217349,0.8685714285714285,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.2914783216674678,0.6033733974217349,0.8685714285714285,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.2897041043509272,0.6022535249696557,0.8951310861423221,1.0,1.0,2/10,8.79%,OPHN1;MSN
prerank,regulation of catecholamine secretion (GO:0050433),0.2411128862844105,0.6019318847839626,0.9359605911330049,1.0,1.0,3/29,11.78%,STX1A;SYT7;SYT4
prerank,regulation of DNA recombination (GO:0000018),-0.20622666984776322,-0.6013886033865594,0.9720812182741116,1.0,1.0,11/32,27.38%,RTEL1;KDM1A;ZRANB3;RAD50;SETD2;SIRT6;ZCWPW1;THOC1;SPIDR;KPNA1;RAD51AP1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2127136750962997,0.6013668900781466,0.9681335356600911,1.0,1.0,8/53,16.40%,CALCRL;HTR2A;AGTR2;CHRM3;MTNR1A;HTR4;OPRD1;SSTR1
prerank,RNA export from nucleus (GO:0006405),-0.16557351862446668,-0.6013448869504457,0.9920318725099602,1.0,1.0,30/100,26.78%,SEH1L;SRSF5;SRSF11;DDX19B;XPO5;SRSF6;CPSF3;NUP205;SRSF4;MCM3AP;HNRNPA2B1;DDX39B;SMG1;FYTTD1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;RAE1;FIP1L1;DDX39A;EIF4A3;POLDIP3;THOC1;SYMPK;NUP155;NUP35;NDC1;TPR
prerank,mRNA export from nucleus (GO:0006406),-0.1644313414067668,-0.6009751527059614,1.0,1.0,1.0,30/102,26.78%,SEH1L;SRSF5;PABPN1;SRSF11;DDX19B;SRSF6;CPSF3;NUP205;SRSF4;MCM3AP;HNRNPA2B1;DDX39B;SMG1;FYTTD1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;RAE1;FIP1L1;DDX39A;EIF4A3;POLDIP3;THOC1;SYMPK;NUP155;NUP35;NDC1;TPR
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.23675003753698784,0.6006721276428919,0.940983606557377,1.0,1.0,8/29,22.45%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;DCPS;EXOSC8
prerank,regulation of actin filament depolymerization (GO:0030834),0.27746498751474064,0.599443521267986,0.9134438305709024,1.0,1.0,1/12,3.93%,VIL1
prerank,cilium movement (GO:0003341),0.2166161535738311,0.5991780872728057,0.96,1.0,1.0,6/47,11.10%,DNHD1;CFAP100;CFAP91;RSPH4A;CFAP54;DNAAF2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.24916671180131583,-0.5988239837605165,0.9324618736383442,1.0,1.0,1/13,3.61%,PRKCD
prerank,myelin assembly (GO:0032288),-0.27733722282541495,-0.5978444061299415,0.9122807017543859,1.0,1.0,2/10,9.73%,EPB41L3;CD9
prerank,lipoxygenase pathway (GO:0019372),-0.2500368160686284,-0.5972206051959097,0.944206008583691,1.0,1.0,7/14,42.30%,PON3;PTGS2;ALOXE3;ALOX12;GPX1;PON1;ALOX5
prerank,protein localization to chromosome (GO:0034502),0.23198948547630477,0.597119946706041,0.9522342064714946,1.0,1.0,10/34,21.73%,TERF2;ACD;CTCF;MSH2;BOD1;RAD21;SLF1;RPA1;PINX1;WAPL
prerank,protein localization to mitochondrion (GO:0070585),-0.259344981058736,-0.5969754726805675,0.948936170212766,1.0,1.0,4/11,22.64%,HK2;LRRK2;COX18;MTCH2
prerank,cranial nerve development (GO:0021545),-0.26563385829001435,-0.5966626908538384,0.9352678571428571,1.0,1.0,1/11,3.34%,SALL1
prerank,tRNA wobble uridine modification (GO:0002098),-0.250538523871885,-0.5954866127707303,0.9461358313817331,1.0,1.0,3/14,15.33%,TRMT9B;ELP3;ELP4
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.1753719892656323,0.5942816496396073,0.9988505747126437,1.0,1.0,81/241,29.86%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;HNRNPC;SNRPC;SNRPE;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;PPWD1;NCBP2;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;FRG1;AQR;PRPF40A;PRPF4;RSRC1;ISY1;USP49;SMU1;SNRPB2;POLR2J;SF3A2;LSM4;SNRPD2;IK;PUF60;CDC5L;RBM8A;HNRNPM;ELAVL2;SF3B3;RBM15;METTL3;NCBP1;PAPOLA;WBP11;PABPC1;PRPF8;PPIE;SNRPA;SMNDC1;DHX38;UPF3B;CSTF2T;SART3;SNW1;PHF5A;CWC27;SNRNP48;HNRNPF;HNRNPA3;CSTF1;CWF19L2;HNRNPL;SNRPD1;SRSF12;SRSF7;SRSF1;LSM6;PRPF31;XAB2;DDX41;HNRNPA1;BCAS2;GEMIN5;PRPF6;ZRSR2
prerank,autophagy of peroxisome (GO:0030242),0.27082979825664105,0.5939516058534225,0.9146341463414634,1.0,1.0,4/12,23.46%,MAP1LC3B;PIK3C3;ACBD5;USP30
prerank,retrograde axonal transport (GO:0008090),0.26502555326963373,0.593862178473331,0.941712204007286,1.0,1.0,1/16,6.87%,KIF1A
prerank,histone deubiquitination (GO:0016578),0.26402938844377605,0.593530089591018,0.9251336898395722,1.0,1.0,6/18,23.26%,ATXN7;TRRAP;USP49;BRCC3;USP21;ENY2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.21579336125348558,0.5934096055279454,0.97339593114241,1.0,1.0,3/48,6.64%,BCL2L1;FNIP2;MCL1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.23398596161885812,-0.5933483078646107,0.9541062801932367,1.0,1.0,8/17,26.78%,PRKN;KDM1A;SNAI1;TWIST1;CD44;RNF34;YJU2;ARMC10
prerank,cellular response to leucine starvation (GO:1990253),0.29357364523862745,0.5930229733563741,0.9113207547169812,1.0,1.0,2/10,9.61%,SESN3;EIF2AK4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.26277650371423833,0.5921424805937416,0.9372693726937269,1.0,1.0,1/15,3.85%,RAPGEF3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.21446192715846027,0.5919224109065496,0.9730586370839936,1.0,1.0,13/54,19.38%,IKBKB;RFFL;BIRC3;ADAM17;SHARPIN;CASP8;SYK;CYLD;TNFAIP3;GAS6;CPNE1;SPPL2A;RBCK1
prerank,double-strand break repair (GO:0006302),0.1819621268933714,0.5918943629905231,1.0,1.0,1.0,25/158,18.81%,TENT4A;SAMHD1;RAD54B;MRE11;UBE2V2;PALB2;BRCA2;KDM4A;HPF1;UBXN1;DNA2;BABAM1;RECQL4;POLB;FAN1;HMGB2;RNF8;SMARCAD1;HERC2;SUMO1;RAD21;HUS1;RPA1;REV3L;BRCC3
prerank,replication fork processing (GO:0031297),0.22162691206979465,0.5917170015140599,0.9791332263242376,1.0,1.0,4/38,9.90%,SAMHD1;MRE11;BRCA2;DNA2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.26010964528478275,-0.5916076484094033,0.9245689655172413,1.0,1.0,3/11,23.43%,PRKN;NONO;NR4A3
prerank,tRNA 5'-end processing (GO:0099116),0.2672262305482174,0.5902650604532717,0.9285714285714286,1.0,1.0,5/15,21.47%,TRMT10C;RPP38;RPP21;HSD17B10;RPP30
prerank,protein localization to chromatin (GO:0071168),-0.22446242497108382,-0.5902110506080482,0.971830985915493,1.0,1.0,8/18,33.06%,SGF29;ESR1;LEMD2;MCM9;PIH1D1;PLK1;MCM8;LRWD1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2558134121221779,-0.590004211663927,0.9261744966442953,1.0,1.0,3/11,19.93%,MDM1;TRIM37;BRCA1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.229862867499118,0.5899761150237619,0.9516908212560387,1.0,1.0,8/31,22.45%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;DCPS;EXOSC8
prerank,ESCRT complex disassembly (GO:1904896),0.2947935076495321,0.5897878426154275,0.8994307400379506,1.0,1.0,1/10,7.83%,CHMP1B
prerank,ESCRT III complex disassembly (GO:1904903),0.2947935076495321,0.5897878426154275,0.8994307400379506,1.0,1.0,1/10,7.83%,CHMP1B
prerank,ovarian follicle development (GO:0001541),0.27328586652356956,0.589303424344508,0.9144851657940664,1.0,1.0,2/13,10.81%,FOXL2;EIF2B2
prerank,negative regulation of translational initiation (GO:0045947),0.2747895723698725,0.5850904851225672,0.9218181818181819,1.0,1.0,3/13,13.44%,EIF3E;EIF2AK4;PAIP2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.2567345367897048,-0.5847419785831932,0.9502369668246445,1.0,1.0,5/11,34.73%,SAFB2;SLTM;SRPK1;PTCD2;SRPK2
prerank,neuron projection fasciculation (GO:0106030),0.28836067467588433,0.5835266814601013,0.9022140221402214,1.0,1.0,2/10,16.29%,EPHA4;NRCAM
prerank,telomere maintenance (GO:0000723),0.21014494898678643,0.5833696482202781,0.9817073170731707,1.0,1.0,7/50,12.47%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1
prerank,regulation of translational initiation (GO:0006446),0.20450280047713046,0.5828140936877396,0.9867256637168141,1.0,1.0,17/63,21.57%,EIF4H;KLHL25;EIF3E;EIF2AK4;HSPB1;EIF2B2;NCBP2;PAIP2;PAIP1;EIF3B;PPP1R15B;EIF1B;NCK1;DAZL;EIF4EBP3;EIF3H;NCBP1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.250669282433925,0.5820403393191719,0.9488117001828154,1.0,1.0,6/18,26.50%,PTBP3;TGFB1;NUDT16;KAT2B;ZC3H12A;RPS13
prerank,regulation of cilium movement (GO:0003352),0.286991574987444,0.5817735436127727,0.9064885496183206,1.0,1.0,1/10,7.92%,DRC1
prerank,regulation of telomere capping (GO:1904353),-0.2152674459907488,-0.5811855009456143,0.9774436090225563,1.0,1.0,9/23,26.60%,TNKS2;ATM;RTEL1;RAD50;NBN;TNKS;PKIB;HNRNPD;MAP3K4
prerank,presynapse assembly (GO:0099054),-0.2327303389810645,-0.58073443070761,0.95,1.0,1.0,6/16,31.51%,NLGN2;PTEN;LRRTM3;DVL1;NLGN3;BSN
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.20374881328872907,-0.5806049364981509,0.974025974025974,1.0,1.0,10/27,27.49%,ZC3H12B;PCF11;CPSF3;RNASE4;LACTB2;CSTF3;PARN;ZC3H12C;TOE1;POP7
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.2184731141970052,-0.580385980929315,0.959731543624161,1.0,1.0,6/20,24.85%,APOE;SREBF1;NR1H4;MBTPS1;EPHX2;KPNB1
prerank,positive regulation of intracellular transport (GO:0032388),0.22369329223174395,0.5795662221971309,0.9790322580645161,1.0,1.0,6/38,15.24%,PRR5L;RIPOR1;OAZ1;PDCD10;B3GAT3;SPAG5
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.19676400788204998,0.579217636547773,0.9883211678832117,1.0,1.0,23/65,28.16%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;ZFYVE19;PINX1;CUL1;PSMC3;PSMD1;PSMD10;PABIR1;NABP2;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,positive regulation of histone acetylation (GO:0035066),0.23877923093296508,0.5791805592191454,0.9347471451876019,1.0,1.0,4/23,12.14%,MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,protein import into nucleus (GO:0006606),-0.16873199462554114,-0.5783537886130345,0.996996996996997,1.0,1.0,16/66,26.85%,APPL2;CBLB;RANBP17;E2F3;FAM53B;KPNA3;IPO7;STAT3;KPNB1;HIKESHI;KPNA6;NUP155;NUP35;IPO8;TPR;KPNA1
prerank,tRNA aminoacylation (GO:0043039),-0.19249124408520907,-0.5772394428871291,0.9945652173913043,1.0,1.0,17/37,29.67%,PPA2;QARS1;EPRS1;YARS1;HARS2;WARS2;RARS2;DARS2;DARS1;FARS2;FARSA;LARS1;TARS1;AIMP1;PPA1;RARS1;KARS1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.22407202096377996,-0.5770174294178707,0.9561200923787528,1.0,1.0,4/17,18.25%,FGF1;APOE;SREBF1;MBTPS1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.19832192370241575,0.5764459599386355,0.9899569583931134,1.0,1.0,10/68,13.02%,TAF1B;GTF2H2;CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;GTF2H4;SNRPB
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.2510246120874136,0.5760834875382822,0.9341864716636198,1.0,1.0,4/18,19.50%,ATXN3;NCK1;BAG6;BAK1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.2416945104001743,-0.5760777061734528,0.9578947368421052,1.0,1.0,3/13,24.36%,SDAD1;XPO1;NOP9
prerank,cellular response to alkaloid (GO:0071312),0.25644604005536265,0.5755375271513355,0.9504273504273504,1.0,1.0,2/17,6.72%,TGM2;CASP7
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.2829690470582932,0.5746015402759482,0.9180952380952381,1.0,1.0,2/10,14.97%,RAPGEF3;HDAC5
prerank,autophagy of mitochondrion (GO:0000422),0.21749256508294737,0.5736942921121294,0.9732704402515723,1.0,1.0,14/38,25.02%,CTSK;MAP1LC3B;ATG12;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;GABARAP;ATG2A;BNIP3;USP30;GABARAPL2;ULK1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.21394172621557986,-0.5732654145208879,0.9697732997481109,1.0,1.0,6/24,23.18%,DNMT3A;PPM1D;RBBP4;EED;EZH2;RBBP7
prerank,autophagy of nucleus (GO:0044804),-0.231366992589013,-0.5716597502025608,0.9522727272727273,1.0,1.0,2/16,6.27%,ULK2;ATG2B
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2770321270198749,0.5694712119723928,0.9340866290018832,1.0,1.0,3/10,15.84%,SPAG5;RCC2;APC
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.17740251659515013,-0.5680797853195148,0.9914529914529915,1.0,1.0,5/49,8.94%,TNRC6A;THBS1;MTURN;TNRC6B;MYL9
prerank,DNA damage checkpoint signaling (GO:0000077),-0.19891826625516346,-0.5676816582347648,0.9754299754299754,1.0,1.0,9/28,23.65%,ATM;PRPF19;CLSPN;ERCC6;ATRIP;DONSON;NBN;CEP63;ATR
prerank,RNA biosynthetic process (GO:0032774),-0.194945424759962,-0.5667752386565212,0.9900497512437811,1.0,1.0,7/31,21.69%,POLR2A;PRMT5;SMARCA5;HELB;PRIM2;BRF1;TBP
prerank,regulation of acute inflammatory response (GO:0002673),0.24630972655033737,0.5654827318820396,0.9461400359066428,1.0,1.0,1/18,4.60%,OSMR
prerank,nucleosome assembly (GO:0006334),0.21852453770285957,0.5629749522330173,0.9720853858784894,1.0,1.0,12/31,25.82%,CHAF1A;NAA60;SOX9;HMGB2;CHAF1B;IPO4;GRWD1;NASP;DAXX;HIRA;NAP1L4;SART3
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.253438134838101,-0.5623984912335398,0.9408033826638478,1.0,1.0,3/10,20.05%,ATP7A;KYAT1;KYNU
prerank,protein localization to kinetochore (GO:0034501),0.25754004146101267,0.5623823296637,0.9353680430879713,1.0,1.0,4/14,19.17%,BUB3;RCC2;ZW10;IK
prerank,natural killer cell mediated immunity (GO:0002228),-0.23169863054833845,-0.5622793991752398,0.9678111587982833,1.0,1.0,4/15,20.96%,PLEKHM2;RAET1E;LYST;ULBP1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2087140318317908,0.5621212844905317,0.9778830963665087,1.0,1.0,8/40,16.58%,UBE2V2;MCL1;UBE2V1;PARG;IER3;NSMCE4A;SIRT7;HMGA2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24979563559956766,0.561104055787257,0.9317343173431735,1.0,1.0,8/15,31.60%,MRE11;HUS1;RAD9B;RAD17;HUS1B;CHEK2;MDC1;EME2
prerank,phagosome acidification (GO:0090383),-0.20001476505135546,-0.5610790555046654,0.9761904761904762,1.0,1.0,7/26,21.50%,ATP6V0A4;ATP6V1C1;ATP6V1G2;ATP6V1E1;TCIRG1;ATP6V1F;ATP6V0D2
prerank,establishment of protein localization to organelle (GO:0072594),-0.1610536597790691,-0.5609031190354296,0.9969512195121951,1.0,1.0,5/72,9.55%,APPL2;LAMP2;RANBP17;HK2;LRSAM1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.23918656990138135,0.5608656228518821,0.9596491228070175,1.0,1.0,5/18,21.31%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,regulation of mRNA catabolic process (GO:0061013),0.17609598404011853,0.5597091745005311,0.9959349593495935,1.0,1.0,28/121,23.49%,PRR5L;PSMB3;PSMD11;PSMC6;GTPBP1;PSME2;HSPA8;HSPB1;PSMD8;DCP2;ZFP36L1;PSMB10;SERBP1;ELAVL1;ZC3HAV1;PSMA8;YWHAZ;YWHAB;PSMD9;SET;XRN1;ZFP36L2;EXOSC9;PSMC3;PSMD1;EXOSC8;PSMD10;PABPC1
prerank,ncRNA export from nucleus (GO:0097064),-0.18667815398222698,-0.5596254994932863,0.9919786096256684,1.0,1.0,16/36,38.06%,PHAX;SEH1L;NUP205;TSC1;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,positive regulation of chromosome organization (GO:2001252),0.25466139266185206,0.5594894374373116,0.9381818181818182,1.0,1.0,4/15,18.30%,MRE11;SHCBP1L;RAD21;DDX11
prerank,receptor recycling (GO:0001881),-0.25207950392559614,-0.5594745564441014,0.9409190371991247,1.0,1.0,5/10,31.00%,ARFGEF2;RAB11B;NSG1;PHETA2;PLEKHJ1
prerank,regulation of superoxide anion generation (GO:0032928),-0.2278600262932568,-0.5592788865887234,0.9606126914660832,1.0,1.0,1/14,3.61%,PRKCD
prerank,regulation of rRNA processing (GO:2000232),-0.22413149910613628,-0.5587169282798435,0.9659367396593674,1.0,1.0,5/16,25.71%,RIOK2;WDR43;TRMT112;DIMT1;USP36
prerank,response to histamine (GO:0034776),0.27228996096797603,0.5586824715464674,0.9424860853432282,1.0,1.0,4/10,25.86%,GABRB1;GABRB2;AOC1;GABRG2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.21281056031807621,0.5581486606019517,0.9858934169278997,1.0,1.0,8/37,19.35%,ANKRD13A;RIN3;SDCBP;MTMR2;EDN1;AP1AR;TFAP2A;LRPAP1
prerank,defense response to fungus (GO:0050832),0.2409513048787365,0.5577783854498455,0.9468085106382979,1.0,1.0,3/17,20.06%,S100A8;BCL10;PLCG2
prerank,regulation of secretion by cell (GO:1903530),-0.16895184756794746,-0.5574110778897936,0.9940119760479041,1.0,1.0,9/54,19.00%,SNCAIP;ANXA1;RAB21;FMR1;P3H1;STX4;RHBDF1;VAMP2;RAB13
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.16315363119217274,0.555679549560046,1.0,1.0,1.0,89/264,29.86%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;HNRNPC;SNRPC;SNRPE;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;PPWD1;NCBP2;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;FRG1;AQR;PRMT7;PRPF40A;PRPF4;RSRC1;ISY1;SCNM1;USP49;SMU1;SNRPB2;POLR2J;SF3A2;LSM4;SNRPD2;IK;PUF60;CDC5L;RBM8A;WDR77;HNRNPM;ELAVL2;SF3B3;RBM15;METTL3;NCBP1;DCPS;PAPOLA;WBP11;PABPC1;PRPF8;PPIE;SNRPA;SMNDC1;DHX38;UPF3B;CSTF2T;SART3;SNW1;PHF5A;CWC27;SCAF11;SNRNP48;HNRNPF;HNRNPA3;CSTF1;CWF19L2;HNRNPL;DDX20;SNRPD1;SRSF12;SRSF7;SRSF1;LSM6;SMN1;PRPF31;XAB2;DDX41;COIL;HNRNPA1;BCAS2;GEMIN5;PRPF6;ZRSR2
prerank,pyroptosis (GO:0070269),0.2583895655434789,0.5549222477683269,0.9458483754512635,1.0,1.0,3/15,16.56%,AIM2;CASP8;NLRC4
prerank,RNA stabilization (GO:0043489),0.21510570430813475,0.5547659368886474,0.9722675367047309,1.0,1.0,5/33,14.77%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.18240551952222978,0.5547297592981784,0.9957264957264957,1.0,1.0,22/88,23.25%,FBXW7;PSMB3;PSMD11;PSMC6;DMAC2;PSME2;FBXL2;PSMD8;FBXO6;PSMB10;RBX1;FBXL8;FBXL15;PSMA8;FBXO2;SKP1;PSMD9;CUL1;PSMC3;PSMD1;PSMD10;FBXL14
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.20457512524051535,0.5545375634986384,0.9871794871794872,1.0,1.0,13/43,25.86%,MRE11;BABAM1;CDC6;ORC1;TRIM39;HMGA2;HUS1;BRCC3;RAD17;PABIR1;TOPBP1;NABP2;BLM
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.26911001889081254,0.5542970488132305,0.9504761904761905,1.0,1.0,3/10,21.70%,PSMC6;THRA;PSMC3
prerank,chromosome organization (GO:0051276),-0.15541912983250886,-0.5529867673823476,1.0,1.0,1.0,35/99,33.85%,TOP2B;SETD7;HMGN3;MTHFR;DDB2;EZH1;PARP1;NUCKS1;ABL1;COPS4;LDB1;CDAN1;LATS1;TOP2A;EZH2;RAE1;CUL4B;COPS8;NUP155;FAM50A;BAHD1;CDCA8;BRWD1;COPS7B;HMGN2;HDAC1;SIRT1;NUF2;GEM;MTF2;LIG4;SOX2;LRWD1;CENPW;DOT1L
prerank,phosphate ion transmembrane transport (GO:0035435),0.25210691770109867,0.5522407968326871,0.944043321299639,1.0,1.0,4/12,23.80%,XPR1;SLC37A3;SLC37A2;SLC37A1
prerank,positive regulation of lipid storage (GO:0010884),0.23162742611897993,0.5518816167318433,0.95929203539823,1.0,1.0,1/21,2.93%,SCARB1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.22480578967642176,0.5500727513546575,0.9749582637729549,1.0,1.0,5/25,14.41%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.24807020923895484,-0.5498951381513194,0.9682875264270613,1.0,1.0,2/10,22.07%,PRKN;AOC3
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.22305935511619018,0.549442795078018,0.965,1.0,1.0,3/29,7.77%,ACBD6;GLYAT;ACSL6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.22305935511619018,0.549442795078018,0.965,1.0,1.0,3/29,7.77%,ACBD6;GLYAT;ACSL6
prerank,mRNA transport (GO:0051028),0.17708739089635853,0.5474298120395426,0.9960369881109643,1.0,1.0,12/101,13.09%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NUP54;NCBP2;ZFP36L1;EIF4E;ZC3H11A
prerank,eye photoreceptor cell development (GO:0042462),-0.22050518607487168,-0.5472760999911894,0.9746543778801844,1.0,1.0,7/15,35.22%,RPGRIP1L;TULP1;THY1;BBS4;MYO7A;CRB2;NRL
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.19143850695893708,0.5467698088256493,0.9940119760479041,1.0,1.0,20/55,28.16%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;PINX1;CUL1;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,mitotic spindle assembly (GO:0090307),0.2016360898010962,0.5465646147855867,0.9841017488076311,1.0,1.0,6/42,11.51%,KIF2A;RAB11A;MZT1;KIF3B;KIF23;MAP10
prerank,protein localization to phagophore assembly site (GO:0034497),-0.24117102113989614,-0.5460182554485017,0.9471544715447154,1.0,1.0,5/11,34.84%,MFN2;ATG9A;WIPI1;STX17;WIPI2
prerank,mitochondrion disassembly (GO:0061726),0.2103770212319918,0.5440371531814792,0.9888,1.0,1.0,13/34,25.02%,CTSK;MAP1LC3B;ATG12;ATG9B;MAP1LC3A;WDR45;ATG7;GABARAP;ATG2A;BNIP3;USP30;GABARAPL2;ULK1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.17233430466132338,0.5421604793968079,1.0,1.0,1.0,17/125,16.09%,EFHC2;MAP4;STMN1;CLIP1;DYNLL1;KIF2A;KIF3B;RPS27;EML1;BUB3;CENPU;DYNC1LI1;PLK2;NUP160;RCC2;CKAP5;CENPN
prerank,regulation of phosphate metabolic process (GO:0019220),0.24248127864022007,0.5400800676013104,0.9618874773139746,1.0,1.0,4/16,23.44%,IKBKB;PGAM1;TIGAR;RAD17
prerank,isotype switching (GO:0045190),0.2603205735257004,0.5398033683038297,0.9383177570093458,1.0,1.0,2/10,15.56%,RNF8;MSH2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.22640927037774045,0.5387214939840064,0.9583333333333334,1.0,1.0,6/20,19.18%,TSNAX;ZC3H7A;TSN;MRPL44;TRIM71;DICER1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.2295028699047267,-0.5383109012484147,0.9813519813519813,1.0,1.0,4/13,17.01%,KDM1A;SNAI1;TWIST1;CD44
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.17505576915076695,0.5366984178965589,0.9986577181208054,1.0,1.0,25/96,26.16%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NUP54;NCBP2;EIF4E;ZC3H11A;NUP160;NUP153;NUP50;RBM8A;UPF2;NCBP1;NUP42;NUP85;NUP210;DHX38;UPF3B;UPF1;NUP188;CHTOP
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.20930209100014446,0.5358309590322314,0.9772357723577236,1.0,1.0,7/38,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.19710248877968323,-0.534678500786523,0.9828431372549019,1.0,1.0,7/22,26.10%,SMARCB1;WDR43;PHF8;RASL11A;ERBB2;NCL;EIF2AK3
prerank,regulation of spindle assembly (GO:0090169),-0.18730513378125058,-0.5325797099390888,0.9900744416873449,1.0,1.0,9/25,30.36%,GPSM2;SENP6;CHMP4C;EML3;HSPA1A;CCSAP;TPR;NUMA1;PLK1
prerank,phasic smooth muscle contraction (GO:0014821),0.2614863168465982,0.5325193692553564,0.9428571428571428,1.0,1.0,10/10,73.87%,EDN1;TIFAB;EDN3;EDNRB;EDN2;DRD2;GDNF;HTR1D;HTR2B;PTGER3
prerank,lipid droplet formation (GO:0140042),0.25855154325651675,0.5320182125063634,0.9357976653696498,1.0,1.0,1/10,6.74%,CDS2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.22965335342878673,0.5314665810737583,0.9622641509433962,1.0,1.0,18/18,77.06%,DNAAF2;AQP4;RFX3;CFAP53;ODAD4;CABYR;NPHP3;SPEF2;CCDC39;NEK10;OFD1;DNAAF1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.25359051351681094,0.5308360191397405,0.9569471624266145,1.0,1.0,5/11,25.54%,LPCAT3;ATL1;BNIP1;VCPIP1;VAPB
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.24180554968050194,0.5303949795686516,0.9597806215722121,1.0,1.0,7/13,29.82%,AAR2;PRPF8;SART3;DDX20;SRSF12;PRPF31;PRPF6
prerank,positive regulation of exocytosis (GO:0045921),0.20678827338145456,0.5292220804256371,0.9836867862969005,1.0,1.0,13/35,28.28%,UNC13D;HGS;SDCBP;CADPS;PDCD6IP;CADPS2;CLASP1;ATP6AP1;SNCA;CLASP2;RAB7A;VPS4B;RAB27A
prerank,steroid catabolic process (GO:0006706),-0.2368514849603936,-0.529001456307737,0.9659318637274549,1.0,1.0,1/10,5.86%,SPP1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.21789768372049068,0.5277762215031132,0.9775862068965517,1.0,1.0,2/23,13.94%,CALM1;METAP2
prerank,establishment of spindle orientation (GO:0051294),0.2124484006071311,0.526543419989468,0.9801324503311258,1.0,1.0,7/28,21.21%,MAP4;CDK5RAP2;ZW10;DCTN1;NSFL1C;CLASP1;NDE1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.21073334449033992,-0.5264248516059217,0.9838709677419355,1.0,1.0,7/16,37.59%,TRA2B;CIRBP;NCL;CELF4;CELF3;SF3B4;NUP98
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.24884640356763588,0.5254174112084896,0.9497098646034816,1.0,1.0,3/10,18.83%,ETFB;ACAD11;ETFDH
prerank,mitotic spindle organization (GO:0007052),0.16202117666607865,0.5253414190949036,1.0,1.0,1.0,21/153,16.46%,EFHC2;MAP4;STMN1;CLIP1;DYNLL1;KIF2A;RAB11A;MZT1;KIF3B;KIF23;RPS27;EML1;BUB3;CENPU;DYNC1LI1;PLK2;NUP160;RCC2;CKAP5;CENPN;SPAST
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.25112980165704246,0.5243637533337202,0.9651376146788991,1.0,1.0,10/10,74.90%,GNB1;PDE6G;PDE6B;PDE6A;CNGA1;GRK1;GNAT1;RHO;SAG;CNGB1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.20458865961832406,-0.5240318042978123,0.9806763285024155,1.0,1.0,4/19,18.28%,AMPD3;GMPR2;DGUOK;POLD2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.16309863253326362,0.5229882406273482,1.0,1.0,1.0,50/132,29.86%,HSP90AB1;RPL38;EIF4H;RPL3;ABT1;RPSA;SNRPF;SNRPC;SNRPE;RPS27;PWP2;MRPL20;SNRPB;RPL11;RPS15;RPS28;PRMT7;ISY1;NAF1;SF3A2;LSM4;SNRPD2;DICER1;PUF60;WDR77;NCBP1;EIF4B;EIF2S2;RSL24D1;RPL24;ERAL1;PTGES3;SART3;SCAF11;RPL6;RPS19;TRAF7;NOL3;DDX20;DHX29;SNRPD1;SRSF1;SETX;SMN1;XAB2;COIL;GEMIN5;PRPF6;RPS14;ZRSR2
prerank,RNA methylation (GO:0001510),0.18277518371495446,0.5213556267011584,0.9985422740524781,1.0,1.0,21/60,26.66%,CBLL1;GTPBP3;TRMT10C;MRM2;TRMT12;TRMT61B;METTL2B;METTL2A;ZC3H13;ALKBH8;CMTR1;TRMT5;NSUN6;RBM15;METTL3;ZCCHC4;TRMO;PCIF1;TARBP1;TRMT10A;TYW3
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.21422632711273482,0.5213067276558399,0.9735973597359736,1.0,1.0,5/25,19.14%,ZMYND11;BRD4;NELFCD;RNF8;EAF1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.20607078142268362,0.5204815089046646,0.9818481848184818,1.0,1.0,8/31,21.57%,GTF2H2;NCBP2;GTF2H4;CMTR2;CMTR1;POLR2J;GTF2H3;NCBP1
prerank,7-methylguanosine RNA capping (GO:0009452),0.20607078142268362,0.5204815089046646,0.9818481848184818,1.0,1.0,8/31,21.57%,GTF2H2;NCBP2;GTF2H4;CMTR2;CMTR1;POLR2J;GTF2H3;NCBP1
prerank,peripheral nervous system development (GO:0007422),0.21617944971906214,0.5185780188938455,0.9667221297836939,1.0,1.0,6/23,24.48%,NFASC;SERPINI1;SOX10;PMP22;BDNF;ADGRG6
prerank,UV-damage excision repair (GO:0070914),-0.22062345452536325,-0.5183415256404378,0.9732142857142857,1.0,1.0,3/12,21.71%,DDB2;ERCC1;CUL4B
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.18657165809944365,0.5179987330072592,0.9969040247678018,1.0,1.0,16/58,21.81%,MRE11;UBE2V2;BABAM1;ZBTB7A;POLB;HMGB2;RNF8;HERC2;SUMO1;BRCC3;POLL;UVRAG;ERCC8;POLA1;ERCC4;DCLRE1C
prerank,positive regulation of mRNA processing (GO:0050685),-0.19357374993177806,-0.5173852454817889,0.9926108374384236,1.0,1.0,10/21,38.35%,PAF1;TRA2B;CIRBP;NCL;CELF4;DHX36;CELF3;SF3B4;NUP98;CDC73
prerank,response to leucine (GO:0043201),0.24982504995286994,0.5159859750346842,0.9536541889483066,1.0,1.0,2/10,12.23%,SESN3;RPTOR
prerank,cellular response to leucine (GO:0071233),0.24982504995286994,0.5159859750346842,0.9536541889483066,1.0,1.0,2/10,12.23%,SESN3;RPTOR
prerank,response to organonitrogen compound (GO:0010243),-0.16786484909432814,-0.5151376821757752,0.9974093264248705,1.0,1.0,8/38,22.31%,RCN3;PRKN;GLRB;IRAK3;SYVN1;NR1H4;KYNU;DERL1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2505378713106672,0.5149646348964728,0.9702602230483272,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.2505378713106672,0.5149646348964728,0.9702602230483272,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2505378713106672,0.5149646348964728,0.9702602230483272,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,tRNA processing (GO:0008033),0.1791069627617764,0.5148289381306307,0.9955947136563876,1.0,1.0,16/61,23.21%,SARS1;CDKAL1;CSTF2;CPSF1;TRMT10C;DTWD2;RTRAF;RPP21;TSEN15;RTCB;THUMPD1;NSUN6;QTRT2;RPP30;CTU2;TSEN34
prerank,RNA interference (GO:0016246),0.22551819847066834,0.513605470865739,0.9706390328151986,1.0,1.0,4/17,19.18%,TSNAX;TSN;MRPL44;DICER1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2257920409122781,0.5121408978401889,0.9696969696969697,1.0,1.0,5/16,25.67%,ZFP36L1;TRIM71;ZFP36L2;UPF1;ZC3H12A
prerank,polarized epithelial cell differentiation (GO:0030859),0.23756088866210523,0.5110785664928904,0.9594843462246777,1.0,1.0,2/13,8.79%,OPHN1;MSN
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.23547683582557638,0.509321362967929,0.9541446208112875,1.0,1.0,4/15,16.74%,STXBP1;NPS;NLGN1;CNTNAP4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.2092438849828555,0.5074961995326772,0.9690721649484536,1.0,1.0,5/21,21.31%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.17487315866176062,-0.5059942985744704,0.9924812030075187,1.0,1.0,6/30,18.52%,NPEPPS;RNF31;HUWE1;HTRA2;PDCD5;ABLIM3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.2457834463030068,0.5057231317733459,0.9572490706319703,1.0,1.0,2/10,16.84%,KLF4;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.2457834463030068,0.5057231317733459,0.9572490706319703,1.0,1.0,2/10,16.84%,KLF4;MBP
prerank,V(D)J recombination (GO:0033151),-0.2237296569844427,-0.5041823788714849,0.9736263736263736,1.0,1.0,4/11,31.43%,LIG1;LIG3;HMGB1;LIG4
prerank,cellular response to hydroxyurea (GO:0072711),0.2434607613225257,0.5033288257480946,0.9696428571428571,1.0,1.0,6/10,32.68%,DDX11;NSMCE3;BLM;TIMELESS;DDI2;RTF2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.22930227839873757,-0.5027066664902438,0.9760348583877996,1.0,1.0,5/10,34.56%,EP300;CREBBP;SIRT1;KAT5;ESCO1
prerank,negative regulation of innate immune response (GO:0045824),0.19409848847853817,0.5024238859844724,0.9902120717781403,1.0,1.0,11/34,27.28%,NLRC5;SAMHD1;USP18;TNFAIP3;LYAR;NMI;METTL3;STAT2;ISG15;ACOD1;RPS19
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.2134524744937894,-0.4994571710077031,0.9752577319587629,1.0,1.0,5/13,25.47%,RCL1;NOP14;NOP9;BMS1;UTP20
prerank,myelin maintenance (GO:0043217),0.24681633359430397,0.4990551798142785,0.9569120287253142,1.0,1.0,3/10,19.06%,ABCD1;DEGS1;ABCD2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.20214060144578766,-0.498706548771176,0.9865168539325843,1.0,1.0,7/15,37.67%,ZC3H12B;LACTB2;ZC3H12C;POP7;ZC3H12D;RPP40;NYNRIN
prerank,cellular response to ATP (GO:0071318),-0.21109525711375376,-0.4984327170058518,0.9883449883449883,1.0,1.0,8/14,38.09%,P2RX4;HSP90B1;RYR3;P2RY1;P2RX3;P2RY12;P2RY2;PDXP
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2058509516154286,0.49802478646876563,0.9826086956521739,1.0,1.0,12/22,30.55%,VPS36;VPS25;VPS37A;PLAA;VPS37B;RNF126;VPS37C;RNF115;VPS4B;VPS28;MVB12B;UBAP1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.24831203167869764,0.4957448316300219,0.9689320388349515,1.0,1.0,4/10,22.16%,CTBP1;SET;NOC2L;SNCA
prerank,tricarboxylic acid metabolic process (GO:0072350),0.23430557968209628,0.49354013090124016,0.9748201438848921,1.0,1.0,5/12,22.50%,IDH3A;IREB2;ASS1;IDH3B;ACLY
prerank,regulation of centrosome cycle (GO:0046605),0.20512070298997037,0.49264613120384493,0.9811965811965812,1.0,1.0,2/21,7.83%,MARK4;CHMP1B
prerank,regulation of chromosome organization (GO:0033044),0.21157475222190586,0.4922038812981457,0.979381443298969,0.9998823677859305,1.0,6/22,25.51%,TERF2;SHCBP1L;YLPM1;WAPL;MYC;UPF1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.20059441861965438,0.49123257762161326,0.9794168096054888,0.9996533536990253,1.0,11/27,32.76%,AK4;CMPK1;GSR;DTYMK;NME2;TYMS;AK2;AK1;GUK1;AK8;AK7
prerank,response to ethanol (GO:0045471),-0.20744604913206377,-0.4907720130898974,0.9631449631449631,1.0,1.0,1/14,4.82%,ADCY7
prerank,DNA integrity checkpoint signaling (GO:0031570),0.1861004025138512,0.48943373545192226,0.9951298701298701,0.9996051765303434,1.0,15/36,29.95%,HINFP;DNA2;CDC6;FBXO6;HUS1;CDC5L;RAD9B;RAD1;RAD17;TIPRL;CLOCK;TIMELESS;HUS1B;CHEK2;MAP3K20
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.223819688598694,0.4884457908762944,0.9800362976406534,0.9993905397200344,1.0,14/14,77.64%,TNFSF11;ATP6AP1;TRAF6;CSF1;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;CCR1;POU4F1;TYROBP
prerank,protein prenylation (GO:0018342),0.23655013991469176,0.4877092642341094,0.9692832764505119,0.9991150504580293,1.0,2/10,17.85%,PGGT1B;RCE1
prerank,androgen metabolic process (GO:0008209),-0.18906089075179722,-0.48578355242769766,0.9976303317535545,1.0,1.0,1/18,5.86%,SPP1
prerank,interstrand cross-link repair (GO:0036297),-0.1497589473028932,-0.48535732892487404,1.0,1.0,1.0,17/53,32.97%,FANCE;FANCI;FAAP100;NUCKS1;ERCC1;ATRIP;FANCD2;ATR;MCM9;RAD51AP1;RNF168;USP1;NEIL3;FAAP24;FANCL;UBE2T;MCM8
prerank,regulation of T cell mediated immunity (GO:0002709),-0.21871159354604647,-0.4848547157209437,0.9916666666666667,1.0,1.0,2/10,14.46%,TRPM4;ZBTB1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.23474767762992726,0.4830378012948887,0.9673076923076923,0.9996456881308009,1.0,10/10,76.54%,NAF1;ZNHIT3;ZNHIT6;RUVBL1;RUVBL2;NUFIP1;SHQ1;PIH1D1;TAF9;PIH1D2
prerank,negative regulation of secretion (GO:0051048),-0.22014425839350932,-0.4812933428371517,0.9762419006479481,1.0,1.0,4/10,36.46%,VAMP3;PTGER3;SPX;CD74
prerank,DNA replication initiation (GO:0006270),-0.15662175786612192,-0.4787273368032217,0.9973190348525469,1.0,1.0,14/37,33.06%,POLE4;PRIM2;CDC45;DBF4;MCM3;MCM4;POLE2;MCM5;ORC2;ORC5;GMNN;CDC34;MCM8;LRWD1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.18638381046729005,-0.47724811238571796,0.9859154929577465,1.0,1.0,5/17,26.06%,ALG1;MPDU1;MVD;DHDDS;SRD5A3
prerank,regulation of transposition (GO:0010528),0.22427423514087164,0.4752577441772444,0.9817850637522769,1.0,1.0,1/13,4.89%,PIWIL1
prerank,mitotic cytokinetic process (GO:1902410),0.20119987360504762,0.47168267717095985,0.9877622377622378,1.0,1.0,3/20,16.43%,CHMP1B;MITD1;PDCD6IP
prerank,estrogen metabolic process (GO:0008210),-0.18642896279597312,-0.47097508634504726,0.9883449883449883,1.0,1.0,7/15,40.16%,CYP1B1;HSD17B2;SULT1A1;HSD17B14;HSD17B1;HSD17B11;CYP1A1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.22131488967641852,0.47007771156412104,0.9678571428571429,1.0,1.0,2/12,15.21%,NELFCD;RNF8
prerank,organophosphate catabolic process (GO:0046434),0.22266358963464578,0.46793396882317545,0.9738317757009346,1.0,1.0,1/11,8.63%,ENPP2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.20824006522354066,-0.4663882350074291,0.9802631578947368,1.0,1.0,5/12,37.08%,PIBF1;BRCA1;APOC1;SIRT1;ERLIN1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.21259033469007083,0.4651596731228038,0.975177304964539,1.0,1.0,5/14,28.36%,NOL9;DDX18;ZNHIT3;RPL7L1;ZNHIT6
prerank,mitochondrion transport along microtubule (GO:0047497),0.21532450766223715,0.4647365738071187,0.9669724770642202,1.0,1.0,5/13,30.69%,HIF1A;SPAST;LRPPRC;UBB;SYBU
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.21661280307524478,0.4642714091594349,0.9698046181172292,0.9999554016096687,1.0,2/13,15.21%,NELFCD;RNF8
prerank,regulation of microtubule-based movement (GO:0060632),0.2210318028419958,0.46309856047812853,0.9765765765765766,0.9997319177813188,1.0,1/11,7.92%,DRC1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.18637250333388863,-0.46191656617153515,0.9915254237288136,1.0,1.0,8/16,39.91%,PTPN22;TNFSF8;AHR;LST1;IKZF3;FGF10;CD22;TNFSF9
prerank,coenzyme A metabolic process (GO:0015936),-0.19282547768089814,-0.46124203495685495,0.9908045977011494,1.0,1.0,2/14,13.43%,DCAKD;CROT
prerank,ribosomal large subunit assembly (GO:0000027),0.18716792560126302,0.4582677805371873,0.9931856899488927,1.0,1.0,7/24,27.56%,RPL3;MRPL20;RPL11;RSL24D1;RPL24;RPL6;TRAF7
prerank,cellular response to oxygen levels (GO:0071453),0.22702736630680398,0.4580725343719628,0.9773156899810964,0.9996705627334779,1.0,10/10,77.31%,CCDC115;ATP6AP1;ATP6V1A;ATP6V0D1;NDUFS2;ATP6V1G1;ATP6V0A2;TMEM199;PICK1;CPEB4
prerank,neuron fate commitment (GO:0048663),-0.1890715847620093,-0.45284728219363457,0.9910112359550561,1.0,1.0,7/14,34.54%,TGFBR1;ID2;POU3F2;SHH;POU4F1;PAX6;ASCL1
prerank,protein import into mitochondrial matrix (GO:0030150),0.20183371012308474,0.45266402311787357,0.9878048780487805,1.0,1.0,18/18,79.84%,DNAJC19;TOMM20L;TIMM21;TIMM50;TOMM70;GRPEL2;GRPEL1;PAM16;TOMM20;DNLZ;ROMO1;TIMM17A;DNAJC15;TOMM40;TIMM17B;TIMM23;TIMM44;TOMM40L
prerank,response to hydroxyurea (GO:0072710),0.2140186394517135,0.45173600510099715,0.9875886524822695,0.9997516661880207,1.0,6/11,32.68%,DDX11;NSMCE3;BLM;TIMELESS;DDI2;RTF2
prerank,sensory perception of pain (GO:0019233),-0.17364421063918145,-0.4511420126836766,0.9858490566037735,1.0,1.0,2/21,7.23%,PTGES;P2RX4
prerank,positive regulation of double-strand break repair (GO:2000781),0.16936416010849145,0.4445898701250965,0.9953632148377125,1.0,1.0,12/39,26.06%,SHLD1;MGMT;WDR48;ACTR2;FANCB;SLF1;DDX11;PARP9;FMN2;ARID2;PNKP;DTX3L
prerank,cell cycle G1/S phase transition (GO:0044843),0.15563788231169348,0.4439402273527898,0.9985380116959064,0.9999238140143335,1.0,16/61,24.77%,MAX;HINFP;EIF4E;PIM2;PLK2;ACVR1;MAP3K11;TRIM71;USP29;CDK6;CDK4;NASP;CUL1;CDKN1B;MYC;CDKN2C
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.20933117951811125,0.4418519604541467,0.9831144465290806,0.9997581469213183,1.0,7/13,34.24%,BNIP3L;BNIP3;PMAIP1;BCL2L11;BAX;BAD;BMF
prerank,eosinophil chemotaxis (GO:0048245),0.20146911099949782,0.44155290506341877,0.9908088235294118,0.9989335646293261,1.0,14/14,79.87%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL3;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2;CCL13
prerank,eosinophil migration (GO:0072677),0.20146911099949782,0.44155290506341877,0.9908088235294118,0.9989335646293261,1.0,14/14,79.87%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL3;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2;CCL13
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.15123666196815896,-0.4376356981902866,1.0,1.0,1.0,14/32,38.06%,SEH1L;NUP205;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,tRNA export from nucleus (GO:0006409),-0.15123666196815896,-0.4376356981902866,1.0,1.0,1.0,14/32,38.06%,SEH1L;NUP205;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,P-body assembly (GO:0033962),0.20476952213785393,0.43534072089527803,0.9927404718693285,0.9992140919810251,1.0,3/12,24.18%,EDC3;LSM4;LSM14A
prerank,tRNA 5'-leader removal (GO:0001682),-0.18282238947484483,-0.4332652969735414,0.9957894736842106,1.0,1.0,6/13,36.33%,PRORP;POP4;RPP25L;POP7;RPP40;SSB
prerank,regulation of chromosome segregation (GO:0051983),-0.17281602262948026,-0.4307373999107993,1.0,1.0,1.0,9/16,44.56%,SMC6;CSNK2A1;NUMA1;RAD18;BUB1;KIF2C;AURKB;MKI67;HORMAD1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.17708338626837994,-0.43059492359478896,0.9954545454545455,1.0,1.0,5/16,29.90%,PDS5B;NAA50;SGO1;DSCC1;PDS5A
prerank,gas transport (GO:0015669),-0.1940439630142279,-0.43007281399467556,0.9936708860759493,1.0,1.0,1/10,8.90%,CYGB
prerank,T cell activation involved in immune response (GO:0002286),-0.1802599446127902,-0.42850509623839056,0.9915611814345991,0.9997075039435995,1.0,9/12,46.96%,MDK;FCER1G;ICAM1;LILRB1;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,protein localization to condensed chromosome (GO:1903083),0.19993070783934752,0.4244491681830654,0.9815837937384899,0.9998883695967373,1.0,3/12,19.17%,BUB3;ZW10;IK
prerank,regulation of mitotic spindle assembly (GO:1901673),0.1791747786221189,0.4242697763936387,0.9982456140350877,0.9994763366436084,1.0,19/19,82.10%,CHMP1B;PDCD6IP;CEP97;CHMP2B;VPS4B;DRG1;CHMP3;CHMP4B;HNRNPU;CHMP5;HSPA1B;CHMP2A;CHMP1A;PLK1;TPR;CCSAP;HSPA1A;EML3;CHMP4C
prerank,regulation of viral transcription (GO:0046782),0.16143889497934982,0.4241990856313802,0.9968798751950078,0.9990516085536822,1.0,1/39,2.37%,TRIM14
prerank,histone lysine methylation (GO:0034968),0.1621130051410004,0.42288093383317504,1.0,0.998741594802727,1.0,8/33,26.11%,MEN1;PRDM9;SETDB1;SMYD1;RBBP5;SETDB2;WDR82;SUV39H1
prerank,phospholipid metabolic process (GO:0006644),0.14105928312532406,0.42213995692207806,1.0,0.9983857794488854,1.0,10/71,20.25%,MBOAT1;PLA2G4B;ENPP2;PIP4K2A;CLN8;PLPPR4;PLPP2;GPX4;PGP;PLAA
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.18547647566242445,-0.42193856459028234,0.9935760171306209,0.9994963344657956,1.0,4/11,40.58%,EXOSC2;PARN;FBLL1;LARP7
prerank,intermediate filament organization (GO:0045109),0.18915033013642052,0.4217705133168363,0.9915110356536503,0.9979881312044231,1.0,3/17,17.78%,KLHL24;GFAP;DNAJB6
prerank,positive regulation of telomere capping (GO:1904355),-0.16705150953196216,-0.42136079540851035,0.9976076555023924,0.9988323177370092,1.0,6/17,26.60%,TNKS2;RTEL1;TNKS;PKIB;HNRNPD;MAP3K4
prerank,negative regulation of viral release from host cell (GO:1902187),-0.171762194739155,-0.42059466152026914,0.9931818181818182,0.9981878139611078,1.0,13/13,82.84%,PML;TRIM8;TRIM5;TRIM21;TRIM35;TRIM13;TRIM15;CHMP3;TRIM28;TRIM32;MID2;TRIM11;TRIM26
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.19505300776834128,0.4188861189777245,0.9925233644859813,0.997826610608013,1.0,3/14,17.43%,WDR48;ACTR2;FANCB
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.16857673933955383,0.4164945582968628,0.9983108108108109,0.9976109731602827,1.0,5/25,18.69%,HSPA8;DNAJC7;HSPA9;HSPE1;ERO1A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.18122491132017304,-0.4142543662137893,1.0,0.9978674343261237,1.0,8/12,48.97%,ZBTB1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,myeloid dendritic cell activation (GO:0001773),0.1797237915881984,0.37968236651479237,0.9929203539823008,0.9994680553101206,1.0,12/12,82.04%,TGFBR2;DOCK2;BATF2;DHRS2;DCSTAMP;SLAMF1;BATF3;IL4;CAMK4;HMGB1;PYCARD;BATF
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.14729986016757052,0.3710450289829471,0.9983333333333333,0.9993715925852431,1.0,9/28,27.60%,SHLD1;SIRT7;HMGA2;ACTR2;PARP9;PNKP;DTX3L;NUDT16L1;CYREN
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.13766460658218949,0.3374725356090714,1.0,0.999706963898906,1.0,8/25,29.82%,MPHOSPH10;PRPF4;SF3B3;PRPF8;SMNDC1;SCAF11;BCAS2;PRPF6
